
<html lang="en"     class="pb-page"  data-request-id="7cd48dbe-dd42-45d2-8fc2-1537005097ff"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-23;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01480;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities" /></meta><meta name="dc.Creator" content="Xiaoying  Jiang" /></meta><meta name="dc.Creator" content="Tao  Zhou" /></meta><meta name="dc.Creator" content="Renren  Bai" /></meta><meta name="dc.Creator" content="Yuanyuan  Xie" /></meta><meta name="dc.Description" content="Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappro..." /></meta><meta name="Description" content="Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 7, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01480" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01480" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01480" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01480" /></link>
        
    
    

<title>Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01480" /></meta><meta property="og:title" content="Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0046.jpeg" /></meta><meta property="og:description" content="Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappropriately located, it becomes toxic. Excess iron can become involved in free radical formation, resulting in oxidative stress and cellular damage. Iron chelators are used to treat serious pathological disorders associated with systemic iron overload. Hydroxypyridinones stand out for their outstanding chelation properties, including high selectivity for Fe3+ in the biological environment, ease of derivatization, and good biocompatibility. Herein, we overview the potential for multifunctional hydroxypyridinone-based chelators to be used as therapeutic agents against a wide range of diseases associated either with systemic or local elevated iron levels." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01480"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01480">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01480&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01480&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01480&amp;href=/doi/10.1021/acs.jmedchem.0c01480" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 14470-14501</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01357" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00797" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xiaoying Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoying Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Collaborative Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoying++Jiang">Xiaoying Jiang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Tao Zhou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tao Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, P.R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Zhou">Tao Zhou</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4510-3639" title="Orcid link">http://orcid.org/0000-0003-4510-3639</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Renren Bai</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Renren Bai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P.R. China</div></div><span class="conrtib-corresp"><strong>*</strong>(R.B.) Address: College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. Email: <a href="/cdn-cgi/l/email-protection#bbc9ded5c9ded5d9dad2fb8a898d95d8d4d6"><span class="__cf_email__" data-cfemail="1b697e75697e75797a725b2a292d35787476">[emailÂ protected]</span></a>, <a href="/cdn-cgi/l/email-protection#6e1c0b001c0b000c0f072e14041b1a400b0a1b400d00"><span class="__cf_email__" data-cfemail="e694838894838884878fa69c8c9392c8838293c88588">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Renren++Bai">Renren Bai</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3511-5794" title="Orcid link">http://orcid.org/0000-0002-3511-5794</a></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Yuanyuan Xie</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuanyuan Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Collaborative Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China</div><div class="loa-info-affiliations-info">College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310014, P.R. China</div></div><span class="conrtib-corresp"><strong>*</strong>(Y.X.) Address: Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China. Email: <a href="/cdn-cgi/l/email-protection#dba3a2a2b8a19ba1b1aeaff5bebfaef5b8b5"><span class="__cf_email__" data-cfemail="8df5f4f4eef7cdf7e7f8f9a3e8e9f8a3eee3">[emailÂ protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuanyuan++Xie">Yuanyuan Xie</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8482-9948" title="Orcid link">http://orcid.org/0000-0001-8482-9948</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01480&amp;href=/doi/10.1021%2Facs.jmedchem.0c01480" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 14470â14501</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 7, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 August 2020</li><li><span class="item_label"><b>Published</b> online</span>7 October 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 December 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01480" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01480</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D14470%26pageCount%3D32%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaoying%2BJiang%252C%2BTao%2BZhou%252C%2BRenren%2BBai%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D23%26contentID%3Dacs.jmedchem.0c01480%26title%3DHydroxypyridinone-Based%2BIron%2BChelators%2Bwith%2BBroad-Ranging%2BBiological%2BActivities%26numPages%3D32%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D14501%26publicationDate%3DDecember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01480"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1471</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01480" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaoying&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Zhou&quot;},{&quot;first_name&quot;:&quot;Renren&quot;,&quot;last_name&quot;:&quot;Bai&quot;},{&quot;first_name&quot;:&quot;Yuanyuan&quot;,&quot;last_name&quot;:&quot;Xie&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;14470-14501&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01480&quot;},&quot;abstract&quot;:&quot;Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappropriately located, it becomes toxic. Excess iron can become involved in free radical formation, resulting in oxidative stress and cellular damage. Iron chelators are used to treat serious pathological disorders associated with systemic iron overload. Hydroxypyridinones stand out for their outstanding chelation properties, including high selectivity for Fe3+ in the biological environment, ease of derivatization, and good biocompatibility. Herein, we overview the potential for multifunctional hydroxypyridinone-based chelators to be used as therapeutic agents against a wide range of diseases associated either with systemic or local elevated iron levels.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01480&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01480" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01480&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01480" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01480&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01480" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01480&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01480&amp;href=/doi/10.1021/acs.jmedchem.0c01480" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01480" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01480" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01480%26sid%3Dliteratum%253Aachs%26pmid%3D33023291%26genre%3Darticle%26aulast%3DJiang%26date%3D2020%26atitle%3DHydroxypyridinone-Based%2BIron%2BChelators%2Bwith%2BBroad-Ranging%2BBiological%2BActivities%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D23%26spage%3D14470%26epage%3D14501%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292263" title="Iron">Iron</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291342" title="Absorption">Absorption</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290715" title="Mechanisms of action">Mechanisms of action</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/jmcmar.2020.63.issue-23/20201210/jmcmar.2020.63.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0046.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Iron plays an essential role in all living cells because of its unique chemical properties. It is also the most abundant trace element in mammals. However, when iron is present in excess or inappropriately located, it becomes toxic. Excess iron can become involved in free radical formation, resulting in oxidative stress and cellular damage. Iron chelators are used to treat serious pathological disorders associated with systemic iron overload. Hydroxypyridinones stand out for their outstanding chelation properties, including high selectivity for Fe<sup>3+</sup> in the biological environment, ease of derivatization, and good biocompatibility. Herein, we overview the potential for multifunctional hydroxypyridinone-based chelators to be used as therapeutic agents against a wide range of diseases associated either with systemic or local elevated iron levels.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30601" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30601" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Iron is a vital metal for all life and is involved in a wide variety of biological events. It is essential for DNA synthesis and repair, energy production, myelination, transport of oxygen, the functioning of numerous enzymes, neurotransmitter synthesis, host defense, and cell signaling processes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> There are about 400 iron-dependent enzymes in the human, involving such binding sites on heme, ironâsulfur clusters, and highly polar oxygen atoms.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> However, although iron is necessary for the normal function of every form of life, it is toxic when it is present in excess or inappropriately placed. In the presence of oxygen, âloosely boundâ iron is able to redox cycle between the Fe(II) and Fe(III), producing highly reactive oxygen free radicals, resulting in peroxidative damage of tissues.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> As a result of this potential toxicity, the iron levels are strictly controlled in all living forms, and thus there is little chance of free radical-generating reactions being catalyzed by the presence of iron.</div><div class="NLM_p">In primates, there is no active mechanism of iron elimination. Iron homeostasis is mainly achieved by regulating the intestinal absorption of iron and the efficient recycling of erythrocyte-derived iron.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Under certain pathological conditions, systemic or local iron overload can occur, leading to free radical-mediated tissue/organ damage and cell death.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Local elevated iron levels are associated with many diseases, particularly neurodegenerative diseases.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> In the presence of inappropriately high iron levels, either systemic or local, it is important to selectively remove excess iron using iron chelators. Among the various forms of iron chelators, hydroxypyridinones (HPOs) stand out for their high and relatively specific iron chelation properties. Indeed, HPOs provide an excellent scaffold, which is capable of generating a wide range of chemical structures, associated with different biological actions.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">1.1.  Iron Distribution in the Normal Human Body</h3><div class="NLM_p">Iron is one of the most abundant trace elements in living organisms, and the content in the normal human body is approximately 3â5 g (40â50 mg/kg).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The absorption, storage, utilization, and secretion of iron are tightly controlled in mammalian cells (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8â10)</a> The absorption of iron in mammals is mainly through the absorption of Fe<sup>2+</sup> and its subsequent oxidation to Fe<sup>3+</sup> by ferroxidases (hephaestin (HEPE) and ceruloplasmin (CP)) and subsequently transfer to transferrin (TF). TF enters the endosome of those cells that express a transferrin receptor (TFR), for instance, TFR1-mediated endocytosis.<a onclick="showRef(event, 'ref8 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref11 ref12">(8,11,12)</a> Fe<sup>3+</sup> is released from TF, reduced by ferriductase, and enters the labile iron pool (LIP) via the divalent metal transporter 1 (DMT1).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of iron homeostasis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Senescent red blood cells (RBCs) are absorbed by phagocytosis in cells of the reticuloendothelial system, providing heme to phagolysosomes.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Other heme forms, such as heme-hemopexin (HPX) and hemoglobin (HB)-haptoglobin (HP), are absorbed by specific receptors and result in the import of heme into macrophages. The heme is then degraded by heme oxygenase 1 (HMOX1).<a onclick="showRef(event, 'ref8 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref14 ref15">(8,14,15)</a></div><div class="NLM_p">Iron is taken up from the blood by cells utilizing several transport proteins. The iron enters the LIP, which serves as a medium for utilization, storage, and export of iron. In most cells, iron in LIP is utilized for synthesizing iron proteins and enzymes. In erythroid cells, iron is mainly delivered to the mitochondria for the synthesis of heme and the biogenesis of ironâsulfur clusters (ISCs).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Excess LIP iron is incorporated and stored in ferritin.<a onclick="showRef(event, 'ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18">(16â18)</a> Iron that is not utilized or stored will be exported from cells via ferroportin (FPN).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p last">Iron homeostasis is regulated at both the cellular level and the tissue level. At the cellular level, iron is primarily post-transcriptional regulated by the iron-responsive element/iron regulatory protein (IRE/IRP) system. The interactions of IRE/IRP regulate the expression of the mRNAs encoding proteins, which are involved in iron absorption, storage, utilization, and export for iron homeostasis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> At the systemic tissue level, iron homeostasis is mainly regulated by the iron sensor hepcidin encoded by the HAMP gene. Hepcidin, a peptide hormone produced by the liver in response to iron and inflammation, forms a negative feedback regulation of iron uptake by binding the iron exporter FPN.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Hepcidin can reduce the expression of FPN, and so reduce intracellular iron excretion, such that iron is retained within the absorption and reticuloendothelial cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Elevated levels of plasma iron or inflammation will stimulate the transcription of hepcidin mRNA in hepatic tissues, thereby reducing iron uptake in duodenal enterocytes and the mobilization of iron storage. When plasma iron is decreased as in the case of anemia, transcription of hepcidin is inhibited, which effectively increases the rate of iron absorption from the intestine.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">1.2.  Influence of Elevated Levels of Iron</h3><div class="NLM_p">A redox cycle between Fe<sup>2+</sup> and Fe<sup>3+</sup> can be initiated with loosely bound iron in the presence of oxygen, producing reactive oxygen species (ROS) via the Fenton reaction.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The production of ROS is controlled by defensive antioxidant systems including catalase, superoxide dismutase (SOD), and glutathione peroxidase (GPX) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). However, this normally effective protective defense system can be overrun in the presence of iron overload. Excess iron can lead to the saturation of transferrin, which is accompanied by an increase of non-transferrin-bound iron (NTBI, Fe<sup>3+</sup>). NTBI can be transported into inappropriate cells via various carries proteins, e.g., solute carrier family 39 members ZIP8 and ZIP14.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21â24)</a> The resulting elevated iron levels lead to free radical-mediated tissue/organ damage and cell death.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">Elevated levels of iron are associated with the occurrence and development of many diseases, such as neurodegenerative diseases (NDDs), cancer, and infections.<a onclick="showRef(event, 'ref11 ref26'); return false;" href="javascript:void(0);" class="ref ref11 ref26">(11,26)</a> Iron overload can also promote oxidative stress to initiate nerve cell damage, promote pathogen competition for iron to aggravate infection, and cause genetic mutations that accelerate the formation of cancer cells with a high iron requirements.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34">(27â34)</a></div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">1.3.  Classification of Iron(III) Chelators</h3><div class="NLM_p">Metal selectivity is an important factor for clinically useful iron chelators. In theory, chelators can be designed as either iron(II)- or iron(III)-selective chelators. However, it is difficult to design nontoxic iron(II) chelators due to their low selectivity, leading to the removal of biologically important bivalent metals (Cu<sup>2+</sup> and Zn<sup>2+</sup>). Iron(III)-selective chelators are preferable as most trivalent metals (e.g., Al<sup>3+</sup>, In<sup>3+</sup>, and Ga<sup>3+</sup>) are not present in living cells.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> High-affinity iron(III) chelators can also chelate iron(II), the resulting complexes being rapidly autoxidized to form the corresponding iron(III) complexes.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Thus, iron(III) chelators with high selectivity and affinity make useful therapeutic agents.</div><div class="NLM_p">According to the theory of hard and soft acids and bases, Fe<sup>2+</sup> has a low charge density and prefers chelators containing âsofterâ donor atoms (aromatic <i>N</i>-containing ligands). In contrast, Fe<sup>3+</sup> has five electrons in the 3d orbital, possessing a stable semifilled structure with a high charge density. Thus, Fe<sup>3+</sup> is classified as a âhardâ Lewis acid, which can form most stable complexes with âhardâ ligands (charged <i>O</i>-containing ligands).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The high spin Fe<sup>3+</sup> coordinates with six donor atoms of the ligands to form a complex in an octahedral manner,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and the chelator can be classified as hexadentate, tridentate, and bidentate ligand according to the number of donor atoms (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref36 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref38">(36,38)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the chelate ring formation in metalâligand complexes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pFe<sup>3+</sup> value is a useful parameter for assessing the affinity of ligands to Fe<sup>3+</sup> under biological conditions (pFe<sup>3+</sup> = âlog[Fe<sup>3+</sup>] when [Fe<sup>3+</sup>]<sub>total</sub> = 10<sup>â6</sup> M and [ligand]<sub>total</sub> = 10<sup>â5</sup> M at pH 7.4). The higher the pFe<sup>3+</sup> value, the greater the affinity for Fe<sup>3+</sup>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> A value greater than 20 is generally considered to be suitable for iron scavenging properties under biological conditions.</div><div class="NLM_p">Chelators that bind both Fe<sup>3+</sup> and Fe<sup>2+</sup> are capable of redox cycling, leading to the production of ROS and increased toxicity. The high selectivity of chelators for Fe<sup>3+</sup> over Fe<sup>2+</sup> results in extremely low redox potentials, and iron complexes with redox potentials below â200 mV render redox cycling under biological conditions unlikely.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Therefore, a good chelator should have a high selectivity and affinity for Fe<sup>3+</sup> and possess a low redox potential (typically < â400 mv), which cannot be reduced under biological conditions.</div><div id="sec1_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7">1.3.1.  Hexadentate Ligands</h4><div class="NLM_p">In 1963, desferrioxamine (DFO, desferal, <b>1</b>) became the first clinically approved hexadentate iron chelator for treating iron overload diseases.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> It is a microbial tris-hydroxamate siderophore isolated from <i>Streptomyces pilosum</i> with a low redox potential (â468 mV) and a pFe<sup>3+</sup> value of 26.6. The thermodynamic stability of DFO is high, but its hydrophilicity and high molecular weight properties limit its absorption and oral activity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p last">EDTA (<b>2a</b>) and DTPA (<b>2b</b>) are aminocarboxylate ligands, which possess a high affinity for Fe<sup>3+</sup>. However, their selectivity for Fe<sup>3+</sup> is relatively poor, leading to the toxicity when used in the clinical situation.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec1_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">1.3.2.  Tridentate Ligands</h4><div class="NLM_p">Desferrithiocin (DFT, <b>3a</b>) is a tridentate siderophore isolated from cultures of <i>Streptomyces antibioticus</i>.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> It is orally active but has side effects of renal and neurological toxicity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The analogues of DFT (deferitrin, <b>3b</b>) and deferitazole (<b>3c</b>) have also demonstrated toxic effects in clinical trials.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a></div><div class="NLM_p">Pyridoxal isonicotinoyl hydrazone (PIH, <b>4a</b>) and salicylaldehyde isonicotinoyl hydrazone (SIH, <b>4b</b>) were initially identified as iron chelators in 1979.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> They can cause oxidative stress as both the ligands, and their Fe<sup>3+</sup> complexes are redox active in the intracellular environment.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a><named-content content-type="anchor" rid="sch1" type="simple"></named-content></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0009.jpeg" id="GRAPHIC-d7e546-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Deferasirox (DFX, Exjade, <b>5</b>) is an oral chelator approved by the United States Food and Drug Administration in 2005 for the treatment of transfusional iron overload.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> It is 4â5 times more capable of removing iron from liver cells than DFO.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The extreme hydrophobicity of DFX renders it able to penetrate membranes easily. It possesses good oral availability. However, DFX forms a highly charged 2:1 iron complex with a molecular weight over 800, rendering it difficult for the complex to efflux from most cells. DFX is also toxic to renal and neural tissues.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a></div></div><div id="sec1_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9">1.3.3.  Bidentate Ligands</h4><div class="NLM_p">Catechols (e.g., DMB, <b>6</b>) and hydroxamates (e.g., acetohydroxamic acid, <b>7</b>) are two common bidentate chelators with relatively weak iron chelation at physiological pH. The pFe<sup>3+</sup> values are 15 and 13 respectively.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> 8-Hydroxyquinoline (<b>8</b>) is a <i>N</i>-containing ligand, possessing a relatively high affinity for both Fe<sup>3+</sup> and Fe<sup>2+</sup> and thus also a high redox potential (â150 mV). By virtue of this redox potential, <b>8</b> has a tendency to redox cycle under biological conditions, resulting in toxicity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a><named-content content-type="anchor" rid="sch2" type="simple"></named-content></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0010.jpeg" id="GRAPHIC-d7e599-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In contrast, deferiprone (DFP, ferriprox, <b>9</b>), which was approved by the FDA in 2011, is an HPO iron chelator with a high affinity and selectivity for Fe<sup>3+</sup>, low redox potential (â620 mV), and high pFe<sup>3+</sup> value of 20.4.<a onclick="showRef(event, 'ref38 ref52'); return false;" href="javascript:void(0);" class="ref ref38 ref52">(38,52)</a> It yields noncharged 3:1 iron(III) complexes, which can efflux from cells by nonfacilitated diffusion. It has the advantages of a strong ability to remove iron from cells and a high bioavailability.</div></div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">1.4.  Advantages of Hydroxypyridinone-Based Iron Chelators</h3><div class="NLM_p">At the present time, only DFX and DFP have been identified as orally active iron chelators suitable for clinical use. DFX is effective in removing excess iron from the liver and possesses acceptable tolerance. However, DFX is associated with many adverse events, such as renal toxicity, transient rash, and gastrointestinal disturbances.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> DFP, an HPO-based iron chelator, has been used to treat systemic iron overload diseases for over two decades.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> It is effective in removing excess iron from the heart and liver but is associated with reversible agranulocytosis in approximately 1% of patients receiving the drug.<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53â55)</a> Thus, neither compound is ideal, and the search for improved orally active iron chelators continues.</div><div class="NLM_p">HPOs have high iron selectivity and affinity for iron. They are <i>O,O</i>-âhardâ ligands that can form stable bonds with high-spin Fe<sup>3+</sup> (hard Lewis acid) by virtue of their high charge density.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This high charge density is also associated with a high affinity for protons. The p<i>K</i><sub>a</sub> values of DFP are 3.7 and 9.8.<a onclick="showRef(event, 'ref38 ref56'); return false;" href="javascript:void(0);" class="ref ref38 ref56">(38,56)</a> The high p<i>K</i><sub>a</sub> value of the carbonyl function and the superior affinity of HPOs for iron(III) result from the extensive delocalization of the lone pair electrons associated with the nitrogen atom on the pyridinone ring (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Low pH sensitivity is reflected in the ability of HPOs to form stable neutral 3:1 iron(III) complexes at physiological pH, which is stable over a wide range of pH values. These neutral complexes can readily penetrate cell membranes by simple diffusion because of their relatively low molecular weight and noncharged properties. This facilitates the removal of iron from iron-overloaded cells.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> HPOs possess the highest pFe<sup>3+</sup> values among the <i>O</i>,<i>O</i>-bidentate ligands, and the affinity for Fe<sup>3+</sup> is much higher than that of divalent metal ions, rendering HPOâs selective for Fe<sup>3+</sup> under biological conditions.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proton equilibria and resonance structures of DFP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">HPOs, when coordinating iron, completely envelop the surface of iron and thus minimize the production of hydroxyl radicals at physiological pH.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Therefore, HPO complexes are less susceptible to oxidation.<a onclick="showRef(event, 'ref35 ref58'); return false;" href="javascript:void(0);" class="ref ref35 ref58">(35,58)</a> The low redox potential of the iron complexes (DFP, â620 mV) renders it unlikely to redox cycle under biological conditions.<a onclick="showRef(event, 'ref38 ref59'); return false;" href="javascript:void(0);" class="ref ref38 ref59">(38,59)</a> Bidentate HPOs do not inhibit haem-containing enzymes; however, they can interfere with non-heme-containing enzymes, such as the lipoxygenase and aromatic hydroxylase families and ribonucleotide reductase. However, HPOs causing minimal enzyme inhibition can be designed by modification of the ring substituents.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> HPOs can be readily modified to introduce other active groups, thereby developing new pharmacological properties.<a onclick="showRef(event, 'ref6 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref6 ref58 ref59 ref60 ref61 ref62 ref63 ref64 ref65">(6,58â65)</a> By virtue of their excellent iron chelation, and nontoxic properties of their iron complexes, they are among the most promising iron chelators for clinical use.</div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">2.  Pharmacological Applications of Hydroxypyridinone Derivatives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this section, the broad-ranging pharmacological applications of HPO derivatives are presented. It is hoped that the content and organization of this section will prove to be useful to medicinal chemists embarking on the exploitation of HPOs.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">2.1.  Hydroxypyridinones for the Treatment of Systemic Iron Overload</h3><div class="NLM_p">Systemic iron overload diseases mainly include hereditary hemochromatosis (HH) and secondary hemochromatosis.<a onclick="showRef(event, 'ref2 ref66'); return false;" href="javascript:void(0);" class="ref ref2 ref66">(2,66)</a> HH is caused by genetic defects such as HAMP, TFR, and other mutations, and secondary hemochromatosis is caused by exogenous iron supplementation therapy or long-term repeated blood transfusions such as is required in the treatment of thalassemia, sickle cell disease, sideroblastic anemia, and myelodysplastic syndromes.<a onclick="showRef(event, 'ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref67 ref68">(67,68)</a> In these patients, excess iron cannot be removed from the body and is deposited in the form of hemosiderin and ferritin in the spleen, liver, endocrine organs, and myocardium, which in the long term lead to organ degeneration, diffuse fibrosis, and metabolic and functional disorders, such as liver failure, cardiac failure, and retinal degeneration.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">2.1.1.  DFP and CP94</h4><div class="NLM_p">DFP is the only bidentate oral alternative to DFO and has been in clinical use since the late 1980s. It is more efficient at removing cardiac iron than DFO.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Although DFP has the advantages of powerful iron chelation and the noncharged nature of the iron complex, its bioavailability is limited by the rapid phase II metabolism involving the glucuronidation of the 3-hydroxyl function of DFP. The 3-hydroxyl group is essential for chelation and iron clearance, and in some patients more than 85% of DFP is converted to the nonchelating 3-<i>O</i>-glucuronide, resulting in lower efficacy.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a></div><div class="NLM_p">The DFP analogue CP94 (<b>10</b>) was also investigated, as it was found to have a higher iron removal capacity than DFP in several rodent and primate models. This is due to a different phase I metabolic pathway to that of DFP, which leads to the formation of the 2-(1â²-hydroxyethyl) metabolite lacking glucuronide conjugates.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> However, in humans, the 3-<i>O</i>-glucuronide conjugation is the major metabolite so much so that CP94 (<b>10</b>) was ineffective at mobilizing iron in humans.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a><named-content content-type="anchor" rid="sch3" type="simple"></named-content></div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0011.jpeg" id="GRAPHIC-d7e779-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.1.2.  <i>N</i>-Substituted HPOs</h4><div class="NLM_p">The influence of the nature of the <i>N</i>-substituted 2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones has been systematically investigated for its influence on biological properties.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a><i>N</i>-Substituents have little effect on iron affinity but have major effects on the ability to remove iron and on toxic side effects. Compounds with a distribution coefficient between 0.5 and 2.0 were found to be more effective than those with a coefficient less than 0.2. Compound <b>11</b> was found to be the most potent among simple derivatives at removing iron from iron-overloaded mice.</div><div class="NLM_p">Subsequently, the same workers evaluated and compared <i>N</i>-(carboxyalkyl)- and <i>N</i>-(hydroxyalkyl)-2-alkyl-3-hydroxypyridin-4-ones. CP102 (<b>12a</b>), a <i>N</i>-hydroxyethyl compound, was found to be the most efficient at facilitating the excretion of iron in bile, while not being metabolized.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> However, CP102 proved to be too hydrophilic and was associated with poor hepatic extraction.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p last">Recently, it has been discovered that the introduction of diverse chiral amino alcohols at the <i>N</i>-1 position of the 3-hydroxypyridin-4-ones can serve as an alternate sacrificial site for glucuronidation, reducing the metabolic problems associated with the 3-hydroxyl function. The Log<i>P</i> values, pharmacokinetic properties, and <i>in vivo</i> efficacy can be modulated by both the variation of substituents on amino alcohol side chains and the chiral configuration.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Most compounds in this series possess higher Log<i>P</i> values, cell membrane penetration rate, and oral efficiency than DFP. CN128 (<b>13</b>) was found to possess optimal properties as it possesses lower glucuronidation and oxidation rates, is more lipophilic (Log<i>P</i> = 0.58), possesses superior iron scavenging ability to that of DFP, possesses a good oral pharmacokinetic profile, and is well tolerated. CN128 is currently in clinical trials for the treatment of Î²-thalassemia.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">2.1.3.  Lipophilic HPOs and Prodrugs</h4><div class="NLM_p">Zanninelli demonstrated that the compounds CP102 (<b>12a</b>), CP41 (<b>14a</b>), together with their respective prodrugs CP117 (<b>12b</b>) and CP165 (<b>14b</b>) can promote the biliary excretion of iron originating as plasma <sup>55</sup>Fe-NTBI and increase the cumulative recovery of <sup>55</sup>Fe in iron-overloaded rats by 30â70 fold.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Rai also described a range of hydrophobic ester prodrugs of 1-hydroxyalkyl HPOs. These hydrophobic prodrugs are absorbed from the gastrointestinal tract and cleaved in the hepatocyte yielding 1-hydroxyalkyl HPOs (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The pivaloyl ester <b>12b</b> was found to be more stable and to cause superior iron excretion than the corresponding benzoyl ester prodrugs.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Indeed, a wide range of ester prodrugs were investigated and found to be more efficient than both <b>12a</b> and <b>14a</b>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Although some of these prodrugs were found to be superior at iron removal when compared to DFP, none generated a sufficiently large enhancement to initiate toxicity studies.<named-content content-type="anchor" rid="sch4" type="simple"></named-content></div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0012.jpeg" id="GRAPHIC-d7e895-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Action of HPO prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The intestinal transport and oral bioavailability of the iron chelator maltosine (<b>15</b>) are increased by conversion to peptide prodrugs. The transepithelial flux of the dipeptide prodrug derivatives <b>16a</b> and <b>16b</b> were 14-fold and 8-fold higher than that of maltosine, respectively. These HPOs are transported by human peptide transporter 1 (hPEPT1) into intestinal cells and then hydrolyzed to free maltosine. Compounds <b>16</b> have been suggested to possess potential for the treatment of iron storage diseases.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><div class="NLM_p">CP411 (<b>17</b>, Log<i>P</i> = 0.96) and CM1 (<b>18</b>, Log<i>P</i> = 0.53, pFe<sup>3+</sup> = 20.3) readily enter the hepatocyte due to their suitable lipophilicity values and were both found to be 2.5 times more effective than DFP (Log<i>P</i> = 0.17) at mobilizing iron in vivo.<a onclick="showRef(event, 'ref63 ref81'); return false;" href="javascript:void(0);" class="ref ref63 ref81">(63,81)</a> However, the phase II metabolism of CM1 is relatively high, and this led to investigation of pegylated HPOs with the possibility of a reduction in their rate of metabolism. For the most promising compound <b>19</b>, glucuronidation was reduced to 20% of that of DFP. However, the Log<i>P</i> value of <b>19</b> (Log<i>P</i> = â2.01) is low and so reduces the rate of penetration of membranes by nonfacilitated diffusion. Further optimization is required.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a><named-content content-type="anchor" rid="sch5" type="simple"></named-content></div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0013.jpeg" id="GRAPHIC-d7e962-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">2.1.4.  HPOs with a High pFe<sup>3+</sup> Value</h4><div class="NLM_p">In order to reduce toxicity and improve chelating efficiency, so that chelators can remove iron effectively at lower concentrations, a series of 1-, 2-, and 6-substituted HPOs possessing higher pFe<sup>3+</sup> values than that of DFP have been synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. pFe Values and Iron Mobilization Efficacy of Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">pFe<sup>3+</sup></th><th class="colsep0 rowsep0" align="center">iron mobilization efficacy (%) dose at 450 Î¼mol/kg<sup>â1</sup></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DFP</td><td class="colsep0 rowsep0" align="left">20.4</td><td class="colsep0 rowsep0" align="left">13.4Â Â±Â 5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="left">21.0</td><td class="colsep0 rowsep0" align="left">60.4Â Â±Â 15.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="left">21.4</td><td class="colsep0 rowsep0" align="left">54.5Â Â±Â 9.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21a</b></td><td class="colsep0 rowsep0" align="left">21.7</td><td class="colsep0 rowsep0" align="left">58.7Â Â±Â 7.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21b</b></td><td class="colsep0 rowsep0" align="left">22.8</td><td class="colsep0 rowsep0" align="left">50.1Â Â±Â 9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">22.0</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">NA means not available</p></div></div></div><div class="NLM_p">The introduction of a 1â²-hydroxyalkyl group at the C-2 position of the HPO ring (<b>20</b>) significantly reduces the p<i>K</i><sub>a</sub> values and consequently increases the pFe<sup>3+</sup> values. These compounds do not undergo rapid glucuronidation and were found to greatly facilitate iron excretion (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> A similar strategy involved the introduction of an amido function at the 2-position. Compounds CP502 (<b>21a</b>, pFe<sup>3+</sup> = 21.7) and CP511 (<b>21b</b>, pFe<sup>3+</sup> = 22.8) were found to be the most effective in this series, providing 59% and 50% iron excretion in the iron-loaded rat, respectively, compared with 13.4% for that of DFP (pFe<sup>3+</sup> = 20.4).<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83,84)</a> The cause of the low p<i>K</i><sub>a</sub> values and resulting high pFe<sup>3+</sup> values are due to the combined effect of intramolecular hydrogen bonding between the 2-substituents with the adjacent 3-hydroxyl group and the negative inductive effect of the 2-substituents from the HPO ring. The X-ray diffraction structures of CP511 demonstrate its ionization pathway and the critically strong intramolecular hydrogen bond (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a></div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ionization equilibrium and X-ray derived structure of CP511.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, Lachowicz presented a study on the coordination ability of compound <b>22</b> toward Fe<sup>3+</sup> by combining computational, chemical, and biological approaches.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a><b>22</b> possesses a high pFe<sup>3+</sup> value (22.0) because its tautomeric isomer is analogous to catechol and the lower protonation constant of the 3-OH group (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The biodistribution studies with mice demonstrated that <b>22</b> was equally effective to DFP, rendering the molecule as a possible candidate for the treatment of iron overload.<named-content content-type="anchor" rid="sch6" type="simple"></named-content></div><figure id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0014.jpeg" id="GRAPHIC-d7e1155-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ionization equilibrium of compound <b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18">2.1.5.  Macromolecular HPOs</h4><div class="NLM_p">In principle, administering iron chelators with a high molecular weight to reduce the efficiency of iron absorption from the intestine is an alternative method of relieving iron overload. Dendrimers and polymers cannot be readily absorbed by the gastrointestinal tract and will irreversibly form nontoxic, kinetically inert iron complexes that are not absorbed and so are excreted in the feces. For this purpose, a range of HPO-based dendrimers (e.g., <b>23</b>â<b>24</b>) and polymers (e.g., <b>25</b>) were synthesized.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86,87)</a> Dendritic and polymeric chelators bind iron with high affinity (pFe<sup>3+</sup> â 28.5) and so have a real potential for reducing Fe<sup>3+</sup> absorption from the intestine.<a onclick="showRef(event, 'ref86 ref87 ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref86 ref87 ref88 ref89">(86â89)</a><named-content content-type="anchor" rid="sch7" type="simple"></named-content></div><figure id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0015.jpeg" id="GRAPHIC-d7e1204-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19">2.1.6.  Combination Therapy</h4><div class="NLM_p">Combination therapy is an effective method to treat iron overload diseases and is widely adopted. Some patients, particularly those with severe iron overload, fail to respond adequately to monotherapy. Combination therapy generates a great difference in the pharmacokinetics of iron removal as demonstrated by the synergism of the two chelators DFP and DFO. These two chelators possess different tissue distributions and accessed different iron pools. The small orally active chelator DFP has a more extensive distribution than DFO and gains access to a wide range of cells. The hexadentate DFO functions as a competitive coligand, scavenges iron from the weaker DFP/iron complex, and facilitates excretion (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The combination of DFP and DFO improves iron excretion, plasma NTBI removal, and the reduction of liver iron, serum ferritin, and cardiac iron. It also improves tolerability, compliance, and survival, rendering adverse effects manageable through dose adjustment.<a onclick="showRef(event, 'ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref90 ref91">(90,91)</a> Combination therapy enhances efficacy and reduces side effects.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concept of combination therapy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In general, the prospect of 1-, 2-, or 6-substituted HPOs with high pFe<sup>3+</sup> values, HPO-based prodrugs, HPO-based dendrimers, and combination therapy using HPOs with other iron chelators is likely to improve iron chelation therapy of patients suffering from systemic iron overload in future years.</div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">2.2.  Hydroxypyridinones as Neuroprotection Agents</h3><div class="NLM_p">NDDs are a class of progressive and fatal complex diseases, such as Alzheimerâs disease (AD) and Parkinsonâs disease (PD). The pathogenesis of these diseases is complicated, and there is no clear etiology. The main characteristics of these diseases are the loss of neurons and protein deposition in specific regions of the brain.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Currently, there is a lack of effective therapies. Among the various pathogeneses in NDDs, iron imbalance and oxidative stress have been associated with progressive neurodegeneration and abnormal protein aggregation.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Mitochondria iron overload has been demonstrated to be a key feature of Friedreichâs ataxia (FRDA).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Interference with iron homeostasis and transport mechanisms will lead to the accumulation of Fe<sup>3+</sup>, which will eventually lead to the formation of ROS, oxidative stress, mitochondrial damage, and cell death through free radical reactions.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Studies have shown that FPN is decreased in damaged neurons, and heme deposition occurs in regions with blood vessel lesions.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> A high concentration of iron and an increase in iron accumulation in pathologic cells lead to increased deposition of AÎ² and an overphosphorylation of the normal Ï-protein.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">In principle, iron chelators are potential therapeutic agents for NDDs and have been demonstrated to be effective against NDDs in a series of animal models.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">2.2.1.  <i>N</i>-Alkyl HPOs</h4><div class="NLM_p">Many of the properties of HPOs render them capable of crossing the bloodâbrain barrier (BBB) and inhibiting prooxidant insults.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> Indeed, DFP, CP94, and CP24 (<b>26b</b>) have been demonstrated to remove excess iron from the brain in the ferrocene-loaded rats.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> The Log<i>P</i> values of <i>N</i>-alkyl HPOs show a direct relationship with <i>N</i>-alkyl chain length. However, there is a dramatic decrease in BBB permeability when a hydroxyl function is introduced on the <i>N</i>-alkyl group as in <b>26e</b>â<b>g</b>.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> However, there are practical limits to increasing the BBB permeability by increasing the Log<i>P</i> value because with an increase in lipophilicity there is an increase of liver first pass absorption, thereby, reducing the overall bioavailability. DFP has been involved in many clinical trials for PD and AD.<a onclick="showRef(event, 'ref98 ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref98 ref99 ref100">(98â100)</a> Kwiatkowski reported that after one yearâs administration of DFP in PD patients, at 30 mg/kg/day, there was an improvement in the Unified Parkinsonâs Disease Rating Scale (UPDRS) score and a decrease in iron accumulation in the bilateral dentate nuclei, as well as the substantia nigra (SN).<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Subsequently, Devos and Bastida also identified the beneficial effects of DFP and reported it to selectively remove iron from different brain regions.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> Currently, a phase 2, randomized, placebo-controlled, multicenter study to investigate the safety and efficacy of DFP is in progress to ascertain whether DFP (15 mg/kg BID orally) slows cognitive decline in Alzheimerâs patients.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><div class="NLM_p">A range of fluorinated HPOs have been found to enhance BBB penetration while not increasing the liver first pass extraction.<a onclick="showRef(event, 'ref52 ref102'); return false;" href="javascript:void(0);" class="ref ref52 ref102">(52,102)</a> However, there was no clear correlation between BBB permeability and Log<i>P</i> values. Three compounds, namely, <b>27c</b>, <b>27d</b>, and <b>27g</b> were found to be superior to DFP, the most effective molecule being CP241 (<b>27c</b>).<named-content content-type="anchor" rid="sch8" type="simple"></named-content></div><figure id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0016.jpeg" id="GRAPHIC-d7e1342-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">2.2.2.  2-Amido HPOs</h4><div class="NLM_p">A small library of highly selective 2-amido-3-hydroxypyridin-4-one iron chelators (<b>28</b>) was designed for the removal of iron under neurodegenerative conditions.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> They possessed high pFe<sup>3+</sup> values (up to 21.5), and their LogD values (0.90â1.52) fell within the lipophilic range for efficient BBB permeability. This series of compounds was designed to provide minimal inhibition of the iron-containing enzymes, lipoxygenase, and tyrosine hydroxylase. Compounds <b>28c</b> and <b>28f</b> were found to be particularly weak inhibitors of both lipoxygenase and tyrosine hydroxylase at 10 Î¼M, while <b>28g</b>, <b>28h</b>, and <b>28j</b> were lipophilic derivatives that showed considerable inhibition on these enzymes at the same concentration. <b>28c</b> and <b>28f</b> were found to reverse FeNTA-induced primary cortical neuron death in a concentration-dependent manner, and this study clearly proved that AÎ² (3 or 10 Î¼M)-induced neuronal cell death was reversed when treated with low concentrations of iron chelators, indicating the negative role of iron in the AÎ² neurotoxic effects. However, in further <i>in vivo</i> studies neither <b>28c</b> or <b>28f</b> was found to efficiently penetrate the BBB.<named-content content-type="anchor" rid="sch9" type="simple"></named-content></div><figure id="sch9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0017.jpeg" id="GRAPHIC-d7e1394-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">2.2.3.  1-Hydroxypyridin-2-ones</h4><div class="NLM_p">Novel 1-hydroxypyridin-2-one iron chelators (<b>29</b>â<b>32</b>) have also been compared with DFP for their neuroprotective properties in a PD culture model induced by the catecholaminergic neurotoxin 6-hydroxydopamine (6-OHDA) to lesion cellular dopaminergic pathways.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a><b>30</b> and <b>31</b> demonstrated a similar defense against 6-OHDA neurotoxicity and iron insults to those of DFP, and provided a similar neuroprotective effect from PD-related neurotoxins.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In contrast, <b>29</b> and <b>32</b> had no significant protective effect, indicating that the relative locations of the carboxylic acid and hydroxymethyl has profound effects on neuroprotection. Compound <b>30</b> was found to provide the greatest protection against 6-OHDA. The same 6-OHDA cell viability assay of the nonmetal binding analogues (e.g., <b>32</b>) demonstrated that the hydroxamic acid iron-binding functionality of <b>30</b> was indeed essential for neuroprotection against 6-OHDA.<named-content content-type="anchor" rid="sch10" type="simple"></named-content></div><figure id="sch10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0018.jpeg" id="GRAPHIC-d7e1439-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">2.2.4.  HPO-Glucosides</h4><div class="NLM_p">Because of the heavy glucose dependence of the brain, the BBB is endowed with a high concentration of the hexose transporters. In principle, it should be possible to enhance the BBB permeability of chelators by coupling the chelators to hexoses.</div><div class="NLM_p">Feralex-G (<b>33</b>) has been reported to have potential for the therapy of various neurodegenerative diseases, but has not been further developed.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Orvigâs group presented a series of modified and functionalized bidentate HPO proligands by using glucose as a mask and directing substituent to solve the potential problem of premature binding of metals (<b>34</b>).<a onclick="showRef(event, 'ref106 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref106 ref107 ref108">(106â108)</a> Once the glucoside is hydrolyzed, these compounds (<b>34a</b>â<b>d</b>) exhibit iron-chelating and antioxidant properties.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In principle, they could significantly reduce the amount of aggregated AÎ². The inclusion of a methylene group (<b>34b</b> vs <b>34c</b>) had little effect on the <i>in vitro</i> antioxidant capacity, toxicity, and ability to dissolve AÎ² aggregates.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> None of these derivatives have been tested under <i>in vivo</i> conditions. <i>N</i>-Substituted HPO glycosylation prodrugs (<b>34f</b>â<b>s</b>), which partly incorporate a framework derived from thioflavin-T (ThT), were also evaluated.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The antioxidant capacities of all the nonglycosylated proligands (HL<sub>1</sub>âHL<sub>7</sub>) were better than that of the positive control Î±-tocopherol. Furthermore, a study of brain uptake with the radiolabeled glycoconjugate pyridinone <sup>125</sup>I-Gipp/<sup>125</sup>I-GL<sub>7</sub> using an <i>in situ</i> rat brain perfusion technique indicated adequate cerebral uptake of this prodrug, establishing the initial effectiveness of brain permeable pyridinones as AD therapeutics. However, the suggestion that the glycosylation of HPOs is a feasible method of enhancing the brain uptake of such compounds has been disputed.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> By directly comparing the brain absorption of DFP with its glycosylated analogue <b>34a</b> in mice using <i>in situ</i> cerebral perfusion. No brain uptake of <b>34a</b> was observed, which is likely to be due to the high hydrophilicity of this molecule. The complete inability of the glycosylated analogue (<b>34a</b>) to cross the BBB indicates that BBB hexose transporters are unlikely to be involved in the permeation of this type of prodrug. Thus, at present, glycosylation of bidentate HPOs has not been clearly demonstrated to facilitate penetration of the BBB.<named-content content-type="anchor" rid="sch11" type="simple"></named-content></div><figure id="sch11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0019.jpeg" id="GRAPHIC-d7e1536-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25">2.2.5.  HPO-Carbamates</h4><div class="NLM_p">Prodrugs resulting from functionalizing hydroxyl groups in the form of carbamates can in principle improve the pharmacokinetics by reducing metabolism and excretion. To obtain the molecules with acetylcholinesterase (AChE) inhibitory activity, a carbamate group was introduced to mimic rivastigmine (<b>35</b>). After brain uptake, the carbamate is partially hydrolyzed by enzymes. Nerve cell line activity tests demonstrated that Cppp (<b>36a</b>) was not toxic at high concentrations (450â650 Î¼M), and the AChE inhibitory activity was enhanced with an IC<sub>50</sub> value of 48.8 Î¼M compared to Hppp (<b>36b</b>, 210 Î¼M).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><div class="NLM_p">This multifunctional HPO scaffold was further explored by means of computational studies. Two new features were investigated: one the carbamate was attached to the HPO ring by a benzyl ether linker, and the second was that the iron-binding site remained intact, the carbamate being relocated to the <i>N</i>-substituent of the HPO.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> After the preliminary screen of the initial database, 15 compounds were selected for molecular docking studies on AChE protein. Cbppp (<b>37</b>) had the best docking score of â5.59 kcal/mol, followed by Cchpp (<b>38</b>) and Chpp (<b>39</b>). All compounds had similar reversible AChE inhibitory activity, with IC<sub>50</sub> values in the range of 200â350 Î¼M. The structureâactivity relationship (SAR) investigation showed that the carbamate group directly attached to the hydroxyl group (<b>36a</b>) on the pyridinone ring was more efficient than when placed at other positions.<named-content content-type="anchor" rid="sch12" type="simple"></named-content></div><figure id="sch12" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0020.jpeg" id="GRAPHIC-d7e1584-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">2.2.6.  HPO-Phenol/propargyl Hybrids</h4><div class="NLM_p">In principle, the combination of iron chelators and free radical scavengers can protect living tissues from oxidative stress to a greater degree than that of chelators alone. A small library of such compounds was demonstrated to be potent inhibitors of lipid peroxidation.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> All compounds (<b>40a</b>â<b>f</b>) showed enhanced inhibitory effects on lipid peroxidation when compared to DFP and the antioxidants butylated hydroxytoluene (BHT), trolox, and di-<i>tert</i>-butyl peroxide (DTBP). <b>40a</b> and <b>40b</b> were the most effective lipid peroxidation inhibitors, providing the optimal protection against indoleacetic acid (IAA)-induced cytotoxicity. <b>40b</b> showed significantly enhanced neuroprotection by inhibiting oxidative stress, which was superior to that provided by DTBP or DFP.</div><div class="NLM_p">Other 1-phenol-HPO derivatives (e.g., <b>41</b>) were designed as quadruply functional agents for AD therapy. Such compounds not only possessed metal ion chelation, AÎ² aggregation inhibition, and radical scavenging capacity, but also are specific H<sub>3</sub> receptor antagonists. H<sub>3</sub> receptor antagonists can increase cognition-related neurotransmitters in the brain.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a><i>In vivo</i> studies were performed through intraperitoneal administration of <b>41</b> (5 mg/kg) in male SpragueâDawley rats. The results showed that <b>41</b> demonstrated acceptable exposure (636 Â± 64 ngÂ·h/mL), suitable half-life (1.6 Â± 0.1 h), high volumes of distribution (18.7 Â± 0.9 L/kg) in plasma, a mean <i>C</i><sub>max</sub> of 207 ng/mL in the brain within half an hour, and a brain/plasma exposure ratio of 0.69, which indicates that <b>41</b> had appropriate pharmacokinetics values and good BBB penetration.</div><div class="NLM_p">Conjugation of propargylamine and HPOs have also been investigated for their potential role in monoamine oxidase-B (MAO-B) inhibition.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> The propargyl function is a key pharmacophore in many MAO-B inhibitors such as rasagiline and selegiline. Three such compounds (<b>42</b>â<b>44</b>) exhibited improved cell viability in cells treated with MPP<sup>+</sup> or AÎ²<sub>1â42</sub>. Compounds <b>42</b>, <b>43</b>, and <b>44</b> were found to more effective than DFP in MPP<sup>+</sup>-induced cell death by inhibiting caspase. They also showed neuroprotective and antiapoptotic effects, <b>42</b> being the most efficient product. The addition of other active groups to the <i>N</i> of propargyl or to the HPO ring may result in multitarget inhibition besides iron chelation and MAO-B inhibition. To date, these compounds have not been progressed any further.<named-content content-type="anchor" rid="sch13" type="simple"></named-content></div><figure id="sch13" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0021.jpeg" id="GRAPHIC-d7e1684-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">2.2.7.  HPO-Benzothiazole Hybrids</h4><div class="NLM_p">Benzothiazole (BTA) is known for its strong affinity for amyloid fibrils and consequently has been used in the design of AÎ² imaging probes. A virtual screen against AChE was implemented to optimize appropriate spacers between HPO and BTA.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> All these compounds had a higher AChE enzyme affinity compared with HPO alone. Series <b>45</b> exerted relatively good BBB permeability and AChE inhibition similar to prodrugs, while series <b>46</b> had high iron chelation (pFe<sup>3+</sup> = 19.2â19.4). Compounds <b>45c</b> and <b>46d</b> displayed the most potent resistance to AÎ², AChE inhibition, and antioxidant capacity.<named-content content-type="anchor" rid="sch14" type="simple"></named-content></div><figure id="sch14" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0022.jpeg" id="GRAPHIC-d7e1714-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The effects of the benzothiazole and benzoxazole functionalities on metal chelation, antioxidant activity, and cytotoxicity have been systematically investigated by Telpoukhovskaia and co-workers (<b>47</b>â<b>51</b>). Compound <b>49</b>, with a phenyl group directly bound to the pyridone, exhibited a higher antioxidant activity than <b>47</b> and <b>48</b>.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> They also reported two compounds (<b>50</b> and <b>51</b>) designing for fluorescence studies to determine interaction with AÎ² as well as cell permeability. The difference of one atom (sulfur or oxygen) showed that compared with <b>50</b>, the interaction between <b>51</b> and the protein resulted in enhanced fluorescence, indicating that the benzothiazole-derivative <b>51</b> exhibited greater binding affinity to AÎ² and higher permeability than its analogous benzoxazole-derivative <b>50</b>.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a><named-content content-type="anchor" rid="sch15" type="simple"></named-content></div><figure id="sch15" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0023.jpeg" id="GRAPHIC-d7e1759-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Resveratrol (<b>52</b>) is a natural distyrene derivative with multiple activities including free radical scavenging activity and high anti-AÎ² aggregation inhibition. Compounds (<b>53</b>) were obtained by connecting benzothiazole with HPO groups through a vinyl moiety. These compounds have activities against metal ions, AÎ² aggregation, and oxidative stress, showing a good triple effect.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Two optimal compounds, <b>53a</b> and <b>53b</b>, exhibited excellent anti-AÎ² aggregation activity, high ABTS (2,2â²-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)) radical scavenger activity, strong metal chelation properties, and depolymerization activity against previously formed fibers. In addition, no cytotoxicity was found in human glioma U251 cells at concentrations less than 50 Î¼M.</div><div class="NLM_p">SAR revealed that the modification of benzothiazole ring significantly affected the activity. The compounds containing benzoxazole and benzothiazole displayed better antioxidant activity than <i>N</i>-Me benzoimidazole derivatives. The introduction of methoxy or hydroxy moiety into the C-6 position or a hydroxy moiety into the C-2 position of benzothiazole resulted in a remarkable enhancement of activity, while the bromo and methoxy moieties were not favorable for activity. Furthermore, the substituents at the C-2 position of pyranone impacted the activity slightly; however, the methyl group in the C-1 position decreased the antioxidant capacities obviously, indicating the detrimental steric effect on antioxidant activity.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> In general, C-2 and C-6 hydroxyl substituted benzothiazole ring and unsubstituted pyranone were superior.<named-content content-type="anchor" rid="sch16" type="simple"></named-content></div><figure id="sch16" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0024.jpeg" id="GRAPHIC-d7e1787-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">2.2.8.  HPO-Resveratrol/Tacrine/Donepezil Hybrids</h4><div class="NLM_p">Because of the efficient AÎ² aggregation inhibitory and radical scavenging activities of resveratrol (<b>52</b>), a series of DFP-resveratrol hybrids (<b>54</b>) were investigated. These compounds were found to possess iron chelation, antioxidant, and anti-AÎ² aggregation activities.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> They showed antioxidant activity superior to that of Trolox, and an inhibitory effect on AÎ²<sub>1â42</sub> aggregation superior to that of resveratrol and curcumin. The SAR analysis of a large of analogues demonstrated that the introduction of hydroxyl, alkoxy, and other electron-donating groups to positions 2 and 4 of the benzene ring was crucial to the aggregation inhibition of AÎ²<sub>1â42</sub>. Molecular docking analysis with AÎ²<sub>1â42</sub> monomer model of compounds <b>54a</b> and <b>54b</b> indicated that they can effectively interact with the C-terminus of AÎ²<sub>1â42</sub> through hydrogen bonding. Compounds <b>54a</b> and <b>54b</b> were identified as the most promising multitarget chelators with triple functions, with micromolar IC<sub>50</sub> values against AÎ²<sub>1â42</sub> aggregation.</div><div class="NLM_p">Tacrine (<b>55</b>) and donepezil (<b>57</b>) are AChE inhibitors approved by the FDA for the treatment of AD. In order to design multitarget-directed ligands (MTDLs) with AChE inhibitory activities, a variety of functional groups have been hybridized with <b>55</b> and <b>57</b>, including HPOs. Molecular docking showed that 2â3 methylene chains coupled to tacrine and HPO resulted in a good double-binding interaction between the compound and the active sites (CAS and PAS).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> The AChE inhibitory activities of those compounds with chloro-substitution and hydroxyl-containing linkers were close to that of tacrine, and the IC<sub>50</sub> values were within the range of 0.64â1.01 Î¼M. Free radical scavenging activity was moderate (Î¼M range) and higher than that of tacrine alone. Compounds <b>56a</b> and <b>56b</b> showed the most potent inhibitory effect on AChE with the IC<sub>50</sub> values of 0.96 Î¼M and 0.86 Î¼M displaying the most potential AÎ²<sub>1â42</sub> self-aggregation inhibition in the range of 85â95%.</div><div class="NLM_p">Similarly, <i>O</i>-benzyl-HPO and benzofuran groups of compound <b>58</b> could simulate donepezil benzyl piperidine and dimethoxyindone, respectively, while 2-methylene-linked hybrid compounds could double bind with the binding sites of each of the active sites (CAS and PAS).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Therefore, the effects of n, R<sup>1</sup>, and R<sup>2</sup> on the activity were investigated. <i>O</i>-Benzyl-HPO hybrid (<b>58a</b>) containing a 2-methylene linker was the most similar to donepezil, although its activity was still lower than donepezil. However, the free-HPO hybrid (<b>58b</b>) presented a higher activity for AÎ² aggregation inhibition and higher metal chelating capacity and radical scavenging activity. These compounds also showed a moderate positive neuroprotective effects in neuronal cells, which could serve as a basis for further development of potential multifunctional drug or pro-drug candidates for AD.<named-content content-type="anchor" rid="sch17" type="simple"></named-content></div><figure id="sch17" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0025.jpeg" id="GRAPHIC-d7e1898-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">2.2.9.  HPO-Coumarin Hybrids</h4><div class="NLM_p">A series of HPO-coumarin hybrids have been designed, synthesized, and evaluated as multitargeting agents against AD.</div><div class="NLM_p">Initially, click chemistry was applied to connect the <i>N</i>-1 position of HPOs with the C-3, C-4, and C-7 positions of coumarins.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> All hybrids displayed excellent iron-chelating activity and the MAO-B inhibitory activity. Most of the 3- or 7-substituted coumarin derivatives were significantly better than those of the 4-substituted compounds. Compounds <b>59a</b> and <b>59b</b> exhibited the most potent MAO-B inhibitory activity with IC<sub>50</sub> values of 0.68 and 0.86 Î¼M, respectively.</div><div class="NLM_p">Replacing the heterocyclic link with a simple alkyl chain generated compounds with a more potent MAO-B inhibitory activity, with IC<sub>50</sub> values ranging from submicromolar to low nanomolar concentrations.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Compound <b>60a</b> exhibited the most potent activity against MAO-B with an IC<sub>50</sub> value of 14.7 nM. This compound also showed a good protective effect on U251 cells and significantly ameliorated the cognitive dysfunction of scopolamine-induced AD mice.</div><div class="NLM_p">Simultaneously, replacing the heterocyclic link with an amide chain also generated compounds with a more potent MAO-B inhibitory activity than <b>59</b>, with IC<sub>50</sub> values around 100 nM.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> The MAO-B inhibitory activity of the C-7 substituted coumarin derivatives was significantly better than those of the C-6/8 substituted compounds. Compound <b>61a</b> was the most potent MAO-B inhibitor with an IC<sub>50</sub> value of 87.9 nM, which was more efficient than <b>60b</b>. Moreover, compound <b>61a</b> exerted favorable antioxidant activity, significantly reversed the AÎ²<sub>1â42</sub> induced PC12 cell damage, and also remarkably ameliorated the cognitive dysfunction in a scopolamine-induced mice AD model.</div><div class="NLM_p">Molecular docking with MAO-B elucidated the probable ligandâreceptor interaction, the HPO moiety was toward the FAD cofactor, and it had important interactions with residues around it, indicating that the HPO moiety not only functions as a chelating agent but also provides a key fragment in binding with MAO-B. Compounds <b>60a</b> and <b>61a</b> are currently the optimal compounds and deserve further structural optimization. It may be possible to simplify the coumarin structure in order to obtain more flexible molecules that bind more tightly to the enzyme cavity.<named-content content-type="anchor" rid="sch18" type="simple"></named-content></div><figure id="sch18" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0026.jpeg" id="GRAPHIC-d7e1973-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">2.2.10.  Summary</h4><div class="NLM_p last">To date, there have only been minor improvements over DFP by simple structural modification, such as rendering the alkyl substituents more lipophilic or introducing fluorine atoms. Although the conjugation with glucose residues is an attractive idea, there is currently no strong evidence for enhanced BBB permeability. The design of hybrids of HPOs and other pharmacophore groups looks more promising. Combinations with propargyl and tacrine appear to have potential for future development.</div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31">2.3.  Hydroxypyridinones as Antibacterial Agents</h3><div class="NLM_p">Iron is necessary for the growth of almost all microorganisms. The ânutritional immunityâ strategy can be used for antibacterial therapy by extracting essential metal ions, especially iron from the bacterial environment.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> However, bacteria and fungi can produce siderophores, which are strong iron chelators that scavenge iron from the environment.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> High iron affinity iron chelators can compete with siderophores for iron and thereby inhibit microorganism growth and so reduce the risk of infection.</div><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">2.3.1.  <i>N</i>-Alkyl Bidentate HPOs</h4><div class="NLM_p">HPOs, as strong iron-chelating agents, inhibit the growth of several bacteria and fungi. The antibacterial effects of HPOs possessing different substituents at positions 2, 3, 5, and 6 on the pyridinone ring have been investigated.<a onclick="showRef(event, 'ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref127 ref128">(127,128)</a> Quantitative structureâactivity relationships (QSAR) were studied using the microplate Alamar Blue assay method and counter propagation artificial neural networks (CP-ANN) method. Compounds <b>62</b>â<b>65</b> were reported to possess antimicrobial activity against <i>Candida albicans</i> and <i>Staphylococcus aureus</i>.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> Faidallah characterized a further 58 HPO derivatives, 26 of which exhibited inhibitory effects on the growth of Gram-positive and Gram-negative bacteria, <b>66</b> being the most potent antibacterial agent.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a><named-content content-type="anchor" rid="sch19" type="simple"></named-content></div><figure id="sch19" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Scheme 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0027.jpeg" id="GRAPHIC-d7e2029-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">2.3.2.  Hexadentate HPOs</h4><div class="NLM_p">The antimicrobial activity of a range of hexadentate HPO chelators has been evaluated by Zhou and co-workers.<a onclick="showRef(event, 'ref130 ref131 ref132 ref133 ref134 ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref130 ref131 ref132 ref133 ref134 ref135 ref136">(130â136)</a> There are two main structural types of these hexadentate chelators: one conjugating an alkyl triamine (CP251, <b>67</b>) or aromatic triamine (CP252, <b>68</b>) with three bidentate units, and the other using a tripodal structure with three carboxyl groups to anchor the bidentate units (<b>71</b>â<b>73</b>).</div><div class="NLM_p">Compounds <b>67</b> and <b>68</b> were compared with DTPA (<b>2b</b>) and was found to possess the most potent inhibitory effect on both Gram-positive and Gram-negative bacteria, followed by DTPA and then <b>68</b>. Significantly <b>67</b> possesses a higher affinity for Fe<sup>3+</sup> (Log<i>K</i> = 30.7, pFe<sup>3+</sup> = 30.5) than DTPA (Log<i>K</i> = 28.6) and is more water-soluble than <b>68</b>.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Both <b>69a</b> and 6<b>9b</b> demonstrated similar antibacterial activity to <b>67</b>.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> In order to investigate the effect of hydrophobicity on the antibacterial activity of hexadentate HPOs, a series with different substituents on nitrogen were synthesized (<b>70a</b>â<b>i</b>). Overall, <b>70c</b> with a cLog<i>P</i> value of â3.6 showed optimal bacterial growth inhibitory activity.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a><named-content content-type="anchor" rid="sch20" type="simple"></named-content></div><figure id="sch20" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0028.jpeg" id="GRAPHIC-d7e2124-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>71b</b> exhibited inhibitory activity against <i>Providencia stuartii</i> and <i>Staphylococcus aureus in vitro</i>, with minimal inhibitory concentration (MIC) values of 320 and 240 Î¼g/mL, respectively.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Compound <b>71b</b> was found to be more effective when used in combination with chloramphenicol.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> More hydrophilic analogues <b>72a</b> and <b>72e</b> showed optimal bacterial growth inhibitory effects against <i>S. aureus</i>, <i>Bacillus subtilis</i>, <i>Pseudomonas aeruginosa</i>, and <i>E. coli</i>, with MIC values of 8, 8, 16, and 8 Î¼g/mL, respectively.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a><b>72b</b>â<b>d</b>, <b>72f</b>â<b>h</b>, and <b>72i</b> showed moderate inhibitory effects against <i>P. aeruginosa</i> with MIC values of 32, 32, and 128 Î¼g/mL, respectively. Compounds <b>72g</b> and <b>72i</b> possessed the poor inhibitory effects against these four strains. This indicates that the presence of a charged amino group may influence the penetration of compounds into the surface of bacteria and thereby a detrimental influence on the antibacterial effect. For noncharged compounds (<b>72a</b>â<b>f</b>), hydrophobic compounds showed lower inhibitory activity.</div><div class="NLM_p last">The overuse and misuse of antibiotics has led to the emergence of the multidrug-resistant bacteria, especially methicillin-resistant <i>S. aureus</i> (MRSA), which has been associated with severe wound infections. A series of hexadentate HPOs have been investigated for their antimicrobial activity against MRSA, and <b>73</b> showed inhibitory activity against both the Gram-positive bacteria MRSA and the Gram-negative bacteria <i>P. aeruginosa</i>.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> SAR indicated that lipophilic chelators can enhance the inhibition of MRSA. The two most hydrophobic compounds <b>73j</b> and <b>73k</b> possessed the highest inhibitory activity against MRSA. However, <b>73j</b>, <b>73k</b>, and the highly hydrophilic <b>73f</b> were found to possess low MIC values against <i>P. aeruginosa</i>.</div></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">2.3.3.  HPOâRosamine Conjugates</h4><div class="NLM_p">The antimycobacterial properties of a series of fluorescent rosamine HPO hexadentate iron chelators were evaluated by Rangel and co-workers.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137,138)</a> Bidentate HPOs were found to lack an inhibitory effect on the growth of <i>Mycobacterium avium</i> in mouse macrophages. Similarly, the hexadentate chelators <b>67</b> and <b>68</b> had no inhibitory effect on the intra-macrophagic growth of <i>M. avium</i>. In contrast, hexadentate HPOs connected to a fluorescent entity were found to inhibit the intramacrophagic growth of <i>M. avium</i>.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137,138)</a> CP777 (<b>74b</b>) demonstrated the strongest inhibitory activity of this tripodal series <b>74</b>. CP777 (<b>74b</b>) successfully competes with carboxy-mycobactin and mycobactin for iron, providing a mechanism for the observed antibacterial action. These molecules thus offer an effective antibacterial strategy that may be used to combat infections, including tuberculosis.<named-content content-type="anchor" rid="sch21" type="simple"></named-content></div><figure id="sch21" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Scheme 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0029.jpeg" id="GRAPHIC-d7e2274-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Rangel and co-workers also investigated the activity of the rhodamine-labeled HPO chelators (<b>75</b>â<b>81</b>) against Gram-negative and Gram-positive bacteria.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Among these chelators, the hexadentate chelators (<b>75</b>â<b>77</b>) were found to possess a stronger antibacterial activity than that of the bidentate chelators (<b>78</b>â<b>80</b>). Both <b>75</b> and <b>77</b> could inhibit the growth of Gram-positive bacteria <i>S. aureus</i> ATCC 25923 and <i>S. epidermis</i> ATCC 12228 with an MIC value of 0.016 mM. Compound <b>75</b> possessed higher bacterial inhibition than compounds <b>76</b> and <b>77</b>, with an MIC of 0.063 mM against Gram-negative bacteria <i>E. coli</i> ATCC 25922. The superior antibacterial effect of compounds <b>75</b> could be attributed to the presence of thiourea linkage and <i>N</i>-ethyl substituents on the xanthene ring, which increased their lipophilicity, thereby enhancing their ability to penetrate the biological membranes. However, surprisingly, bidentate chelator <b>81</b> exhibited the most potent inhibition among all the rhodamine-labeled HPO chelators (<b>75</b>â<b>81</b>) against Gram-positive strains from different genera and species with MIC values of 0.011â0.022 mM, such as the clinically relevant species <i>S. aureus</i>, <i>S. epidermidis</i>, <i>E. faecium</i>, and <i>E. faecalis</i>.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> This enhanced activity may be due to the absence of one carboxyl group on the position 2â² of phenyl ring in compound <b>81</b>, thus possessing a positive charge at neutral pH, which may increase the antibacterial effect by favoring the occurrence of electrostatic interactions with the surface of the bacterial membrane.<named-content content-type="anchor" rid="sch22" type="simple"></named-content></div><figure id="sch22" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0030.jpeg" id="GRAPHIC-d7e2361-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">2.3.4.  Macromolecular HPOs</h4><div class="NLM_p">Macromolecular iron chelators, such as dendrimers and polymers, have considerable potential in the medical area due to their many advantages over the traditional small-molecule drugs. They can effectively bind iron irreversibly to form nontoxic, kinetically inert complexes that are not absorbed by the mammalian gastrointestinal tract.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> The first macromolecular HPO chelators were prepared by immobilizing HPO onto sepharose gels. Initially, a series of monomers with 3-hydroxy-2-methyl-4(l<i>H</i>)-pyridinone (HMP) groups were synthesized (<b>82</b>â<b>84</b>).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> These compounds (<b>82</b>â<b>84</b>) were water-soluble and found to inhibit the growth of <i>Escherichia coli</i> and <i>Listeria inocula</i> bacteria. However, it is difficult to separate water-soluble iron chelators from the treated effluents; iron was chelated but not removed from the system, resulting in toxicity. Therefore, water-insoluble iron-chelating resins were investigated (AHMP-DMAA, <b>85</b>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Compound <b>85</b> exhibited similar antibacterial activity compared to that of <b>82</b>â<b>84</b> against <i>E. coli</i> and <i>L. inocula</i>.<named-content content-type="anchor" rid="sch23" type="simple"></named-content></div><figure id="sch23" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Scheme 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0031.jpeg" id="GRAPHIC-d7e2420-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A series of HPO hexadentate-functionalized iron-chelating copolymers <b>87</b> were synthesized by copolymerization of compound <b>86</b> with 2-hydroxyethyl acrylate (HEA) at different molar ratios.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> It was found that monomer <b>86</b> and polymer <b>87</b> possessed similar pFe<sup>3+</sup> values, 29.7 and 29.8, respectively. Both exhibited appreciable inhibitory activity with a similar MIC value (41â82 Î¼M) against both Gram-positive (<i>S. aureus</i> and <i>B. subtilis</i>) and Gram-negative bacteria (<i>E. coli</i>, <i>Salmonella spp.</i> and <i>P. aeruginosa</i>), indicating that both <b>86</b> and <b>87</b> inhibit bacterial growth by removing iron from the bacterial environment. Such compounds have the potential for the treatment wound infections. There are two potential advantages of the polymer <b>87</b> when applied in wound healing. First, it may be covalently coupled to wound dressing materials; second, it is less likely to gain access to the systemic circulation when administered topically. It has also been reported that a series of macromolecular iron chelators prepared via RAFT-polymerization can inhibit the growth of MRSA.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a><named-content content-type="anchor" rid="sch24" type="simple"></named-content></div><figure id="sch24" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Scheme 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0032.jpeg" id="GRAPHIC-d7e2471-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The antimicrobial activity of some HPO hexadentate-based dendritic chelators was evaluated by Zhou and co-workers. Among the three tested dendritic chelators, <b>24</b> showed the best antibacterial activity against two Gram-negative bacteria (<i>E. coli</i> and <i>P. aeruginosa</i>), while its antibacterial activity against Gram-positive bacteria (<i>S. aureus</i> and <i>B. subtilis</i>) was not as good as that of DFP.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> This is probably because compound <b>24</b> inhibits the growth of bacteria by scavenging iron around the surface of bacteria, whereas the inhibitory effect of DFP can be attributed its small molecular weight, which renders it accessible to the bacterial cytosol. When <b>24</b> was used in combination with norfloxacin, a synergistic inhibitory effect against both <i>S. aureus</i> and <i>E. coli</i> was observed. The higher the concentration of chelator <b>24</b>, the stronger the synergism exhibited, possibly suggesting that the microorganisms are more sensitive to norfloxacin under the conditions of iron deprivation.</div><div class="NLM_p">More recently, Zhouâs group synthesized a range of novel hexadentate HPO-terminated dendrimers (<b>88</b>) using a convergent strategy.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> These chelators exhibited marked inhibition against both Gram-positive and Gram-negative bacteria. Compounds <b>88a</b> and <b>88b</b> displayed the highest bacterial inhibition rates against <i>P. aeruginosa</i>/<i>S. aureus</i> (<b>88a</b>: 90.4%, <b>88b</b>: 90.0%) and <i>E. coli</i>/<i>B. subtilis</i> (<b>88a</b>: 99.7%, <b>88b</b>: 95.0%). These dendritic chelators (or their combination with antibiotics) may have clinical potential, especially in the treatment of external infections, such as in the gastrointestinal tract, wounds, and ulcers.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a><named-content content-type="anchor" rid="sch25" type="simple"></named-content></div><figure id="sch25" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Scheme 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0033.jpeg" id="GRAPHIC-d7e2551-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Holbein reported the synthesis of a novel HPO-based polymeric chelator, DIBI (<b>89b</b>), by the copolymerization of an HPO methacrylamide monomer (<b>89a</b>) and <i>N</i>-vinylpyrrolidone. A series of DIBI related copolymers (MW of 2â9 kDa) were prepared. MIC assays indicated that DIBI was effective in inhibiting the Gram-positive and Gram-negative bacterial reference strains <i>S. aureus</i>, <i>A. baumannii</i>, and <i>C. albicans</i>. Compared with the small molecular iron chelators DFO and DFP, DIBI inhibited the initial bacterial growth by 100â1000-fold.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> The sensitivity study indicated that DIBI possessed a potent inhibitory effect on all the 18 isolates of <i>S. aureus</i> from human, bovine, and canine infections, being almost 100-fold greater than those of DFP. Antibiotic-resistant and antibiotic-sensitive isolates, including hospital-acquired and community-acquired MRSA, showed susceptibility similar to DIBI.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a><named-content content-type="anchor" rid="sch26" type="simple"></named-content></div><figure id="sch26" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Scheme 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0034.jpeg" id="GRAPHIC-d7e2583-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">2.3.5.  HPOs with Î²-Lactams</h4><div class="NLM_p">A series of 14 cephalosporins with an oxadiazolyl HPO moiety at C-7 have been investigated for <i>in vitro</i> and <i>in vivo</i> antibacterial activity.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> The most selected cephalosporins against <i>P. aeruginosa</i> were found to be superior to that of cefotaxime (CTX) <i>in vitro</i>. Among them, compounds containing a pyridinium thiomethyl group (<b>90</b>) at the C-3 position were found to possess a higher efficacy against both <i>S. aureus</i> and <i>P. aeruginosa</i>. Compound <b>90b</b> showed the best efficacy and was more than 10-fold potent compared with CTX and ceftazidime (CAZ) <i>in vivo</i>. In particular, for the protective effect against <i>S. aureus</i>, it showed that <b>90b</b> (ED<sub>50</sub>: 0.96 mg/kg) had superior protective effects compared to that of cefpirome (ED<sub>50</sub>: 1.5 mg/kg).</div><div class="NLM_p">To identify new agents for the treatment of multidrug-resistant <i>P. aeruginosa</i>, and to solve the known problems of the physical properties and stability of monocyclic lactam compounds, a series of siderophore-conjugated monocarbams had been described.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> A monocyclic Î²-lactam core renders them stable to metallo-Î²-lactamases, and the 1,3-dihydroxypyridinone mimics the bacteriaâs natural siderophores and hijacks its iron uptake machinery for penetration into the periplasm to improve the efficacy. These monocarbams displayed excellent biochemical and cellular activity against <i>P. aeruginosa</i>, good hydrolytic stability, and favorable pharmacokinetics parameters. Compared with a triazole functionality, optimal physical properties (i.e., high free fraction and good hydrolytic stability) can be successfully obtained by introducing a saturated linked chain on 6-position of the HPO ring. Lactam rings were not readily hydrolyzed, while side chains more readily modified. In the optimization process, a low clearance rate and an increase of free drug concentration in the body should be maintained. Compound <b>91</b>, with good free fraction levels (>20% free), hydrolytic stability (<i>t</i><sub>1/2</sub> â¥ 100 h) and cellular activity against <i>P. aeruginosa</i> (MIC = 0.5 Î¼g/mL, <i>P. aeruginosa</i> MIC<sub>90</sub> (<i>n</i> = 2) = 2 Î¼g/mL), was identified as a lead compound.<named-content content-type="anchor" rid="sch27" type="simple"></named-content></div><figure id="sch27" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Scheme 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0035.jpeg" id="GRAPHIC-d7e2669-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, the growth of bacteria is largely influenced by iron levels in the environment, and HPOs, as strong iron chelating agents, can effectively inhibit the growth of bacteria. HPO-based macromolecules may have more potential in antibacterial treatment because of their high pFe<sup>3+</sup> values and different Log<i>P</i> values in comparison with small molecular HPOs. Because they have the characteristics of potent iron chelation, hydrophilicity, and difficulty in gastrointestinal absorption and low toxicity, they have the potential for the treatment of superficial skin wound infections, ulcers, and other external infections.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37">2.4.  Hydroxypyridinones as Antiviral Agents</h3><div class="NLM_p">As an important element in DNA and RNA synthetic pathways, iron affects the activation of some viral nuclear transcription factors. Studies have demonstrated that iron and oxidative stress might play an important role in the activation of HIV-1. Thus, HIV-1 replication can be inhibited by reducing iron availability.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Iron chelators could influence the replication of HIV in many possible paths: (1) the long terminal repeats of HIV-1 contain nuclear factor (NF)-ÎºB response elements that regulate proviral transcription, and iron can affect the activation of NF-ÎºB through the production of ROS;<a onclick="showRef(event, 'ref29 ref151'); return false;" href="javascript:void(0);" class="ref ref29 ref151">(29,151)</a> (2) iron chelation inhibits DNA synthesis by inhibiting iron-dependent nucleotide reductase, thereby affecting HIV replication;<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> and (3) iron chelators attack viral DNA or RNA directly by inhibiting viral proliferation and the resulting apoptosis.<a onclick="showRef(event, 'ref153 ref154'); return false;" href="javascript:void(0);" class="ref ref153 ref154">(153,154)</a> These mechanisms have brought iron chelators into focus as potential therapeutic antiviral agents.</div><div id="sec2_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">2.4.1.  Bidentate HPOs</h4><div class="NLM_p">DFP and mimosine (<b>92</b>) have been reported to inhibit deoxyhypusyl hydroxylase in T-lymphocytic and promonocytic cell lines by the Hanauske-Abel group as early as 1988.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> They were able to demonstrate a decrease in the replication of HIV-1 and the biosynthesis of HIV-1-directed protein in a concentration-dependent manner. HPOs had no influence on the formation of unspliced or multispliced HIV-1 transcription. By interfering with the mRNA translation of incomplete splicing retroviruses, these compounds limit HIV-1 to the early nonreproductive phase of its reproductive cycle. The presence of HPOs selectively inhibit the biosynthesis of proteins, leading to the apoptosis of the infected cells. HPOs preferentially promote apoptosis of retrovirally infected human T lymphocytes, suggesting that they have the potential to selectively ablate HIV1-producing cells. In addition, the iron chelators DFP and DFO were found to inhibit HIV-1 replication by the iron-catalyzed inactivation of the iron chelator-complex.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The chelators reduced the expression of the p24 antigen in peripheral blood lymphocytes (PBL) and macrophages derived from human monocytes. Furthermore, it was found that CP502 (<b>21a</b>) and CP511 (<b>21b</b>) inhibited the replication of HIV-1 by decreasing cellular proliferation in a similar manner to that of DFO and DFP.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Both CP502 (IC<sub>50</sub> = 33.3 Â± 8.7 Î¼M) and CP511 (IC<sub>50</sub> = 20.0 Â± 6.4 Î¼M) possess a higher affinity for iron and stronger inhibition for HIV-1 than DFP (IC<sub>50</sub> = 102.5 Â± 37.4 Î¼M) (see <a class="ref internalNav" href="#sec2_1_4" aria-label="section 2.1.4">section 2.1.4</a>). The inhibition of HIV-1 replication demonstrated by these chelators was achieved by inhibiting cellular proliferation rather than a direct antiviral effect.</div><div class="NLM_p">The combined use of HPOs and the nucleoside analogue deoxyinosine has been shown to synergistically reduce HIV in human PBL <i>in vitro</i>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><named-content content-type="anchor" rid="sch28" type="simple"></named-content></div><figure id="sch28" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Scheme 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0036.jpeg" id="GRAPHIC-d7e2744-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">2.4.2.  Deoxynucleoside HPOs</h4><div class="NLM_p">Some Î±- and Î²-dideoxynucleoside derivatives with the base replaced by an HPO moiety (<b>93</b>â<b>96</b>) have been evaluated against various viruses, including vaccinia virus, HIV-1, HIV-2, herpes simplex virus type 1 (HSV-1), and type 2 (HSV-2).<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> However, these compounds possessed no activity against any of the tested viruses except the HSVs. Compounds <b>93b</b>, <b>94a</b>, and <b>94b</b> were found to exert only moderate activity against wild-type HSV-1 and HSV-2, and moderate activity against thymidine kinase-deficient strains of HSV-1. These activities suggest that these new nucleosides were metabolized to their 5â²-triphosphates or were recognized by viral DNA polymerases.</div><div class="NLM_p">A series of cyclic and acyclic nucleoside analogs (<b>95</b>â<b>97</b>) derived from HPO were also investigated, but no activity was observed against HIV and only moderate activity against HSV-1 and HSV-2.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> The absence of anti-HIV activity may arise due either to a lack of intracellular phosphorylation or to difficulties associated with crossing the cellular membrane.</div><div class="NLM_p">At the present time, there have been no HPOs identified that possess antiviral properties markedly superior to those of DFP.<named-content content-type="anchor" rid="sch29" type="simple"></named-content></div><figure id="sch29" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Scheme 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0037.jpeg" id="GRAPHIC-d7e2786-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch29"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40">2.5.  Hydroxypyridinones as Antiprotozoal Agents</h3><div class="NLM_p">Malaria is a major global health problem, and there is a pressing need for the scientific community to develop new antimalarial drugs. Iron deficiency has a detrimental effect on the development of human malaria,<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> and in contrast, iron administration may exacerbate malaria.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> In principle, therefore, iron chelators could be used to treat malaria by inhibiting iron-dependent metabolic pathways of the parasite or by forming toxic iron complexes that possess antimalarial activity.</div><div id="sec2_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">2.5.1.  Lipophilic HPOs</h4><div class="NLM_p">DFO demonstrated <i>in vivo</i> antimalarial activity in several mammalian species; however, its application is limited because of its poor absorption and short half-life.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> The antimalarial effects of a series of HPOs have also been explored, and dose-dependent inhibition was observed <i>in vitro</i>.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Among these compounds, DFP (<b>9</b>), CP38 (<b>98</b>), and CP40 (<b>99</b>) failed to inhibit malaria, while the more lipophilic CP51 (<b>11</b>), CP94 (<b>10</b>), and CP96 (<b>100</b>) had strong inhibitory effects on malaria growth, indeed superior to DFO. These HPOs can inhibit malaria both <i>in vitro</i> and <i>in vivo</i>.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> The prodrug concept can be utilized to overcome the disadvantage of poor oral absorption and hydrophilicity, such as CP38 ester prodrugs which can facilitate the transport of CP38 to the blood supply.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> In order to improve the efficiency of the antimalaria activity of HPOs, nitrogen centers were introduced to HPOs in order to target acidic vacuoles, such as those found in the parasite. Compounds <b>101</b> and <b>102</b> were found to be the most promising candidates, with appropriate Log<i>P</i> values to facilitate their penetration into intracellular organelles while being sufficiently hydrophilic to lack the general toxicity.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a><named-content content-type="anchor" rid="sch30" type="simple"></named-content></div><figure id="sch30" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Scheme 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0038.jpeg" id="GRAPHIC-d7e2860-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch30"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">2.5.2.  Piperidone Analogues</h4><div class="NLM_p">Piperidone analogues have been designed as inhibitors of <i>Plasmodium falciparum</i>, where they are targeted against deoxyhypusine hydroxylase (DHH).<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> DHH is an iron-dependent enzyme, and alkyl 4-oxo-piperidine-3-carboxylates are inhibitors of this enzyme and were found to possess antiplasmodium effects both <i>in vitro</i> and <i>in vivo</i>. The saturated 4-oxo-piperidine-3-monoester (<b>103</b>) was reported to be more efficient than <b>104</b> and the tetra- and dihydropyridone monoesters (<b>105</b> and <b>106</b>) in inhibiting the growth of the parasite. However, DHH7 (<b>107</b>) was reported to be the most potent compound in the series with an IC<sub>50</sub> value of 1.4 Î¼M.<named-content content-type="anchor" rid="sch31" type="simple"></named-content></div><figure id="sch31" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Scheme 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0039.jpeg" id="GRAPHIC-d7e2902-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch31"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">2.5.3.  HPO-Chloroquine Hybrids</h4><div class="NLM_p">In order to improve the antimalarial activity of HPOs, the synthesis of a series of DFPâchloroquine (CQ) hybrids has been investigated. HPO conjugates, such as <b>108</b> and <b>109</b>, showed enhanced antiplasmodial activities when compared to that of DFP, but were less active than CQ alone.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a><b>108</b> and <b>109</b> were also tested against <i>Trypanosoma brucei</i>, <i>Trypanosoma cruzi</i>, and <i>Leishmania infantum</i>, <b>108</b> being the most potent conjugate. The antitrypanosomal activity of <b>108</b> was 4-fold greater than that of CQ.</div><div class="NLM_p">Moreover, Chibaleâs group synthesized a series of non-cytotoxic 4-aminoquinoline-HPO hybrids and were tested against CQ-resistant (K1 and W2) and CQ-sensitive (3D7) strains of <i>Plasmodium falciparum</i>.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> These hybrid molecules were found to inhibit Î²-hematin synthesis. The 3-benzylated (<b>110</b> and <b>111</b>) and 3-hydroxy (<b>112</b>) HPO hybrids all showed greater Î²-hematin inhibition activity than that of the corresponding HPO and CQ alone. For the most part, 3-hydroxy HPO hybrids were observed to be less efficient in the inhibition of Î²-hematin formation. The antiplasmodial activity of the hybrids was enhanced due to accumulation in the digestive vacuole mediated by the CQ moiety. The most promising hybrids inhibiting strains K1, 3D7, and W2 were <b>110</b> (0.13, 0.004, and 0.1 Î¼M), <b>111</b> (0.08, 0.01, and 0.02 Î¼M), and <b>112</b> (0.07, 0.03, and 0.08 Î¼M), respectively.</div><div class="NLM_p">An extension of this work led to the identification of <b>113</b> and <b>114</b>, which possess antimalarial activity against <i>Plasmodium falciparum</i> CQ-sensitive (3D7 and D10) and CQ-resistant strains (K1 and Dd2).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> The IC<sub>50</sub> values were 0.064 and 0.047 Î¼M (<b>113</b>), 0.041 and 0.122 Î¼M (<b>114</b>), 0.505 and 0.463 Î¼M (<b>113</b>), 0.089 and 0.076 Î¼M (<b>114</b>), respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Both compounds were more active than CQ <i>in vitro</i>, but the <i>in vivo</i> pharmacokinetics evaluation of these hybrids showed a low oral bioavailability. When dosed intravenously, compound <b>114</b> could reduce parasitemia levels and showed improved pharmacokinetics properties in <i>P. berghei</i> infected mice. Thus, these HPO-CQ hybrids need additional structural modification in order to improve their <i>in vivo</i> efficacy.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In vitro IC<sub>50</sub> values (Î¼M) of Compounds <b>113</b> and <b>114</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="rowsep1 colsep0" colspan="2" align="center">sensitive strains</th><th class="rowsep1 colsep0" colspan="2" align="center">resistant strains</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">3D7</th><th class="colsep0 rowsep0" align="center">D10</th><th class="colsep0 rowsep0" align="center">K1</th><th class="colsep0 rowsep0" align="center">Dd2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>113</b></td><td class="colsep0 rowsep0" align="left">0.064Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="left">0.047Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="left">0.505Â Â±Â 0.10</td><td class="colsep0 rowsep0" align="left">0.463Â Â±Â 0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>114</b></td><td class="colsep0 rowsep0" align="left">0.041Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="left">0.122Â Â±Â 0.03</td><td class="colsep0 rowsep0" align="left">0.089Â Â±Â 0.01</td><td class="colsep0 rowsep0" align="left">0.076Â Â±Â 0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CQ</b></td><td class="colsep0 rowsep0" align="left">0.019Â Â±Â 0.00</td><td class="colsep0 rowsep0" align="left">0.023Â Â±Â 0.00</td><td class="colsep0 rowsep0" align="left">0.279Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="left">0.180Â Â±Â 0.01</td></tr></tbody></table></div></div><div class="NLM_p">In summary, structural optimization of HPOs can enhance antimalarial activity, and conjugation of the HPO iron chelator to a second bioactive component presents a promising antiparasitic strategy.<named-content content-type="anchor" rid="sch32" type="simple"></named-content></div><figure id="sch32" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Scheme 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0040.jpeg" id="GRAPHIC-d7e3109-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch32"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45">2.6.  Hydroxypyridinones as Anti-Inflammatory Agents</h3><div class="NLM_p">Many inflammatory signals are regulated by hepcidin gene expression, and one of the most significant effects of inflammation is its effect on iron transport.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Inflammation will stimulate the upregulation of hepcidin, leading to the downregulation of FPN, the increase of iron storage, and the release of inflammatory factors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Iron plays an essential role in the regulation of inflammatory processes and hosts immuno-surveillance by regulating the proliferation, differentiation, activation, and apoptosis of B, T, and NK cells; by interfering with cytokine activities and the cell-mediated immune effector pathways; and by catalyzing the formation of toxic radicals for the host defense.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Many studies have shown that iron chelators can block the production of inflammatory cytokines and attenuate lipid peroxidation and the production of ROS.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div><div id="sec2_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">2.6.1.  Bidentate HPOs</h4><div class="NLM_p">In 2001, Ozturk and co-workers described the synthesis and structural and pharmacological properties of two new HPO derivatives (<b>115</b>, <b>116</b>) and the 1,2,5-trisubstituted series (<b>117</b>, <b>118</b>).<a onclick="showRef(event, 'ref168 ref169'); return false;" href="javascript:void(0);" class="ref ref168 ref169">(168,169)</a> Analgesic and anti-inflammatory activities were investigated by acetic acid-induced writhing syndrome and carrageenan rat paw edema tests with acetylsalicylic acid and indomethacin as comparison compounds. All compounds exhibited higher analgesic activity than acetylsalicylic acid and showed higher anti-inflammatory activities than indomethacin. <b>116d</b> and <b>118c</b> were identified as the most promising compounds. Furthermore, compound <b>118c</b> showed almost no ulcerogenic activity when compared to indomethacin.</div><div class="NLM_p">The pharmacological properties of HPO derivatives suggested that they could inhibit the synthesis of prostaglandin E and arachidonic acid. However, the most promising aspect of their analgesic and anti-inflammatory effects is probably due to their iron-chelating properties.<named-content content-type="anchor" rid="sch33" type="simple"></named-content></div><figure id="sch33" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Scheme 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0041.jpeg" id="GRAPHIC-d7e3164-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch33"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">2.6.2.  DIBI</h4><div class="NLM_p last">Lehmann and co-workers have investigated the anti-inflammatory efficacy of a polymeric HPO iron chelator (DIBI, <b>89b</b>) in experimental sepsis and local and systemic models of endotoxin-induced uveitis (EIU).<a onclick="showRef(event, 'ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref170 ref171">(170,171)</a> DIBI is a novel iron chelator comprising nine pyridinone chelating monomers copolymerized to vinylpyrrolidone. In experimental sepsis, DIBI-A (<i>m</i> = 9), DIBI-B and MAHMP (<b>89a</b>, the chelating monomer) were compared. DIBI-B reduced the number of adhering leukocytes in submucosal collecting venules in endotoxemic mice by 68% and restored the functional capillary density (FCD) in the intestinal muscle layer. These results indicated that DIBI-B reduced leukocyte recruitment, improved FCD, and prevented mucosal damage in experimental endotoxemia, outperforming the other two iron chelators tested. DIBI-Bâs ability to selectively bind iron, while remaining nontoxic and biocompatible renders it a candidate drug for further investigation. Recently, in local and systemic models of EIU, DIBI was demonstrated to possess anti-inflammatory properties by decreasing leukocyte adhesion and by improving the FCD in the iridial microcirculation without local adverse effects in the eye.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div></div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48">2.7.  Hydroxypyridinones as Anticancer Agents</h3><div class="NLM_p">Overloaded iron in the body is associated with the development and progression of cancer.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> The associated iron generated free radicals can promote DNA strand breakage, oncogene activation, and tumor suppressor gene suppression.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Many iron metabolic-related proteins are also involved in the development, proliferation, and metastasis of malignant tumors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Cancer cells require a larger amount of iron than normal cells, which is manifested in the overexpression of TFR1, DMT1, and hepcidin to absorb more iron into cells or low-expression of FNP and HEPH to increase intracellular iron.<a onclick="showRef(event, 'ref174 ref175'); return false;" href="javascript:void(0);" class="ref ref174 ref175">(174,175)</a> The synthesis of DNA in tumor cells also requires iron-dependent ribonucleotide reductase to catalyze the reduction of RNA to DNA.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> This increased dependence of cancer cells on iron indicates that iron chelation could be an effective cancer treatment strategy.<a onclick="showRef(event, 'ref177 ref178'); return false;" href="javascript:void(0);" class="ref ref177 ref178">(177,178)</a></div><div id="sec2_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">2.7.1.  Bidentate HPOs</h4><div class="NLM_p">Hoyes and co-workers studied the synchronization and growth inhibition of the leukemia cell cycle by HPO iron chelators.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Both HPOs and DFO inhibited the cell cycle in a dose-dependent manner, but when the chelators were subsequently removed, the HPO-treated cells cascaded into the S phase synchronously, while the DFO-treated cells resumed cycling in an asynchronous manner. HPOs were clearly superior to DFO as cell cycle synchronizers, and this may be a helpful adjuvant in cell cycle-specific therapy. <i>In vitro</i> studies also found that iron chelators, such as DFO and DFP, displayed different inhibitory effects on the proliferation of nerve tumor cell lines and human liver cancer cells.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180,181)</a> It has also been suggested that iron chelators may also inhibit the proliferation and apoptosis of human cervical cancer cells, which could occur in a time- and dose-dependent manner, thereby inhibiting the growth and inducing apoptosis of human papillomavirus (HPV)-positive cancer cells.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> The efficiency of CP411 liver cell uptake and its inhibition on tumor cell proliferation were both greater than those of DFP. CP411 was found to have a significant effect on the protection of liver cells from the toxicity of iron overload and the inhibition of tumor cell proliferation.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> The polyamine-iron chelator conjugate <b>119</b> was at least 230 times more potent than the parent HPO ligand in inhibiting the growth of L1210 mouse leukemia cells, providing a promising indicator for further studies on the effects of iron chelators on tumor cell growth.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a><named-content content-type="anchor" rid="sch34" type="simple"></named-content></div><figure id="sch34" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Scheme 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0042.jpeg" id="GRAPHIC-d7e3242-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch34"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">2.7.2.  Hydroxypyridin-2-ones</h4><div class="NLM_p">Hydroxypyridin-2-ones possess antitumor activity, the enzymes involved in the regulation of protein phosphorylation being the targets for cancer treatment. In particular, the protein phosphatases of the Cdc25 family have attracted attention because of their important role in cell cycle regulation. TMC-69-6H (<b>120</b>) is an inhibitor of phosphatase VHR, tyrosine protein phosphatase PTB1B.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a></div><div class="NLM_p">The antitumor activities of 3-[(4-hydroxy-6-methyl-2(1<i>H</i>)-pyridinones)-3-yl]-4- substituted-(1<i>H</i>)-1,2,4-triazole-5-thiones (<b>121</b> and <b>122</b>) were demonstrated <i>in vitro</i> to be highly inhibitory against KB cells, and compound <b>122</b> was highly inhibitory against Bel-7402 cells.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> SAR showed that the compounds with electron-withdrawing substitutes (such as F, Cl, Br) on the aryl ring exhibited more potent activities than those with electron-donating substitutes. Compounds with the electron-withdrawing substitutes at the <i>meta</i> position had activity superior to those with substitutes at the <i>para</i> position.</div><div class="NLM_p">ERCC1-XPF endonuclease plays an important role in nucleotide resection repair (NER) and interchain cross-linking repair (ICR). Therefore, inhibition of ERCC1-XPF endonuclease may improve the efficacy of chemotherapy drugs such as cisplatin. 3-Hydroxypyridin-2-ones are able to inhibit ERCC1-XPF, compounds <b>123</b> and <b>124</b> being the most promising compounds.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></div><div class="NLM_p">HPO chelators are rarely investigated as antitumor agents, but further investigation on these compounds has potential.<named-content content-type="anchor" rid="sch35" type="simple"></named-content></div><figure id="sch35" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Scheme 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0043.jpeg" id="GRAPHIC-d7e3298-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch35"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51">2.8.  Hydroxypyridinones as Iron-Containing Metalloenzyme Inhibitors</h3><div class="NLM_p">Metalloenzymes account for at least one-third of all proteases and utilize a wide variety of metal ion cofactors for their electron transfer, catalytic, structural, or other critical functions.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Metalloenzyme inhibitors can be linked to the treatment of a number of diseases, such as cancer, arthritis, atherosclerosis, and heart disease. One of the major targets for metalloenzyme inhibition are the non-heme iron-containing enzymes such as cyclooxygenase, lipoxygenase, ribonucleotide reductase, aromatic hydroxylases, and ferrochelatase.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></div><div id="sec2_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">2.8.1.  Ribonucleotide Reductase Inhibitors</h4><div class="NLM_p last">The inhibition of ribonucleotide reductase renders it possible to synchronize cell cycling, which is associated with the combination of chemotherapy for tumors. The anticancer effect of HPOs reported by Hoyes was largely due to the inhibition of ribonucleotide reductase.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Subsequently, they simultaneously examined the relationship between intracellular iron chelation and the rate of clearance and regeneration of ribonucleotide reductase in intact human leukemia K562 cells using electron paramagnetic resonance (EPR) technology.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> HPOs (DFP and CP94) remove the tyrosyl radical more quickly than DFO because of the depletion of the intracellular iron pools, which is necessary to regenerate the active enzyme. This property is attributed to the increased membrane permeability of the unchelated form of HPOs. Hydrophobic and/or uncharged HPO chelators will rapidly gain access to the cell. Effective iron mobilization also requires that the iron-chelate complex be able to efflux from the cell. Thus, an ideal chelator for clinical use will be hydrophobic and neutral in both the chelated and unchelated forms and thus able to mobilize iron from cells quickly.</div></div><div id="sec2_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">2.8.2.  5-Lipoxygenase and Tyrosine Hydroxylase Inhibitors</h4><div class="NLM_p">5-Lipoxygenase (5-LOX) is a non-heme iron-containing enzyme catalyzing the oxidation of polyunsaturated fatty acids to produce hydroperoxides. The first two steps in the conversion of arachidonic acid to leukotriene A<sub>4</sub> is one such example.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> Hider and co-workers investigated the SAR of 1- and 2-substituted HPOs (<b>126</b>â<b>128</b>) with 5-LOX and ribonucleotide reductase compared with DFO and the non-iron-binding analogue Ome-25 (<b>125</b>).<a onclick="showRef(event, 'ref191 ref192'); return false;" href="javascript:void(0);" class="ref ref191 ref192">(191,192)</a> The molecular dimensions, lipophilicity, and iron-binding constant had critical effects on the ability of these chelators to inhibit 5-LOX and ribonucleotide reductase. When R<sup>2</sup> was methyl, compounds with bulky R<sup>1</sup> substituents tended to be strong inhibitors, and the most hydrophobic chelator (CP26, <b>127c</b>) was found to possess the most potent inhibitory effects on 5-LOX and DNA synthesis. In contrast, hydrophilic ligands with bulky R<sup>2</sup> substitutes were weak inhibitors, and CP358 (<b>128j</b>) possessed the weakest inhibition of 5-LO activity and DNA synthesis compared with DFP. Studies on the influence of size and hydrophobicity of the substituent of HPOs on mammalian tyrosine hydroxylase inhibition provided results similar to those found with 5-LO.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Changing the alkyl substituents does not affect the affinity constants of these ligands for Fe<sup>3+</sup>.<named-content content-type="anchor" rid="sch36" type="simple"></named-content></div><figure id="sch36" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Scheme 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0044.jpeg" id="GRAPHIC-d7e3372-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">HPOs can be used to inhibit metalloenzymes such as 5-LOX, ribonucleotide reductase, and tyrosine hydroxylase for therapeutic purposes when functionalized appropriately.</div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54">2.9.  Hydroxypyridinones and Photodynamic Therapy</h3><div class="NLM_p">Photodynamic therapy (PDT) is a method of selective tissue ablation.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> 5-Aminolevulinic acid (ALA)-based PDT uses the prodrug ALA or methyl aminolevulinate (MAL) as a means of increasing the synthesis of protoporphyrin IX (PpIX), which is a photosensitizer. Light-activated photosensitization leads to the formation of the lethal strong oxidant singlet oxygen, resulting in the loss of a variety of cell substrates and leading to cell death.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> PpIX will insert Fe<sup>2+</sup> using the ferrochelatase enzyme to produce heme.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Thus, an exogenous increase in the concentration of ALA or MAL, and the blocking of PpIX conversion to heme by inhibiting ferrochelatase with iron chelators, can both increase the accumulation of PpIX in target cells. The increase in PpIX levels renders such cells light sensitive.</div><div id="sec2_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">2.9.1.  CP94</h4><div class="NLM_p last">Initially, iron chelators were employed in combination with ALA/MAL/hexyl aminolevulinate (HAL) to potentially increase the accumulation of PpIX in all cell lines. The iron chelator CP94 (<b>10</b>) is an efficient promoter of ALA/MAL/HAL-induced PpIX accumulation and can enhance the treatment of nodular basal cell carcinoma (BCC).<a onclick="showRef(event, 'ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref197 ref198">(197,198)</a> The results show that enhanced PDT using 40% CP94 (dose-ratio) resulted in significantly greater clearance rates in nodular BCC than with ALA/MAL-PDT alone. This method of enhancement was safely applied <i>in vivo</i> to a clinical PDT protocol with no adverse effects. CP94 can also be used in combination with fluorescence-guided resection (FGR) to highlight and destroy human glioma cells that can not be surgically resected.<a onclick="showRef(event, 'ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref199 ref200">(199,200)</a> At the highest concentrations of ALA (250 Î¼M) and MAL (1000 Î¼M), CP94 enhanced PpIX fluorescence significantly at 3 h for ALA and by more than 50% at 6 h for MAL. Cells subsequently treated with ALA/MAL-induced PDT in combination with CP94 produced the greatest cytotoxicity. The intracellular PpIX generates singlet oxygen and can be detected by electron paramagnetic resonance spectroscopy conjugated with a spin trap.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div></div><div id="sec2_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">2.9.2.  ALA-HPO conjugates</h4><div class="NLM_p">The introduction of HPO iron chelators can inhibite ferrochelatase and then enhance the uprate of ALA. Thus, Zhouâs group designed, synthesized, and evaluated a series of ALAâHPO conjugates as potential PDT agents. Initially, the group synthesized two series of ALAâHPO conjugates (<b>129</b> and <b>130</b>), where ALA was both linked to HPO by ester bonds and either linked to phenylalanine or leucine by peptide bonds.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> It was predicted that the ester and peptide bonds would be hydrolyzed by esterases and peptidases, respectively, to release ALA and HPO. Phototoxicity of these ALAâHPO hybrids demonstrated that, whereas the<b>129</b> group showed no significant improvement in potency, the <b>130</b> group with higher lipophilicity and noncharged properties, was more effective. Within series <b>130</b>, ALA and leucine linkers were found to be more active than ALA and phenylalanine linkers. Compound <b>130i</b> was the most efficient phototoxic conjugate on the MDA-MB-468 cell line, with an LD<sub>50</sub> value of 3 Î¼M. In the same cell line, the LD<sub>50</sub> value of ALA was 195 Î¼M.</div><div class="NLM_p">Subsequently, a further series of ALA-HPO prodrugs (<b>131</b>) were synthesized by the conjugation of ALA to HPO using amino acid linkages.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Most of these compounds (<b>131</b>) were found not to markedly enhance the synthesis of PpIX in a range of cell lines when compared to ALA, with the exception of <b>131a</b>. Compared with the combined use of ALA with CP94.</div><div class="NLM_p">The authors also investigated the length of the chain of the ester linkage at the 1-position of the HPO ring and compared it with the application of ALA alone. All of the compounds (<b>132</b>â<b>135</b>) significantly increased the intracellular PpIX levels in the KB, MCF-7, and MCF-7R cell lines, which was higher than that of ALA.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> For instance, higher levels of PpIX fluorescence were observed using these conjugates (<b>132</b>â<b>135</b>), which were closely related to the phototoxicity observed after cell exposure to light. There is a clear relationship between the length of the hydrocarbon linkers and PpIX accumulation. The compounds with longer hydrocarbon spacers demonstrated efficient PpIX production, which was further enhanced by the presence of HPO over incubation time ranging between 2 and 24 h. Compound <b>132e</b> (<i>n</i> = 10) was the optimal hybrid for both enhancing the cellular PpIX levels and the phototoxicity to tumor cells.</div><div class="NLM_p">Curnow has evaluated whether the effectiveness of PpIX-induced PDT could be improved when ALA and CP94 were conjugated with an ester (AP2â18, <b>136</b>).<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> No prominent dark toxicity was observed in human lung fibroblasts, and AP2â18 remarkably increased the accumulation of PpIX in dermal fibroblasts and epithelial squamous cancer cells, which was higher than the level of accumulation produced by ALA or MAL Â± CP94. Thus, ALAâHPO hybrids can be considered to be effective prodrugs for PpIX-induced PDT, achieving a better effect than the existing drugs at a lower concentration.<named-content content-type="anchor" rid="sch37" type="simple"></named-content></div><figure id="sch37" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Scheme 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0045.jpeg" id="GRAPHIC-d7e3497-autogenerated" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A series of ALAâHPO dendrimers with an aromatic core with suitable spacers have been synthesized.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> The ALAâHPO dendrimers demonstrated higher efficacies for PpIX generation and higher phototoxicities in two human cancer cell lines than ALA. Conjugation of methionine at the <i>N</i>-terminus of the ALA moieties in the dendrimers (<b>137</b>) amplified PpIX generation. Dendrimers could be used as carriers to improve the delivery of ALA and HPO or other synergistic compounds to carcinoma cells to synergistically amplify the <i>in vitro</i> PpIX levels and enhance the PDT efficacy.</div><div class="NLM_p last">All of these conjugates (<b>129</b>â<b>137</b>) showed no significant cytotoxicity in the absence of light exposure and significantly increased the formation and phototoxicity of PDT metabolites.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">3.  Conclusions and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Among the various iron chelators available for clinical use, HPO iron chelators have received considerable attention due to their high affinity and selectivity for iron(III) and ready structural modification, enabling the formation of hexadentate, dendritic, and polymeric ligands. HPO conjugates possess a wide range of pharmacological properties.</div><div class="NLM_p">Bidentate HPOs are orally active, and indeed, DFP has been successfully used for the treatment of systemic iron overload for over 30 years. HPO iron chelators have potential as neuroprotection, antibacterial, antiviral, antiparasitic, anti-inflammatory and antitumor agents, and also play an important role in PDT (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). HPO derivatives have the potential to be lead compounds for the design of multitargeted drugs with improved pharmacological activities using rational drug design methods.</div><figure id="fig8" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Broad-ranging pharmacological applications of HPOs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Hexadentate HPO-based macromolecules (e.g., polymers and dendrimers) could find application in iron overload therapy by reducing iron absorption in the gastrointestinal tract due to their excellent iron scavenging behavior and nontoxic nature. They also have considerable potential in the treatment of external infections, such as wound healing, especially ulcers in the elderly.</div><div class="NLM_p">HPOs have a promising application in PDT for the treatment of skin and bladder cancer. The combination of HPOs with photosensitizers can in principle achieve an improved therapeutic effect.</div><div class="NLM_p last">As our knowledge of iron-dependent biochemistry and physiology improves, the discovery of novel iron-related targets for the treatment of diseases will become more extensive. Iron is an increasingly important pharmacological target.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01480" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renren Bai</span> - <span class="hlFld-Affiliation affiliation">College
of Pharmaceutical Science, Zhejiang University
of Technology, Hangzhou, 310014, P.R. China</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3511-5794" title="Orcid link">http://orcid.org/0000-0002-3511-5794</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1d3c4cfd3c4cfc3c0c8e19093978fc2cecc81d3c4cfd3c4cfc3c0c8e1dbcbd4d58fc4c5d48fc2cf"><span class="__cf_email__" data-cfemail="1c6e79726e79727e7d755c2d2e2a327f7371">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="82f0e7ecf0e7ece0e3ebc2f8e8f7f6ace7e6f7ace1ec">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuanyuan Xie</span> - <span class="hlFld-Affiliation affiliation">Collaborative
Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China</span>;Â 
    <span class="hlFld-Affiliation affiliation">College
of Pharmaceutical Science, Zhejiang University
of Technology, Hangzhou, 310014, P.R. China</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8482-9948" title="Orcid link">http://orcid.org/0000-0001-8482-9948</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ed9594948e97ad97879899c3888998c38e83"><span class="__cf_email__" data-cfemail="592120203a231923332c2d773c3d2c773a37">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoying Jiang</span> - <span class="hlFld-Affiliation affiliation">Collaborative
Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou, 310014, P.R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Zhou</span> - <span class="hlFld-Affiliation affiliation">School
of Food Science and Biotechnology, Zhejiang
Gongshang University, Hangzhou, 310018, P.R. China</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4510-3639" title="Orcid link">http://orcid.org/0000-0003-4510-3639</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="46" class="article__inlineFigure"><h2 class="fig-label">Xiaoying Jiang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=BIO-d7e3547-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiaoying Jiang</b> is currently a Ph.D. student at Collaborative Innovation Centre of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology. She joined Prof. Yuanyuan Xieâs lab in 2013 and received her B.S. degree in pharmacology in 2014, and M.A. degree in medicinal chemistry from Zhejiang University of Technology in 2017. She studied as a short-term visitor under the guidance of Professor Robert C. Hider in Kingâs College London from August 2016 to November 2016. Her research interests include design, research, and synthesis of potential anti-Alzheimerâs agents and iron chelators.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="47" class="article__inlineFigure"><h2 class="fig-label">Tao Zhou</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=BIO-d7e3552-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Tao Zhou</b> received his B.Sc. degree in Chemistry from Zhejiang Normal University in 1986 and received his Ph.D. degree in Organic Chemistry from Zhejiang University in 2001. He worked as a postdoctoral research fellow under the supervision of Professor Robert C. Hider in Kingâs College London over the period January 2002 to April 2008. He is currently a Professor of Medicinal Chemistry at Zhejiang Gongshang University, China. He has published over 100 scientific papers. His research interests involve the areas of medicinal chemistry and food science, mainly centered on the design of clinically useful iron chelators and bioactive polysaccharides.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="48" class="article__inlineFigure"><h2 class="fig-label">Renren Bai</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=BIO-d7e3557-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Renren Bai</b> received his B.S. in Pharmaceutical Engineering in 2008 and his Ph.D. in Medicinal Chemistry in 2013 from China Pharmaceutical University. He followed his research with postdoctoral training at Emory University School of Medicine for three years, first in Department of Radiology and Imaging Science and later in Department of Radiation Oncology. He joined the School of Pharmaceutical Science at Zhejiang University of Technology in 2017. His research interests involve drug discovery, medicinal chemistry, and structural modification of natural products.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="49" class="article__inlineFigure"><h2 class="fig-label">Yuanyuan Xie</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=BIO-d7e3562-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yuanyuan Xie</b> graduated from Zhejiang University and acquired her Ph.D. in Organic Chemistry. In 2007, she was awarded the Second Price of National Award for Science and Technology. She pursued advanced study under the supervision of Professor Robert C. Hider in Kingâs College London as a senior visiting scholar from 2011 to 2012. Currently, she is a professor and deputy director of Collaborative Innovation Center of Green Pharmaceuticals and College of Pharmaceutical Sciences, Zhejiang University of Technology. She has published over 40 articles in organic chemistry and medicinal chemistry.</p></figure></div><div class="ack" id="ACK-d7e4096-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65872" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65872" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This project was supported by the National Natural Science Foundation of China, NSFC (Grant No. 21576239 and 81803340) and Zhejiang Natural Science Foundation (LY20H300004).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ABTS</td><td class="NLM_def"><p class="first last">2,2â²-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimerâs disease</p></td></tr><tr><td class="NLM_term">ALA</td><td class="NLM_def"><p class="first last">5-aminolevulinic acid</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">bloodâbrain barrier</p></td></tr><tr><td class="NLM_term">BCC</td><td class="NLM_def"><p class="first last">basal cell carcinoma</p></td></tr><tr><td class="NLM_term">BHT</td><td class="NLM_def"><p class="first last">butylated hydroxytoluene</p></td></tr><tr><td class="NLM_term">BTA</td><td class="NLM_def"><p class="first last">benzothiazole</p></td></tr><tr><td class="NLM_term">CAZ</td><td class="NLM_def"><p class="first last">ceftazidime</p></td></tr><tr><td class="NLM_term">CD91</td><td class="NLM_def"><p class="first last">cluster of differentiation 91</p></td></tr><tr><td class="NLM_term">CP</td><td class="NLM_def"><p class="first last">ceruloplasmin</p></td></tr><tr><td class="NLM_term">CP-ANN</td><td class="NLM_def"><p class="first last">counter propagation artificial neural networks</p></td></tr><tr><td class="NLM_term">CQ</td><td class="NLM_def"><p class="first last">chloroquine</p></td></tr><tr><td class="NLM_term">CTX</td><td class="NLM_def"><p class="first last">cefotaxime</p></td></tr><tr><td class="NLM_term">Dcytb</td><td class="NLM_def"><p class="first last">duodenal cytochrome <i>b</i></p></td></tr><tr><td class="NLM_term">DFO</td><td class="NLM_def"><p class="first last">desferrioxamine</p></td></tr><tr><td class="NLM_term">DFT</td><td class="NLM_def"><p class="first last">desferrithiocin</p></td></tr><tr><td class="NLM_term">DFX</td><td class="NLM_def"><p class="first last">deferasirox</p></td></tr><tr><td class="NLM_term">DFP</td><td class="NLM_def"><p class="first last">deferiprone</p></td></tr><tr><td class="NLM_term">DHH</td><td class="NLM_def"><p class="first last">deoxyhypusine hydroxylase</p></td></tr><tr><td class="NLM_term">DMB</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethyl-2,3-dihydroxybenzamide</p></td></tr><tr><td class="NLM_term">DMT1</td><td class="NLM_def"><p class="first last">divalent metal transporter 1</p></td></tr><tr><td class="NLM_term">DTBP</td><td class="NLM_def"><p class="first last">di-<i>tert</i> butylphenol</p></td></tr><tr><td class="NLM_term">DTPA</td><td class="NLM_def"><p class="first last">diethylenetriaminepentaacetic acid</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">EIU</td><td class="NLM_def"><p class="first last">endotoxin-induced uveitis</p></td></tr><tr><td class="NLM_term">EPR</td><td class="NLM_def"><p class="first last">electron paramagnetic resonance</p></td></tr><tr><td class="NLM_term">FCD</td><td class="NLM_def"><p class="first last">functional capillary density</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">USA Food and Drug Administration</p></td></tr><tr><td class="NLM_term">FGR</td><td class="NLM_def"><p class="first last">fluorescence-guided resection</p></td></tr><tr><td class="NLM_term">FLVCR2</td><td class="NLM_def"><p class="first last">feline leukemia virus subgroup C receptor 2</p></td></tr><tr><td class="NLM_term">FPN</td><td class="NLM_def"><p class="first last">ferroportin</p></td></tr><tr><td class="NLM_term">FRDA</td><td class="NLM_def"><p class="first last">Friedreichâs ataxia</p></td></tr><tr><td class="NLM_term">GPX</td><td class="NLM_def"><p class="first last">glutathione peroxidase</p></td></tr><tr><td class="NLM_term">HAL</td><td class="NLM_def"><p class="first last">hexyl aminolevulinate</p></td></tr><tr><td class="NLM_term">HB</td><td class="NLM_def"><p class="first last">hemoglobin</p></td></tr><tr><td class="NLM_term">HEPE</td><td class="NLM_def"><p class="first last">hephaestin</p></td></tr><tr><td class="NLM_term">HH</td><td class="NLM_def"><p class="first last">hereditary hemochromatosis</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">HMOX1</td><td class="NLM_def"><p class="first last">heme oxygenase 1</p></td></tr><tr><td class="NLM_term">HPOs</td><td class="NLM_def"><p class="first last">hydroxypyridinones</p></td></tr><tr><td class="NLM_term">HP</td><td class="NLM_def"><p class="first last">haptoglobin</p></td></tr><tr><td class="NLM_term">hPEPT1</td><td class="NLM_def"><p class="first last">human peptide transporter 1</p></td></tr><tr><td class="NLM_term">HPX</td><td class="NLM_def"><p class="first last">hemopexin</p></td></tr><tr><td class="NLM_term">HPV</td><td class="NLM_def"><p class="first last">human papillomavirus</p></td></tr><tr><td class="NLM_term">HSV</td><td class="NLM_def"><p class="first last">herpes simplex virus</p></td></tr><tr><td class="NLM_term">HRG-1</td><td class="NLM_def"><p class="first last">heme response gene-1</p></td></tr><tr><td class="NLM_term">IAA</td><td class="NLM_def"><p class="first last">indoleacetic acid</p></td></tr><tr><td class="NLM_term">IBE</td><td class="NLM_def"><p class="first last">iron binding equivalents</p></td></tr><tr><td class="NLM_term">ICR</td><td class="NLM_def"><p class="first last">interchain cross-linking repair</p></td></tr><tr><td class="NLM_term">IRE/IRP</td><td class="NLM_def"><p class="first last">iron-responsive element/iron regulatory protein</p></td></tr><tr><td class="NLM_term">ISCs</td><td class="NLM_def"><p class="first last">ironâsulfur clusters</p></td></tr><tr><td class="NLM_term">LIP</td><td class="NLM_def"><p class="first last">labile iron pool</p></td></tr><tr><td class="NLM_term">5-LOX</td><td class="NLM_def"><p class="first last">5-Lipoxygenases</p></td></tr><tr><td class="NLM_term">MAL</td><td class="NLM_def"><p class="first last">methyl aminolevulinic</p></td></tr><tr><td class="NLM_term">MAO-B</td><td class="NLM_def"><p class="first last">monoamine oxidase-B</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimal inhibitory concentration</p></td></tr><tr><td class="NLM_term">MTDLs</td><td class="NLM_def"><p class="first last">multitarget-directed ligands</p></td></tr><tr><td class="NLM_term">MRSA</td><td class="NLM_def"><p class="first last">methicillin-resistant <i>Staphylococcus aureus</i></p></td></tr><tr><td class="NLM_term">NDDs</td><td class="NLM_def"><p class="first last">neurodegenerative diseases</p></td></tr><tr><td class="NLM_term">NER</td><td class="NLM_def"><p class="first last">nucleotide resection repair</p></td></tr><tr><td class="NLM_term">NF</td><td class="NLM_def"><p class="first last">nuclear factor</p></td></tr><tr><td class="NLM_term">NTBI</td><td class="NLM_def"><p class="first last">nontransferrin-bound iron</p></td></tr><tr><td class="NLM_term">6-OHDA</td><td class="NLM_def"><p class="first last">6-hydroxydopamine</p></td></tr><tr><td class="NLM_term">PBL</td><td class="NLM_def"><p class="first last">peripheral blood lymphocytes</p></td></tr><tr><td class="NLM_term">PCBP</td><td class="NLM_def"><p class="first last">poly(rC) binding protein</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinsonâs disease</p></td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">PIH</td><td class="NLM_def"><p class="first last">pyridoxal isonicotinoyl hydrazine</p></td></tr><tr><td class="NLM_term">PpIX</td><td class="NLM_def"><p class="first last">photosensitizer protoporphyrin IX</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structureâactivity relationships</p></td></tr><tr><td class="NLM_term">RBCs</td><td class="NLM_def"><p class="first last">red blood cells</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">oxygen free radicals</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationships</p></td></tr><tr><td class="NLM_term">SFKs</td><td class="NLM_def"><p class="first last">Src family kinases</p></td></tr><tr><td class="NLM_term">SIH</td><td class="NLM_def"><p class="first last">salicylaldehyde isonicotinoyl hydrazine</p></td></tr><tr><td class="NLM_term">SN</td><td class="NLM_def"><p class="first last">substantia nigra</p></td></tr><tr><td class="NLM_term">SOD</td><td class="NLM_def"><p class="first last">superoxide dismutase</p></td></tr><tr><td class="NLM_term">STEAP3</td><td class="NLM_def"><p class="first last">six-transmembrane epithelial antigen of the prostate 3</p></td></tr><tr><td class="NLM_term">TF</td><td class="NLM_def"><p class="first last">transferrin</p></td></tr><tr><td class="NLM_term">TFR</td><td class="NLM_def"><p class="first last">transferrin receptor</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavin-T</p></td></tr><tr><td class="NLM_term">UPDRS</td><td class="NLM_def"><p class="first last">Unified Parkinsonâs Disease Rating Scale</p></td></tr><tr><td class="NLM_term">ZIP8</td><td class="NLM_def"><p class="first last">solute carrier family 39 member 8</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87680" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87680" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 206 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lieu, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiskala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">The roles of iron in health and disease</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">87</span>, <span class="refDoi">Â DOI: 10.1016/S0098-2997(00)00006-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0098-2997%2800%2900006-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11207374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Olu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=1-87&author=P.+T.+Lieuauthor=M.+Heiskalaauthor=P.+A.+Petersonauthor=Y.+Yang&title=The+roles+of+iron+in+health+and+disease&doi=10.1016%2FS0098-2997%2800%2900006-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of iron in health and disease</span></div><div class="casAuthors">Lieu, P. T.; Heiskala, M.; Peterson, P. A.; Yang, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">1-87</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Iron is vital for almost all living organisms by participating in a wide variety of metabolic processes, including oxygen transport, DNA synthesis, and electron transport.  However, iron concns. in body tissues must be tightly regulated because excessive iron leads to tissue damage, as a result of formation of free radicals.  Disorders of iron metab. are among the most common diseases of humans and encompass a broad spectrum of diseases with diverse clin. manifestations, ranging from anemia to iron overload and, possibly, to neurodegenerative diseases.  The mol. understanding of iron regulation in the body is crit. in identifying the underlying causes for each disease and in providing proper diagnosis and treatments.  Recent advances in genetics, mol. biol. and biochem. of iron metab. have assisted in elucidating the mol. mechanisms of iron homeostasis.  The coordinate control of iron uptake and storage is tightly regulated by the feedback system of iron responsive element-contg. gene products and iron regulatory proteins that modulate the expression levels of the genes involved in iron metab.  Recent identification and characterization of the hemochromatosis protein HFE, the iron importer Nramp2, the iron exporter ferroportin 1, and the second transferrin-binding and -transport protein transferrin receptor 2, have demonstrated their important roles in maintaining body's iron homeostasis.  Functional studies of these gene products have expanded our knowledge at the mol. level about the pathways of iron metab. and have provided valuable insight into the defects of iron metab. disorders.  In addn., a variety of animal models have implemented the identification of many genetic defects that lead to abnormal iron homeostasis and have provided crucial clin. information about the pathophysiol. of iron disorders.  In this review, we discuss the latest progress in studies of iron metab. and our current understanding of the mol. mechanisms of iron absorption, transport, utilization, and storage.  Finally, we will discuss the clin. presentations of iron metab. disorders, including secondary iron disorders that are either assocd. with or the result of abnormal iron accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozlLi_XTFS5rVg90H21EOLACvtfcHk0lgZJedmcMoeZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Olu7s%253D&md5=3b46448bc79fb418f08dfb7fcdd585e5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0098-2997%2800%2900006-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0098-2997%252800%252900006-6%26sid%3Dliteratum%253Aachs%26aulast%3DLieu%26aufirst%3DP.%2BT.%26aulast%3DHeiskala%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DP.%2BA.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DThe%2520roles%2520of%2520iron%2520in%2520health%2520and%2520disease%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2001%26volume%3D22%26spage%3D1%26epage%3D87%26doi%3D10.1016%2FS0098-2997%2800%2900006-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gozzelino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, P.</span></span> <span> </span><span class="NLM_article-title">Iron homeostasis in health and disease</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">130</span>â <span class="NLM_lpage">143</span>, <span class="refDoi">Â DOI: 10.3390/ijms17010130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fijms17010130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2isbfN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=130-143&issue=1&author=R.+Gozzelinoauthor=P.+Arosio&title=Iron+homeostasis+in+health+and+disease&doi=10.3390%2Fijms17010130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Iron homeostasis in health and disease</span></div><div class="casAuthors">Gozzelino, Raffaella; Arosio, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130/1-130/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Iron is required for the survival of most organisms, including bacteria, plants, and humans.  Its homeostasis in mammals must be fine-tuned to avoid iron deficiency with a reduced oxygen transport and diminished activity of Fe-dependent enzymes, and also iron excess that may catalyze the formation of highly reactive hydroxyl radicals, oxidative stress, and programmed cell death.  The advance in understanding the main players and mechanisms involved in iron regulation significantly improved since the discovery of genes responsible for hemochromatosis, the IRE/IRPs machinery, and the hepcidin-ferroportin axis.  This review provides an update on the mol. mechanisms regulating cellular and systemic Fe homeostasis and their roles in pathophysiol. conditions that involve alterations of iron metab., and provides novel therapeutic strategies to prevent the deleterious effect of its deficiency/overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNQ1liVuKcwLVg90H21EOLACvtfcHk0lgZJedmcMoeZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2isbfN&md5=bccc936de52cb94bb39b1f7bdca01b9b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3390%2Fijms17010130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17010130%26sid%3Dliteratum%253Aachs%26aulast%3DGozzelino%26aufirst%3DR.%26aulast%3DArosio%26aufirst%3DP.%26atitle%3DIron%2520homeostasis%2520in%2520health%2520and%2520disease%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26issue%3D1%26spage%3D130%26epage%3D143%26doi%3D10.3390%2Fijms17010130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poprac, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jomova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simunkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valko, M.</span></span> <span> </span><span class="NLM_article-title">Targeting free radicals in oxidative stress-related human diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">592</span>â <span class="NLM_lpage">607</span>, <span class="refDoi">Â DOI: 10.1016/j.tips.2017.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tips.2017.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28551354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2gu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=592-607&issue=7&author=P.+Popracauthor=K.+Jomovaauthor=M.+Simunkovaauthor=V.+Kollarauthor=C.+J.+Rhodesauthor=M.+Valko&title=Targeting+free+radicals+in+oxidative+stress-related+human+diseases&doi=10.1016%2Fj.tips.2017.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Free Radicals in Oxidative Stress-Related Human Diseases</span></div><div class="casAuthors">Poprac, Patrik; Jomova, Klaudia; Simunkova, Miriama; Kollar, Vojtech; Rhodes, Christopher J.; Valko, Marian</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">592-607</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cancer and Alzheimer's disease (AD) are characterized by (i) opposing biol. mechanisms, (ii) an inverse correlation between their incidences, and (iii) oxidative stress being a common denominator of both diseases.  Increased formation of reactive oxygen species (ROS) in cancer cells from oncogenic signaling and/or metabolic disturbances leads to upregulation of cellular antioxidant capacity to maintain ROS levels below a toxic threshold.  Combining drugs that induce high levels of ROS with compds. that suppress cellular antioxidant capacity by depleting antioxidant systems [glutathione (GSH), superoxide dismutase (SOD), and thioredoxin (TRX)] and/or targeting glucose metab. represents a potential anticancer strategy.  In AD, free metals and/or AÎ²:metal complexes may cause damage to biomols. in the brain (via Fenton reaction), including DNA.  Metal chelation, based on the application of selective metal chelators or metal delivery, may induce neuroprotective signaling and represents a promising therapeutic strategy.  This review examines therapeutic strategies based on the modulation of oxidative stress in cancer and AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLptt0dD9HmLVg90H21EOLACvtfcHk0liedpasPcpxbQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2gu78%253D&md5=651460c1dc146fc35509f224da3b73db</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2017.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DPoprac%26aufirst%3DP.%26aulast%3DJomova%26aufirst%3DK.%26aulast%3DSimunkova%26aufirst%3DM.%26aulast%3DKollar%26aufirst%3DV.%26aulast%3DRhodes%26aufirst%3DC.%2BJ.%26aulast%3DValko%26aufirst%3DM.%26atitle%3DTargeting%2520free%2520radicals%2520in%2520oxidative%2520stress-related%2520human%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26issue%3D7%26spage%3D592%26epage%3D607%26doi%3D10.1016%2Fj.tips.2017.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, N. C.</span></span> <span> </span><span class="NLM_article-title">Disorders of iron metabolism</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">1986</span>â <span class="NLM_lpage">1995</span>, <span class="refDoi">Â DOI: 10.1056/NEJM199912233412607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1056%2FNEJM199912233412607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10607817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVaqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=1986-1995&author=N.+C.+Andrews&title=Disorders+of+iron+metabolism&doi=10.1056%2FNEJM199912233412607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Disorders of iron metabolism</span></div><div class="casAuthors">Andrews, Nancy C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">1986-1995</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review is given with 86 refs. on Fe homeostasis disorders including the topics Fe transport physiol. and Fe deficiency and overload diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXvIU5YpQp0bVg90H21EOLACvtfcHk0liedpasPcpxbQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVaqsw%253D%253D&md5=79d235f4a56153a748299697fc317461</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJM199912233412607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199912233412607%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DN.%2BC.%26atitle%3DDisorders%2520of%2520iron%2520metabolism%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D1986%26epage%3D1995%26doi%3D10.1056%2FNEJM199912233412607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papanikolaou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantopoulos, K.</span></span> <span> </span><span class="NLM_article-title">Iron metabolism and toxicity</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>202</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">211</span>, <span class="refDoi">Â DOI: 10.1016/j.taap.2004.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.taap.2004.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15629195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvF2g" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=199-211&issue=2&author=G.+Papanikolaouauthor=K.+Pantopoulos&title=Iron+metabolism+and+toxicity&doi=10.1016%2Fj.taap.2004.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Iron metabolism and toxicity</span></div><div class="casAuthors">Papanikolaou, G.; Pantopoulos, K.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-211</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Iron is an essential nutrient with limited bioavailability.  When present in excess, iron poses a threat to cells and tissues, and therefore iron homeostasis has to be tightly controlled.  Iron's toxicity is largely based on its ability to catalyze the generation of radicals, which attack and damage cellular macromols. and promote cell death and tissue injury.  This is lucidly illustrated in diseases of iron overload, such as hereditary hemochromatosis or transfusional siderosis, where excessive iron accumulation results in tissue damage and organ failure.  Pathol. iron accumulation in the liver has also been linked to the development of hepatocellular cancer.  Here we provide a background on the biol. and toxicity of iron and the basic concepts of iron homeostasis at the cellular and systemic level.  In addn., we provide an overview of the various disorders of iron overload, which are directly linked to iron's toxicity.  Finally, we discuss the potential role of iron in malignant transformation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQPZQpSwwwMbVg90H21EOLACvtfcHk0liedpasPcpxbQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvF2g&md5=a9185266c08a2d837bd2aa2f7bddd234</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2004.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2004.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DPapanikolaou%26aufirst%3DG.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DIron%2520metabolism%2520and%2520toxicity%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2005%26volume%3D202%26issue%3D2%26spage%3D199%26epage%3D211%26doi%3D10.1016%2Fj.taap.2004.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crisponi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remelli, M.</span></span> <span> </span><span class="NLM_article-title">Iron chelating agents for the treatment of iron overload</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>252</i></span> (<span class="NLM_issue">10â11</span>),  <span class="NLM_fpage">1225</span>â <span class="NLM_lpage">1240</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2007.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ccr.2007.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVGktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2008&pages=1225-1240&issue=10%E2%80%9311&author=G.+Crisponiauthor=M.+Remelli&title=Iron+chelating+agents+for+the+treatment+of+iron+overload&doi=10.1016%2Fj.ccr.2007.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelating agents for the treatment of iron overload</span></div><div class="casAuthors">Crisponi, Guido; Remelli, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">10+11</span>),
    <span class="NLM_cas:pages">1225-1240</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The importance of iron chelators in medicine has significantly increased in recent years.  Iron is essential for life but it is also potentially more toxic than other trace elements.  This is because we lack effective means to protect human cells against iron overload and because of the role of iron in the generation of free radicals.  In order to protect patients from the consequences of iron toxicity, iron chelating agents have been introduced in clin. practice.  Unfortunately, the ideal chelator for treating iron overload in humans has not been identified yet.  In this paper we examine a few characteristics of iron chelators, with some emphasis on the effects of redox cycling, on absorption mechanisms and on some properties of the pFe.  A brief summary is then made of the chelators recently proposed or in development for the treatment of iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5xtdkguWee7Vg90H21EOLACvtfcHk0liedpasPcpxbQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVGktLs%253D&md5=01ef992d180be285b1f013dbe1882109</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DCrisponi%26aufirst%3DG.%26aulast%3DRemelli%26aufirst%3DM.%26atitle%3DIron%2520chelating%2520agents%2520for%2520the%2520treatment%2520of%2520iron%2520overload%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2008%26volume%3D252%26issue%3D10%25E2%2580%259311%26spage%3D1225%26epage%3D1240%26doi%3D10.1016%2Fj.ccr.2007.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisponi, G.</span></span> <span> </span><span class="NLM_article-title">Iron chelating agents in clinical practice</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">291</span>â <span class="NLM_lpage">310</span>, <span class="refDoi">Â DOI: 10.1016/S0010-8545(99)00056-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0010-8545%2899%2900056-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXis1Kitr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=1999&pages=291-310&author=G.+Faaauthor=G.+Crisponi&title=Iron+chelating+agents+in+clinical+practice&doi=10.1016%2FS0010-8545%2899%2900056-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelating agents in clinical practice</span></div><div class="casAuthors">Faa, Gavino; Crisponi, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-310</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review with 144 refs.  The relevance of iron chelators in medicine has increased in recent years.  Iron is essential for life but it is also potentially more toxic than other trace elements.  This is due to the lack of effective means to protect human cells against iron overload and to the role of iron in the generation of free radicals.  To protect patients from the consequences of iron toxicity, iron chelating agents have been introduced in clin. practice.  Unfortunately, the ideal chelator for treating iron overload in humans has not been identified yet.  The aim of this review is to report the experience with desferrioxamine therapy in patients affected by Î²-thalassemia major according to: bioavailability; mechanism of interactions with hepatocellular iron: release of iron chelates and their excretion; impact of iron chelation on survival in thalassemia patients and side effects of prolonged therapy.  Problems related to the development of non-toxic oral iron chelators are also discussed, with particular emphasis on the preliminary data on usefulness and safety of deferiprone (L1), recently evaluated in different clin. trials.  Iron chelating therapy has been introduced, in recent years, even in the therapy of disorders not characterized by iron overload.  Here the following new therapeutic indications are discussed: adult respiratory distress syndrome, myocardial ischemia, cancer and malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsl26WRz7hZLVg90H21EOLACvtfcHk0ljwdqbmQdgnkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis1Kitr4%253D&md5=8f197bb9070580847cb2ecb4ac8f8c2a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2899%2900056-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252899%252900056-9%26sid%3Dliteratum%253Aachs%26aulast%3DFaa%26aufirst%3DG.%26aulast%3DCrisponi%26aufirst%3DG.%26atitle%3DIron%2520chelating%2520agents%2520in%2520clinical%2520practice%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D1999%26volume%3D184%26spage%3D291%26epage%3D310%26doi%3D10.1016%2FS0010-8545%2899%2900056-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span> <span> </span><span class="NLM_article-title">An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs)</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">118</span>â <span class="NLM_lpage">129</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2018.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.freeradbiomed.2018.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30053508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVGrt7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2019&pages=118-129&author=K.+Hirota&title=An+intimate+crosstalk+between+iron+homeostasis+and+oxygen+metabolism+regulated+by+the+hypoxia-inducible+factors+%28HIFs%29&doi=10.1016%2Fj.freeradbiomed.2018.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs)</span></div><div class="casAuthors">Hirota, Kiichi</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">118-129</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxygen and iron are among the most abundant elements and have significant roles in human biol.  Iron is essential for oxygen transport and is a component of mol. O2-carrying proteins, such as Hb and myoglobin.  Iron is also a constituent of redox enzymes and can occupy multiple oxidn. states.  An elaborate system has evolved to stringently regulate the concns. of both, free iron and oxygen, in various sites of the body.  The final destination for iron and oxygen in the cells is the mitochondria.  The mitochondria require substantial amts. of iron for heme synthesis and maturation of iron-sulfur clusters, and oxygen, as the electron acceptor in oxidative phosphorylation.  Therefore, the balance between the control of iron availability and the physiol. of hypoxic responses is crit. for maintaining cell homeostasis.  Several lines of study have clearly demonstrated that the transcription factors, hypoxia-inducible factors (HIFs), play a central role in cellular adaptation to critically low oxygen levels in both normal and compromised tissues.  It has also been shown that several target genes of HIFs are involved in iron homeostasis, reflecting the mol. links between oxygen homeostasis and iron metab.  Furthermore, HIF activation is modulated by intracellular iron, through regulation of hydroxylase activity, which requires iron as a cofactor.  In addn., HIF-2Î± translation is controlled by iron regulatory protein (IRP) activity, providing another level of interdependence between iron and oxygen homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbWhPHssqzfLVg90H21EOLACvtfcHk0ljwdqbmQdgnkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVGrt7nK&md5=fe7619f8a28d0b6e954a00dbd045aed5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DAn%2520intimate%2520crosstalk%2520between%2520iron%2520homeostasis%2520and%2520oxygen%2520metabolism%2520regulated%2520by%2520the%2520hypoxia-inducible%2520factors%2520%2528HIFs%2529%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2019%26volume%3D133%26spage%3D118%26epage%3D129%26doi%3D10.1016%2Fj.freeradbiomed.2018.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camaschella, C.</span></span> <span> </span><span class="NLM_article-title">Iron-deficiency anemia</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>372</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1832</span>â <span class="NLM_lpage">1843</span>, <span class="refDoi">Â DOI: 10.1056/NEJMra1401038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1056%2FNEJMra1401038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25946282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC2MfhsVajuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2015&pages=1832-1843&issue=19&author=C.+Camaschella&title=Iron-deficiency+anemia&doi=10.1056%2FNEJMra1401038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-deficiency anemia</span></div><div class="casAuthors">Camaschella Clara</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1832-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTD0Ma6Pz-Y57mQt-ICR3qNfW6udTcc2eZWq_TtcWejyrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfhsVajuw%253D%253D&md5=eb574f46a2062be164b5fc5ad7c139ba</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1401038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1401038%26sid%3Dliteratum%253Aachs%26aulast%3DCamaschella%26aufirst%3DC.%26atitle%3DIron-deficiency%2520anemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D372%26issue%3D19%26spage%3D1832%26epage%3D1843%26doi%3D10.1056%2FNEJMra1401038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peyssonnaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span> <span> </span><span class="NLM_article-title">Role of the hypoxia inducible factors HIF in iron metabolism</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">28</span>â <span class="NLM_lpage">32</span>, <span class="refDoi">Â DOI: 10.4161/cc.7.1.5145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4161%2Fcc.7.1.5145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18212530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVKntbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=28-32&issue=1&author=C.+Peyssonnauxauthor=V.+Nizetauthor=R.+S.+Johnson&title=Role+of+the+hypoxia+inducible+factors+HIF+in+iron+metabolism&doi=10.4161%2Fcc.7.1.5145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the hypoxia inducible factors in iron metabolism</span></div><div class="casAuthors">Peyssonnaux, Carole; Nizet, Victor; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-32</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Fe is an essential element in all living organisms and is required as a cofactor for O2-binding proteins.  Fe metab., O2 homeostasis, and erythropoiesis are consequently strongly interconnected.  Fe needs to be tightly regulated, as Fe insufficiency induces a hypoferric anemia in mammals, coupled to hypoxia in tissues, whereas excess Fe is toxic, and causes the generation of free radicals.  Given the links between O2 transport and Fe metab., assocns. between the physiol. of hypoxic response and the control of Fe availability are important.  Numerous lines of investigation have proven that the hypoxia-inducible factors (HIFs) function as central mediators of cellular adaptation to critically low O2 levels in both normal and compromised tissues.  Several of these target genes are involved in Fe homeostasis, reflecting the mol. links between O2 homeostasis and Fe metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPOQCmM5opiLVg90H21EOLACvtfcHk0ljwdqbmQdgnkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVKntbw%253D&md5=fa9b895b40687527bcce1fe2a2d90afa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.1.5145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.1.5145%26sid%3Dliteratum%253Aachs%26aulast%3DPeyssonnaux%26aufirst%3DC.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DRole%2520of%2520the%2520hypoxia%2520inducible%2520factors%2520HIF%2520in%2520iron%2520metabolism%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26issue%3D1%26spage%3D28%26epage%3D32%26doi%3D10.4161%2Fcc.7.1.5145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cunha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maselli, L. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bydlowski, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spada, C.</span></span> <span> </span><span class="NLM_article-title">Hepcidin: homeostasis and diseases related to iron metabolism</span>. <i>Acta Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">220</span>â <span class="NLM_lpage">236</span>, <span class="refDoi">Â DOI: 10.1159/000471838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1159%2F000471838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28514781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGltb%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2017&pages=220-236&issue=4&author=C.+O.+Reichertauthor=J.+da+Cunhaauthor=D.+Levyauthor=L.+M.+F.+Maselliauthor=S.+P.+Bydlowskiauthor=C.+Spada&title=Hepcidin%3A+homeostasis+and+diseases+related+to+iron+metabolism&doi=10.1159%2F000471838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hepcidin: Homeostasis and Diseases Related to Iron Metabolism</span></div><div class="casAuthors">Reichert, Cadiele Oliana; da Cunha, Joel; Levy, Debora; Maselli, Luciana Morganti Ferreira; Bydlowski, Sergio Paulo; Spada, Celso</div><div class="citationInfo"><span class="NLM_cas:title">Acta Haematologica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">220-236</span>CODEN:
                <span class="NLM_cas:coden">ACHAAH</span>;
        ISSN:<span class="NLM_cas:issn">0001-5792</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Iron is an essential metal for cell survival that is regulated by the peptide hormone hepcidin.  However, its influence on certain diseases is directly related to iron metab. or secondary to underlying diseases.  Genetic alterations influence the serum hepcidin concn., which can lead to an iron overload in tissues, as obsd. in haemochromatosis, in which serum hepcidin or defective hepcidin synthesis is obsd.  Another genetic imbalance of iron is iron-refractory anemia, in which serum concns. of hepcidin are increased, precluding the flow and efflux of extra- and intracellular iron.  During the pathogenesis of certain diseases, the resulting oxidative stress, as well as the increase in inflammatory cytokines, influences the transcription of the HAMP gene to generate a secondary anemia due to the increase in the serum concn. of hepcidin.  To date, there is no available drug to inhibit or enhance hepcidin transcription, mostly due to the cytotoxicity described in the in vitro models.  The proposed therapeutic targets are still in the early stages of clin. trials.  Some candidates are promising, such as heparin derivs. and minihepcidins.  This review describes the main pathways of systemic and genetic regulation of hepcidin, as well as its influence on the disorders related to iron metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzsDoCfNY4mLVg90H21EOLACvtfcHk0lila0vtuRe7Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGltb%252FJ&md5=7bd8f19af4a461164e08ec9979361bab</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1159%2F000471838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000471838%26sid%3Dliteratum%253Aachs%26aulast%3DReichert%26aufirst%3DC.%2BO.%26aulast%3Dda%2BCunha%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DMaselli%26aufirst%3DL.%2BM.%2BF.%26aulast%3DBydlowski%26aufirst%3DS.%2BP.%26aulast%3DSpada%26aufirst%3DC.%26atitle%3DHepcidin%253A%2520homeostasis%2520and%2520diseases%2520related%2520to%2520iron%2520metabolism%26jtitle%3DActa%2520Haematol.%26date%3D2017%26volume%3D137%26issue%3D4%26spage%3D220%26epage%3D236%26doi%3D10.1159%2F000471838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hentze, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckenthaler, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camaschella, C.</span></span> <span> </span><span class="NLM_article-title">Two to tango: regulation of mammalian iron metabolism</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>â <span class="NLM_lpage">38</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2010.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.cell.2010.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20603012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Cjt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=24-38&issue=1&author=M.+W.+Hentzeauthor=M.+U.+Muckenthalerauthor=B.+Galyauthor=C.+Camaschella&title=Two+to+tango%3A+regulation+of+mammalian+iron+metabolism&doi=10.1016%2Fj.cell.2010.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Two to tango: regulation of mammalian iron metabolism</span></div><div class="casAuthors">Hentze, Matthias W.; Muckenthaler, Martina U.; Galy, Bruno; Camaschella, Clara</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-38</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Disruptions in iron homeostasis from both iron deficiency and overload account for some of the most common human diseases.  Iron metab. is balanced by 2 regulatory systems, 1 that functions systemically and relies on the hormone hepcidin and the iron exporter ferroportin, and another that predominantly controls cellular iron metab. through iron-regulatory proteins that bind iron-responsive elements in regulated mRNAs.  We describe how the 2 distinct systems function and how they tango together in a coordinated manner.  We also highlight some of the current questions in mammalian iron metab. and discuss therapeutic opportunities arising from a better understanding of the underlying biol. principles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8FBfNAaqRrVg90H21EOLACvtfcHk0lila0vtuRe7Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Cjt7k%253D&md5=666a7208872dc65c09a987b0b1f62b24</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DHentze%26aufirst%3DM.%2BW.%26aulast%3DMuckenthaler%26aufirst%3DM.%2BU.%26aulast%3DGaly%26aufirst%3DB.%26aulast%3DCamaschella%26aufirst%3DC.%26atitle%3DTwo%2520to%2520tango%253A%2520regulation%2520of%2520mammalian%2520iron%2520metabolism%26jtitle%3DCell%26date%3D2010%26volume%3D142%26issue%3D1%26spage%3D24%26epage%3D38%26doi%3D10.1016%2Fj.cell.2010.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babitt, J. L.</span></span> <span> </span><span class="NLM_article-title">Overview of iron metabolism in health and disease</span>. <i>Hemodial. Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">S6</span>â <span class="NLM_lpage">S20</span>, <span class="refDoi">Â DOI: 10.1111/hdi.12542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fhdi.12542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28296010" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=S6-S20&author=S.+Devauthor=J.+L.+Babitt&title=Overview+of+iron+metabolism+in+health+and+disease&doi=10.1111%2Fhdi.12542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fhdi.12542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fhdi.12542%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DS.%26aulast%3DBabitt%26aufirst%3DJ.%2BL.%26atitle%3DOverview%2520of%2520iron%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DHemodial.%2520Int.%26date%3D2017%26volume%3D21%26spage%3DS6%26epage%3DS20%26doi%3D10.1111%2Fhdi.12542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span> <span> </span><span class="NLM_article-title">Heme oxygenase and heme degradation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">558</span>â <span class="NLM_lpage">567</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2005.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bbrc.2005.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16115609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=558-567&issue=1&author=G.+Kikuchiauthor=T.+Yoshidaauthor=M.+Noguchi&title=Heme+oxygenase+and+heme+degradation&doi=10.1016%2Fj.bbrc.2005.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Heme oxygenase and heme degradation</span></div><div class="casAuthors">Kikuchi, Goro; Yoshida, Tadashi; Noguchi, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">558-567</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The microsomal heme oxygenase system consists of heme oxygenase (HO) and NADPH-cytochrome P 450 reductase, and plays a key role in the physiol. catabolism of heme which yields biliverdin, CO, and Fe as the final products.  Heme degrdn. proceeds essentially as a series of autocatalytic oxidn. reactions involving heme bound to HO.  Large amts. of HO proteins from human and rat can now be prepd. in truncated sol. form, and the crystal structures of some HO proteins have been detd.  These advances have greatly facilitated the understanding of the mechanisms of individual steps of the HO reaction.  HO can be induced in animals by the administration of heme or several other substances; the induction is shown to involve Bach1, a translational repressor.  The induced HO is assumed to have cytoprotective effects.  An uninducible HO isoenzyme, HO-2, has been identified, so the authentic HO is now called HO-1.  HOs are also widely distributed in invertebrates, higher plants, algae, and bacteria, and function in various ways according to the needs of individual species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDtfLjsqFCeLVg90H21EOLACvtfcHk0lg-Kjoir-Seqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrvO&md5=90b28d7eff7e8f0cc7f7204e73c3e956</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DG.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DM.%26atitle%3DHeme%2520oxygenase%2520and%2520heme%2520degradation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D338%26issue%3D1%26spage%3D558%26epage%3D567%26doi%3D10.1016%2Fj.bbrc.2005.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiabrando, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrillo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagoonee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camporeale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlo, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altruda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolosano, E.</span></span> <span> </span><span class="NLM_article-title">The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4569</span>â <span class="NLM_lpage">4579</span>, <span class="refDoi">Â DOI: 10.1172/JCI62422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1172%2FJCI62422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23187127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVakt7bE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=4569-4579&issue=12&author=D.+Chiabrandoauthor=S.+Marroauthor=S.+Mercurioauthor=C.+Giorgiauthor=S.+Petrilloauthor=F.+Vinchiauthor=V.+Fioritoauthor=S.+Fagooneeauthor=A.+Camporealeauthor=E.+Turcoauthor=G.+R.+Merloauthor=L.+Silengoauthor=F.+Altrudaauthor=P.+Pintonauthor=E.+Tolosano&title=The+mitochondrial+heme+exporter+FLVCR1b+mediates+erythroid+differentiation&doi=10.1172%2FJCI62422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation</span></div><div class="casAuthors">Chiabrando, Deborah; Marro, Samuele; Mercurio, Sonia; Giorgi, Carlotta; Petrillo, Sara; Vinchi, Francesca; Fiorito, Veronica; Fagoonee, Sharmila; Camporeale, Annalisa; Turco, Emilia; Merlo, Giorgio R.; Silengo, Lorenzo; Altruda, Fiorella; Pinton, Paolo; Tolosano, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4569-4579</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Feline leukemia virus subgroup C receptor 1 (FLVCR1) is a cell membrane heme exporter that maintains the balance between heme levels and globin synthesis in erythroid precursors.  It was previously shown that Flvcr1-null mice died in utero due to a failure of erythropoiesis.  Here, we identify Flvcr1b, a mitochondrial Flvcr1 isoform that promotes heme efflux into the cytoplasm.  Flvcr1b overexpression promoted heme synthesis and in vitro erythroid differentiation, whereas silencing of Flvcr1b caused mitochondrial heme accumulation and termination of erythroid differentiation.  Furthermore, mice lacking the plasma membrane isoform (Flvcr1a) but expressing Flvcr1b had normal erythropoiesis, but exhibited hemorrhages, edema, and skeletal abnormalities.  Thus, FLVCR1b regulates erythropoiesis by controlling mitochondrial heme efflux, whereas FLVCR1a expression is required to prevent hemorrhages and edema.  The aberrant expression of Flvcr1 isoforms may play a role in the pathogenesis of disorders characterized by an imbalance between heme and globin synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSVBRWMTlIcrVg90H21EOLACvtfcHk0lg-Kjoir-Seqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVakt7bE&md5=c4036d413d168b8cd9f55a0a21e8c33c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1172%2FJCI62422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI62422%26sid%3Dliteratum%253Aachs%26aulast%3DChiabrando%26aufirst%3DD.%26aulast%3DMarro%26aufirst%3DS.%26aulast%3DMercurio%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DC.%26aulast%3DPetrillo%26aufirst%3DS.%26aulast%3DVinchi%26aufirst%3DF.%26aulast%3DFiorito%26aufirst%3DV.%26aulast%3DFagoonee%26aufirst%3DS.%26aulast%3DCamporeale%26aufirst%3DA.%26aulast%3DTurco%26aufirst%3DE.%26aulast%3DMerlo%26aufirst%3DG.%2BR.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DTolosano%26aufirst%3DE.%26atitle%3DThe%2520mitochondrial%2520heme%2520exporter%2520FLVCR1b%2520mediates%2520erythroid%2520differentiation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26issue%3D12%26spage%3D4569%26epage%3D4579%26doi%3D10.1172%2FJCI62422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingrassia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavadini, P.</span></span> <span> </span><span class="NLM_article-title">Ferritins: a family of molecules for iron storage, antioxidation and more</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1790</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">589</span>â <span class="NLM_lpage">599</span>, <span class="refDoi">Â DOI: 10.1016/j.bbagen.2008.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bbagen.2008.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18929623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1yjtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1790&publication_year=2009&pages=589-599&issue=7&author=P.+Arosioauthor=R.+Ingrassiaauthor=P.+Cavadini&title=Ferritins%3A+a+family+of+molecules+for+iron+storage%2C+antioxidation+and+more&doi=10.1016%2Fj.bbagen.2008.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritins: A family of molecules for iron storage, antioxidation and more</span></div><div class="casAuthors">Arosio, Paolo; Ingrassia, Rosaria; Cavadini, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1790</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">589-599</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ferritins are characterized by highly conserved 3-dimensional structures similar to spherical shells, designed to accommodate large amts. of Fe in a safe, sol., and bioavailable form.  They can have different architectures with 12 or 24 equiv. or non-equiv. subunits, all surrounding a large cavity.  All ferritins readily interact with Fe(II) to induce its oxidn. and deposition in the cavity in a mineral form, in a reaction that is catalyzed by a ferroxidase center.  This is an anti-oxidant activity that consumes Fe(II) and peroxides, the reagents that produce toxic free radicals in the Fenton reaction.  The mechanism of ferritin Fe incorporation has been characterized in detail, while that of Fe release and recycling has been less thoroughly studied.  Generally ferritin expression is regulated by Fe and by oxidative damage, and in vertebrates it plays a central role in the control of cellular iron homeostasis.  Ferritin is mostly cytosolic, but is also found in mammalian mitochondria and nuclei, in plant plastids, and is secreted in insects.  In vertebrates, the cytosolic ferritins are composed of H and L subunit types and their assembly in a tissue-specific ratio that permits flexibility to adapt to cell needs.  The H-ferritin can translocate to the nuclei in some cell types to protect DNA from Fe toxicity, or can be actively secreted, accomplishing various functions.  Mitochondrial ferritin is found in mammals, has a restricted tissue distribution, and seems to protect mitochondria from Fe toxicity and oxidative damage.  The various functions attributed to the cytosolic, nuclear, secretory, and mitochondrial ferritins are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSpcr96o0_hbVg90H21EOLACvtfcHk0lg-Kjoir-Seqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1yjtL4%253D&md5=f6cf377564ba32153f377a82fd70ec51</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2008.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2008.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DArosio%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DR.%26aulast%3DCavadini%26aufirst%3DP.%26atitle%3DFerritins%253A%2520a%2520family%2520of%2520molecules%2520for%2520iron%2520storage%252C%2520antioxidation%2520and%2520more%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2009%26volume%3D1790%26issue%3D7%26spage%3D589%26epage%3D599%26doi%3D10.1016%2Fj.bbagen.2008.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, Y.</span></span> <span> </span><span class="NLM_article-title">Regulators of iron homeostasis: new players in metabolism, cell death, and disease</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">274</span>â <span class="NLM_lpage">286</span>, <span class="refDoi">Â DOI: 10.1016/j.tibs.2015.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tibs.2015.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26725301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSktbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=274-286&issue=3&author=A.+R.+Bogdanauthor=M.+Miyazawaauthor=K.+Hashimotoauthor=Y.+Tsuji&title=Regulators+of+iron+homeostasis%3A+new+players+in+metabolism%2C+cell+death%2C+and+disease&doi=10.1016%2Fj.tibs.2015.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">regulators of iron homeostasis-new players in metabolism, cell death, and disease</span></div><div class="casAuthors">Bogdan, Alexander R.; Miyazawa, Masaki; Hashimoto, Kazunori; Tsuji, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">274-286</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Iron is necessary for life, but can also cause cell death.  Accordingly, cells evolved a robust, tightly regulated suite of genes for maintaining iron homeostasis.  Previous mechanistic studies on iron homeostasis have granted insight into the role of iron in human health and disease.  We highlight new regulators of iron metab., including iron-trafficking proteins [solute carrier family 39, SLC39, also known as ZRT/IRT-like protein, ZIP; and poly-(rC)-binding protein, PCBP] and a cargo receptor (NCOA4) that is crucial for release of ferritin-bound iron.  We also discuss emerging roles of iron in apoptosis and a novel iron-dependent cell death pathway termed 'ferroptosis', the dysregulation of iron metab. in human pathologies, and the use of iron chelators in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGA66e9AaR87Vg90H21EOLACvtfcHk0lghJ33pZ0dRsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSktbvP&md5=72dae0b46d3d001915cdcc9533de7ee6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2015.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2015.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DBogdan%26aufirst%3DA.%2BR.%26aulast%3DMiyazawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTsuji%26aufirst%3DY.%26atitle%3DRegulators%2520of%2520iron%2520homeostasis%253A%2520new%2520players%2520in%2520metabolism%252C%2520cell%2520death%252C%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2016%26volume%3D41%26issue%3D3%26spage%3D274%26epage%3D286%26doi%3D10.1016%2Fj.tibs.2015.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancias, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontano Vaites, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biancur, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goessling, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span> <span> </span><span class="NLM_article-title">Ferritinophagy <i>via</i> NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">10308</span>â <span class="NLM_lpage">10327</span>, <span class="refDoi">Â DOI: 10.7554/eLife.10308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.7554%2FeLife.10308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls1Snsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=10308-10327&author=J.+D.+Manciasauthor=L.+Pontano+Vaitesauthor=S.+Nissimauthor=D.+E.+Biancurauthor=A.+J.+Kimauthor=X.+X.+Wangauthor=Y.+Liuauthor=W.+Goesslingauthor=A.+C.+Kimmelmanauthor=J.+W.+Harper&title=Ferritinophagy+via+NCOA4+is+required+for+erythropoiesis+and+is+regulated+by+iron+dependent+HERC2-mediated+proteolysis&doi=10.7554%2FeLife.10308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis</span></div><div class="casAuthors">Mancias, Joseph D.; Vaites, Laura Pontano; Nissim, Sahar; Biancur, Douglas E.; Kim, Andrew J.; Wang, Xiaoxu; Liu, Yu; Goessling, Wolfram; Kimmelman, Alec C.; Harper, J. Wade</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e10308/1-e10308/19</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">NCOA4 is a selective cargo receptor for the autophagic turnover of ferritin, a process crit. for regulation of intracellular iron bioavailability.  However, how ferritinophagy flux is controlled and the roles of NCOA4 in iron-dependent processes are poorly understood.  Through anal. of the NCOA4-FTH1 interaction, we demonstrate that direct assocn. via a key surface arginine in FTH1 and a C-terminal element in NCOA4 is required for delivery of ferritin to the lysosome via autophagosomes.  Moreover, NCOA4 abundance is under dual control via autophagy and the ubiquitin proteasome system.  Ubiquitin-dependent NCOA4 turnover is promoted by excess iron and involves an iron-dependent interaction between NCOA4 and the HERC2 ubiquitin ligase.  In zebrafish and cultured cells, NCOA4 plays an essential role in erythroid differentiation.  This work reveals the mol. nature of the NCOA4-ferritin complex and explains how intracellular iron levels modulate NCOA4-mediated ferritinophagy in cells and in an iron-dependent physiol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHja4uWUDFuLVg90H21EOLACvtfcHk0lghJ33pZ0dRsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls1Snsr4%253D&md5=2669906c24fa9619c03b9ac0b0e58af5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.7554%2FeLife.10308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10308%26sid%3Dliteratum%253Aachs%26aulast%3DMancias%26aufirst%3DJ.%2BD.%26aulast%3DPontano%2BVaites%26aufirst%3DL.%26aulast%3DNissim%26aufirst%3DS.%26aulast%3DBiancur%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DX.%2BX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGoessling%26aufirst%3DW.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26atitle%3DFerritinophagy%2520via%2520NCOA4%2520is%2520required%2520for%2520erythropoiesis%2520and%2520is%2520regulated%2520by%2520iron%2520dependent%2520HERC2-mediated%2520proteolysis%26jtitle%3DeLife%26date%3D2015%26volume%3D4%26spage%3D10308%26epage%3D10327%26doi%3D10.7554%2FeLife.10308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwanhaeusser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr-Ivacevic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selbach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckenthaler, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentze, M. W.</span></span> <span> </span><span class="NLM_article-title">Iron regulatory protein-1 and â2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">e168</span>â <span class="NLM_lpage">e179</span>, <span class="refDoi">Â DOI: 10.1182/blood-2011-04-343541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood-2011-04-343541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21940823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=e168-e179&issue=22&author=M.+Sanchezauthor=B.+Galyauthor=B.+Schwanhaeusserauthor=J.+Blakeauthor=T.+Bahr-Ivacevicauthor=V.+Benesauthor=M.+Selbachauthor=M.+U.+Muckenthalerauthor=M.+W.+Hentze&title=Iron+regulatory+protein-1+and+%E2%88%922%3A+transcriptome-wide+definition+of+binding+mRNAs+and+shaping+of+the+cellular+proteome+by+iron+regulatory+proteins&doi=10.1182%2Fblood-2011-04-343541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Iron regulatory protein-1 and -2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins</span></div><div class="casAuthors">Sanchez, Mayka; Galy, Bruno; Schwanhaeusser, Bjoern; Blake, Jonathon; Baehr-Ivacevic, Tomi; Benes, Vladimir; Selbach, Matthias; Muckenthaler, Martina U.; Hentze, Matthias W.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">e168-e179</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Iron regulatory proteins (IRPs) 1 and 2 are RNA-binding proteins that control cellular iron metab. by binding to conserved RNA motifs called iron-responsive elements (IREs).  The currently known IRP-binding mRNAs encode proteins involved in iron uptake, storage, and release as well as heme synthesis.  To systematically define the IRE/IRP regulatory network on a transcriptome-wide scale, IRP1/IRE and IRP2/IRE messenger ribonucleoprotein complexes were immunoselected, and the mRNA compn. was detd. using microarrays.  We identify 35 novel mRNAs that bind both IRP1 and IRP2, and we also report for the first time cellular mRNAs with exclusive specificity for IRP1 or IRP2.  To further explore cellular iron metab. at a system-wide level, we undertook proteomic anal. by pulsed stable isotope labeling by amino acids in cell culture in an iron-modulated mouse hepatic cell line and in bone marrow-derived macrophages from IRP1- and IRP2-deficient mice.  This work investigates cellular iron metab. in unprecedented depth and defines a wide network of mRNAs and proteins with iron-dependent regulation, IRP-dependent regulation, or both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyXVb4VoW2dLVg90H21EOLACvtfcHk0lghJ33pZ0dRsQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfE&md5=8b5c81ae913c190fef0b883707ad2261</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-04-343541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-04-343541%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DM.%26aulast%3DGaly%26aufirst%3DB.%26aulast%3DSchwanhaeusser%26aufirst%3DB.%26aulast%3DBlake%26aufirst%3DJ.%26aulast%3DBahr-Ivacevic%26aufirst%3DT.%26aulast%3DBenes%26aufirst%3DV.%26aulast%3DSelbach%26aufirst%3DM.%26aulast%3DMuckenthaler%26aufirst%3DM.%2BU.%26aulast%3DHentze%26aufirst%3DM.%2BW.%26atitle%3DIron%2520regulatory%2520protein-1%2520and%2520%25E2%2588%25922%253A%2520transcriptome-wide%2520definition%2520of%2520binding%2520mRNAs%2520and%2520shaping%2520of%2520the%2520cellular%2520proteome%2520by%2520iron%2520regulatory%2520proteins%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26issue%3D22%26spage%3De168%26epage%3De179%26doi%3D10.1182%2Fblood-2011-04-343541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comporti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonocore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccoli, L.</span></span> <span> </span><span class="NLM_article-title">Iron release, oxidative stress and erythrocyte ageing</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">568</span>â <span class="NLM_lpage">576</span>, <span class="refDoi">Â DOI: 10.1016/S0891-5849(02)00759-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0891-5849%2802%2900759-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11909691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWlsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=568-576&issue=7&author=M.+Comportiauthor=C.+Signoriniauthor=G.+Buonocoreauthor=L.+Ciccoli&title=Iron+release%2C+oxidative+stress+and+erythrocyte+ageing&doi=10.1016%2FS0891-5849%2802%2900759-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Iron release, oxidative stress and erythrocyte aging</span></div><div class="casAuthors">Comporti, Mario; Signorini, Cinzia; Buonocore, Giuseppe; Ciccoli, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">568-576</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 61 refs.  Fe, to be redox cycling active, has to be released from its macromol. complexes (ferritin, transferrin, hemoproteins, etc.).  Fe is released from Hb or its derivs. in a nonprotein-bound, desferrioxamine-chelatable form (DCI) in a no. of conditions in which the erythrocytes are subjected to oxidative stress.  Such conditions can be related to toxicol. events (hemolytic drugs) or to physiol. situations (erythrocyte ageing, reproduced in a model of prolonged aerobic incubation), but can also result from more subtle circumstances in which a state of ischemia-reperfusion is imposed on erythrocytes (e.g., childbirth).  The released Fe could play a central role in the oxidn. of membrane proteins and senescent cell antigen (SCA) formation, one of the major pathways for erythrocyte removal.  Fe chelators able to enter cells (such as ferrozine, quercetin, and fluorobenzoylpyridoxal hydrazone) prevent both membrane protein oxidn. and SCA formation.  The increased release of Fe obsd. in Î²-thalassemia patients and newborns (particularly premature babies) suggests that fetal Hb is more prone to release Fe than adult Hb.  In newborns the release of Fe in erythrocytes is correlated with plasma nonprotein-bound Fe and may contribute to its appearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcgeowwiAdeLVg90H21EOLACvtfcHk0lg6MWN8qOc3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWlsbw%253D&md5=c649bd698d4cdd430ff01e03e165b765</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2900759-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252900759-1%26sid%3Dliteratum%253Aachs%26aulast%3DComporti%26aufirst%3DM.%26aulast%3DSignorini%26aufirst%3DC.%26aulast%3DBuonocore%26aufirst%3DG.%26aulast%3DCiccoli%26aufirst%3DL.%26atitle%3DIron%2520release%252C%2520oxidative%2520stress%2520and%2520erythrocyte%2520ageing%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D32%26issue%3D7%26spage%3D568%26epage%3D576%26doi%3D10.1016%2FS0891-5849%2802%2900759-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beserra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrick, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Prion protein functions as a ferrireductase partner for ZIP14 and DMT1</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">322</span>â <span class="NLM_lpage">330</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2015.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.freeradbiomed.2015.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25862412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFequ7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2015&pages=322-330&author=A.+K.+Tripathiauthor=S.+Haldarauthor=J.+Qianauthor=A.+Beserraauthor=S.+Sudaauthor=A.+Singhauthor=U.+Hopferauthor=S.+G.+Chenauthor=M.+D.+Garrickauthor=J.+R.+Turnerauthor=M.+D.+Knutsonauthor=N.+Singh&title=Prion+protein+functions+as+a+ferrireductase+partner+for+ZIP14+and+DMT1&doi=10.1016%2Fj.freeradbiomed.2015.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Prion protein functions as a ferrireductase partner for ZIP14 and DMT1</span></div><div class="casAuthors">Tripathi, Ajai K.; Haldar, Swati; Qian, Juan; Beserra, Amber; Suda, Srinivas; Singh, Ajay; Hopfer, Ulrich; Chen, Shu G.; Garrick, Michael D.; Turner, Jerrold R.; Knutson, Mitchell D.; Singh, Neena</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-330</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Excess circulating iron is stored in the liver, and requires redn. of non-Tf-bound iron (NTBI) and transferrin (Tf) iron at the plasma membrane and endosomes, resp., by ferrireductase (FR) proteins for transport across biol. membranes through divalent metal transporters.  Here, we report that prion protein (PrPC), a ubiquitously expressed glycoprotein most abundant on neuronal cells, functions as a FR partner for divalent-metal transporter-1 (DMT1) and ZIP14.  Thus, absence of PrPC in PrP-knock-out (PrP-/-) mice resulted in markedly reduced liver iron stores, a deficiency that was not cor. by chronic or acute administration of iron by the oral or i.p. routes.  Likewise, preferential radiolabeling of circulating NTBI with 59Fe revealed significantly reduced uptake and storage of NTBI by the liver of PrP-/- mice relative to matched PrP+/+ controls.  However, uptake, storage, and utilization of ferritin-bound iron that does not require redn. for uptake were increased in PrP-/- mice, indicating a compensatory response to the iron deficiency.  Expression of exogenous PrPC in HepG2 cells increased uptake and storage of ferric iron (Fe3+), not ferrous iron (Fe2+), from the medium, supporting the function of PrPC as a plasma membrane FR.  Coexpression of PrPC with ZIP14 and DMT1 in HepG2 cells increased uptake of Fe3+ significantly, and surprisingly, increased the ratio of N-terminally truncated PrPC forms lacking the FR domain relative to full-length PrPC.  Together, these observations indicate that PrPC promotes, and possibly regulates, the uptake of NTBI through DMT1 and Zip14 via its FR activity.  Implications of these observations for neuronal iron homeostasis under physiol. and pathol. conditions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTHlYryZ9JrVg90H21EOLACvtfcHk0lg6MWN8qOc3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFequ7Y%253D&md5=d0282869356ae5b39d41ac390856bd31</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DTripathi%26aufirst%3DA.%2BK.%26aulast%3DHaldar%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DBeserra%26aufirst%3DA.%26aulast%3DSuda%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DHopfer%26aufirst%3DU.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DGarrick%26aufirst%3DM.%2BD.%26aulast%3DTurner%26aufirst%3DJ.%2BR.%26aulast%3DKnutson%26aufirst%3DM.%2BD.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DPrion%2520protein%2520functions%2520as%2520a%2520ferrireductase%2520partner%2520for%2520ZIP14%2520and%2520DMT1%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D84%26spage%3D322%26epage%3D330%26doi%3D10.1016%2Fj.freeradbiomed.2015.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkitkasemwong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparkman, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, M. D.</span></span> <span> </span><span class="NLM_article-title">ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">34032</span>â <span class="NLM_lpage">34043</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M112.367284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1074%2Fjbc.M112.367284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22898811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=34032-34043&issue=41&author=C.+Y.+Wangauthor=S.+Jenkitkasemwongauthor=S.+Duarteauthor=B.+K.+Sparkmanauthor=A.+Shawkiauthor=B.+Mackenzieauthor=M.+D.+Knutson&title=ZIP8+is+an+iron+and+zinc+transporter+whose+cell-surface+expression+is+up-regulated+by+cellular+iron+loading&doi=10.1074%2Fjbc.M112.367284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ZIP8 Is an Iron and Zinc Transporter Whose Cell-surface Expression Is Up-regulated by Cellular Iron Loading</span></div><div class="casAuthors">Wang, Chia-Yu; Jenkitkasemwong, Supak; Duarte, Stephanie; Sparkman, Brian K.; Shawki, Ali; MacKenzie, Bryan; Knutson, Mitchell D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">34032-34043</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">ZIP8 (SLC39A8) belongs to the ZIP family of metal-ion transporters.  Among the ZIP proteins, ZIP8 is most closely related to ZIP14, which can transport iron, zinc, manganese, and cadmium.  Here, we investigated the iron transport ability of ZIP8, its subcellular localization, pH dependence, and regulation by iron.  Transfection of HEK 293T cells with ZIP8 cDNA enhanced the uptake of 59Fe and 65Zn by 200 and 40%, resp., compared with controls.  Excess iron inhibited the uptake of zinc and vice versa.  In RNA-injected Xenopus oocytes, ZIP8-mediated 55Fe2+ transport was saturable (K0.5 of â¼0.7 Î¼m) and inhibited by zinc.  ZIP8 also mediated the uptake of 109Cd2+, 57Co2+, 65Zn2+ > 54Mn2+, but not 64Cu (I or II).  By using immunofluorescence anal., we found that ZIP8 expressed in HEK 293T cells localized to the plasma membrane and partially in early endosomes.  Iron loading increased total and cell-surface levels of ZIP8 in H4IIE rat hepatoma cells.  We also detd. by using site-directed mutagenesis that asparagine residues 40, 88, and 96 of rat ZIP8 are glycosylated and that N-glycosylation is not required for iron or zinc transport.  Anal. of 20 different human tissues revealed abundant ZIP8 expression in lung and placenta and showed that its expression profile differs markedly from ZIP14, suggesting nonredundant functions.  Suppression of endogenous ZIP8 expression in BeWo cells, a placental cell line, reduced iron uptake by â¼40%, suggesting that ZIP8 participates in placental iron transport.  Collectively, these data identify ZIP8 as an iron transport protein that may function in iron metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PjK5H_MI2LVg90H21EOLACvtfcHk0lg6MWN8qOc3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLrM&md5=70d2c40d7f358747a89f2a4da7218030</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.367284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.367284%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DJenkitkasemwong%26aufirst%3DS.%26aulast%3DDuarte%26aufirst%3DS.%26aulast%3DSparkman%26aufirst%3DB.%2BK.%26aulast%3DShawki%26aufirst%3DA.%26aulast%3DMackenzie%26aufirst%3DB.%26aulast%3DKnutson%26aufirst%3DM.%2BD.%26atitle%3DZIP8%2520is%2520an%2520iron%2520and%2520zinc%2520transporter%2520whose%2520cell-surface%2520expression%2520is%2520up-regulated%2520by%2520cellular%2520iron%2520loading%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D41%26spage%3D34032%26epage%3D34043%26doi%3D10.1074%2Fjbc.M112.367284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2274</span>â <span class="NLM_lpage">2296</span>, <span class="refDoi">Â DOI: 10.3390/nu7042274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fnu7042274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25835049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVyqu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2274-2296&issue=4&author=D.+J.+Laneauthor=D.+H.+Baeauthor=A.+M.+Merlotauthor=S.+Sahniauthor=D.+R.+Richardson&title=Duodenal+cytochrome+b+%28DCYTB%29+in+iron+metabolism%3A+an+update+on+function+and+regulation&doi=10.3390%2Fnu7042274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation</span></div><div class="casAuthors">Lane, Darius J. R.; Bae, Dong-Hun; Merlot, Angelica M.; Sahni, Sumit; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrients</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2274-2296</span>CODEN:
                <span class="NLM_cas:coden">NUTRHU</span>;
        ISSN:<span class="NLM_cas:issn">2072-6643</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Iron and ascorbate are vital cellular constituents in mammalian systems.  The bulk-requirement for iron is during erythropoiesis leading to the generation of Hb-contg. erythrocytes.  Addnl., both iron and ascorbate are required as co-factors in numerous metabolic reactions.  Iron homeostasis is controlled at the level of uptake, rather than excretion.  Accumulating evidence strongly suggests that in addn. to the known ability of dietary ascorbate to enhance non-heme iron absorption in the gut, ascorbate regulates iron homeostasis.  The involvement of ascorbate in dietary iron absorption extends beyond the direct chem. redn. of non-heme iron by dietary ascorbate.  Among other activities, intra-enterocyte ascorbate appears to be involved in the provision of electrons to a family of trans-membrane redox enzymes, namely those of the cytochroe b561 class.  These hemoproteins oxidize a pool of ascorbate on one side of the membrane in order to reduce an electron acceptor (e.g., non-heme iron) on the opposite side of the membrane.  One member of this family, duodenal cytochrome b (DCYTB), may play an important role in ascorbate-dependent redn. of non-heme iron in the gut prior to uptake by ferrous-iron transporters.  This review discusses the emerging relationship between cellular iron homeostasis, the emergent "IRP1-HIF2Î± axis", DCYTB and ascorbate in relation to iron metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl-NPgYEANlrVg90H21EOLACvtfcHk0lg6MWN8qOc3vQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVyqu70%253D&md5=0c219c57ee57b67a9e8384bb6fa5e1ee</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fnu7042274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu7042274%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DD.%2BJ.%26aulast%3DBae%26aufirst%3DD.%2BH.%26aulast%3DMerlot%26aufirst%3DA.%2BM.%26aulast%3DSahni%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DDuodenal%2520cytochrome%2520b%2520%2528DCYTB%2529%2520in%2520iron%2520metabolism%253A%2520an%2520update%2520on%2520function%2520and%2520regulation%26jtitle%3DNutrients%26date%3D2015%26volume%3D7%26issue%3D4%26spage%3D2274%26epage%3D2296%26doi%3D10.3390%2Fnu7042274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinilla-Tenas, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparkman, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illing, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuzzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousins, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, B.</span></span> <span> </span><span class="NLM_article-title">Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron</span>. <i>Am. J. Physiol. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>301</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">C862</span>â <span class="NLM_lpage">C871</span>, <span class="refDoi">Â DOI: 10.1152/ajpcell.00479.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1152%2Fajpcell.00479.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21653899" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=C862-C871&issue=4&author=J.+J.+Pinilla-Tenasauthor=B.+K.+Sparkmanauthor=A.+Shawkiauthor=A.+C.+Illingauthor=C.+J.+Mitchellauthor=N.+Zhaoauthor=J.+P.+Liuzziauthor=R.+J.+Cousinsauthor=M.+D.+Knutsonauthor=B.+Mackenzie&title=Zip14+is+a+complex+broad-scope+metal-ion+transporter+whose+functional+properties+support+roles+in+the+cellular+uptake+of+zinc+and+nontransferrin-bound+iron&doi=10.1152%2Fajpcell.00479.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00479.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00479.2010%26sid%3Dliteratum%253Aachs%26aulast%3DPinilla-Tenas%26aufirst%3DJ.%2BJ.%26aulast%3DSparkman%26aufirst%3DB.%2BK.%26aulast%3DShawki%26aufirst%3DA.%26aulast%3DIlling%26aufirst%3DA.%2BC.%26aulast%3DMitchell%26aufirst%3DC.%2BJ.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DLiuzzi%26aufirst%3DJ.%2BP.%26aulast%3DCousins%26aufirst%3DR.%2BJ.%26aulast%3DKnutson%26aufirst%3DM.%2BD.%26aulast%3DMackenzie%26aufirst%3DB.%26atitle%3DZip14%2520is%2520a%2520complex%2520broad-scope%2520metal-ion%2520transporter%2520whose%2520functional%2520properties%2520support%2520roles%2520in%2520the%2520cellular%2520uptake%2520of%2520zinc%2520and%2520nontransferrin-bound%2520iron%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D301%26issue%3D4%26spage%3DC862%26epage%3DC871%26doi%3D10.1152%2Fajpcell.00479.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung-Toung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spino, M.</span></span> <span> </span><span class="NLM_article-title">Iron chelator research: past, present, and future</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">983</span>â <span class="NLM_lpage">995</span>, <span class="refDoi">Â DOI: 10.2174/0929867033457593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F0929867033457593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12678671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=983-995&author=T.+F.+Tamauthor=R.+Leung-Toungauthor=W.+Liauthor=Y.+S.+Wangauthor=K.+Karimianauthor=M.+Spino&title=Iron+chelator+research%3A+past%2C+present%2C+and+future&doi=10.2174%2F0929867033457593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelator research: Past, present, and future</span></div><div class="casAuthors">Tam, Tim F.; Leung-Toung, Regis; Li, Wanren; Wang, Yingsheng; Karimian, Khashayar; Spino, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">983-995</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of in vivo iron toxicity in the human body can be categorized into iron overload and noniron overload conditions.  Iron overload conditions are common in Î²-thalassemia and hereditary hemochromatosis patients, and anthracycline-mediated cardiotoxicity is an example of a noniron overload condition in cancer patients, in which the toxicity is iron-dependent.  While hundreds of iron chelators have been evaluated in animal studies, only a few have been studied in humans.  Examples of iron chelator drugs are desferrioxamine (DFO), Deferiprone (LI), and Dexrazoxane (ICRF 187).  The compd. ICL670 has completed phase II clin. trials and a phase III trial is planned in 2003.  Triapine is currently in phase II clin. trial as an anticancer agent.  CP502, GT56-252, NaHBED, and MPB0201 are examples of new chelators in preclin./clin. development.  In the past decade, many new viable utilities for iron chelators have been reported.  This includes the use of iron chelators as antiviral, photoprotective, antiproliferative, and antifibrotic agents.  This review will focus on the status of drug development for the treatment of iron overload in patients with Î²-thalassemia and the potential use of iron chelators in the prevention and treatment of other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcNjtxrkc9rVg90H21EOLACvtfcHk0lhxx1JGTjyTdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtLY%253D&md5=d9efe5f4ace7278ed9fec88145dc5af3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F0929867033457593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457593%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DT.%2BF.%26aulast%3DLeung-Toung%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DKarimian%26aufirst%3DK.%26aulast%3DSpino%26aufirst%3DM.%26atitle%3DIron%2520chelator%2520research%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D983%26epage%3D995%26doi%3D10.2174%2F0929867033457593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessling-Resnick, M.</span></span> <span> </span><span class="NLM_article-title">Iron homeostasis and the inflammatory response</span>. <i>Annu. Rev. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">105</span>â <span class="NLM_lpage">122</span>, <span class="refDoi">Â DOI: 10.1146/annurev.nutr.012809.104804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1146%2Fannurev.nutr.012809.104804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20420524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWgsb3E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=105-122&author=M.+Wessling-Resnick&title=Iron+homeostasis+and+the+inflammatory+response&doi=10.1146%2Fannurev.nutr.012809.104804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Iron homeostasis and the inflammatory response</span></div><div class="casAuthors">Wessling-Resnick, Marianne</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Nutrition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-122</span>CODEN:
                <span class="NLM_cas:coden">ARNTD8</span>;
        ISSN:<span class="NLM_cas:issn">0199-9885</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Iron and its homeostasis are intimately tied to the inflammatory response.  The adaptation to iron deficiency, which confers resistance to infection and improves the inflammatory condition, underlies what is probably the most obvious link: the anemia of inflammation or chronic disease.  A large no. of stimulatory inputs must be integrated to tightly control iron homeostasis during the inflammatory response.  In order to understand the pathways of iron trafficking and how they are regulated, this article presents a brief overview of iron homeostasis.  A major focus is on the regulation of the peptide hormone hepcidin during the inflammatory response and how its function contributes to the process of iron withdrawal.  The review also summarizes new and emerging information about other iron metabolic regulators and effectors that contribute to the inflammatory response.  Potential benefits of treatment to ameliorate the hypoferremic condition promoted by inflammation are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI-h7L4t-_JLVg90H21EOLACvtfcHk0lhxx1JGTjyTdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWgsb3E&md5=062cc48100f9329ab396758e05a53d63</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1146%2Fannurev.nutr.012809.104804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.nutr.012809.104804%26sid%3Dliteratum%253Aachs%26aulast%3DWessling-Resnick%26aufirst%3DM.%26atitle%3DIron%2520homeostasis%2520and%2520the%2520inflammatory%2520response%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D2010%26volume%3D30%26spage%3D105%26epage%3D122%26doi%3D10.1146%2Fannurev.nutr.012809.104804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apostolakis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kypraiou, A. M.</span></span> <span> </span><span class="NLM_article-title">Iron in neurodegenerative disorders: being in the wrong place at the wrong time?</span>. <i>Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">893</span>â <span class="NLM_lpage">911</span>, <span class="refDoi">Â DOI: 10.1515/revneuro-2017-0020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1515%2Frevneuro-2017-0020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28792913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsrbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=893-911&issue=8&author=S.+Apostolakisauthor=A.+M.+Kypraiou&title=Iron+in+neurodegenerative+disorders%3A+being+in+the+wrong+place+at+the+wrong+time%3F&doi=10.1515%2Frevneuro-2017-0020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Iron in neurodegenerative disorders: being in the wrong place at the wrong time?</span></div><div class="casAuthors">Apostolakis, Sotirios; Kypraiou, Anna-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">893-911</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Brain iron deposits have been reported consistently in imaging and histol. examns. of patients with neurodegenerative disorders.  While the origins of this finding have not been clarified yet, it is speculated that impaired iron homeostasis or deficient transport mechanisms result in the accumulation of this highly toxic metal ultimately leading to formation of reactive oxygen species and cell death.  On the other hand, there are also those who support that iron is just an incidental finding, a by product of neuronal loss.  A literature review has been performed in order to present the key findings in support of the iron hypothesis of neurodegeneration, as well as to identify conditions causing or resulting from iron overload and compare and contrast their features with the most prominent neurodegenerative disorders.  There is an abundance of exptl. and observational findings in support of the hypothesis in question; however, as neurodegeneration is a rare incident of commonly encountered iron-assocd. disorders of the nervous system, and this metal is found in non-neurodegenerative disorders as well, it is possible that iron is the result or even an incidental finding in neurodegeneration.  Understanding the underlying processes of iron metab. in the brain and particularly its release during cell damage is expected to provide a deeper understanding of the origins of neurodegeneration in the years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsuxA8GYkFLVg90H21EOLACvtfcHk0lhxx1JGTjyTdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsrbO&md5=d744c79a309cf4b13b3ab4016d2e6af2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1515%2Frevneuro-2017-0020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Frevneuro-2017-0020%26sid%3Dliteratum%253Aachs%26aulast%3DApostolakis%26aufirst%3DS.%26aulast%3DKypraiou%26aufirst%3DA.%2BM.%26atitle%3DIron%2520in%2520neurodegenerative%2520disorders%253A%2520being%2520in%2520the%2520wrong%2520place%2520at%2520the%2520wrong%2520time%253F%26jtitle%3DRev.%2520Neurosci.%26date%3D2017%26volume%3D28%26issue%3D8%26spage%3D893%26epage%3D911%26doi%3D10.1515%2Frevneuro-2017-0020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Asbeck, B.S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, N.A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Bruggen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudshoorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottet, H.S.L.M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, J.J.M.</span></span> <span> </span><span class="NLM_article-title">Anti-HIV effect of iron chelators: different mechanisms involved</span>. <i>J. Clin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">141</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/S1386-6532(00)00122-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1386-6532%2800%2900122-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11166663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSmuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=141-147&author=B.S.+van%0AAsbeckauthor=N.A.+Georgiouauthor=T.+van+der+Bruggenauthor=M.+Oudshoornauthor=H.S.L.M.+Nottetauthor=J.J.M.+Marx&title=Anti-HIV+effect+of+iron+chelators%3A+different+mechanisms+involved&doi=10.1016%2FS1386-6532%2800%2900122-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV effect of iron chelators: different mechanisms involved</span></div><div class="casAuthors">van Asbeck, B. S.; Georgiou, N. A.; van der Bruggen, T.; Oudshoorn, M.; Nottet, H. S. L. M.; Marx, J. J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">141-147</span>CODEN:
                <span class="NLM_cas:coden">JCVIFB</span>;
        ISSN:<span class="NLM_cas:issn">1386-6532</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review and discussion with 40 refs.  Background: Drugs for the treatment of AIDS have been directed to specific events in the human immunodeficiency virus (HIV-1) life cycle, aimed to stop viral replication by inhibition of reverse transcriptase or protease activity.  Studies showing that oxidative stress and iron may be important in the activation of HIV-1 have focused attention on the potential therapeutic use of iron chelators.  Objectives: The goal of this review is to describe several possibilities as to how iron is involved in the replication of HIV and how iron chelation may interfere in this process.  Study design: First some physico-chem. properties of iron concerning soly., oxidn.-redn. potential, catalysis, and chelation will be discussed.  In the second part, the role of iron in various biochem. systems is explained.  Results: Nuclear factor kappa B (NF-ÎºB) activation, regulating proviral transcription, can be influenced by iron through the prodn. of reactive oxygen species.  A second route by which iron chelation could influence HIV replication is by inhibition of DNA synthesis through inactivation of iron-dependent ribonucleotide reductase.  Another strategy which can be employed in targeting iron chelators against HIV-1 is direct oxidative viral RNA/DNA attack.  This could be achieved by bleomycin, a cytostatic agent with the ability to form a complex with DNA and RNA.  Conclusion: Chelation may withhold iron from viral metab. but on the other hand may also favor catalysis of reactive oxygen species directed to viral constituents.  In combination with existing antivirals, iron chelation could add to improve the treatment of HIV disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkq8hQ99PjM7Vg90H21EOLACvtfcHk0lhq0hrNWYQbYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSmuw%253D%253D&md5=11ba558a040ad4b321a1fed4a74840c7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1386-6532%2800%2900122-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1386-6532%252800%252900122-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BAsbeck%26aufirst%3DB.S.%26aulast%3DGeorgiou%26aufirst%3DN.A.%26aulast%3Dvan%2Bder%2BBruggen%26aufirst%3DT.%26aulast%3DOudshoorn%26aufirst%3DM.%26aulast%3DNottet%26aufirst%3DH.S.L.M.%26aulast%3DMarx%26aufirst%3DJ.J.M.%26atitle%3DAnti-HIV%2520effect%2520of%2520iron%2520chelators%253A%2520different%2520mechanisms%2520involved%26jtitle%3DJ.%2520Clin.%2520Virol.%26date%3D2001%26volume%3D20%26spage%3D141%26epage%3D147%26doi%3D10.1016%2FS1386-6532%2800%2900122-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sappey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelaert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand-poels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forceille, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span> <span> </span><span class="NLM_article-title">Iron chelation decreases NF-ÎºB and HIV type 1 activation due to oxidative stress</span>. <i>AIDS Res. Hum. Retroviruses</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1049</span>â <span class="NLM_lpage">1061</span>, <span class="refDoi">Â DOI: 10.1089/aid.1995.11.1049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1089%2Faid.1995.11.1049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=8554902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2MXos1Cgtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1995&pages=1049-1061&issue=9&author=C.+Sappeyauthor=J.+R.+Boelaertauthor=S.+Legrand-poelsauthor=C.+Forceilleauthor=A.+Favierauthor=J.+Piette&title=Iron+chelation+decreases+NF-%CE%BAB+and+HIV+type+1+activation+due+to+oxidative+stress&doi=10.1089%2Faid.1995.11.1049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelation decreases NF-kB and HIV type 1 activation due to oxidative stress</span></div><div class="casAuthors">Sappey, Christine; Boelaert, Johan R.; Legrand-Poels, Sylvie; Forceille, Christine; Favier, Alain; Piette, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">AIDS Research and Human Retroviruses</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1049-61</span>CODEN:
                <span class="NLM_cas:coden">ARHRE7</span>;
        ISSN:<span class="NLM_cas:issn">0889-2229</span>.
    
            (<span class="NLM_cas:orgname">Liebert</span>)
        </div><div class="casAbstract">An important aspect of human immunodeficiency virus (HIV-1) infection is the regulation of its expression by nuclear factor ÎºB (NF-ÎºB) through redox-controlled signal transduction pathways.  In this study, we demonstrate that iron chelation by deferoxamine (DFO) protects against the cytotoxic and reactivating effects of hydrogen peroxide (H2O2).  These protective effects were obsd. both in lymphocytic (ACH-2) and promonocytic (U1) cells latently infected by HIV-1.  Concomitantly, NF-ÎºB activation by H2O2, when followed by gel retardation assay, was decreased in the DFO-treated U1 and ACH-2 cells.  This latter DFO-mediated effect was specific, as DFO did not clearly affect AP-1 DNA-binding activity when studied after H2O2-induced stress.  More importantly, DFO protected against the H2O2-induced activation of HIV-1 as evidenced by reverse transcriptase activity in the supernatant.  DFO also protected against PMA-induced NF-ÎºB activation as well as TNF-Î±-induced HIV-1 activation.  Furthermore, DFO attenuated the p24 response in PBMC infected with HIV-1 and stimulated with IL-2.  These different effects of DFO were obtained at DFO concns. lower than 5 Î¼M.  Other chem. unrelated iron chelators also provided protection against cytotoxicity, NF-ÎºB activation, and HIV-1 activation in U1 cells challenged with H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMgbUUe7257Vg90H21EOLACvtfcHk0lhq0hrNWYQbYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1Cgtb0%253D&md5=5a064e12b48eedd9a8d74e448bee1a3b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Faid.1995.11.1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Faid.1995.11.1049%26sid%3Dliteratum%253Aachs%26aulast%3DSappey%26aufirst%3DC.%26aulast%3DBoelaert%26aufirst%3DJ.%2BR.%26aulast%3DLegrand-poels%26aufirst%3DS.%26aulast%3DForceille%26aufirst%3DC.%26aulast%3DFavier%26aufirst%3DA.%26aulast%3DPiette%26aufirst%3DJ.%26atitle%3DIron%2520chelation%2520decreases%2520NF-%25CE%25BAB%2520and%2520HIV%2520type%25201%2520activation%2520due%2520to%2520oxidative%2520stress%26jtitle%3DAIDS%2520Res.%2520Hum.%2520Retroviruses%26date%3D1995%26volume%3D11%26issue%3D9%26spage%3D1049%26epage%3D1061%26doi%3D10.1089%2Faid.1995.11.1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Bruggen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudshoorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottet, H. S. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Asbeck, B. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">484</span>â <span class="NLM_lpage">490</span>, <span class="refDoi">Â DOI: 10.1086/315223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1086%2F315223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10669330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFCjsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2000&pages=484-490&author=N.+A.+Georgiouauthor=T.+van+der+Bruggenauthor=M.+Oudshoornauthor=H.+S.+L.+M.+Nottetauthor=J.+J.+M.+Marxauthor=B.+S.+van%0AAsbeck&title=Inhibition+of+human+immunodeficiency+virus+type+1+replication+in+human+mononuclear+blood+cells+by+the+iron+chelators+deferoxamine%2C+deferiprone%2C+and+bleomycin&doi=10.1086%2F315223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin</span></div><div class="casAuthors">Georgiou, Niki A.; Van der Bruggen, Tjomme; Oudshoorn, Maroeska; Nottet, Hans S. L. M.; Marx, Joannes J. M.; Van Asbeck, B. Sweder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">484-490</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Replication of human immunodeficiency virus type 1 (HIV-1) can be influenced by iron.  Hence, decreasing the availability of iron may inhibit HIV-1 replication.  Deferoxamine and deferiprone, both forming catalytically inactive iron-chelator complexes, and bleomycin, by use of which iron catalyzes oxidative nucleic acid destruction, were investigated.  Expression of p24 antigen in human monocyte-derived macrophages and peripheral blood lymphocytes (PBL) was reduced by all 3 iron chelators.  In PBL, p24 redn. was mirrored by a decrease in proliferation after incubation with deferoxamine or deferiprone, suggesting that viral inhibition is closely linked to a decrease in cellular proliferation.  In contrast, clin. relevant bleomycin concns. reduced p24 levels by â¼50% without affecting proliferation.  When deferoxamine and the nucleoside analog dideoxyinosine were used in combination, they acted synergistically in inhibiting HIV-1 replication.  These observations suggest that iron chelators with different mechanisms of action could be of addnl. benefit in antiretroviral combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKJKzRN-BKz7Vg90H21EOLACvtfcHk0lhq0hrNWYQbYA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFCjsbY%253D&md5=ecb515f7302b5a9bad48774555567e9a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1086%2F315223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F315223%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiou%26aufirst%3DN.%2BA.%26aulast%3Dvan%2Bder%2BBruggen%26aufirst%3DT.%26aulast%3DOudshoorn%26aufirst%3DM.%26aulast%3DNottet%26aufirst%3DH.%2BS.%2BL.%2BM.%26aulast%3DMarx%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3Dvan%2BAsbeck%26aufirst%3DB.%2BS.%26atitle%3DInhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520in%2520human%2520mononuclear%2520blood%2520cells%2520by%2520the%2520iron%2520chelators%2520deferoxamine%252C%2520deferiprone%252C%2520and%2520bleomycin%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2000%26volume%3D181%26spage%3D484%26epage%3D490%26doi%3D10.1086%2F315223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schalk, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mislin, G. L. A.</span></span> <span> </span><span class="NLM_article-title">Bacterial iron uptake pathways: gates for the import of bactericide compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4573</span>â <span class="NLM_lpage">4576</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00554</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00554" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslegurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4573-4576&issue=11&author=I.+J.+Schalkauthor=G.+L.+A.+Mislin&title=Bacterial+iron+uptake+pathways%3A+gates+for+the+import+of+bactericide+compounds&doi=10.1021%2Facs.jmedchem.7b00554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial Iron Uptake Pathways: Gates for the Import of Bactericide Compounds</span></div><div class="casAuthors">Schalk, Isabelle J.; Mislin, Gaetan L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4573-4576</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bacterial resistance to most antibiotics in clin. use has reached alarming proportions.  A challenge for modern medicine will be to discover new antibiotics or strategies to combat multidrug resistant bacteria, esp. Gram-neg. bacteria for which the situation is particularly crit.  Vectorization of bactericide compds. by siderophores (iron chelators produced by bacteria) is a promising strategy able to considerably increase the efficacy of drugs.  Such a Trojan horse strategy can also extend activity of Gram-pos. only antibiotics to Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyqDdsohxqRLVg90H21EOLACvtfcHk0liXL28JpHO-3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslegurc%253D&md5=3406ceacf25b62b486f373b0bbcfcf5a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00554%26sid%3Dliteratum%253Aachs%26aulast%3DSchalk%26aufirst%3DI.%2BJ.%26aulast%3DMislin%26aufirst%3DG.%2BL.%2BA.%26atitle%3DBacterial%2520iron%2520uptake%2520pathways%253A%2520gates%2520for%2520the%2520import%2520of%2520bactericide%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D11%26spage%3D4573%26epage%3D4576%26doi%3D10.1021%2Facs.jmedchem.7b00554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichmann, H.</span></span> <span> </span><span class="NLM_article-title">Role of iron in neurodegenerative diseases</span>. <i>J. Neural. Transm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">389</span>â <span class="NLM_lpage">399</span>, <span class="refDoi">Â DOI: 10.1007/s00702-016-1508-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00702-016-1508-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26794939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=389-399&issue=4&author=K.+Liauthor=H.+Reichmann&title=Role+of+iron+in+neurodegenerative+diseases&doi=10.1007%2Fs00702-016-1508-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">role of iron in neurodegenerative diseases</span></div><div class="casAuthors">Li, Kai; Reichmann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">Currently, we still lack effective measures to modify disease progression in neurodegenerative diseases.  Iron-contg. proteins play an essential role in many fundamental biol. processes in the central nervous system.  In addn., iron is a redox-active ion and can induce oxidative stress in the cell.  Although the causes and pathol. hallmarks of different neurodegenerative diseases vary, iron dyshomeostasis, oxidative stress and mitochondrial injury constitute a common pathway to cell death in several neurodegenerative diseases.  MRI is capable of depicting iron content in the brain, and serves as a potential biomarker for early and differential diagnosis, tracking disease progression and evaluating the effectiveness of neuroprotective therapy.  Iron chelators have shown their efficacy against neurodegeneration in a series of animal models, and been applied in several clin. trials.  In this review, we summarize recent developments on iron dyshomeostasis in Parkinson's disease, Alzheimer's disease, Friedreich ataxia, and Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobktfTwhBVErVg90H21EOLACvtfcHk0liXL28JpHO-3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOitb4%253D&md5=ab652b0d08fc4b6ed939846566119026</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00702-016-1508-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-016-1508-7%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DReichmann%26aufirst%3DH.%26atitle%3DRole%2520of%2520iron%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2016%26volume%3D123%26issue%3D4%26spage%3D389%26epage%3D399%26doi%3D10.1007%2Fs00702-016-1508-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, P.</span></span> <span> </span><span class="NLM_article-title">Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1545</span>â <span class="NLM_lpage">1565</span>, <span class="refDoi">Â DOI: 10.3390/ijms19051545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fijms19051545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOqtrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1545-1565&issue=5&author=L.+F.+Zhouauthor=B.+Zhaoauthor=L.+X.+Zhangauthor=S.+H.+Wangauthor=D.+D.+Dongauthor=H.+H.+Lvauthor=P.+Shang&title=Alterations+in+cellular+iron+metabolism+provide+more+therapeutic+opportunities+for+cancer&doi=10.3390%2Fijms19051545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer</span></div><div class="casAuthors">Zhou, Liangfu; Zhao, Bin; Zhang, Lixiu; Wang, Shenghang; Dong, Dandan; Lv, Huanhuan; Shang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1545/1-1545/21</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Iron is an essential element for the growth and proliferation of cells.  Cellular iron uptake, storage, utilization and export are tightly regulated to maintain iron homeostasis.  However, cellular iron metab. pathways are disturbed in most cancer cells.  To maintain rapid growth and proliferation, cancer cells acquire large amts. of iron by altering expression of iron metab.-related proteins.  In this paper, normal cellular iron metab. and the alterations of iron metabolic pathways in cancer cells were summarized.  Therapeutic strategies based on targeting the altered iron metab. were also discussed and disrupting redox homeostasis by intracellular high levels of iron provides new insight for cancer therapy.  Altered iron metab. constitutes a promising therapeutic target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQt8v6wc-xgrVg90H21EOLACvtfcHk0liXL28JpHO-3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOqtrbI&md5=d073b8c634336b5cbfdc12700895da1c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fijms19051545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19051545%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%2BF.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DL.%2BX.%26aulast%3DWang%26aufirst%3DS.%2BH.%26aulast%3DDong%26aufirst%3DD.%2BD.%26aulast%3DLv%26aufirst%3DH.%2BH.%26aulast%3DShang%26aufirst%3DP.%26atitle%3DAlterations%2520in%2520cellular%2520iron%2520metabolism%2520provide%2520more%2520therapeutic%2520opportunities%2520for%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26issue%3D5%26spage%3D1545%26epage%3D1565%26doi%3D10.3390%2Fijms19051545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Iron metabolism in cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>â <span class="NLM_lpage">116</span>, <span class="refDoi">Â DOI: 10.3390/ijms20010095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fijms20010095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFahsbbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=95-116&issue=1&author=Y.+F.+Wangauthor=L.+Yuauthor=J.+Dingauthor=Y.+Chen&title=Iron+metabolism+in+cancer&doi=10.3390%2Fijms20010095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Iron metabolism in cancer</span></div><div class="casAuthors">Wang, Yafang; Yu, Lei; Ding, Jian; Chen, Yi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95/1-95/22</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though.  By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidn., DNA, and protein damages, leading to carcinogenesis or ferroptosis.  Iron also plays profound roles in modulating tumor microenvironment and metastasis, maintaining genomic stability and controlling epigenetics. in order to meet the high requirement of iron, neoplastic cells have remodeled iron metab. pathways, including acquisition, storage, and efflux, which makes manipulating iron homeostasis a considerable approach for cancer therapy.  Several iron chelators and iron oxide nanoparticles (IONPs) has recently been developed for cancer intervention and presented considerable effects.  This review summarizes some latest findings about iron metab. function and regulation mechanism in cancer and the application of iron chelators and IONPs in cancer diagnosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp8mOaOJNVrbVg90H21EOLACvtfcHk0lhodQ4ciRCb6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFahsbbE&md5=dce81cca77f823bbfb8a555b3a49df56</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fijms20010095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20010095%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DIron%2520metabolism%2520in%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26issue%3D1%26spage%3D95%26epage%3D116%26doi%3D10.3390%2Fijms20010095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of iron chelators with therapeutic application</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6371</span>â <span class="NLM_lpage">6389</span>, <span class="refDoi">Â DOI: 10.1039/c2dt12159j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc2dt12159j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22391807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1Srsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=6371-6389&issue=21&author=T.+Zhouauthor=Y.+M.+Maauthor=X.+L.+Kongauthor=R.+C.+Hider&title=Design+of+iron+chelators+with+therapeutic+application&doi=10.1039%2Fc2dt12159j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design of iron chelators with therapeutic application</span></div><div class="casAuthors">Zhou, Tao; Ma, Yongmin; Kong, Xiaole; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6371-6389</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Iron is essential for the proper functioning of all living cells, however it is toxic when present in excess.  Thus, using iron chelators as therapeutic agents, namely chelation therapy, has received increasing attention.  The objective of this review is to discuss the factors which should be considered when designing clin. useful iron chelators, to present the application of iron chelators in the treatment of iron overload assocd. with Î²-thalassemia major and sickle cell anemia, and to highlight the potential applications in the treatment of neurodegenerative disorders and microbial infection.  This article reviews recent knowledge centered on these themes and indicates the growing importance of the concept of iron chelation in medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXM3r1rHtjGbVg90H21EOLACvtfcHk0lhodQ4ciRCb6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1Srsbs%253D&md5=751df1f5f06cb8a7122fb607db0a9ff6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fc2dt12159j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2dt12159j%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520iron%2520chelators%2520with%2520therapeutic%2520application%26jtitle%3DDalton%2520Trans.%26date%3D2012%26volume%3D41%26issue%3D21%26spage%3D6371%26epage%3D6389%26doi%3D10.1039%2Fc2dt12159j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of clinically useful iron(III)-selective chelators</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">26</span>â <span class="NLM_lpage">64</span>, <span class="refDoi">Â DOI: 10.1002/med.1027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fmed.1027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11746175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3MnpvVGksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=26-64&issue=1&author=Z.+D.+Liuauthor=R.+C.+Hider&title=Design+of+clinically+useful+iron%28III%29-selective+chelators&doi=10.1002%2Fmed.1027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Design of clinically useful iron(III)-selective chelators</span></div><div class="casAuthors">Liu Zu D; Hider Robert C</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal research reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-64</span>
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">Iron overload is a serious clinical condition which can be largely prevented by the use of iron-specific chelating agents.  Desferrioxamine-B, the most widely used iron chelator in haematology over the past 30 years, has a major disadvantage of being orally inactive.  Consequently, the successful design of an orally active, nontoxic, selective iron chelator has become a much sought after goal.  In order to identify an ideal iron chelator for clinical use, a range of specifications must be considered such as metal selectivity and affinity, kinetic stability of the complex, bioavailability and toxicity.  A wide range of chelator types bind iron(III) and of these, hexa-, tri-, and bidentate are capable of providing iron(III) with the favoured octahedral environment.  In this review, the comparative properties of such ligands are discussed, examples being selected from hydroxamates, aminocarboxylates, hydroxypyridinones, orthosubstituted phenols and triazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVWVkt39Ar8_h3YQQtAhNufW6udTcc2eYedArwA8_Fsbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnpvVGksw%253D%253D&md5=a7853ebc327a36a048da2169aca3559e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fmed.1027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1027%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520clinically%2520useful%2520iron%2528III%2529-selective%2520chelators%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2002%26volume%3D22%26issue%3D1%26spage%3D26%26epage%3D64%26doi%3D10.1002%2Fmed.1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of iron chelators with therapeutic application</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>232</i></span> (<span class="NLM_issue">1â2</span>),  <span class="NLM_fpage">151</span>â <span class="NLM_lpage">171</span>, <span class="refDoi">Â DOI: 10.1016/S0010-8545(02)00050-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0010-8545%2802%2900050-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XntF2kur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2002&pages=151-171&issue=1%E2%80%932&author=Z.+D.+Liuauthor=R.+C.+Hider&title=Design+of+iron+chelators+with+therapeutic+application&doi=10.1016%2FS0010-8545%2802%2900050-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design of iron chelators with therapeutic application</span></div><div class="casAuthors">Liu, Zu D.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">151-171</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Iron overload is a serious clin. condition which can be largely prevented by the use of iron-specific chelating agents.  Desferrioxamine-B, the most widely used iron chelator in hematol. over the past 30 yr, has a major disadvantage of being orally inactive.  Consequently, the successful design of an orally active, non-toxic, selective iron chelator has become a much sought after goal.  In order to identify an ideal iron chelator for clin. use, a range of specifications must be considered such as metal selectivity and affinity, kinetic stability of the complex, bioavailability and toxicity.  A wide range of chelator types bind iron(III) and of these, hexa-, tri-, and bidentate are capable of providing iron(III) with the favored octahedral environment.  In this review, the comparative properties of such ligands are discussed, examples being selected from hydroxamates, aminocarboxylates, hydroxypyridinones, ortho-substituted phenols and triazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruzUdRBE0uKbVg90H21EOLACvtfcHk0lhodQ4ciRCb6g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntF2kur4%253D&md5=ef3674011aab611a6cecfe3471871237</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2802%2900050-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252802%252900050-4%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520iron%2520chelators%2520with%2520therapeutic%2520application%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2002%26volume%3D232%26issue%3D1%25E2%2580%25932%26spage%3D151%26epage%3D171%26doi%3D10.1016%2FS0010-8545%2802%2900050-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Recent developments centered on orally active iron chelators</span>. <i>Thalassemia Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2261</span>â <span class="NLM_lpage">2269</span>, <span class="refDoi">Â DOI: 10.4081/thal.2014.2261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4081%2Fthal.2014.2261" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=2261-2269&author=R.+C.+Hider&title=Recent+developments+centered+on+orally+active+iron+chelators&doi=10.4081%2Fthal.2014.2261"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4081%2Fthal.2014.2261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Fthal.2014.2261%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DRecent%2520developments%2520centered%2520on%2520orally%2520active%2520iron%2520chelators%26jtitle%3DThalassemia%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D2261%26epage%3D2269%26doi%3D10.4081%2Fthal.2014.2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, J.</span></span> <span> </span><span class="NLM_article-title">The potential application of iron chelators for the treatment of neurodegenerative diseases</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">239</span>â <span class="NLM_lpage">249</span>, <span class="refDoi">Â DOI: 10.1039/c0mt00087f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc0mt00087f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21344071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=239-249&issue=3&author=R.+C.+Hiderauthor=S.+Royauthor=Y.+M.+Maauthor=X.+Le+Kongauthor=J.+Preston&title=The+potential+application+of+iron+chelators+for+the+treatment+of+neurodegenerative+diseases&doi=10.1039%2Fc0mt00087f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The potential application of iron chelators for the treatment of neurodegenerative diseases</span></div><div class="casAuthors">Hider, Robert C.; Roy, Sourav; Ma, Yong Min; Le Kong, Xiao; Preston, Jane</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Many forms of neurodegenerative disease, for instance Alzheimer's disease, Parkinson's disease, Friedreich's ataxia, Hallervorden Spatz syndrome and macular degeneration, are assocd. with elevated levels of redox active metals in the brain and eye.  A logical therapeutic approach therefore, is to remove the toxic levels of these metals, copper and iron in particular, by selective chelation.  The increased no. of iron-selective chelators now available for clin. use has enhanced interest in this type of therapy.  This review summarises the recent developments in the design of chelators for treatment of neurodegenerative disease, identifies some of the essential properties for such mols. and suggests some future strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_QWZw98vWsbVg90H21EOLACvtfcHk0lhFqzPZvlt62g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D&md5=d5efb2da19e8a08dccb014614ba4b71e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2Fc0mt00087f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0mt00087f%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DLe%2BKong%26aufirst%3DX.%26aulast%3DPreston%26aufirst%3DJ.%26atitle%3DThe%2520potential%2520application%2520of%2520iron%2520chelators%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DMetallomics%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D239%26epage%3D249%26doi%3D10.1039%2Fc0mt00087f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brittenham, G. M.</span></span> <span> </span><span class="NLM_article-title">Development of iron-chelating agents for clinical use</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">569</span>â <span class="NLM_lpage">574</span>, <span class="refDoi">Â DOI: 10.1182/blood.V80.3.569.bloodjournal803569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V80.3.569.bloodjournal803569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1638016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADyaK38zksFGruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1992&pages=569-574&issue=3&author=G.+M.+Brittenham&title=Development+of+iron-chelating+agents+for+clinical+use&doi=10.1182%2Fblood.V80.3.569.bloodjournal803569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of iron-chelating agents for clinical use</span></div><div class="casAuthors">Brittenham G M</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-74</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7WK6v1nO4Sx0LsK7uFuY7fW6udTcc2ebZ-lsJing9i7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zksFGruw%253D%253D&md5=a7a32cfc8313378b3005daa25e00c137</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood.V80.3.569.bloodjournal803569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V80.3.569.bloodjournal803569%26sid%3Dliteratum%253Aachs%26aulast%3DBrittenham%26aufirst%3DG.%2BM.%26atitle%3DDevelopment%2520of%2520iron-chelating%2520agents%2520for%2520clinical%2520use%26jtitle%3DBlood%26date%3D1992%26volume%3D80%26issue%3D3%26spage%3D569%26epage%3D574%26doi%3D10.1182%2Fblood.V80.3.569.bloodjournal803569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Codd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson-Sanchez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telfer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotsbacher, M. P.</span></span> <span> </span><span class="NLM_article-title">Advances in the chemical biology of Desferrioxamine B</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11</span>â <span class="NLM_lpage">25</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.7b00851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=11-25&issue=1&author=R.+Coddauthor=T.+Richardson-Sanchezauthor=T.+J.+Telferauthor=M.+P.+Gotsbacher&title=Advances+in+the+chemical+biology+of+Desferrioxamine+B&doi=10.1021%2Facschembio.7b00851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the Chemical Biology of Desferrioxamine B</span></div><div class="casAuthors">Codd, Rachel; Richardson-Sanchez, Tomas; Telfer, Thomas J.; Gotsbacher, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-25</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Desferrioxamine B (DFOB) was discovered in the late 1950s as a hydroxamic acid metabolite of the soil bacterium Streptomyces pilosus.  The exquisite affinity of DFOB for Fe(III) identified its potential for removing excess iron from patients with transfusion-dependent Hb disorders.  Many studies have used semisynthetic chem. to produce DFOB adducts with new properties and broad-ranging functions.  More recent approaches in chem. biol. have revealed some nuances of DFOB biosynthesis and discovered new DFOB-derived drugs and radiometal imaging agents.  The current and potential applications of DFOB continue to inspire a rich body of chem. biol. research focused on this bacterial metabolite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrW8DRStp7bVg90H21EOLACvtfcHk0lhFqzPZvlt62g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73O&md5=e06b2bf31367431bd9c0de676063f6a8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00851%26sid%3Dliteratum%253Aachs%26aulast%3DCodd%26aufirst%3DR.%26aulast%3DRichardson-Sanchez%26aufirst%3DT.%26aulast%3DTelfer%26aufirst%3DT.%2BJ.%26aulast%3DGotsbacher%26aufirst%3DM.%2BP.%26atitle%3DAdvances%2520in%2520the%2520chemical%2520biology%2520of%2520Desferrioxamine%2520B%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26issue%3D1%26spage%3D11%26epage%3D25%26doi%3D10.1021%2Facschembio.7b00851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionis, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eglikarmakka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxleytencer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, H. H.</span></span> <span> </span><span class="NLM_article-title">Evaluation of desferrithiocin and its synthetic analogs as orally effective iron chelators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2072</span>â <span class="NLM_lpage">2078</span>, <span class="refDoi">Â DOI: 10.1021/jm00111a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00111a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3MXksV2iu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2072-2078&issue=7&author=R.+J.+Bergeronauthor=J.+Wiegandauthor=J.+B.+Dionisauthor=M.+Eglikarmakkaauthor=J.+Freiauthor=A.+Huxleytencerauthor=H.+H.+Peter&title=Evaluation+of+desferrithiocin+and+its+synthetic+analogs+as+orally+effective+iron+chelators&doi=10.1021%2Fjm00111a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of desferrithiocin and its synthetic analogs as orally effective iron chelators</span></div><div class="casAuthors">Bergeron, Raymond J.; Wiegand, Jan; Dionis, John B.; Egli-Karmakka, Majia; Frei, Joerg; Huxley-Tencer, Alica; Peter, Heinrich H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2072-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Desferrithiocin (I), a novel microbial siderophore isolated from cultures of Streptomyces antibioticus DSM 1865, and a no. of its derivs. and analogs were evaluated for their ability to promote iron clearance.  The compds. were designed to identify the structural features of desferrithiocin which render this ligand an orally effective iron chelator.  The desferrithiocin arom. hydroxyl and the thiazoline ring carboxyl group and sulfur are shown to be central to desferrithiocin's activity.  The animal model chosen for this study, the bile duct cannulated rat, provides information regarding both the chelator-induced total iron output and the kinetics of both biliary and urinary ion excretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqICbITltkPkrVg90H21EOLACvtfcHk0ljAyS5M-5aA0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksV2iu70%253D&md5=ef28c660a101ec5b104e39fba4d6050e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00111a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00111a023%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DDionis%26aufirst%3DJ.%2BB.%26aulast%3DEglikarmakka%26aufirst%3DM.%26aulast%3DFrei%26aufirst%3DJ.%26aulast%3DHuxleytencer%26aufirst%3DA.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26atitle%3DEvaluation%2520of%2520desferrithiocin%2520and%2520its%2520synthetic%2520analogs%2520as%2520orally%2520effective%2520iron%2520chelators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26issue%3D7%26spage%3D2072%26epage%3D2078%26doi%3D10.1021%2Fjm00111a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharti, N.</span></span> <span> </span><span class="NLM_article-title">Desferrithiocin: a search for clinically effective iron chelators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9259</span>â <span class="NLM_lpage">9291</span>, <span class="refDoi">Â DOI: 10.1021/jm500828f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500828f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9259-9291&issue=22&author=R.+J.+Bergeronauthor=J.+Wiegandauthor=J.+S.+McManisauthor=N.+Bharti&title=Desferrithiocin%3A+a+search+for+clinically+effective+iron+chelators&doi=10.1021%2Fjm500828f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Desferrithiocin: A Search for Clinically Effective Iron Chelators</span></div><div class="casAuthors">Bergeron, Raymond J.; Wiegand, Jan; McManis, James S.; Bharti, Neelam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9259-9291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The successful search for orally active iron chelators to treat transfusional iron-overload diseases, e.g., thalassemia, is overviewed.  The crit. role of iron in nature as a redox engine is first described, as well as how primitive life forms and humans manage the metal.  The problems that derive when iron homeostasis in humans is disrupted and the mechanism of the ensuing damage, uncontrolled Fenton chem., are discussed.  The soln. to the problem, chelator-mediated iron removal, is clear.  Design options for the assembly of ligands that sequester and decorporate iron are reviewed, along with the shortcomings of the currently available therapeutics.  The rationale for choosing desferrithiocin, a natural product iron chelator (a siderophore), as a platform for structure-activity relationship studies in the search for an orally active iron chelator is thoroughly developed.  The study provides an excellent example of how to systematically reengineer a pharmacophore in order to overcome toxicol. problems while maintaining iron clearing efficacy and has led to three ligands being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30r9OJMpq-rVg90H21EOLACvtfcHk0ljAyS5M-5aA0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrbI&md5=6356fb75827071827d74c2548bc5fef8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500828f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500828f%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DMcManis%26aufirst%3DJ.%2BS.%26aulast%3DBharti%26aufirst%3DN.%26atitle%3DDesferrithiocin%253A%2520a%2520search%2520for%2520clinically%2520effective%2520iron%2520chelators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D22%26spage%3D9259%26epage%3D9291%26doi%3D10.1021%2Fjm500828f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, J.</span></span> <span> </span><span class="NLM_article-title">Preclinical and clinical development of deferitrin, a novel, orally available iron chelator</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1054</i></span>,  <span class="NLM_fpage">492</span>â <span class="NLM_lpage">494</span>, <span class="refDoi">Â DOI: 10.1196/annals.1345.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1196%2Fannals.1345.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16339704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlKmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1054&publication_year=2005&pages=492-494&author=J.+M.+Donovanauthor=M.+Ploneauthor=R.+Dagherauthor=M.+Breeauthor=J.+Marquis&title=Preclinical+and+clinical+development+of+deferitrin%2C+a+novel%2C+orally+available+iron+chelator&doi=10.1196%2Fannals.1345.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical development of deferitrin, a novel, orally available iron chelator</span></div><div class="casAuthors">Donovan, Joanne M.; Plone, Melissa; Dagher, Rafif; Bree, Mark; Marquis, Judith</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1054</span>
        (<span class="NLM_cas:issue">Cooley's Anemia</span>),
    <span class="NLM_cas:pages">492-494</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Deferitrin, a novel, orally available iron chelator, is in the early stage of clin. development for the treatment of chronic iron overload due to transfusional therapy.  Preclin. pharmacol. studies demonstrate iron excretion largely by the fecal route.  Initial clin. studies have shown deferitrin to be well absorbed.  Further clin. studies are ongoing to det. the efficiency and safety of deferitrin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Z9dLXiJtIrVg90H21EOLACvtfcHk0ljAyS5M-5aA0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlKmsA%253D%253D&md5=e4b0dd09706b2585c064a363278669d3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1196%2Fannals.1345.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1345.071%26sid%3Dliteratum%253Aachs%26aulast%3DDonovan%26aufirst%3DJ.%2BM.%26aulast%3DPlone%26aufirst%3DM.%26aulast%3DDagher%26aufirst%3DR.%26aulast%3DBree%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DJ.%26atitle%3DPreclinical%2520and%2520clinical%2520development%2520of%2520deferitrin%252C%2520a%2520novel%252C%2520orally%2520available%2520iron%2520chelator%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2005%26volume%3D1054%26spage%3D492%26epage%3D494%26doi%3D10.1196%2Fannals.1345.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, T.</span></span> <span> </span><span class="NLM_article-title">Deferitazole, a new orally active iron chelator</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5197</span>â <span class="NLM_lpage">5204</span>, <span class="refDoi">Â DOI: 10.1039/C5DT00063G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC5DT00063G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25687725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVClt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=5197-5204&issue=11&author=R.+C.+Hiderauthor=X.+L.+Kongauthor=V.+Abbateauthor=R.+Harlandauthor=K.+Conlonauthor=T.+Luker&title=Deferitazole%2C+a+new+orally+active+iron+chelator&doi=10.1039%2FC5DT00063G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Deferitazole, a new orally active iron chelator</span></div><div class="casAuthors">Hider, Robert C.; Kong, Xiaole; Abbate, Vincenzo; Harland, Rachel; Conlon, Kelly; Luker, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5197-5204</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Following a systematic search of desferrithiocin analogs, a polyether deriv., deferitazole (formerly FBS0701), has entered into phase 1 and 2 clin. trials with promising biol. properties.  However, until now, detailed physicochem. properties of this chelator have not been reported.  The compd. displays a high affinity and selectivity for iron(III) as demonstrated by the log Î²2 = 33.39 Â± 0.03 and the pFe3+ value of 22.3.  Two equilibrating isomeric forms of the iron(III) complex exist under biol. conditions.  Deferitazole also binds the trivalent metals AlIII and LaIII with high affinity; log Î²2 values, 26.68 and 21.55 resp.  The affinity of deferitazole for divalent cations is somewhat lower, with the exception of CuII which possesses a log Î²2 value of 25.5; deferitazole scavenges iron from labile sources such as citrate and albumin with efficiencies comparable with those of other therapeutic iron chelators, including deferasirox, deferiprone and desferrioxamine.  The FeIII(deferitazole)2 is stable under physiol. conditions and does not redox cycle.  The high affinity of deferitazole for iron(III) renders it unlikely that this chelator will lead to the redistribution of iron and consequently deferitazole shows considerable promise as a therapeutic iron(III) chelator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdAavFLtWpI7Vg90H21EOLACvtfcHk0lh9zk-F01dTnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVClt7s%253D&md5=0cca81397522335f582113be0eb4dfec</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2FC5DT00063G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5DT00063G%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DHarland%26aufirst%3DR.%26aulast%3DConlon%26aufirst%3DK.%26aulast%3DLuker%26aufirst%3DT.%26atitle%3DDeferitazole%252C%2520a%2520new%2520orally%2520active%2520iron%2520chelator%26jtitle%3DDalton%2520Trans.%26date%3D2015%26volume%3D44%26issue%3D11%26spage%3D5197%26epage%3D5204%26doi%3D10.1039%2FC5DT00063G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">194</span>â <span class="NLM_lpage">203</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2017.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.jinorgbio.2017.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29329026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtlejsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2018&pages=194-203&author=Y.+L.+Chenauthor=X.+L.+Kongauthor=Y.+Y.+Xieauthor=R.+C.+Hider&title=The+interaction+of+pyridoxal+isonicotinoyl+hydrazone+%28PIH%29+and+salicylaldehyde+isonicotinoyl+hydrazone+%28SIH%29+with+iron&doi=10.1016%2Fj.jinorgbio.2017.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron</span></div><div class="casAuthors">Chen, Yu-Lin; Kong, Xiaole; Xie, Yuanyuan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">194-203</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH), two important biol. active chelators, with iron has been investigated by spectrophotometric methods.  High iron(III) affinity consts. were detd. for PIH, logÎ²2 = 37.0 and SIH, logÎ²2 = 37.6.  The assocd. redox potentials of the iron complexes were detd. using cyclic voltammetry at pH 7.4 as + 130 mV (vs normal hydrogen electrode, NHE) for PIH and + 136 mV(vs NHE) for SIH.  These redox potentials are much higher than those corresponding to iron chelators in clin. use, namely deferiprone, - 620 mV; desferasirox, - 600 mV and desferrioxamine, - 468 mV.  Although the pos. redox potentials of SIH and PIH are similar to that of EDTA, namely + 120 mV, the iron complexes of these two hydrazone chelators, unlike the iron complex of EDTA, do not redox cycle in the presence of vitamin C.  These properties render PIH and SIH as excellent scavengers of iron, under biol. conditions.  Both SIH and PIH scavenge mononuclear iron(II) and iron(III) rapidly.  These fast kinetic properties of the hydrazone-based chelators provide a ready explanation for the adoption of SIH in fluorescence-based methods for the quantification of cytosolic iron(II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLuwqxJ_Iu2rVg90H21EOLACvtfcHk0lh9zk-F01dTnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtlejsQ%253D%253D&md5=f44857681aa713441071a6d4dce8dd96</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520interaction%2520of%2520pyridoxal%2520isonicotinoyl%2520hydrazone%2520%2528PIH%2529%2520and%2520salicylaldehyde%2520isonicotinoyl%2520hydrazone%2520%2528SIH%2529%2520with%2520iron%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D180%26spage%3D194%26epage%3D203%26doi%3D10.1016%2Fj.jinorgbio.2017.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buss, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuzil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponka, P.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>421</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">9</span>, <span class="refDoi">Â DOI: 10.1016/j.abb.2003.09.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.abb.2003.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=14678779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWmsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2004&pages=1-9&issue=1&author=J.+L.+Bussauthor=J.+Neuzilauthor=P.+Ponka&title=Oxidative+stress+mediates+toxicity+of+pyridoxal+isonicotinoyl+hydrazone+analogs&doi=10.1016%2Fj.abb.2003.09.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs</span></div><div class="casAuthors">Buss, Joan L.; Neuzil, Jiri; Ponka, Prem</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Pyridoxal isonicotinoyl hydrazone (PIH) and many of its analogs are effective iron chelators in vivo and in vitro, and are of interest for the treatment of secondary iron overload.  Because previous work has implicated the Fe3+-chelator complexes as a determinant of toxicity, the role of iron-based oxidative stress in the toxicity of PIH analogs was assessed.  The Fe3+ complexes of PIH analogs were reduced by K562 cells and the physiol. reductant, ascorbate.  Depletion of the antioxidant, glutathione, sensitized Jurkat T lymphocytes to the toxicity of PIH analogs and their Fe3+ complexes, and toxicity of the chelators increased with oxygen tension.  Fe3+ complexes of pyridoxal benzoyl hydrazone (PBH) and salicyloyl isonicotinoyl hydrazone (SIH) caused lipid peroxidn. and toxicity in K562 cells loaded with eicosapentenoic acid (EPA), a readily oxidized fatty acid, whereas Fe(PIH)2 did not.  The lipophilic antioxidant, vitamin E, completely prevented both the toxicity and lipid peroxidn. caused by Fe(PBH)2 in EPA-loaded cells, indicating a causal relationship between oxidative stress and toxicity.  PBH also caused concomitant lipid peroxidn. and toxicity in EPA-loaded cells, both of which were reversed as its concn. increased.  In contrast, PIH was inactive, while SIH was equally toxic toward control and EPA-loaded cells, without causing lipid peroxidn., indicating a much smaller contribution of oxidative stress to the mechanism of toxicity of these analogs.  In summary, PIH analogs and their Fe3+ complexes are redox active in the intracellular environment.  The contribution of oxidative stress to the overall mechanism of toxicity varies across the series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECrMgd79RX7Vg90H21EOLACvtfcHk0lh9zk-F01dTnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWmsLY%253D&md5=194d47e3b153ad9a9306e9d5dd1440e9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2003.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2003.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DBuss%26aufirst%3DJ.%2BL.%26aulast%3DNeuzil%26aufirst%3DJ.%26aulast%3DPonka%26aufirst%3DP.%26atitle%3DOxidative%2520stress%2520mediates%2520toxicity%2520of%2520pyridoxal%2520isonicotinoyl%2520hydrazone%2520analogs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D421%26issue%3D1%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.abb.2003.09.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nick, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acklin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buehlmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauffe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schupp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberti, D.</span></span> <span> </span><span class="NLM_article-title">Development of tridentate iron chelators: from desferrithiocin to ICL670</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1065</span>â <span class="NLM_lpage">1076</span>, <span class="refDoi">Â DOI: 10.2174/0929867033457610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F0929867033457610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12678677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1065-1076&issue=12&author=H.+Nickauthor=P.+Acklinauthor=R.+Lattmannauthor=P.+Buehlmayerauthor=S.+Hauffeauthor=J.+Schuppauthor=D.+Alberti&title=Development+of+tridentate+iron+chelators%3A+from+desferrithiocin+to+ICL670&doi=10.2174%2F0929867033457610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development of tridentate iron chelators: From desferrithiocin to ICL670</span></div><div class="casAuthors">Nick, Hanspeter; Acklin, Pierre; Lattmann, Rene; Buchlmayer, Peter; Hauffe, Suzanne; Schupp, Joachim; Alberti, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1065-1076</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Successful treatment of Î²-thalassemia requires two key elements: blood transfusion and iron chelation.  Regular blood transfusions considerably expand the lifespan of patients, however, without the removal of the consequential accumulation of body iron, few patients live beyond their second decade.  In 1963, the introduction of desferrioxamine (DFO), a hexadentate chelator, marked a breakthrough in the treatment of Î²-thalassemia.  DFO significantly reduces body iron burden and iron-related morbidity and mortality.  DFO is still the only drug for general use in the treatment of transfusion dependent iron overload.  However, its very short plasma half-life and poor oral activity necessitate special modes of application (s.c. or i.v. infusion) which are inconvenient, can cause local reactions and are difficult to be accepted by many patients.  Over the past four decades, many different labs. have invested major efforts in the identification of orally active iron chelators from several hundreds of mols. of synthetic, microbial or plant origin.  The discovery of ferrithiocin in 1980, followed by the synthesis of the tridentate chelator desferrithiocin and proof of its oral activity raised a lot of hope.  However, the compd. proved to be toxic in animals.  Over a period of about fifteen years many desferrithiocin derivs. and mols. with broader alterations led to the discovery of numerous new compds. some of which were much better tolerated and were more efficacious than desferrithiocin in animals, however, none was safe enough to proceed to the clin. use.  The discovery of a new chem. class of iron chelators: The bishydroxyphenyltriazoles re-energized the search for a safe tridentate chelator.  The basic structure of this completely new chem. class of iron chelators was discovered by a combination of rational design, intuition and experience.  More than forty derivs. of the triazole series were synthesized at Novartis.  These compds. were evaluated, together with more than 700 chelators from various chem. classes.  Using vigorous selection criteria with a focus on tolerability, the tridentate chelator 4-[(3,5-Bis-(2-hydroxyphenyl)-1,2,4)triazol-1-yl]-benzoic acid (ICL670) emerged as an entity which best combined high oral potency and tolerability in animals.  ICL670 is presently being evaluated in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMGzszYalorVg90H21EOLACvtfcHk0lgj36D9ZVJODw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtbo%253D&md5=fd24642d14d46cf2fae2f3eaf0a8bd80</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F0929867033457610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457610%26sid%3Dliteratum%253Aachs%26aulast%3DNick%26aufirst%3DH.%26aulast%3DAcklin%26aufirst%3DP.%26aulast%3DLattmann%26aufirst%3DR.%26aulast%3DBuehlmayer%26aufirst%3DP.%26aulast%3DHauffe%26aufirst%3DS.%26aulast%3DSchupp%26aufirst%3DJ.%26aulast%3DAlberti%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520tridentate%2520iron%2520chelators%253A%2520from%2520desferrithiocin%2520to%2520ICL670%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26issue%3D12%26spage%3D1065%26epage%3D1076%26doi%3D10.2174%2F0929867033457610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konijn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nick, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabantchik, Z. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, G.</span></span> <span> </span><span class="NLM_article-title">ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1115</span>â <span class="NLM_lpage">1122</span>, <span class="refDoi">Â DOI: 10.1182/blood.V97.4.1115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V97.4.1115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11159545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Gis78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2001&pages=1115-1122&issue=4&author=C.+Hershkoauthor=A.+M.+Konijnauthor=H.+P.+Nickauthor=W.+Breuerauthor=Z.+I.+Cabantchikauthor=G.+Link&title=ICL670A%3A+a+new+synthetic+oral+chelator%3A+evaluation+in+hypertransfused+rats+with+selective+radioiron+probes+of+hepatocellular+and+reticuloendothelial+iron+stores+and+in+iron-loaded+rat+heart+cells+in+culture&doi=10.1182%2Fblood.V97.4.1115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture</span></div><div class="casAuthors">Hershko, Chaim; Konijn, Abraham M.; Nick, Hans Peter; Breuer, William; Cabantchik, Zvi Ioav; Link, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1115-1122</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">ICL670A (formerly CGP 72 670) or 4-[3,5-bis-(hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid is a tridentate iron-selective synthetic chelator of the bis-hydroxyphenyl-triazole class of compds.  The present studies used selective radioiron probes of hepatocellular and reticuloendothelial (RE) iron stores in hypertransfused rats and iron-loaded heart cells to define the source of iron chelated in vivo by ICL670A and its mode of excretion, to examine its ability to remove iron directly from iron-loaded myocardial cells, and to examine its ability to interact with other chelators through a possible additive or synergistic effect.  Results indicate that ICL670A given orally is 4 to 5 times more effective than parenteral deferoxamine (DFO) in promoting the excretion of chelatable iron from hepatocellular iron stores.  The pattern of iron excretion produced by ICL670A is quite different from that of DFO and all iron excretion is restricted to the bile regardless of whether it is derived from RE or hepatocellular iron stores.  Studies in heart cell cultures have shown a favorable interaction between DFO and ICL670A manifested in improved chelating efficiency of ICL670A, which is most probably explained by an exchange of chelated iron between ICL670A and DFO.  These unique chelating properties of ICL670A may have practical implications for current efforts to design better therapeutic strategies for the management of transfusional iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTobgVlg-cr7Vg90H21EOLACvtfcHk0lgj36D9ZVJODw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Gis78%253D&md5=f5799e9e85c3b9505436a6d10c988d1c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1182%2Fblood.V97.4.1115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V97.4.1115%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DC.%26aulast%3DKonijn%26aufirst%3DA.%2BM.%26aulast%3DNick%26aufirst%3DH.%2BP.%26aulast%3DBreuer%26aufirst%3DW.%26aulast%3DCabantchik%26aufirst%3DZ.%2BI.%26aulast%3DLink%26aufirst%3DG.%26atitle%3DICL670A%253A%2520a%2520new%2520synthetic%2520oral%2520chelator%253A%2520evaluation%2520in%2520hypertransfused%2520rats%2520with%2520selective%2520radioiron%2520probes%2520of%2520hepatocellular%2520and%2520reticuloendothelial%2520iron%2520stores%2520and%2520in%2520iron-loaded%2520rat%2520heart%2520cells%2520in%2520culture%26jtitle%3DBlood%26date%3D2001%26volume%3D97%26issue%3D4%26spage%3D1115%26epage%3D1122%26doi%3D10.1182%2Fblood.V97.4.1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cappellini, M. D.</span></span> <span> </span><span class="NLM_article-title">Iron-chelating therapy with the new oral agent ICL670 (Exjade)</span>. <i>Best Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">289</span>â <span class="NLM_lpage">298</span>, <span class="refDoi">Â DOI: 10.1016/j.beha.2004.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.beha.2004.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15737891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=289-298&issue=2&author=M.+D.+Cappellini&title=Iron-chelating+therapy+with+the+new+oral+agent+ICL670+%28Exjade%29&doi=10.1016%2Fj.beha.2004.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-chelating therapy with the new oral agent ICL670 (Exjade)</span></div><div class="casAuthors">Cappellini, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Iron-chelation therapy is essential in iron-overloaded patients.  The long-term efficacy of this approach has been demonstrated unequivocally with deferoxamine, which effectively controls iron concns., thereby limiting organ damage and preventing premature death.  However, as deferoxamine is administered parenterally, poor compliance is a significant limitation to successful patient management.  ICL670 (Exjade) is a highly efficient and selective oral iron chelator.  The results of phase I and phase II clin. studies indicate that ICL670 is at least as effective as current std. therapy (deferoxamine), with a tolerability and safety profile suitable for chronic, once-daily administration.  These encouraging results have provided the rationale for the ongoing phase III program, and offer physicians and patients the promise of an oral, once-daily, iron-chelating agent for the prevention and management of iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgubpaNiVNf7Vg90H21EOLACvtfcHk0lgj36D9ZVJODw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbo%253D&md5=b1e677bfcd9748ebbd81f858c8ed17e4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2004.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2004.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DCappellini%26aufirst%3DM.%2BD.%26atitle%3DIron-chelating%2520therapy%2520with%2520the%2520new%2520oral%2520agent%2520ICL670%2520%2528Exjade%2529%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2005%26volume%3D18%26issue%3D2%26spage%3D289%26epage%3D298%26doi%3D10.1016%2Fj.beha.2004.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, M. B.</span></span> <span> </span><span class="NLM_article-title">Deferasirox: oral, once daily iron chelator-an expert opinion</span>. <i>Indian J. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">191</span>, <span class="refDoi">Â DOI: 10.1007/s12098-010-0030-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs12098-010-0030-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20178010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ivFarug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=185-191&author=M.+B.+Agarwal&title=Deferasirox%3A+oral%2C+once+daily+iron+chelator-an+expert+opinion&doi=10.1007%2Fs12098-010-0030-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Deferasirox: oral, once daily iron chelator--an expert opinion</span></div><div class="casAuthors">Agarwal M B</div><div class="citationInfo"><span class="NLM_cas:title">Indian journal of pediatrics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Iron overload is a serious and potentially fatal condition that results from multiple blood transfusions required over a long period of time to treat certain types of anemias such as, that caused by beta-thalassemia, sickle cell disease and myelodysplastic syndrome.  Deferoxamine, which has been used since four decades as an iron chelator has limited efficacy due to its demanding therapeutic regimen, leading to poor compliance.  Deferasirox, once daily oral iron chelator provides an effective alternative to Deferoxamine in the treatment of transfusional hemosiderosis.  In this review, the role of Deferasirox as an ideal iron chelator has been discussed.  Pubmed searches on Deferasirox were carried out for the same.  Several studies demonstrated the safety and efficacy of Deferasirox in reducing iron burden in iron-overloaded patients with beta-thalassemia, sickle cell anemia and myelodysplastic anemia.  Thus, convenient, effective and tolerable chelation therapy with oral Deferasirox is likely to be a significant development in the treatment of transfusional iron overload, due to its ability to provide constant chelation coverage and the potential to improve compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7yS7-aSqx6bP3FVUi_gf8fW6udTcc2ebbBRvvUrC6Vrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ivFarug%253D%253D&md5=e4a2c72f9a383b9a2f2b8f154f9b5b9b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs12098-010-0030-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12098-010-0030-4%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DM.%2BB.%26atitle%3DDeferasirox%253A%2520oral%252C%2520once%2520daily%2520iron%2520chelator-an%2520expert%2520opinion%26jtitle%3DIndian%2520J.%2520Pediatr.%26date%3D2010%26volume%3D77%26spage%3D185%26epage%3D191%26doi%3D10.1007%2Fs12098-010-0030-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2185</span>â <span class="NLM_lpage">2195</span>, <span class="refDoi">Â DOI: 10.1021/jm201475u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201475u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlCqu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2185-2195&issue=5&author=Y.+M.+Maauthor=S.+Royauthor=X.+L.+Kongauthor=Y.+L.+Chenauthor=D.+Y.+Liuauthor=R.+C.+Hider&title=Design+and+synthesis+of+fluorinated+iron+chelators+for+metabolic+study+and+brain+uptake&doi=10.1021%2Fjm201475u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Fluorinated Iron Chelators for Metabolic Study and Brain Uptake</span></div><div class="casAuthors">Ma, Yongmin; Roy, Sourav; Kong, Xiaole; Chen, Yulin; Liu, Dingyong; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2185-2195</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of fluorinated 3-hydroxypyridin-4-ones has been synthesized where fluorine or fluorinated substituent was attached at 2- or 5- position of the pyridine ring in order to improve chem. and biol. properties of 3-hydroxypyridin-4-ones.  The synthetic route is different from conventional counterparts where a functional group is introduced to a preformed 3-hydroxypyridin-4-one ring.  Herein, we introduce a novel method which starts with a fluorine contg. precursor and the two hydroxyl groups at 3- and 4- positions of the pyridine ring are introduced at a later stage.  The pKa values of the free ligands and the affinity consts. of their iron complexes demonstrate that the presence of fluorine dramatically alters the values.  The distribution coeff. values of the free ligands and corresponding iron(III) complexes between 1-octanol and MOPS buffer (pH 7.4) are also influenced.  Glucuronidation and oxidn. studies of selected fluorinated 3-hydroxypyridin-4-ones demonstrate that some such fluorinated compds. have clear advantage over deferiprone in that they are metabolized more slowly.  Blood-brain barrier permeability studies indicated that although lipophilicity influences the permeability it is not the only factor.  Two of the selected seven fluorinated 3-hydroxypyridin-4-ones have improved brain distribution when compared with deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrddgmxFyu3d7Vg90H21EOLACvtfcHk0lgATHdUlmFytQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlCqu7o%253D&md5=c2f53c633a5600e64892e23aca5310e9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm201475u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201475u%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520fluorinated%2520iron%2520chelators%2520for%2520metabolic%2520study%2520and%2520brain%2520uptake%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D5%26spage%3D2185%26epage%3D2195%26doi%3D10.1021%2Fjm201475u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span> <span> </span><span class="NLM_article-title">Synthetic and natural iron chelators: therapeutic potential and clinical use</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1643</span>â <span class="NLM_lpage">1670</span>, <span class="refDoi">Â DOI: 10.4155/fmc.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4155%2Ffmc.09.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21425984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVejuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1643-1670&issue=9&author=H.+C.+Hatcherauthor=R.+N.+Singhauthor=F.+M.+Tortiauthor=S.+V.+Torti&title=Synthetic+and+natural+iron+chelators%3A+therapeutic+potential+and+clinical+use&doi=10.4155%2Ffmc.09.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic and natural iron chelators: therapeutic potential and clinical use</span></div><div class="casAuthors">Hatcher, Heather C.; Singh, Ravi N.; Torti, Frank M.; Torti, Suzy V.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1643-1670</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Iron-chelation therapy has its origins in the treatment of iron-overload syndromes.  For many years, the std. for this purpose was deferoxamine.  Recently, considerable progress was made in identifying synthetic chelators with improved pharmacol. properties relative to deferoxamine.  Most notable are deferasirox (Exjade) and deferiprone (Ferriprox), which are now available clin.  In addn. to treatment of iron overload, there is an emerging role for iron chelators in the treatment of diseases characterized by oxidative stress, including cardiovascular disease, atherosclerosis, neurodegenerative diseases, and cancer.  While iron is not regarded as the underlying cause of these diseases, it does play an important role in disease progression, either through promotion of cellular growth and proliferation or through participation in redox reactions that catalyze the formation of reactive oxygen species and increase oxidative stress.  Thus, iron chelators may be of therapeutic benefit in many of these conditions.  Phytochems., many of which bind iron, may also owe some of their beneficial properties to iron chelation.  This review will focus on the advances in iron-chelation therapy for the treatment of iron-overload disease and cancer, as well as neurodegenerative and chronic inflammatory diseases.  Established and novel iron chelators will be discussed, as well as the emerging role of dietary plant polyphenols that effectively modulate iron biochem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT6Cm-2BLzOLVg90H21EOLACvtfcHk0lgATHdUlmFytQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVejuw%253D%253D&md5=d4e0da1164fc51106fa87954c8116777</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DH.%2BC.%26aulast%3DSingh%26aufirst%3DR.%2BN.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26atitle%3DSynthetic%2520and%2520natural%2520iron%2520chelators%253A%2520therapeutic%2520potential%2520and%2520clinical%2520use%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26issue%3D9%26spage%3D1643%26epage%3D1670%26doi%3D10.4155%2Ffmc.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huehns, E. R.</span></span> <span> </span><span class="NLM_article-title">The development of hydroxypyridin-4-ones as orally active iron chelators</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>612</i></span>,  <span class="NLM_fpage">327</span>â <span class="NLM_lpage">338</span>, <span class="refDoi">Â DOI: 10.1111/j.1749-6632.1990.tb24320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1749-6632.1990.tb24320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=2291561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3MXkvVCls7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=612&publication_year=1990&pages=327-338&author=R.+C.+Hiderauthor=S.+Singhauthor=J.+B.+Porterauthor=E.+R.+Huehns&title=The+development+of+hydroxypyridin-4-ones+as+orally+active+iron+chelators&doi=10.1111%2Fj.1749-6632.1990.tb24320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The development of hydroxypyridin-4-ones as orally active iron chelators</span></div><div class="casAuthors">Hider, R. C.; Singh, S.; Porter, J. B.; Huehns, E. R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">612</span>
        (<span class="NLM_cas:issue">Cooley's Anemia Symp., 6th, 1990</span>),
    <span class="NLM_cas:pages">327-38</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">A review with 28 refs., mainly on the authors' work, which led to the development of CP94 (I) as an effective compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKJU4bzUdYo7Vg90H21EOLACvtfcHk0lgATHdUlmFytQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvVCls7w%253D&md5=294cf4c1dbc45ac09b6d1a56bba4c380</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1990.tb24320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1990.tb24320.x%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DHuehns%26aufirst%3DE.%2BR.%26atitle%3DThe%2520development%2520of%2520hydroxypyridin-4-ones%2520as%2520orally%2520active%2520iron%2520chelators%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1990%26volume%3D612%26spage%3D327%26epage%3D338%26doi%3D10.1111%2Fj.1749-6632.1990.tb24320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Victor
Hoffbrand, A.</span></span> <span> </span><span class="NLM_article-title">Deferiprone therapy for transfusional iron overload</span>. <i>Best. Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">299</span>â <span class="NLM_lpage">317</span>, <span class="refDoi">Â DOI: 10.1016/j.beha.2004.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.beha.2004.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15737892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=299-317&issue=2&author=A.+Victor%0AHoffbrand&title=Deferiprone+therapy+for+transfusional+iron+overload&doi=10.1016%2Fj.beha.2004.08.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Deferiprone therapy for transfusional iron overload</span></div><div class="casAuthors">Victor Hoffbrand, A.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-317</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Iron chelation is needed to prevent damage to the heart, liver and endocrine glands from iron overload in patients with refractory anemias who receive regular blood transfusions.  Desferrioxamine is still the first-line drug, but because of its expense in many countries, and lack of compliance because of difficulty with administration, there is a major need for an orally active (and cheaper) chelating drug.  Seventeen years after the first clin. trials deferiprone, which is orally active, has emerged as suitable for patients for whom desferrioxamine is, for one reason or another, inadequate.  Many patients are successfully chelated at a dose of deferiprone 75 mg/kg/day.  Some patients may need higher doses (up to 100 mg/kg), or combination therapy of deferiprone every day and desferrioxamine on several days each week.  Recent data suggest that deferiprone may be superior to desferrioxamine at protecting the heart from iron overload.  The side-effects of deferiprone-agranulocytosis, neutropenia, gastrointestinal symptoms, arthropathy, transient changes in liver enzymes, and zinc deficiency-are now well recognized; they result in discontinuation of the drug in only 5-10% of patients.  Deferiprone is now licensed in 43 countries for thalassemia major patients for whom desferrioxamine is inadequate.  If results of current trials confirm its superiority at reducing cardiac damage, it may well become the first-line drug for many patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY1tNeTcz2tbVg90H21EOLACvtfcHk0li_A1b-nacAEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbs%253D&md5=273a462366256913490ea8c798a8c984</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2004.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2004.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DVictor%2BHoffbrand%26aufirst%3DA.%26atitle%3DDeferiprone%2520therapy%2520for%2520transfusional%2520iron%2520overload%26jtitle%3DBest.%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2005%26volume%3D18%26issue%3D2%26spage%3D299%26epage%3D317%26doi%3D10.1016%2Fj.beha.2004.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span> <span> </span><span class="NLM_article-title">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe<sup>3+</sup> values</span>. <i>Transfus. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">201</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/S0955-3886(00)00090-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0955-3886%2800%2900090-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11099896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=201-209&issue=3&author=R.+C.+Hiderauthor=Z.+D.+Liuauthor=S.+Piyamongkol&title=The+design+and+properties+of+3-hydroxypyridin-4-one+iron+chelators+with+high+pFe3%2B+values&doi=10.1016%2FS0955-3886%2800%2900090-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values</span></div><div class="casAuthors">Hider R C; Liu Z D; Piyamongkol S</div><div class="citationInfo"><span class="NLM_cas:title">Transfusion science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-9</span>
        ISSN:<span class="NLM_cas:issn">0955-3886</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lZ-efNfxxVUIs6wFK5xJfW6udTcc2eb-YnEiBQ4db7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D&md5=af5a6096617fc38e6b49ba48661c87c5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0955-3886%2800%2900090-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-3886%252800%252900090-4%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26atitle%3DThe%2520design%2520and%2520properties%2520of%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520with%2520high%2520pFe3%252B%2520values%26jtitle%3DTransfus.%2520Sci.%26date%3D2000%26volume%3D23%26issue%3D3%26spage%3D201%26epage%3D209%26doi%3D10.1016%2FS0955-3886%2800%2900090-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cilibrizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinone journey into metal chelation</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7657</span>â <span class="NLM_lpage">7701</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrev.8b00254</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00254" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGhu73K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=7657-7701&issue=16&author=A.+Cilibrizziauthor=V.+Abbateauthor=Y.+L.+Chenauthor=Y.+Maauthor=T.+Zhouauthor=R.+C.+Hider&title=Hydroxypyridinone+journey+into+metal+chelation&doi=10.1021%2Facs.chemrev.8b00254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinone Journey into Metal Chelation</span></div><div class="casAuthors">Cilibrizzi, Agostino; Abbate, Vincenzo; Chen, Yu-Lin; Ma, Yongmin; Zhou, Tao; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7657-7701</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hydroxypyridinones (HOPOs) form outstanding building blocks for the development of a variety of agents in the field of metal chelation.  The pyridinone ring is easily synthesized and readily converted into tetradentate, hexadentate, and octadentate chelators.  There is considerable potential for the control of the stereochem. of the resulting metal complex and hence the properties of these multidentate mols.  Their ability to rapidly bind hard metals in aq. media has facilitated the development of efficient applications in both biol. and medical contexts.  In this Review, an in-depth anal. of the synthetic methodologies for HOPO-based ligands is presented, as well as the many aspects to achieve optimal biol. activity.  Recent advances and current challenges for the future application of HOPO structures are outlined.  The present flourishing development of drug candidates and diagnostic agents based on this chem. scaffold opens access to many new applications in anal., environmental, and clin. science.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFMvYhVBhi07Vg90H21EOLACvtfcHk0li_A1b-nacAEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGhu73K&md5=66d9a710574490018bffef41a8bb8a2c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00254%26sid%3Dliteratum%253Aachs%26aulast%3DCilibrizzi%26aufirst%3DA.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DHydroxypyridinone%2520journey%2520into%2520metal%2520chelation%26jtitle%3DChem.%2520Rev.%26date%3D2018%26volume%3D118%26issue%3D16%26spage%3D7657%26epage%3D7701%26doi%3D10.1021%2Facs.chemrev.8b00254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Potential protection from toxicity by oral iron chelators</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>82/83</i></span>,  <span class="NLM_fpage">961</span>â <span class="NLM_lpage">967</span>, <span class="refDoi">Â DOI: 10.1016/0378-4274(95)03606-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0378-4274%2895%2903606-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK28Xht1KqtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82%2F83&publication_year=1995&pages=961-967&author=R.+C.+Hider&title=Potential+protection+from+toxicity+by+oral+iron+chelators&doi=10.1016%2F0378-4274%2895%2903606-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Potential protection from toxicity by oral iron chelators</span></div><div class="casAuthors">Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">82/83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">961-7</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review and discussion with 23 refs.  The design of clin. useful iron chelators requires attention to be paid to 3 key parameters: oral absorption, selectivity and affinity for iron(III) and toxicity.  Factors which influence these 3 parameters are discussed.  Hydroxypyridinones are identified as key ligands and properties leading to minimal toxicity and optimum distribution for the treatment of thalassemia are presented.  Key metalloenzymes which are inhibited by iron chelators are identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkSva8smMpLVg90H21EOLACvtfcHk0li_A1b-nacAEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1KqtLk%253D&md5=8c8d0a42563ef31be0935aabe8b7cd54</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2895%2903606-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252895%252903606-7%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DPotential%2520protection%2520from%2520toxicity%2520by%2520oral%2520iron%2520chelators%26jtitle%3DToxicol.%2520Lett.%26date%3D1995%26volume%3D82%252F83%26spage%3D961%26epage%3D967%26doi%3D10.1016%2F0378-4274%2895%2903606-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Oral iron chelators-development and application</span>. <i>Best Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">369</span>â <span class="NLM_lpage">384</span>, <span class="refDoi">Â DOI: 10.1053/beha.2002.0209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1053%2Fbeha.2002.0209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12401312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ansb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=369-384&issue=2&author=D.+Y.+Liuauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=Oral+iron+chelators-development+and+application&doi=10.1053%2Fbeha.2002.0209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Oral iron chelators - development and application</span></div><div class="casAuthors">Liu, Ding Y.; Liu, Zu D.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-384</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bailliere Tindall</span>)
        </div><div class="casAbstract">A review.  Iron chelation therapy is the only therapeutic approach that leads to enhanced iron excretion in Î²-thalassemia major and other transfusion-dependent patients.  Although desferrioxamine has been used in such treatment over the last three decades, it is not an ideal drug due to its poor oral availability.  Consequently extensive research effort has been directed towards the identification of non-toxic, orally active iron chelators.  An ideal candidate must possess a range of crit. physicochem. and biol. properties, such as high selectivity and affinity for iron(III), tightly controlled distribution and metabolic profiles and low toxicity.  Unfortunately, hexadentate ligands are generally assocd. with poor oral bioavailability, whereas many tridentate and bidentate mols. are orally active.  The tridentate triazoles have been investigated for clin. potential; they are readily absorbed from the gastrointestinal tract and promote iron excretion with high efficacy.  In similar fashion, several bidentate hydroxypyridinones have been demonstrated to possess potential as oral chelating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsujkNXu-Lk7Vg90H21EOLACvtfcHk0lhHi1-Kivw-Zw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ansb8%253D&md5=d64526ce64ae1a337cd229477da6beda</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1053%2Fbeha.2002.0209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fbeha.2002.0209%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DOral%2520iron%2520chelators-development%2520and%2520application%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2002%26volume%3D15%26issue%3D2%26spage%3D369%26epage%3D384%26doi%3D10.1053%2Fbeha.2002.0209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span> <span> </span><span class="NLM_article-title">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe<sup>3+</sup> values</span>. <i>Transfus. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">201</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/S0955-3886(00)00090-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0955-3886%2800%2900090-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11099896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=201-209&author=R.+C.+Hiderauthor=Z.+D.+Liuauthor=S.+Piyamongkol&title=The+design+and+properties+of+3-hydroxypyridin-4-one+iron+chelators+with+high+pFe3%2B+values&doi=10.1016%2FS0955-3886%2800%2900090-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values</span></div><div class="casAuthors">Hider R C; Liu Z D; Piyamongkol S</div><div class="citationInfo"><span class="NLM_cas:title">Transfusion science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-9</span>
        ISSN:<span class="NLM_cas:issn">0955-3886</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lZ-efNfxxVUIs6wFK5xJfW6udTcc2eaw39QfB_u9kbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D&md5=af5a6096617fc38e6b49ba48661c87c5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0955-3886%2800%2900090-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-3886%252800%252900090-4%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26atitle%3DThe%2520design%2520and%2520properties%2520of%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520with%2520high%2520pFe3%252B%2520values%26jtitle%3DTransfus.%2520Sci.%26date%3D2000%26volume%3D23%26spage%3D201%26epage%3D209%26doi%3D10.1016%2FS0955-3886%2800%2900090-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical characterization, and biological evaluation of 2-(1â²-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe<sup>3+</sup> values</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4814</span>â <span class="NLM_lpage">4823</span>, <span class="refDoi">Â DOI: 10.1021/jm991080o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991080o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4814-4823&author=Z.+D.+Liuauthor=H.+H.+Khodrauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+characterization%2C+and+biological+evaluation+of+2-%281%E2%80%B2-hydroxyalkyl%29-3-hydroxypyridin-4-ones%3A+novel+iron+chelators+with+enhanced+pFe3%2B+values&doi=10.1021%2Fjm991080o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Physicochemical Characterization, and Biological Evaluation of 2-(1'-Hydroxyalkyl)-3-hydroxypyridin-4-ones: Novel Iron Chelators with Enhanced pFe3+ Values</span></div><div class="casAuthors">Liu, Zu D.; Khodr, Hicham H.; Liu, Ding Y.; Lu, Shu L.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4814-4823</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a range of 2-(1-hydroxyalkyl)-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described.  The pKa values of the ligands and the stability consts. of their iron(III) complexes have been detd.  Results indicate that the introduction of a 1'-hydroxyalkyl group at the 2-position leads to a significant improvement in the pFe3+ values.  Such an effect was found to be greater with the hydroxyethyl substituent than with the hydroxymethyl substituent, particularly in the cases of 1-ethyl-2-(1-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.4) and 1,6-dimethyl-2-(1'-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.5) where an enhancement on pFe3+ values in the region of two orders of magnitude is obsd., as compared with Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) (pFe3+ = 19.4).  The ability of these novel 3-hydroxypyridin-4-ones to facilitate the iron excretion in bile was investigated using a [59Fe]ferritin-loaded rat model.  Chelators and prodrug chelators possessing high pFe3+ values show great promise in their ability to remove iron under in vivo conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-7JLiGBw6MLVg90H21EOLACvtfcHk0lhHi1-Kivw-Zw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D&md5=6ba15911983ff3fbb19515acf8732dd4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm991080o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991080o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%25202-%25281%25E2%2580%25B2-hydroxyalkyl%2529-3-hydroxypyridin-4-ones%253A%2520novel%2520iron%2520chelators%2520with%2520enhanced%2520pFe3%252B%2520values%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4814%26epage%3D4823%26doi%3D10.1021%2Fjm991080o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-amido-3-hydroxypyridin-4(1<i>H</i>)-ones: novel iron chelators with enhanced pFe<sup>3+</sup> values</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">563</span>â <span class="NLM_lpage">573</span>, <span class="refDoi">Â DOI: 10.1016/S0968-0896(00)00273-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0968-0896%2800%2900273-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11310590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1aht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=563-573&author=Z.+D.+Liuauthor=S.+Piyamongkolauthor=D.+Y.+Liuauthor=H.+H.+Khodrauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis+of+2-amido-3-hydroxypyridin-4%281H%29-ones%3A+novel+iron+chelators+with+enhanced+pFe3%2B+values&doi=10.1016%2FS0968-0896%2800%2900273-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values</span></div><div class="casAuthors">Liu, Zu D.; Piyamongkol, S.; Liu, Ding Y.; Khodr, Hicham H.; Lu, Shu L.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The synthesis of a range of 2-amido-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described.  The pKa values of the ligands together with the stability consts. of their iron(III) complexes have been detd.  Results indicate that the introduction of an amido substituent at the 2-position leads to an appreciable enhancement of the pFe3+ values.  The ability of these novel 3-hydroxypyridin-4-ones to facilitate iron excretion in bile was investigated using a 59Fe-ferritin loaded rat model.  The optimal effect was obsd. with the N-methylamido deriv. I, which has an assocd. pFe3+ value of 21.7, more than two orders of magnitude higher than that of deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) (pFe3+ = 19.4).  Dose-response studies suggest that chelators with high pFe3+ values scavenge iron more effectively at lower doses when compared with simple dialkyl-substituted hydroxypyridinones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqR7Y7aGKdrVg90H21EOLACvtfcHk0lgRQTT01y3F5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1aht7Y%253D&md5=a3bc9b8ff46d17bdd61681c920dc20b8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2800%2900273-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252800%252900273-X%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%2520of%25202-amido-3-hydroxypyridin-4%25281H%2529-ones%253A%2520novel%2520iron%2520chelators%2520with%2520enhanced%2520pFe3%252B%2520values%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D563%26epage%3D573%26doi%3D10.1016%2FS0968-0896%2800%2900273-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pangjit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banjerdpongchai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phisalaphong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucharoen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srichairatanakool, S.</span></span> <span> </span><span class="NLM_article-title">Characterisation of a novel oral iron chelator: 1-(<i>N</i>-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">703</span>â <span class="NLM_lpage">713</span>, <span class="refDoi">Â DOI: 10.1111/jphp.12373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fjphp.12373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25627251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslymtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=703-713&issue=5&author=K.+Pangjitauthor=R.+Banjerdpongchaiauthor=C.+Phisalaphongauthor=S.+Fucharoenauthor=Y.+Y.+Xieauthor=Z.+D.+Luauthor=R.+C.+Hiderauthor=S.+Srichairatanakool&title=Characterisation+of+a+novel+oral+iron+chelator%3A+1-%28N-acetyl-6-aminohexyl%29-3-hydroxy-2-methylpyridin-4-one&doi=10.1111%2Fjphp.12373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one</span></div><div class="casAuthors">Pangjit, Kanjana; Banjerdpongchai, Ratana; Phisalaphong, Chada; Fucharoen, Suthat; Xie, Yuan Yuan; Lu, Zi Dong; Hider, Robert C.; Srichairatanakool, Somdet</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">703-713</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives : Desferrioxamine (DFO), deferiprone (DFP) and deferasirox (DFX) are iron chelators currently in clin. use for the treatment of iron overload.  Due to difficulties with administration and assocd. side effects with these three mols., the search continues for an efficient nontoxic orally active iron chelator.  This communication describes the properties of one such candidate, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1).  Methods : Physicochem. characterization techniques, including partition coeff., pKa values and logK values for iron(III).  Iron scavenging assays, from iron citrate, nontransferrin bound iron and iron-loaded rats.  Cytotoxicity studies using white cells, hepatocytes and cardiomyocytes.  Key findings : CM1 possesses high affinity and selectivity for iron(III) and a suitable partition coeff. to permeate membranes.  CM1 forms a neutral 3 : 1 iron(III) complex under physiol. conditions and so, it is predicted to be capable of entry into mammalian cells to scavenge excess intracellular iron and to efflux from cells as the neutral 3 : 1 complex.  CM1 is demonstrated to be orally active and to possess a higher efficacy than DFP in rats.  CM1 displays no toxicity to a range of cell types.  Conclusion : The above promising studies will be extended to monitor the pharmacokinetics and metab. of CM1.  CM1 is an excellent candidate for phase 1 clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6NrHhHYIVyrVg90H21EOLACvtfcHk0lgRQTT01y3F5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslymtLg%253D&md5=1d7b7ae01e9aace227f7577546eb5dd2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12373%26sid%3Dliteratum%253Aachs%26aulast%3DPangjit%26aufirst%3DK.%26aulast%3DBanjerdpongchai%26aufirst%3DR.%26aulast%3DPhisalaphong%26aufirst%3DC.%26aulast%3DFucharoen%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DSrichairatanakool%26aufirst%3DS.%26atitle%3DCharacterisation%2520of%2520a%2520novel%2520oral%2520iron%2520chelator%253A%25201-%2528N-acetyl-6-aminohexyl%2529-3-hydroxy-2-methylpyridin-4-one%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2015%26volume%3D67%26issue%3D5%26spage%3D703%26epage%3D713%26doi%3D10.1111%2Fjphp.12373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R.</span></span> <span> </span><span class="NLM_article-title">Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1<i>H</i>)-pyridones - attempted optimization of the orally active iron chelator, deferiprone</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">132</span>â <span class="NLM_lpage">140</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27014847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVCjs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=132-140&author=Y.+Y.+Xieauthor=Z.+Luauthor=X.+L.+Kongauthor=T.+Zhouauthor=S.+Bansalauthor=R.+Hider&title=Systematic+comparison+of+the+mono-%2C+dimethyl-+and+trimethyl+3-hydroxy-4%281H%29-pyridones+-+attempted+optimization+of+the+orally+active+iron+chelator%2C+deferiprone&doi=10.1016%2Fj.ejmech.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone</span></div><div class="casAuthors">Xie, Yuan-Yuan; Lu, Zidong; Kong, Xiao-Le; Zhou, Tao; Bansal, Sukhi; Hider, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-140</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A range of close analogs of deferiprone have been synthesized.  The group includes mono-, di- and tri-methyl-3-hydroxy-4(1H)-pyridones.  These compds. were found to possess similar pFe3+ values to that of deferiprone, with the exception of the 2.5-dimethylated derivs.  Surprisingly the NH-contg. hydroxy-4(1H)-pyridones were found to be marginally more lipophilic than the corresponding N-Me contg. analogs.  This same group are also metabolised less efficiently by Phase 1 hydroxylating enzymes than the corresponding N-Me analogs.  As result of this study, three compds. have been identified for further investigation centered on neutropenia and agranulocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruZa1RQjbhjbVg90H21EOLACvtfcHk0lgRQTT01y3F5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVCjs70%253D&md5=c315386b9a4ecc09f9b2e11076ae201a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%26atitle%3DSystematic%2520comparison%2520of%2520the%2520mono-%252C%2520dimethyl-%2520and%2520trimethyl%25203-hydroxy-4%25281H%2529-pyridones%2520-%2520attempted%2520optimization%2520of%2520the%2520orally%2520active%2520iron%2520chelator%252C%2520deferiprone%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D132%26epage%3D140%26doi%3D10.1016%2Fj.ejmech.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of new iron chelators and their therapeutic potential</span>. <i>Inorg. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">470</span>â <span class="NLM_lpage">480</span>, <span class="refDoi">Â DOI: 10.1016/S0020-1693(02)01040-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0020-1693%2802%2901040-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFOks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2002&pages=470-480&author=F.+Aouadauthor=A.+Florenceauthor=Y.+Zhangauthor=F.+Collinsauthor=C.+Henryauthor=R.+J.+Wardauthor=R.+R.+Crichton&title=Evaluation+of+new+iron+chelators+and+their+therapeutic+potential&doi=10.1016%2FS0020-1693%2802%2901040-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of new iron chelators and their therapeutic potential</span></div><div class="casAuthors">Aouad, Fouad; Florence, Anne; Zhang, Ying; Collins, Fiona; Henry, Christophe; Ward, Roberta J.; Crichton, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">470-480</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  One of the most important challenges for biol. inorg. chem. is to understand metal ion homeostasis, particularly since the authors are becoming increasingly aware that its disequil. is at the basis of a large no. of clin. disorders.  It is, therefore, also an important objective of the authors' research to seek solns., which can alleviate the consequences of the perturbation of the homeostasis of key metal ions within cells, tissues, and organisms.  Iron is 1 of the key metals in biol., for which disorders of homeostasis are implicated in a vast panoply of pathol. conditions.  The authors review here the ways in which potential iron chelators can be evaluated, using appropriate in vivo or in vitro screening systems, and discuss their potential applications in the chelation of both Fe and Al in the treatment of a no. of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5iBNkRKdRR7Vg90H21EOLACvtfcHk0lgRQTT01y3F5g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFOks70%253D&md5=15f2f4a397020a5ee99bbc396aaee18d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0020-1693%2802%2901040-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-1693%252802%252901040-X%26sid%3Dliteratum%253Aachs%26aulast%3DAouad%26aufirst%3DF.%26aulast%3DFlorence%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26atitle%3DEvaluation%2520of%2520new%2520iron%2520chelators%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2002%26volume%3D339%26spage%3D470%26epage%3D480%26doi%3D10.1016%2FS0020-1693%2802%2901040-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, R.</span></span> <span> </span><span class="NLM_article-title">Iron metabolism: from health to disease</span>. <i>J. Clin. Lab. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">210</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1002/jcla.21668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fjcla.21668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24478115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFCgu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=210-218&issue=3&author=F.+Oliveiraauthor=S.+Rochaauthor=R.+Fernandes&title=Iron+metabolism%3A+from+health+to+disease&doi=10.1002%2Fjcla.21668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Iron Metabolism: From Health to Disease</span></div><div class="casAuthors">Oliveira, Fernando; Rocha, Sara; Fernandes, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Laboratory Analysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">210-218</span>CODEN:
                <span class="NLM_cas:coden">JCANEM</span>;
        ISSN:<span class="NLM_cas:issn">0887-8013</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Background : Iron is vital for almost all living organisms by participating in a wide range of metabolic processes.  However, iron concn. in body tissues must be tightly regulated since excessive iron may lead to microbial infections or cause tissue damage.  Disorders of iron metab. are among the most common human diseases and cover several conditions with varied clin. manifestations.  Methods : An extensive literature review on the basic aspects of iron metab. was performed, and the most recent findings on this field were highlighted as well.  Results : New insights on iron metab. have shed light into its real complexity, and its role in both healthy and pathol. states has been recognized.  Important discoveries about the iron regulatory machine and imbalances in its regulation have been made, which may lead in a near future to the development of new therapeutic strategies against iron disorders.  Besides, the toxicity of free iron and its assocn. with several pathologies has been addressed, although it requires further investigations.  Conclusion : This review will provide students in the fields of biochem. and health sciences a brief and clear overview of iron physiol. and toxicity, as well as imbalances in the iron homeostasis and assocd. pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMxjm29hqh57Vg90H21EOLACvtfcHk0lhkPxlB32DJvw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFCgu70%253D&md5=90884bcb63b40900485c194e1c02a4e4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fjcla.21668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcla.21668%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DF.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DR.%26atitle%3DIron%2520metabolism%253A%2520from%2520health%2520to%2520disease%26jtitle%3DJ.%2520Clin.%2520Lab.%2520Anal.%26date%3D2014%26volume%3D28%26issue%3D3%26spage%3D210%26epage%3D218%26doi%3D10.1002%2Fjcla.21668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voskaridou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douskou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terpos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamoulakatou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meletis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ourailidis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papassotiriou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loukopoulos, D.</span></span> <span> </span><span class="NLM_article-title">Deferiprone as an oral iron chelator in sickle cell disease</span>. <i>Ann. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">434</span>â <span class="NLM_lpage">440</span>, <span class="refDoi">Â DOI: 10.1007/s00277-005-1015-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00277-005-1015-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15809885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVCksro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2005&pages=434-440&issue=7&author=E.+Voskaridouauthor=M.+Douskouauthor=E.+Terposauthor=A.+Stamoulakatouauthor=J.+Meletisauthor=A.+Ourailidisauthor=I.+Papassotiriouauthor=D.+Loukopoulos&title=Deferiprone+as+an+oral+iron+chelator+in+sickle+cell+disease&doi=10.1007%2Fs00277-005-1015-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Deferiprone as an oral iron chelator in sickle cell disease</span></div><div class="casAuthors">Voskaridou, Ersi; Douskou, Maroussa; Terpos, Evangelos; Stamoulakatou, Alexandra; Meletis, John; Ourailidis, Akis; Papassotiriou, Ioannis; Loukopoulos, Dimitris</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Iron overload is not uncommon in sickle cell disease (SCD) and requires regular chelation therapy in several instances.  The present study evaluates the effect of deferiprone in 15 adult patients with SCD (ten Î²s/Î²0thalassemia and five Î²s/Î²s) and iron overload.  Deferiprone was given at a dose of 75 mg/kg daily for 12 mo.  The evaluation considered pre- and post-treatment values of serum ferritin, urinary iron excretion, and T2 values of liver and heart obtained by magnetic resonance imaging (MRI).  Eleven patients had a liver biopsy prior to starting therapy to evaluate iron concn. (LIC).  Twelve patients completed the study with satisfactory compliance.  In ten of them (83.3%) the serum ferritin levels decreased significantly at the end of the trial; in eight patients (66.6%) the redn. of serum ferritin was accompanied by a significant increase of their liver T2 values.  All patients had a significant increase of urinary iron excretion in response to the drug.  Ferritin levels and liver T2 values correlated with liver iron concn.; on the contrary, ferritin levels and liver T2 values failed to show any correlation with heart T2 values.  Heart T2 values did not also show any correlation with left ventricular ejection fraction.  Deferiprone was well tolerated and did not cause any significant adverse effects.  These results suggest that deferiprone may effectively decrease the iron deposition in patients with SCD; moreover, T2 MRI proves to be a reliable and rapid, noninvasive method for assessing the liver iron load in patients with SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6UoktA2JYXbVg90H21EOLACvtfcHk0lgbzEBEuOX0bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVCksro%253D&md5=425c4a636df7671ff24f3bf3af06efd0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00277-005-1015-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-005-1015-7%26sid%3Dliteratum%253Aachs%26aulast%3DVoskaridou%26aufirst%3DE.%26aulast%3DDouskou%26aufirst%3DM.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DStamoulakatou%26aufirst%3DA.%26aulast%3DMeletis%26aufirst%3DJ.%26aulast%3DOurailidis%26aufirst%3DA.%26aulast%3DPapassotiriou%26aufirst%3DI.%26aulast%3DLoukopoulos%26aufirst%3DD.%26atitle%3DDeferiprone%2520as%2520an%2520oral%2520iron%2520chelator%2520in%2520sickle%2520cell%2520disease%26jtitle%3DAnn.%2520Hematol.%26date%3D2005%26volume%3D84%26issue%3D7%26spage%3D434%26epage%3D440%26doi%3D10.1007%2Fs00277-005-1015-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javidroozi, M.</span></span> <span> </span><span class="NLM_article-title">Iron overload and toxicity: implications for anesthesiologists</span>. <i>J. Clin. Anesth.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">419</span>â <span class="NLM_lpage">425</span>, <span class="refDoi">Â DOI: 10.1016/j.jclinane.2011.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.jclinane.2011.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22658368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVWjsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=419-425&issue=5&author=A.+Shanderauthor=U.+Berthauthor=J.+Bettaauthor=M.+Javidroozi&title=Iron+overload+and+toxicity%3A+implications+for+anesthesiologists&doi=10.1016%2Fj.jclinane.2011.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Iron overload and toxicity: implications for anesthesiologists</span></div><div class="casAuthors">Shander, Aryeh; Berth, Ulrike; Betta, Joanne; Javidroozi, Mazyar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Anesthesia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">419-425</span>CODEN:
                <span class="NLM_cas:coden">JCLBE7</span>;
        ISSN:<span class="NLM_cas:issn">0952-8180</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Conditions leading to iron overload range from rare hereditary disorders to more common medical conditions assocd. with chronic blood transfusions.  Iron overload has deleterious effects on various vital organs (eg, liver, heart, and endocrine glands).  Serum ferritin (in conjunction with transferrin satn.) is the most widely used test to evaluate iron burden and to screen for iron overload.  The management plan should be adjusted to account for iron overload and potential consequences of liver, heart, and other organ involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJr26zsrSfaLVg90H21EOLACvtfcHk0lgbzEBEuOX0bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVWjsL8%253D&md5=413d99826cbbf9e3bee89b3368b01b60</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jclinane.2011.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jclinane.2011.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShander%26aufirst%3DA.%26aulast%3DBerth%26aufirst%3DU.%26aulast%3DBetta%26aufirst%3DJ.%26aulast%3DJavidroozi%26aufirst%3DM.%26atitle%3DIron%2520overload%2520and%2520toxicity%253A%2520implications%2520for%2520anesthesiologists%26jtitle%3DJ.%2520Clin.%2520Anesth.%26date%3D2012%26volume%3D24%26issue%3D5%26spage%3D419%26epage%3D425%26doi%3D10.1016%2Fj.jclinane.2011.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhoiwala, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaief, J. L.</span></span> <span> </span><span class="NLM_article-title">Retinal abnormalities in Î²-thalassemia major</span>. <i>Surv. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">50</span>, <span class="refDoi">Â DOI: 10.1016/j.survophthal.2015.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.survophthal.2015.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26325202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC287otVSjtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2016&pages=33-50&issue=1&author=D.+L.+Bhoiwalaauthor=J.+L.+Dunaief&title=Retinal+abnormalities+in+%CE%B2-thalassemia+major&doi=10.1016%2Fj.survophthal.2015.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal abnormalities in Î²-thalassemia major</span></div><div class="casAuthors">Bhoiwala Devang L; Dunaief Joshua L</div><div class="citationInfo"><span class="NLM_cas:title">Survey of ophthalmology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Patients with beta (Î²)-thalassemia (Î²-TM: Î²-thalassemia major, Î²-TI: Î²-thalassemia intermedia) have a variety of complications that may affect all organs, including the eye.  Ocular abnormalities include retinal pigment epithelial degeneration, angioid streaks, venous tortuosity, night blindness, visual field defects, decreased visual acuity, color vision abnormalities, and acute visual loss.  Patients with Î²-thalassemia major are transfusion dependent and require iron chelation therapy to survive.  Retinal degeneration may result from either retinal iron accumulation from transfusion-induced iron overload or retinal toxicity induced by iron chelation therapy.  Some who were never treated with iron chelation therapy exhibited retinopathy, and others receiving iron chelation therapy had chelator-induced retinopathy.  We will focus on retinal abnormalities present in individuals with Î²-thalassemia major viewed in light of new findings on the mechanisms and manifestations of retinal iron toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnzeDrdeD2GkwlCcfExbvbfW6udTcc2eY6-DSVwEeQE7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287otVSjtA%253D%253D&md5=9a9600888713a7becb52167288ae0b8d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.survophthal.2015.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.survophthal.2015.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DBhoiwala%26aufirst%3DD.%2BL.%26aulast%3DDunaief%26aufirst%3DJ.%2BL.%26atitle%3DRetinal%2520abnormalities%2520in%2520%25CE%25B2-thalassemia%2520major%26jtitle%3DSurv.%2520Ophthalmol.%26date%3D2016%26volume%3D61%26issue%3D1%26spage%3D33%26epage%3D50%26doi%3D10.1016%2Fj.survophthal.2015.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assomull, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennell, D. J.</span></span> <span> </span><span class="NLM_article-title">A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">1876</span>â <span class="NLM_lpage">1884</span>, <span class="refDoi">Â DOI: 10.1161/CIRCULATIONAHA.106.648790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1161%2FCIRCULATIONAHA.106.648790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=17372174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Oltbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=1876-1884&issue=14&author=M.+A.+Tannerauthor=R.+Galanelloauthor=C.+Dessiauthor=G.+C.+Smithauthor=M.+A.+Westwoodauthor=A.+Agusauthor=M.+Roughtonauthor=R.+Assomullauthor=S.+V.+Nairauthor=J.+M.+Walkerauthor=D.+J.+Pennell&title=A+randomized%2C+placebo-controlled%2C+double-blind+trial+of+the+effect+of+combined+therapy+with+deferoxamine+and+deferiprone+on+myocardial+iron+in+thalassemia+major+using+cardiovascular+magnetic+resonance&doi=10.1161%2FCIRCULATIONAHA.106.648790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance</span></div><div class="casAuthors">Tanner, M. A.; Galanello, R.; Dessi, C.; Smith, G. C.; Westwood, M. A.; Agus, A.; Roughton, M.; Assomull, R.; Nair, S. V.; Walker, J. M.; Pennell, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1876-1884</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Cardiac complications secondary to iron overload are the leading cause of death in Î²-thalassemia major.  Approx. two thirds of patients maintained on the parenteral iron chelator deferoxamine have myocardial iron loading.  The oral iron chelator deferiprone has been demonstrated to remove myocardial iron, and it has been proposed that in combination with deferoxamine it may have addnl. effect.  Methods and Results: Myocardial iron loading was assessed with the use of myocardial T2* cardiovascular magnetic resonance in 167 patients with thalassemia major receiving std. maintenance chelation monotherapy with s.c. deferoxamine.  Of these patients, 65 with mild to moderate myocardial iron loading (T2* 8 to 20 ms) entered the trial with continuation of s.c. deferoxamine and were randomized to receive addnl. oral placebo (deferoxamine group) or oral deferiprone 75 mg/kg per day (combined group).  The primary end point was the change in myocardial T2* over 12 mo.  Secondary end points of endothelial function (flow-mediated dilatation of the brachial artery) and cardiac function were also measured with cardiovascular magnetic resonance.  There were significant improvements in the combined treatment group compared with the deferoxamine group in myocardial T2* (ratio of change in geometric means 1.50 vs. 1.24; P=0.02), abs. left ventricular ejection fraction (2.6% vs. 0.6%; P=0.05), and abs. endothelial function (8.8% vs. 3.3%; P=0.02).  There was also a significantly greater improvement in serum ferritin in the combined group (-976 vs. -233 Î¼g/L; P<0.001).  Conclusions: In comparison to the std. chelation monotherapy of deferoxamine, combination treatment with addnl. deferiprone reduced myocardial iron and improved the ejection fraction and endothelial function in thalassemia major patients with mild to moderate cardiac iron loading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Nqg-rZA8K7Vg90H21EOLACvtfcHk0liu7GfnExpd_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Oltbw%253D&md5=c2b83d663873801ab29cef2f63d437b8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.106.648790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.106.648790%26sid%3Dliteratum%253Aachs%26aulast%3DTanner%26aufirst%3DM.%2BA.%26aulast%3DGalanello%26aufirst%3DR.%26aulast%3DDessi%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DWestwood%26aufirst%3DM.%2BA.%26aulast%3DAgus%26aufirst%3DA.%26aulast%3DRoughton%26aufirst%3DM.%26aulast%3DAssomull%26aufirst%3DR.%26aulast%3DNair%26aufirst%3DS.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DPennell%26aufirst%3DD.%2BJ.%26atitle%3DA%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520trial%2520of%2520the%2520effect%2520of%2520combined%2520therapy%2520with%2520deferoxamine%2520and%2520deferiprone%2520on%2520myocardial%2520iron%2520in%2520thalassemia%2520major%2520using%2520cardiovascular%2520magnetic%2520resonance%26jtitle%3DCirculation%26date%3D2007%26volume%3D115%26issue%3D14%26spage%3D1876%26epage%3D1884%26doi%3D10.1161%2FCIRCULATIONAHA.106.648790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontoghiorghes, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neocleous, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolnagou, A.</span></span> <span> </span><span class="NLM_article-title">Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">584</span>, <span class="refDoi">Â DOI: 10.2165/00002018-200326080-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2165%2F00002018-200326080-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12825969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVenurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=553-584&author=G.+J.+Kontoghiorghesauthor=K.+Neocleousauthor=A.+Kolnagou&title=Benefits+and+risks+of+deferiprone+in+iron+overload+in+thalassaemia+and+other+conditions%3A+comparison+of+epidemiological+and+therapeutic+aspects+with+deferoxamine&doi=10.2165%2F00002018-200326080-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Benefits and risks of deferiprone in iron overload in thalassemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine</span></div><div class="casAuthors">Kontoghiorghes, George J.; Neocleous, Katia; Kolnagou, Annita</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">553-584</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review. Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload.  It is an orphan drug designed and developed primarily by academic initiatives for the treatment of iron overload in thalassemia, which is endemic in the Mediterranean, Middle East and Southeast Asia and is considered an orphan disease in the European Union and North America.  Deferiprone has been used in several other iron or other metal imbalance conditions and has prospects of wider clin. applications.  Deferiprone has high affinity for iron and interacts with almost all the iron pools at the mol., cellular, tissue and organ levels.  Doses of 50-120 mg/kg/day appear to be effective in bringing patients to neg. iron balance.  It increases urinary iron excretion, which mainly depends on the iron load of patients and the dose of the drug.  At doses >80 mg/kg/day, it decreases serum ferritin and reduces the liver and heart iron content in the majority of chronically transfused iron-loaded patients.  It is metabolized to a glucuronide conjugate and cleared through the urine in the metabolized and s nonmetabolized form, usually a 3 deferiprone:1 iron complex, which gives the characteristic red color to urine.  Peak serum levels of deferiprone occur within 1 h of its oral administration and clearance from blood is within 6 h.  There is variation among patients in iron excretion and the metab. and pharmacokinetics of deferiprone.  Deferiprone has been used in >7500 patients aged 2-85 yr in >50 countries, in some cases daily for >14 yr.  All the adverse effects of deferiprone are considered reversible, controllable and manageable.  These include agranulocytosis with frequency of about 0.6%, neutropenia 6%, musculoskeletal and joint pains 15%, gastrointestinal complaints 6% and zinc deficiency 1%.  Discontinuation of the drug is recommended for patients developing agranulocytosis.  Deferiprone has a therapeutic index similar to that of s.c. deferoxamine but is more effective in iron removal from the heart, which is the target organ of iron toxicity and mortality in iron-loaded thalassemia patients.  Deferiprone is much less expensive to produce than deferoxamine.  Combination therapy with deferoxamine and deferiprone has been used in patients not complying with s.c. deferoxamine or experiencing toxicity or not excreting sufficient amts. of iron with use of either drug alone.  New oral iron-chelating drugs are being developed, but even if successful these are likely to be more expensive than deferiprone and are not likely to become available in the next 5-8 yr.  About 25% of treated thalassemia patients in Europe and >50% in India are using deferiprone.  For most thalassemia patients worldwide who are not at present receiving any form of chelation therapy the choice is between deferiprone and fatal iron toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZUzrBAetCdbVg90H21EOLACvtfcHk0liu7GfnExpd_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVenurg%253D&md5=2425c5ef9e7a88e9424690222cb93e2f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2165%2F00002018-200326080-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200326080-00003%26sid%3Dliteratum%253Aachs%26aulast%3DKontoghiorghes%26aufirst%3DG.%2BJ.%26aulast%3DNeocleous%26aufirst%3DK.%26aulast%3DKolnagou%26aufirst%3DA.%26atitle%3DBenefits%2520and%2520risks%2520of%2520deferiprone%2520in%2520iron%2520overload%2520in%2520thalassaemia%2520and%2520other%2520conditions%253A%2520comparison%2520of%2520epidemiological%2520and%2520therapeutic%2520aspects%2520with%2520deferoxamine%26jtitle%3DDrug%2520Saf.%26date%3D2003%26volume%3D26%26spage%3D553%26epage%3D584%26doi%3D10.2165%2F00002018-200326080-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creary, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, H. H.</span></span> <span> </span><span class="NLM_article-title">A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one and deferoxamine</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1882</span>â <span class="NLM_lpage">1890</span>, <span class="refDoi">Â DOI: 10.1182/blood.V79.7.1882.bloodjournal7971882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V79.7.1882.1882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1558978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK38XitVOlsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1992&pages=1882-1890&author=R.+J.+Bergeronauthor=R.+R.+Streiffauthor=J.+Wiegandauthor=G.+Luchettaauthor=E.+A.+Crearyauthor=H.+H.+Peter&title=A+comparison+of+the+iron-clearing+properties+of+1%2C2-dimethyl-3-hydroxypyrid-4-one%2C+1%2C2-diethyl-3-hydroxypyrid-4-one+and+deferoxamine&doi=10.1182%2Fblood.V79.7.1882.bloodjournal7971882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine</span></div><div class="casAuthors">Bergeron, Raymond J.; Streiff, Richard R.; Wiegand, Jan; Luchetta, Gabriel; Creary, Elizabeth A.; Peter, Heinrich H.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1882-90</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">A comparative study of the iron-clearing properties of s.c. administered deferoxamine (DFO) with those of orally administered 1,2-dimethyl-3-hydroxypyrid-4-one (CP20) and 1,2-diethyl-3-hydroxypyrid-4-one (CP94) is presented.  The studies were performed in both a non-iron-overloaded, bile duct-cannulated rat model and an iron-loaded Cebus monkey model.  All three drugs performed well in the rodent, promoting the excretion of iron in both the urine and the bile, with total iron output efficiencies of 2.8, 1.2, and 7.1%, resp.  The efficiency of DFO increased slightly in the Cebus model, while that of the hydroxypyridones was essentially the same in the monkey, with total iron output efficiencies of 5.5, 2.1, and 7.4%, resp.  Iron balance studies showed that both DFO and CP94 were able to maintain the animals in a neg. iron balance, while CP20 had little impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowgJs9FR55f7Vg90H21EOLACvtfcHk0liu7GfnExpd_g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitVOlsLs%253D&md5=7f9cc390cefa196c40ddc768a66ce1a9</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1182%2Fblood.V79.7.1882.1882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V79.7.1882.1882%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DStreiff%26aufirst%3DR.%2BR.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DLuchetta%26aufirst%3DG.%26aulast%3DCreary%26aufirst%3DE.%2BA.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26atitle%3DA%2520comparison%2520of%2520the%2520iron-clearing%2520properties%2520of%25201%252C2-dimethyl-3-hydroxypyrid-4-one%252C%25201%252C2-diethyl-3-hydroxypyrid-4-one%2520and%2520deferoxamine%26jtitle%3DBlood%26date%3D1992%26volume%3D79%26spage%3D1882%26epage%3D1890%26doi%3D10.1182%2Fblood.V79.7.1882.bloodjournal7971882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical characterization, and biological evaluation of 2-(1â²-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe<sup>3+</sup> values</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4814</span>â <span class="NLM_lpage">4823</span>, <span class="refDoi">Â DOI: 10.1021/jm991080o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991080o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4814-4823&issue=23&author=Z.+D.+Liuauthor=H.+H.+Khodrauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+characterization%2C+and+biological+evaluation+of+2-%281%E2%80%B2-hydroxyalkyl%29-3-hydroxypyridin-4-ones%3A+novel+iron+chelators+with+enhanced+pFe3%2B+values&doi=10.1021%2Fjm991080o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Physicochemical Characterization, and Biological Evaluation of 2-(1'-Hydroxyalkyl)-3-hydroxypyridin-4-ones: Novel Iron Chelators with Enhanced pFe3+ Values</span></div><div class="casAuthors">Liu, Zu D.; Khodr, Hicham H.; Liu, Ding Y.; Lu, Shu L.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4814-4823</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a range of 2-(1-hydroxyalkyl)-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described.  The pKa values of the ligands and the stability consts. of their iron(III) complexes have been detd.  Results indicate that the introduction of a 1'-hydroxyalkyl group at the 2-position leads to a significant improvement in the pFe3+ values.  Such an effect was found to be greater with the hydroxyethyl substituent than with the hydroxymethyl substituent, particularly in the cases of 1-ethyl-2-(1-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.4) and 1,6-dimethyl-2-(1'-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.5) where an enhancement on pFe3+ values in the region of two orders of magnitude is obsd., as compared with Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) (pFe3+ = 19.4).  The ability of these novel 3-hydroxypyridin-4-ones to facilitate the iron excretion in bile was investigated using a [59Fe]ferritin-loaded rat model.  Chelators and prodrug chelators possessing high pFe3+ values show great promise in their ability to remove iron under in vivo conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-7JLiGBw6MLVg90H21EOLACvtfcHk0ljSMIqx5bCOMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D&md5=6ba15911983ff3fbb19515acf8732dd4</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm991080o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991080o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%25202-%25281%25E2%2580%25B2-hydroxyalkyl%2529-3-hydroxypyridin-4-ones%253A%2520novel%2520iron%2520chelators%2520with%2520enhanced%2520pFe3%252B%2520values%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D23%26spage%3D4814%26epage%3D4823%26doi%3D10.1021%2Fjm991080o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarpong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderhelm, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties, and biological evaluation of <i>N</i>-substituted 2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones - orally active iron chelators with clinical potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2448</span>â <span class="NLM_lpage">2458</span>, <span class="refDoi">Â DOI: 10.1021/jm00069a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00069a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3sXmslSqtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2448-2458&issue=17&author=P.+S.+Dobbinauthor=R.+C.+Hiderauthor=A.+D.+Hallauthor=P.+D.+Taylorauthor=P.+Sarpongauthor=J.+B.+Porterauthor=G.+Y.+Xiaoauthor=D.+Vanderhelm&title=Synthesis%2C+physicochemical+properties%2C+and+biological+evaluation+of+N-substituted+2-alkyl-3-hydroxy-4%281H%29-pyridinones+-+orally+active+iron+chelators+with+clinical+potential&doi=10.1021%2Fjm00069a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential</span></div><div class="casAuthors">Dobbin, Paul S.; Hider, Robert C.; Hall, Adrian D.; Taylor, Paul D.; Sarpong, Patience; Porter, John B.; Xiao, Gaoyi; van der Helm, Dick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2448-58</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis of a range of novel bidentate ligands contg. the chelating moiety 3-hydroxy-4(1H)-pyridinone is described.  The pKa values of the ligands and the stability consts. of their iron(III) complexes have been detd.  The crystal structures of one of the ligands and one of the iron(III) complexes are presented.  The distribution coeffs. of the ligands are reported and are related to the ability of the ligands to remove iron from hepatocytes.  The influence of 3-hydroxy-4(1H)-pyridinones on oxidative damage to cells is described.  In contrast to the iron chelator in current therapeutic use, desferrioxamine-B, many of the bidentate ligands described in this study are orally active in iron-overloaded mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqK247sbJ3DrVg90H21EOLACvtfcHk0ljSMIqx5bCOMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmslSqtLw%253D&md5=f6e0ff0febe3b6bd408ada4cb445fdbd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm00069a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00069a002%26sid%3Dliteratum%253Aachs%26aulast%3DDobbin%26aufirst%3DP.%2BS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DHall%26aufirst%3DA.%2BD.%26aulast%3DTaylor%26aufirst%3DP.%2BD.%26aulast%3DSarpong%26aufirst%3DP.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DXiao%26aufirst%3DG.%2BY.%26aulast%3DVanderhelm%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%252C%2520and%2520biological%2520evaluation%2520of%2520N-substituted%25202-alkyl-3-hydroxy-4%25281H%2529-pyridinones%2520-%2520orally%2520active%2520iron%2520chelators%2520with%2520clinical%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D17%26spage%3D2448%26epage%3D2458%26doi%3D10.1021%2Fjm00069a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhordi, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties, and evaluation of <i>N</i>-substituted-2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3347</span>â <span class="NLM_lpage">3359</span>, <span class="refDoi">Â DOI: 10.1021/jm9707784</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9707784" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXkvF2nt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3347-3359&issue=18&author=B.+L.+Raiauthor=L.+S.+Dekhordiauthor=H.+Khodrauthor=Y.+Jinauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+properties%2C+and+evaluation+of+N-substituted-2-alkyl-3-hydroxy-4%281H%29-pyridinones&doi=10.1021%2Fjm9707784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Physicochemical Properties, and Evaluation of N-Substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones</span></div><div class="casAuthors">Rai, Bijaya L.; Dekhordi, Lotfollah S.; Khodr, Hicham; Jin, Yi; Liu, Zudong; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3347-3359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a range of 3-hydroxy-4(1H)-pyridinones with potential for the chelation of iron(III) is described.  The pKa values of resp. ligands and the stability consts. of their iron(III) complexes are presented.  The distribution coeff. values of a range of 48 hydroxypyridinones and their corresponding iron(III) complexes between 1-octanol and MOPS buffer (pH 7.4) are reported.  The range of log Dcomplex values covers 7 orders of magnitude.  The results suggest the existence of a biphasic relationship between the distribution coeff. values of the chelator and the corresponding iron(III) complexes.  For ligands with a log Dligand = -1, a linear relationship exists with a value of the slope 2.53, whereas with ligands with a log Dligand < -1, a linear relationship exists with a slope of 0.49.  The reduced slope for the more hydrophilic mols. of the series offers some advantage for this type of hydroxypyridinone as the distribution coeffs. for such complexes do not change so rapidly with increasing ligand hydrophilicity.  The ability of selected 3-hydroxypyridinones to facilitate the excretion of iron in bile was investigated in non-iron-overloaded, bile duct-cannulated rats and in a [59Fe]ferritin-loaded rat model.  Both systems compare the ability of chelators to remove iron from the liver, the prime target organ in thalassemia.  The N-(hydroxyalkyl)-3-hydroxypyridin-4-ones are demonstrated to be orally active under the in vivo conditions adopted.  Thus both 1-(hydroxyalkyl)- and 1-(carboxyalkyl)pyridinones are able to remove iron from the liver.  Although 1-(carboxyalkyl)hydroxypyridinones are active, they do not demonstrate any clear advantage over Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one).  Indeed 1-(hydroxyalkyl)hydroxypyridinones which are known to be rapidly converted to 1-(carboxyalkyl)hydroxypyridinones are also marginally superior to Deferiprone.  In contrast, 2-ethyl-1-(2'-hydroxyethyl)-3-hydroxypyridin-4-one, which is not metabolized to the corresponding (carboxyalkyl)hydroxypyridinone, was found to be superior to Deferiprone and therefore deserves further consideration as an orally active iron chelator with potential for the treatment of iron overload assocd. with transfusion-dependent thalassemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2cgWCGM5bJLVg90H21EOLACvtfcHk0ljSMIqx5bCOMQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvF2nt74%253D&md5=82ec8ae0997f72d9b12a115219edc3c4</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm9707784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707784%26sid%3Dliteratum%253Aachs%26aulast%3DRai%26aufirst%3DB.%2BL.%26aulast%3DDekhordi%26aufirst%3DL.%2BS.%26aulast%3DKhodr%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%252C%2520and%2520evaluation%2520of%2520N-substituted-2-alkyl-3-hydroxy-4%25281H%2529-pyridinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D18%26spage%3D3347%26epage%3D3359%26doi%3D10.1021%2Fjm9707784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2â²-hydroxyethyl)-2-ethyl-3hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">555</span>â <span class="NLM_lpage">564</span>, <span class="refDoi">Â DOI: 10.1211/0022357991772655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1211%2F0022357991772655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10411215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXksVKhtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=555-564&author=Z.+D.+Liuauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+properties+and+biological+evaluation+of+aromatic+ester+prodrugs+of+1-%282%E2%80%B2-hydroxyethyl%29-2-ethyl-3hydroxypyridin-4-one+%28CP102%29%3A+orally+active+iron+chelators+with+clinical+potential&doi=10.1211%2F0022357991772655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential</span></div><div class="casAuthors">Liu, Zu Dong; Liu, Ding Yong; Lu, Shu Li; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">The synthesis of seven arom. ester derivs. of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one is described.  These ester prodrugs have been designed to target iron chelators to the liver, the major iron storage organ.  In principle this should improve chelation efficacy and minimize toxicity.  The distribution coeffs. of these ester prodrugs between 1-octanol and MOPS buffer pH 7.4 were measured together with their rates of hydrolysis at pH 2 and pH 7.4, in rat blood and liver homogenate.  Esters with heteroarom. acid moieties were less stable than benzoyl analogs.  The in-vivo iron mobilization efficacy of these ester prodrugs has been compared with that of the parent drug using a 59Fe-ferritin loaded rat model.  Many prodrugs were found to enhance the ability of the parent hydroxypyridinone to facilitate 59Fe excretion.  However, not all prodrugs provided increased efficacy, demonstrating that lipophilicity is not the only factor which influences drug efficacy.  Furthermore, no clear correlation between efficacy and susceptibility to hydrolysis was detected.  The picolinic and nicotinic ester derivs. appear to offer the best potential as prodrugs as they have a relatively low Log-P value and yet lead to enhanced efficacy over the parent hydroxypyridinone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq72iY_wXRkprVg90H21EOLACvtfcHk0lgGaik8YE8pHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVKhtb0%253D&md5=1c6d0c34482fa76b19b123e2ab65d8db</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1211%2F0022357991772655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357991772655%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%2520and%2520biological%2520evaluation%2520of%2520aromatic%2520ester%2520prodrugs%2520of%25201-%25282%25E2%2580%25B2-hydroxyethyl%2529-2-ethyl-3hydroxypyridin-4-one%2520%2528CP102%2529%253A%2520orally%2520active%2520iron%2520chelators%2520with%2520clinical%2520potential%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1999%26volume%3D51%26spage%3D555%26epage%3D564%26doi%3D10.1211%2F0022357991772655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. P.</span></span> <span> </span><span class="NLM_article-title">CN128: A new orally active hydroxypyridinone iron chelator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4215</span>â <span class="NLM_lpage">4226</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.0c00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls1CjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4215-4226&issue=8&author=W.+T.+Chenauthor=X.+Yuanauthor=Z.+Liauthor=Z.+D.+Luauthor=S.+S.+Kongauthor=H.+D.+Jiangauthor=H.+B.+Duauthor=X.+H.+Panauthor=M.+Nandiauthor=X.+L.+Kongauthor=K.+Brownauthor=Z.+D.+Liuauthor=G.+L.+Zhangauthor=R.+C.+Hiderauthor=Y.+P.+Yu&title=CN128%3A+A+new+orally+active+hydroxypyridinone+iron+chelator&doi=10.1021%2Facs.jmedchem.0c00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">CN128: A New Orally Active Hydroxypyridinone Iron Chelator</span></div><div class="casAuthors">Chen, Wenteng; Yuan, Xin; Li, Zhi; Lu, Zidong; Kong, Sisi; Jiang, Huidi; Du, Houbing; Pan, Xiuhong; Nandi, Manasi; Kong, Xiaole; Brown, Kathryn; Liu, Zudong; Zhang, Guolin; Hider, Robert C.; Yu, Yongping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4215-4226</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deferoxamine, deferiprone, and deferasirox are used for the treatment of systemic iron overload, although they possess limitations due to lack of oral activity, lower efficacy, and side effects.  These limitations led to a search for an orally active iron chelator with an improved therapeutic index.  The lower efficacy of deferiprone is due to rapid glucuronidation, leading to the formation of a nonchelating metabolite.  Here, we demonstrate that the influence of metab. can be reduced by introducing a sacrificial site for glucuronidation.  A log P-guided investigation of 20 hydroxpyridinones led to the identification of CN128 (I).  The Fe(III) affinity and metal selectivity of CN128 are similar to those of deferiprone, the log P value is more lipophilic, and its iron scavenging ability is superior.  Overall, CN128 was demonstrated to be safe in a range of toxicity assessments and is now in clin. trials for the treatment of Î²-thalassemia after regular blood transfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWwz1TyBtEULVg90H21EOLACvtfcHk0lgGaik8YE8pHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls1CjtbY%253D&md5=7c33de49bc80e50c669cc27f852db37d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DZ.%2BD.%26aulast%3DKong%26aufirst%3DS.%2BS.%26aulast%3DJiang%26aufirst%3DH.%2BD.%26aulast%3DDu%26aufirst%3DH.%2BB.%26aulast%3DPan%26aufirst%3DX.%2BH.%26aulast%3DNandi%26aufirst%3DM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DZhang%26aufirst%3DG.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DYu%26aufirst%3DY.%2BP.%26atitle%3DCN128%253A%2520A%2520new%2520orally%2520active%2520hydroxypyridinone%2520iron%2520chelator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D8%26spage%3D4215%26epage%3D4226%26doi%3D10.1021%2Facs.jmedchem.0c00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanninelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyader, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span> <span> </span><span class="NLM_article-title">Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">176</span>â <span class="NLM_lpage">184</span>, <span class="refDoi">Â DOI: 10.1016/S0168-8278(97)80299-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0168-8278%2897%2980299-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9252093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2sXltVOrsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=176-184&author=G.+Zanninelliauthor=R.+Chouduryauthor=O.+Lorealauthor=D.+Guyaderauthor=G.+Lescoatauthor=J.+Arnaudauthor=R.+Vernaauthor=B.+Cossonauthor=S.+Singhauthor=R.+C.+Hiderauthor=P.+Brissot&title=Novel+orally+active+iron+chelators+%283-hydroxypyridin-4-ones%29+enhance+the+biliary+excretion+of+plasma+non-transferrin-bound+iron+in+rats&doi=10.1016%2FS0168-8278%2897%2980299-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats</span></div><div class="casAuthors">Zanninelli, Giuliana; Choudury, Ruksana; Loreal, Olivier; Guyader, Dominique; Lescoat, Gerard; Arnaud, Josiane; Verna, Roberto; Cosson, Bertrand; Singh, Surinder; Hider, Robert C.; Brissot, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-184</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">It is well documented that levels of plasma non-transferrin-bound iron (NTBI), a particularly toxic form of iron, are increased in iron overload disorders.  In light of the pathogenetic importance of NTBI in chronic iron overload, we have studied the ability of new orally active iron chelators to promote the biliary excretion of iron originating as plasma 55Fe-NTBI.  Biliary iron kinetics of plasma 55Fe-labeled NTBI and cumulative recoveries of 55Fe in bile were detd. in normal and carbonyl iron-loaded rats receiving a single intragastric dose of iron chelator.  These chelators were the novel hydroxypyridin-4-one compds. CP102, CP41, and their resp. prodrugs CP117 and CP165.  The cumulative recovery of 55Fe in bile of normal rats was increased by 5.2-, 7.9-, 11.5-, and 9.2-fold with CP102, CP117, CP41 and CP165, resp.  In iron overloaded rats, these compds. increased the cumulative recovery by 28.6-, 48.6-, 72.6-, and 32-fold, resp.  All the chelators had a choleretic effect, were metabolized by the liver as demonstrated by HPLC study of bile, and were not cytotoxic since normal plasma transaminase levels were maintained at the end of the expts.  These chelators have potential interest for the treatment of iron overload conditions and may offer advantages over simple N-alkyl-hydroxypyridinones such as deferiprone (CP20, L1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovXlA0iiBsYLVg90H21EOLACvtfcHk0lgGaik8YE8pHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltVOrsLY%253D&md5=24818350919564cd7e28ba4624a22754</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0168-8278%2897%2980299-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-8278%252897%252980299-1%26sid%3Dliteratum%253Aachs%26aulast%3DZanninelli%26aufirst%3DG.%26aulast%3DChoudury%26aufirst%3DR.%26aulast%3DLoreal%26aufirst%3DO.%26aulast%3DGuyader%26aufirst%3DD.%26aulast%3DLescoat%26aufirst%3DG.%26aulast%3DArnaud%26aufirst%3DJ.%26aulast%3DVerna%26aufirst%3DR.%26aulast%3DCosson%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBrissot%26aufirst%3DP.%26atitle%3DNovel%2520orally%2520active%2520iron%2520chelators%2520%25283-hydroxypyridin-4-ones%2529%2520enhance%2520the%2520biliary%2520excretion%2520of%2520plasma%2520non-transferrin-bound%2520iron%2520in%2520rats%26jtitle%3DJ.%2520Hepatol.%26date%3D1997%26volume%3D27%26spage%3D176%26epage%3D184%26doi%3D10.1016%2FS0168-8278%2897%2980299-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties and biological evaluation of ester prodrugs of 3-hydroxypyridin-4-ones: design of orally active chelators with clinical potential</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">475</span>â <span class="NLM_lpage">485</span>, <span class="refDoi">Â DOI: 10.1016/S0223-5234(99)80097-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0223-5234%2899%2980097-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFGkt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=475-485&issue=6&author=B.+L.+Raiauthor=Z.+D.+Liuauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+properties+and+biological+evaluation+of+ester+prodrugs+of+3-hydroxypyridin-4-ones%3A+design+of+orally+active+chelators+with+clinical+potential&doi=10.1016%2FS0223-5234%2899%2980097-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physicochemical properties and biological evaluation of ester prodrugs of 3-hydroxypyridin-4-ones: design of orally active chelators with clinical potential</span></div><div class="casAuthors">Rai, Bijaya L.; Liu, Zu Dong; Liu, Ding Yong; Lu, Shu Li; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">475-485</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The synthesis of a range of hydrophobic ester prodrugs of 3-hydroxypyridin-4-ones, I (R = CMe3, Ph, Me, CHMe2, R2 = Et, Me, n = 2, 3), with potential for oral administration is described.  The distribution coeff. values of a range of these ester prodrugs and the corresponding alcs. in 1-octanol and MOPS buffer pH 7.4 are presented together with their rates of hydrolysis at pH 2, pH 7.4, in rat blood and liver homogenate.  In vivo iron mobilization efficacy of the pivaloyl and benzoyl prodrugs has been compared with their parent drugs using a 59Fe-ferritin loaded rat model.  Both classes of prodrug enhanced the ability of the parent hydroxypyridinone to facilitate the excretion of 59Fe.  The influence of the pivaloyl function was more marked than that of the benzoyl function.  The optimal effect was obsd. with 1-[2'-(pivaloyloxy)ethyl]-2-methyl-3-hydroxy-4(1H)-pyridinone I (R = CMe3, R2 = Me, n = 2).  However, not all the prodrugs provide increased efficacy which suggests that lipophilicity is not the only factor which influences the drug efficacy.  The metab. of the compd. may have a dominating influence on the overall efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDhrRuEyBBrVg90H21EOLACvtfcHk0lgJWDGXmegEGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFGkt78%253D&md5=63c42ce4c514cd0226bd3bb7071b7838</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2899%2980097-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252899%252980097-X%26sid%3Dliteratum%253Aachs%26aulast%3DRai%26aufirst%3DB.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%2520and%2520biological%2520evaluation%2520of%2520ester%2520prodrugs%2520of%25203-hydroxypyridin-4-ones%253A%2520design%2520of%2520orally%2520active%2520chelators%2520with%2520clinical%2520potential%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1999%26volume%3D34%26issue%3D6%26spage%3D475%26epage%3D485%26doi%3D10.1016%2FS0223-5234%2899%2980097-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellwig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwardt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsch, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>â <span class="NLM_lpage">82</span>, <span class="refDoi">Â DOI: 10.1016/j.ejpb.2010.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejpb.2010.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21216287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOru7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2011&pages=75-82&issue=1&author=S.+Geisslerauthor=M.+Hellwigauthor=F.+Markwardtauthor=T.+Henleauthor=M.+Brandsch&title=Synthesis+and+intestinal+transport+of+the+iron+chelator+maltosine+in+free+and+dipeptide+form&doi=10.1016%2Fj.ejpb.2010.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form</span></div><div class="casAuthors">Geissler, Stefanie; Hellwig, Michael; Markwardt, Fritz; Henle, Thomas; Brandsch, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-82</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maltosine, a 3-hydroxy-4-pyridinone deriv. of lysine formed in the course of the advanced Maillard reaction, is an effective metal chelating agent.  It therefore represents an interesting compd. for the treatment of metal ion storage diseases.  We synthesized 6-(3-hydroxy-4-oxo-2-methyl-4(1H)-pyridin-1-yl)-L-norleucine (free maltosine) and its dipeptide derivs. alanylmaltosine (Ala-Mal) and maltosinylalanine (Mal-Ala) and examd. the transepithelial flux of these compds. across Caco-2 cells and their interaction with membrane transporters.  Transepithelial flux of maltosine was significantly higher when added as Ala-Mal and Mal-Ala than in free form.  Assays at Caco-2 cells and at HeLa cells expressing the human peptide transporter (hPEPT) 1 revealed that Ala-Mal and Mal-Ala show medium to high affinity to the system.  Only free but not peptide-bound maltosine inhibited the uptake of L-[3H]lysine in Caco-2 and OK cells.  Maltosine dipeptides were transported by hPEPT1 across cell membranes and accumulated in hPEPT1-transfected HeLa cells.  In electrophysiol. measurements at hPEPT1-expressing Xenopus laevis oocytes, Ala-Mal and Mal-Ala induced significant inward directed currents.  We conclude that Ala-Mal and Mal-Ala are transported by hPEPT1 into intestinal cells and then hydrolyzed to free maltosine and alanine.  The results suggest that the oral bioavailability of maltosine can be increased significantly by applying this drug candidate in peptide-bound form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2zS-MWQfoLVg90H21EOLACvtfcHk0lgJWDGXmegEGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOru7o%253D&md5=de0246dd311ab487913e7c1e55bc6682</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2010.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2010.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DGeissler%26aufirst%3DS.%26aulast%3DHellwig%26aufirst%3DM.%26aulast%3DMarkwardt%26aufirst%3DF.%26aulast%3DHenle%26aufirst%3DT.%26aulast%3DBrandsch%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520intestinal%2520transport%2520of%2520the%2520iron%2520chelator%2520maltosine%2520in%2520free%2520and%2520dipeptide%2520form%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2011%26volume%3D78%26issue%3D1%26spage%3D75%26epage%3D82%26doi%3D10.1016%2Fj.ejpb.2010.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrel-Groussard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasdeloup, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span> <span> </span><span class="NLM_article-title">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1479</span>â <span class="NLM_lpage">1487</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2003.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bcp.2003.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15041465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=1479-1487&issue=8&author=F.+Gaboriauauthor=K.+Chantrel-Groussardauthor=N.+Rakbaauthor=P.+Loyerauthor=N.+Pasdeloupauthor=R.+C.+Hiderauthor=P.+Brissotauthor=G.+Lescoat&title=Iron+mobilization%2C+cytoprotection%2C+and+inhibition+of+cell+proliferation+in+normal+and+transformed+rat+hepatocyte+cultures+by+the+hydroxypyridinone+CP411%2C+compared+to+CP20%3A+a+biological+and+physicochemical+study&doi=10.1016%2Fj.bcp.2003.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span></div><div class="casAuthors">Gaboriau, Francois; Chantrel-Groussard, Karine; Rakba, Nafissa; Loyer, Pascal; Pasdeloup, Nicole; Hider, Robert C.; Brissot, Pierre; Lescoat, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1479-1487</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study analyzes the iron mobilization, the cytoprotective, and the antiproliferative effects of the lipophilic hydroxypyridinone CP411, in comparison with the hydrophilic chelator CP20 or deferiprone used in the treatment of iron overload.  Primary rat hepatocyte cultures and the rat hepatoma cell line Fao were used.  Chelator cell uptake was evaluated by mass spectrometry in the two models.  This method was also used to investigate the stability of the chelators in an acellular system as well as their scavenging and chelating effects against the hydroxyl radical generated by the Fenton reaction.  The iron mobilization and the cytoprotective effects of the chelators were evaluated in primary cultures by measuring resp. 55Fe and lactate dehydrogenase release in the culture medium.  The antiproliferative effect of the chelators was studied using the Fao cell line and measuring DNA synthesis by thymidine incorporation and DNA content by flow cytometry.  The authors obsd. that CP411 entered the hepatocytes and the Fao cells resp. 4 and 13 times more than CP20.  CP411 was 2.5 times more effective than CP20 to mobilize iron from preloaded hepatocytes.  Pretreatment of the hepatocytes with CP20 or CP411 decreased the toxic effect of iron and CP411 was 1.6 times more effective than CP20.  A dose-dependent decrease of DNA synthesis, correlated to an accumulation of cells in S phase, was obsd. in the Fao cell line in the presence of CP411, while CP20 was without effect.  CP411 effect was inhibited by addn. of iron simultaneously with the chelator, the addn. of Zn or Cu was without effect.  The inhibitory effect of CP411 was reversible since, 24 h after removal of the chelator, DNA replication reached the control level.  The results show that CP411 is more efficient to protect the hepatocyte from the toxic effect of iron load and to inhibit tumor cell proliferation.  Its higher efficiency may result from its better cell uptake since equimolar solns. of the two chelators in an acellular system exhibit the same ability to inhibit the Fenton reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUGkeFexh2rVg90H21EOLACvtfcHk0lgJWDGXmegEGA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D&md5=d1063e9c5ddc87451852258c44f900e3</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2003.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriau%26aufirst%3DF.%26aulast%3DChantrel-Groussard%26aufirst%3DK.%26aulast%3DRakba%26aufirst%3DN.%26aulast%3DLoyer%26aufirst%3DP.%26aulast%3DPasdeloup%26aufirst%3DN.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBrissot%26aufirst%3DP.%26aulast%3DLescoat%26aufirst%3DG.%26atitle%3DIron%2520mobilization%252C%2520cytoprotection%252C%2520and%2520inhibition%2520of%2520cell%2520proliferation%2520in%2520normal%2520and%2520transformed%2520rat%2520hepatocyte%2520cultures%2520by%2520the%2520hydroxypyridinone%2520CP411%252C%2520compared%2520to%2520CP20%253A%2520a%2520biological%2520and%2520physicochemical%2520study%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26issue%3D8%26spage%3D1479%26epage%3D1487%26doi%3D10.1016%2Fj.bcp.2003.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel pegylated iron chelators with decreased metabolic rate</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2439</span>â <span class="NLM_lpage">2349</span>, <span class="refDoi">Â DOI: 10.4155/fmc.15.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4155%2Ffmc.15.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26670054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVeqtL7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2439-2349&issue=18&author=J.+P.+Liauthor=Z.+D.+Luauthor=X.+L.+Kongauthor=Y.+M.+Maauthor=X.+Y.+Zhangauthor=S.+S.+Bansalauthor=V.+Abbateauthor=R.+C.+Hider&title=Design+and+synthesis+of+novel+pegylated+iron+chelators+with+decreased+metabolic+rate&doi=10.4155%2Ffmc.15.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel pegylated iron chelators with decreased metabolic rate</span></div><div class="casAuthors">Li, Junpei; Lu, Zidong; Kong, Xiaole; Ma, Yongmin; Zhang, Xingyuan; Bansal, Sukhvinder S.; Abbate, Vincenzo; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2439-2449</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: Deferiprone has proved to be a successful iron selective chelator in a range of pathologies.  However, its use is limited by rapid Phase II metab., necessitating the administration of large doses.  In an attempt to modify metabolic rate of this class of compds., a range of pegylated 3-hydroxypyridin-4-ones has been synthesized.  Exptl.: The synthetic route in which the polyethylene glycol counterparts are introduced to a protected pyran ring involves either a Williamson etherification reaction or direct addn. leading to polyethylene glycol-contg. precursors.  Results & discussion: The introduction of the pegylated substituent was found to lead to a relatively low rate of metab. for some of the derivs. (6a, 6b, 8a and 8b), offering a possible improvement over deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtCr-cUoR99LVg90H21EOLACvtfcHk0lgaTjCWNDZUZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVeqtL7N&md5=21e2fc00c64b13d38ea48e6d1c0e2c8a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.154%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DLu%26aufirst%3DZ.%2BD.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DBansal%26aufirst%3DS.%2BS.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520pegylated%2520iron%2520chelators%2520with%2520decreased%2520metabolic%2520rate%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D18%26spage%3D2439%26epage%3D2349%26doi%3D10.4155%2Ffmc.15.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span> <span> </span><span class="NLM_article-title">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe<sup>3+</sup> values</span>. <i>Transfusion Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">201</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/S0955-3886(00)00090-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0955-3886%2800%2900090-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11099896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=201-209&author=R.+C.+Hiderauthor=Z.+D.+Liuauthor=S.+Piyamongkol&title=The+design+and+properties+of+3-hydroxypyridin-4-one+iron+chelators+with+high+pFe3%2B+values&doi=10.1016%2FS0955-3886%2800%2900090-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values</span></div><div class="casAuthors">Hider R C; Liu Z D; Piyamongkol S</div><div class="citationInfo"><span class="NLM_cas:title">Transfusion science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-9</span>
        ISSN:<span class="NLM_cas:issn">0955-3886</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lZ-efNfxxVUIs6wFK5xJfW6udTcc2eav-Mf6cjUvqrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D&md5=af5a6096617fc38e6b49ba48661c87c5</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2FS0955-3886%2800%2900090-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-3886%252800%252900090-4%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26atitle%3DThe%2520design%2520and%2520properties%2520of%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520with%2520high%2520pFe3%252B%2520values%26jtitle%3DTransfusion%2520Science%26date%3D2000%26volume%3D23%26spage%3D201%26epage%3D209%26doi%3D10.1016%2FS0955-3886%2800%2900090-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aytemir, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Amido-3-hydroxypyridin-4-ones as iron(III) ligands</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6374</span>â <span class="NLM_lpage">6381</span>, <span class="refDoi">Â DOI: 10.1002/chem.200902455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fchem.200902455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20397153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVGqtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=6374-6381&issue=21&author=S.+Piyamongkolauthor=Y.+M.+Maauthor=X.+L.+Kongauthor=Z.+D.+Liuauthor=M.+D.+Aytemirauthor=D.+van+der+Helmauthor=R.+C.+Hider&title=Amido-3-hydroxypyridin-4-ones+as+iron%28III%29+ligands&doi=10.1002%2Fchem.200902455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Amido-3-hydroxypyridin-4-ones as Iron(III) Ligands</span></div><div class="casAuthors">Piyamongkol, Sirivipa; Ma, Yong M.; Kong, Xiao L.; Liu, Zu D.; Aytemir, Mutlu D.; van der Helm, Dick; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6374-6381, S6374/1-S6374/53</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis and physicochem. properties of a range of 2- and 6-amido-3-hydroxypyridin-4-ones are described.  All the amido-substituted 3-hydroxypyridin-4-ones have lower pKa values than 1,2-dimethyl-3-hydroxypyridin-4-one (deferiprone).  This is due to the inductive effect of the amido group.  Also, the pKa values of the 3-hydroxy group in 1-nonsubstituted pyridinones are dramatically lower than those of the corresponding 1-alkyl analogs, indicating that a strong hydrogen bond exists between the 2-amido function and the 3-oxygen anion, which stabilizes the anion.  As a result of the decreased competition with protons, the pFe3+ values of this group of mols. are higher than that of deferiprone.  The distribution coeffs. of these mols. are also increased despite the lack of a hydrophobic 1-alkyl substituent and this is ascribed to the intramol. hydrogen bond.  X-ray diffraction studies confirm the existence of the intramol. hydrogen bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr66U4MU4X9HrVg90H21EOLACvtfcHk0lgaTjCWNDZUZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVGqtb8%253D&md5=5ff945a48139d6a74408c87968b8df72</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fchem.200902455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200902455%26sid%3Dliteratum%253Aachs%26aulast%3DPiyamongkol%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DAytemir%26aufirst%3DM.%2BD.%26aulast%3Dvan%2Bder%2BHelm%26aufirst%3DD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DAmido-3-hydroxypyridin-4-ones%2520as%2520iron%2528III%2529%2520ligands%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26issue%3D21%26spage%3D6374%26epage%3D6381%26doi%3D10.1002%2Fchem.200902455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lachowicz, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurchi, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisponi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaraquemada-Pelaez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintanova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoroddu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Martin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choquesillo-Lazarte, D.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinones with enhanced iron chelating properties. synthesis, characterization and <i>in vivo</i> tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1<i>H</i>)-one</span>. <i>Dalton. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6517</span>â <span class="NLM_lpage">6528</span>, <span class="refDoi">Â DOI: 10.1039/C6DT00129G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC6DT00129G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26956442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFKls7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=6517-6528&issue=15&author=J.+I.+Lachowiczauthor=V.+M.+Nurchiauthor=G.+Crisponiauthor=M.+G.+Jaraquemada-Pelaezauthor=M.+Arcaauthor=A.+Pintusauthor=M.+A.+Santosauthor=C.+Quintanovaauthor=L.+Ganoauthor=Z.+Szewczukauthor=M.+A.+Zorodduauthor=M.+Peanaauthor=A.+Dominguez-Martinauthor=D.+Choquesillo-Lazarte&title=Hydroxypyridinones+with+enhanced+iron+chelating+properties.+synthesis%2C+characterization+and+in+vivo+tests+of+5-hydroxy-2-%28hydroxymethyl%29pyridine-4%281H%29-one&doi=10.1039%2FC6DT00129G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one</span></div><div class="casAuthors">Lachowicz, J. I.; Nurchi, V. M.; Crisponi, G.; Jaraquemada-Pelaez, M. G.; Arca, M.; Pintus, A.; Santos, M. A.; Quintanova, C.; Gano, L.; Szewczuk, Z.; Zoroddu, M. A.; Peana, M.; Dominguez-Martin, A.; Choquesillo-Lazarte, D.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6517-6528</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one (P1) is presented, together with the evaluation of its coordination ability towards Fe3+ (I), studied by a combination of chem., computational, and animal approaches.  The use of complementary anal. techniques has allowed the authors to give evidence of the tautomeric changes of P1 as a function of pH, and to det. their influence on the coordinating ability of P1 towards Fe3+.  The pFe3+ value 22.0 of P1-iron complexes is noticeably higher than that of deferiprone (20.6), one of the three clin. chelating agents in therapeutic use for iron overload diseases.  This is due on one side to the tautomeric change to the catechol form, and on the other to the lower protonation const. of the OH group.  Bio-distribution studies on mice allowed the authors to confirm in vivo the efficacy of P1.  Furthermore the coordinating ability toward Al3+, Cu2+ and Zn2+ was studied to evaluate the possible use of P1 against a second toxic metal ion (Al3+), and to envisage its potential influence on the homeostatic equil. of essential metal ions.  The chelating ability of P1 toward these ions, not higher than that of the corresponding deferiprone, contributes to render P1 a more selective iron chelator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzh8qcYwKH5rVg90H21EOLACvtfcHk0lgEQaUOpo7YUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFKls7s%253D&md5=5be541e65ab8ef796361a495e50d3f2c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1039%2FC6DT00129G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT00129G%26sid%3Dliteratum%253Aachs%26aulast%3DLachowicz%26aufirst%3DJ.%2BI.%26aulast%3DNurchi%26aufirst%3DV.%2BM.%26aulast%3DCrisponi%26aufirst%3DG.%26aulast%3DJaraquemada-Pelaez%26aufirst%3DM.%2BG.%26aulast%3DArca%26aufirst%3DM.%26aulast%3DPintus%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26aulast%3DQuintanova%26aufirst%3DC.%26aulast%3DGano%26aufirst%3DL.%26aulast%3DSzewczuk%26aufirst%3DZ.%26aulast%3DZoroddu%26aufirst%3DM.%2BA.%26aulast%3DPeana%26aufirst%3DM.%26aulast%3DDominguez-Martin%26aufirst%3DA.%26aulast%3DChoquesillo-Lazarte%26aufirst%3DD.%26atitle%3DHydroxypyridinones%2520with%2520enhanced%2520iron%2520chelating%2520properties.%2520synthesis%252C%2520characterization%2520and%2520in%2520vivo%2520tests%2520of%25205-hydroxy-2-%2528hydroxymethyl%2529pyridine-4%25281H%2529-one%26jtitle%3DDalton.%2520Trans.%26date%3D2016%26volume%3D45%26issue%3D15%26spage%3D6517%26epage%3D6528%26doi%3D10.1039%2FC6DT00129G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Iron binding dendrimers: a novel approach for the treatment of haemochromatosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4171</span>â <span class="NLM_lpage">4182</span>, <span class="refDoi">Â DOI: 10.1021/jm0600949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0600949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSiuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4171-4182&issue=14&author=T.+Zhouauthor=H.+Neubertauthor=D.+Y.+Liuauthor=Z.+D.+Liuauthor=Y.+M.+Maauthor=X.+L.+Kongauthor=W.+Luoauthor=S.+Markauthor=R.+C.+Hider&title=Iron+binding+dendrimers%3A+a+novel+approach+for+the+treatment+of+haemochromatosis&doi=10.1021%2Fjm0600949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Iron Binding Dendrimers: A Novel Approach for the Treatment of Hemochromatosis</span></div><div class="casAuthors">Zhou, Tao; Neubert, Hendrik; Liu, Ding Yong; Liu, Zu Dong; Ma, Yong Min; Kong, Xiao Le; Luo, Wei; Mark, Sykes; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4171-4182</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of iron binding dendrimers terminated with hexadentate ligands formed from hydroxypyridinone, hydroxypyranone, and catechol moieties have been synthesized in order to investigate their potential as clin. useful iron(III)-selective chelators capable of removing dietary iron from the gastrointestinal tract and preventing the development of iron overload typical of hemochromatosis and thalassemia intermedia.  The iron chelating abilities of these mols. have been characterized by MALDI-TOF mass spectrometry and UV spectrometry.  Hydroxypyridinone-terminated dendrimers were found to possess a high affinity and selectivity for iron(III).  A hydroxypyridinone-based dendrimer was demonstrated to be highly efficient at reducing the absorption of iron(III) in rat intestine.  This family of dendrimers may find an application in the treatment of iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ_MHunLD_srVg90H21EOLACvtfcHk0lgEQaUOpo7YUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSiuro%253D&md5=0fa8f8c882058c3c3cae339c50215d20</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0600949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0600949%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DNeubert%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DMark%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DIron%2520binding%2520dendrimers%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520haemochromatosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D14%26spage%3D4171%26epage%3D4182%26doi%3D10.1021%2Fjm0600949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1372</span>â <span class="NLM_lpage">1380</span>, <span class="refDoi">Â DOI: 10.1021/bm701122u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bm701122u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvFOluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1372-1380&author=T.+Zhouauthor=X.+L.+Kongauthor=Z.+D.+Liuauthor=D.+Y.+Liuauthor=R.+C.+Hider&title=Synthesis+and+iron%28III%29-chelating+properties+of+novel+3-hydroxypyridin-4-one+hexadentate+ligand-containing+copolymers&doi=10.1021%2Fbm701122u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Iron(III)-Chelating Properties of Novel 3-Hydroxypyridin-4-one Hexadentate Ligand-Containing Copolymers</span></div><div class="casAuthors">Zhou, Tao; Kong, Xiao Le; Liu, Zu Dong; Liu, Ding Yong; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1372-1380</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iron overload is a crit. clin. problem that can be prevented by the use of iron-specific chelating agents.  An alternative method of relieving iron overload is to reduce the efficiency of iron absorption from the intestine by administering iron chelators, which can bind iron irreversibly to form nontoxic, kinetically inert complexes that are not absorbed and are therefore excreted in the feces.  A series of polymeric chelators with various iron binding capacities were therefore prepd. as nonabsorbable iron-selective additives.  A novel 3-hydroxypyridin-4-one hexadentate ligand CP254 has been synthesized and incorporated into polymers by copolymn. with N,N-dimethylacrylamide (DMAA), and N,N'-ethylene-bis-acrylamide (EBAA) using (NH4)2S2O8 as the initiator.  The physicochem. properties of CP254 were detd., namely, log K = 33.2 and pFe3+ = 27.24.  The chelating capacity of the CP254-DMAA copolymers was detd. at physiol. pH.  The iron(III) chelation was found to achieve 80% capacity after 1 h and was virtually complete after 5 h, which is much quicker than that of the com. available chelating resin Chelex100.  The chelating copolymers were found to be readily regenerated and reusable.  The copolymers possess a high selectivity for iron(III).  The conditional affinity (log K') for iron(III) at pH 7.46 was detd. to be 26.55, which is not significantly different to that of the hexadentate ligand CP254 (log K' = 26.47).  In vitro perfusion studies indicate that the polymeric chelators described in this study can reduce iron absorption from the intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp3V-cqnjrorVg90H21EOLACvtfcHk0lgEQaUOpo7YUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvFOluro%253D&md5=e0d95739749a769b3513447463ddeb77</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fbm701122u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm701122u%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%2520and%2520iron%2528III%2529-chelating%2520properties%2520of%2520novel%25203-hydroxypyridin-4-one%2520hexadentate%2520ligand-containing%2520copolymers%26jtitle%3DBiomacromolecules%26date%3D2008%26volume%3D9%26spage%3D1372%26epage%3D1380%26doi%3D10.1021%2Fbm701122u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, A. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">New tris(hydroxypyridinones) as iron and aluminium sequestering agents: synthesis, complexation and <i>in vivo</i> studies</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">10535</span>â <span class="NLM_lpage">10545</span>, <span class="refDoi">Â DOI: 10.1002/chem.201001335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fchem.201001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20665585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=10535-10545&issue=34&author=S.+Chavesauthor=S.+M.+Marquesauthor=A.+M.+F.+Matosauthor=A.+Nunesauthor=L.+Ganoauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=M.+A.+Santos&title=New+tris%28hydroxypyridinones%29+as+iron+and+aluminium+sequestering+agents%3A+synthesis%2C+complexation+and+in+vivo+studies&doi=10.1002%2Fchem.201001335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">New Tris(hydroxypyridinones) as Iron and Aluminium Sequestering Agents: synthesis, Complexation and In Vivo Studies</span></div><div class="casAuthors">Chaves, Silvia; Marques, Sergio M.; Matos, Andre M. F.; Nunes, Andreia; Gano, Lurdes; Tuccinardi, Tiziano; Martinelli, Adriano; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10535-10545</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two new tripodal tris(3-hydroxy-4-pyridinone) hexadentate chelators-NTA(BuHP)3 and NTP(PrHP)3 (NTA=nitrilotriacetic acid, NTP=nitrilotripropionic acid, HP=hydroxypyridone)-have been developed and studied in soln. for their iron and aluminum binding affinity, and also assayed in vivo for their capacity to remove metal from an animal model that is overloaded.  These chelators are positional isomers, possessing identical general structures based on aminotricarboxylic acid skeletons attached to three bidentate 3-hydroxy-4-pyridinones (3,4-HPs), but differing in the position of the amide linkage along the chelating "arm".  In spite of expected differences in the tripodal ligands, such as acidity and hydrogen-bonding networks, they share important properties, namely, a mild hydrophilic character (log P ca. -1.2 to -1.4) and a strong chelating affinity for Fe and Al (pFe=27.9 and pAl=22.0 for NTA(BuHP)3; pFe=29.4 and pAl=22.4 for NTP(PrHP)3).  They also evidenced identical effects on the biodistribution and on the excretion of a radiotracer (67Ga) previously administered to mice, as models of iron overload animals.  Comparison of the new compds. with reported analogs shows good improvement in terms of soln. and in vivo sequestering properties, thus giving support to expectations about their potential clin. application as metal removal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXKBLX9o9CWrVg90H21EOLACvtfcHk0lgSyfZSe_jFuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbrP&md5=7cf028ffe7847aa32504f0a825ba7dde</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fchem.201001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201001335%26sid%3Dliteratum%253Aachs%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DMarques%26aufirst%3DS.%2BM.%26aulast%3DMatos%26aufirst%3DA.%2BM.%2BF.%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DGano%26aufirst%3DL.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DNew%2520tris%2528hydroxypyridinones%2529%2520as%2520iron%2520and%2520aluminium%2520sequestering%2520agents%253A%2520synthesis%252C%2520complexation%2520and%2520in%2520vivo%2520studies%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26issue%3D34%26spage%3D10535%26epage%3D10545%26doi%3D10.1002%2Fchem.201001335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkelmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of clinically useful macromolecular iron chelators</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">893</span>â <span class="NLM_lpage">903</span>, <span class="refDoi">Â DOI: 10.1111/j.2042-7158.2011.01291.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.2042-7158.2011.01291.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21635254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotV2iur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=893-903&issue=7&author=T.+Zhouauthor=G.+Winkelmannauthor=Z.+Y.+Daiauthor=R.+C.+Hider&title=Design+of+clinically+useful+macromolecular+iron+chelators&doi=10.1111%2Fj.2042-7158.2011.01291.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Design of clinically useful macromolecular iron chelators</span></div><div class="casAuthors">Zhou, Tao; Winkelmann, Gunther; Dai, Zhi-Yuan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-903</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, macromol. Fe chelators have received increasing attention as human therapeutic agents.  The objectives of this article are: one, to discuss the factors which should be considered when designing iron binding macromols. as human therapeutic agents, and two, to report recent achievements in the design and synthesis of appropriate macromol. chelators that have resulted in the prodn. of a no. of agents with therapeutic potential.  Macromol. drugs exhibit unique pharmaceutical properties that are fundamentally different from their traditional small-mol. counterparts.  By virtue of their high-mol.-wt. characteristics, many are confined to extracellular compartments, for instance, the serum and the gastrointestinal tract.  In addn., they have potential for topical administration.  Consequently, these macromol. drugs are free from many of the toxic effects that are assocd. with their low-mol.-wt. analogs.  The design and synthesis of macromol. Fe chelators provides a novel aspect to chelation therapy.  3-Hydroxypyridin-4-one hexadentate-based macromol. chelators have considerable potential for the development of new treatments for iron overload and for topical treatment of infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOxMX43pL_3bVg90H21EOLACvtfcHk0lgSyfZSe_jFuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotV2iur8%253D&md5=7296f0399ea06878424308c2ea3657b7</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2011.01291.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2011.01291.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DWinkelmann%26aufirst%3DG.%26aulast%3DDai%26aufirst%3DZ.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520clinically%2520useful%2520macromolecular%2520iron%2520chelators%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2011%26volume%3D63%26issue%3D7%26spage%3D893%26epage%3D903%26doi%3D10.1111%2Fj.2042-7158.2011.01291.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galanello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danjou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giardina, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, R. W.</span></span> <span> </span><span class="NLM_article-title">Combined iron chelation therapy</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1202</i></span>,  <span class="NLM_fpage">79</span>â <span class="NLM_lpage">86</span>, <span class="refDoi">Â DOI: 10.1111/j.1749-6632.2010.05591.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1749-6632.2010.05591.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20712777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGms7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1202&publication_year=2010&pages=79-86&author=R.+Galanelloauthor=A.+Agusauthor=S.+Campusauthor=F.+Danjouauthor=P.+J.+Giardinaauthor=R.+W.+Grady&title=Combined+iron+chelation+therapy&doi=10.1111%2Fj.1749-6632.2010.05591.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Combined iron chelation therapy</span></div><div class="casAuthors">Galanello, Renzo; Agus, Annalisa; Campus, Simona; Danjou, Fabrice; Giardina, Patricia J.; Grady, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1202</span>
        (<span class="NLM_cas:issue">Cooley's Anemia</span>),
    <span class="NLM_cas:pages">79-86</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Patients with thalassemia major accumulate body iron over time as a consequence of continuous red blood cell transfusions which cause hepatic, endocrine, and cardiac complications.  Despite the availability of three iron chelators, some patients fail to respond adequately to monotherapy with any of them.  Combination therapy, consisting in the use of two chelators on the same day, has been introduced to increase the efficacy and to induce neg. iron balance in patients with severe iron overload.  Extensive long-term experience has shown that combined chelation with deferiprone and deferoxamine (DFO) rapidly reduces liver iron, serum ferritin, and myocardial siderosis, improves cardiac function, reverses and prevents endocrine complications, reduces cardiac mortality, and improves survival.  Side effects, though significant, are manageable if properly monitored.  Preliminary promising results have been obtained using combined chelation with deferasirox and DFO.  As more drug combination regimes are evaluated, it should be possible to better tailor iron chelation to the needs of the patients, minimizing toxicity and maximizing efficacy throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yCxDDoxizLVg90H21EOLACvtfcHk0lgSyfZSe_jFuw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGms7fN&md5=5f22ea73095cc2ab58111651b42e76b4</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2010.05591.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2010.05591.x%26sid%3Dliteratum%253Aachs%26aulast%3DGalanello%26aufirst%3DR.%26aulast%3DAgus%26aufirst%3DA.%26aulast%3DCampus%26aufirst%3DS.%26aulast%3DDanjou%26aufirst%3DF.%26aulast%3DGiardina%26aufirst%3DP.%2BJ.%26aulast%3DGrady%26aufirst%3DR.%2BW.%26atitle%3DCombined%2520iron%2520chelation%2520therapy%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1202%26spage%3D79%26epage%3D86%26doi%3D10.1111%2Fj.1749-6632.2010.05591.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontoghiorghes, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eracleous, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Economides, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolnagou, A.</span></span> <span> </span><span class="NLM_article-title">Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56â252, L1NAll and their combinations</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2663</span>â <span class="NLM_lpage">2681</span>, <span class="refDoi">Â DOI: 10.2174/092986705774463003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F092986705774463003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16305464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2663-2681&author=G.+J.+Kontoghiorghesauthor=E.+Eracleousauthor=C.+Economidesauthor=A.+Kolnagou&title=Advances+in+iron+overload+therapies.+Prospects+for+effective+use+of+deferiprone+%28L1%29%2C+deferoxamine%2C+the+new+experimental+chelators+ICL670%2C+GT56%E2%80%93252%2C+L1NAll+and+their+combinations&doi=10.2174%2F092986705774463003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations</span></div><div class="casAuthors">Kontoghiorghes, George J.; Eracleous, Eleni; Economides, Charalambos; Kolnagou, Annita</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2663-2681</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Effective new therapies and mechanisms have been developed for the targeting and prevention of iron overload and toxicity in thalassemia and idiopathic haemochromatosis patients.  A new era in the development of chelating drugs began with the introduction of deferiprone or L1, which as a monotherapy or in combination with deferoxamine can be used universally for effective chelation treatments, rapid iron removal, maintenance of low iron stores and prevention of heart and other organ damage caused by iron overload.  Several exptl. iron chelators such as deferasirox (4-[3,5-bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid) or ICL670, deferitrin (4,5-dihydro-2- (2,4-dihydroxyphenyl)-4-methylthiazole-4 (S)-carboxylic acid) or GT56-252, 1-allyl-2-methyl-3-hydroxypyrid-4-one or L1NAll and starch deferoxamine polymers have reached different stages of clin. development.  The lipophilic ICL670, which can only be administered once daily is generally ineffective in causing neg. iron balance but is effective in reducing liver iron.  It is suspected that it may increase iron absorption and the redistribution of iron from the liver to the heart and other organs.  The exptl. iron chelators do not appear to have significant advantages in efficacy and toxicity by comparison to deferiprone, deferoxamine or their combination.  However, the prospect of combination therapies using deferiprone, deferoxamine and new chelators will provide new mechanisms of chelator interactions, which may lead to higher efficacy and lower toxicity by comparison to monotherapies.  A major disadvantage of the exptl. chelators is that even if they are approved for clin. use, they are unlikely to be as inexpensive as deferiprone and become available to the vast majority of thalassemia patients, who live in developing countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdjCvfb55tLVg90H21EOLACvtfcHk0lhEi0qSuj3IaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrrI&md5=e5f8a0fba238a6f66f45693bb9f3daf1</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2174%2F092986705774463003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774463003%26sid%3Dliteratum%253Aachs%26aulast%3DKontoghiorghes%26aufirst%3DG.%2BJ.%26aulast%3DEracleous%26aufirst%3DE.%26aulast%3DEconomides%26aufirst%3DC.%26aulast%3DKolnagou%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520iron%2520overload%2520therapies.%2520Prospects%2520for%2520effective%2520use%2520of%2520deferiprone%2520%2528L1%2529%252C%2520deferoxamine%252C%2520the%2520new%2520experimental%2520chelators%2520ICL670%252C%2520GT56%25E2%2580%2593252%252C%2520L1NAll%2520and%2520their%2520combinations%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2663%26epage%3D2681%26doi%3D10.2174%2F092986705774463003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, S. K.</span></span> <span> </span><span class="NLM_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimerâs disease and potential therapeutic strategies</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">53</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1016/j.pneurobio.2018.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.pneurobio.2018.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30599179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFajsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2019&pages=53-89&author=P.+Sharmaauthor=P.+Srivastavaauthor=A.+Sethauthor=P.+N.+Tripathiauthor=A.+G.+Banerjeeauthor=S.+K.+Shrivastava&title=Comprehensive+review+of+mechanisms+of+pathogenesis+involved+in+Alzheimer%E2%80%99s+disease+and+potential+therapeutic+strategies&doi=10.1016%2Fj.pneurobio.2018.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies</span></div><div class="casAuthors">Sharma, Piyoosh; Srivastava, Pavan; Seth, Ankit; Tripathi, Prabhash Nath; Banerjee, Anupam G.; Shrivastava, Sushant K.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-89</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  AD is a progressive neurodegenerative disorder and a leading cause of dementia in an aging population worldwide.  An in-depth anal. of the extensive available data assocd. with the AD is needed for a more comprehensive understanding of underlying mol. mechanisms and pathophysiol. pathways assocd. with the onset and progression of the AD.  The currently understood pathol. and biochem. manifestations include cholinergic, AÎ², tau, excitotoxicity, oxidative stress, ApoE, CREB signaling pathways, insulin resistance, etc.  However, these hypotheses have been criticized with several conflicting reports for their involvement in the disease progression.  Several issues need to be addressed such as benefits to cost ratio with cholinesterase therapy, the dilemma of AChE selectivity over BChE, BBB permeability of peptidic BACE-1 inhibitors, hurdles related to the implementation of vaccination and immunization therapy, and clin. failure of candidates related to newly available targets.  The present review provides an insight to the different mol. mechanisms involved in the development and progression of the AD and potential therapeutic strategies, enlightening perceptions into structural information of conventional and novel targets along with the successful applications of computational approaches for the design of target-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ggPpSxf8_bVg90H21EOLACvtfcHk0lhEi0qSuj3IaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFajsQ%253D%253D&md5=0d4cf0a5d03797cbc07f5112c30550c8</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DSrivastava%26aufirst%3DP.%26aulast%3DSeth%26aufirst%3DA.%26aulast%3DTripathi%26aufirst%3DP.%2BN.%26aulast%3DBanerjee%26aufirst%3DA.%2BG.%26aulast%3DShrivastava%26aufirst%3DS.%2BK.%26atitle%3DComprehensive%2520review%2520of%2520mechanisms%2520of%2520pathogenesis%2520involved%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520potential%2520therapeutic%2520strategies%26jtitle%3DProg.%2520Neurobiol.%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89%26doi%3D10.1016%2Fj.pneurobio.2018.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reelfs, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cilibrizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourzand, C.</span></span> <span> </span><span class="NLM_article-title">The role of mitochondrial labile iron in Friedreichâs ataxia skin fibroblasts sensitivity to ultraviolet A</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">656</span>â <span class="NLM_lpage">665</span>, <span class="refDoi">Â DOI: 10.1039/C8MT00257F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC8MT00257F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30778428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtlClt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=656-665&issue=3&author=O.+Reelfsauthor=V.+Abbateauthor=A.+Cilibrizziauthor=M.+A.+Pookauthor=R.+C.+Hiderauthor=C.+Pourzand&title=The+role+of+mitochondrial+labile+iron+in+Friedreich%E2%80%99s+ataxia+skin+fibroblasts+sensitivity+to+ultraviolet+A&doi=10.1039%2FC8MT00257F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A</span></div><div class="casAuthors">Reelfs, Olivier; Abbate, Vincenzo; Cilibrizzi, Agostino; Pook, Mark A.; Hider, Robert C.; Pourzand, Charareh</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-665</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Mitochondrial labile iron (LI) is a major contributor to the susceptibility of skin fibroblasts to UV A (UVA)-induced oxidative damage leading to necrotic cell death via ATP depletion.  Mitochondria iron overload is a key feature of the neurodegenerative disease Friedreich's ataxia (FRDA).  We demonstrate that FRDA cells display higher levels of mitochondrial LI (up to 6-fold on av. compared to healthy counterparts) and show higher increase in mitochondrial reactive oxygen species (ROS) generation after UVA irradn. (up to 2-fold on av.), consistent with their differential sensitivity to UVA.  Pre-treatment of the FRDA cells with a bespoke mitochondrial iron chelator fully abrogates the UVA-mediated cell death and reduces UVA-induced damage to mitochondrial membrane and the resulting ATP depletion by a factor of 2.  Our results reveal a link between FRDA as a disease of mitochondrial iron overload and sensitivity to UVA of skin fibroblasts.  Our findings suggest that the high levels of mitochondrial LI in FRDA cells which contribute to high levels of mitochondrial ROS prodn. after UVA irradn. are likely to play a crucial role in the marked sensitivity of these cells to UVA-induced oxidative damage.  This study may have implications not only for FRDA but also for other diseases of mitochondrial iron overload, with the view to develop topical mitochondria-targeted iron chelators as skin photoprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFFOkOcdEP-bVg90H21EOLACvtfcHk0lhEi0qSuj3IaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtlClt74%253D&md5=533867dc87771b4ec6166889644c73bb</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1039%2FC8MT00257F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MT00257F%26sid%3Dliteratum%253Aachs%26aulast%3DReelfs%26aufirst%3DO.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DCilibrizzi%26aufirst%3DA.%26aulast%3DPook%26aufirst%3DM.%2BA.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DPourzand%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520mitochondrial%2520labile%2520iron%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%2520skin%2520fibroblasts%2520sensitivity%2520to%2520ultraviolet%2520A%26jtitle%3DMetallomics%26date%3D2019%26volume%3D11%26issue%3D3%26spage%3D656%26epage%3D665%26doi%3D10.1039%2FC8MT00257F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucca, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecca, L.</span></span> <span> </span><span class="NLM_article-title">The role of iron in brain ageing and neurodegenerative disorders</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1045</span>â <span class="NLM_lpage">1060</span>, <span class="refDoi">Â DOI: 10.1016/S1474-4422(14)70117-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1474-4422%2814%2970117-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25231526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyrt7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1045-1060&issue=10&author=R.+J.+Wardauthor=F.+A.+Zuccaauthor=J.+H.+Duynauthor=R.+R.+Crichtonauthor=L.+Zecca&title=The+role+of+iron+in+brain+ageing+and+neurodegenerative+disorders&doi=10.1016%2FS1474-4422%2814%2970117-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The role of iron in brain aging and neurodegenerative disorders</span></div><div class="casAuthors">Ward, Roberta J.; Zucca, Fabio A.; Duyn, Jeff H.; Crichton, Robert R.; Zecca, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1045-1060</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the CNS, iron in several proteins is involved in many important processes such as oxygen transportation, oxidative phosphorylation, myelin prodn., and the synthesis and metab. of neurotransmitters.  Abnormal iron homoeostasis can induce cellular damage through hydroxyl radical prodn., which can cause the oxidn. and modification of lipids, proteins, carbohydrates, and DNA.  During aging, different iron complexes accumulate in brain regions assocd. with motor and cognitive impairment.  In various neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, changes in iron homoeostasis result in altered cellular iron distribution and accumulation.  MRI can often identify these changes, thus providing a potential diagnostic biomarker of neurodegenerative diseases.  An important avenue to reduce iron accumulation is the use of iron chelators that are able to cross the blood-brain barrier, penetrate cells, and reduce excessive iron accumulation, thereby affording neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUvbm7wD6rkbVg90H21EOLACvtfcHk0lj_3kcVq51rIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyrt7zN&md5=469d9dd8f50e41d5795c9bf45354bc64</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970117-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970117-6%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DZucca%26aufirst%3DF.%2BA.%26aulast%3DDuyn%26aufirst%3DJ.%2BH.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26aulast%3DZecca%26aufirst%3DL.%26atitle%3DThe%2520role%2520of%2520iron%2520in%2520brain%2520ageing%2520and%2520neurodegenerative%2520disorders%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26issue%3D10%26spage%3D1045%26epage%3D1060%26doi%3D10.1016%2FS1474-4422%2814%2970117-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, J.</span></span> <span> </span><span class="NLM_article-title">The potential application of iron chelators for the treatment of neurodegenerative diseases</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">239</span>â <span class="NLM_lpage">249</span>, <span class="refDoi">Â DOI: 10.1039/c0mt00087f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc0mt00087f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21344071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=239-249&issue=3&author=R.+C.+Hiderauthor=S.+Royauthor=Y.+M.+Maauthor=X.+Le+Kongauthor=J.+Preston&title=The+potential+application+of+iron+chelators+for+the+treatment+of+neurodegenerative+diseases&doi=10.1039%2Fc0mt00087f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">The potential application of iron chelators for the treatment of neurodegenerative diseases</span></div><div class="casAuthors">Hider, Robert C.; Roy, Sourav; Ma, Yong Min; Le Kong, Xiao; Preston, Jane</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Many forms of neurodegenerative disease, for instance Alzheimer's disease, Parkinson's disease, Friedreich's ataxia, Hallervorden Spatz syndrome and macular degeneration, are assocd. with elevated levels of redox active metals in the brain and eye.  A logical therapeutic approach therefore, is to remove the toxic levels of these metals, copper and iron in particular, by selective chelation.  The increased no. of iron-selective chelators now available for clin. use has enhanced interest in this type of therapy.  This review summarises the recent developments in the design of chelators for treatment of neurodegenerative disease, identifies some of the essential properties for such mols. and suggests some future strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_QWZw98vWsbVg90H21EOLACvtfcHk0lj_3kcVq51rIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D&md5=d5efb2da19e8a08dccb014614ba4b71e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1039%2Fc0mt00087f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0mt00087f%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DLe%2BKong%26aufirst%3DX.%26aulast%3DPreston%26aufirst%3DJ.%26atitle%3DThe%2520potential%2520application%2520of%2520iron%2520chelators%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DMetallomics%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D239%26epage%3D249%26doi%3D10.1039%2Fc0mt00087f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aouad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span> <span> </span><span class="NLM_article-title">Brain iron in the freeocene-loaded rat: its chelation and influence on dopamine metabolism</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1821</span>â <span class="NLM_lpage">1826</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(94)00521-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0006-2952%2894%2900521-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=7598744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2MXms1enur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=1821-1826&issue=12&author=R.+J.+Wardauthor=D.+Dexterauthor=A.+Florenceauthor=F.+Aouadauthor=R.+C.+Hiderauthor=P.+Jennerauthor=R.+R.+Crichton&title=Brain+iron+in+the+freeocene-loaded+rat%3A+its+chelation+and+influence+on+dopamine+metabolism&doi=10.1016%2F0006-2952%2894%2900521-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Brain iron in the ferrocene-loaded rat: its chelation and influence of dopamine metabolism</span></div><div class="casAuthors">Ward, Roberta J.; Dexter, David; Florence, Anne; Aouad, Fouad; Hider, Robert; Jenner, Peter; Crichton, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1821-6</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">After administration of the ferrocene deriv. 3,5,5-tri-Me hexanoyl ferrocene to rats for 4 wk, various brain regions including substantia nigra, cerebellum and cerebral cortex showed â¤50% increase in iron content.  Subsequent administration of one of the hydroxypyridones CP20, CP24, and CP94, or the siderophore desferrioxamine caused a significant decrease in the iron content of these various brain regions.  Each of the hydroxypyridones and the siderophore influenced dopamine metab. by causing significant variations in both homovanillic acid and dopamine turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFZ1wuH8PVhbVg90H21EOLACvtfcHk0lj_3kcVq51rIg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1enur8%253D&md5=22cfa34d1b45d886e9f23008a69995c3</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2894%2900521-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252894%252900521-M%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DDexter%26aufirst%3DD.%26aulast%3DFlorence%26aufirst%3DA.%26aulast%3DAouad%26aufirst%3DF.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26atitle%3DBrain%2520iron%2520in%2520the%2520freeocene-loaded%2520rat%253A%2520its%2520chelation%2520and%2520influence%2520on%2520dopamine%2520metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26issue%3D12%26spage%3D1821%26epage%3D1826%26doi%3D10.1016%2F0006-2952%2894%2900521-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habgood, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehkordi, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1305</span>â <span class="NLM_lpage">1310</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(99)00031-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-2952%2899%2900031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10230774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXivVCjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=1305-1310&issue=11&author=M.+D.+Habgoodauthor=Z.+D.+Liuauthor=L.+S.+Dehkordiauthor=H.+H.+Khodrauthor=J.+Abbottauthor=R.+C.+Hider&title=Investigation+into+the+correlation+between+the+structure+of+hydroxypyridinones+and+blood-brain+barrier+permeability&doi=10.1016%2FS0006-2952%2899%2900031-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability</span></div><div class="casAuthors">Habgood, Mark D.; Liu, Zu Dong; Dehkordi, Lotfollah S.; Khodr, Hicham H.; Abbott, Joan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1305-1310</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Bidentate hydroxypyridinones are under active development as orally active iron chelators.  With applications for the treatment of general body iron overload, for instance with thalassemia, the distribution of the chelators should be limited to peripheral tissue and they should not enter the central nervous system.  This study compares the predictive abilities of LogPoctanol and LogPcyclohexane and reports the existence of good correlations between blood-brain barrier (BBB) permeability and both values for N-alkylpyridinones.  1,Ï-Hydroxyalkyl hydroxypyridinones penetrate the BBB much more slowly than the simple 1-alkyl derivs.  This observation is likely to have important toxicol. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5j4-vbHr9urVg90H21EOLACvtfcHk0ligcf2iHwgpyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivVCjtbY%253D&md5=ba96880d418da2ac6f0909ad8469e2ad</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2899%2900031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252899%252900031-3%26sid%3Dliteratum%253Aachs%26aulast%3DHabgood%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DDehkordi%26aufirst%3DL.%2BS.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DAbbott%26aufirst%3DJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DInvestigation%2520into%2520the%2520correlation%2520between%2520the%2520structure%2520of%2520hydroxypyridinones%2520and%2520blood-brain%2520barrier%2520permeability%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1999%26volume%3D57%26issue%3D11%26spage%3D1305%26epage%3D1310%26doi%3D10.1016%2FS0006-2952%2899%2900031-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, J. L.</span></span> <span> </span><span class="NLM_article-title">Current recommendations for chelation for transfusion-dependent thalassemia</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1368</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">114</span>, <span class="refDoi">Â DOI: 10.1111/nyas.13088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fnyas.13088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27186943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSksrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1368&publication_year=2016&pages=107-114&author=J.+L.+Kwiatkowski&title=Current+recommendations+for+chelation+for+transfusion-dependent+thalassemia&doi=10.1111%2Fnyas.13088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Current recommendations for chelation for transfusion-dependent thalassemia</span></div><div class="casAuthors">Kwiatkowski, Janet L.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1368</span>
        (<span class="NLM_cas:issue">1, Cooley's Anemia</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Regular red cell transfusions used to treat thalassemia cause iron loading that must be treated with chelation therapy.  Morbidity and mortality in thalassemia major are closely linked to the adequacy of chelation.  Chelation therapy removes accumulated iron and detoxifies iron, which can prevent and reverse much of the iron-mediated organ injury.  Currently, three chelators are com. available--deferoxamine, deferasirox, and deferiprone--and each can be used as monotherapy or in combination.  Close monitoring of hepatic and cardiac iron burden is central to tailoring chelation.  Other factors, including properties of the individual chelators, ongoing transfusional iron burden, and patient preference, must be considered.  Monotherapy generally is utilized if the iron burden is in an acceptable or near-acceptable range and the dose is adjusted accordingly.  Combination chelation often is employed for patients with high iron burden, iron-related organ injury, or where adverse effects of chelators preclude administration of an appropriate chelator dose.  The combination of deferoxamine and deferiprone is the best studied, but increasing data are available on the safety and efficacy of newer chelator combinations, including deferasirox with deferoxamine and the oral-only combination of deferasirox with deferiprone.  The expanding chelation repertoire should enable better control of iron burden and improved outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxD5luP4JAYLVg90H21EOLACvtfcHk0ligcf2iHwgpyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSksrk%253D&md5=7bfe90fadf4cd928bcdae42c0547692c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1111%2Fnyas.13088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.13088%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DJ.%2BL.%26atitle%3DCurrent%2520recommendations%2520for%2520chelation%2520for%2520transfusion-dependent%2520thalassemia%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2016%26volume%3D1368%26spage%3D107%26epage%3D114%26doi%3D10.1111%2Fnyas.13088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devedjian, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrault, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laloux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonneaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckewaert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouaix, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jissendi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dujardin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravasi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grolez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablonniere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strubi-Vuillaume, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poltl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Defebvre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabantchik, Z. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordet, R.</span></span> <span> </span><span class="NLM_article-title">Targeting chelatable iron as a therapeutic modality in Parkinsonâs disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">195</span>â <span class="NLM_lpage">210</span>, <span class="refDoi">Â DOI: 10.1089/ars.2013.5593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1089%2Fars.2013.5593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24251381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWmurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=195-210&issue=2&author=D.+Devosauthor=C.+Moreauauthor=J.+C.+Devedjianauthor=J.+Kluzaauthor=M.+Petraultauthor=C.+Lalouxauthor=A.+Jonneauxauthor=G.+Ryckewaertauthor=G.+Garconauthor=N.+Rouaixauthor=A.+Duhamelauthor=P.+Jissendiauthor=K.+Dujardinauthor=F.+Augerauthor=L.+Ravasiauthor=L.+Hopesauthor=G.+Grolezauthor=W.+Firdausauthor=B.+Sablonniereauthor=I.+Strubi-Vuillaumeauthor=N.+Zahrauthor=A.+Desteeauthor=J.+C.+Corvolauthor=D.+Poltlauthor=M.+Leistauthor=C.+Roseauthor=L.+Defebvreauthor=P.+Marchettiauthor=Z.+I.+Cabantchikauthor=R.+Bordet&title=Targeting+chelatable+iron+as+a+therapeutic+modality+in+Parkinson%E2%80%99s+disease&doi=10.1089%2Fars.2013.5593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease</span></div><div class="casAuthors">Devos, David; Moreau, Caroline; Devedjian, Jean Christophe; Kluza, Jerome; Petrault, Maud; Laloux, Charlotte; Jonneaux, Aurelie; Ryckewaert, Gilles; Garcon, Guillaume; Rouaix, Nathalie; Duhamel, Alain; Jissendi, Patrice; Dujardin, Kathy; Auger, Florent; Ravasi, Laura; Hopes, Lucie; Grolez, Guillaume; Firdaus, Wance; Sablonniere, Bernard; Strubi-Vuillaume, Isabelle; Zahr, Noel; Destee, Alain; Corvol, Jean-Christophe; Poeltl, Dominik; Leist, Marcel; Rose, Christian; Defebvre, Luc; Marchetti, Philippe; Cabantchik, Z. Ioav; Bordet, Regis</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-210</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The pathophysiol. role of iron in Parkinson's disease (PD) was assessed by a chelation strategy aimed at reducing oxidative damage assocd. with regional iron deposition without affecting circulating metals.  Translational cell and animal models provided concept proofs and a delayed-start (DS) treatment paradigm, the basis for preliminary clin. assessments.  Results: For translational studies, we assessed the effect of oxidative insults in mice systemically prechelated with deferiprone (DFP) by following motor functions, striatal dopamine (HPLC and MRI-PET), and brain iron deposition (relaxation-R2*-MRI) aided by spectroscopic measurements of neuronal labile iron (with fluorescence-sensitive iron sensors) and oxidative damage by markers of protein, lipid, and DNA modification.  DFP significantly reduced labile iron and biol. damage in oxidn.-stressed cells and animals, improving motor functions while raising striatal dopamine.  For a pilot, double-blind, placebo-controlled randomized clin. trial, early-stage Parkinson's patients on stabilized dopamine regimens enrolled in a 12-mo single-center study with DFP (30 mg/kg/day).  Based on a 6-mo DS paradigm, early-start patients (n=19) compared to DS patients (n=18) (37/40 completed) responded significantly earlier and sustainably to treatment in both substantia nigra iron deposits (R2* MRI) and Unified Parkinson's Disease Rating Scale motor indicators of disease progression (p<0.03 and p<0.04, resp.).  Apart from three rapidly resolved neutropenia cases, safety was maintained throughout the trial.  Innovation: A moderate iron chelation regimen that avoids changes in systemic iron levels may constitute a novel therapeutic modality for PD.  Conclusions: The therapeutic features of a chelation modality established in translational models and in pilot clin. trials warrant comprehensive evaluation of symptomatic and/or disease-modifying potential of chelation in PD.  Antioxid. Redox Signal. 21, 195-210.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOSmNzpWgbCLVg90H21EOLACvtfcHk0ligcf2iHwgpyg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWmurk%253D&md5=9124979c22409bfbfba32180c84df393</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1089%2Fars.2013.5593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2013.5593%26sid%3Dliteratum%253Aachs%26aulast%3DDevos%26aufirst%3DD.%26aulast%3DMoreau%26aufirst%3DC.%26aulast%3DDevedjian%26aufirst%3DJ.%2BC.%26aulast%3DKluza%26aufirst%3DJ.%26aulast%3DPetrault%26aufirst%3DM.%26aulast%3DLaloux%26aufirst%3DC.%26aulast%3DJonneaux%26aufirst%3DA.%26aulast%3DRyckewaert%26aufirst%3DG.%26aulast%3DGarcon%26aufirst%3DG.%26aulast%3DRouaix%26aufirst%3DN.%26aulast%3DDuhamel%26aufirst%3DA.%26aulast%3DJissendi%26aufirst%3DP.%26aulast%3DDujardin%26aufirst%3DK.%26aulast%3DAuger%26aufirst%3DF.%26aulast%3DRavasi%26aufirst%3DL.%26aulast%3DHopes%26aufirst%3DL.%26aulast%3DGrolez%26aufirst%3DG.%26aulast%3DFirdaus%26aufirst%3DW.%26aulast%3DSablonniere%26aufirst%3DB.%26aulast%3DStrubi-Vuillaume%26aufirst%3DI.%26aulast%3DZahr%26aufirst%3DN.%26aulast%3DDestee%26aufirst%3DA.%26aulast%3DCorvol%26aufirst%3DJ.%2BC.%26aulast%3DPoltl%26aufirst%3DD.%26aulast%3DLeist%26aufirst%3DM.%26aulast%3DRose%26aufirst%3DC.%26aulast%3DDefebvre%26aufirst%3DL.%26aulast%3DMarchetti%26aufirst%3DP.%26aulast%3DCabantchik%26aufirst%3DZ.%2BI.%26aulast%3DBordet%26aufirst%3DR.%26atitle%3DTargeting%2520chelatable%2520iron%2520as%2520a%2520therapeutic%2520modality%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D21%26issue%3D2%26spage%3D195%26epage%3D210%26doi%3D10.1089%2Fars.2013.5593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Bastida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newbould, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabba, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tricta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D. T.</span></span> <span> </span><span class="NLM_article-title">Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinsonâs disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1398</span>â <span class="NLM_lpage">1406</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-01402-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2Fs41598-017-01402-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28469157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC1crjslOktA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1398-1406&issue=1&author=A.+Martin-Bastidaauthor=R.+J.+Wardauthor=R.+Newbouldauthor=P.+Picciniauthor=D.+Sharpauthor=C.+Kabbaauthor=M.+C.+Patelauthor=M.+Spinoauthor=J.+Connellyauthor=F.+Trictaauthor=R.+R.+Crichtonauthor=D.+T.+Dexter&title=Brain+iron+chelation+by+deferiprone+in+a+phase+2+randomised+double-blinded+placebo+controlled+clinical+trial+in+Parkinson%E2%80%99s+disease&doi=10.1038%2Fs41598-017-01402-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease</span></div><div class="casAuthors">Martin-Bastida Antonio; Ward Roberta J; Piccini Paola; Sharp David; Kabba Christina; Dexter David T; Ward Roberta J; Crichton Robert R; Newbould Rexford; Patel Maneesh C; Spino Michael; Connelly John; Tricta Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1398</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is associated with increased iron levels in the substantia nigra (SNc).  This study evaluated whether the iron chelator, deferiprone, is well tolerated, able to chelate iron from various brain regions and improve PD symptomology.  In a randomised double-blind, placebo controlled trial, 22 early onset PD patients, were administered deferiprone, 10 or 15 mg/kg BID or placebo, for 6 months.  Patients were evaluated for PD severity, cognitive function, depression rating and quality of life.  Iron concentrations were assessed in the substantia nigra (SNc), dentate and caudate nucleus, red nucleus, putamen and globus pallidus by T2* MRI at baseline and after 3 and 6 months of treatment.  Deferiprone therapy was well tolerated and was associated with a reduced dentate and caudate nucleus iron content compared to placebo.  Reductions in iron content of the SNc occurred in only 3 patients, with no changes being detected in the putamen or globus pallidus.  Although 30 mg/kg deferiprone treated patients showed a trend for improvement in motor-UPDRS scores and quality of life, this did not reach significance.  Cognitive function and mood were not adversely affected by deferiprone therapy.  Such data supports more extensive clinical trials into the potential benefits of iron chelation in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcf_k-H9XLw2x8TEN9K18QfW6udTcc2eYznTYuWmrbSrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjslOktA%253D%253D&md5=b6f45da6d098961227e00eb0a25845cf</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-01402-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-01402-2%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Bastida%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DNewbould%26aufirst%3DR.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DSharp%26aufirst%3DD.%26aulast%3DKabba%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DM.%2BC.%26aulast%3DSpino%26aufirst%3DM.%26aulast%3DConnelly%26aufirst%3DJ.%26aulast%3DTricta%26aufirst%3DF.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26atitle%3DBrain%2520iron%2520chelation%2520by%2520deferiprone%2520in%2520a%2520phase%25202%2520randomised%2520double-blinded%2520placebo%2520controlled%2520clinical%2520trial%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D1398%26epage%3D1406%26doi%3D10.1038%2Fs41598-017-01402-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">The efficacy of iron chelators for removing iron from specific brain regions and the pituitary-ironing out the brain</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">138</span>â <span class="NLM_lpage">150</span>, <span class="refDoi">Â DOI: 10.3390/ph12030138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fph12030138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFGht7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=138-150&issue=3&author=R.+R.+Crichtonauthor=R.+J.+Wardauthor=R.+C.+Hider&title=The+efficacy+of+iron+chelators+for+removing+iron+from+specific+brain+regions+and+the+pituitary-ironing+out+the+brain&doi=10.3390%2Fph12030138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of iron chelators for removing iron from specific brain regions and the pituitary-ironing out the brain</span></div><div class="casAuthors">Crichton, Robert R.; Ward, Roberta J.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">138</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Iron chelation therapy, either s.c. or orally administered, has been used successfully in various clin. conditions.  The removal of excess iron from various tissues, e.g., the liver spleen, heart, and the pituitary, in beta thalassemia patients, has become an essential therapy to prolong life.  More recently, the use of deferiprone to chelate iron from various brain regions in Parkinson's Disease and Friederich's Ataxia has yielded encouraging results, although the side effects, in <2% of Parkinson's Disease(PD) patients, have limited its long-term use.  A new class of hydroxpyridinones has recently been synthesized, which showed no adverse effects in preliminary trials.  A vital question remaining is whether inflammation may influence chelation efficacy, with a recent study suggesting that high levels of inflammation may diminish the ability of the chelator to bind the excess iron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybJThsYfyzrVg90H21EOLACvtfcHk0lhpF-r-nT62gA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFGht7c%253D&md5=bd0b7413a7f2afb3fdfe51394321baef</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.3390%2Fph12030138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph12030138%26sid%3Dliteratum%253Aachs%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520efficacy%2520of%2520iron%2520chelators%2520for%2520removing%2520iron%2520from%2520specific%2520brain%2520regions%2520and%2520the%2520pituitary-ironing%2520out%2520the%2520brain%26jtitle%3DPharmaceuticals%26date%3D2019%26volume%3D12%26issue%3D3%26spage%3D138%26epage%3D150%26doi%3D10.3390%2Fph12030138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of fluorine-substituted 3-hydroxypyridin-4-ones</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">5230</span>â <span class="NLM_lpage">5233</span>, <span class="refDoi">Â DOI: 10.1016/j.tetlet.2010.07.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tetlet.2010.07.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaiu73E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=5230-5233&issue=40&author=Y.+M.+Maauthor=R.+C.+Hider&title=Design+and+synthesis+of+fluorine-substituted+3-hydroxypyridin-4-ones&doi=10.1016%2Fj.tetlet.2010.07.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of fluorine-substituted 3-hydroxypyridin-4-ones</span></div><div class="casAuthors">Ma, Yong Min; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">5230-5233</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The presence of fluorine in an org. mol. can dramatically alter its chem. and biol. properties due to its unique characteristics.  Several 2- and 5-fluorine-substituted 3-hydroxypyridin-4-ones, e.g I [R1 = R2 = H, R3 = OH, R4 = F; R1 = OH, R2 = Me, R3 = F, R4 = H] have been synthesized with the intention of improving the pharmaceutical profile of deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHnaMqmoIPPrVg90H21EOLACvtfcHk0lhpF-r-nT62gA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaiu73E&md5=cb60e452df8c5bd73663393e419a14b0</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2010.07.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2010.07.134%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520fluorine-substituted%25203-hydroxypyridin-4-ones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26issue%3D40%26spage%3D5230%26epage%3D5233%26doi%3D10.1016%2Fj.tetlet.2010.07.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaeta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina-Holgado, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1<i>H</i>)-ones: iron chelators with the potential for treating Alzheimerâs disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1285</span>â <span class="NLM_lpage">1297</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmc.2010.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21236688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKks7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1285-1297&issue=3&author=A.+Gaetaauthor=F.+Molina-Holgadoauthor=X.+L.+Kongauthor=S.+Salvageauthor=S.+Fakihauthor=P.+T.+Francisauthor=R.+J.+Williamsauthor=R.+C.+Hider&title=Synthesis%2C+physical-chemical+characterisation+and+biological+evaluation+of+novel+2-amido-3-hydroxypyridin-4%281H%29-ones%3A+iron+chelators+with+the+potential+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2010.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physical-chemical characterization and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease</span></div><div class="casAuthors">Gaeta, Alessandra; Molina-Holgado, Francisco; Kong, Xiao L.; Salvage, Sarah; Fakih, Sarah; Francis, Paul T.; Williams, Robert J.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1285-1297</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of 2-amido-3-hydroxypyridin-4-one iron chelators is described.  These compds. have been designed to behave as suitable mol. probes which will improve our knowledge of the role of iron in neurodegenerative conditions.  Neurodegenerative disorders, such as Alzheimer's disease (AD) and Parkinson disease (PD), can be considered as diverse pathol. conditions sharing crit. metabolic processes such as protein aggregation and oxidative stress.  Interestingly, both these metabolic alterations seem to be assocd. with the involvement of metal ions, including iron.  Iron chelation is therefore a potential therapeutic approach.  The physico-chem. (pKa, pFe3+ and log P) and biol. properties (inhibition of iron-contg. enzymes) of these chelators have been investigated in order to obtain a suitable profile for the treatment of neurodegenerative conditions.  Studies with neuronal cell cultures confirm that the new iron chelators are neuroprotective against Î²-amyloid-induced toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRwAhEYhCUJbVg90H21EOLACvtfcHk0lic-7PLwsJkdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKks7o%253D&md5=af9ab71746b35530f0fc01072428d05b</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DMolina-Holgado%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DSalvage%26aufirst%3DS.%26aulast%3DFakih%26aufirst%3DS.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DWilliams%26aufirst%3DR.%2BJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physical-chemical%2520characterisation%2520and%2520biological%2520evaluation%2520of%2520novel%25202-amido-3-hydroxypyridin-4%25281H%2529-ones%253A%2520iron%2520chelators%2520with%2520the%2520potential%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26issue%3D3%26spage%3D1285%26epage%3D1297%26doi%3D10.1016%2Fj.bmc.2010.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mousadoust, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peers, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duce, J. A.</span></span> <span> </span><span class="NLM_article-title">Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinsonâs with novel 1-hydroxypyridin-2-one metal chelators</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">867</span>â <span class="NLM_lpage">876</span>, <span class="refDoi">Â DOI: 10.1039/C4MT00326H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC4MT00326H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25781076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Onu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=867-876&issue=5&author=D.+G.+Workmanauthor=A.+Tsatsanisauthor=F.+W.+Lewisauthor=J.+P.+Boyleauthor=M.+Mousadoustauthor=N.+T.+Hettiarachchiauthor=M.+Hunterauthor=C.+S.+Peersauthor=D.+Tetardauthor=J.+A.+Duce&title=Protection+from+neurodegeneration+in+the+6-hydroxydopamine+%286-OHDA%29+model+of+Parkinson%E2%80%99s+with+novel+1-hydroxypyridin-2-one+metal+chelators&doi=10.1039%2FC4MT00326H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators</span></div><div class="casAuthors">Workman, David G.; Tsatsanis, Andrew; Lewis, Frank W.; Boyle, John P.; Mousadoust, Maryam; Hettiarachchi, Nishani T.; Hunter, Michael; Peers, Chris S.; Tetard, David; Duce, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">867-876</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Brain iron accumulation has been assocd. with inciting the generation of oxidative stress in a host of chronic neurol. diseases, including Parkinson's disease.  Using the catecholaminergic neurotoxin 6-hydroxydopamine to lesion cellular dopaminergic pathways as a model of Parkinson's disease in culture, a selection of 1-hydroxypyridin-2-one (1,2-HOPO) metal chelators were synthesized and their neuroprotective properties were compared to the 3-hydroxypyridin-4-one; deferiprone (3,4-HOPO; DFP).  Protection against 6-OHDA and iron insult by the novel compds. 6 and 9 was comparable to DFP.  Iron assocd. changes by 6-OHDA imply that the neuroprotective capacity of these compds. are due to chelation of the neuronal labile iron pool and the requirement of the iron binding moiety of compd. 6 for efficacy supported this hypothesis.  In conclusion, two novel 1,2-HOPO's and DFP have comparable neuroprotection against Parkinsonian-assocd. neurotoxins and supports the continued development of hydroxypyridinone compds. as a non-toxic therapeutic agent in the treatment of neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonDB_JRKPjLVg90H21EOLACvtfcHk0lic-7PLwsJkdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Onu78%253D&md5=757d5a5f8aec3199931886c689f90723</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1039%2FC4MT00326H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00326H%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DD.%2BG.%26aulast%3DTsatsanis%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DF.%2BW.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DMousadoust%26aufirst%3DM.%26aulast%3DHettiarachchi%26aufirst%3DN.%2BT.%26aulast%3DHunter%26aufirst%3DM.%26aulast%3DPeers%26aufirst%3DC.%2BS.%26aulast%3DTetard%26aufirst%3DD.%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26atitle%3DProtection%2520from%2520neurodegeneration%2520in%2520the%25206-hydroxydopamine%2520%25286-OHDA%2529%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520with%2520novel%25201-hydroxypyridin-2-one%2520metal%2520chelators%26jtitle%3DMetallomics%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D867%26epage%3D876%26doi%3D10.1039%2FC4MT00326H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruck, T. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamoto, T.</span></span> <span> </span><span class="NLM_article-title">A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated Ï of Alzheimerâs disease</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>961</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">146</span>, <span class="refDoi">Â DOI: 10.1016/S0006-8993(02)03893-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-8993%2802%2903893-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12535786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVGitg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=961&publication_year=2003&pages=139-146&author=R.+W.+Shinauthor=T.+P.+A.+Kruckauthor=H.+Murayamaauthor=T.+Kitamoto&title=A+novel+trivalent+cation+chelator+Feralex+dissociates+binding+of+aluminum+and+iron+associated+with+hyperphosphorylated+%CF%84+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0006-8993%2802%2903893-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated Ï of Alzheimer's disease</span></div><div class="casAuthors">Shin, Ryong-Woon; Kruck, Theo P. A.; Murayama, Harunobu; Kitamoto, Tetsuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">961</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-146</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Aluminum (Al(III)) and iron (Fe(III)) are reported to accumulate in neurofibrillary tangles of the Alzheimer's disease (AD) brain.  In these lesions Al (III) and Fe (III) bind with hyperphosphorylated Ï (PHFÏ), the major constituent of the lesions, and induce its aggregation.  It is thought that inhibition and dissocn. of such Al (III)/Fe (III) binding assocd. with PHFÏ could slow or halt the Ï-related neurofibrillary degeneration in patients with AD.  A study, using a previously developed in vitro system in which Al (III) and Fe (III) interact with PHFÏ on AD brain sections and on immunoblot membranes showed that the potent Al (III)/Fe (III) chelator desferrioxamine elicited Al (III) chelation when subjected to autoclave heating.  Here, the ability of a recently developed chem. chelator Feralex-G to remove PHFÏ-bound Al (III)/Fe (III), using reaction conditions at 37, was examd. and compared with that of desferrioxamine.  Chelation of Fe(III) was achieved by both compds. with no discernible difference in their chelating ability.  In contrast, in the present system, the two chelators gave a different Al (III) chelation response.  When incubated at 37, desferrioxamine failed to attain notable Al (III) chelation, while Feralex-G displayed efficient Al (III) chelation.  Thus, when considering competitive Al (III) removal from brain PHFÏ, Feralex-G is a stronger chelator for Al(III) than desferrioxamine.  The efficient Al (III) chelation attainable by Feralex-G adds wt. to its potential clin. usefulness as a medicine in the aluminum/iron chelation therapy for patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfnz9rqCNJOrVg90H21EOLACvtfcHk0lic-7PLwsJkdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVGitg%253D%253D&md5=c0abd148b3a9788775968eaac468f098</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903893-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903893-3%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DR.%2BW.%26aulast%3DKruck%26aufirst%3DT.%2BP.%2BA.%26aulast%3DMurayama%26aufirst%3DH.%26aulast%3DKitamoto%26aufirst%3DT.%26atitle%3DA%2520novel%2520trivalent%2520cation%2520chelator%2520Feralex%2520dissociates%2520binding%2520of%2520aluminum%2520and%2520iron%2520associated%2520with%2520hyperphosphorylated%2520%25CF%2584%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Res.%26date%3D2003%26volume%3D961%26spage%3D139%26epage%3D146%26doi%3D10.1016%2FS0006-8993%2802%2903893-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schugar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohmerle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockman, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Combating Alzheimerâs disease with multifunctional molecules designed for metal passivation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1716</span>â <span class="NLM_lpage">1718</span>, <span class="refDoi">Â DOI: 10.1002/anie.200603866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fanie.200603866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFWisbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1716-1718&issue=10&author=H.+Schugarauthor=D.+E.+Greenauthor=M.+L.+Bowenauthor=L.+E.+Scottauthor=T.+Storrauthor=K.+Bohmerleauthor=F.+Thomasauthor=D.+D.+Allenauthor=P.+R.+Lockmanauthor=M.+Merkelauthor=K.+H.+Thompsonauthor=C.+Orvig&title=Combating+Alzheimer%E2%80%99s+disease+with+multifunctional+molecules+designed+for+metal+passivation&doi=10.1002%2Fanie.200603866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Combating Alzheimer's disease with multifunctional molecules designed for metal passivation</span></div><div class="casAuthors">Schugar, Harvey; Green, David E.; Bowen, Meryn L.; Scott, Lauren E.; Storr, Tim; Bohmerle, Karin; Thomas, Fancy; Allen, David D.; Lockman, Paul R.; Merkel, Michael; Thompson, Katherine H.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1716-1718</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A trifunctional approach: 3-hydroxy-4-pyridinones that contain phenol groups for antioxidant functionality are further elaborated with pendant glucosyl moieties for improved blood-brain barrier targeting (R = Ph, 4-hydroxyphenyl).  Glycosidase removal of the carbohydrate substituents gives ligands that are ready to passivate excess metal ions, esp. copper and zinc, in the brain.  These mols. are potential prodrugs for treatment of neurodegenerative diseases, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFC1-rUojBSLVg90H21EOLACvtfcHk0lg3bhjd2LzCkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFWisbs%253D&md5=75c067beafdf6c17db1ae4ed64889772</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1002%2Fanie.200603866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200603866%26sid%3Dliteratum%253Aachs%26aulast%3DSchugar%26aufirst%3DH.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DBohmerle%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DK.%2BH.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DCombating%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520multifunctional%2520molecules%2520designed%2520for%2520metal%2520passivation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26issue%3D10%26spage%3D1716%26epage%3D1718%26doi%3D10.1002%2Fanie.200603866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Altering pyridinone <i>N</i>-substituents to optimize activity as potential prodrugs for Alzheimerâs disease</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">6364</span>â <span class="NLM_lpage">6367</span>, <span class="refDoi">Â DOI: 10.1039/b815404j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fb815404j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19002321" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2008&pages=6364-6367&author=L.+E.+Scottauthor=B.+D.+Pageauthor=B.+O.+Patrickauthor=C.+Orvig&title=Altering+pyridinone+N-substituents+to+optimize+activity+as+potential+prodrugs+for+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fb815404j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1039%2Fb815404j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb815404j%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DAltering%2520pyridinone%2520N-substituents%2520to%2520optimize%2520activity%2520as%2520potential%2520prodrugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDalton%2520Trans.%26date%3D2008%26volume%3D45%26spage%3D6364%26epage%3D6367%26doi%3D10.1039%2Fb815404j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RodrÃ­guez-RodrÃ­guez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockman, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Aryl-substituted 3-(Î²-D-glucopyranosyloxy)-2-methyl-4(1<i>H</i>)-pyridinones as agents for Alzheimerâs therapy</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">642</span>â <span class="NLM_lpage">648</span>, <span class="refDoi">Â DOI: 10.1039/C0SC00544D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC0SC00544D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGltb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=642-648&issue=4&author=L.+E.+Scottauthor=M.+Telpoukhovskaiaauthor=C.+Rodr%C3%ADguez-Rodr%C3%ADguezauthor=M.+Merkelauthor=M.+L.+Bowenauthor=B.+D.+G.+Pageauthor=D.+E.+Greenauthor=T.+Storrauthor=F.+Thomasauthor=D.+D.+Allenauthor=P.+R.+Lockmanauthor=B.+O.+Patrickauthor=M.+J.+Adamauthor=C.+Orvig&title=N-Aryl-substituted+3-%28%CE%B2-D-glucopyranosyloxy%29-2-methyl-4%281H%29-pyridinones+as+agents+for+Alzheimer%E2%80%99s+therapy&doi=10.1039%2FC0SC00544D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">N-Aryl-substituted 3-(Î²-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy</span></div><div class="casAuthors">Scott, Lauren E.; Telpoukhovskaia, Maria; Rodriguez-Rodriguez, Cristina; Merkel, Michael; Bowen, Meryn L.; Page, Brent D. G.; Green, David E.; Storr, Tim; Thomas, Fancy; Allen, David D.; Lockman, Paul R.; Patrick, Brian O.; Adam, Michael J.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">642-648</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Mols. designed to sequester, redistribute and/or remove metal ions are attractive therapeutic agents in neurodegenerative diseases such as Alzheimer's disease.  The multifactorial nature of the condition and the generally poor target specificity assocd. with metal ion-binding therapy has led to the development of multifunctional 3-hydroxy-4-(1H)-pyridinone pro-ligands.  The excellent qualities of the basic 3-hydroxy-4-pyridinone framework as a low toxicity metal chelator and an antioxidant, as well as its antibacterial and analgesic properties among other functions, inspired us to functionalize it with a framework derived from thioflavin-T, the well-known traditional dye used as a marker to detect amyloid deposits in tissue sections.  Thus 2-methyl-3-hydroxy-1-(4-dimethylaminophenyl)-4(1H)-pyridinone (HL1), 2-methyl-3-hydroxy-1-(4-methylaminophenyl)-4(1H)-pyridinone (HL2), 1-(4-aminophenyl)-3-hydroxy-2-methyl-4(1H)-pyridinone (HL3), 1-(6-benzothiazolyl)-3-hydroxy-2-methyl-4(1H)-pyridinone (HL4), 1-(2-benzothiazolyl)-3-hydroxy-2-methyl-4(1H)-pyridinone (HL5) and 2-methyl-3-hydroxy-1-[4-(4-bromophenyl)-2-thiazolyl]-4(1H)-pyridinone (HL6) were obtained.  Glycosylation, as well as incorporation of structures mimicking those of known amyloid imaging agents, may target drug action to the site of interest, the metal-overloaded amyloid plaques in the Alzheimer's brain.  The pro-ligands were assessed for their antioxidant activity, cytotoxicity and ability to interfere with metal ion-induced amyloid peptide aggregation to screen promising lead compds.  Finally, in a brain uptake study with a radiolabeled glucoconjugate pyridinone, 3-(Î²-D-glucopyranosyloxy)-1-[4-(4-[125I]iodophenyl)-2-thiazolyl]-2-methyl-4(1H)-pyridinone ([125I]-GL7) was shown to cross the blood-brain barrier using an in situ rat brain perfusion technique.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjckkaMqjd_LVg90H21EOLACvtfcHk0lg3bhjd2LzCkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGltb4%253D&md5=81d4f0e8fd01b8ca8aa1247c16c1a230</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2FC0SC00544D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0SC00544D%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez-Rodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DAdam%26aufirst%3DM.%2BJ.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DN-Aryl-substituted%25203-%2528%25CE%25B2-D-glucopyranosyloxy%2529-2-methyl-4%25281H%2529-pyridinones%2520as%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520therapy%26jtitle%3DChem.%2520Sci.%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D642%26epage%3D648%26doi%3D10.1039%2FC0SC00544D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span> <span> </span><span class="NLM_article-title">Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood-brain barrier</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5886</span>â <span class="NLM_lpage">5889</span>, <span class="refDoi">Â DOI: 10.1021/jm100380k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100380k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFemsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5886-5889&issue=15&author=S.+Royauthor=J.+E.+Prestonauthor=R.+C.+Hiderauthor=Y.+M.+Ma&title=Glucosylated+deferiprone+and+its+brain+uptake%3A+implications+for+developing+glucosylated+hydroxypyridinone+analogues+intended+to+cross+the+blood-brain+barrier&doi=10.1021%2Fjm100380k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Glucosylated Deferiprone and Its Brain Uptake: Implications for Developing Glucosylated Hydroxypyridinone Analogues Intended to Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Roy, Sourav; Preston, Jane E.; Hider, Robert C.; Ma, Yong Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5886-5889</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report presents that Deferiprone, the only clin. used 3-hydroxypyridin-4-one (HPO), is able to penetrate the blood-brain barrier (BBB) in guinea pigs, whereas its glucosylated analog is unable to do so.  This finding is contrary to published information suggesting that the glucosylation of HPOs is a viable means of enhancing the brain uptake of this group of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUW7x7AHjPU7Vg90H21EOLACvtfcHk0lg3bhjd2LzCkA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFemsLg%253D&md5=588a4a077d3ecb7b28b1ff4e670eaa76</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm100380k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100380k%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DPreston%26aufirst%3DJ.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DMa%26aufirst%3DY.%2BM.%26atitle%3DGlucosylated%2520deferiprone%2520and%2520its%2520brain%2520uptake%253A%2520implications%2520for%2520developing%2520glucosylated%2520hydroxypyridinone%2520analogues%2520intended%2520to%2520cross%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D15%26spage%3D5886%26epage%3D5889%26doi%3D10.1021%2Fjm100380k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimerâs disease</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">792</span>â <span class="NLM_lpage">805</span>, <span class="refDoi">Â DOI: 10.1039/c3mb25600f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc3mb25600f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23435553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsVKrsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=792-805&issue=4&author=M.+A.+Telpoukhovskaiaauthor=B.+O.+Patrickauthor=C.+Rodriguez-Rodriguezauthor=C.+Orvig&title=Exploring+the+multifunctionality+of+thioflavin-+and+deferiprone-based+molecules+as+acetylcholinesterase+inhibitors+for+potential+application+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc3mb25600f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Patrick, Brian O.; Rodriguez-Rodriguez, Cristina; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">792-805</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a devastating neurodegenerative disease that affects millions of people worldwide.  With no prevention or cure available, this progressive disease has a significant impact on society - dementia patients and their caretakers, healthcare systems, and the economy.  Previously, we have reported initial developments of multifunctional drug candidates for AD based on two scaffolds - thioflavin-T and deferiprone.  Individually, these mols. have shown several favorable functionalities, including dissocn. of toxic amyloid-Î² aggregates, antioxidant and/or metal chelating ability that can pacify reactive oxygen species, plaque targeting, and blood-brain barrier penetration.  In this work, the two scaffolds are augmented with a new functionality - acetylcholinesterase inhibition.  This functionality is incorporated by derivatization with a carbamate group, which is the active group in some AD drugs currently in the market.  We present the rationale for designing three novel compds., their synthesis and characterization, including X-ray crystallog. data, and encouraging results from in vitro and computational acetylcholinesterase inhibition studies.  Also, we evaluate the compds. as potential drug candidates by Lipinski's rules and cytotoxicity studies in a neuronal cell line.  Overall, we demonstrate the feasibility of improving on two well established scaffolds, as well as show in vitro efficacy plus initial mode of action and biol. compatibility data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbZH1FdJg6LVg90H21EOLACvtfcHk0lhkhkIVNzC19w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsVKrsL0%253D&md5=51b2998a266314ba4186cc52bffedb14</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1039%2Fc3mb25600f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3mb25600f%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DExploring%2520the%2520multifunctionality%2520of%2520thioflavin-%2520and%2520deferiprone-based%2520molecules%2520as%2520acetylcholinesterase%2520inhibitors%2520for%2520potential%2520application%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520BioSyst.%26date%3D2013%26volume%3D9%26issue%3D4%26spage%3D792%26epage%3D805%26doi%3D10.1039%2Fc3mb25600f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">In silico to <i>in vitro</i> screening of hydroxypyridinones as acetylcholinesterase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1624</span>â <span class="NLM_lpage">1628</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.01.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2016.01.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26869193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XisValsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1624-1628&issue=6&author=M.+A.+Telpoukhovskaiaauthor=B.+O.+Patrickauthor=C.+Rodriguez-Rodriguezauthor=C.+Orvig&title=In+silico+to+in+vitro+screening+of+hydroxypyridinones+as+acetylcholinesterase+inhibitors&doi=10.1016%2Fj.bmcl.2016.01.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Patrick, Brian O.; Rodriguez-Rodriguez, Cristina; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1624-1628</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have previously shown the improved acetylcholinesterase inhibitory activity of a model hydroxypyridinone compd. transforming the hydroxyl group on the main ring into an N,N-dimethylcarbamate group; in the course of that study the authors developed a computational model to screen compds. for enzymic activity.  Herein the authors report development of second generation libraries.  Candidates that adhere to drug-like criteria from a virtual library of compds. were tested using computational docking studies.  Synthesis and characterization of chosen test compds. and their acetylcholinesterase inhibitory activity are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2VSMQ8l0arVg90H21EOLACvtfcHk0lhkhkIVNzC19w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisValsrs%253D&md5=40bb05a0dd6ab64d40e3b816b53dc555</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.080%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DIn%2520silico%2520to%2520in%2520vitro%2520screening%2520of%2520hydroxypyridinones%2520as%2520acetylcholinesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D1624%26epage%3D1628%26doi%3D10.1016%2Fj.bmcl.2016.01.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bebbington, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monck, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benwell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. H.</span></span> <span> </span><span class="NLM_article-title">3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1<i>H</i>)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">2779</span>â <span class="NLM_lpage">2782</span>, <span class="refDoi">Â DOI: 10.1021/jm990945v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990945v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Wnsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2779-2782&issue=15&author=D.+Bebbingtonauthor=N.+J.+Monckauthor=S.+Gaurauthor=A.+M.+Palmerauthor=K.+Benwellauthor=V.+Harveyauthor=C.+S.+Malcolmauthor=R.+H.+Porter&title=3%2C5-Disubstituted-4-hydroxyphenyls+linked+to+3-hydroxy-2-methyl-4%281H%29-pyridinone%3A+potent+inhibitors+of+lipid+peroxidation+and+cell+toxicity&doi=10.1021%2Fjm990945v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl-4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity</span></div><div class="casAuthors">Bebbington, David; Monck, Nathaniel J. T.; Gaur, Suneel; Palmer, Alan M.; Benwell, Karen; Harvey, Victoria; Malcolm, Craig S.; Porter, Richard H. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2779-2782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The title compds., 1-[2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethyl]-3-hydroxy-2-methyl-4(1H)-pyridinone, 1-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]propyl]-3-hydroxy-2-methyl-4(1H)-pyridinone, 1-[4-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]butyl]-3-hydroxy-2-methyl-4(1H)-pyridinone, 1-[2-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]ethyl]-3-hydroxy-2-methyl-4(1H)-pyridinone and derivs. and salts thereof were prepd. and evaluated as lipid peroxidn. inhibitors and neuroprotective, cytoprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8sIAI4TJuLVg90H21EOLACvtfcHk0lhkhkIVNzC19w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Wnsbs%253D&md5=7ba047350e850fde02a4b63653728b63</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm990945v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990945v%26sid%3Dliteratum%253Aachs%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMonck%26aufirst%3DN.%2BJ.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26aulast%3DBenwell%26aufirst%3DK.%26aulast%3DHarvey%26aufirst%3DV.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26atitle%3D3%252C5-Disubstituted-4-hydroxyphenyls%2520linked%2520to%25203-hydroxy-2-methyl-4%25281H%2529-pyridinone%253A%2520potent%2520inhibitors%2520of%2520lipid%2520peroxidation%2520and%2520cell%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D15%26spage%3D2779%26epage%3D2782%26doi%3D10.1021%2Fjm990945v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as multifunctional agents for the therapy of Alzheimerâs disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>â <span class="NLM_lpage">81</span>, <span class="refDoi">Â DOI: 10.1021/acschemneuro.5b00224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurnJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=69-81&issue=1&author=R.+Shengauthor=L.+Tangauthor=L.+Jiangauthor=L.+Hongauthor=Y.+Shiauthor=N.+Zhouauthor=Y.+Hu&title=Novel+1-phenyl-3-hydroxy-4-pyridinone+derivatives+as+multifunctional+agents+for+the+therapy+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.5b00224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease</span></div><div class="casAuthors">Sheng, Rong; Tang, Li; Jiang, Liu; Hong, Lingjuan; Shi, Ying; Zhou, Naiming; Hu, Yongzhou</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-81</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 1-phenyl-3-hydroxy-4-pyridinone derivs. were designed and synthesized as multifunctional agents for Alzheimer's disease (AD) therapy through incorporation of 3-hydroxy-4-pyridinone moiety from deferiprone into the scaffold of H3 receptor antagonists.  Most of these new compds. displayed designed quadruple functions, H3 receptor antagonism, AÎ² aggregation inhibition, metal ion chelation, and radical scavenging.  Esp., the most promising compd. I displayed nanomolar IC50 values in H3 receptor antagonism with high selectivity, efficient capability to interrupt the formation of AÎ²1-42 fibrils, good copper and iron chelating properties, and more potent 2,2'-azino-bis(3-ethyl-benzothiazoline-6-sulfonic acid) radical cation (ABTSâ¢+) scavenging activity than Trolox.  Further biol. evaluation revealed that it did not show obvious cytotoxicity and hERG potassium channel inhibition at micromolar concn.  In addn., compd. I demonstrated suitable pharmacokinetic properties and acceptable blood-brain barrier permeability in vivo.  All these results indicate that compd. I is a potential multifunctional candidate for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIWDXJyxn1bVg90H21EOLACvtfcHk0ljcYnO1e9d5SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurnJ&md5=66c8440d6a02d18c7cbbd948f5b97540</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00224%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DNovel%25201-phenyl-3-hydroxy-4-pyridinone%2520derivatives%2520as%2520multifunctional%2520agents%2520for%2520the%2520therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D69%26epage%3D81%26doi%3D10.1021%2Facschemneuro.5b00224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arduino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs</span>. <i>Front. Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">6763</span>â <span class="NLM_lpage">6774</span>, <span class="refDoi">Â DOI: 10.2741/3187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2741%2F3187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18508693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOitbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=6763-6774&author=D.+Arduinoauthor=D.+Silvaauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=C.+R.+Oliveiraauthor=M.+A.+Santos&title=New+hydroxypyridinone+iron-chelators+as+potential+anti-neurodegenerative+drugs&doi=10.2741%2F3187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs</span></div><div class="casAuthors">Arduino, Daniela; Silva, Daniel; Cardoso, Sandra M.; Chaves, Silvia; Oliveira, Catarina R.; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6763-6774</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">The neuroprotective action of a set of new hydroxypyridinone-based (3,4-HP) compds. (A, B and C), which are iron chelators extra-functionalized with a propargylamino group for potential MAO-B inhibition, was evaluated after cell treatment with MPP+ (an in vivo inducer of parkinsonism) and Abeta1-40 and/or Abeta1-42 peptides.  Our results show that all these compds. improved cell viability in cells treated with MPP+ and Abeta1-40 peptide or Abeta1-42 peptide.  In order to evaluate the cellular mechanisms underlying the activity of these compds., we studied their protective role in caspase activation All compds. tested were able to prevent MPP+ and Brefeldin A induced caspase-2 activation.  They also sowed quite effective in the inhibition of caspase-4 and caspase-3 activity, an effector caspase in the apoptotic process.  Finally, detection of apoptotic-like cell death after cell exposure to MPP+ was also performed by TUNEL assay.  Our results demonstrated that all tested compds. prevented DNA fragmentation by decreasing TUNEL pos. cells.  A, B and C were more effective than DFP (a 3,4-HP iron-chelating agent in clin. use) in MPP+ induced cell death.  Therefore, these results evidenced a neuroprotective and antiapoptotic role for the compds. studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYVwyCd5V27bVg90H21EOLACvtfcHk0ljcYnO1e9d5SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOitbo%253D&md5=a84b7def01a9234f15ac198039881610</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2741%2F3187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3187%26sid%3Dliteratum%253Aachs%26aulast%3DArduino%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DD.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DNew%2520hydroxypyridinone%2520iron-chelators%2520as%2520potential%2520anti-neurodegenerative%2520drugs%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D6763%26epage%3D6774%26doi%3D10.2741%2F3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintanova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Multifunctional iron-chelators with protective roles against neurodegenerative diseases</span>. <i>Dalton. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6058</span>â <span class="NLM_lpage">6073</span>, <span class="refDoi">Â DOI: 10.1039/c3dt50406a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc3dt50406a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23487286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1agu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=6058-6073&issue=17&author=A.+Nunesauthor=S.+M.+Marquesauthor=C.+Quintanovaauthor=D.+F.+Silvaauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Multifunctional+iron-chelators+with+protective+roles+against+neurodegenerative+diseases&doi=10.1039%2Fc3dt50406a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional iron-chelators with protective roles against neurodegenerative diseases</span></div><div class="casAuthors">Nunes, Andreia; Marques, Sergio M.; Quintanova, Catarina; Silva, Diana F.; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6058-6073</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The multifactorial nature of Alzheimer's disease (AD), and the absence of a disease modifying drug, makes the development of new multifunctional drugs an attractive therapeutic strategy.  Taking into account the hallmarks of AD patient brains, such as low levels of acetylcholine, misfolding of proteins and assocd. beta-amyloid (AÎ²) aggregation, oxidative stress and metal dyshomeostasis, the authors have developed a series of compds. that merge three different approaches: metal attenuation, anti-AÎ² aggregation and anti-acetylcholinesterase activity.  Therefore, 3-hydroxy-4-pyridinone (3,4-HP) and benzothiazole mol. moieties were selected as starting frameworks due to their well known affinity for iron and AÎ² peptides, resp.  The linkers between these two main functional groups were selected on the basis of virtual screening, so that the final mol. could further inhibit the acetylcholinesterase, responsible for the cholinergic losses.  The authors describe herein the design and synthesis of the new hybrid compds., followed by the assessment of soln. properties, namely iron chelation and anti-oxidant capacity.  The compds. were bioassayed for their capacity to inhibit AChE, as well as self- and Zn mediated-AÎ²1-42 aggregation.  Finally, the authors assessed their effects on the viability of neuronal cells stressed with AÎ²42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXIOGOGFYObVg90H21EOLACvtfcHk0lgrSiuNmNRF1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1agu7c%253D&md5=67cb5814ab29cbe487b22f0fdb443bef</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1039%2Fc3dt50406a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3dt50406a%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DMarques%26aufirst%3DS.%2BM.%26aulast%3DQuintanova%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DD.%2BF.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DMultifunctional%2520iron-chelators%2520with%2520protective%2520roles%2520against%2520neurodegenerative%2520diseases%26jtitle%3DDalton.%2520Trans.%26date%3D2013%26volume%3D42%26issue%3D17%26spage%3D6058%26epage%3D6073%26doi%3D10.1039%2Fc3dt50406a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawthray, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali-Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">249</span>â <span class="NLM_lpage">262</span>, <span class="refDoi">Â DOI: 10.1039/C3MT00135K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC3MT00135K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23999879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyktbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=249-262&issue=2&author=M.+A.+Telpoukhovskaiaauthor=C.+Rodriguez-Rodriguezauthor=J.+F.+Cawthrayauthor=L.+E.+Scottauthor=B.+D.+Pageauthor=J.+Ali-Torresauthor=M.+Sodupeauthor=G.+A.+Baileyauthor=B.+O.+Patrickauthor=C.+Orvig&title=3-Hydroxy-4-pyridinone+derivatives+as+metal+ion+and+amyloid+binding+agents&doi=10.1039%2FC3MT00135K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Rodriguez-Rodriguez, Cristina; Cawthray, Jacqueline F.; Scott, Lauren E.; Page, Brent D. G.; Ali-Torres, Jorge; Sodupe, Mariona; Bailey, Gwendolyn A.; Patrick, Brian O.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-262</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Metal ions have been implicated in several neurodegenerative diseases, including Alzheimer's disease, as their dyshomeostasis may lead to prodn. of reactive oxygen species as well as increased toxicity of amyloid protein aggregates.  In this work, we present design and synthesis of three novel multifunctional hydroxypyridinone ligands, HL11, HL12, and HL13, bearing benzothiazole and benzoxazole functionalities.  We study the ability of these compds. to bind metal ions Cu(II), Zn(II), and Fe(III), as well as their antioxidant activity and cytotoxicity.  Addnl., we det. the pro-ligands' (compds. prior to chelation) propensity to target amyloid protein.  Through these studies we det. the effect of combining amyloid- and metal-binding functionalities within the HPO scaffold on different aspects of AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodP3C4WeqQ5bVg90H21EOLACvtfcHk0lgrSiuNmNRF1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyktbo%253D&md5=9d17919474a429077d5c86e1a1c7fdd1</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1039%2FC3MT00135K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MT00135K%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DCawthray%26aufirst%3DJ.%2BF.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DAli-Torres%26aufirst%3DJ.%26aulast%3DSodupe%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DG.%2BA.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3D3-Hydroxy-4-pyridinone%2520derivatives%2520as%2520metal%2520ion%2520and%2520amyloid%2520binding%2520agents%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26issue%3D2%26spage%3D249%26epage%3D262%26doi%3D10.1039%2FC3MT00135K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawthray, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">3654</span>â <span class="NLM_lpage">3657</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.06.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2015.06.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26141772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtLjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3654-3657&issue=17&author=M.+A.+Telpoukhovskaiaauthor=J.+F.+Cawthrayauthor=C.+Rodriguez-Rodriguezauthor=L.+E.+Scottauthor=B.+D.+G.+Pageauthor=B.+O.+Patrickauthor=C.+Orvig&title=3-Hydroxy-4-pyridinone+derivatives+designed+for+fluorescence+studies+to+determine+interaction+with+amyloid+protein+as+well+as+cell+permeability&doi=10.1016%2Fj.bmcl.2015.06.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Cawthray, Jacqueline F.; Rodriguez-Rodriguez, Cristina; Scott, Lauren E.; Page, Brent D. G.; Patrick, Brian O.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3654-3657</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Finding a cure for Alzheimer's disease is an urgent goal.  Multifunctional metal binders are used to elucidate its pathol. features and investigated as potential therapeutics.  The use of physicochem. and TD-DFT calcns. constituted successful strategy in the design of 1-(4-(benzo[d]oxazol-2-yl)phenyl)-3-hydroxy-2-methylpyridin-4(1H)-one (HL21) and 1-(4-(benzo[d]thiazol-2-yl)phenyl)-3-hydroxy-2-methylpyridin-4(1H)-one (HL22).  We report the synthesis and full characterization of these compds., including X-ray crystallog.  Using fluorescent signal as the readout, it was detd. that HL22 interacts with amyloid-beta protein fibrils, and permeates into bEnd.3 cells used as a mimic of the blood-brain barrier.  This provides the first example of direct investigation of our hydroxypyridinone compds. within a biol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_4prGh1Ku0rVg90H21EOLACvtfcHk0lgrSiuNmNRF1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtLjE&md5=fc8c03c3ebfe59044d0afa33cf8e7b31</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.059%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DCawthray%26aufirst%3DJ.%2BF.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3D3-Hydroxy-4-pyridinone%2520derivatives%2520designed%2520for%2520fluorescence%2520studies%2520to%2520determine%2520interaction%2520with%2520amyloid%2520protein%2520as%2520well%2520as%2520cell%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3654%26epage%3D3657%26doi%3D10.1016%2Fj.bmcl.2015.06.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span> <span> </span><span class="NLM_article-title">Identification of 2-subsituted benzothiazole derivatives as triple-functional agents with potential for AD therapy</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">17318</span>â <span class="NLM_lpage">17327</span>, <span class="refDoi">Â DOI: 10.1039/C5RA25788C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC5RA25788C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSjsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=17318-17327&author=L.+Jiangauthor=M.+Zhangauthor=L.+Tangauthor=Q.+Wengauthor=Y.+Shenauthor=Y.+Huauthor=R.+Sheng&title=Identification+of+2-subsituted+benzothiazole+derivatives+as+triple-functional+agents+with+potential+for+AD+therapy&doi=10.1039%2FC5RA25788C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 2-substituted benzothiazole derivatives as triple-functional agents with potential for AD therapy</span></div><div class="casAuthors">Jiang, Liu; Zhang, Minkui; Tang, Li; Weng, Qinjie; Shen, Yanhong; Hu, Yongzhou; Sheng, Rong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">17318-17327</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel series of 2-substituted benzothiazole derivs. as MTDLs were designed and synthesized for AD therapy using pharmacophore-combine strategy.  The benzothiazole moiety from ThT and the HPO moiety from deferiprone were connected with vinyl linker to achieve target compds.  The biol. evaluation results revealed that the majority of them demonstrated desirable triple functions by interfering with AÎ² aggregation, oxidative stress and metal dyshomeostasis simultaneously.  The two most attractive compds. 9c and 9i exhibited excellent self-AÎ²1-42 aggregation inhibitory activity, efficient ABTSÌ + scavenging activity, potent biometals chelating properties, as well as disaggregation activity against previous formed AÎ²1-42 fibrils.  In addn. to these advantages, both of them displayed no cytotoxicity to human glioma U251 cells up to 50 Î¼M, thereby meriting further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRLYEs5ITYbVg90H21EOLACvtfcHk0lgQfH3M8msEhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSjsLo%253D&md5=c24a4a35ba6d9596b6ab99e12a337776</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1039%2FC5RA25788C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA25788C%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DR.%26atitle%3DIdentification%2520of%25202-subsituted%2520benzothiazole%2520derivatives%2520as%2520triple-functional%2520agents%2520with%2520potential%2520for%2520AD%2520therapy%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D17318%26epage%3D17327%26doi%3D10.1039%2FC5RA25788C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, AÎ²<sub>1â42</sub> aggregation inhibitors and metal-chelating agents for Alzheimerâs disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">186</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2016.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28061347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislGnsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=174-186&author=P.+Xuauthor=M.+Zhangauthor=R.+Shengauthor=Y.+Ma&title=Synthesis+and+biological+evaluation+of+deferiprone-resveratrol+hybrids+as+antioxidants%2C+A%CE%B21%E2%80%9342+aggregation+inhibitors+and+metal-chelating+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2016.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, AÎ²1-42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease</span></div><div class="casAuthors">Xu, Ping; Zhang, Minkui; Sheng, Rong; Ma, Yongmin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-186</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of deferiprone-resveratrol hybrids have been designed and synthesized as multitarget-directed ligands (MTDLs) through merging the chelating moiety 3-hydroxypyridin-4-one into the structure of resveratrol, a natural antioxidant agent and Î²-amyloid peptide (AÎ²) aggregation inhibitor.  The in vitro biol. evaluation revealed that most of these newly synthesized compds. exhibited good inhibitory activity against self-induced AÎ²1-42 aggregation, excellent antioxidant activity and potent metal chelating capability.  Compds. I (R1 = H, R2 = OH) and I (R1 = Me, R2 = OEt) were identified as the most promising MTDLs with triple functions, possessing micromolar IC50 values for AÎ²1-42 aggregation inhibition, greater 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTSâ¢+) scavenging activity than Trolox and similar pFe(III) values to that of deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKEBgf65MBK7Vg90H21EOLACvtfcHk0lgQfH3M8msEhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislGnsA%253D%253D&md5=4a5137ac2246f2afe1d65cbcd2e15ee4</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520deferiprone-resveratrol%2520hybrids%2520as%2520antioxidants%252C%2520A%25CE%25B21%25E2%2580%259342%2520aggregation%2520inhibitors%2520and%2520metal-chelating%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D174%26epage%3D186%26doi%3D10.1016%2Fj.ejmech.2016.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeshwari</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candeias, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimerâs disease: a two-in-one drug</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1460</span>â <span class="NLM_lpage">1475</span>, <span class="refDoi">Â DOI: 10.1039/C8MT00143J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC8MT00143J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30183790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtb3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1460-1475&issue=10&author=K.+Chandauthor=+Rajeshwariauthor=E.+Candeiasauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Tacrine-deferiprone+hybrids+as+multi-target-directed+metal+chelators+against+Alzheimer%E2%80%99s+disease%3A+a+two-in-one+drug&doi=10.1039%2FC8MT00143J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug</span></div><div class="casAuthors">Chand, Karam; Rajeshwari; Candeias, Emanuel; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1460-1475</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a severe age-dependent neurodegenerative disorder affecting several million people worldwide.  So far, there is no adequate medication to prevent or slow down the progression of the disease, only medication with palliative effects allowing temporary symptomatic reliefs.  As part of our continuing efforts into the development of innovative drugs following a polypharmacol. strategy, we decided to use a former anti-AD palliative drug (tacrine) and to reposition it by hybridization with a metal chelating drug (deferiprone, DFP).  This combination endows the hybrids with good capacity to inhibit acetylcholinesterase (low micromolar range) and self-/Cu-induced AÎ² aggregation (up to ca. 90%) as well as a good radical scavenging ability (micromolar range) and metal (M) chelating capacity, with pM (pM = -log[M], CL/CM = 10, CM = 10-6 M at pH = 7.4, M = Fe, Cu, Zn) values close to those of DFP.  The most promising compds. have 2-hydroxypropyl linkers, and a selection of compds. have demonstrated neuroprotective roles in neuroblastoma cells treated with AÎ²1-42 and ascorbate/iron stressors.  Consequently, these hybrids can be considered as attractive multipotent therapeutic mols. that will eventually play key roles against AD progression, namely in the control of cholinergic dysfunction, amyloid peptide aggregation, oxidative stress, and metal modulation, besides presenting a good pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruaIf7wxvIdLVg90H21EOLACvtfcHk0lgQfH3M8msEhg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtb3K&md5=08c03fbff71a09f319633f8f710bee8a</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1039%2FC8MT00143J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MT00143J%26sid%3Dliteratum%253Aachs%26aulast%3DChand%26aufirst%3DK.%26aulast%3DRajeshwari%26aulast%3DCandeias%26aufirst%3DE.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DTacrine-deferiprone%2520hybrids%2520as%2520multi-target-directed%2520metal%2520chelators%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520two-in-one%2520drug%26jtitle%3DMetallomics%26date%3D2018%26volume%3D10%26issue%3D10%26spage%3D1460%26epage%3D1475%26doi%3D10.1039%2FC8MT00143J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiremathad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolayan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeshwari</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keri, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteves, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimerâs disease therapy</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">82</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2017.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.jinorgbio.2017.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29182921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOhsr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2018&pages=82-96&author=A.+Hiremathadauthor=K.+Chandauthor=L.+Tolayanauthor=+Rajeshwariauthor=R.+S.+Keriauthor=A.+R.+Estevesauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Hydroxypyridinone-benzofuran+hybrids+with+potential+protective+roles+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2Fj.jinorgbio.2017.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer's disease therapy</span></div><div class="casAuthors">Hiremathad, Asha; Chand, Karam; Tolayan, Lori; Rajeshwari; Keri, Rangappa S.; Esteves, A. Raquel; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-96</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A series of (3-hydroxy-4-pyridinone)-benzofuran hybrids have been developed and studied as potential multitargeting drugs for Alzheimer's disease (AD).  Their design envisaged mainly to mimic the donepezil drug, a marketed inhibitor of acetylcholinesterase (AChE), and to endow the conjugate mols. with extra-properties such as metal chelation, radical scavenging and inhibition of amyloid peptide (AÎ²) aggregation.  Thus, a set of eleven new hybrid compds. was developed and evaluated for chem. and biol. properties, in soln. and in neuronal cell environment.  The results are discussed in terms of the type of substituents on both main moieties and the linker size.  The closest similarity with donepezil, in terms of AChE inhibitory activity, was obtained for the O-benzyl-hydroxypyridinone hybrids contg. a 2-methylene linker, although still less active than the drug.  However, the free-hydroxypyridinone hybrids present higher activity for the AÎ² aggregation inhibition, metal chelating capacity and radical scavenging activity.  Overall, some compds. demonstrated capacity to exert a multiple action by hitting three- (7d (N-(2-(3-(benzyloxy)-2-methyl-4-oxopyridin-1(4H)-yl)ethyl)-7-methoxybenzofuran-2-carboxamide)) or four- (8d (N-(2-(3-hydroxy-2-methyl-4-oxopyridin-1(4H)-yl)ethyl)-7-methoxybenzofuran-2-carboxamide), 8f (N-(4-(3-hydroxy-2-methyl-4-oxopyridin-1(4H)-yl)butyl)-7-methoxybenzofuran-2-carboxamide)) pathophysiol. targets of AD.  Furthermore, the compds. showed neuroprotective effects in neuronal cells subjected to model stressors of AD, but not significant dependence on the substituent groups.  Importantly, the compds. evidenced drug-likeness properties, including good membrane permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zXYMWURzTLVg90H21EOLACvtfcHk0lhTxoNBPqHwxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOhsr7F&md5=9c2b08a2f02c2e03f1bb525c5e990873</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DHiremathad%26aufirst%3DA.%26aulast%3DChand%26aufirst%3DK.%26aulast%3DTolayan%26aufirst%3DL.%26aulast%3DRajeshwari%26aulast%3DKeri%26aufirst%3DR.%2BS.%26aulast%3DEsteves%26aufirst%3DA.%2BR.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DHydroxypyridinone-benzofuran%2520hybrids%2520with%2520potential%2520protective%2520roles%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D179%26spage%3D82%26epage%3D96%26doi%3D10.1016%2Fj.jinorgbio.2017.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Dual-target anti-Alzheimerâs disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1489</span>â <span class="NLM_lpage">1497</span>, <span class="refDoi">Â DOI: 10.1080/14756366.2019.1634703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1080%2F14756366.2019.1634703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=31416364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyktr7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=1489-1497&issue=1&author=Z.+S.+Miauthor=B.+Ganauthor=S.+H.+Yuauthor=J.+N.+Guoauthor=C.+J.+Zhangauthor=X.+Y.+Jiangauthor=T.+Zhouauthor=J.+Suauthor=R.+R.+Baiauthor=Y.+Y.+Xie&title=Dual-target+anti-Alzheimer%E2%80%99s+disease+agents+with+both+iron+ion+chelating+and+monoamine+oxidase-B+inhibitory+activity&doi=10.1080%2F14756366.2019.1634703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity</span></div><div class="casAuthors">Mi, Zhisheng; Gan, Bing; Yu, Sihang; Guo, Jianan; Zhang, Changjun; Jiang, Xiaoying; Zhou, Tao; Su, Jing; Bai, Renren; Xie, Yuanyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1489-1497</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">MAO-B leads to an increase in the levels of hydrogen peroxide and oxidative free radicals, which contribute to the etiol. of the AD.  Thus, both iron ion chelators and MAO-B inhibitors can be used to treat AD.  Taking the coumarin derivs. and hydroxypyridinones as the lead compds., a series of dual-target hybrids were designed and synthesized by Click Chem.  The compds. were biol. evaluated for their iron ion chelating and MAO-B inhibitory activity.  Most of the compds. displayed excellent iron ion chelating activity and moderate to good anti-MAO-B activity.  Compds. and exhibited the most potent MAO-B inhibitory activity, with IC50 values of 0.68 and 0.86 Î¼M, resp.  In summary, these dual-target compds. have the potential anti-AD activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc25Ihf5dF_7Vg90H21EOLACvtfcHk0lhTxoNBPqHwxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyktr7N&md5=d743ef80bf4011b0f8abaa7e69c1fb88</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1634703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1634703%26sid%3Dliteratum%253Aachs%26aulast%3DMi%26aufirst%3DZ.%2BS.%26aulast%3DGan%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DJ.%2BN.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DJiang%26aufirst%3DX.%2BY.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DR.%2BR.%26aulast%3DXie%26aufirst%3DY.%2BY.%26atitle%3DDual-target%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%2520with%2520both%2520iron%2520ion%2520chelating%2520and%2520monoamine%2520oxidase-B%2520inhibitory%2520activity%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1489%26epage%3D1497%26doi%3D10.1080%2F14756366.2019.1634703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimerâs disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">367</span>â <span class="NLM_lpage">382</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2019.07.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2019.07.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=31325784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWltLvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2019&pages=367-382&author=C.+J.+Zhangauthor=K.+Yangauthor=S.+H.+Yuauthor=J.+Suauthor=S.+L.+Yuanauthor=J.+X.+Hanauthor=Y.+Chenauthor=J.+P.+Guauthor=T.+Zhouauthor=R.+R.+Baiauthor=Y.+Y.+Xie&title=Design%2C+synthesis+and+biological+evaluation+of+hydroxypyridinone-coumarin+hybrids+as+multimodal+monoamine+oxidase+B+inhibitors+and+iron+chelates+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.07.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease</span></div><div class="casAuthors">Zhang, Changjun; Yang, Ke; Yu, Sihang; Su, Jing; Yuan, Shengli; Han, Jiaxin; Chen, Yan; Gu, Jinping; Zhou, Tao; Bai, Renren; Xie, Yuanyuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">367-382</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Hydroxypyridinone-substituted coumarins I (R1 = H, Me; R2 = H, Me, Et; R3 = H, R4O; R4 = Me, PhCH2, HCâ¡CCH2, 3-ClC6H4CH2, 3-FC6H4CH2, 4-FC6H4CH2, 3,5-F2C6H3CH2) were prepd. as dual iron chelators and monoamine oxidase B (MAO-B) inhibitors for potential use in the treatment of Alzheimer's disease.  I (R1 = H; R2 = Me; R3 = 3-FC6H4CH2O) (II) exhibited the most potent activity against MAO-B, with an IC50 value of 14.7 nM.  II protected U251 cells against oxidative stress and ameliorated murine scopolamine-induced cognitive dysfunction in a model for Alzheimer's disease.  Mol. docking calcns. for the binding of II to MAO-B were performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgVzvO3fV-0LVg90H21EOLACvtfcHk0lhTxoNBPqHwxQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWltLvK&md5=422cebd0966ebb383e0e5384e276ea21</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.07.031%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DS.%2BH.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DS.%2BL.%26aulast%3DHan%26aufirst%3DJ.%2BX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%2BP.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DR.%2BR.%26aulast%3DXie%26aufirst%3DY.%2BY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520hydroxypyridinone-coumarin%2520hybrids%2520as%2520multimodal%2520monoamine%2520oxidase%2520B%2520inhibitors%2520and%2520iron%2520chelates%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D180%26spage%3D367%26epage%3D382%26doi%3D10.1016%2Fj.ejmech.2019.07.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">115550</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2020.115550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmc.2020.115550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=32503694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVWis7bL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115550&issue=12&author=X.+Y.+Jiangauthor=J.+N.+Guoauthor=Y.+J.+Lvauthor=C.+S.+Yaoauthor=C.+J.+Zhangauthor=Z.+S.+Miauthor=Y.+Shiauthor=J.+P.+Guauthor=T.+Zhouauthor=R.+R.+Baiauthor=Y.+Y.+Xie&title=Rational+design%2C+synthesis+and+biological+evaluation+of+novel+multitargeting+anti-AD+iron+chelators+with+potent+MAO-B+inhibitory+and+antioxidant+activity&doi=10.1016%2Fj.bmc.2020.115550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity</span></div><div class="casAuthors">Jiang, Xiaoying; Guo, Jianan; Lv, Yangjing; Yao, Chuansheng; Zhang, Changjun; Mi, Zhisheng; Shi, Yuan; Gu, Jinping; Zhou, Tao; Bai, Renren; Xie, Yuanyuan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">115550</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of (3-hydroxypyridin-4-one)-coumarin hybrids I (R1 = H, OMe; R2, R3 = H, Me), II (R1, R3 = H, OH, Me, OMe, OBn; R2 = Me, OEt, 4-F-OBn, etc.) were developed and investigated as potential multitargeting candidates for the treatment of Alzheimer's disease (AD) through the incorporation of iron-chelating and monoamine oxidase B (MAO-B) inhibition.  This combination endowed the hybrids with good capacity to inhibit MAO-B as well as excellent iron-chelating effects.  The pFe3+ values of the compds. were ranging from 16.91 to 20.16, comparable to more potent than the ref. drug deferiprone (DFP).  Among them, compd. I (R1 = OMe; R2 = Me; R3 = H) exhibited the most promising activity against MAO-B, with an IC50 value of 87.9 nM.  Moreover, compd. I (R1 = OMe; R2 = Me; R3 = H) exerted favorable antioxidant activity, significantly reversed the amyloid-Î²1-42 (AÎ²1-42) induced PC12 cell damage.  More importantly, I (R1 = OMe; R2 = Me; R3 = H) remarkably ameliorated the cognitive dysfunction in a scopolamine-induced mice AD model.  In brief, a series of hybrids with potential anti-AD effect were successfully obtained, indicating that the design of iron chelators with MAO-B inhibitory and antioxidant activities is an attractive strategy against AD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph5JdPfXWFVbVg90H21EOLACvtfcHk0lgMSfqeNi-C4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVWis7bL&md5=5dc324488081d4ce09411efbff7f725b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2020.115550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2020.115550%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%2BY.%26aulast%3DGuo%26aufirst%3DJ.%2BN.%26aulast%3DLv%26aufirst%3DY.%2BJ.%26aulast%3DYao%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DMi%26aufirst%3DZ.%2BS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%2BP.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DR.%2BR.%26aulast%3DXie%26aufirst%3DY.%2BY.%26atitle%3DRational%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520multitargeting%2520anti-AD%2520iron%2520chelators%2520with%2520potent%2520MAO-B%2520inhibitory%2520and%2520antioxidant%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115550%26doi%3D10.1016%2Fj.bmc.2020.115550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilitewski, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blodgett, J. A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhme-Klair, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallavalle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laschat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span> <span> </span><span class="NLM_article-title">Chemical and biological aspects of nutritional immunity-perspectives for new anti-infectives that target iron uptake systems</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">14360</span>â <span class="NLM_lpage">14382</span>, <span class="refDoi">Â DOI: 10.1002/anie.201701586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fanie.201701586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=14360-14382&issue=46&author=U.+Bilitewskiauthor=J.+A.+V.+Blodgettauthor=A.+K.+Duhme-Klairauthor=S.+Dallavalleauthor=S.+Laschatauthor=A.+Routledgeauthor=R.+Schobert&title=Chemical+and+biological+aspects+of+nutritional+immunity-perspectives+for+new+anti-infectives+that+target+iron+uptake+systems&doi=10.1002%2Fanie.201701586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Biological Aspects of Nutritional Immunity-Perspectives for New Anti-Infectives that Target Iron Uptake Systems</span></div><div class="casAuthors">Bilitewski, Ursula; Blodgett, Joshua A. V.; Duhme-Klair, Anne-Kathrin; Dallavalle, Sabrina; Laschat, Sabine; Routledge, Anne; Schobert, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">14360-14382</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Upon bacterial infection, one of the defense mechanisms of the host is the withdrawal of essential metal ions, in particular iron, which leads to "nutritional immunity".  However, bacteria have evolved strategies to overcome iron starvation, for example, by stealing iron from the host or other bacteria through specific iron chelators with high binding affinity.  Fortunately, these complex interactions between the host and pathogen that lead to metal homeostasis provide several opportunities for interception and, thus, allow the development of novel antibacterial compds.  This Review focuses on iron, discusses recent highlights, and gives some future perspectives which are relevant in the fight against antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9b1dRctsmobVg90H21EOLACvtfcHk0lgMSfqeNi-C4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrrP&md5=f7541941c314f5793bca2899708c47e8</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1002%2Fanie.201701586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201701586%26sid%3Dliteratum%253Aachs%26aulast%3DBilitewski%26aufirst%3DU.%26aulast%3DBlodgett%26aufirst%3DJ.%2BA.%2BV.%26aulast%3DDuhme-Klair%26aufirst%3DA.%2BK.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DLaschat%26aufirst%3DS.%26aulast%3DRoutledge%26aufirst%3DA.%26aulast%3DSchobert%26aufirst%3DR.%26atitle%3DChemical%2520and%2520biological%2520aspects%2520of%2520nutritional%2520immunity-perspectives%2520for%2520new%2520anti-infectives%2520that%2520target%2520iron%2520uptake%2520systems%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D46%26spage%3D14360%26epage%3D14382%26doi%3D10.1002%2Fanie.201701586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of siderophores</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">637</span>â <span class="NLM_lpage">657</span>, <span class="refDoi">Â DOI: 10.1039/b906679a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fb906679a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20376388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1Wrsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2010&pages=637-657&issue=5&author=R.+C.+Hiderauthor=X.+L.+Kong&title=Chemistry+and+biology+of+siderophores&doi=10.1039%2Fb906679a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of siderophores</span></div><div class="casAuthors">Hider, Robert C.; Kong, Xiao-Le</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-657</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Siderophores are compds. produced by bacteria, fungi and graminaceous plants for scavenging iron from the environment.  They are low-mol.-wt. compds. (500-1500 daltons) possessing a high affinity for iron(iii) (Kf > 1030), the biosynthesis of which is regulated by iron levels and the function of which is to supply iron to the cell.  This article briefly describes the classification and chem. properties of siderophores, before outlining research on siderophore biosynthesis and transport.  Clin. important siderophores and the therapeutic potential of siderophore design are described.  Appendix 1 provides a comprehensive list of siderophore structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqych5anPlbwLVg90H21EOLACvtfcHk0lgMSfqeNi-C4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1Wrsb0%253D&md5=e4e2a8e10cc41de3d7f526b33802b4f7</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1039%2Fb906679a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb906679a%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DKong%26aufirst%3DX.%2BL.%26atitle%3DChemistry%2520and%2520biology%2520of%2520siderophores%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2010%26volume%3D27%26issue%3D5%26spage%3D637%26epage%3D657%26doi%3D10.1039%2Fb906679a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fassihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghaie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostaki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deilami, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadinpour, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2145</span>â <span class="NLM_lpage">2157</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2008.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2008.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19056147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsl2gs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2145-2157&issue=5&author=A.+Fassihiauthor=D.+Abediauthor=L.+Saghaieauthor=R.+Sabetauthor=H.+Fazeliauthor=G.+Bostakiauthor=O.+Deilamiauthor=H.+Sadinpour&title=Synthesis%2C+antimicrobial+evaluation+and+QSAR+study+of+some+3-hydroxypyridine-4-one+and+3-hydroxypyran-4-one+derivatives&doi=10.1016%2Fj.ejmech.2008.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives</span></div><div class="casAuthors">Fassihi, Afshin; Abedi, Daryoush; Saghaie, Lotfollah; Sabet, Razieh; Fazeli, Hossein; Bostaki, Ghasem; Deilami, Omid; Sadinpour, Hekmatollah</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2145-2157</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of Mannich bases of 2-alkyl-3-hydroxy-pyridine-4-ones were prepd.  They were screened for their antibacterial and antifungal activities against a variety of microorganisms using micro plate Alamar Blue assay (MABA) method.  Multiple linear regressions (MLR) anal. was performed for the synthesized compds. as well as a series of pyridinone and pyranone derivs. which have been synthesized and evaluated for antimicrobial activity by other researchers previously.  Studied compds. showed a better quant. structure-activity relationship (QSAR) model for the antimicrobial activity against Candida albicans and Staphylococcus aureus in comparison with other tested microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOVnfcChq27Vg90H21EOLACvtfcHk0lhrIYctIVXegg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsl2gs70%253D&md5=ee162cf8d85fb7a35ea6727ec2abdbe1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DFassihi%26aufirst%3DA.%26aulast%3DAbedi%26aufirst%3DD.%26aulast%3DSaghaie%26aufirst%3DL.%26aulast%3DSabet%26aufirst%3DR.%26aulast%3DFazeli%26aufirst%3DH.%26aulast%3DBostaki%26aufirst%3DG.%26aulast%3DDeilami%26aufirst%3DO.%26aulast%3DSadinpour%26aufirst%3DH.%26atitle%3DSynthesis%252C%2520antimicrobial%2520evaluation%2520and%2520QSAR%2520study%2520of%2520some%25203-hydroxypyridine-4-one%2520and%25203-hydroxypyran-4-one%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26issue%3D5%26spage%3D2145%26epage%3D2157%26doi%3D10.1016%2Fj.ejmech.2008.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmateenejad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghaei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gholami, M.</span></span> <span> </span><span class="NLM_article-title">Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">349</span>â <span class="NLM_lpage">361</span>, <span class="refDoi">Â DOI: 10.1007/s10822-012-9561-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs10822-012-9561-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22456859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFOqsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=349-361&issue=3&author=R.+Sabetauthor=A.+Fassihiauthor=B.+Hemmateenejadauthor=L.+Saghaeiauthor=R.+Miriauthor=M.+Gholami&title=Computer-aided+design+of+novel+antibacterial+3-hydroxypyridine-4-ones%3A+application+of+QSAR+methods+based+on+the+MOLMAP+approach&doi=10.1007%2Fs10822-012-9561-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach</span></div><div class="casAuthors">Sabet, Razieh; Fassihi, Afshin; Hemmateenejad, Bahram; Saghaei, Lotfollah; Miri, Ramin; Gholami, Maryam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-361</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">3-Hydroxypyridine-4-one derivs. have shown good inhibitory activity against bacterial strains.  In this work we report the application of MOLMAP descriptors based on empirical physicochem. properties with genetic algorithm partial least squares (GA-PLS) and counter propagation artificial neural networks (CP-ANN) methods to propose some novel 3-hydroxypyridine-4-one derivs. with improved antibacterial activity against Staphylococcus aureus.  A large collection of 302 novel derivs. of this chem. scaffold was selected for this purpose.  The activity classes of these compds. were detd. using the two quant. structure activity relationships models.  To evaluate the predictability and accuracy of the obtained models, nineteen compds. belonging to all three activity classes were prepd. and the activity of them was detd. against S. aureus.  Comparing the exptl. results and the predicted activity classes revealed the accuracy of the obtained models.  Seventeen of the nineteen synthesized mols. were correctly predicted by GA-PLS model according to the antimicrobial evaluation method.  Mols. 5f and 5h proved to be moderately active and active exptl., but were predicted as inactive and moderately active compds., resp. by this model.  The CP-ANN based prediction was correct for sixteen out of the nineteen synthesized mols. 5a, 5h and 5q were moderately active and active based on the antimicrobial assays, but they were introduced as members of inactive, moderately active and inactive classes of compds., resp. according to CP-ANN model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT3fsStFzNxbVg90H21EOLACvtfcHk0lhrIYctIVXegg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFOqsrk%253D&md5=9fb8e3cacf14ae4b5e7884f6feecbf7b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1007%2Fs10822-012-9561-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-012-9561-2%26sid%3Dliteratum%253Aachs%26aulast%3DSabet%26aufirst%3DR.%26aulast%3DFassihi%26aufirst%3DA.%26aulast%3DHemmateenejad%26aufirst%3DB.%26aulast%3DSaghaei%26aufirst%3DL.%26aulast%3DMiri%26aufirst%3DR.%26aulast%3DGholami%26aufirst%3DM.%26atitle%3DComputer-aided%2520design%2520of%2520novel%2520antibacterial%25203-hydroxypyridine-4-ones%253A%2520application%2520of%2520QSAR%2520methods%2520based%2520on%2520the%2520MOLMAP%2520approach%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26issue%3D3%26spage%3D349%26epage%3D361%26doi%3D10.1007%2Fs10822-012-9561-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faidallah, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostom, S. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basaif, S. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">926</span>â <span class="NLM_lpage">935</span>, <span class="refDoi">Â DOI: 10.3109/14756366.2012.694880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3109%2F14756366.2012.694880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22803670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSlsb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=926-935&issue=5&author=H.+M.+Faidallahauthor=S.+A.+F.+Rostomauthor=K.+A.+Khanauthor=S.+A.+Basaif&title=Synthesis+and+characterization+of+some+hydroxypyridone+derivatives+and+their+evaluation+as+antimicrobial+agents&doi=10.3109%2F14756366.2012.694880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents</span></div><div class="casAuthors">Faidallah, Hassan M.; Rostom, Sherif A. F.; Khan, Khalid A.; Basaif, Salem A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">926-935</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The synthesis, in vitro antimicrobial activities of some novel hydroxy pyridines supported with various pharmacophores is described.  Twenty-six out of the tested 58 compds. exhibited variable inhibitory effects on the growth of the tested Gram pos. and Gram neg. bacteria.  The tested compds. revealed better activity against the Gram pos. rather than the Gram neg. strains.  The synthesized hydroxypyridones have shown significant inhibitory effect against Staphylococcus aureus and Bacillus subtilis.  Twelve compds. namely; 5d, 5f, 6a, 6b, 8b, 18b, 18c, 19c, 21d, 22b, 22d and 23d were able to produce appreciable growth inhibitory activity against Candida albicans when compared to Clotrimazole.  Among these, 22d (I) proved to be the most potent antifungal agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkqQtnXXCkrVg90H21EOLACvtfcHk0lhrIYctIVXegg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSlsb7M&md5=9cdd0c8868c8a2de22a935280de07a68</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.694880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.694880%26sid%3Dliteratum%253Aachs%26aulast%3DFaidallah%26aufirst%3DH.%2BM.%26aulast%3DRostom%26aufirst%3DS.%2BA.%2BF.%26aulast%3DKhan%26aufirst%3DK.%2BA.%26aulast%3DBasaif%26aufirst%3DS.%2BA.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520some%2520hydroxypyridone%2520derivatives%2520and%2520their%2520evaluation%2520as%2520antimicrobial%2520agents%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26issue%3D5%26spage%3D926%26epage%3D935%26doi%3D10.3109%2F14756366.2012.694880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> inhibition of bacterial growth by iron chelators</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>314</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1111/j.1574-6968.2010.02153.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1574-6968.2010.02153.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21114684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2qt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2011&pages=107-111&issue=2&author=D.+H.+Qiuauthor=Z.+L.+Huangauthor=T.+Zhouauthor=C.+Shenauthor=R.+C.+Hider&title=In+vitro+inhibition+of+bacterial+growth+by+iron+chelators&doi=10.1111%2Fj.1574-6968.2010.02153.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro inhibition of bacterial growth by iron chelators</span></div><div class="casAuthors">Qiu, Di-Hong; Huang, Zhu-Liang; Zhou, Tao; Shen, Chen; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-111</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antimicrobial activity of the iron(III)-selective 3-hydroxypyridin-4-one chelators, CP251(1) and CP252(2), was evaluated in comparison with that of diethylenetriamine-penta acetic acid (3).  CP251 was found to exhibit an inhibitory effect on the growth of both Gram-pos. and Gram-neg. bacteria.  CP251 may find application in the treatment of external infections such as those assocd. with wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDlfXNRfP00bVg90H21EOLACvtfcHk0lgMSy_I7O7JsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2qt7o%253D&md5=b383ed9bb538d56548217683f7482316</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-6968.2010.02153.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-6968.2010.02153.x%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DHuang%26aufirst%3DZ.%2BL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DIn%2520vitro%2520inhibition%2520of%2520bacterial%2520growth%2520by%2520iron%2520chelators%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2011%26volume%3D314%26issue%3D2%26spage%3D107%26epage%3D111%26doi%3D10.1111%2Fj.1574-6968.2010.02153.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, iron(III)-binding affinity and <i>in vitro</i> evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6376</span>â <span class="NLM_lpage">6380</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.08.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2011.08.097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21937227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6376-6380&issue=21&author=B.+Xuauthor=X.+L.+Kongauthor=T.+Zhouauthor=D.+H.+Qiuauthor=Y.+L.+Chenauthor=M.+S.+Liuauthor=R.+H.+Yangauthor=R.+C.+Hider&title=Synthesis%2C+iron%28III%29-binding+affinity+and+in+vitro+evaluation+of+3-hydroxypyridin-4-one+hexadentate+ligands+as+potential+antimicrobial+agents&doi=10.1016%2Fj.bmcl.2011.08.097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, iron(III)-binding affinity and in vitro evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents</span></div><div class="casAuthors">Xu, Bo; Kong, Xiao-Le; Zhou, Tao; Qiu, Di-Hong; Chen, Yu-Lin; Liu, Mu-Song; Yang, Rong-Hua; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6376-6380</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Iron is a crit. element for the survival of bacteria.  Two novel 3-hydroxypyridin-4-one hexadentate ligands with high affinity for iron(III), which disrupt bacterial iron absorption, were designed and synthesized.  Biol. studies demonstrate that these two chelators have significant inhibitory effect against both Gram-pos. and Gram-neg. bacteria, and therefore have potential as antimicrobial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWdpVdFgTLrLVg90H21EOLACvtfcHk0lgMSy_I7O7JsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FE&md5=29b17e9c31f88d851f2b5de91a24cfd3</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.097%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DB.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DYang%26aufirst%3DR.%2BH.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520iron%2528III%2529-binding%2520affinity%2520and%2520in%2520vitro%2520evaluation%2520of%25203-hydroxypyridin-4-one%2520hexadentate%2520ligands%2520as%2520potential%2520antimicrobial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6376%26epage%3D6380%26doi%3D10.1016%2Fj.bmcl.2011.08.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physico-chemical properties, and antimicrobial evaluation of a new series of iron(III) hexadentate chelators</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2351</span>â <span class="NLM_lpage">2359</span>, <span class="refDoi">Â DOI: 10.1007/s00044-012-0229-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00044-012-0229-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsbnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=2351-2359&issue=5&author=Y.+Y.+Xieauthor=M.+S.+Liuauthor=P.+P.+Huauthor=X.+L.+Kongauthor=D.+H.+Qiuauthor=J.+L.+Xuauthor=R.+C.+Hiderauthor=T.+Zhou&title=Synthesis%2C+physico-chemical+properties%2C+and+antimicrobial+evaluation+of+a+new+series+of+iron%28III%29+hexadentate+chelators&doi=10.1007%2Fs00044-012-0229-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physico-chemical properties, and antimicrobial evaluation of a new series of iron(III) hexadentate chelators</span></div><div class="casAuthors">Xie, Yuan-Yuan; Liu, Mu-Song; Hu, Pan-Pan; Kong, Xiao-Le; Qiu, Di-Hong; Xu, Ji-Lin; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2351-2359</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">A series of related 3-hydroxypyridin-4-one hexadentate ligands I (R = H, Me, n-hexyl, CH2CH2OH, etc.) have been synthesized.  These chelators were found to possess a high affinity for iron(III), with a pFe value of about 30.  As iron is a crit. element to the survival of bacteria, these chelators were predicted to inhibit the growth of bacteria by disrupting bacterial iron absorption.  Indeed, they were demonstrated to possess appreciable inhibitory activity against both Gram-pos. and Gram-neg. bacteria, and therefore, they have potential as antimicrobial agents.  I (R = Et, CH2CH2OMe) were found to be particularly effective against Gram-neg. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFM1R6mDebbVg90H21EOLACvtfcHk0lgMSy_I7O7JsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsbnK&md5=ed75aac8960cda4f672d0e94b8d90df4</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0229-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0229-1%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DHu%26aufirst%3DP.%2BP.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DXu%26aufirst%3DJ.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520physico-chemical%2520properties%252C%2520and%2520antimicrobial%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520iron%2528III%2529%2520hexadentate%2520chelators%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26issue%3D5%26spage%3D2351%26epage%3D2359%26doi%3D10.1007%2Fs00044-012-0229-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in-vitro</i> antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">512</span>â <span class="NLM_lpage">520</span>, <span class="refDoi">Â DOI: 10.1111/jphp.12013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fjphp.12013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23488779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFaqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=512-520&issue=4&author=C.+F.+Zhuauthor=D.+H.+Qiuauthor=X.+L.+Kongauthor=R.+C.+Hiderauthor=T.+Zhou&title=Synthesis+and+in-vitro+antimicrobial+evaluation+of+a+high-affinity+iron+chelator+in+combination+with+chloramphenicol&doi=10.1111%2Fjphp.12013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in-vitro antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol</span></div><div class="casAuthors">Zhu, Chun-Feng; Qiu, Di-Hong; Kong, Xiao-Le; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-520</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The objectives of this study were first to design and synthesize a hexadentate chelator with high iron(III) affinity and, second, to evaluate its antimicrobial activity in the presence and absence of chloramphenicol.  A hexadentate ligand was synthesized by conjugating a protected bidentate compd. onto a tripodal structure.  The pKa values and iron affinity of the chelator were detd. by spectrophotometric titrn.  Min. inhibitory concns. were detd. by visual inspection of broth turbidity.  The bactericidal rates were calcd. by counting the colony nos. on a light board after incubation with and without an antimicrobial agent.  A hexadentate 3-hydroxypyridin-4-one was found to possess a high affinity for iron(III), with a pFe value of 31.2 (neg. logarithm of concn. of the free iron(III) in soln. (when [Fe3+]Total = 10-6 M; [Ligand]Total = 10-5 M; pH = 7.4).  We found that this chelator had an appreciable inhibitory effect in vitro against the two bacterial strains Providencia stuartii and Staphylococcus aureus, particularly in the presence of chloramphenicol.  A 3-hydroxypyridin-4-one hexadentate ligand has potential as an antimicrobial agent.  Combination therapy with this iron chelator plus chloramphenicol has potential for the treatment of extracellular infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqniQzxR7CBGLVg90H21EOLACvtfcHk0lgMSy_I7O7JsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFaqtbY%253D&md5=3ac460fce2e2df43057006111be615e7</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12013%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in-vitro%2520antimicrobial%2520evaluation%2520of%2520a%2520high-affinity%2520iron%2520chelator%2520in%2520combination%2520with%2520chloramphenicol%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26issue%3D4%26spage%3D512%26epage%3D520%26doi%3D10.1111%2Fjphp.12013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antimicrobial evaluation of hexadentate hydroxypyridinones with high iron(III) affinity</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">659</span>â <span class="NLM_lpage">668</span>, <span class="refDoi">Â DOI: 10.1111/cbdd.12358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fcbdd.12358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24890019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSqurzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=659-668&issue=6&author=M.+X.+Zhangauthor=C.+F.+Zhuauthor=Y.+J.+Zhouauthor=X.+L.+Kongauthor=R.+C.+Hiderauthor=T.+Zhou&title=Design%2C+synthesis%2C+and+antimicrobial+evaluation+of+hexadentate+hydroxypyridinones+with+high+iron%28III%29+affinity&doi=10.1111%2Fcbdd.12358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Antimicrobial Evaluation of Hexadentate Hydroxypyridinones with High Iron(III) Affinity</span></div><div class="casAuthors">Zhang, Ming-Xia; Zhu, Chun-Feng; Zhou, Ying-Jun; Kong, Xiao-Le; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-668</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A range of hexadentate 3-hydroxy-4-pyridinone derivs. (HPOs) with a high affinity for iron(III) has been synthesized.  The log stability consts. of two HPO-iron complexes (logK1) were detd. to be over 34 and pFe values of the two HPOs were detd. to be over 31.  An antimicrobial assay indicated that they are able to markedly inhibit the growth of both Gram-pos. and Gram-neg. bacteria.  Two compds. were found to exhibit the strongest inhibitory activity against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, and Escherichia coli with MIC values of 8, 8, 16, 8 Î¼g/mL, resp.  These results indicate that hexadentate 3-hydroxy-4-pyridinone derivs. have potential application as antimicrobial agents, esp. in the treatment of wound infection.  The synthesis of the target compds. was achieved using N-[4-amino-7-[[(1,1-dimethylethoxy)carbonyl]amino]-4-[3-[[(1,1-dimethylethoxy)carbonyl]amino]propyl]heptyl]carbamic acid 1,1-dimethylethyl ester and butanoyl chloride and N-[(phenylmethoxy)carbonyl]--L-leucine as reactants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYwPO10zEyzbVg90H21EOLACvtfcHk0lghMNP_Wu78vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSqurzO&md5=ccf203cd741fbcdcea06b0b10945d539</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12358%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BX.%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antimicrobial%2520evaluation%2520of%2520hexadentate%2520hydroxypyridinones%2520with%2520high%2520iron%2528III%2529%2520affinity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D84%26issue%3D6%26spage%3D659%26epage%3D668%26doi%3D10.1111%2Fcbdd.12358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Novel 3-hydroxypyridin-4-one hexadentate ligand-based polymeric iron chelator: synthesis, characterization and antimicrobial evaluation</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1620</span>â <span class="NLM_lpage">1625</span>, <span class="refDoi">Â DOI: 10.1039/C5MD00264H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC5MD00264H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2hsb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1620-1625&issue=9&author=Y.+J.+Zhouauthor=X.+L.+Kongauthor=J.+P.+Liauthor=Y.+M.+Maauthor=R.+C.+Hiderauthor=T.+Zhou&title=Novel+3-hydroxypyridin-4-one+hexadentate+ligand-based+polymeric+iron+chelator%3A+synthesis%2C+characterization+and+antimicrobial+evaluation&doi=10.1039%2FC5MD00264H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-hydroxypyridin-4-one hexadentate ligand-based polymeric iron chelator: synthesis, characterization and antimicrobial evaluation</span></div><div class="casAuthors">Zhou, Ying-Jun; Kong, Xiao-Le; Li, Jun-Pei; Ma, Yong-Min; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1620-1625</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel 3-hydroxypyridin-4-one (HPO) hexadentate monomeric chelator 14 has been synthesized and incorporated into polymers by copolymn. with 2-hydroxyethyl acrylate (HEA), using azobisisobutyronitrile (AIBN) as an initiator.  The monomeric chelator was found to possess very high affinity for iron(III), with the log stability const. of the iron complex (log K1) = 33.61 and pFe3+ = 30.37.  The iron binding capacity and monomer recovery of the copolymers were detd. using spectrophotometry.  The in vitro antimicrobial activity of monomeric chelator 14 and polymeric chelator 16-4 against both Gram-pos. bacteria (Staphylococcus aureus and Bacillus subtilis) and Gram-neg. bacteria (Escherichia coli, Salmonella spp., and Pseudomonas aeruginosa) was evaluated by inhibition zone and min. inhibitory concn. (MIC) assays, which demonstrated that both monomeric and polymeric chelators possess inhibitory activity.  The polymeric chelators possess potential application for the treatment of wound infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWNLonC1Y8EbVg90H21EOLACvtfcHk0lghMNP_Wu78vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2hsb%252FK&md5=1d91abccb08b0e16fb7c4fdb17a2f0e2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1039%2FC5MD00264H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00264H%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DNovel%25203-hydroxypyridin-4-one%2520hexadentate%2520ligand-based%2520polymeric%2520iron%2520chelator%253A%2520synthesis%252C%2520characterization%2520and%2520antimicrobial%2520evaluation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26issue%3D9%26spage%3D1620%26epage%3D1625%26doi%3D10.1039%2FC5MD00264H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osamah, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant <i>Staphylococcus aureus</i> and <i>Pseudomonas strains</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">8</span>â <span class="NLM_lpage">21</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2015.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2015.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25747496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslCjs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=8-21&author=Y.+J.+Zhouauthor=M.+S.+Liuauthor=A.+R.+Osamahauthor=X.+L.+Kongauthor=S.+Alsamauthor=S.+Battahauthor=Y.+Y.+Xieauthor=R.+C.+Hiderauthor=T.+Zhou&title=Hexadentate+3-hydroxypyridin-4-ones+with+high+iron%28III%29+affinity%3A+design%2C+synthesis+and+inhibition+on+methicillin+resistant+Staphylococcus+aureus+and+Pseudomonas+strains&doi=10.1016%2Fj.ejmech.2015.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: Design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains</span></div><div class="casAuthors">Zhou, Ying-Jun; Liu, Mu-Song; Osamah, Al Rugaie; Kong, Xiao-Le; Alsam, Selwa; Battah, Sinan; Xie, Yuan-Yuan; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-21</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A range of hexadentate 3-hydroxypyridin-4-ones (I; R, R1 = alkyl, alkoxyalkyl) have been synthesized.  These compds. were found to possess a high affinity for iron(III), with logK1 values of about 34 and pFe values over 30.  Antimicrobial assays indicated that they can inhibit the growth of three clin. isolates of methicillin resistant Staphylococcus aureus (MRSA) and three clin. isolates of Pseudomonas, suggesting that hexadentate 3-hydroxypyridin-4-ones have potential application in the treatment of wound infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquYgjqlnQ3FbVg90H21EOLACvtfcHk0lghMNP_Wu78vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslCjs7Y%253D&md5=fc815116906155261600bd4060e98f10</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DOsamah%26aufirst%3DA.%2BR.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DAlsam%26aufirst%3DS.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DHexadentate%25203-hydroxypyridin-4-ones%2520with%2520high%2520iron%2528III%2529%2520affinity%253A%2520design%252C%2520synthesis%2520and%2520inhibition%2520on%2520methicillin%2520resistant%2520Staphylococcus%2520aureus%2520and%2520Pseudomonas%2520strains%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D8%26epage%3D21%26doi%3D10.1016%2Fj.ejmech.2015.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, M. S.</span></span> <span> </span><span class="NLM_article-title">Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of <i>Mycobacterium avium</i></span>. <i>Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">287</span>â <span class="NLM_lpage">294</span>, <span class="refDoi">Â DOI: 10.1016/j.micinf.2010.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.micinf.2010.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20097303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFynsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=287-294&issue=4&author=S.+S.+Fernandesauthor=A.+Nunesauthor=A.+R.+Gomesauthor=B.+de+Castroauthor=R.+C.+Hiderauthor=M.+Rangelauthor=R.+Appelbergauthor=M.+S.+Gomes&title=Identification+of+a+new+hexadentate+iron+chelator+capable+of+restricting+the+intramacrophagic+growth+of+Mycobacterium+avium&doi=10.1016%2Fj.micinf.2010.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium</span></div><div class="casAuthors">Fernandes, Sofia Sousa; Nunes, Ana; Gomes, Ana Rita; de Castro, Baltazar; Hider, Robert C.; Rangel, Maria; Appelberg, Rui; Gomes, Maria Salome</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Iron accumulation has been suggested to contribute to an increase of the susceptibility to mycobacterial infections.  In this study we tested the effect of an array of iron chelating ligands of the 3-hydroxy-4-pyridinone family, in the intramacrophagic growth of Mycobacterium avium.  We found that bidentate chelators, namely N-alkyl-3-hydroxy-4-pyridinones and N-aryl-3-hydroxy-4-pyridinones, did not affect the growth of M. avium inside mouse macrophages.  In the case of the hexadentate chelators, those synthesized using an alkylamine (CP262) or a benzene ring (CP252) to link the three bidentate units, did not have an inhibitory effect on intramacrophagic growth of M. avium while those synthesized from a tripodal structure to anchor the bidentate units were capable of inhibiting the intramacrophagic growth of M. avium.  The mol. we designated CP777 had the strongest inhibitory activity.  The growth-reducing activity of CP777 was abrogated when this mol. was satd. with iron.  These results confirm that iron deprivation, by the use of iron chelating compds., restricts M. avium growth and that new iron chelators offer an approach to controlling mycobacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjtnjRP6r327Vg90H21EOLACvtfcHk0liEKqEraJEM0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFynsr4%253D&md5=9f24a4512c992a329197e125e145b5e4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.micinf.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micinf.2010.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DS.%2BS.%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DGomes%26aufirst%3DA.%2BR.%26aulast%3Dde%2BCastro%26aufirst%3DB.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRangel%26aufirst%3DM.%26aulast%3DAppelberg%26aufirst%3DR.%26aulast%3DGomes%26aufirst%3DM.%2BS.%26atitle%3DIdentification%2520of%2520a%2520new%2520hexadentate%2520iron%2520chelator%2520capable%2520of%2520restricting%2520the%2520intramacrophagic%2520growth%2520of%2520Mycobacterium%2520avium%26jtitle%3DMicrobes%2520Infect.%26date%3D2010%26volume%3D12%26issue%3D4%26spage%3D287%26epage%3D294%26doi%3D10.1016%2Fj.micinf.2010.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podinovskaia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leite, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaible, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span> <span> </span><span class="NLM_article-title">Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">861</span>â <span class="NLM_lpage">877</span>, <span class="refDoi">Â DOI: 10.1007/s00775-010-0650-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00775-010-0650-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20364296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1aqtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=861-877&issue=6&author=A.+Nunesauthor=M.+Podinovskaiaauthor=A.+Leiteauthor=P.+Gameiroauthor=T.+Zhouauthor=Y.+Maauthor=X.+Kongauthor=U.+E.+Schaibleauthor=R.+C.+Hiderauthor=M.+Rangel&title=Fluorescent+3-hydroxy-4-pyridinone+hexadentate+iron+chelators%3A+intracellular+distribution+and+the+relevance+to+antimycobacterial+properties&doi=10.1007%2Fs00775-010-0650-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties</span></div><div class="casAuthors">Nunes, Ana; Podinovskaia, Maria; Leite, Andreia; Gameiro, Paula; Zhou, Tao; Ma, Yongmin; Kong, Xiaole; Schaible, Ulrich E.; Hider, Robert C.; Rangel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">861-877</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: We report the synthesis and characterization of a fluorescent iron chelator (4), shown to be effective in inhibiting the growth of Mycobacterium avium in macrophages, together with the synthesis and characterization of two unsuccessful analogs selected to facilitate identification of the mol. properties responsible for the antimicrobial activity.  Partition of the chelators in liposomes was investigated and the compds. were assessed with respect to uptake by macrophages, responsiveness to iron overload/iron deprivation and intracellular distribution by flow cytometry and confocal microscopy.  The synthesis of the hexadentate chelators is based on a tetrahedral structure to which three bidentate 3-hydroxy-4-pyridinone chelating units are linked via amide bonds.  The structure is synthetically versatile, allowing further addn. of functional groups such as fluorophores.  Here, we analyze the non-functionalized hexadentate unit (3) and the corresponding rhodamine B (4) and fluorescein (5) labeled chelators.  The iron(III) stability const. was detd. for 3 and the values log Î² = 34.4 and pFe3+ = 29.8 indicate an affinity for iron of the same order of magnitude as that of mycobacteria siderophores.  Fluorescence properties in the presence of liposomes show that 4 strongly interacts with the lipid phase, whereas 5 does not.  Such different behavior may explain their distinct intracellular localization as revealed by confocal microscopy.  The flow cytometry and confocal microscopy studies indicate that 4 is readily engulfed by macrophages and targeted to cytosol and vesicles of the endolysosomal continuum, whereas 5 is differentially distributed and only partially colocalizes with 4 after prolonged incubation.  Differential distribution of the compds. is likely to account for their different efficacy against mycobacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknrfgdG0GjrVg90H21EOLACvtfcHk0liEKqEraJEM0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1aqtbk%253D&md5=bab314f755a7aab465d892f97d9b6d18</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1007%2Fs00775-010-0650-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-010-0650-1%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DPodinovskaia%26aufirst%3DM.%26aulast%3DLeite%26aufirst%3DA.%26aulast%3DGameiro%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DSchaible%26aufirst%3DU.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRangel%26aufirst%3DM.%26atitle%3DFluorescent%25203-hydroxy-4-pyridinone%2520hexadentate%2520iron%2520chelators%253A%2520intracellular%2520distribution%2520and%2520the%2520relevance%2520to%2520antimycobacterial%2520properties%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2010%26volume%3D15%26issue%3D6%26spage%3D861%26epage%3D877%26doi%3D10.1007%2Fs00775-010-0650-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span> <span> </span><span class="NLM_article-title">Study of the effect of thiourea and <i>N</i>-ethyl groups on antibacterial activity of rhodamine-labeled 3,4-HPO iron chelators against Gram (Â±) bacteria</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1472</span>â <span class="NLM_lpage">1477</span>, <span class="refDoi">Â DOI: 10.1007/s00044-018-2165-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00044-018-2165-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGqtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=1472-1477&issue=5&author=T.+Monizauthor=M.+Feioauthor=D.+Silvaauthor=B.+de+Castroauthor=M.+Rangel&title=Study+of+the+effect+of+thiourea+and+N-ethyl+groups+on+antibacterial+activity+of+rhodamine-labeled+3%2C4-HPO+iron+chelators+against+Gram+%28%C2%B1%29+bacteria&doi=10.1007%2Fs00044-018-2165-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Study of the effect of thiourea and N-ethyl groups on antibacterial activity of rhodamine-labeled 3,4-HPO iron chelators against Gram (+/-) bacteria</span></div><div class="casAuthors">Moniz, Tania; Feio, Maria; Silva, Daniel; de Castro, Baltazar; Rangel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1472-1477</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the sequence of the work in which we identified functional groups of rhodamine labeled 3,4-HPO chelators that are crucial for their activity against Mycobacterium avium infection we now scrutinize if the same groups are also relevant for the chelators antibacterial activity against Gram (+/-) bacteria.  In this new infection scenario, we confirmed that a thiourea linkage and N-Et substituents on the xanthene ring are important and there is an advantage of the assocn. of both groups in the mol. framework.  In particular, we found that three hexadentate chelators (MRH7, MRH8, and MRH10) inhibit bacterial growth of Staphylococcus (S). aureus ATCC 25923 and S. epidermis ATCC 12228 and one hexadentate chelator (MRH7) also inhibits the growth of Escherichia (E.) coli ATCC 25922.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcaFNytKPOVrVg90H21EOLACvtfcHk0lhk18ERzNYOig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGqtLk%253D&md5=6f52b6f2f90305fb023e6d46f457a643</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1007%2Fs00044-018-2165-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-018-2165-1%26sid%3Dliteratum%253Aachs%26aulast%3DMoniz%26aufirst%3DT.%26aulast%3DFeio%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DD.%26aulast%3Dde%2BCastro%26aufirst%3DB.%26aulast%3DRangel%26aufirst%3DM.%26atitle%3DStudy%2520of%2520the%2520effect%2520of%2520thiourea%2520and%2520N-ethyl%2520groups%2520on%2520antibacterial%2520activity%2520of%2520rhodamine-labeled%25203%252C4-HPO%2520iron%2520chelators%2520against%2520Gram%2520%2528%25C2%25B1%2529%2520bacteria%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2018%26volume%3D27%26issue%3D5%26spage%3D1472%26epage%3D1477%26doi%3D10.1007%2Fs00044-018-2165-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novais, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebelo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixe, L.</span></span> <span> </span><span class="NLM_article-title">New fluorescent rosamine chelator showing promising antibacterial activity against Gram-positive bacteria</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">341</span>â <span class="NLM_lpage">349</span>, <span class="refDoi">Â DOI: 10.1016/j.bioorg.2018.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bioorg.2018.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29807207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVamsrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2018&pages=341-349&author=A.+Novaisauthor=T.+Monizauthor=A.+R.+Rebeloauthor=A.+M.+G.+Silvaauthor=M.+Rangelauthor=L.+Peixe&title=New+fluorescent+rosamine+chelator+showing+promising+antibacterial+activity+against+Gram-positive+bacteria&doi=10.1016%2Fj.bioorg.2018.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">New fluorescent rosamine chelator showing promising antibacterial activity against Gram-positive bacteria</span></div><div class="casAuthors">Novais, Angela; Moniz, Tania; Rebelo, Ana Rita; Silva, Ana M. G.; Rangel, Maria; Peixe, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The restricted no. of antibiotics to treat infections caused by common multidrug resistant bacterial pathogens in the clin. setting demands a continuous search for new mols. with antibacterial properties.  Bacterial iron deprivation represents a promising alternative, being iron chelators an attractive class for drug design in which particular compds. seem to have antibacterial effect.  In this work, we report the synthesis and characterization of a new fluorescent 3-hydroxy-4-pyridinone (3,4-HPO) iron chelator functionalized with a carboxyrosamine fluorophore (MRB20).  The antibacterial activity of MRB20 was assessed against representative strains from clin. relevant Gram-pos. and Gram-neg. bacterial species and further compared with the inhibitory effect of a set of structurally related iron chelators including Deferiprone (1,2-dimethyl-3-hydroxy-4-pyridinone).  Compds. exhibiting a promising minimal inhibitory concn. (MIC<10mg/L) were further tested against a wider range of bacterial genera and species (Staphylococcus spp. Enterococcus spp. Listeria monocytogenes, Bacillus spp.), including multidrug resistant bacteria.  With the exception of the novel compd. (MRB20), all chelators inhibited the strains assayed at very high concns. [min. inhibitory concns. (MIC) ranging from 70mg/L to >180mg/L].  MRB20 revealed a good antibacterial activity (6.7-13.2mg/L) against Gram-pos. strains from different genera and species, including clin. relevant species (Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecium, Enterococcus faecalis), which might be eventually compatible with a therapeutic application or as adjuvant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZEaeFFujaobVg90H21EOLACvtfcHk0lhk18ERzNYOig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVamsrfJ&md5=e9ac7991af1fb4bef523280e64fe9607</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DNovais%26aufirst%3DA.%26aulast%3DMoniz%26aufirst%3DT.%26aulast%3DRebelo%26aufirst%3DA.%2BR.%26aulast%3DSilva%26aufirst%3DA.%2BM.%2BG.%26aulast%3DRangel%26aufirst%3DM.%26aulast%3DPeixe%26aufirst%3DL.%26atitle%3DNew%2520fluorescent%2520rosamine%2520chelator%2520showing%2520promising%2520antibacterial%2520activity%2520against%2520Gram-positive%2520bacteria%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D79%26spage%3D341%26epage%3D349%26doi%3D10.1016%2Fj.bioorg.2018.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhal, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polomoscanik, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes-Farley, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. J.</span></span> <span> </span><span class="NLM_article-title">Functional polymers as therapeutic agents: concept to market place</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1121</span>â <span class="NLM_lpage">1130</span>, <span class="refDoi">Â DOI: 10.1016/j.addr.2009.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.addr.2009.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19682515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWht7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=1121-1130&issue=13&author=P.+K.+Dhalauthor=S.+C.+Polomoscanikauthor=L.+Z.+Avilaauthor=S.+R.+Holmes-Farleyauthor=R.+J.+Miller&title=Functional+polymers+as+therapeutic+agents%3A+concept+to+market+place&doi=10.1016%2Fj.addr.2009.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Functional polymers as therapeutic agents: Concept to market place</span></div><div class="casAuthors">Dhal, Pradeep K.; Polomoscanik, Steven C.; Avila, Louis Z.; Holmes-Farley, S. Randall; Miller, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1121-1130</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Biol. active synthetic polymers have received considerable scientific interest and attention in recent years for their potential as promising novel therapeutic agents to treat human diseases.  Although a significant amt. of research has been carried out involving polymer-linked drugs as targeted and sustained release drug delivery systems and prodrugs, examples on bioactive polymers that exhibit intrinsic therapeutic properties are relatively less.  Several appealing characteristics of synthetic polymers including high mol. wt., mol. architecture, and controlled polydispersity can all be utilized to discover a new generation of therapies.  For example, high mol. wt. bioactive polymers can be restricted to gastrointestinal tract, where they can selectively recognize, bind, and remove target disease causing substances from the body.  The appealing features of GI tract restriction and stability in biol. environment render these polymeric drugs to be devoid of systemic toxicity that are generally assocd. with small mol. systemic drugs.  The present article highlights recent developments in the rational design and synthesis of appropriate functional polymers that have resulted in a no. of promising polymer based therapies and biomaterials, including some marketed products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDQZgGslmborVg90H21EOLACvtfcHk0lhk18ERzNYOig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWht7fJ&md5=67b98d7c4d52f7fb0b112d5fd1871814</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2009.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2009.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DDhal%26aufirst%3DP.%2BK.%26aulast%3DPolomoscanik%26aufirst%3DS.%2BC.%26aulast%3DAvila%26aufirst%3DL.%2BZ.%26aulast%3DHolmes-Farley%26aufirst%3DS.%2BR.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DFunctional%2520polymers%2520as%2520therapeutic%2520agents%253A%2520concept%2520to%2520market%2520place%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26issue%3D13%26spage%3D1121%26epage%3D1130%26doi%3D10.1016%2Fj.addr.2009.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderdoes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantjes, A.</span></span> <span> </span><span class="NLM_article-title">Iron(III)-chelating resins. 3. synthesis, iron(III)-chelating properties, and <i>in-vitro</i> antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1<i>H</i>)-pyridinone ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2822</span>â <span class="NLM_lpage">2827</span>, <span class="refDoi">Â DOI: 10.1021/jm00071a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00071a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFKjsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2822-2827&issue=19&author=M.+H.+Fengauthor=L.+Vanderdoesauthor=A.+Bantjes&title=Iron%28III%29-chelating+resins.+3.+synthesis%2C+iron%28III%29-chelating+properties%2C+and+in-vitro+antibacterial+activity+of+compounds+containing+3-hydroxy-2-methyl-4%281H%29-pyridinone+ligands&doi=10.1021%2Fjm00071a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Iron(III)-chelating resins. 3. Synthesis, iron(III)-chelating properties, and in vitro antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1H)-pyridinone ligands</span></div><div class="casAuthors">Feng, Min Hua; van der Does, Leen; Bantjes, Adriaan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2822-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis, iron(III)-chelating properties, and antibacterial activity of several compds. contg. the 3-hydroxy-2-methyl-4(1H)-pyridinone (HMP) moiety are described.  Using the HMP derivs., iron(III) could be mobilized from iron(III)-binding proteins at physiol. pH with a rate order of transferrin > lactoferrin > ferritin.  Addn. of HMP-contg. compds. to a growth medium at a concn. of 20 mM/L resulted in a complete inhibition of the growth of Escherichia coli and about 90% inhibition for Listeria inocua after 7 h of incubation at 37 Â°C.  After inhibition of bacteria growth by the HMP derivs., growth started again when ferric ions were added to the medium, which implies that the antibacterial activity is due to a limitation of iron available to the organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjP8tmq10cPbVg90H21EOLACvtfcHk0lhk18ERzNYOig"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFKjsLg%253D&md5=bb48168ab601c31942907e798617b027</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm00071a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00071a013%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DM.%2BH.%26aulast%3DVanderdoes%26aufirst%3DL.%26aulast%3DBantjes%26aufirst%3DA.%26atitle%3DIron%2528III%2529-chelating%2520resins.%25203.%2520synthesis%252C%2520iron%2528III%2529-chelating%2520properties%252C%2520and%2520in-vitro%2520antibacterial%2520activity%2520of%2520compounds%2520containing%25203-hydroxy-2-methyl-4%25281H%2529-pyridinone%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D19%26spage%3D2822%26epage%3D2827%26doi%3D10.1021%2Fjm00071a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderdoes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantjes, A.</span></span> <span> </span><span class="NLM_article-title">Iron(III)-chelating resins. IX. antibacterial activity of a water-insoluble iron(III)-chelating resin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">924</span>â <span class="NLM_lpage">927</span>, <span class="refDoi">Â DOI: 10.1021/jm00033a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00033a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2cXitVOqu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=924-927&issue=7&author=M.+H.+Fengauthor=L.+Vanderdoesauthor=A.+Bantjes&title=Iron%28III%29-chelating+resins.+IX.+antibacterial+activity+of+a+water-insoluble+iron%28III%29-chelating+resin&doi=10.1021%2Fjm00033a009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Iron(III)-Chelating Resins. IX. Antibacterial Activity of a Water-Insoluble Iron(III)-Chelating Resin</span></div><div class="casAuthors">Feng, Minhua; van der Does, Leen; Bantjes, Adriaan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">924-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Antibacterial activity of a water-insol. iron(III)-chelating resin with covalently bonded 3-hydroxy-2-methyl-4(1H)-pyridinone (HMP) groups was evaluated in a brain heart infusion (BHI) medium.  The activity of the resin against Escherichia coli was lower than that of sol. HMP iron(III) chelators, whereas against Listeria inocua, an activity approx. equal to those of the sol. chelators was found.  It was obsd. that the growth of E. coli and L. inocua was reduced by increasing the amts. of the resin from 2 to 40 mg of resin/mL of medium.  Inhibition of bacterial growth in the presence of the resin (10 mg/mL) was abolished by addn. of ferric ion to the medium, indicating that the growth of E. coli and L. inocua was dependent on the available iron in the medium.  Reducing the iron concn. in the medium from 14.2 to 0.16 Î¼M (by action of the resin) resulted in a decrease in the growth response from 100% to 19% for E. coli and from 100% to 10% for L. inocua.  In addn., the influence of citrate was studied, but only small effects of citrate supplementation on the growth of bacteria and on the antibacterial activity of the resin were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Oo86zLVlj7Vg90H21EOLACvtfcHk0lgfIES2VecOkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitVOqu7k%253D&md5=f520b0955a8f57e8605f653cc26f1945</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm00033a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00033a009%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DM.%2BH.%26aulast%3DVanderdoes%26aufirst%3DL.%26aulast%3DBantjes%26aufirst%3DA.%26atitle%3DIron%2528III%2529-chelating%2520resins.%2520IX.%2520antibacterial%2520activity%2520of%2520a%2520water-insoluble%2520iron%2528III%2529-chelating%2520resin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D7%26spage%3D924%26epage%3D927%26doi%3D10.1021%2Fjm00033a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaleye, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Rugaie, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span> <span> </span><span class="NLM_article-title">Macromolecular iron-chelators <i>via</i> RAFT-polymerization for the inhibition of methicillin-resistant <i>Staphylococcus aureus</i> growth</span>. <i>Polymer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">64</span>â <span class="NLM_lpage">72</span>, <span class="refDoi">Â DOI: 10.1016/j.polymer.2016.01.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.polymer.2016.01.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVahsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2016&pages=64-72&author=J.+Liauthor=E.+D.+Olaleyeauthor=X.+Kongauthor=T.+Zhouauthor=Y.+Maauthor=J.+Jurachauthor=O.+Al+Rugaieauthor=R.+C.+Hiderauthor=G.+Zhangauthor=S.+Alsamauthor=V.+Abbate&title=Macromolecular+iron-chelators+via+RAFT-polymerization+for+the+inhibition+of+methicillin-resistant+Staphylococcus+aureus+growth&doi=10.1016%2Fj.polymer.2016.01.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Macromolecular iron-chelators via RAFT-polymerization for the inhibition of methicillin-resistant Staphylococcus aureus growth</span></div><div class="casAuthors">Li, Junpei; Olaleye, Eniola D.; Kong, Xiaole; Zhou, Tao; Ma, Yongmin; Jurach, Jagoda; Al Rugaie, Osamah; Hider, Robert C.; Zhang, Guoqing; Alsam, Selwa; Abbate, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Polymer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-72</span>CODEN:
                <span class="NLM_cas:coden">POLMAG</span>;
        ISSN:<span class="NLM_cas:issn">0032-3861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of linear poly (glycidyl methacrylate) (PGMA) polymers were synthesized via RAFT polymn. and conjugated with amine-contg. 3-hydroxypyridin-4-ones (HPOs) to generate a panel of HPO-contg. materials with controlled structures and specific iron-binding functions.  The structures of the resulting polymers were characterized via 1H NMR, GPC and FT-IR and their chelating capacity for iron was investigated using UV-Vis spectrophotometric titrn. of the iron(III) complexes.  In vitro antimicrobial studies of selected ligand-contg. homopolymers demonstrate that the homopolymers are capable of inhibiting the growth of methicillin-resistant Staphylococcus aureus (MRSA).  It is proposed that the inhibition activity of MRSA is derived from the iron-chelating capability of the iron-binding polymers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkLLYRNmB5d7Vg90H21EOLACvtfcHk0lgeD8pKQq7T-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVahsbo%253D&md5=f1207e9ce02a66e793fabc4b3cce339f</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.polymer.2016.01.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.polymer.2016.01.073%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DOlaleye%26aufirst%3DE.%2BD.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DJurach%26aufirst%3DJ.%26aulast%3DAl%2BRugaie%26aufirst%3DO.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAlsam%26aufirst%3DS.%26aulast%3DAbbate%26aufirst%3DV.%26atitle%3DMacromolecular%2520iron-chelators%2520via%2520RAFT-polymerization%2520for%2520the%2520inhibition%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520growth%26jtitle%3DPolymer%26date%3D2016%26volume%3D87%26spage%3D64%26epage%3D72%26doi%3D10.1016%2Fj.polymer.2016.01.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>355</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">124</span>â <span class="NLM_lpage">130</span>, <span class="refDoi">Â DOI: 10.1111/1574-6968.12465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2F1574-6968.12465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24813898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsb3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2014&pages=124-130&issue=2&author=Y.+J.+Zhouauthor=M.+X.+Zhangauthor=R.+C.+Hiderauthor=T.+Zhou&title=In+vitro+antimicrobial+activity+of+hydroxypyridinone+hexadentate-based+dendrimeric+chelators+alone+and+in+combination+with+norfloxacin&doi=10.1111%2F1574-6968.12465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin</span></div><div class="casAuthors">Zhou, Ying-Jun; Zhang, Ming-Xia; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-130</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antimicrobial activity of one 3-hydroxypyridin-4-one (HPO) hexadentate (1) and three HPO hexadentate-based dendrimeric chelators (2-4) was evaluated.  They were found to exhibit marked inhibitory effect on the growth of two Gram-pos. bacteria and two Gram-neg. bacteria.  The combination treatment of dendrimeric chelator 2 with norfloxacin against Staphyloccocus aureus and Escherichia coli showed a dramatic synergistic bactericidal effect.  As the dendrimeric chelator has a large mol. wt., its combination with norfloxacin may find application in the treatment of external infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-3AbL0iS97Vg90H21EOLACvtfcHk0lgeD8pKQq7T-Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsb3I&md5=0878bde8da2644e8b1b80c97026ba820</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1111%2F1574-6968.12465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1574-6968.12465%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DM.%2BX.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DIn%2520vitro%2520antimicrobial%2520activity%2520of%2520hydroxypyridinone%2520hexadentate-based%2520dendrimeric%2520chelators%2520alone%2520and%2520in%2520combination%2520with%2520norfloxacin%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2014%26volume%3D355%26issue%3D2%26spage%3D124%26epage%3D130%26doi%3D10.1111%2F1574-6968.12465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, iron binding and antimicrobial properties of hexadentate 3-hydroxypyridinones-terminated dendrimers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2504</span>â <span class="NLM_lpage">2512</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2018.05.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2018.05.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29886020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtV2gt7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2504-2512&issue=14&author=T.+Zhouauthor=K.+Chenauthor=L.+M.+Kongauthor=M.+S.+Liuauthor=Y.+M.+Maauthor=Y.+Y.+Xieauthor=R.+C.+Hider&title=Synthesis%2C+iron+binding+and+antimicrobial+properties+of+hexadentate+3-hydroxypyridinones-terminated+dendrimers&doi=10.1016%2Fj.bmcl.2018.05.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, iron binding and antimicrobial properties of hexadentate 3-hydroxypyridinones-terminated dendrimers</span></div><div class="casAuthors">Zhou, Tao; Chen, Kai; Kong, Li-Min; Liu, Mu-Song; Ma, Yong-Min; Xie, Yuan-Yuan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2504-2512</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Macromol. chelators have potential applications in the medical area, for instance, in treatment of iron overload-related disorders and in the treatment of external infections.  In this investigation, several novel iron(III)-selective hydroxypyridinone hexadentate-terminated first and second generation dendrimeric chelators were synthesized using a convergent strategy.  Their iron chelating ability was demonstrated by UV/Visible spectrometry and high resoln. mass spectrometry (HRMS).  The iron binding affinities were also investigated by the competition with a fluorescent iron chelator CP691.  The result indicated that these dendrimers possesses a high affinity for iron with a very high pFe3+ value, which is close to that of an isolated hexadentate unit.  These dendrimeric chelators were found to exhibit inhibitory effect on the growth of both Gram-pos. and Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovKTghr5PgdLVg90H21EOLACvtfcHk0lhhZDXkPtPL6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtV2gt7nK&md5=bd934c67f08fd7339138b9e70671ee11</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.058%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKong%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520iron%2520binding%2520and%2520antimicrobial%2520properties%2520of%2520hexadentate%25203-hydroxypyridinones-terminated%2520dendrimers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2504%26epage%3D2512%26doi%3D10.1016%2Fj.bmcl.2018.05.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ang, M. T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumbau-Brisa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierenstiel, M.</span></span> <span> </span><span class="NLM_article-title">DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1206</span>â <span class="NLM_lpage">1212</span>, <span class="refDoi">Â DOI: 10.1039/C8MD00192H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC8MD00192H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30109009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCmtLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1206-1212&issue=7&author=M.+T.+C.+Angauthor=R.+Gumbau-Brisaauthor=D.+S.+Allanauthor=R.+McDonaldauthor=M.+J.+Fergusonauthor=B.+E.+Holbeinauthor=M.+Bierenstiel&title=DIBI%2C+a+3-hydroxypyridin-4-one+chelator+iron-binding+polymer+with+enhanced+antimicrobial+activity&doi=10.1039%2FC8MD00192H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity</span></div><div class="casAuthors">Ang, M. Trisha C.; Gumbau-Brisa, Roger; Allan, David S.; McDonald, Robert; Ferguson, Michael J.; Holbein, Bruce E.; Bierenstiel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1206-1212</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Depriving microorganisms of bioavailable iron is a promising strategy for new anti-infective agents.  The new, highly water-sol., low mol. wt. co-polymer DIBI was developed to selectively bind iron(III) ions as a tris chelate and acts as a standalone anti-infective.  Min. inhibitory concn. (MIC) studies show DIBI is effective against representative ref. strains for Gram-pos. and Gram-neg. bacteria S. aureus and A. baumannii, and the fungus C. albicans.  Compared to the small mol. iron chelators, deferiprone and deferoxamine, DIBI outclassed these by factors of 100 to 1000 for inhibition of initial growth.  DIBI and a series of related co-polymers (Mw of 2-9 kDa) were synthesized via reversible addn.-fragmentation chain transfer (RAFT) polymn. of a chelating 3-hydroxypyridin-4-one (HPO) methacrylamide monomer and N-vinylpyrrolidone (NVP).  Full incorporation of the HPO monomer into the co-polymers from the reaction soln. was detd. by 1H NMR spectroscopy and ranged from 4.6 to 25.6 mol%.  UV-vis spectroscopy showed that all the HPO in DIBI binds readily to iron(III) in a tris chelate mode to the max. theor. iron(III) binding capacity of the co-polymer.  Chem. characterization including single crystal X-ray diffraction analyses of the O-benzyl protected and the functional HPO monomer are discussed.  By design, DIBI is highly water sol.; the highest mass fraction in water tested was 70% wt./wt., without the need of org. co-solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWgqj6WHYL_bVg90H21EOLACvtfcHk0lhhZDXkPtPL6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmtLvM&md5=7fbf6b641592fe2624535978ad990712</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1039%2FC8MD00192H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00192H%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DM.%2BT.%2BC.%26aulast%3DGumbau-Brisa%26aufirst%3DR.%26aulast%3DAllan%26aufirst%3DD.%2BS.%26aulast%3DMcDonald%26aufirst%3DR.%26aulast%3DFerguson%26aufirst%3DM.%2BJ.%26aulast%3DHolbein%26aufirst%3DB.%2BE.%26aulast%3DBierenstiel%26aufirst%3DM.%26atitle%3DDIBI%252C%2520a%25203-hydroxypyridin-4-one%2520chelator%2520iron-binding%2520polymer%2520with%2520enhanced%2520antimicrobial%2520activity%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26issue%3D7%26spage%3D1206%26epage%3D1212%26doi%3D10.1039%2FC8MD00192H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parquet, M. D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B. E.</span></span> <span> </span><span class="NLM_article-title">Novel iron-chelator DIBI inhibits staphylococcus aureus growth, suppresses experimental MRSA infection in mice and enhances the activities of diverse antibiotics <i>in vitro</i></span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1811</span>â <span class="NLM_lpage">1821</span>, <span class="refDoi">Â DOI: 10.3389/fmicb.2018.01811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3389%2Ffmicb.2018.01811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30154764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BB3c3islyisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1811-1821&author=M.+D.+C.+Parquetauthor=K.+A.+Savageauthor=D.+S.+Allanauthor=R.+J.+Davidsonauthor=B.+E.+Holbein&title=Novel+iron-chelator+DIBI+inhibits+staphylococcus+aureus+growth%2C+suppresses+experimental+MRSA+infection+in+mice+and+enhances+the+activities+of+diverse+antibiotics+in+vitro&doi=10.3389%2Ffmicb.2018.01811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro</span></div><div class="casAuthors">Parquet Maria Del Carmen; Savage Kimberley A; Allan David S; Holbein Bruce E; Davidson Ross J; Holbein Bruce E; Davidson Ross J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1811</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">DIBI, a purpose-designed hydroxypyridinone-containing iron-chelating antimicrobial polymer was studied for its anti-staphylococcal activities in vitro in comparison to deferiprone, the chemically related, small molecule hydroxypyridinone chelator.  The sensitivities of 18 clinical isolates of Staphylococcus aureus from human, canine and bovine infections were determined.  DIBI was strongly inhibitory to all isolates, displaying approximately 100-fold more inhibitory activity than deferiprone when compared on their molar iron-binding capacities.  Sensitivity to DIBI was similar for both antibiotic-resistant and -sensitive isolates, including hospital- and community-acquired (United States 300) MRSA.  DIBI inhibition was primarily bacteriostatic in nature at low concentration and was reversible by addition of Fe.  DIBI also exhibited in vivo anti-infective activity in two distinct MRSA ATCC43300 infection and colonization models in mice.  In a superficial skin wound infection model, topical application of DIBI provided a dose-dependent suppression of infection along with reduced wound inflammation.  Intranasal DIBI reduced staphylococcal burden by >2 log in a MRSA nares carriage model.  DIBI was also examined for its influence on antibiotic activities with a reference isolate ATCC6538, typically utilized to assess new antimicrobials.  Sub-bacteriostatic concentrations of DIBI resulted in Fe-restricted growth and this physiological condition displayed increased sensitivity to GEN, CIP, and VAN.  DIBI did not impair antibiotic activity but rather it enhanced overall killing.  Importantly, recovery growth of survivors that typically followed an initial sub-MIC antibiotic killing phase was substantially suppressed by DIBI for each of the antibiotics examined.  DIBI has promise for restricting staphylococcal infection on its own, regardless of the isolate's animal source or antibiotic resistance profile.  DIBI also has potential for use in combination with various classes of currently available antibiotics to improve their responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDbfJpItTH4hLSh9fo81bfW6udTcc2ebj4SKbGhdwdbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3islyisQ%253D%253D&md5=84e201118675b8bfccd6595a7a0647af</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.01811%26sid%3Dliteratum%253Aachs%26aulast%3DParquet%26aufirst%3DM.%2BD.%2BC.%26aulast%3DSavage%26aufirst%3DK.%2BA.%26aulast%3DAllan%26aufirst%3DD.%2BS.%26aulast%3DDavidson%26aufirst%3DR.%2BJ.%26aulast%3DHolbein%26aufirst%3DB.%2BE.%26atitle%3DNovel%2520iron-chelator%2520DIBI%2520inhibits%2520staphylococcus%2520aureus%2520growth%252C%2520suppresses%2520experimental%2520MRSA%2520infection%2520in%2520mice%2520and%2520enhances%2520the%2520activities%2520of%2520diverse%2520antibiotics%2520in%2520vitro%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D1811%26epage%3D1821%26doi%3D10.3389%2Ffmicb.2018.01811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological-activity of a novel class of cephalosporins with a oxadiazolyl hydroxypyridone moiety at C-7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2777</span>â <span class="NLM_lpage">2782</span>, <span class="refDoi">Â DOI: 10.1016/0960-894X(95)00485-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0960-894X%2895%2900485-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVShs73N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2777-2782&issue=23&author=K.+Obiauthor=A.+Kojimaauthor=H.+Fukudaauthor=K.+Hirai&title=Synthesis+and+biological-activity+of+a+novel+class+of+cephalosporins+with+a+oxadiazolyl+hydroxypyridone+moiety+at+C-7&doi=10.1016%2F0960-894X%2895%2900485-C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of a novel class of cephalosporins with a oxadiazolyl hydroxypyridone moiety at C-7</span></div><div class="casAuthors">Obi, Kikoh; Kojima, Akihiko; Fukuda, Hideyuki; Hirai, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2777-82</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Synthesis and biol. properties of a novel class of cephalosporins I [R = heterocyclylthio] are described.  Among them, the compds. having a pyridiniumthiomethyl group at C-3 position were found to possess high in vitro potency and showed excellent in vivo efficacy against both S. aureus and P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVoVWD8QIzLVg90H21EOLACvtfcHk0lhRT0cnoFzFag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVShs73N&md5=6598a7076846fef21f79c6da26009270</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900485-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900485-C%26sid%3Dliteratum%253Aachs%26aulast%3DObi%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DA.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DHirai%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520biological-activity%2520of%2520a%2520novel%2520class%2520of%2520cephalosporins%2520with%2520a%2520oxadiazolyl%2520hydroxypyridone%2520moiety%2520at%2520C-7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26issue%3D23%26spage%3D2777%26epage%3D2782%26doi%3D10.1016%2F0960-894X%2895%2900485-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy-Benenato, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagunde, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand-Reville, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galullo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatoum-Mokdad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiroga, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uria-Nickelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span> <span> </span><span class="NLM_article-title">Discovery of efficacious <i>Pseudomonas aeruginosa</i>-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2195</span>â <span class="NLM_lpage">2205</span>, <span class="refDoi">Â DOI: 10.1021/jm501506f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501506f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Sguro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2195-2205&issue=5&author=K.+E.+Murphy-Benenatoauthor=P.+R.+Bhagundeauthor=A.+Chenauthor=H.+E.+Davisauthor=T.+F.+Durand-Revilleauthor=D.+E.+Ehmannauthor=V.+Galulloauthor=J.+J.+Harrisauthor=H.+Hatoum-Mokdadauthor=H.+Jahicauthor=A.+Kimauthor=M.+R.+Manjunathaauthor=E.+L.+Manyakauthor=J.+Muellerauthor=S.+Pateyauthor=O.+Quirogaauthor=M.+Rooneyauthor=L.+Shaauthor=A.+B.+Shapiroauthor=M.+Sylvesterauthor=B.+Tanauthor=A.+S.+Tsaiauthor=M.+Uria-Nickelsenauthor=Y.+Wuauthor=M.+Zambrowskiauthor=S.+X.+Zhao&title=Discovery+of+efficacious+Pseudomonas+aeruginosa-targeted+siderophore-conjugated+monocarbams+by+application+of+a+semi-mechanistic+pharmacokinetic%2Fpharmacodynamic+model&doi=10.1021%2Fjm501506f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Efficacious Pseudomonas aeruginosa-Targeted Siderophore-Conjugated Monocarbams by Application of a Semi-mechanistic Pharmacokinetic/Pharmacodynamic Model</span></div><div class="casAuthors">Murphy-Benenato, Kerry E.; Bhagunde, Pratik R.; Chen, April; Davis, Hajnalka E.; Durand-Reville, Thomas F.; Ehmann, David E.; Galullo, Vincent; Harris, Jennifer J.; Hatoum-Mokdad, Holia; Jahic, Haris; Kim, Aryun; Manjunatha, M. R.; Manyak, Erika L.; Mueller, John; Patey, Sara; Quiroga, Olga; Rooney, Michael; Sha, Li; Shapiro, Adam B.; Sylvester, Mark; Tan, Beesan; Tsai, Andy S.; Uria-Nickelsen, Maria; Wu, Ye; Zambrowski, Mark; Zhao, Shannon X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2195-2205</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To identify new agents for the treatment of multidrug-resistant Pseudomonas aeruginosa, the authors focused on siderophore-conjugated monocarbams.  This class of monocyclic Î²-lactams are stable to metallo-Î²-lactamases and have excellent P. aeruginosa activities due to their ability to exploit the iron uptake machinery of Gram-neg. bacteria.  The medicinal chem. plan focused on identifying a mol. with optimal potency and phys. properties and activity for in vivo efficacy.  Modifications to the monocarbam linker, siderophore, and oxime portion of the mols. were examd.  Through these efforts, a series of pyrrolidinone-based monocarbams with good P. aeruginosa cellular activity (P. aeruginosa MIC90 = 2 Î¼g/mL), free fraction levels (>20% free), and hydrolytic stability (t1/2 â¥ 100 h) were identified.  To differentiate the lead compds. and enable prioritization for in vivo studies, the authors applied a semi-mechanistic pharmacokinetic/pharmacodynamic model to enable prediction of in vivo efficacy from in vitro data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcG0PvqAMbi7Vg90H21EOLACvtfcHk0lhRT0cnoFzFag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Sguro%253D&md5=ff3e470724b850b37ae818216f4471b2</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm501506f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501506f%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy-Benenato%26aufirst%3DK.%2BE.%26aulast%3DBhagunde%26aufirst%3DP.%2BR.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DH.%2BE.%26aulast%3DDurand-Reville%26aufirst%3DT.%2BF.%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DHarris%26aufirst%3DJ.%2BJ.%26aulast%3DHatoum-Mokdad%26aufirst%3DH.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DManyak%26aufirst%3DE.%2BL.%26aulast%3DMueller%26aufirst%3DJ.%26aulast%3DPatey%26aufirst%3DS.%26aulast%3DQuiroga%26aufirst%3DO.%26aulast%3DRooney%26aufirst%3DM.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DTsai%26aufirst%3DA.%2BS.%26aulast%3DUria-Nickelsen%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZambrowski%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520efficacious%2520Pseudomonas%2520aeruginosa-targeted%2520siderophore-conjugated%2520monocarbams%2520by%2520application%2520of%2520a%2520semi-mechanistic%2520pharmacokinetic%252Fpharmacodynamic%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D5%26spage%3D2195%26epage%3D2205%26doi%3D10.1021%2Fjm501506f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltimore, D.</span></span> <span> </span><span class="NLM_article-title">An inducible transcription factor activates expression of human immunodeficiency virus in T cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>326</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">711</span>â <span class="NLM_lpage">713</span>, <span class="refDoi">Â DOI: 10.1038/326711a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2F326711a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=3031512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaL2sXitVyls7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1987&pages=711-713&issue=16&author=G.+Nabelauthor=D.+Baltimore&title=An+inducible+transcription+factor+activates+expression+of+human+immunodeficiency+virus+in+T+cells&doi=10.1038%2F326711a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">An inducible transcription factor activates expression of human immunodeficiency virus in T cells</span></div><div class="casAuthors">Nabel, Gary; Baltimore, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">6114</span>),
    <span class="NLM_cas:pages">711-13</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Human immunodeficiency virus (HIV) prodn. from latently infected T lymphocytes can be induced with compds. that activate the cells to secrete lymphokines.  The elements in the HIV genome which control activation are not known but expression might be regulated through a variety of DNA elements.  The cis-acting control elements of the viral genome are enhancer and promoter regions.  The virus also encodes trans-acting factors specified by the tat-III and art genes.  The authors examd. whether products specific to activated T cells might stimulate viral transcription by binding to regions on viral DNA.  Activation of T cells, which increases HIV expression up to 50-fold, correlated with induction of a DNA binding protein indistinguishable from a recognized transcription factor, called NF-ÎºB, with binding sites in the viral enhancer.  Mutation of these binding sites abolished inducibility.  That NF-ÎºB acts in synergy with the viral tat-III gene product to enhance HIV expression in T cells may have implications for the pathogenesis of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroPK8QwklBhbVg90H21EOLACvtfcHk0lhhJHVdB-YZoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXitVyls7Y%253D&md5=2dc52c063f31c15a7dd01a09a8066b21</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2F326711a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F326711a0%26sid%3Dliteratum%253Aachs%26aulast%3DNabel%26aufirst%3DG.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3DAn%2520inducible%2520transcription%2520factor%2520activates%2520expression%2520of%2520human%2520immunodeficiency%2520virus%2520in%2520T%2520cells%26jtitle%3DNature%26date%3D1987%26volume%3D326%26issue%3D16%26spage%3D711%26epage%3D713%26doi%3D10.1038%2F326711a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffbrand, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeshaguru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooton, J. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattersall, M. H. N.</span></span> <span> </span><span class="NLM_article-title">Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">517</span>â <span class="NLM_lpage">526</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2141.1976.tb03570.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1365-2141.1976.tb03570.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1009024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaE28XltFKlsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1976&pages=517-526&author=A.+V.+Hoffbrandauthor=K.+Ganeshaguruauthor=J.+W.+L.+Hootonauthor=M.+H.+N.+Tattersall&title=Effect+of+iron+deficiency+and+desferrioxamine+on+DNA+synthesis+in+human+cells&doi=10.1111%2Fj.1365-2141.1976.tb03570.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells</span></div><div class="casAuthors">Hoffbrand, A. V.; Ganeshaguru, K.; Hooton, J. W. L.; Tattersall, M. H. N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-26</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">Desferrioxamine [70-51-9] (10-3M) caused a fall in the deoxyadenosine triphosphate [1927-31-7] level after 4 hr incubation in normal phytohemagglutinin-stimulated lymphocytes.  There was a rise in the concns. of the other 3 deoxyribonucleoside triphosphates (deoxythymidine- [365-08-2], deoxycytidine- [2056-98-6], and deoxyguanosine triphosphate [2564-35-4]).  The changes were similar to those caused by hydroxyurea [127-07-1], a known inhibitor of ribonucleotide reductase.  Desferrioxamine (10-3M) inhibited human lymphocyte ribonucleotide reductase [9040-57-7] to a mean of 11% of control activity after 45 min incubation.  Both drugs, desferrioxamine and hydroxyurea, inhibited incorporation of [3H]thymidine DNA into lymphocytes in the presence or absence of deoxyuridine, and inhibited prodn. of lymphocytic thymidine kinase [9002-06-6], having opposite effects to methotrexate [59-05-2] on both [3H]thymidine incorporation and thymidine kinase activity.  Phytohemagglutinin-stimulated lymphocytes from patients with chronic iron deficiency showed lower levels of all 4 deoxyribonucleoside triphosphates than normal lymphocytes.  It is suggested that this may be due to reduced ribonucleotide reductase activity of the iron-deficient cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgAXi9HM0xrVg90H21EOLACvtfcHk0lhhJHVdB-YZoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltFKlsro%253D&md5=a20ded5b109ab1c23cb3a7299923477a</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1976.tb03570.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1976.tb03570.x%26sid%3Dliteratum%253Aachs%26aulast%3DHoffbrand%26aufirst%3DA.%2BV.%26aulast%3DGaneshaguru%26aufirst%3DK.%26aulast%3DHooton%26aufirst%3DJ.%2BW.%2BL.%26aulast%3DTattersall%26aufirst%3DM.%2BH.%2BN.%26atitle%3DEffect%2520of%2520iron%2520deficiency%2520and%2520desferrioxamine%2520on%2520DNA%2520synthesis%2520in%2520human%2520cells%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1976%26volume%3D33%26spage%3D517%26epage%3D526%26doi%3D10.1111%2Fj.1365-2141.1976.tb03570.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Bruggen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudshoorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Asbeck, B. S.</span></span> <span> </span><span class="NLM_article-title">Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis</span>. <i>Eur. J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2362.2002.0320s1091.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1046%2Fj.1365-2362.2002.0320s1091.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11886438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFaksb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=91-96&issue=1&author=N.+A.+Georgiouauthor=T.+van+der+Bruggenauthor=M.+Oudshoornauthor=R.+C.+Hiderauthor=J.+J.+M.+Marxauthor=B.+S.+van%0AAsbeck&title=Human+immunodeficiency+virus+type+1+replication+inhibition+by+the+bidentate+iron+chelators+CP502+and+CP511+is+caused+by+proliferation+inhibition+and+the+onset+of+apoptosis&doi=10.1046%2Fj.1365-2362.2002.0320s1091.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Human immunodeficiency virus type I replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis</span></div><div class="casAuthors">Georgiou, N. A.; van der Bruggen, T.; Oudshoorn, M.; Hider, R. C.; Marx, J. J. M.; van Asbeck, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">EJCIB8</span>;
        ISSN:<span class="NLM_cas:issn">0014-2972</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: The iron chelators deferoxamine (DF) and deferiprone (CP20) have been shown to inhibit human immunodeficiency virus type 1 (HIV-1) replication in human peripheral blood lymphocytes (PBL).  The orally active bidentate chelators CP502 and CP511, which also belong to the 3-hydroxypyridin-4-one family, but with higher affinities for iron than CP20, were monitored for their antiviral properties by checking for p24 antigen prodn. and nuclear factor (NF)-ÎºB activation, and their ability to induce apoptosis.  Materials and methods: Human PBLs were isolated from HIV-1 seroneg. donors and subsequently infected with HIV-1Ba-L for 2 h.  After 5 days' incubation, HIV-1 replication was monitored by p24 antigen prodn.  Cellular proliferation as well as caspase-3 activity were monitored in uninfected cells after a period of 5 days and after 1 day infection, resp.  NF-ÎºB activity was also monitored by electromobility shift assays (EMSA) performed on nuclear exts. of Jurkat cells treated with the different chelators for 4 h.  Results CP502 and CP511 decrease HIV-1 replication by decreasing cellular proliferation in a similar manner to DF and CP20.  CP511 seemed to be more potent than either CP502 or CP20.  Due to the redn. in cellular proliferation, there was an increase in caspase-3 activity after 24 h incubation.  NF-ÎºB activity was not affected by any of the chelators.  Conclusions: Iron chelators with high affinities for iron, which are under development for the treatment of iron overload, could contribute to the redn. of HIV-1 replication in infected patients by cellular proliferation inhibition rather than by a direct antiviral action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZI54sKUSZArVg90H21EOLACvtfcHk0lhdzUmAmVXjUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFaksb8%253D&md5=d2d5d9f4534518854376e72a327d6821</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2362.2002.0320s1091.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2362.2002.0320s1091.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiou%26aufirst%3DN.%2BA.%26aulast%3Dvan%2Bder%2BBruggen%26aufirst%3DT.%26aulast%3DOudshoorn%26aufirst%3DM.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DMarx%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3Dvan%2BAsbeck%26aufirst%3DB.%2BS.%26atitle%3DHuman%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520inhibition%2520by%2520the%2520bidentate%2520iron%2520chelators%2520CP502%2520and%2520CP511%2520is%2520caused%2520by%2520proliferation%2520inhibition%2520and%2520the%2520onset%2520of%2520apoptosis%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D32%26issue%3D1%26spage%3D91%26epage%3D96%26doi%3D10.1046%2Fj.1365-2362.2002.0320s1091.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. M.</span></span> <span> </span><span class="NLM_article-title">RNA degradation by bleomycin, a naturally occurring bioconjugate</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">526</span>, <span class="refDoi">Â DOI: 10.1021/bc00030a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc00030a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVCksb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=513-526&author=S.+M.+Hecht&title=RNA+degradation+by+bleomycin%2C+a+naturally+occurring+bioconjugate&doi=10.1021%2Fbc00030a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">RNA Degradation by Bleomycin, a Naturally Occurring Bioconjugate</span></div><div class="casAuthors">Hecht, Sidney M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">513-26</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    </div><div class="casAbstract">A review with 93 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKcKIUxsaH7Vg90H21EOLACvtfcHk0lhdzUmAmVXjUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVCksb0%253D&md5=a85b2647c3cf66b3cda8c0ab307c31c0</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fbc00030a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc00030a006%26sid%3Dliteratum%253Aachs%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DRNA%2520degradation%2520by%2520bleomycin%252C%2520a%2520naturally%2520occurring%2520bioconjugate%26jtitle%3DBioconjugate%2520Chem.%26date%3D1994%26volume%3D5%26spage%3D513%26epage%3D526%26doi%3D10.1021%2Fbc00030a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanauske, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huima-Byron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slowinska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagulska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanauske-Abel, H. M.</span></span> <span> </span><span class="NLM_article-title">Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors-a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1)</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1807</span>â <span class="NLM_lpage">1818</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(98)00053-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-2952%2898%2900053-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9714299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVehtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=1807-1818&issue=11&author=L.+Andrusauthor=P.+Szaboauthor=R.+W.+Gradyauthor=A.+R.+Hanauskeauthor=T.+Huima-Byronauthor=B.+Slowinskaauthor=S.+Zagulskaauthor=H.+M.+Hanauske-Abel&title=Antiretroviral+effects+of+deoxyhypusyl+hydroxylase+inhibitors-a+hypusine-dependent+host+cell+mechanism+for+replication+of+human+immunodeficiency+virus+type+1+%28HIV-1%29&doi=10.1016%2FS0006-2952%2898%2900053-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors. A hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1)</span></div><div class="casAuthors">Andrus, Linda; Szabo, Paul; Grady, Robert W.; Hanauske, Axel-R.; Huima-Byron, Tellervo; Slowinska, Bozena; Zagulska, Sylwia; Hanauske-Abel, Hartmut M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1807-1818</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The HIV-1 protein Rev, crit. for translation of incompletely spliced retroviral mRNAs encoding capsid elements, requires a host cell protein termed "eukaryotic initiation factor 5A" (eIF-5A).  This is the only protein contg. hypusine, a lysine-derived hydroxylated residue that dets. its proposed bioactivity, the translation of a subset of cellular mRNAs controlling G1-to-S transit of the cell cycle.  We postulated that inhibiting the hypusine-forming deoxyhypusyl hydroxylase (DOHH) should, by depleting eukaryotic initiation factor 5A, compromise Rev function and thus reduce HIV-1 multiplication.  We now report that the Î±-hydroxypyridones, specifically mimosine, a natural product, and deferiprone, an exptl. drug, inhibited deoxyhypusyl hydroxylase in T-lymphocytic and promonocytic cell lines and, in a concn.-dependent manner, suppressed replication of HIV-1.  However, the Î±-hydroxypyridones did not affect the formation of unspliced or multiply spliced HIV-1 transcripts.  Rather, these agents caused Rev-dependent incompletely spliced HIV-1 mRNA such as gag, but not cellular "housekeeping" mRNAs, to disappear from polysomes.  Consequently, Î±-hydroxypyridone-mediated depletion of eIF-5A decreased biosynthesis of structural HIV-1 protein encoded by gag, measured as p24, whereas the induced formation of cellular protein like tumor necrosis factor alpha remained unaffected.  By interfering with the translation of incompletely spliced retroviral mRNAs, these compds. restrict HIV-1 to the early, nongenerative phase of its reproductive cycle.  In the inducibly HIV-1 expressing T-cell line ACH-2, the deoxyhypusyl hydroxylase inhibitors triggered extensive apoptosis, particularly of cells that actively produce HIV-1.  Selective suppression of retroviral protein biosynthesis and preferential apoptosis of retrovirally infected cells by Î±-hydroxypyridones point to a novel mode of antiretroviral action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8AGxV_zaQ5bVg90H21EOLACvtfcHk0lhdzUmAmVXjUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVehtr8%253D&md5=8eeb3fc388ee90231973d0232c7b477f</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2898%2900053-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252898%252900053-7%26sid%3Dliteratum%253Aachs%26aulast%3DAndrus%26aufirst%3DL.%26aulast%3DSzabo%26aufirst%3DP.%26aulast%3DGrady%26aufirst%3DR.%2BW.%26aulast%3DHanauske%26aufirst%3DA.%2BR.%26aulast%3DHuima-Byron%26aufirst%3DT.%26aulast%3DSlowinska%26aufirst%3DB.%26aulast%3DZagulska%26aufirst%3DS.%26aulast%3DHanauske-Abel%26aufirst%3DH.%2BM.%26atitle%3DAntiretroviral%2520effects%2520of%2520deoxyhypusyl%2520hydroxylase%2520inhibitors-a%2520hypusine-dependent%2520host%2520cell%2520mechanism%2520for%2520replication%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1998%26volume%3D55%26issue%3D11%26spage%3D1807%26epage%3D1818%26doi%3D10.1016%2FS0006-2952%2898%2900053-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camplo, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">4371</span>â <span class="NLM_lpage">4374</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2003.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2003.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=14643328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1yrtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4371-4374&issue=24&author=K.+Barralauthor=R.+C.+Hiderauthor=J.+Balzariniauthor=J.+Neytsauthor=E.+De+Clercqauthor=M.+Camplo&title=Synthesis+and+antiviral+evaluation+of+3-hydroxy-2-methylpyridin-4-one+dideoxynucleoside+derivatives&doi=10.1016%2Fj.bmcl.2003.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives</span></div><div class="casAuthors">Barral, Karine; Hider, Robert C.; Balzarini, Jan; Neyts, Johan; De Clercq, Erik; Camplo, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4371-4374</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We describe the synthesis and the antiviral evaluation of novel Î± and Î² dideoxynucleoside derivs. in which the base has been replaced by a 3-hydroxy-2-methylpyridin-4-one.  The syntheses were successfully achieved by the use of the std. Vorbruggen coupling conditions.  Moderate activity of these compds. (between 32 to 900 Î¼M) were found on herpes simplex virus (HSV) type 1 and type 2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiNMyf76qAPbVg90H21EOLACvtfcHk0ljcJ1CONzB1Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1yrtb0%253D&md5=7a6a09c7afea7a07db57e5c8edb08da1</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DBarral%26aufirst%3DK.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DCamplo%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antiviral%2520evaluation%2520of%25203-hydroxy-2-methylpyridin-4-one%2520dideoxynucleoside%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D24%26spage%3D4371%26epage%3D4374%26doi%3D10.1016%2Fj.bmcl.2003.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camplo, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>â <span class="NLM_lpage">50</span>, <span class="refDoi">Â DOI: 10.1021/jm0504306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12nsrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=43-50&issue=1&author=K.+Barralauthor=J.+Balzariniauthor=J.+Neytsauthor=E.+De+Clercqauthor=R.+C.+Hiderauthor=M.+Camplo&title=Synthesis+and+antiviral+evaluation+of+cyclic+and+acyclic+2-methyl-3-hydroxy-4-pyridinone+nucleoside+derivatives&doi=10.1021%2Fjm0504306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiviral Evaluation of Cyclic and Acyclic 2-Methyl-3-hydroxy-4-pyridinone Nucleoside Derivatives</span></div><div class="casAuthors">Barral, Karine; Balzarini, Jan; Neyts, Johan; De Clercq, Erik; Hider, Robert C.; Camplo, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cyclic and acyclic nucleoside analogs derived from 3-hydroxy-4-pyridinone were synthesized using the Vorbrueggen reaction.  Iron chelation studies, and antiviral evaluation against a broad panel of viruses, were performed.  The pKa value of ligand 25 and the stability const. of the corresponding iron(III) complex were compared to those of deferiprone.  The pFe3+ values were found to be similar.  Some compds. showed moderate activity against both wild-type HSV-1 and HSV-2, as well as against a thymidine kinase deficient strain of HSV-1.  These results suggest a novel mode of action for this group of nucleoside analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_SZ97sVPypLVg90H21EOLACvtfcHk0ljcJ1CONzB1Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12nsrfJ&md5=8a38c86017017ebe8b575ed5cdc4042c</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Fjm0504306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504306%26sid%3Dliteratum%253Aachs%26aulast%3DBarral%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DCamplo%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antiviral%2520evaluation%2520of%2520cyclic%2520and%2520acyclic%25202-methyl-3-hydroxy-4-pyridinone%2520nucleoside%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D1%26spage%3D43%26epage%3D50%26doi%3D10.1021%2Fjm0504306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershko, C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, T E</span></span> <span> </span><span class="NLM_article-title">Deferoxamine inhibition of malaria is independent of host iron status</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">375</span>â <span class="NLM_lpage">387</span>, <span class="refDoi">Â DOI: 10.1084/jem.168.1.375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1084%2Fjem.168.1.375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=3294334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaL1cXltVChsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1988&pages=375-387&issue=1&author=C+Hershkoauthor=T+E+Peto&title=Deferoxamine+inhibition+of+malaria+is+independent+of+host+iron+status&doi=10.1084%2Fjem.168.1.375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Deferoxamine inhibition of malaria is independent of host iron status</span></div><div class="casAuthors">Hershko, Chaim; Peto, Timothy E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">375-87</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">The mechanism whereby deferoxamine (DF) inhibits the growth of malaria parasites was studied in rats infected with Plasmodium berghei.  Peak parasitemia was 32.6% (day 14) in untreated controls and 0.15% (day 7) in rats receiving 0.33 mg DF/g/day s.c.  DF inhibition of parasite growth was achieved without any redn. in transferrin satn. or Hb synthesis and with only a partial (56%) depletion of hepatic iron stores.  Dietary iron depletion resulted in anemia, microcytosis, and reduced transferrin satn. without any effect on infection.  Similarly, parenteral iron loading with ferric citrate over 10 days (75 mg iron/kg) failed to aggravate infection.  In a search for evidence of direct interaction between DF and parasitized erythrocytes, gel filtration and ultrafiltration was performed on hemolyzates obtained from in vivo 59Fe-labeled parasitized erythrocytes.  This showed that 1.1-1.9% of the intracellular radioiron was located in a chelatable, labile iron pool.  Incubation of intact cells with 0-500 Î¼M DF resulted in a proportional increase in intracellular iron chelation, and the chelation of all available labile intracellular iron was completed within 6 h.  These observations indicate that the severity of P. berghei infection in rats and its in vivo suppression by DF are independent of host iron status and suggest that DF inhibition of malaria involves intracellular chelation of a labile iron pool in parasitized erythrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAu182JG4XiLVg90H21EOLACvtfcHk0ljcJ1CONzB1Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVChsbs%253D&md5=a16d3668a64c61095e4f8b85347ee838</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1084%2Fjem.168.1.375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.168.1.375%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DC%26aulast%3DPeto%26aufirst%3DT%2BE%26atitle%3DDeferoxamine%2520inhibition%2520of%2520malaria%2520is%2520independent%2520of%2520host%2520iron%2520status%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1988%26volume%3D168%26issue%3D1%26spage%3D375%26epage%3D387%26doi%3D10.1084%2Fjem.168.1.375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mabeza, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyevsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordeuk, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G.</span></span> <span> </span><span class="NLM_article-title">Iron chelation therapy for malaria: a review</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">53</span>â <span class="NLM_lpage">75</span>, <span class="refDoi">Â DOI: 10.1016/S0163-7258(98)00037-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0163-7258%2898%2900037-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10051178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADyaK1M7lvVCrtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1999&pages=53-75&issue=1&author=G.+F.+Mabezaauthor=M.+Loyevskyauthor=V.+R.+Gordeukauthor=G.+Weiss&title=Iron+chelation+therapy+for+malaria%3A+a+review&doi=10.1016%2FS0163-7258%2898%2900037-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelation therapy for malaria: a review</span></div><div class="casAuthors">Mabeza G F; Loyevsky M; Gordeuk V R; Weiss G</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-75</span>
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">Malaria is one of the major global health problems, and an urgent need for the development of new antimalarial agents faces the scientific community.  A considerable number of iron(III) chelators, designed for purposes other than treating malaria, have antimalarial activity in vitro, apparently through the mechanism of withholding iron from vital metabolic pathways of the intra-erythrocytic parasite.  Certain iron(II) chelators also have antimalarial activity, but the mechanism of action appears to be the formation of toxic complexes with iron rather than the withholding of iron.  Several of the iron(III)-chelating compounds also have antimalarial activity in animal models of plasmodial infection.  Iron chelation therapy with desferrioxamine, the only compound of this nature that is widely available for use in humans, has clinical activity in both uncomplicated and severe malaria in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSr6JXMYvtZGgyMywPm6HgQfW6udTcc2eaxqQuxsRqNNbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7lvVCrtQ%253D%253D&md5=8a35b795b890b124497de08b6188a809</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900037-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900037-0%26sid%3Dliteratum%253Aachs%26aulast%3DMabeza%26aufirst%3DG.%2BF.%26aulast%3DLoyevsky%26aufirst%3DM.%26aulast%3DGordeuk%26aufirst%3DV.%2BR.%26aulast%3DWeiss%26aufirst%3DG.%26atitle%3DIron%2520chelation%2520therapy%2520for%2520malaria%253A%2520a%2520review%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D81%26issue%3D1%26spage%3D53%26epage%3D75%26doi%3D10.1016%2FS0163-7258%2898%2900037-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theanacho, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spira, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">The effect of <i>N</i>-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">637</span>â <span class="NLM_lpage">643</span>, <span class="refDoi">Â DOI: 10.1182/blood.V77.3.637.637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V77.3.637.637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1991172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3MXktVShs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1991&pages=637-643&issue=3&author=C.+Hershkoauthor=E.+N.+Theanachoauthor=D.+T.+Spiraauthor=H.+H.+Peterauthor=P.+Dobbinauthor=R.+C.+Hider&title=The+effect+of+N-alkyl+modification+on+the+antimalarial+activity+of+3-hydroxypyridin-4-one+oral+iron+chelators&doi=10.1182%2Fblood.V77.3.637.637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators</span></div><div class="casAuthors">Hershko, C.; Theanacho, E. N.; Spira, D. T.; Peter, H. H.; Dobbin, P.; Hider, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-43</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">The antimalarial effect of iron chelators is attributed to their interaction with a labile iron pool within parasitized erythrocytes, and it was postulated that increased affinity to iron as well as increased lipophilicity may improve antimalarial activity.  The authors have examd. the antimalarial effect of 3-hydroxypyridin-4-ones (I; R1 = Me, Et; R2 = Me, Et, C2H4CO2H, C2H4OH, C2H4OMe), a family of bidentate orally effective iron chelators whose lipophilicity may be modified by altering the length of the R2 substituent on the ring nitrogen.  A significant dose-related suppression of Plasmodium falciparum cultures was obsd. with all drugs tested in vitro at concns. of 5 Î¼mol/L or higher.  In contrast, there was a clear segregation of the in vivo effect on P. berghei in rats (300 mg/kg/d s.c.) into two categories: compds. CP20, 38, and 40 failed to suppress malaria, whereas CP51, 94, and 96 had a strong antimalarial effect, similar or better than deferoxamine.  There was a close linear correlation between the suppression of peak parasite counts and the redn. in hepatic nonheme iron induced by the various drugs tested.  The most lipophilic compds. were also the most effective in suppressing malaria and in depleting hepatic iron stores.  These data indicate that 3-hydroxypyridin-4-ones are able to suppress malaria in vivo and in vitro.  Because lipid soly. is an important determinant of antimalarial action, this study provides useful information regarding the selection of orally effective iron-chelating compds. that may be suitable for clin. application as antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNldImTtcvfLVg90H21EOLACvtfcHk0lixCsaRqfqwmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVShs7c%253D&md5=8a1cc8421a16b7f82e8181599836954f</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1182%2Fblood.V77.3.637.637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V77.3.637.637%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DC.%26aulast%3DTheanacho%26aufirst%3DE.%2BN.%26aulast%3DSpira%26aufirst%3DD.%2BT.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26aulast%3DDobbin%26aufirst%3DP.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520effect%2520of%2520N-alkyl%2520modification%2520on%2520the%2520antimalarial%2520activity%2520of%25203-hydroxypyridin-4-one%2520oral%2520iron%2520chelators%26jtitle%3DBlood%26date%3D1991%26volume%3D77%26issue%3D3%26spage%3D637%26epage%3D643%26doi%3D10.1182%2Fblood.V77.3.637.637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fakorede, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxpyridin-4-one prodrugs as novel antimalarials</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">113</span>, <span class="refDoi">Â DOI: 10.1111/j.2042-7158.1998.tb02313.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.2042-7158.1998.tb02313.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlKltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=113-113&author=F.+A.+Fakoredeauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=3-Hydroxpyridin-4-one+prodrugs+as+novel+antimalarials&doi=10.1111%2Fj.2042-7158.1998.tb02313.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxypyridin-4-one prodrugs as novel antimalarials</span></div><div class="casAuthors">Fakorede, F. A.; Liu, Z. D.; Hider, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Suppl., British Pharmaceutical Conference 1998</span>),
    <span class="NLM_cas:pages">113</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpr2am0Z1VrVg90H21EOLACvtfcHk0liIw0KCr-KM0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlKltro%253D&md5=e24b105df3841a963687520daa9077b0</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1998.tb02313.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1998.tb02313.x%26sid%3Dliteratum%253Aachs%26aulast%3DFakorede%26aufirst%3DF.%2BA.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3D3-Hydroxpyridin-4-one%2520prodrugs%2520as%2520novel%2520antimalarials%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1998%26volume%3D50%26spage%3D113%26epage%3D113%26doi%3D10.1111%2Fj.2042-7158.1998.tb02313.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehkordi, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Basic 3-hydroxypyridin-4-ones: potential antimalarial agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1035</span>â <span class="NLM_lpage">1047</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2007.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2007.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=17869385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslKmtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1035-1047&issue=5&author=L.+S.+Dehkordiauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=Basic+3-hydroxypyridin-4-ones%3A+potential+antimalarial+agents&doi=10.1016%2Fj.ejmech.2007.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Basic 3-hydroxypyridin-4-ones: Potential antimalarial agents</span></div><div class="casAuthors">Dehkordi, Lotfollah S.; Liu, Zu D.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">3-Hydroxypyridin-4-ones selectively bind iron under biol. conditions and one such compd. has found application in the treatment of thalassemia-linked iron overload.  Related mols. have also been demonstrated to possess an antimalarial effect at levels which are nontoxic to mammalian cells.  In an attempt to improve the efficiency of such mols. the authors have investigated the effect of introducing basic nitrogen centers into 3-hydroxypyridin-4-ones in an attempt to achieve targeting to lysosomes and other intracellular acidic vacuoles.  Several of the compds. reported in this communication possess enhanced antimalarial activity over that of the simple hydroxypyridinone class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnQAOfMSEHLVg90H21EOLACvtfcHk0liIw0KCr-KM0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslKmtbs%253D&md5=f5d69004b70ebe5401e56747a52d84e4</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DDehkordi%26aufirst%3DL.%2BS.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DBasic%25203-hydroxypyridin-4-ones%253A%2520potential%2520antimalarial%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26issue%3D5%26spage%3D1035%26epage%3D1047%26doi%3D10.1016%2Fj.ejmech.2007.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saeftel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarite, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njuguna, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span> <span> </span><span class="NLM_article-title">Piperidones with activity against Plasmodium falciparum</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">281</span>â <span class="NLM_lpage">286</span>, <span class="refDoi">Â DOI: 10.1007/s00436-006-0173-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00436-006-0173-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16550432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD28vgtlGiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=281-286&issue=3&author=M.+Saeftelauthor=R.+S.+Sariteauthor=T.+Njugunaauthor=U.+Holzgrabeauthor=D.+Ulmerauthor=A.+Hoeraufauthor=A.+Kaiser&title=Piperidones+with+activity+against+Plasmodium+falciparum&doi=10.1007%2Fs00436-006-0173-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidones with activity against Plasmodium falciparum</span></div><div class="casAuthors">Saeftel Michael; Sarite Ramadan Salem; Njuguna Tujo; Holzgrabe Ulrike; Ulmer Daniela; Hoerauf Achim; Kaiser Annette</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-6</span>
        ISSN:<span class="NLM_cas:issn">0932-0113</span>.
    </div><div class="casAbstract">The increasing resistance of the malaria parasites has enforced new strategies of finding new drug targets.  We have isolated two genes involved in spermidine metabolism, encoding deoxyhypusine synthase (DHS) and eukaryotic initiation factor 5A (eIF-5A) in the malaria parasites. eIF-5A is activated by the formation of the unusual amino acid hypusine.  This process occurs in two steps.  DHS transfers an aminobutyl moiety from the triamine spermidine to a specific lysine residue in the eIF-5A precursor protein to form deoxyhypusine.  In a second step, deoxyhypusine hydroxylase (DHH), completes hypusine biosynthesis.  We used DHH inhibitors, being effective in mammalian cells, to study an antiplasmodicidal effect in Plasmodium falciparum.  Experiments with the antifungal drug ciclopiroxolamine, an alpha-hydroxypyridone, and the plant amino acid L: -mimosine, a 4-pyridone, resulted in an antiplasmodial effect in vitro.  Using mimosine as a lead structure, alkyl 4-oxo-piperidine 3-carboxylates were found to have the most efficient antiplasmodial effects in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6Di7xJiS0yEloaUqgkFHkfW6udTcc2eZQw14jJkZm6Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vgtlGiuw%253D%253D&md5=35c902517b711bc782f9cf6afa68cf0c</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1007%2Fs00436-006-0173-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-006-0173-4%26sid%3Dliteratum%253Aachs%26aulast%3DSaeftel%26aufirst%3DM.%26aulast%3DSarite%26aufirst%3DR.%2BS.%26aulast%3DNjuguna%26aufirst%3DT.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DUlmer%26aufirst%3DD.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DKaiser%26aufirst%3DA.%26atitle%3DPiperidones%2520with%2520activity%2520against%2520Plasmodium%2520falciparum%26jtitle%3DParasitol.%2520Res.%26date%3D2006%26volume%3D99%26issue%3D3%26spage%3D281%26epage%3D286%26doi%3D10.1007%2Fs00436-006-0173-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehrke, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleban, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempone, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of deferiprone-type iron chelators</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">805</span>â <span class="NLM_lpage">813</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2012.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmc.2012.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23266185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqu7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=805-813&issue=3&author=S.+S.+Gehrkeauthor=E.+G.+Pintoauthor=D.+Steverdingauthor=K.+Plebanauthor=A.+G.+Temponeauthor=R.+C.+Hiderauthor=G.+K.+Wagner&title=Conjugation+to+4-aminoquinoline+improves+the+anti-trypanosomal+activity+of+deferiprone-type+iron+chelators&doi=10.1016%2Fj.bmc.2012.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators</span></div><div class="casAuthors">Gehrke, Sebastian S.; Pinto, Erika G.; Steverding, Dietmar; Pleban, Karin; Tempone, Andre G.; Hider, Robert C.; Wagner, Gerd K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">805-813</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Iron is an essential growth component in all living organisms and plays a central role in numerous biochem. processes due to its redox potential and high affinity for oxygen.  The use of iron chelators has been suggested as a novel therapeutic approach towards parasitic infections, such as malaria, sleeping sickness and leishmaniasis.  Known iron chelating agents such as Deferoxamine and the 3-hydroxypyridin-4-one (HPO) Deferiprone possess anti-parasitic activity but suffer from mammalian toxicity, relatively modest potency, and/or poor oral availability.  In this study, we have developed novel derivs. of Deferiprone with increased anti-parasitic activity and reduced cytotoxicity against human cell lines.  Of particular interest are several new derivs. in which the HPO scaffold has been conjugated, via a linker, to the 4-aminoquinoline ring system present in the known anti-malaria drug Chloroquine.  We report the inhibitory activity of these novel analogs against four parasitic protozoa, Trypanosoma brucei, Trypanosoma cruzi, Leishmania infantum and Plasmodium falciparum, and, for direct comparison, against human cells lines.  We also present data, which support the hypothesis that iron starvation is the major cause of growth inhibition of these new Deferiprone-Chloroquine conjugates in T. brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooOuVYNxfv5bVg90H21EOLACvtfcHk0lhzUY5jII0laA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqu7nK&md5=f4898e3e3b444c58541d0990c5bb158f</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DGehrke%26aufirst%3DS.%2BS.%26aulast%3DPinto%26aufirst%3DE.%2BG.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DPleban%26aufirst%3DK.%26aulast%3DTempone%26aufirst%3DA.%2BG.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DWagner%26aufirst%3DG.%2BK.%26atitle%3DConjugation%2520to%25204-aminoquinoline%2520improves%2520the%2520anti-trypanosomal%2520activity%2520of%2520deferiprone-type%2520iron%2520chelators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D3%26spage%3D805%26epage%3D813%26doi%3D10.1016%2Fj.bmc.2012.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andayi, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antiplasmodial activity, and beta-hematin inhibition of hydroxypyridone-chloroquine hybrids</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">642</span>â <span class="NLM_lpage">646</span>, <span class="refDoi">Â DOI: 10.1021/ml4001084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4001084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvFyitLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=642-646&issue=7&author=W.+A.+Andayiauthor=T.+J.+Eganauthor=J.+Gutauthor=P.+J.+Rosenthalauthor=K.+Chibale&title=Synthesis%2C+antiplasmodial+activity%2C+and+beta-hematin+inhibition+of+hydroxypyridone-chloroquine+hybrids&doi=10.1021%2Fml4001084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Antiplasmodial Activity, and Î²-Hematin Inhibition of Hydroxypyridone-Chloroquine Hybrids</span></div><div class="casAuthors">Andayi, Warren A.; Egan, Timothy J.; Gut, Jiri; Rosenthal, Philip J.; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">642-646</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of noncytotoxic 4-aminoquinoline-3-hydroxypyridin-4-one hybrids I [R2 = Me, Et, R3 = Bn, H, Me, X = (CH2)n, n = 1, 2, 3, 5] were synthesized on the basis of a synergistic in vitro combination of a precursor N-alkyl-3-hydroxypyridin-4-one with chloroquine (CQ) and tested in vitro against CQ resistant (K1 and W2) and sensitive (3D7) strains of Plasmodium falciparum.  In vitro antiplasmodial activity of the precursors was negated by blocking the chelator moiety via complexation with gallium(III) or benzyl protection.  None of the precursors inhibited Î²-hematin formation.  Most hybrids were more potent inhibitors of Î²-hematin formation than CQ, and a correlation between antiplasmodial activity and inhibition of Î²-hematin formation was obsd.  Potent hybrids against K1, 3D7, and W2, resp., were I [R2 = Et, R3 = Bn, X = (CH2)3] (0.13, 0.004, and 0.1 Î¼M); I [R2 = Et, R3 = Bn, X = (CH2)5] (0.08, 0.01, and 0.02 Î¼M); and I [R2 = Me, R3 = H, X = (CH2)3] (0.07, 0.03, and 0.08 Î¼M).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbaoGOOnhBLrVg90H21EOLACvtfcHk0lhzUY5jII0laA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvFyitLk%253D&md5=1a24c2a65d73199d8b7e6cd6bae9369f</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fml4001084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001084%26sid%3Dliteratum%253Aachs%26aulast%3DAndayi%26aufirst%3DW.%2BA.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DSynthesis%252C%2520antiplasmodial%2520activity%252C%2520and%2520beta-hematin%2520inhibition%2520of%2520hydroxypyridone-chloroquine%2520hybrids%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D7%26spage%3D642%26epage%3D646%26doi%3D10.1021%2Fml4001084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dambuza, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andayi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesner, L.</span></span> <span> </span><span class="NLM_article-title">Antiplasmodial activity, <i>in vivo</i> pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">505</span>â <span class="NLM_lpage">512</span>, <span class="refDoi">Â DOI: 10.1186/s12936-015-1032-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1186%2Fs12936-015-1032-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26671222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVamtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=505-512&author=N.+S.+Dambuzaauthor=P.+Smithauthor=A.+Evansauthor=J.+Normanauthor=D.+Taylorauthor=A.+Andayiauthor=T.+Eganauthor=K.+Chibaleauthor=L.+Wiesner&title=Antiplasmodial+activity%2C+in+vivo+pharmacokinetics+and+anti-malarial+efficacy+evaluation+of+hydroxypyridinone+hybrids+in+a+mouse+model&doi=10.1186%2Fs12936-015-1032-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model</span></div><div class="casAuthors">Dambuza, Ntokozo S.; Smith, Peter; Evans, Alicia; Norman, Jennifer; Taylor, Dale; Andayi, Andrew; Egan, Timothy; Chibale, Kelly; Wiesner, Lubbe</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">505/1-505/8</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: During the erythrocytic stage in humans, malaria parasites digest Hb of the host cell, and the toxic haem moiety crystallizes into haemozoin.  Chloroquine acts by forming toxic complexes with haem mols. and interfering with their crystn.  In chloroquine-resistant strains, the drug is excluded from the site of action, which causes the parasites to accumulate less chloroquine in their acid food vacuoles than chloroquine-sensitive parasites.  3-Hydroxylpyridin-4-ones are known to chelate iron; hydroxypyridone-chloroquine (HPO-CQ) hybrids were synthesized in order to det. whether they can inhibit parasites proliferation in the parasitic digestive vacuole by withholding iron from plasmodial parasite metabolic pathway.  Methods: Two HPO-CQ hybrids were tested against Plasmodium falciparum chloroquine-sensitive (D10 and 3D7) and -resistant strains (Dd2 and K1).  The pharmacokinetic properties of active compds. were detd. using a mouse model and blood samples were collected at different time intervals and analyzed using LC-MS/MS.  For in vivo efficacy the mice were infected with Plasmodium berghei in a 4-day Peters' test.  The parasitemia was detd. from day 3 and the course of the infection was followed by microscopic examn. of stained blood films every 2-3 days until a rise in parasitemia was obsd. in all test subjects.  Results: IC50 values of the two compds. for sensitive and resistant strains were 0.064 and 0.047 Î¼M (compd. 1), 0.041 and 0.122 Î¼M (compd. 2) and 0.505 and 0.463 Î¼M (compd. 1), 0.089 and 0.076 Î¼M (compd. 2), resp.  Pharmacokinetic evaluation of these compds. showed low oral bioavailability and this affected in vivo efficacy when compds. were dosed orally.  However, when dosed i.v. compd. 1 showed a clearance rate of 28 mL/min/kg, an apparent vol. of distribution of 20 l/kg and a half-life of 4.3 h.  A redn. in parasitemia was obsd. when compd. 1 was dosed i.v. for four consecutive days in P. berghei-infected mice.  However, a rise in parasitemia levels was obsd. on day 6 and on day 9 for chloroquine-treated mice.  Conclusion: The hybrid compds. that were tested were able to reduce parasitemia levels in P. berghei-infected mice when dosed i.v., but parasites recrudesced 24 h after the administration of the least dose.  Despite low oral bioavailability, the IV data obtained suggests that further structural modifications may lead to the identification of more HPO-CQ hybrids with improved pharmacokinetic properties and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh53X88-Apq7Vg90H21EOLACvtfcHk0lhzUY5jII0laA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVamtA%253D%253D&md5=00f5489e2e36782f48e6b2fff1f759b0</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-1032-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-1032-5%26sid%3Dliteratum%253Aachs%26aulast%3DDambuza%26aufirst%3DN.%2BS.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DA.%26aulast%3DNorman%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DAndayi%26aufirst%3DA.%26aulast%3DEgan%26aufirst%3DT.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DWiesner%26aufirst%3DL.%26atitle%3DAntiplasmodial%2520activity%252C%2520in%2520vivo%2520pharmacokinetics%2520and%2520anti-malarial%2520efficacy%2520evaluation%2520of%2520hydroxypyridinone%2520hybrids%2520in%2520a%2520mouse%2520model%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26spage%3D505%26epage%3D512%26doi%3D10.1186%2Fs12936-015-1032-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varesio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raggi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, M. C.</span></span> <span> </span><span class="NLM_article-title">Macrophage-inflammatory protein-3Î±/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-ÎºB</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">685</span>â <span class="NLM_lpage">693</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2009.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.molimm.2009.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19939449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsFKl" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2010&pages=685-693&issue=4&author=L.+Varesioauthor=F.+Battagliaauthor=F.+Raggiauthor=B.+Leddaauthor=M.+C.+Bosco&title=Macrophage-inflammatory+protein-3%CE%B1%2FCCL-20+is+transcriptionally+induced+by+the+iron+chelator+desferrioxamine+in+human+mononuclear+phagocytes+through+nuclear+factor+%28NF%29-%CE%BAB&doi=10.1016%2Fj.molimm.2009.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage-inflammatory protein-3Î±/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-ÎºB</span></div><div class="casAuthors">Varesio, Luigi; Battaglia, Florinda; Raggi, Federica; Ledda, Bernadetta; Bosco, Maria Carla</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-693</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Alterations in iron availability can trigger pro-inflammatory signals in various cell types.  The authors demonstrate that desferrioxamine (DFX), an iron chelator used in clinics for the treatment of iron overload, neoplasias, and Alzheimer disease, stimulates the expression and secretion of CCL20, a chemoattractant for immature dendritic cells, activated/memory T lymphocytes, and naive B cells, in primary human monocytes and monocyte-derived macrophages.  Iron chelation was part of the mechanism by which DFX induced CCL20, because addn. of iron sulfate counteracted its stimulatory effects.  Functional studies of the CCL20 promoter, using a series of 5'-deleted and mutated reporter constructs, demonstrated that CCL20 mRNA induction was dependent on gene transcription activation and mediated by the NF-ÎºB pathway.  The NF-ÎºB element located at position -92/-82 of the CCL20 promoter was required for gene transactivation by DFX because: (i) transcription was abrogated by a 3 bp mutation of the NF-ÎºB-binding motif; (ii) treatment with DFX increased specific NF-ÎºB binding to this sequence.  Nuclear translocation of both NF-ÎºBp65 and NF-ÎºBp50 family members was increased in response to DFX and assocd. with I-ÎºBÎ± degrdn., suggesting a role for these subunits in CCL20 promoter transactivation.  In conclusion, this study provides the first evidence that iron chelation can transcriptionally induce CCL20 in mononuclear phagocytes and identify the NF-ÎºB binding site as a regulatory sequence of the CCL20 promoter that is activated by iron deprivation.  These results add new insights into the authors' understanding of the mechanisms by which iron perturbations affect mononuclear phagocyte immune functions and regulate inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUyCET0z4AGLVg90H21EOLACvtfcHk0ljkjxI6gZI3-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsFKl&md5=bc6864575be0320b42ab1c077e61e2d4</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2009.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2009.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DVaresio%26aufirst%3DL.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DRaggi%26aufirst%3DF.%26aulast%3DLedda%26aufirst%3DB.%26aulast%3DBosco%26aufirst%3DM.%2BC.%26atitle%3DMacrophage-inflammatory%2520protein-3%25CE%25B1%252FCCL-20%2520is%2520transcriptionally%2520induced%2520by%2520the%2520iron%2520chelator%2520desferrioxamine%2520in%2520human%2520mononuclear%2520phagocytes%2520through%2520nuclear%2520factor%2520%2528NF%2529-%25CE%25BAB%26jtitle%3DMol.%2520Immunol.%26date%3D2010%26volume%3D47%26issue%3D4%26spage%3D685%26epage%3D693%26doi%3D10.1016%2Fj.molimm.2009.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozturk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erol, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzbay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aytemir, M. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4(1<i>H</i>)-pyridinone derivatives and investigation of analgesic and antiinflammatory activities</span>. <i>Farmaco</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">251</span>â <span class="NLM_lpage">256</span>, <span class="refDoi">Â DOI: 10.1016/S0014-827X(01)01083-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0014-827X%2801%2901083-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11421252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFKru7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=251-256&author=G.+Ozturkauthor=D.+D.+Erolauthor=T.+Uzbayauthor=M.+D.+Aytemir&title=Synthesis+of+4%281H%29-pyridinone+derivatives+and+investigation+of+analgesic+and+antiinflammatory+activities&doi=10.1016%2FS0014-827X%2801%2901083-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4(1H)-pyridinone derivatives and investigation of analgesic and antiinflammatory activities</span></div><div class="casAuthors">Ozturk, Gulcan; Erol, Dilek Demir; Uzbay, Tayfun; Aytemir, Mutlu Dilsiz</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-256</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">This paper describes recent results of a research program aimed at the synthesis and pharmacol. evaluation of new 4(1H)-pyridinone derivs. belonging to the 1,3-disubstituted series, i.e., I (R = piperidino, 2-pyridinyl, 1-methyl-2-pyrrolidinyl, morpholino; R1 = benzyl, H).  These compds. were structurally planned by applying the mol. hybridization strategy on previously described 1,2-disubstituted 4(1H)-pyridinone derivs., considered as lead compds., which present potent analgesic properties.  Their chem. structures have been proved by means of their IR and 1H NMR data and by elemental anal.  The analgesic profile of I, evaluated by the model of abdominal constrictions induced by acetic acid, showed that all the 4(1H)-pyridinone derivs. were active, exhibiting an analgesic activity comparable with that of aspirin (acetylsalicylic acid) used as a std.  The antiinflammatory profile of I, evaluated by the model of carrageenan rat paw edema, showed that all compds. were active and were comparable with an indomethacin std.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosgO-jvJtIKrVg90H21EOLACvtfcHk0ljkjxI6gZI3-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFKru7k%253D&md5=1aefde2e13d05d7149d225f5860cedb1</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2801%2901083-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252801%252901083-7%26sid%3Dliteratum%253Aachs%26aulast%3DOzturk%26aufirst%3DG.%26aulast%3DErol%26aufirst%3DD.%2BD.%26aulast%3DUzbay%26aufirst%3DT.%26aulast%3DAytemir%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520of%25204%25281H%2529-pyridinone%2520derivatives%2520and%2520investigation%2520of%2520analgesic%2520and%2520antiinflammatory%2520activities%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D251%26epage%3D256%26doi%3D10.1016%2FS0014-827X%2801%2901083-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozturk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erol, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aytemir, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzbay, T.</span></span> <span> </span><span class="NLM_article-title">New analgesic and antiinflammatory agents 4(1<i>H</i>)-pyridinone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">829</span>â <span class="NLM_lpage">834</span>, <span class="refDoi">Â DOI: 10.1016/S0223-5234(02)01390-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0223-5234%2802%2901390-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12446041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38Xosl2itLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=829-834&issue=10&author=G.+Ozturkauthor=D.+D.+Erolauthor=M.+D.+Aytemirauthor=T.+Uzbay&title=New+analgesic+and+antiinflammatory+agents+4%281H%29-pyridinone+derivatives&doi=10.1016%2FS0223-5234%2802%2901390-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">New analgesic and antiinflammatory agents 4(1H)-pyridinone derivatives</span></div><div class="casAuthors">Ozturk, Gulcan; Erol, Dilek Demir; Aytemir, Mutlu Dilsiz; Uzbay, Tayfun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">829-834</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A series of 1,2,5-trisubstituted 4(1H)-pyridinone derivs. were synthesized by using 4-pyrone derivs. with primary amines in ethanol.  Analgesic and antiinflammatory activities of the synthesized compds. were investigated by acetic acid-induced writhing syndrome and carrageenan rat paw edema tests.  All of the test compds. exhibited higher analgesic activities than acetyl salicylic acid and showed higher antiinflammatory activities than indomethacin.  The anti-inflammatory activity and gastric ulceration potential of the compds. were tested using indomethacin as ref. drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavaRsF34SsbVg90H21EOLACvtfcHk0ljkjxI6gZI3-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xosl2itLk%253D&md5=e6f81d6ae833df5061d6b1640013b800</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2802%2901390-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252802%252901390-9%26sid%3Dliteratum%253Aachs%26aulast%3DOzturk%26aufirst%3DG.%26aulast%3DErol%26aufirst%3DD.%2BD.%26aulast%3DAytemir%26aufirst%3DM.%2BD.%26aulast%3DUzbay%26aufirst%3DT.%26atitle%3DNew%2520analgesic%2520and%2520antiinflammatory%2520agents%25204%25281H%2529-pyridinone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26issue%3D10%26spage%3D829%26epage%3D834%26doi%3D10.1016%2FS0223-5234%2802%2901390-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeTourneau-Paci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoskin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, C.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis</span>. <i>Clin. Hemorheol. Microcirc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">3â4</span>),  <span class="NLM_fpage">241</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.3233/CH-179205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3233%2FCH-179205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28869457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtL%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2017&pages=241-250&issue=3%E2%80%934&author=T.+Thorburnauthor=M.+Aaliauthor=L.+Kostekauthor=C.+LeTourneau-Paciauthor=P.+Colpauthor=J.+Zhouauthor=B.+Holbeinauthor=D.+Hoskinauthor=C.+Lehmann&title=Anti-inflammatory+effects+of+a+novel+iron+chelator%2C+DIBI%2C+in+experimental+sepsis&doi=10.3233%2FCH-179205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis</span></div><div class="casAuthors">Thorburn, Taylor; Aali, Maral; Kostek, Lisanne; LeTourneau-Paci, Chloe; Colp, Patricia; Zhou, Juan; Holbein, Bruce; Hoskin, David; Lehmann, Christian; Juenger, M.; Krueger-Genge, A.; Jung, F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Hemorheology and Microcirculation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">CHMIFQ</span>;
        ISSN:<span class="NLM_cas:issn">1386-0291</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Iron catalyzes the generation of reactive oxygen species (ROS) as part of the innate antimicrobial defense.  During sepsis, the dysregulated systemic inflammatory response to infection, iron homeostasis becomes disrupted, generating an excess of ROS causing damage to tissues.  This can be potentially suppressed using iron chelators that selectively bind iron to prevent its participation in ROS-related inflammatory reactions.  We hypothesize that administration of DIBI, a novel iron-chelator, attenuates the dysregulated systemic immune response and reduces tissue damage in exptl. endotoxemia.  Five groups of animals (n=5-10) were included in this study: control, untreated endotoxemia, and endotoxemia animals treated with either DIBI-A, MAHMP, or DIBI-B.  Intravital microscopy was performed on the intestine of anesthesized mice to observe leukocyte endothelial interactions and evaluate the intestinal microcirculation.  Treatment of endotoxemic mice with DIBI-B reduced the no. of adhering leukocytes in submucosal collecting (V1) venules by 68%.  DIBI-B, MAHMP, and DIBI-A were able to restore functional capillary d. (FCD) in the intestinal muscle layer by 74%, 44%, and 11%, resp.  DIBI-B reduces leukocyte recruitment and improves FCD in exptl. endotoxemia, outperforming other chelators tested.  These findings suggest a potential role for DIBI-B as a candidate drug for sepsis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUYCcJ_2urbVg90H21EOLACvtfcHk0lglLg7sA0BlHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtL%252FM&md5=e1d549c0358f87cdd84919c785c4da21</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.3233%2FCH-179205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FCH-179205%26sid%3Dliteratum%253Aachs%26aulast%3DThorburn%26aufirst%3DT.%26aulast%3DAali%26aufirst%3DM.%26aulast%3DKostek%26aufirst%3DL.%26aulast%3DLeTourneau-Paci%26aufirst%3DC.%26aulast%3DColp%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHolbein%26aufirst%3DB.%26aulast%3DHoskin%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DC.%26atitle%3DAnti-inflammatory%2520effects%2520of%2520a%2520novel%2520iron%2520chelator%252C%2520DIBI%252C%2520in%2520experimental%2520sepsis%26jtitle%3DClin.%2520Hemorheol.%2520Microcirc.%26date%3D2017%26volume%3D67%26issue%3D3%25E2%2580%25934%26spage%3D241%26epage%3D250%26doi%3D10.3233%2FCH-179205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczesniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Banna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharawy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, C.</span></span> <span> </span><span class="NLM_article-title">DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis</span>. <i>Clin. Hemorheol. Microcirc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1â2</span>),  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">164</span>, <span class="refDoi">Â DOI: 10.3233/CH-189109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3233%2FCH-189109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29630535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlyhsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2018&pages=153-164&issue=1%E2%80%932&author=N.+Aroraauthor=A.+Caldwellauthor=K.+Wafaauthor=A.+Szczesniakauthor=M.+Caldwellauthor=N.+Al-Bannaauthor=N.+Sharawyauthor=S.+Islamauthor=J.+Zhouauthor=B.+E.+Holbeinauthor=M.+E.+M.+Kellyauthor=C.+Lehmann&title=DIBI%2C+a+polymeric+hydroxypyridinone+iron+chelator%2C+reduces+ocular+inflammation+in+local+and+systemic+endotoxin-induced+uveitis&doi=10.3233%2FCH-189109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis</span></div><div class="casAuthors">Arora, N.; Caldwell, A.; Wafa, K.; Szczesniak, A.; Caldwell, M.; Al-Banna, N.; Sharawy, N.; Islam, S.; Zhou, J.; Holbein, B. E.; Kelly, M. E. M.; Lehmann, Ch.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Hemorheology and Microcirculation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">153-164</span>CODEN:
                <span class="NLM_cas:coden">CHMIFQ</span>;
        ISSN:<span class="NLM_cas:issn">1386-0291</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Non-infectious uveitis is an inflammatory disease of the eye commonly treated by corticosteroids, though important side effects may result.  A main mediator of inflammation are oxygen free radicals generated in iron-dependent pathways.  As such, we investigated the efficacy of a novel iron chelator, DIBI, as an anti-inflammatory agent in local and systemic models of endotoxin induced uveitis (EIU).  Firstly, the effects of DIBI in systemic EIU in Lewis rats were established.  In 2 h post i.v. LPS or LPS/DIBI injections, leukocyte activation and functional capillary d. (FCD) were examd. using intravital microscopy (IVM) of the iridial microcirculation.  Secondly, the toxicity of DIBI was evaluated in BALB/C mice for both acute and chronic dosages through gross ocular examn., intraocular pressure measurements and hematoxylin-eosin staining of ocular tissue.  Lastly, three groups of BALB/C mice, control, LPS or DIBI + LPS, were studied to evaluate the effectiveness of DIBI in treating local EIU.  Five hours post-local intravitreal (i.v) injection, leukocyte activation and capillary d. were examd. via IVM.  Treatment of systemic EIU with DIBI resulted in a redn. of leukocyte activation and FCD improvement within the iridial microcirculation.  Toxicity studies suggested that acute and chronic DIBI administration had no adverse effects in the eye.  In the local EIU model, DIBI was shown to reduce leukocyte activation and restored the FCD/DCD ratio, providing evidence for its anti-inflammatory properties.  This study has provided evidence that DIBI has anti-inflammatory effects in exptl. uveitis.  Addnl., no local ocular toxicity was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yg1W5hy69rVg90H21EOLACvtfcHk0lglLg7sA0BlHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlyhsL4%253D&md5=a4d2dae305e9e75d4c53928659cdfbeb</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.3233%2FCH-189109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FCH-189109%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DN.%26aulast%3DCaldwell%26aufirst%3DA.%26aulast%3DWafa%26aufirst%3DK.%26aulast%3DSzczesniak%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DM.%26aulast%3DAl-Banna%26aufirst%3DN.%26aulast%3DSharawy%26aufirst%3DN.%26aulast%3DIslam%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHolbein%26aufirst%3DB.%2BE.%26aulast%3DKelly%26aufirst%3DM.%2BE.%2BM.%26aulast%3DLehmann%26aufirst%3DC.%26atitle%3DDIBI%252C%2520a%2520polymeric%2520hydroxypyridinone%2520iron%2520chelator%252C%2520reduces%2520ocular%2520inflammation%2520in%2520local%2520and%2520systemic%2520endotoxin-induced%2520uveitis%26jtitle%3DClin.%2520Hemorheol.%2520Microcirc.%26date%3D2018%26volume%3D69%26issue%3D1%25E2%2580%25932%26spage%3D153%26epage%3D164%26doi%3D10.3233%2FCH-189109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crielaard, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivella, S.</span></span> <span> </span><span class="NLM_article-title">Targeting iron metabolism in drug discovery and delivery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">400</span>â <span class="NLM_lpage">423</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2016.248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2Fnrd.2016.248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28154410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWnu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=400-423&issue=6&author=B.+J.+Crielaardauthor=T.+Lammersauthor=S.+Rivella&title=Targeting+iron+metabolism+in+drug+discovery+and+delivery&doi=10.1038%2Fnrd.2016.248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting iron metabolism in drug discovery and delivery</span></div><div class="casAuthors">Crielaard, Bart J.; Lammers, Twan; Rivella, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">400-423</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Iron fulfils a central role in many essential biochem. processes in human physiol.; thus, proper processing of iron is crucial.  Although iron metab. is subject to relatively strict physiol. control, numerous disorders, such as cancer and neurodegenerative diseases, have recently been linked to deregulated iron homeostasis.  Consequently, iron metab. constitutes a promising and largely unexploited therapeutic target for the development of new pharmacol. treatments for these diseases.  Several iron metab.-targeted therapies are already under clin. evaluation for haematol. disorders, and these and newly developed therapeutic agents are likely to have substantial benefit in the clin. management of iron metab.-assocd. diseases, for which few efficacious treatments are currently available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUIjZKhRkw6bVg90H21EOLACvtfcHk0lglLg7sA0BlHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWnu70%253D&md5=c67f64a3d87dab3d6843b10b8d426c0b</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.248%26sid%3Dliteratum%253Aachs%26aulast%3DCrielaard%26aufirst%3DB.%2BJ.%26aulast%3DLammers%26aufirst%3DT.%26aulast%3DRivella%26aufirst%3DS.%26atitle%3DTargeting%2520iron%2520metabolism%2520in%2520drug%2520discovery%2520and%2520delivery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D6%26spage%3D400%26epage%3D423%26doi%3D10.1038%2Fnrd.2016.248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galaris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbouti, A.</span></span> <span> </span><span class="NLM_article-title">Redox signaling and cancer: the role of â³labileâ³ iron</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>266</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>â <span class="NLM_lpage">29</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2008.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.canlet.2008.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18374479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKlu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=2008&pages=21-29&issue=1&author=D.+Galarisauthor=V.+Skiadaauthor=A.+Barbouti&title=Redox+signaling+and+cancer%3A+the+role+of+%E2%80%B3labile%E2%80%B3+iron&doi=10.1016%2Fj.canlet.2008.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Redox signaling and cancer: The role of "labile" iron</span></div><div class="casAuthors">Galaris, Dimitrios; Skiada, Vasiliki; Barbouti, Alexandra</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) were viewed for a long time as unavoidable byproducts of normal cell catabolism.  This view has recently changed and it is now apparent that ROS generation is a tightly regulated process that plays a central role in cell signaling.  Thus, it is known that regulated changes in intracellular ROS levels can induce biochem. signaling processes that control basic cellular functions, such as proliferation and apoptosis which are prevalent in the development of cancer.  In this short review, we will try to provide a background to this emerging field by summarizing the biochem. of ROS-mediated cell signaling and its relation to carcinogenesis.  Special emphasis will be focused on the emerging role of the so called "labile" iron (the redox-active form of iron) in ROS-mediated signaling in relation to cancer development.  It is tempting to speculate that elucidation of the exact mol. mechanisms that govern ROS-mediated regulation of cell signaling will provide the basis for development of new therapeutic strategies for cancer prevention and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYafQ17MgQKbVg90H21EOLACvtfcHk0lhwGcj2rHBhnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKlu7k%253D&md5=e358581c913eaf72d362c5b524af2713</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DGalaris%26aufirst%3DD.%26aulast%3DSkiada%26aufirst%3DV.%26aulast%3DBarbouti%26aufirst%3DA.%26atitle%3DRedox%2520signaling%2520and%2520cancer%253A%2520the%2520role%2520of%2520%25E2%2580%25B3labile%25E2%2580%25B3%2520iron%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D266%26issue%3D1%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.canlet.2008.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buss, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span> <span> </span><span class="NLM_article-title">The role of iron chelation in cancer therapy</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1021</span>â <span class="NLM_lpage">1034</span>, <span class="refDoi">Â DOI: 10.2174/0929867033457638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F0929867033457638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12678674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1021-1034&author=J.+L.+Bussauthor=F.+M.+Tortiauthor=S.+V.+Torti&title=The+role+of+iron+chelation+in+cancer+therapy&doi=10.2174%2F0929867033457638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The role of iron chelation in cancer therapy</span></div><div class="casAuthors">Buss, Joan L.; Torti, Frank M.; Torti, Suzy V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review which focuses on advances and strategies in the use of iron chelators as antitumor therapies.  Although the development of iron chelators for human disease has focused primarily on their use in the treatment of secondary iron overload, chelators may also be useful antitumor agents.  They can deplete iron or cause oxidative stress in the tumor due to redox perturbations in its environment.  Iron chelators have been tested for their antitumor activity in cell culture expts., animal models, and human clin. trials.  Largely for pragmatic reasons, clin. studies of the antitumor activity of iron chelators have generally focused on desferrioxamine (DFO), a drug approved for the treatment of iron overload.  These studies have shown that DFO can retard tumor growth in many different exptl. contexts.  However, the activity of DFO is modest, and advances in the use of chelators as anticancer agents will require the development of new chelators based on new paradigms.  Examples of iron chelators that have shown promising antitumor activity (in various stages of development) include heterocyclic carboxaldehyde thiosemicarbazones, analogs of pyridoxal isonicotinoyl hydrazone, tachpyridine, O-Trensox, desferrithiocin, and other natural and synthetic chelators.  Apart from their use as single agents, chelators may also synergize with other anticancer therapies.  The development of chelators as anticancer agents is largely an unexplored field, but one with extraordinary potential to impact human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj9aYolI-AdbVg90H21EOLACvtfcHk0lhwGcj2rHBhnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtb8%253D&md5=b5ac5166c32ae335bb5ed58b16ec8c2c</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.2174%2F0929867033457638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457638%26sid%3Dliteratum%253Aachs%26aulast%3DBuss%26aufirst%3DJ.%2BL.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26atitle%3DThe%2520role%2520of%2520iron%2520chelation%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D1021%26epage%3D1034%26doi%3D10.2174%2F0929867033457638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span> <span> </span><span class="NLM_article-title">Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal</span>. <i>Mutat. Res., Fundam. Mol. Mech. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>533</i></span> (<span class="NLM_issue">1â2</span>),  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">171</span>, <span class="refDoi">Â DOI: 10.1016/j.mrfmmm.2003.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.mrfmmm.2003.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=14643418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1eru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2003&pages=153-171&issue=1%E2%80%932&author=X.+Huang&title=Iron+overload+and+its+association+with+cancer+risk+in+humans%3A+evidence+for+iron+as+a+carcinogenic+metal&doi=10.1016%2Fj.mrfmmm.2003.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal</span></div><div class="casAuthors">Huang, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">153-171</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Unlike arsenic, chromium, or nickel, the carcinogenicity of iron is still under debate.  In this review, evidence for iron as a carcinogenic metal was summarized from epidemiol., animal, and cell culture studies.  The role of iron in various cancers, such as colorectal cancer and liver cancer was presented.  Recent advancements on the mol. mechanisms of iron carcinogenesis were also reviewed.  These include: (1) iron autoxidn. involving only Fe2++O2 in oxidant formation in biol. systems and its pH dependency; (2) activation of oxidative responsive transcription factors and pro-inflammatory cytokines; and (3) iron-induced hypoxia signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKAhbCERVpqbVg90H21EOLACvtfcHk0lhwGcj2rHBhnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1eru74%253D&md5=6881582cd029a92cdde45fe64004b5f7</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2003.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2003.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DIron%2520overload%2520and%2520its%2520association%2520with%2520cancer%2520risk%2520in%2520humans%253A%2520evidence%2520for%2520iron%2520as%2520a%2520carcinogenic%2520metal%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2003%26volume%3D533%26issue%3D1%25E2%2580%25932%26spage%3D153%26epage%3D171%26doi%3D10.1016%2Fj.mrfmmm.2003.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">The iron metabolism of neoplastic cells: alterations that facilitate proliferation?</span>. <i>Crit. Rev. Oncol. Hemat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">65</span>â <span class="NLM_lpage">78</span>, <span class="refDoi">Â DOI: 10.1016/S1040-8428(01)00213-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1040-8428%2801%2900213-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11923069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD387ptVWjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=65-78&author=J.+C.+Kwokauthor=D.+R.+Richardson&title=The+iron+metabolism+of+neoplastic+cells%3A+alterations+that+facilitate+proliferation%3F&doi=10.1016%2FS1040-8428%2801%2900213-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">The iron metabolism of neoplastic cells: alterations that facilitate proliferation?</span></div><div class="casAuthors">Kwok Juliana C; Richardson Des R</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-78</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">For many years it has been known that neoplastic cells express high levels of the transferrin receptor 1 (TfR1) and internalize iron (Fe) from transferrin (Tf) at a tremendous rate.  Considering the high requirement of neoplastic cells for Fe, understanding its metabolism is vital in terms of devising potential new therapies.  Apart from TfR1, a number of molecules have been identified that may have roles in Fe metabolism and cellular proliferation.  These molecules include transferrin (Tf), the oestrogen-inducible transferrin receptor-like protein, transferrin receptor 2 (TfR2), melanotransferrin (MTf), ceruloplasmin, and ferritin.  In the present review these latter molecules are discussed in terms of their potential functions in tumour cell Fe metabolism and proliferation.  Further studies are essential to determine the specific roles of these proteins in the pathogenesis of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTb9RtHss_DR5PlX7E30qdzfW6udTcc2eZxCx97npj7hrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ptVWjsQ%253D%253D&md5=580e73c9d1a27818900294e646e24d8e</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2FS1040-8428%2801%2900213-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-8428%252801%252900213-X%26sid%3Dliteratum%253Aachs%26aulast%3DKwok%26aufirst%3DJ.%2BC.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DThe%2520iron%2520metabolism%2520of%2520neoplastic%2520cells%253A%2520alterations%2520that%2520facilitate%2520proliferation%253F%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hemat.%26date%3D2002%26volume%3D42%26spage%3D65%26epage%3D78%26doi%3D10.1016%2FS1040-8428%2801%2900213-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Iron chelators as therapeutic agents for the treatment of cancer</span>. <i>Crit. Rev. Oncol. Hemat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">267</span>â <span class="NLM_lpage">281</span>, <span class="refDoi">Â DOI: 10.1016/S1040-8428(01)00218-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1040-8428%2801%2900218-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12050019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD38zgsl2quw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=267-281&author=D.+R.+Richardson&title=Iron+chelators+as+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1016%2FS1040-8428%2801%2900218-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelators as therapeutic agents for the treatment of cancer</span></div><div class="casAuthors">Richardson D R</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-81</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">A wide variety of studies in vitro, in vivo, and in clinical trials have demonstrated that the chelator currently used to treat iron overload disease, desferrioxamine, has anti-proliferative effects against both leukemia and neuroblastoma.  However, the efficacy of desferrioxamine is severely limited due to its poor ability to permeate cell membranes and chelate intracellular iron pools.  These studies have led to the development of other iron chelators that are far more effective than desferrioxamine.  Some of these chelators such as 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) have entered phase I clinical trials, while other chelators such as 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone or tachpyridine require evaluation in animal models.  The high anti-tumor activity observed with these ligands certainly suggests further development of chelators as anti-cancer agents is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjdTjmMHxKL2K_SFaaT9INfW6udTcc2ebPVy1cjazivLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zgsl2quw%253D%253D&md5=dd926b5db7f5b8dc9c322c006d8f87fd</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2FS1040-8428%2801%2900218-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-8428%252801%252900218-9%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DIron%2520chelators%2520as%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hemat.%26date%3D2002%26volume%3D42%26spage%3D267%26epage%3D281%26doi%3D10.1016%2FS1040-8428%2801%2900218-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarangelo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span> <span> </span><span class="NLM_article-title">An iron age for cancer therapy</span>. <i>Nat. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">921</span>â <span class="NLM_lpage">922</span>, <span class="refDoi">Â DOI: 10.1038/nnano.2016.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2Fnnano.2016.199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27668797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFyms7fM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=921-922&author=A.+Tarangeloauthor=S.+J.+Dixon&title=An+iron+age+for+cancer+therapy&doi=10.1038%2Fnnano.2016.199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomedicine An iron age for cancer therapy</span></div><div class="casAuthors">Tarangelo, Amy; Dixon, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Nanotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">921-922</span>CODEN:
                <span class="NLM_cas:coden">NNAABX</span>;
        ISSN:<span class="NLM_cas:issn">1748-3387</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two reports show FDA-approved nanoparticles can kill cancer cells through iron- and reactive oxygen species-dependent mechanisms, offering new strategies for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouDJzQMIALp7Vg90H21EOLACvtfcHk0lhjEYh65d04kw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFyms7fM&md5=947732fe431e41f74435c02a7f453afb</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1038%2Fnnano.2016.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnnano.2016.199%26sid%3Dliteratum%253Aachs%26aulast%3DTarangelo%26aufirst%3DA.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26atitle%3DAn%2520iron%2520age%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Nanotechnol.%26date%3D2016%26volume%3D11%26spage%3D921%26epage%3D922%26doi%3D10.1038%2Fnnano.2016.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoyes, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span> <span> </span><span class="NLM_article-title">Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in Leukemia cell lines</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4591</span>â <span class="NLM_lpage">4599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1511427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK38XlvVCnsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=4591-4599&author=K.+P.+Hoyesauthor=R.+C.+Hiderauthor=J.+B.+Porter&title=Cell+cycle+synchronization+and+growth+inhibition+by+3-hydroxypyridin-4-one+iron+chelators+in+Leukemia+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines</span></div><div class="casAuthors">Hoyes, Katharine P.; Hider, Robert C.; Porter, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4591-9</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The effect of the bidentate 3-hydroxypyridin-4-one (HPO) iron chelator CP94 (I) on cell cycle arrest with subsequent cycle synchronization has been compared with that of the hexadentate desferrioxamine (DFO) in K562 and Daudi cells.  The relationships between chelator concn. and inhibition of growth, DNA synthesis and ribonucleotide reductase, and phase of cell cycle arrest have also been explored.  HPOs and DFO arrest the cell cycle in a dose-dependent manner causing a blockade at the G1-S border after 24 h at concns. above 30 mM iron-binding equiv.  This is assocd. with reduced ribonucleotide reductase activity and concomitant cessation of DNA synthesis and growth.  When the chelator is subsequently removed, HPO-treated cells synchronously cascade into S phase, unlike DFO-treated cells which resume cycling in a nonsynchronous manner.  Chelator concns. of approx. 25 Î¼M and 3 Î¼M iron-binding equiv. inhibited growth, DNA synthesis, and ribonucleotide reductase activity by 50% in K562 and Daudi cells, resp.  Concns. less than 10 Î¼M iron-binding equiv. inhibited K562 cell growth without an effect on DNA synthesis but with accumulation of cells in G2 and M phases.  These results suggest that HPOs have advantages over DFO as cell cycle synchronization agents and may be useful adjuncts in cell cycle-specific treatment regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJl3Z_cyYZvrVg90H21EOLACvtfcHk0lhjEYh65d04kw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVCnsLo%253D&md5=4cf82738818f3fae91cb0a890702a624</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyes%26aufirst%3DK.%2BP.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26atitle%3DCell%2520cycle%2520synchronization%2520and%2520growth%2520inhibition%2520by%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520in%2520Leukemia%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D4591%26epage%3D4599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renton, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeitner, T. M.</span></span> <span> </span><span class="NLM_article-title">Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1553</span>â <span class="NLM_lpage">1561</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(96)00099-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0006-2952%2896%2900099-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=8630097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK28XjtVSmtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=1553-1561&author=F.+J.+Rentonauthor=T.+M.+Jeitner&title=Cell+cycle-dependent+inhibition+of+the+proliferation+of+human+neural+tumor+cell+lines+by+iron+chelators&doi=10.1016%2F0006-2952%2896%2900099-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators</span></div><div class="casAuthors">Renton, Fiona J.; Jeitner, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1553-1561</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The current studies were designed to examine the conditions under which the ferritic iron chelator desferrioxamine (DFO) arrested cell cycle progression and hence the proliferation of neural cell lines in vitro.  DFO arrested proliferation at different stages of the cell cycle depending on the concn. and duration of drug exposure.  Twenty-four-hour treatment with 160 Î¼M DFO arrested glioma cells in G1, whereas 72-h treatment with 10 Î¼M DFO acted to slow the passage of glioma cells through the cell cycle, eventually accumulating in G2/M.  Another iron chelator, ADR 529, also inhibited the proliferation of glioma cells by lengthening the period of the cycle and causing the cells to arrest in G2/M.  The effects of 10 and 160 Î¼M DFO were irreversible after 24 and 48 h, resp., and 10 Î¼M DFO became cytotoxic after 3 days.  These observations demonstrate that DFO has different effects on the proliferation of neural tumor cell lines depending on the concn. and time of exposure, which result in different sites of cell cycle arrest.  These different in vitro actions of DFO may have ramifications for the successful application of iron chelator therapy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWhwhszTrcA7Vg90H21EOLACvtfcHk0lgGxHOagh8ySw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVSmtbk%253D&md5=f4b30bc75f3ce686b7b97cf8c4f58b05</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2896%2900099-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252896%252900099-8%26sid%3Dliteratum%253Aachs%26aulast%3DRenton%26aufirst%3DF.%2BJ.%26aulast%3DJeitner%26aufirst%3DT.%2BM.%26atitle%3DCell%2520cycle-dependent%2520inhibition%2520of%2520the%2520proliferation%2520of%2520human%2520neural%2520tumor%2520cell%2520lines%2520by%2520iron%2520chelators%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D51%26spage%3D1553%26epage%3D1561%26doi%3D10.1016%2F0006-2952%2896%2900099-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leray, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouffier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troadec, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span> <span> </span><span class="NLM_article-title">Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG</span>. <i>BioMetals</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">231</span>â <span class="NLM_lpage">245</span>, <span class="refDoi">Â DOI: 10.1007/s10534-009-9281-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs10534-009-9281-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19997770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFelu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=231-245&issue=2&author=F.+Gaboriauauthor=A.+M.+Lerayauthor=M.+Ropertauthor=L.+Gouffierauthor=I.+Cannieauthor=M.+B.+Troadecauthor=O.+Lorealauthor=P.+Brissotauthor=G.+Lescoat&title=Effects+of+deferasirox+and+deferiprone+on+cellular+iron+load+in+the+human+hepatoma+cell+line+HepaRG&doi=10.1007%2Fs10534-009-9281-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG</span></div><div class="casAuthors">Gaboriau, Francois; Leray, Anne-Marie; Ropert, Martine; Gouffier, Lucie; Cannie, Isabelle; Troadec, Marie-Berengere; Loreal, Olivier; Brissot, Pierre; Lescoat, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">BioMetals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-245</span>CODEN:
                <span class="NLM_cas:coden">BOMEEH</span>;
        ISSN:<span class="NLM_cas:issn">0966-0844</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Two oral chelators, CP20 (deferiprone) and ICL670 (deferasirox), have been synthesized for the purpose of treating iron overload diseases, esp. thalassemias.  Given their antiproliferative effects resulting from the essential role played by iron in cell processes, such compds. might also be useful as anticancer agents.  In the present study, we tested the impact of these two iron chelators on iron metab., in the HepaRG cell line which allowed us to study proliferating and differentiated hepatocytes.  ICL670 uptake was greater than the CP20 uptake.  The iron depletion induced by ICL670 in differentiated cells increased sol. transferrin receptor expression, decreased intracellular ferritin expression, inhibited 55Fe (III) uptake, and reduced the hepatocyte concn. of the labile iron pool.  In contrast, CP20 induced an unexpected slight increase in intracellular ferritin, which was amplified by iron-treated chelator exposure.  CP20 also promoted Fe(III) uptake in differentiated HepaRG cells, thus leading to an increase of both the labile pool and storage forms of iron evaluated by calcein fluorescence and Perls staining, resp.  In acellular conditions, compared to CP20, iron removing ability from the calcein-Fe(III) complex was 40 times higher for ICL670.  On the whole, biol. responses of HepaRG cells to ICL670 treatment were characteristic of expected iron depletion.  In contrast, the effects of CP20 suggest the potential involvement of this compd. in the iron uptake from the external medium into the hepatocytes from the HepaRG cell line, therefore acting like a siderophore in this cell model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMVE3XnMNgobVg90H21EOLACvtfcHk0lgGxHOagh8ySw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFelu78%253D&md5=7371937823dbd369bf39e194451be33d</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1007%2Fs10534-009-9281-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10534-009-9281-9%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriau%26aufirst%3DF.%26aulast%3DLeray%26aufirst%3DA.%2BM.%26aulast%3DRopert%26aufirst%3DM.%26aulast%3DGouffier%26aufirst%3DL.%26aulast%3DCannie%26aufirst%3DI.%26aulast%3DTroadec%26aufirst%3DM.%2BB.%26aulast%3DLoreal%26aufirst%3DO.%26aulast%3DBrissot%26aufirst%3DP.%26aulast%3DLescoat%26aufirst%3DG.%26atitle%3DEffects%2520of%2520deferasirox%2520and%2520deferiprone%2520on%2520cellular%2520iron%2520load%2520in%2520the%2520human%2520hepatoma%2520cell%2520line%2520HepaRG%26jtitle%3DBioMetals%26date%3D2010%26volume%3D23%26issue%3D2%26spage%3D231%26epage%3D245%26doi%3D10.1007%2Fs10534-009-9281-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonart, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelaert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosselmans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>â <span class="NLM_lpage">102</span>, <span class="refDoi">Â DOI: 10.1006/gyno.2001.6570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1006%2Fgyno.2001.6570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11925126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVamu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2002&pages=95-102&issue=1&author=T.+Simonartauthor=J.+R.+Boelaertauthor=R.+Mosselmansauthor=G.+Andreiauthor=J.+C.+Noelauthor=E.+De+Clercqauthor=R.+Snoeck&title=Antiproliferative+and+apoptotic+effects+of+iron+chelators+on+human+cervical+carcinoma+cells&doi=10.1006%2Fgyno.2001.6570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and Apoptotic Effects of Iron Chelators on Human Cervical Carcinoma Cells</span></div><div class="casAuthors">Simonart, Thierry; Boelaert, Johan R.; Mosselmans, Roger; Andrei, Graciela; Noel, Jean-Christophe; De Clercq, Erik; Snoeck, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-102</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Objective. Cervical carcinoma is a human papillomavirus (HPV)-assocd. cancer for which treatment options still mainly rely on surgical procedures, with or without adjuvant radiotherapy and chemotherapy.  As iron may participate in the pathogenesis of viral infections and cancer in several ways, the present study was designed to investigate the effect of iron chelation on HPV-16- and HPV-18-pos. cervical carcinoma cell lines.  Methods.  Desferrioxamine and deferiprone, two chem. unrelated iron chelators, were used to investigate the effect of iron chelation on SiHa and HeLa cells.  Proliferation was investigated by cells counts, by [3H]thymidine uptake assay, and by immunostaining with Ki-67 and proliferating cell nuclear antigen (PCNA).  Apoptosis was detd. by morphol. anal., by a TUNEL assay, and by flow cytometry detecting FITC-conjugated annexin-V.  Results.  Desferrioxamine and deferiprone induced a time- and dose-dependent inhibition of SiHa and HeLa cell growth.  The inhibition of cell growth was assocd. with a decrease in the expression of both stable and total PCNA and Ki-67, a proliferation marker whose expression may predict survival in uterine cervical carcinoma.  TUNEL assay, flow cytometry with annexin-V-fluorescein, and morphol. anal. indicated that iron chelation also induced a time- and dose-dependent apoptosis of both cell lines.  This apoptotic effect was prevented by the addn. of exogenous iron.  Conclusion.  These results show that iron chelation inhibits the growth and induces the apoptosis of HPV-pos. carcinoma cells.  This suggests that iron chelators may represent a potential therapeutic approach for the management of cervical carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hpcKrzjPVrVg90H21EOLACvtfcHk0lgGxHOagh8ySw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVamu7o%253D&md5=6980d669f7144b9c576e117c9a1f1e8b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1006%2Fgyno.2001.6570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgyno.2001.6570%26sid%3Dliteratum%253Aachs%26aulast%3DSimonart%26aufirst%3DT.%26aulast%3DBoelaert%26aufirst%3DJ.%2BR.%26aulast%3DMosselmans%26aufirst%3DR.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DNoel%26aufirst%3DJ.%2BC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSnoeck%26aufirst%3DR.%26atitle%3DAntiproliferative%2520and%2520apoptotic%2520effects%2520of%2520iron%2520chelators%2520on%2520human%2520cervical%2520carcinoma%2520cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2002%26volume%3D85%26issue%3D1%26spage%3D95%26epage%3D102%26doi%3D10.1006%2Fgyno.2001.6570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrel-Groussard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasdeloup, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span> <span> </span><span class="NLM_article-title">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1479</span>â <span class="NLM_lpage">1487</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2003.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bcp.2003.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15041465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=1479-1487&issue=8&author=F.+Gaboriauauthor=K.+Chantrel-Groussardauthor=N.+Rakbaauthor=P.+Loyerauthor=N.+Pasdeloupauthor=R.+C.+Hiderauthor=P.+Brissotauthor=G.+Lescoat&title=Iron+mobilization%2C+cytoprotection%2C+and+inhibition+of+cell+proliferation+in+normal+and+transformed+rat+hepatocyte+cultures+by+the+hydroxypyridinone+CP411%2C+compared+to+CP20%3A+a+biological+and+physicochemical+study&doi=10.1016%2Fj.bcp.2003.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span></div><div class="casAuthors">Gaboriau, Francois; Chantrel-Groussard, Karine; Rakba, Nafissa; Loyer, Pascal; Pasdeloup, Nicole; Hider, Robert C.; Brissot, Pierre; Lescoat, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1479-1487</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study analyzes the iron mobilization, the cytoprotective, and the antiproliferative effects of the lipophilic hydroxypyridinone CP411, in comparison with the hydrophilic chelator CP20 or deferiprone used in the treatment of iron overload.  Primary rat hepatocyte cultures and the rat hepatoma cell line Fao were used.  Chelator cell uptake was evaluated by mass spectrometry in the two models.  This method was also used to investigate the stability of the chelators in an acellular system as well as their scavenging and chelating effects against the hydroxyl radical generated by the Fenton reaction.  The iron mobilization and the cytoprotective effects of the chelators were evaluated in primary cultures by measuring resp. 55Fe and lactate dehydrogenase release in the culture medium.  The antiproliferative effect of the chelators was studied using the Fao cell line and measuring DNA synthesis by thymidine incorporation and DNA content by flow cytometry.  The authors obsd. that CP411 entered the hepatocytes and the Fao cells resp. 4 and 13 times more than CP20.  CP411 was 2.5 times more effective than CP20 to mobilize iron from preloaded hepatocytes.  Pretreatment of the hepatocytes with CP20 or CP411 decreased the toxic effect of iron and CP411 was 1.6 times more effective than CP20.  A dose-dependent decrease of DNA synthesis, correlated to an accumulation of cells in S phase, was obsd. in the Fao cell line in the presence of CP411, while CP20 was without effect.  CP411 effect was inhibited by addn. of iron simultaneously with the chelator, the addn. of Zn or Cu was without effect.  The inhibitory effect of CP411 was reversible since, 24 h after removal of the chelator, DNA replication reached the control level.  The results show that CP411 is more efficient to protect the hepatocyte from the toxic effect of iron load and to inhibit tumor cell proliferation.  Its higher efficiency may result from its better cell uptake since equimolar solns. of the two chelators in an acellular system exhibit the same ability to inhibit the Fenton reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUGkeFexh2rVg90H21EOLACvtfcHk0lgG2dB2FzVwcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D&md5=d1063e9c5ddc87451852258c44f900e3</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2003.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriau%26aufirst%3DF.%26aulast%3DChantrel-Groussard%26aufirst%3DK.%26aulast%3DRakba%26aufirst%3DN.%26aulast%3DLoyer%26aufirst%3DP.%26aulast%3DPasdeloup%26aufirst%3DN.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBrissot%26aufirst%3DP.%26aulast%3DLescoat%26aufirst%3DG.%26atitle%3DIron%2520mobilization%252C%2520cytoprotection%252C%2520and%2520inhibition%2520of%2520cell%2520proliferation%2520in%2520normal%2520and%2520transformed%2520rat%2520hepatocyte%2520cultures%2520by%2520the%2520hydroxypyridinone%2520CP411%252C%2520compared%2520to%2520CP20%253A%2520a%2520biological%2520and%2520physicochemical%2520study%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26issue%3D8%26spage%3D1479%26epage%3D1487%26doi%3D10.1016%2Fj.bcp.2003.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weimar, W. R.</span></span> <span> </span><span class="NLM_article-title">Polyamine-iron chelator conjugate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5478</span>â <span class="NLM_lpage">5483</span>, <span class="refDoi">Â DOI: 10.1021/jm0302694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0302694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVClt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5478-5483&author=R.+J.+Bergeronauthor=J.+S.+McManisauthor=A.+M.+Franklinauthor=H.+Yaoauthor=W.+R.+Weimar&title=Polyamine-iron+chelator+conjugate&doi=10.1021%2Fjm0302694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Polyamine-Iron Chelator Conjugate</span></div><div class="casAuthors">Bergeron, Raymond J.; McManis, James S.; Franklin, April M.; Yao, Hua; Weimar, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5478-5483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study demonstrates unequivocally that polyamines can serve as vectors for the intracellular delivery of the bidentate chelator 1,2-dimethyl-3-hydroxypyridin-4-one (L1).  The polyamine-hydroxypyridinone conjugate 1-(12-amino-4,9-diazadodecyl)-2-methyl-3-hydroxy-4(1H)-pyridinone is assembled from spermine and 3-O-benzylmaltol.  The conjugate is shown to form a 3:1 complex with Fe(III) and to be taken up by the polyamine transporter 1900-fold against a concn. gradient.  The Ki of the conjugate is 3.7 Î¼M vs. spermidine for the polyamine transporter.  The conjugate is also at least 230 times more active in suppressing the growth of L1210 murine leukemia cells than is the parent ligand, decreases the activities of the polyamine biosynthetic enzymes ornithine decarboxylase and S-adenosylmethionine decarboxylase, and upregulates spermidine-spermine N 1-acetyltransferase.  However, the effect on native polyamine pools is a moderate one.  These findings are in keeping with the idea that polyamines can also serve as efficient vectors for the intracellular delivery of other iron chelators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp2TTYL13vZbVg90H21EOLACvtfcHk0lgG2dB2FzVwcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVClt7s%253D&md5=4ab7c219ccfa8e79113c8e3e094ff0c3</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Fjm0302694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0302694%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DMcManis%26aufirst%3DJ.%2BS.%26aulast%3DFranklin%26aufirst%3DA.%2BM.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DWeimar%26aufirst%3DW.%2BR.%26atitle%3DPolyamine-iron%2520chelator%2520conjugate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5478%26epage%3D5483%26doi%3D10.1021%2Fjm0302694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">FÃ¼rstner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of the antitumor agent TMC-69â6H and a focused library of analogs</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">9543</span>â <span class="NLM_lpage">9558</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2004.06.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tet.2004.06.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFagsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=9543-9558&issue=43&author=A.+F%C3%BCrstnerauthor=F.+Feyenauthor=H.+Prinzauthor=H.+Waldmann&title=Synthesis+and+evaluation+of+the+antitumor+agent+TMC-69%E2%80%936H+and+a+focused+library+of+analogs&doi=10.1016%2Fj.tet.2004.06.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of the antitumor agent TMC-69-6H and a focused library of analogs</span></div><div class="casAuthors">Fuerstner, Alois; Feyen, Fabian; Prinz, Heino; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">9543-9558</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A concise, efficient and flexible total synthesis of the potent antitumor agent TMC-69-6H (I) is described.  Key steps involved the palladium-catalyzed regioselective addn. of 4-hydroxy-2-pyridone to pyranyl acetate which was accompanied by a spontaneous 1,4-addn. of the phenolic -OH group to the emerging enone to give the corresponding tricyclic product in excellent yield.  When this reaction was carried out with optically enriched pyranyl acetate in the presence of a chiral ligand and allylpalladium chloride dimer, the ensuing matched situation delivers the key building block in excellent enantiomeric excess.  Its further elaboration into I involved a Julia-Kocienski olefination with a tetrazolylsulfone and a final N-oxidn. effected by the peroxomolybdenum complex [(pyridine)MoO5(HMPA)] to form the hydroxamic acid motif.  The flexibility inherent to this route allowed for the prepn. of a focused library of analogs for biochem. evaluation.  The results obtained showed that N-hydroxy-2-pyridone derivs. constituted a promising class of selective phosphatase inhibitors.  In contrast to previous reports in the literature, however, TMC-69-6H and congeners were found to exhibit pronounced activities against the tyrosine protein phosphatase PTB1B, the dual specific phosphatase VHR, and the serine/threonine phosphatase PP1, while being only weak inhibitors for the dual specific phosphatases Cdc25 A and B.  Two of the key intermediates have been characterized by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPCJr36kVLq7Vg90H21EOLACvtfcHk0lgG2dB2FzVwcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFagsr0%253D&md5=a28b017976b841a704c26c94e8d602c1</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.06.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.06.139%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DFeyen%26aufirst%3DF.%26aulast%3DPrinz%26aufirst%3DH.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520the%2520antitumor%2520agent%2520TMC-69%25E2%2580%25936H%2520and%2520a%2520focused%2520library%2520of%2520analogs%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26issue%3D43%26spage%3D9543%26epage%3D9558%26doi%3D10.1016%2Fj.tet.2004.06.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F. Y.</span></span> <span> </span><span class="NLM_article-title">New 3-[(4-hydroxy-6-methly-2(1<i>H</i>)-pyridinones)-3-yl]-4-substituted-(1<i>H</i>) 1,2,4-triazole-5-thiones: efficient synthesis, X-ray crystallographic analysis, and antitumor activity</span>. <i>Lett. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">137</span>â <span class="NLM_lpage">141</span>, <span class="refDoi">Â DOI: 10.2174/157017807780414181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F157017807780414181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslSksr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=137-141&author=J.+G.+Yangauthor=F.+Y.+Pan&title=New+3-%5B%284-hydroxy-6-methly-2%281H%29-pyridinones%29-3-yl%5D-4-substituted-%281H%29+1%2C2%2C4-triazole-5-thiones%3A+efficient+synthesis%2C+X-ray+crystallographic+analysis%2C+and+antitumor+activity&doi=10.2174%2F157017807780414181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">New 3-[(4-hydroxy-6-methyl-2(1H)-pyridinones)-3-yl]-4-substituted-(1H)-1,2,4-triazole-5-thiones. Efficient synthesis, X-ray crystallographic analysis, and antitumor activity</span></div><div class="casAuthors">Yang, Jian-Guo; Pan, Fu-You</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-141</span>CODEN:
                <span class="NLM_cas:coden">LOCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1570-1786</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Fifteen new 3-(4-hydroxy-6-methyl-2(1H)-pyridinone-3-yl)-4-substituted-(1H)-1,2,4-triazole-5-thione compds. were synthesized from Me 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate in good overall yields by four step reactions.  Mol. structure of these compds. was confirmed by IR, NMR, MS, elemental anal. and X-ray diffraction.  Their antitumor activities were evaluated in vitro by the SRB and MTT methods.  The results show that there are two compds. which are highly effective against KB cells and one compd. which is highly effective against Bel-7402 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQr3RQ5wrRQ7Vg90H21EOLACvtfcHk0lgoHxP8eT2-DA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslSksr0%253D&md5=0ebec407660024a09bdd88bf9585c4c6</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.2174%2F157017807780414181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157017807780414181%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%2BG.%26aulast%3DPan%26aufirst%3DF.%2BY.%26atitle%3DNew%25203-%255B%25284-hydroxy-6-methly-2%25281H%2529-pyridinones%2529-3-yl%255D-4-substituted-%25281H%2529%25201%252C2%252C4-triazole-5-thiones%253A%2520efficient%2520synthesis%252C%2520X-ray%2520crystallographic%2520analysis%252C%2520and%2520antitumor%2520activity%26jtitle%3DLett.%2520Org.%2520Chem.%26date%3D2007%26volume%3D4%26spage%3D137%26epage%3D141%26doi%3D10.2174%2F157017807780414181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillen, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakrania, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stennett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bureau, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownlees, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melton, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, B.</span></span> <span> </span><span class="NLM_article-title">Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4097</span>â <span class="NLM_lpage">4103</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2015.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26318993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqt7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4097-4103&issue=19&author=T.+M.+Chapmanauthor=K.+J.+Gillenauthor=C.+Wallaceauthor=M.+T.+Leeauthor=P.+Bakraniaauthor=P.+Khuranaauthor=P.+J.+Coombsauthor=L.+Stennettauthor=S.+Foxauthor=E.+A.+Bureauauthor=J.+Brownleesauthor=D.+W.+Meltonauthor=B.+Saxty&title=Catechols+and+3-hydroxypyridones+as+inhibitors+of+the+DNA+repair+complex+ERCC1-XPF&doi=10.1016%2Fj.bmcl.2015.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF</span></div><div class="casAuthors">Chapman, Timothy M.; Gillen, Kevin J.; Wallace, Claire; Lee, Maximillian T.; Bakrania, Preeti; Khurana, Puneet; Coombs, Peter J.; Stennett, Laura; Fox, Simon; Bureau, Emilie A.; Brownlees, Janet; Melton, David W.; Saxty, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4097-4103</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Catechol-based inhibitors of ERCC1-XPF endonuclease activity were identified from a high-throughput screen.  Exploration of the structure-activity relationships within this series yielded compd. 13, which displayed an ERCC1-XPF IC50 of 0.6 Î¼M, high selectivity against FEN-1 and DNase I and activity in nucleotide excision repair, cisplatin enhancement and Î³H2AX assays in A375 melanoma cells.  Screening of fragments as potential alternatives to the catechol group revealed that 3-hydroxypyridones are able to inhibit ERCC1-XPF with high ligand efficiency, and elaboration of the hit gave compds. 36 and 37 which showed promising ERCC1-XPF IC50 values of <10 Î¼M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphJYIaCd3V3bVg90H21EOLACvtfcHk0lgoHxP8eT2-DA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqt7%252FI&md5=1d27d6aa3a959de7ec370b72c8229fa4</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DT.%2BM.%26aulast%3DGillen%26aufirst%3DK.%2BJ.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BT.%26aulast%3DBakrania%26aufirst%3DP.%26aulast%3DKhurana%26aufirst%3DP.%26aulast%3DCoombs%26aufirst%3DP.%2BJ.%26aulast%3DStennett%26aufirst%3DL.%26aulast%3DFox%26aufirst%3DS.%26aulast%3DBureau%26aufirst%3DE.%2BA.%26aulast%3DBrownlees%26aufirst%3DJ.%26aulast%3DMelton%26aufirst%3DD.%2BW.%26aulast%3DSaxty%26aufirst%3DB.%26atitle%3DCatechols%2520and%25203-hydroxypyridones%2520as%2520inhibitors%2520of%2520the%2520DNA%2520repair%2520complex%2520ERCC1-XPF%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D19%26spage%3D4097%26epage%3D4103%26doi%3D10.1016%2Fj.bmcl.2015.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullagar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Identifying chelators for metalloprotein inhibitors using a fragment-based approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">591</span>â <span class="NLM_lpage">602</span>, <span class="refDoi">Â DOI: 10.1021/jm101266s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101266s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=591-602&issue=2&author=J.+A.+Jacobsenauthor=J.+L.+Fullagarauthor=M.+T.+Millerauthor=S.+M.+Cohen&title=Identifying+chelators+for+metalloprotein+inhibitors+using+a+fragment-based+approach&doi=10.1021%2Fjm101266s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Jacobsen, Jennifer A.; Fullagar, Jessica L.; Miller, Melissa T.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors.  When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compds. produced hit rates ranging from 29% to 43% for five matrix metalloproteases (MMPs), 24% for anthrax lethal factor (LF), 49% for 5-lipoxygenase (5-LO), and 60% for tyrosinase (TY).  The ligand efficiencies (LE) of the fragment hits are excellent, in the range of 0.4-0.8 kcal/mol.  The MMP enzymes all generally elicit the same chelators as hits from CFL-1.1; however, the chelator fragments that inhibit structurally unrelated metalloenzymes (LF, 5-LO, TY) vary considerably.  To develop more advanced hits, one hit from CFL-1.1, 8-hydroxyquinoline, was elaborated at four different positions around the ring system to generate new fragments. 8-Hydroxyquinoline fragments substituted at either the 5- or 7-positions gave potent hits against MMP-2, with IC50 values in the low micromolar range.  The 8-hydroxyquinoline represents a promising new chelator scaffold for the development of MMP inhibitors that was discovered by use of a metalloprotein-focused chelator fragment library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEhMn4K1QBJLVg90H21EOLACvtfcHk0ljgJZxDYlFjJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE&md5=1ef31ce8e5939f7d1c69aed8a409cd8d</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1021%2Fjm101266s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101266s%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DFullagar%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DIdentifying%2520chelators%2520for%2520metalloprotein%2520inhibitors%2520using%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D2%26spage%3D591%26epage%3D602%26doi%3D10.1021%2Fjm101266s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buczynski, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">A macrophage cell model for selective metalloproteinase inhibitor design</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2087</span>â <span class="NLM_lpage">2095</span>, <span class="refDoi">Â DOI: 10.1002/cbic.200800148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fcbic.200800148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18666306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFansrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2087-2095&issue=13&author=F.+E.+Jacobsenauthor=M.+W.+Buczynskiauthor=E.+A.+Dennisauthor=S.+M.+Cohen&title=A+macrophage+cell+model+for+selective+metalloproteinase+inhibitor+design&doi=10.1002%2Fcbic.200800148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">A macrophage cell model for selective metalloproteinase inhibitor design</span></div><div class="casAuthors">Jacobsen, Faith E.; Buczynski, Matthew W.; Dennis, Edward A.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2087-2095</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The desire to inhibit zinc-dependent matrix metalloproteinases (MMPs) has, over the course of the last 30 years, led to the development of a plethora of MMP inhibitors that bind directly to the active-site metal.  With one exception, all of these drugs have failed in clin. trials, due to many factors, including an apparent lack of specificity for MMPs.  To address the question of whether these inhibitors are selective for MMPs in a biol. setting, a cell-based screening method is presented to compare the relative activities of zinc, heme iron, and non-heme iron enzymes in the presence of these compds. using the RAW264.7 macrophage cell line.  We screened nine different zinc-binding groups (ZBGs), four established MMP inhibitors (MMPis), and two novel MMP inhibitors developed in our lab. to det. their selectivities against five different metalloenzymes.  Using this model, we identified two nitrogen donor compds.-2,2'-dipyridylamine (DPA) and triazacyclononane (TACN)-as the most selective ZBGs for zinc metalloenzyme inhibitor development.  We also demonstrated that the model could predict known nonspecific interactions of some of the most commonly used MMPis, and could also give cross-reactivity information for newly developed MMPis.  This work demonstrates the utility of cell-based assays in both the design and the screening of novel metalloenzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-1TJwCwwW6bVg90H21EOLACvtfcHk0ljgJZxDYlFjJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFansrvM&md5=9a8edf352232edb040bf25558307540d</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800148%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DF.%2BE.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DA%2520macrophage%2520cell%2520model%2520for%2520selective%2520metalloproteinase%2520inhibitor%2520design%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26issue%3D13%26spage%3D2087%26epage%3D2095%26doi%3D10.1002%2Fcbic.200800148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynagh, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyes, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span> <span> </span><span class="NLM_article-title">The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">20291</span>â <span class="NLM_lpage">20299</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.34.20291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1074%2Fjbc.271.34.20291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=8702762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK28Xlt1ygtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=20291-20299&issue=34&author=C.+E.+Cooperauthor=G.+R.+Lynaghauthor=K.+P.+Hoyesauthor=R.+C.+Hiderauthor=R.+Cammackauthor=J.+B.+Porter&title=The+relationship+of+intracellular+iron+chelation+to+the+inhibition+and+regeneration+of+human+ribonucleotide+reductase&doi=10.1074%2Fjbc.271.34.20291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase</span></div><div class="casAuthors">Cooper, Chris E.; Lynagh, Gayle R.; Hoyes, Katharine P.; Hider, Robert C.; Cammack, Richard; Porter, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">20291-20299</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation.  ESR (EPR) spectroscopy has been used to examine simultaneously for the first time the relation between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells.  The different physicochem. characteristics of relatively hydrophobic low mol. wt. bidentate hydroxypyridinone chelators and the higher mol. wt. hexadentate ferrioxamine have been exploited to elucidate these interactions further.  The base-line concn. of EPR-detectable mononuclear nonheme iron complexes was 3.15Â±1.05 Î¼M, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine.  Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity.  The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase.  Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopSMGlPXmrGrVg90H21EOLACvtfcHk0ljgJZxDYlFjJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xlt1ygtLo%253D&md5=d3ee03092a3ccd245fc2c9445995e7d1</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.34.20291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.34.20291%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DC.%2BE.%26aulast%3DLynagh%26aufirst%3DG.%2BR.%26aulast%3DHoyes%26aufirst%3DK.%2BP.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DCammack%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520relationship%2520of%2520intracellular%2520iron%2520chelation%2520to%2520the%2520inhibition%2520and%2520regeneration%2520of%2520human%2520ribonucleotide%2520reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D34%26spage%3D20291%26epage%3D20299%26doi%3D10.1074%2Fjbc.271.34.20291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kayyali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">48814</span>â <span class="NLM_lpage">48822</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M109551200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1074%2Fjbc.M109551200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11602611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XktleisA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48814-48822&issue=52&author=R.+Kayyaliauthor=J.+B.+Porterauthor=Z.+D.+Liuauthor=N.+A.+Daviesauthor=J.+H.+Nugentauthor=C.+E.+Cooperauthor=R.+C.+Hider&title=Structure-function+investigation+of+the+interaction+of+1-+and+2-substituted+3-hydroxypyridin-4-ones+with+5-lipoxygenase+and+ribonucleotide+reductase&doi=10.1074%2Fjbc.M109551200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase</span></div><div class="casAuthors">Kayyali, Reem; Porter, John B.; Liu, Zu Dong; Davies, Nathan A.; Nugent, Jonathan H.; Cooper, Chris E.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">48814-48822</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structural and physiochem. properties of 3-hydroxypyridin-4-one chelators (HPOs) which influence inhibition of the iron-contg. metalloenzymes ribonucleotide reductase (RR) and 5-lipoxygenase (5-LO) have been investigated.  HPOs with substituents at the 1- and 2-positions of the pyridinone ring have been synthesized, and their inhibitory properties compared with those of desferrioxamine (DFO).  Varying the alkyl substituents does not affect the affinity const. of these ligands for iron(III), but permits a systematic investigation of the effect of hydrophobicity and mol. shape on inhibitory properties.  The inhibition of RR was monitored, indirectly by measuring tritiated thymidine incorporation into DNA and directly by the quantification of the EPR signal of the enzyme tyrosyl radical.  5-LO inhibition was examd. spectrophotometrically, measuring the rate of linoleic hydroperoxide formation by soybean lipoxygenase.  The results indicate that the substituent size introduced at the 2-position of the HPO ring is crit. for detg. inhibition of both enzymes.  Large substituents on the 2-position, introduce a steric factor which interferes with accessibility to the iron centers.  These studies have identified chelators such as 1,6-dimethyl-2-(N-4',N-propylsuccinamido) methyl-3-hydroxypyridin-4-one (CP358), which causes only a 10% inhibition of 5-LO after 24 h of incubation at 110 Î¼M IBE (iron-binding equiv.) in comparison to simple dialkyl HPOs such as Deferiprone (CP20) which cause up to 70% inhibition.  Using EPR spectroscopy, CP358 inhibits RR at a slower rate than CP20, while chelating intracellular iron(III) at a similar rate, a finding consistent with an indirect inhibition of the tyrosyl radical.  However, hepatocellular iron is mobilized at a faster rate by CP358 (P < 0.001).  These findings demonstrate that it is possible to design bidentate HPOs which access intracellular iron pools rapidly while inhibiting non-heme iron-contg. enzymes relatively slowly, at rates comparable to DFO.  It is anticipated that such compds. will possess a superior therapeutic safety margin to currently available bidentate HPOs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRj2V4i6As1LVg90H21EOLACvtfcHk0lgVFksep2j6EQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktleisA%253D%253D&md5=686d50f9e3eb835da3dcb55e63eeee4c</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109551200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109551200%26sid%3Dliteratum%253Aachs%26aulast%3DKayyali%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DDavies%26aufirst%3DN.%2BA.%26aulast%3DNugent%26aufirst%3DJ.%2BH.%26aulast%3DCooper%26aufirst%3DC.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DStructure-function%2520investigation%2520of%2520the%2520interaction%2520of%25201-%2520and%25202-substituted%25203-hydroxypyridin-4-ones%2520with%25205-lipoxygenase%2520and%2520ribonucleotide%2520reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D52%26spage%3D48814%26epage%3D48822%26doi%3D10.1074%2Fjbc.M109551200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayyali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, A. E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">631</span>â <span class="NLM_lpage">639</span>, <span class="refDoi">Â DOI: 10.1021/jm010817i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010817i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVaisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=631-639&issue=3&author=Z.+D.+Liuauthor=R.+Kayyaliauthor=R.+C.+Hiderauthor=J.+B.+Porterauthor=A.+E.+Theobald&title=Design%2C+synthesis%2C+and+evaluation+of+novel+2-substituted+3-hydroxypyridin-4-ones%3A+structure-activity+investigation+of+metalloenzyme+inhibition+by+iron+chelators&doi=10.1021%2Fjm010817i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Novel 2-Substituted 3-Hydroxypyridin-4-ones: Structure-Activity Investigation of Metalloenzyme Inhibition by Iron Chelators</span></div><div class="casAuthors">Liu, Zu D.; Kayyali, Reem; Hider, Robert C.; Porter, John B.; Theobald, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of novel 3-hydroxy-1-methylpyridin-4-ones with different substituents at the 2-position has been synthesized for the investigation of the structure-activity relationship between the chem. nature of the ligand and the inhibitory activity of the iron-contg. metalloenzyme 5-lipoxygenase.  Results indicate that the mol. dimensions, together with the lipophilicity, have a crit. impact on the ability of this class of chelator to inhibit 5-lipoxygenase.  Hydrophilic ligands with a bulky 2-substituent tend to be weak inhibitors; thus 1,6-dimethyl-2-(4'-N-propylsuccinamido)methyl-3-hydroxypyridin-4(1H)-one which has the largest 2-substituent only caused 2% inhibition of the enzyme activity after 30 min incubation at 110 Î¼M IBE (iron-binding equiv.), as compared with deferiprone which caused 40% inhibition of the enzyme activity, under the same conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReo2mZMAgwbVg90H21EOLACvtfcHk0lgVFksep2j6EQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVaisg%253D%253D&md5=a93837cadbedc6e801d2afef179a075c</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Fjm010817i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010817i%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DKayyali%26aufirst%3DR.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DTheobald%26aufirst%3DA.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%25202-substituted%25203-hydroxypyridin-4-ones%253A%2520structure-activity%2520investigation%2520of%2520metalloenzyme%2520inhibition%2520by%2520iron%2520chelators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D3%26spage%3D631%26epage%3D639%26doi%3D10.1021%2Fjm010817i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-activity investigation of the inhibition of 3-hydroxypyridin-4ones on mammalian tyrosine hydroxylase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">285</span>â <span class="NLM_lpage">290</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(00)00551-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-2952%2800%2900551-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11172732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtFegsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=285-290&author=Z.+D.+Liuauthor=M.+Lockwoodauthor=S.+Roseauthor=A.+E.+Theobaldauthor=R.+C.+Hider&title=Structure-activity+investigation+of+the+inhibition+of+3-hydroxypyridin-4ones+on+mammalian+tyrosine+hydroxylase&doi=10.1016%2FS0006-2952%2800%2900551-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase</span></div><div class="casAuthors">Liu, Z. D.; Lockwood, M.; Rose, S.; Theobald, A. E.; Hider, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">285-290</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">3-Hydroxypyridin-4-ones are currently one of the main candidates for the development of orally active iron chelators.  Small bidentate ligands tend to inhibit iron-contg. metalloenzymes and therefore can cause undesirable side effects.  A range of 3-hydroxypyridin-4-ones with different substituents at position 2 was selected for the investigation of the structure-activity relation between the chem. nature of the ligand and the inhibition of mammalian tyrosine hydroxylase.  Results indicated that lipophilicity was the dominant factor in controlling the ability of this class of chelator to inhibit mammalian tyrosine hydroxylase.  Ligands with hydrophilic substituents tended to be weak inhibitors.  No significant correlation was found in this study between iron-binding affinity, extended substituent chain length, and enzyme inhibitory activity.  In contrast, both the LogP values of the entire mol. and of the substituent segment correlated well with inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdKaujaly94rVg90H21EOLACvtfcHk0lgVFksep2j6EQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtFegsrs%253D&md5=fa438d391d5ee52d39a94739f15d1031</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2800%2900551-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252800%252900551-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLockwood%26aufirst%3DM.%26aulast%3DRose%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DA.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DStructure-activity%2520investigation%2520of%2520the%2520inhibition%2520of%25203-hydroxypyridin-4ones%2520on%2520mammalian%2520tyrosine%2520hydroxylase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D285%26epage%3D290%26doi%3D10.1016%2FS0006-2952%2800%2900551-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">How does photodynamic therapy work</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">145</span>â <span class="NLM_lpage">157</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.1992.tb04222.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.1992.tb04222.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1603846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK38XnvFCiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1992&pages=145-157&issue=1&author=B.+W.+Hendersonauthor=T.+J.+Dougherty&title=How+does+photodynamic+therapy+work&doi=10.1111%2Fj.1751-1097.1992.tb04222.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">How does photodynamic therapy work?</span></div><div class="casAuthors">Henderson, Barbara W.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-57</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    </div><div class="casAbstract">A review with many refs. on the mechanisms relevant to photodynamic therapy and in vivo responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2ylXEYQKO7Vg90H21EOLACvtfcHk0lh-LFGiVhS1KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XnvFCiuw%253D%253D&md5=fe907b7bcadce2313ddae92d36389309</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1992.tb04222.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1992.tb04222.x%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DHow%2520does%2520photodynamic%2520therapy%2520work%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1992%26volume%3D55%26issue%3D1%26spage%3D145%26epage%3D157%26doi%3D10.1111%2Fj.1751-1097.1992.tb04222.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kloek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkermans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegouwen, G.</span></span> <span> </span><span class="NLM_article-title">Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">150</span>â <span class="NLM_lpage">154</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.1998.tb05178.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.1998.tb05178.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9477773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVWqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=150-154&issue=1&author=J.+Kloekauthor=W.+Akkermansauthor=G.+Henegouwen&title=Derivatives+of+5-aminolevulinic+acid+for+photodynamic+therapy%3A+enzymatic+conversion+into+protoporphyrin&doi=10.1111%2Fj.1751-1097.1998.tb05178.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymic conversion into protoporphyrin</span></div><div class="casAuthors">Kloek, Joris; Akkermans, Willem; Van Henegouwen, Gerard M. J. Beijersbergen</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-154</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">American Society for Photobiology</span>)
        </div><div class="casAbstract">In recent years, 5-aminolevulinic acid (ALA) has become a widespread agent for photodynamic therapy (PDT).  In nucleated cells, ALA is converted into the endogenous photosensitizer protoporphyrin IX (PpIX).  A major drawback of ALA is its low bioavailability.  As a result, high doses of ALA must be administered in order to reach clin. relevant levels of PpIX.  Moreover, only superficially located lesions can be treated as a result of the poor penetration of ALA into tissues.  A possible soln. for this problem may be provided by the prodrug concept.  In the present study, prodrugs of ALA have been synthesized.  These ALA prodrugs are shown to result in higher PpIX levels in cells than does ALA itself.  Of a range of ester prodrugs of ALA, the ALA-pentyl ester elicits the highest fluorescence.  Furthermore, the enzymic conversion of the derivs. into ALA and PpIX has been studied in lysed cells.  Under these circumstances, the esters with the shorter alkyl chains induce the highest fluorescence.  The alcs. that arise as side products from enzymic conversion of the prodrugs are shown to have no influence on the expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofIL9upgTDe7Vg90H21EOLACvtfcHk0lh-LFGiVhS1KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVWqsg%253D%253D&md5=e900697151e7a52c02fffd3578958744</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1998.tb05178.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1998.tb05178.x%26sid%3Dliteratum%253Aachs%26aulast%3DKloek%26aufirst%3DJ.%26aulast%3DAkkermans%26aufirst%3DW.%26aulast%3DHenegouwen%26aufirst%3DG.%26atitle%3DDerivatives%2520of%25205-aminolevulinic%2520acid%2520for%2520photodynamic%2520therapy%253A%2520enzymatic%2520conversion%2520into%2520protoporphyrin%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1998%26volume%3D67%26issue%3D1%26spage%3D150%26epage%3D154%26doi%3D10.1111%2Fj.1751-1097.1998.tb05178.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongshaug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesland, J. M.</span></span> <span> </span><span class="NLM_article-title">5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">235</span>â <span class="NLM_lpage">251</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.1997.tb08549.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.1997.tb08549.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9066303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVejtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1997&pages=235-251&issue=2&author=Q.+Pengauthor=K.+Bergauthor=J.+Moanauthor=M.+Kongshaugauthor=J.+M.+Nesland&title=5-Aminolevulinic+acid-based+photodynamic+therapy%3A+principles+and+experimental+research&doi=10.1111%2Fj.1751-1097.1997.tb08549.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">5-aminolevulinic acid-based photodynamic therapy: principles and experimental research</span></div><div class="casAuthors">Peng, Qian; Berg, Kristian; Moan, Johan; Kongshaug, Magne; Nesland, Jahn M.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-251</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">American Society for Photobiology</span>)
        </div><div class="casAbstract">A review, with 234 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9U7C0t7IiULVg90H21EOLACvtfcHk0lh-LFGiVhS1KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVejtrs%253D&md5=e8bee8821dff2f8966d0761c29e5e9d6</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1997.tb08549.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1997.tb08549.x%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DMoan%26aufirst%3DJ.%26aulast%3DKongshaug%26aufirst%3DM.%26aulast%3DNesland%26aufirst%3DJ.%2BM.%26atitle%3D5-Aminolevulinic%2520acid-based%2520photodynamic%2520therapy%253A%2520principles%2520and%2520experimental%2520research%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1997%26volume%3D65%26issue%3D2%26spage%3D235%26epage%3D251%26doi%3D10.1111%2Fj.1751-1097.1997.tb08549.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alyahya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>159</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">387</span>â <span class="NLM_lpage">393</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2133.2008.08668.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1365-2133.2008.08668.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18544077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCqs7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2008&pages=387-393&issue=2&author=S.+M.+Campbellauthor=C.+A.+Mortonauthor=R.+Alyahyaauthor=S.+Hortonauthor=A.+Pyeauthor=A.+Curnow&title=Clinical+investigation+of+the+novel+iron-chelating+agent%2C+CP94%2C+to+enhance+topical+photodynamic+therapy+of+nodular+basal+cell+carcinoma&doi=10.1111%2Fj.1365-2133.2008.08668.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma</span></div><div class="casAuthors">Campbell, S. M.; Morton, C. A.; Alyahya, R.; Horton, S.; Pye, A.; Curnow, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-393</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) involves the activation of a photosensitizer by visible light to produce activated oxygen species within target cells, resulting in their destruction.  Evidence-based guidelines support the efficacy of PDT using topical 5-aminolaevulinic acid (ALA-PDT) in actinic keratoses, Bowen disease and basal cell carcinoma (BCC).  Efficacy for nodular BCC appears inferior to that for superficial BCC unless prior debulking or repeat treatments are performed.  The aim of this study was to assess the safety and efficacy of adding a novel iron-chelating agent, CP94 (1,2-diethyl-3-hydroxypyridin-4-one hydrochloride), to topical ALA, to temporarily increase the accumulation of the photosensitizer in the tumor.  A mixed topical formulation of ALA + increasing concns. of CP94, was used to carry out PDT on previously biopsied nodular BCC with no prior lesion prepn. using std. light delivery.  The area was assessed clin. and surgically excised 6 wk later for histol. examn.  Enhanced PDT using 40% CP94 resulted in significantly greater clearance rates in nodular BCC than with ALA-PDT alone, in our protocol of single-treatment PDT with no lesion prepn.  The results of this study demonstrate the safe and effective use of an enhanced ALA-PDT protocol for nodular BCC using CP94, with no adverse reactions to this modification.  This is the first time this formulation has been used in patients.  This formulation is now the focus of further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2LSpmPqKnLrVg90H21EOLACvtfcHk0ljr_B56wiCsaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCqs7nK&md5=f05550d56dc365ad30187d3bea4ff689</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2008.08668.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2008.08668.x%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DS.%2BM.%26aulast%3DMorton%26aufirst%3DC.%2BA.%26aulast%3DAlyahya%26aufirst%3DR.%26aulast%3DHorton%26aufirst%3DS.%26aulast%3DPye%26aufirst%3DA.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DClinical%2520investigation%2520of%2520the%2520novel%2520iron-chelating%2520agent%252C%2520CP94%252C%2520to%2520enhance%2520topical%2520photodynamic%2520therapy%2520of%2520nodular%2520basal%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2008%26volume%3D159%26issue%3D2%26spage%3D387%26epage%3D393%26doi%3D10.1111%2Fj.1365-2133.2008.08668.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an <i>in vitro</i> investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">841</span>â <span class="NLM_lpage">849</span>, <span class="refDoi">Â DOI: 10.1007/s00432-008-0358-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00432-008-0358-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18239941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWktrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=841-849&issue=8&author=A.+Pyeauthor=S.+Campbellauthor=A.+Curnow&title=Enhancement+of+methyl-aminolevulinate+photodynamic+therapy+by+iron+chelation+with+CP94%3A+an+in+vitro+investigation+and+clinical+dose-escalating+safety+study+for+the+treatment+of+nodular+basal+cell+carcinoma&doi=10.1007%2Fs00432-008-0358-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma</span></div><div class="casAuthors">Pye, Andrew; Campbell, Sandra; Curnow, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">841-849</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Methyl-aminolevulinate (MAL) photodynamic therapy (PDT) is a cancer therapy that combines the selective accumulation of a photosensitizer in tumor tissue with visible light (and tissue oxygen) to produce reactive oxygen species.  This results in cellular damage and ablation of tumor tissue.  Combining iron chelators with MAL has the potential to increase the accumulation of the photosensitizer protoporphyrin IX (PpIX) by reducing its bioconversion to heme.  This paper investigates this method of enhancement both in vitro and for the first time clin. for the treatment of nodular basal cell carcinoma (BCC).  Enhancement of MAL-induced PpIX accumulation by the iron chelator CP94 was quantified fluorometrically in human cultured cells (including three dermatol. cell types).  An open, dose-escalating, pilot study was then conducted in patients with nodular BCC, to det. the safety of this pharmacol. modification.  Large enhancements in PpIX accumulation were obsd. in the cultured cells when co-incubated with the iron chelator CP94.  Clin. the addn. of CP94 was found to be feasible and safe.  In addn. greater redns. in tumor depth were obsd. in the CP94 co-incubated tumors.  Iron chelation by CP94 is an effective enhancer of MAL-induced PpIX accumulation in vitro.  This method of enhancement was safely applied to a clin. PDT protocol with no unexpected adverse effects reported.  Although the clin. investigation was only intended to be a small pilot to assess safety, enhancements in tumor clearance were obsd. both clin. and histol. when CP94 was included in the photosensitizing cream.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPZexxeyvELVg90H21EOLACvtfcHk0ljr_B56wiCsaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWktrw%253D&md5=aa4dcb8df4f0880f6750c5245c3b43b0</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1007%2Fs00432-008-0358-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-008-0358-6%26sid%3Dliteratum%253Aachs%26aulast%3DPye%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DEnhancement%2520of%2520methyl-aminolevulinate%2520photodynamic%2520therapy%2520by%2520iron%2520chelation%2520with%2520CP94%253A%2520an%2520in%2520vitro%2520investigation%2520and%2520clinical%2520dose-escalating%2520safety%2520study%2520for%2520the%2520treatment%2520of%2520nodular%2520basal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D134%26issue%3D8%26spage%3D841%26epage%3D849%26doi%3D10.1007%2Fs00432-008-0358-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1154</span>â <span class="NLM_lpage">1160</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.2010.00770.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.2010.00770.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20573043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtleqtr3J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=1154-1160&author=E.+Blakeauthor=A.+Curnow&title=The+hydroxypyridinone+iron+chelator+CP94+can+enhance+PpIX-induced+PDT+of+cultured+human+glioma+cells&doi=10.1111%2Fj.1751-1097.2010.00770.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells</span></div><div class="casAuthors">Blake, Emma; Curnow, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1154-1160</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) with the pro-drugs 5-aminolevulinic acid (ALA) or Me aminolevulinate (MAL) utilizes the combined interaction of a photosensitizer, light and mol. oxygen to ablate tumor tissue.  To potentially increase accumulation of the photosensitizer, protoporphyrin IX (PpIX), within tumor cells an iron chelator can be employed.  This study analyzed the effects of ALA/MAL-induced PDT combined with the iron chelator 1, 2-diethyl-3-hydroxypyridin-4-one hydrochloride (CP94) on the accumulation of PpIX in human glioma cells in vitro.  Cells were incubated for 0, 3 and 6 h with various concns. of ALA/MAL with or without CP94 and the resulting accumulations of PpIX, which naturally fluoresces, were quantified prior to and following light irradn.  In addn., counts of viable cells were recorded.  The use of CP94 in combination with ALA/MAL produced significant enhancements of PpIX fluorescence in human glioma cells.  At the highest concns. of each prodrug, CP94 enhanced PpIX fluorescence significantly at 3 h for ALA and by more than 50% at 6 h for MAL.  Cells subsequently treated with ALA/MAL-induced PDT in combination with CP94 produced the greatest cytotoxicity.  It is therefore concluded that with further study CP94 may be a useful adjuvant to photodiagnosis and/or PpIX-induced PDT treatment of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo95LzZ6u6IN7Vg90H21EOLACvtfcHk0ljr_B56wiCsaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtleqtr3J&md5=d15626f8fd55fc94429a6ab3fe14a81e</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2010.00770.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2010.00770.x%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DE.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DThe%2520hydroxypyridinone%2520iron%2520chelator%2520CP94%2520can%2520enhance%2520PpIX-induced%2520PDT%2520of%2520cultured%2520human%2520glioma%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2010%26volume%3D86%26spage%3D1154%26epage%3D1160%26doi%3D10.1111%2Fj.1751-1097.2010.00770.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">An <i>in vitro</i> comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1419</span>â <span class="NLM_lpage">1426</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.2011.00985.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.2011.00985.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21834866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2011&pages=1419-1426&issue=6&author=E.+Blakeauthor=J.+Allenauthor=A.+Curnow&title=An+in+vitro+comparison+of+the+effects+of+the+iron-chelating+agents%2C+CP94+and+dexrazoxane%2C+on+protoporphyrin+IX+accumulation+for+photodynamic+therapy+and%2For+fluorescence+guided+resection&doi=10.1111%2Fj.1751-1097.2011.00985.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection</span></div><div class="casAuthors">Blake, Emma; Allen, James; Curnow, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1419-1426</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) utilizes the combined interaction of a photosensitizer, light and mol. oxygen to ablate tumor tissue.  Maximizing the accumulation of the photosensitizer protoporphyrin IX (PpIX) within different cell types would be clin. useful.  Dermatol. PpIX-induced PDT regimes produce good clin. outcomes but this currently only applies when the lesion remains superficial.  Also, as an adjuvant therapy for the treatment of primary brain tumors, fluorescence guided resection (FGR) and PDT can be used to highlight and destroy tumor cells unreachable by surgical resection.  By employing iron chelators PpIX accumulation can be enhanced.  Two iron-chelating agents, 1,2-diethyl-3-hydroxypyridin-4-one hydrochloride (CP94) and dexrazoxane, were individually combined with the porphyrin precursors aminolevulinic acid (ALA), Me aminolevulinate (MAL) and hexyl aminolevulinate (HAL).  Efficacies of the iron-chelating agents were compared by recording the PpIX fluorescence in human squamous epithelial carcinoma cells (A431) and human glioma cells (U-87 MG) every hour for up to 6 h.  Coincubation of ALA/MAL/HAL with CP94 resulted in a greater accumulation of PpIX compared to that produced by coincubation of these congeners with dexrazoxane.  Therefore the clin. employment of iron chelation, particularly with CP94 could potentially increase and/or accelerate the accumulation of ALA/MAL/HAL-induced PpIX for PDT or FGR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvyaEjtyk7V7Vg90H21EOLACvtfcHk0lgFMwa00Kh8WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nK&md5=a3df7449f9fcbd7d50ea95b5968e054e</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2011.00985.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2011.00985.x%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DE.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DAn%2520in%2520vitro%2520comparison%2520of%2520the%2520effects%2520of%2520the%2520iron-chelating%2520agents%252C%2520CP94%2520and%2520dexrazoxane%252C%2520on%2520protoporphyrin%2520IX%2520accumulation%2520for%2520photodynamic%2520therapy%2520and%252For%2520fluorescence%2520guided%2520resection%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2011%26volume%3D87%26issue%3D6%26spage%3D1419%26epage%3D1426%26doi%3D10.1111%2Fj.1751-1097.2011.00985.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dogra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, N. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smerdon, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winyard, P. G.</span></span> <span> </span><span class="NLM_article-title">The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">90</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1016/j.redox.2016.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.redox.2016.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27454766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1eis7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=90-99&author=Y.+Dograauthor=D.+C.+J.+Fergusonauthor=N.+J.+F.+Doddauthor=G.+R.+Smerdonauthor=A.+Curnowauthor=P.+G.+Winyard&title=The+hydroxypyridinone+iron+chelator+CP94+increases+methyl-aminolevulinate-based+photodynamic+cell+killing+by+increasing+the+generation+of+reactive+oxygen+species&doi=10.1016%2Fj.redox.2016.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species</span></div><div class="casAuthors">Dogra, Yuktee; Ferguson, Daniel C. J.; Dodd, Nicholas J. F.; Smerdon, Gary R.; Curnow, Alison; Winyard, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Methyl-aminolevulinate-based photodynamic therapy (MAL-PDT) is utilized clin. for the treatment of non-melanoma skin cancers and pre-cancers and the hydroxypyridinone iron chelator, CP94, has successfully been demonstrated to increase MAL-PDT efficacy in an initial clin. pilot study.  However, the biochem. and photochem. processes leading to CP94-enhanced photodynamic cell death, beyond the well-documented increases in accumulation of the photosensitizer protoporphyrin IX (PpIX), have not yet been fully elucidated.  This investigation demonstrated that MAL-based photodynamic cell killing of cultured human squamous carcinoma cells (A431) occurred in a predominantly necrotic manner following the generation of singlet oxygen and ROS.  Augmenting MAL-based photodynamic cell killing with CP94 co-treatment resulted in increased PpIX accumulation, MitoSOX-detectable ROS generation (probably of mitochondrial origin) and necrotic cell death, but did not affect singlet oxygen generation.  We also report (to our knowledge, for the first time) the detection of intracellular PpIX-generated singlet oxygen in whole cells via ESR spectroscopy in conjunction with a spin trap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlb_6IW4EfMrVg90H21EOLACvtfcHk0lgFMwa00Kh8WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1eis7nJ&md5=16d5ba70b278c85f51a28048b5b5daca</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2016.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2016.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DDogra%26aufirst%3DY.%26aulast%3DFerguson%26aufirst%3DD.%2BC.%2BJ.%26aulast%3DDodd%26aufirst%3DN.%2BJ.%2BF.%26aulast%3DSmerdon%26aufirst%3DG.%2BR.%26aulast%3DCurnow%26aufirst%3DA.%26aulast%3DWinyard%26aufirst%3DP.%2BG.%26atitle%3DThe%2520hydroxypyridinone%2520iron%2520chelator%2520CP94%2520increases%2520methyl-aminolevulinate-based%2520photodynamic%2520cell%2520killing%2520by%2520increasing%2520the%2520generation%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DRedox%2520Biol.%26date%3D2016%26volume%3D9%26spage%3D90%26epage%3D99%26doi%3D10.1016%2Fj.redox.2016.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">558</span>â <span class="NLM_lpage">561</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2014.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25556100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2rsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=558-561&issue=3&author=C.+F.+Zhuauthor=S.+Battahauthor=X.+L.+Kongauthor=B.+J.+Reederauthor=R.+C.+Hiderauthor=T.+Zhou&title=Design%2C+synthesis+and+biological+evaluation+of+5-aminolaevulinic+acid%2F3-hydroxypyridinone+conjugates+as+potential+photodynamic+therapeutical+agents&doi=10.1016%2Fj.bmcl.2014.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents</span></div><div class="casAuthors">Zhu, Chun-Feng; Battah, Sinan; Kong, Xiaole; Reeder, Brandon J.; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">558-561</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">5-Aminolaevulinic acid (ALA) prodrugs have been widely used in photodynamic therapy (PDT) as precursors to the natural photosensitizer, protoporphyrin IX (PpIX).  The main disadvantage of this therapy is that ALA is poorly absorbed by cells due to its high hydrophilicity.  In order to improve the therapeutical effect and induce higher yields of PpIX, a range of prodrugs of ALA conjugated to 3-hydroxypyridin-4-ones (HPO) were synthesized.  Pharmacokinetic studies indicated that some of the ALA-HPO conjugates are more efficient than ALA for PpIX prodn. in the human breast adenocarcinoma cell line (MDA-MB-468).  The intracellular porphyrin fluorescence levels showed good correlation with cellular phototoxicity following light exposure, suggesting the potential application of the ALA-HPO conjugates in photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUt3cW-UJD3bVg90H21EOLACvtfcHk0lgFMwa00Kh8WQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2rsw%253D%253D&md5=80f5710febca397fbe839512e11ba009</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DReeder%26aufirst%3DB.%2BJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25205-aminolaevulinic%2520acid%252F3-hydroxypyridinone%2520conjugates%2520as%2520potential%2520photodynamic%2520therapeutical%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D558%26epage%3D561%26doi%3D10.1016%2Fj.bmcl.2014.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRobert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X. L.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates for photodynamic therapy: enhancement of protoporphyrin IX production and photo-toxicity in tumor cells</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1190</span>â <span class="NLM_lpage">1196</span>, <span class="refDoi">Â DOI: 10.1039/C6MD00040A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC6MD00040A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2lu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1190-1196&issue=6&author=T.+Zhouauthor=L.+L.+Shaoauthor=S.+Battahauthor=C.+F.+Zhuauthor=R.+C.+Hiderauthor=B.+J.+Reederauthor=A.+Jabeenauthor=A.+J.+MacRobertauthor=G.+R.+Renauthor=X.+L.+Liang&title=Design+and+synthesis+of+5-aminolaevulinic+acid%2F3-hydroxypyridinone+conjugates+for+photodynamic+therapy%3A+enhancement+of+protoporphyrin+IX+production+and+photo-toxicity+in+tumor+cells&doi=10.1039%2FC6MD00040A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates for photodynamic therapy: enhancement of protoporphyrin IX production and photo-toxicity in tumor cells</span></div><div class="casAuthors">Zhou, Tao; Shao, Le-Le; Battah, Sinan; Zhu, Chun-Feng; Hider, Robert C.; Reeder, Brandon J.; Jabeen, Asma; MacRobert, Alexander J.; Ren, Gerui; Liang, Xinle</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1190-1196</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">5-Aminolaevulinic acid (ALA) and its derivs. have been widely used in photodynamic therapy (PDT) as precursors of the photosensitizer, protoporphyrin IX (PpIX) in dermatol. and urol.  However, ALA-PDT is limited by the low bioavailability of ALA due to the fact that ALA is poorly absorbed by cells by virtue of its zwitterionic nature at physiol. pH.  In order to improve the therapeutic effect and induce higher levels of PpIX, a series of ALA prodrugs were synthesized by the conjugation of ALA to 3-hydroxypyridin-4-one (HPO) iron chelator using an amino acid linkage via amide bonds.  Pharmacokinetic studies indicated that one ALA-HPO conjugate significantly enhanced PpIX prodn. in a range of tumor cell lines over ALA alone or the co-administration of ALA and CP94 (1,2-diethyl-3-hydroxypyridin-4-one).  The intracellular porphyrin fluorescence levels showed good correlation with cellular photo-toxicity following light exposure, suggesting the potential application of the ALA-HPO conjugates in photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiT54Rmu9p87Vg90H21EOLACvtfcHk0lgXfDaQxyUFOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2lu7g%253D&md5=b6b58eb36ccb603c696436644ef5679b</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1039%2FC6MD00040A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00040A%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DShao%26aufirst%3DL.%2BL.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DReeder%26aufirst%3DB.%2BJ.%26aulast%3DJabeen%26aufirst%3DA.%26aulast%3DMacRobert%26aufirst%3DA.%2BJ.%26aulast%3DRen%26aufirst%3DG.%2BR.%26aulast%3DLiang%26aufirst%3DX.%2BL.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205-aminolaevulinic%2520acid%252F3-hydroxypyridinone%2520conjugates%2520for%2520photodynamic%2520therapy%253A%2520enhancement%2520of%2520protoporphyrin%2520IX%2520production%2520and%2520photo-toxicity%2520in%2520tumor%2520cells%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D1190%26epage%3D1196%26doi%3D10.1039%2FC6MD00040A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRobert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinone and 5-aminolaevulinic acid conjugates for photodynamic therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3498</span>â <span class="NLM_lpage">3510</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVygtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3498-3510&issue=8&author=S.+Battahauthor=R.+C.+Hiderauthor=A.+J.+MacRobertauthor=P.+S.+Dobbinauthor=T.+Zhou&title=Hydroxypyridinone+and+5-aminolaevulinic+acid+conjugates+for+photodynamic+therapy&doi=10.1021%2Facs.jmedchem.7b00346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy</span></div><div class="casAuthors">Battah, Sinan; Hider, Robert C.; MacRobert, Alexander J.; Dobbin, Paul S.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3498-3510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a promising treatment strategy for malignant and non-malignant lesions. 5-Aminolevulinic acid (ALA) is used has a precursor of the photosensitizer, protoporphyrin IX (PpIX) in dermatol. and urol.  However, the effectiveness of ALA-PDT is limited by the relatively poor bioavailability of ALA and rapid conversion of PpIX to haem.  The main goal of this study was to prep. and investigate a library of single conjugates designed to co-administer the bioactive agents ALA and hydroxypyridinone (HPO) iron chelators.  A significant increase in intracellular PpIX levels was obsd. in all cell lines tested when compared to the administration of ALA alone.  The higher PpIX levels obsd. using the conjugates correlated well with the obsd. phototoxicity following exposure of cells to light.  Passive diffusion appears to be the main mechanism for the majority of ALA-HPOs investigated.  This study demonstrates that ALA-HPOs significantly enhance phototherapeutic metabolite formation and phototoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4V_Sqk-tKLVg90H21EOLACvtfcHk0lgXfDaQxyUFOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVygtrc%253D&md5=0f83ed82793fce2ed87174a12276347a</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00346%26sid%3Dliteratum%253Aachs%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DMacRobert%26aufirst%3DA.%2BJ.%26aulast%3DDobbin%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DHydroxypyridinone%2520and%25205-aminolaevulinic%2520acid%2520conjugates%2520for%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D8%26spage%3D3498%26epage%3D3510%26doi%3D10.1021%2Facs.jmedchem.7b00346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span> <span> </span><span class="NLM_article-title">Improving <i>in vitro</i> photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">157</span>â <span class="NLM_lpage">165</span>, <span class="refDoi">Â DOI: 10.1016/j.pdpdt.2018.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.pdpdt.2018.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30553949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Snsb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=157-165&author=A.+Curnowauthor=A.+Perryauthor=M.+Wood&title=Improving+in+vitro+photodynamic+therapy+through+the+development+of+a+novel+iron+chelating+aminolaevulinic+acid+prodrug&doi=10.1016%2Fj.pdpdt.2018.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug</span></div><div class="casAuthors">Curnow, Alison; Perry, Alexis; Wood, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a light activated drug therapy that can be used to treat a no. of cancers and precancers.  It is particularly useful in its topical form in dermatol. but improvement of efficacy is required to widen its application.  An ester between aminolaevulinic acid (ALA) and CP94 was synthesized (AP2-18) and exptl. evaluated to det. whether protoporphyrin IX (PpIX)-induced PDT effectiveness could be improved.  A biol. evaluation of AP2-18 was conducted in cultured human primary cells with both PpIX fluorescence and cell viability (as detd. via the neutral red assay) being assessed in comparison to the PpIX prodrugs normally utilized in clin. practice (aminolaevulinic acid (ALA) or its Me ester (MAL)) either administered alone or with the comparator iron chelator, CP94.  No significant dark toxicity was obsd. in human lung fibroblasts but AP2-18 significantly increased PpIX accumulation above and beyond that achieved with ALA or MAL administration +/- CP94 in both human dermal fibroblasts and epithelial squamous carcinoma cells.  On light exposure, the combined hydroxypyridinone iron chelating ALA prodrug AP2-18 generated significantly greater cytotoxicity than any of the other treatment parameters investigated when the lowest concn. (250Î¼M) was employed.  Newly synthesized AP2-18 is therefore concluded to be an efficacious prodrug for PpIX-induced PDT in these dermatol. relevant human cells, achieving enhanced effects at lower concns. than currently possible with existing pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0LyU82b2u2bVg90H21EOLACvtfcHk0lgXfDaQxyUFOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Snsb%252FI&md5=5f9abe319b1a48388b1059afc2f99b78</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2018.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2018.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCurnow%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DImproving%2520in%2520vitro%2520photodynamic%2520therapy%2520through%2520the%2520development%2520of%2520a%2520novel%2520iron%2520chelating%2520aminolaevulinic%2520acid%2520prodrug%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2019%26volume%3D25%26spage%3D157%26epage%3D165%26doi%3D10.1016%2Fj.pdpdt.2018.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzacuva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRobert, A. J.</span></span> <span> </span><span class="NLM_article-title">Design of bifunctional dendritic 5-aminolevulinic acid and hydroxypyridinone conjugates for photodynamic therapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3411</span>â <span class="NLM_lpage">3428</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.8b00574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOhsLvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=3411-3428&issue=10&author=T.+Zhouauthor=S.+Battahauthor=F.+Mazzacuvaauthor=R.+C.+Hiderauthor=P.+Dobbinauthor=A.+J.+MacRobert&title=Design+of+bifunctional+dendritic+5-aminolevulinic+acid+and+hydroxypyridinone+conjugates+for+photodynamic+therapy&doi=10.1021%2Facs.bioconjchem.8b00574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy</span></div><div class="casAuthors">Zhou, Tao; Battah, Sinan; Mazzacuva, Francesca; Hider, Robert C.; Dobbin, Paul; MacRobert, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3411-3428</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iron chelators have recently attracted interest in the field of photodynamic therapy (PDT) owing to their role in enhancement of intracellular protoporphyrin IX (PpIX) generation induced by 5-aminolevulinic acid (ALA) via the biosynthetic heme cycle.  Although ALA is widely used in PDT, cellular uptake of ALA is limited by its hydrophilicity.  In order to improve ALA delivery and enhance the PpIX prodn., several dendrimers incorporating both ALA and 3-hydroxy-4-pyridinone (HPO) were synthesized.  The ability of the dendrimers to enter cells and be metabolized to the PpIX photosensitizer was studied in several human cancer cell lines.  The dendrimers were found to be significantly more efficient than ALA alone in PpIX prodn.  The higher intracellular PpIX levels showed a clear correlation with enhanced cellular phototoxicity following light exposure.  Dendritic derivs. are therefore capable of efficiently delivering both ALA and HPO, which act synergistically to amplify in vitro PpIX levels and enhance PDT efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIHxzvmrXz-rVg90H21EOLACvtfcHk0liQ3-d1CVXauA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOhsLvJ&md5=28811890431818f70f08d8e1e4de1969</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00574%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DMazzacuva%26aufirst%3DF.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DDobbin%26aufirst%3DP.%26aulast%3DMacRobert%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520of%2520bifunctional%2520dendritic%25205-aminolevulinic%2520acid%2520and%2520hydroxypyridinone%2520conjugates%2520for%2520photodynamic%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26issue%3D10%26spage%3D3411%26epage%3D3428%26doi%3D10.1021%2Facs.bioconjchem.8b00574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Usama Abbasi, Srinivas Abbina, Arshdeep Gill, Lily E. Takuechi, <span class="NLM_string-name hlFld-ContribAuthor">Jayachandran N. Kizhakkedathu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 945-972. <a href="https://doi.org/10.1021/acschembio.1c00122" title="DOI URL">https://doi.org/10.1021/acschembio.1c00122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.1c00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.1c00122%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DRole%252Bof%252BIron%252Bin%252Bthe%252BMolecular%252BPathogenesis%252Bof%252BDiseases%252Band%252BTherapeutic%252BOpportunities%26aulast%3DAbbasi%26aufirst%3DUsama%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19022021%26date%3D27052021%26date%3D09062021%26volume%3D16%26issue%3D6%26spage%3D945%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  He</span>, <span class="hlFld-ContribAuthor ">Meiyan  Fan</span>, <span class="hlFld-ContribAuthor ">Zhiyun  Peng</span>, <span class="hlFld-ContribAuthor ">Guangcheng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113546. <a href="https://doi.org/10.1016/j.ejmech.2021.113546" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113546%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Boverview%252Bof%252Bhydroxypyranone%252Band%252Bhydroxypyridinone%252Bas%252Bprivileged%252Bscaffolds%252Bfor%252Bnovel%252Bdrug%252Bdiscovery%26aulast%3DHe%26aufirst%3DMin%26date%3D2021%26volume%3D221%26spage%3D113546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangjing  Lv</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimerâs disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105070. <a href="https://doi.org/10.1016/j.bioorg.2021.105070" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bexploration%252Bof%252Bmultifunctional%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bas%252Bpotential%252Bdrug%252Bcandidates%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChangjun%26date%3D2021%26volume%3D114%26spage%3D105070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianan  Guo</span>, <span class="hlFld-ContribAuthor ">Yujia  Zhang</span>, <span class="hlFld-ContribAuthor ">Changjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Chuansheng  Yao</span>, <span class="hlFld-ContribAuthor ">Jingqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhichao  Zhong</span>, <span class="hlFld-ContribAuthor ">Jiamin  Ge</span>, <span class="hlFld-ContribAuthor ">Tao  Zhou</span>, <span class="hlFld-ContribAuthor ">Renren  Bai</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">N-Propargylamine-hydroxypyridinone hybrids as multitarget agents for the treatment of Alzheimerâs disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105013. <a href="https://doi.org/10.1016/j.bioorg.2021.105013" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DN-Propargylamine-hydroxypyridinone%252Bhybrids%252Bas%252Bmultitarget%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DGuo%26aufirst%3DJianan%26date%3D2021%26volume%3D113%26spage%3D105013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Hider</span>, <span class="hlFld-ContribAuthor ">Mayra Vera  Aviles</span>, <span class="hlFld-ContribAuthor ">Yu-Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Gladys Oluyemisi  Latunde-Dada</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of GSH in Intracellular Iron Trafficking. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1278. <a href="https://doi.org/10.3390/ijms22031278" title="DOI URL">https://doi.org/10.3390/ijms22031278</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031278%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DThe%252BRole%252Bof%252BGSH%252Bin%252BIntracellular%252BIron%252BTrafficking%26aulast%3DHider%26aufirst%3DRobert%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0046.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0046.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Mechanism of iron homeostasis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the chelate ring formation in metalâligand complexes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0009.jpeg" id="rightTab-GRAPHIC-d7e546-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0010.jpeg" id="rightTab-GRAPHIC-d7e599-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Proton equilibria and resonance structures of DFP.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0011.jpeg" id="rightTab-GRAPHIC-d7e779-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0012.jpeg" id="rightTab-GRAPHIC-d7e895-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Action of HPO prodrugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0013.jpeg" id="rightTab-GRAPHIC-d7e962-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Ionization equilibrium and X-ray derived structure of CP511.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0014.jpeg" id="rightTab-GRAPHIC-d7e1155-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Ionization equilibrium of compound <b>22</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0015.jpeg" id="rightTab-GRAPHIC-d7e1204-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Concept of combination therapy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0016.jpeg" id="rightTab-GRAPHIC-d7e1342-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0017.jpeg" id="rightTab-GRAPHIC-d7e1394-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0018.jpeg" id="rightTab-GRAPHIC-d7e1439-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch11" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0019.jpeg" id="rightTab-GRAPHIC-d7e1536-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch12" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0020.jpeg" id="rightTab-GRAPHIC-d7e1584-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch13" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0021.jpeg" id="rightTab-GRAPHIC-d7e1684-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch14" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0022.jpeg" id="rightTab-GRAPHIC-d7e1714-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch15" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Scheme 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0023.jpeg" id="rightTab-GRAPHIC-d7e1759-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch16" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Scheme 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0024.jpeg" id="rightTab-GRAPHIC-d7e1787-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch17" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Scheme 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0025.jpeg" id="rightTab-GRAPHIC-d7e1898-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch18" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Scheme 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0026.jpeg" id="rightTab-GRAPHIC-d7e1973-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch19" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Scheme 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0027.jpeg" id="rightTab-GRAPHIC-d7e2029-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch20" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Scheme 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0028.jpeg" id="rightTab-GRAPHIC-d7e2124-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch21" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Scheme 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0029.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0029.jpeg" id="rightTab-GRAPHIC-d7e2274-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch22" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Scheme 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0030.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0030.jpeg" id="rightTab-GRAPHIC-d7e2361-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0030.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch23" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Scheme 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0031.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0031.jpeg" id="rightTab-GRAPHIC-d7e2420-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0031.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch24" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Scheme 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0032.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0032.jpeg" id="rightTab-GRAPHIC-d7e2471-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch25" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Scheme 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0033.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0033.jpeg" id="rightTab-GRAPHIC-d7e2551-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0033.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch26" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Scheme 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0034.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0034.jpeg" id="rightTab-GRAPHIC-d7e2583-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0034.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch27" data-index="34" class="article__inlineFigure"><h2 class="fig-label">Scheme 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0035.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0035.jpeg" id="rightTab-GRAPHIC-d7e2669-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0035.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch28" data-index="35" class="article__inlineFigure"><h2 class="fig-label">Scheme 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0036.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0036.jpeg" id="rightTab-GRAPHIC-d7e2744-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0036.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch28"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch29" data-index="36" class="article__inlineFigure"><h2 class="fig-label">Scheme 29</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0037.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0037.jpeg" id="rightTab-GRAPHIC-d7e2786-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0037.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch29"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch30" data-index="37" class="article__inlineFigure"><h2 class="fig-label">Scheme 30</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0038.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0038.jpeg" id="rightTab-GRAPHIC-d7e2860-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0038.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch30"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch31" data-index="38" class="article__inlineFigure"><h2 class="fig-label">Scheme 31</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0039.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0039.jpeg" id="rightTab-GRAPHIC-d7e2902-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0039.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch31"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch32" data-index="39" class="article__inlineFigure"><h2 class="fig-label">Scheme 32</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0040.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0040.jpeg" id="rightTab-GRAPHIC-d7e3109-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0040.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch32"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch33" data-index="40" class="article__inlineFigure"><h2 class="fig-label">Scheme 33</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0041.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0041.jpeg" id="rightTab-GRAPHIC-d7e3164-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0041.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch33"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch34" data-index="41" class="article__inlineFigure"><h2 class="fig-label">Scheme 34</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0042.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0042.jpeg" id="rightTab-GRAPHIC-d7e3242-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0042.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch34"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch35" data-index="42" class="article__inlineFigure"><h2 class="fig-label">Scheme 35</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0043.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0043.jpeg" id="rightTab-GRAPHIC-d7e3298-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0043.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch35"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch36" data-index="43" class="article__inlineFigure"><h2 class="fig-label">Scheme 36</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0044.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0044.jpeg" id="rightTab-GRAPHIC-d7e3372-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0044.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch36"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch37" data-index="44" class="article__inlineFigure"><h2 class="fig-label">Scheme 37</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0045.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0045.jpeg" id="rightTab-GRAPHIC-d7e3497-autogenerated" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0045.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=sch37"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="45" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/medium/jm0c01480_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Broad-ranging pharmacological applications of HPOs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-23/acs.jmedchem.0c01480/20201203/images/large/jm0c01480_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01480&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i64">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10801" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10801" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 206 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lieu, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiskala, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span> <span> </span><span class="NLM_article-title">The roles of iron in health and disease</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">87</span>, <span class="refDoi">Â DOI: 10.1016/S0098-2997(00)00006-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0098-2997%2800%2900006-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11207374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Olu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2001&pages=1-87&author=P.+T.+Lieuauthor=M.+Heiskalaauthor=P.+A.+Petersonauthor=Y.+Yang&title=The+roles+of+iron+in+health+and+disease&doi=10.1016%2FS0098-2997%2800%2900006-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of iron in health and disease</span></div><div class="casAuthors">Lieu, P. T.; Heiskala, M.; Peterson, P. A.; Yang, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">1-87</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Iron is vital for almost all living organisms by participating in a wide variety of metabolic processes, including oxygen transport, DNA synthesis, and electron transport.  However, iron concns. in body tissues must be tightly regulated because excessive iron leads to tissue damage, as a result of formation of free radicals.  Disorders of iron metab. are among the most common diseases of humans and encompass a broad spectrum of diseases with diverse clin. manifestations, ranging from anemia to iron overload and, possibly, to neurodegenerative diseases.  The mol. understanding of iron regulation in the body is crit. in identifying the underlying causes for each disease and in providing proper diagnosis and treatments.  Recent advances in genetics, mol. biol. and biochem. of iron metab. have assisted in elucidating the mol. mechanisms of iron homeostasis.  The coordinate control of iron uptake and storage is tightly regulated by the feedback system of iron responsive element-contg. gene products and iron regulatory proteins that modulate the expression levels of the genes involved in iron metab.  Recent identification and characterization of the hemochromatosis protein HFE, the iron importer Nramp2, the iron exporter ferroportin 1, and the second transferrin-binding and -transport protein transferrin receptor 2, have demonstrated their important roles in maintaining body's iron homeostasis.  Functional studies of these gene products have expanded our knowledge at the mol. level about the pathways of iron metab. and have provided valuable insight into the defects of iron metab. disorders.  In addn., a variety of animal models have implemented the identification of many genetic defects that lead to abnormal iron homeostasis and have provided crucial clin. information about the pathophysiol. of iron disorders.  In this review, we discuss the latest progress in studies of iron metab. and our current understanding of the mol. mechanisms of iron absorption, transport, utilization, and storage.  Finally, we will discuss the clin. presentations of iron metab. disorders, including secondary iron disorders that are either assocd. with or the result of abnormal iron accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozlLi_XTFS5rVg90H21EOLACvtfcHk0lgVf4e2hPRcTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Olu7s%253D&md5=3b46448bc79fb418f08dfb7fcdd585e5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0098-2997%2800%2900006-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0098-2997%252800%252900006-6%26sid%3Dliteratum%253Aachs%26aulast%3DLieu%26aufirst%3DP.%2BT.%26aulast%3DHeiskala%26aufirst%3DM.%26aulast%3DPeterson%26aufirst%3DP.%2BA.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DThe%2520roles%2520of%2520iron%2520in%2520health%2520and%2520disease%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2001%26volume%3D22%26spage%3D1%26epage%3D87%26doi%3D10.1016%2FS0098-2997%2800%2900006-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gozzelino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, P.</span></span> <span> </span><span class="NLM_article-title">Iron homeostasis in health and disease</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">130</span>â <span class="NLM_lpage">143</span>, <span class="refDoi">Â DOI: 10.3390/ijms17010130</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fijms17010130" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2isbfN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=130-143&issue=1&author=R.+Gozzelinoauthor=P.+Arosio&title=Iron+homeostasis+in+health+and+disease&doi=10.3390%2Fijms17010130"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Iron homeostasis in health and disease</span></div><div class="casAuthors">Gozzelino, Raffaella; Arosio, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">130/1-130/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Iron is required for the survival of most organisms, including bacteria, plants, and humans.  Its homeostasis in mammals must be fine-tuned to avoid iron deficiency with a reduced oxygen transport and diminished activity of Fe-dependent enzymes, and also iron excess that may catalyze the formation of highly reactive hydroxyl radicals, oxidative stress, and programmed cell death.  The advance in understanding the main players and mechanisms involved in iron regulation significantly improved since the discovery of genes responsible for hemochromatosis, the IRE/IRPs machinery, and the hepcidin-ferroportin axis.  This review provides an update on the mol. mechanisms regulating cellular and systemic Fe homeostasis and their roles in pathophysiol. conditions that involve alterations of iron metab., and provides novel therapeutic strategies to prevent the deleterious effect of its deficiency/overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNQ1liVuKcwLVg90H21EOLACvtfcHk0lh_cYTTVyTSXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2isbfN&md5=bccc936de52cb94bb39b1f7bdca01b9b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3390%2Fijms17010130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms17010130%26sid%3Dliteratum%253Aachs%26aulast%3DGozzelino%26aufirst%3DR.%26aulast%3DArosio%26aufirst%3DP.%26atitle%3DIron%2520homeostasis%2520in%2520health%2520and%2520disease%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2016%26volume%3D17%26issue%3D1%26spage%3D130%26epage%3D143%26doi%3D10.3390%2Fijms17010130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poprac, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jomova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simunkova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valko, M.</span></span> <span> </span><span class="NLM_article-title">Targeting free radicals in oxidative stress-related human diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">592</span>â <span class="NLM_lpage">607</span>, <span class="refDoi">Â DOI: 10.1016/j.tips.2017.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tips.2017.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28551354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnsl2gu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=592-607&issue=7&author=P.+Popracauthor=K.+Jomovaauthor=M.+Simunkovaauthor=V.+Kollarauthor=C.+J.+Rhodesauthor=M.+Valko&title=Targeting+free+radicals+in+oxidative+stress-related+human+diseases&doi=10.1016%2Fj.tips.2017.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Free Radicals in Oxidative Stress-Related Human Diseases</span></div><div class="casAuthors">Poprac, Patrik; Jomova, Klaudia; Simunkova, Miriama; Kollar, Vojtech; Rhodes, Christopher J.; Valko, Marian</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">592-607</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cancer and Alzheimer's disease (AD) are characterized by (i) opposing biol. mechanisms, (ii) an inverse correlation between their incidences, and (iii) oxidative stress being a common denominator of both diseases.  Increased formation of reactive oxygen species (ROS) in cancer cells from oncogenic signaling and/or metabolic disturbances leads to upregulation of cellular antioxidant capacity to maintain ROS levels below a toxic threshold.  Combining drugs that induce high levels of ROS with compds. that suppress cellular antioxidant capacity by depleting antioxidant systems [glutathione (GSH), superoxide dismutase (SOD), and thioredoxin (TRX)] and/or targeting glucose metab. represents a potential anticancer strategy.  In AD, free metals and/or AÎ²:metal complexes may cause damage to biomols. in the brain (via Fenton reaction), including DNA.  Metal chelation, based on the application of selective metal chelators or metal delivery, may induce neuroprotective signaling and represents a promising therapeutic strategy.  This review examines therapeutic strategies based on the modulation of oxidative stress in cancer and AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLptt0dD9HmLVg90H21EOLACvtfcHk0lh_cYTTVyTSXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnsl2gu78%253D&md5=651460c1dc146fc35509f224da3b73db</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2017.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2017.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DPoprac%26aufirst%3DP.%26aulast%3DJomova%26aufirst%3DK.%26aulast%3DSimunkova%26aufirst%3DM.%26aulast%3DKollar%26aufirst%3DV.%26aulast%3DRhodes%26aufirst%3DC.%2BJ.%26aulast%3DValko%26aufirst%3DM.%26atitle%3DTargeting%2520free%2520radicals%2520in%2520oxidative%2520stress-related%2520human%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2017%26volume%3D38%26issue%3D7%26spage%3D592%26epage%3D607%26doi%3D10.1016%2Fj.tips.2017.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, N. C.</span></span> <span> </span><span class="NLM_article-title">Disorders of iron metabolism</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">1986</span>â <span class="NLM_lpage">1995</span>, <span class="refDoi">Â DOI: 10.1056/NEJM199912233412607</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1056%2FNEJM199912233412607" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10607817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVaqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1999&pages=1986-1995&author=N.+C.+Andrews&title=Disorders+of+iron+metabolism&doi=10.1056%2FNEJM199912233412607"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Disorders of iron metabolism</span></div><div class="casAuthors">Andrews, Nancy C.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">1986-1995</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review is given with 86 refs. on Fe homeostasis disorders including the topics Fe transport physiol. and Fe deficiency and overload diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXvIU5YpQp0bVg90H21EOLACvtfcHk0lh_cYTTVyTSXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVaqsw%253D%253D&md5=79d235f4a56153a748299697fc317461</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJM199912233412607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199912233412607%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DN.%2BC.%26atitle%3DDisorders%2520of%2520iron%2520metabolism%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1999%26volume%3D341%26spage%3D1986%26epage%3D1995%26doi%3D10.1056%2FNEJM199912233412607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Papanikolaou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pantopoulos, K.</span></span> <span> </span><span class="NLM_article-title">Iron metabolism and toxicity</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>202</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">199</span>â <span class="NLM_lpage">211</span>, <span class="refDoi">Â DOI: 10.1016/j.taap.2004.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.taap.2004.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15629195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvF2g" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2005&pages=199-211&issue=2&author=G.+Papanikolaouauthor=K.+Pantopoulos&title=Iron+metabolism+and+toxicity&doi=10.1016%2Fj.taap.2004.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Iron metabolism and toxicity</span></div><div class="casAuthors">Papanikolaou, G.; Pantopoulos, K.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-211</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Iron is an essential nutrient with limited bioavailability.  When present in excess, iron poses a threat to cells and tissues, and therefore iron homeostasis has to be tightly controlled.  Iron's toxicity is largely based on its ability to catalyze the generation of radicals, which attack and damage cellular macromols. and promote cell death and tissue injury.  This is lucidly illustrated in diseases of iron overload, such as hereditary hemochromatosis or transfusional siderosis, where excessive iron accumulation results in tissue damage and organ failure.  Pathol. iron accumulation in the liver has also been linked to the development of hepatocellular cancer.  Here we provide a background on the biol. and toxicity of iron and the basic concepts of iron homeostasis at the cellular and systemic level.  In addn., we provide an overview of the various disorders of iron overload, which are directly linked to iron's toxicity.  Finally, we discuss the potential role of iron in malignant transformation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQPZQpSwwwMbVg90H21EOLACvtfcHk0lgfV04bol20eA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvF2g&md5=a9185266c08a2d837bd2aa2f7bddd234</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2004.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2004.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DPapanikolaou%26aufirst%3DG.%26aulast%3DPantopoulos%26aufirst%3DK.%26atitle%3DIron%2520metabolism%2520and%2520toxicity%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2005%26volume%3D202%26issue%3D2%26spage%3D199%26epage%3D211%26doi%3D10.1016%2Fj.taap.2004.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crisponi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remelli, M.</span></span> <span> </span><span class="NLM_article-title">Iron chelating agents for the treatment of iron overload</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>252</i></span> (<span class="NLM_issue">10â11</span>),  <span class="NLM_fpage">1225</span>â <span class="NLM_lpage">1240</span>, <span class="refDoi">Â DOI: 10.1016/j.ccr.2007.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ccr.2007.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkvVGktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=2008&pages=1225-1240&issue=10%E2%80%9311&author=G.+Crisponiauthor=M.+Remelli&title=Iron+chelating+agents+for+the+treatment+of+iron+overload&doi=10.1016%2Fj.ccr.2007.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelating agents for the treatment of iron overload</span></div><div class="casAuthors">Crisponi, Guido; Remelli, Maurizio</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">10+11</span>),
    <span class="NLM_cas:pages">1225-1240</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The importance of iron chelators in medicine has significantly increased in recent years.  Iron is essential for life but it is also potentially more toxic than other trace elements.  This is because we lack effective means to protect human cells against iron overload and because of the role of iron in the generation of free radicals.  In order to protect patients from the consequences of iron toxicity, iron chelating agents have been introduced in clin. practice.  Unfortunately, the ideal chelator for treating iron overload in humans has not been identified yet.  In this paper we examine a few characteristics of iron chelators, with some emphasis on the effects of redox cycling, on absorption mechanisms and on some properties of the pFe.  A brief summary is then made of the chelators recently proposed or in development for the treatment of iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5xtdkguWee7Vg90H21EOLACvtfcHk0lgfV04bol20eA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkvVGktLs%253D&md5=01ef992d180be285b1f013dbe1882109</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2007.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2007.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DCrisponi%26aufirst%3DG.%26aulast%3DRemelli%26aufirst%3DM.%26atitle%3DIron%2520chelating%2520agents%2520for%2520the%2520treatment%2520of%2520iron%2520overload%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2008%26volume%3D252%26issue%3D10%25E2%2580%259311%26spage%3D1225%26epage%3D1240%26doi%3D10.1016%2Fj.ccr.2007.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisponi, G.</span></span> <span> </span><span class="NLM_article-title">Iron chelating agents in clinical practice</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>184</i></span>,  <span class="NLM_fpage">291</span>â <span class="NLM_lpage">310</span>, <span class="refDoi">Â DOI: 10.1016/S0010-8545(99)00056-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0010-8545%2899%2900056-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXis1Kitr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=1999&pages=291-310&author=G.+Faaauthor=G.+Crisponi&title=Iron+chelating+agents+in+clinical+practice&doi=10.1016%2FS0010-8545%2899%2900056-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelating agents in clinical practice</span></div><div class="casAuthors">Faa, Gavino; Crisponi, Guido</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">184</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-310</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">A review with 144 refs.  The relevance of iron chelators in medicine has increased in recent years.  Iron is essential for life but it is also potentially more toxic than other trace elements.  This is due to the lack of effective means to protect human cells against iron overload and to the role of iron in the generation of free radicals.  To protect patients from the consequences of iron toxicity, iron chelating agents have been introduced in clin. practice.  Unfortunately, the ideal chelator for treating iron overload in humans has not been identified yet.  The aim of this review is to report the experience with desferrioxamine therapy in patients affected by Î²-thalassemia major according to: bioavailability; mechanism of interactions with hepatocellular iron: release of iron chelates and their excretion; impact of iron chelation on survival in thalassemia patients and side effects of prolonged therapy.  Problems related to the development of non-toxic oral iron chelators are also discussed, with particular emphasis on the preliminary data on usefulness and safety of deferiprone (L1), recently evaluated in different clin. trials.  Iron chelating therapy has been introduced, in recent years, even in the therapy of disorders not characterized by iron overload.  Here the following new therapeutic indications are discussed: adult respiratory distress syndrome, myocardial ischemia, cancer and malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsl26WRz7hZLVg90H21EOLACvtfcHk0lgfV04bol20eA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXis1Kitr4%253D&md5=8f197bb9070580847cb2ecb4ac8f8c2a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2899%2900056-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252899%252900056-9%26sid%3Dliteratum%253Aachs%26aulast%3DFaa%26aufirst%3DG.%26aulast%3DCrisponi%26aufirst%3DG.%26atitle%3DIron%2520chelating%2520agents%2520in%2520clinical%2520practice%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D1999%26volume%3D184%26spage%3D291%26epage%3D310%26doi%3D10.1016%2FS0010-8545%2899%2900056-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirota, K.</span></span> <span> </span><span class="NLM_article-title">An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs)</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>133</i></span>,  <span class="NLM_fpage">118</span>â <span class="NLM_lpage">129</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2018.07.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.freeradbiomed.2018.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30053508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVGrt7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2019&pages=118-129&author=K.+Hirota&title=An+intimate+crosstalk+between+iron+homeostasis+and+oxygen+metabolism+regulated+by+the+hypoxia-inducible+factors+%28HIFs%29&doi=10.1016%2Fj.freeradbiomed.2018.07.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs)</span></div><div class="casAuthors">Hirota, Kiichi</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">118-129</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxygen and iron are among the most abundant elements and have significant roles in human biol.  Iron is essential for oxygen transport and is a component of mol. O2-carrying proteins, such as Hb and myoglobin.  Iron is also a constituent of redox enzymes and can occupy multiple oxidn. states.  An elaborate system has evolved to stringently regulate the concns. of both, free iron and oxygen, in various sites of the body.  The final destination for iron and oxygen in the cells is the mitochondria.  The mitochondria require substantial amts. of iron for heme synthesis and maturation of iron-sulfur clusters, and oxygen, as the electron acceptor in oxidative phosphorylation.  Therefore, the balance between the control of iron availability and the physiol. of hypoxic responses is crit. for maintaining cell homeostasis.  Several lines of study have clearly demonstrated that the transcription factors, hypoxia-inducible factors (HIFs), play a central role in cellular adaptation to critically low oxygen levels in both normal and compromised tissues.  It has also been shown that several target genes of HIFs are involved in iron homeostasis, reflecting the mol. links between oxygen homeostasis and iron metab.  Furthermore, HIF activation is modulated by intracellular iron, through regulation of hydroxylase activity, which requires iron as a cofactor.  In addn., HIF-2Î± translation is controlled by iron regulatory protein (IRP) activity, providing another level of interdependence between iron and oxygen homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbWhPHssqzfLVg90H21EOLACvtfcHk0lhusWB2iRIRoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVGrt7nK&md5=fe7619f8a28d0b6e954a00dbd045aed5</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2018.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2018.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DHirota%26aufirst%3DK.%26atitle%3DAn%2520intimate%2520crosstalk%2520between%2520iron%2520homeostasis%2520and%2520oxygen%2520metabolism%2520regulated%2520by%2520the%2520hypoxia-inducible%2520factors%2520%2528HIFs%2529%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2019%26volume%3D133%26spage%3D118%26epage%3D129%26doi%3D10.1016%2Fj.freeradbiomed.2018.07.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camaschella, C.</span></span> <span> </span><span class="NLM_article-title">Iron-deficiency anemia</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>372</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">1832</span>â <span class="NLM_lpage">1843</span>, <span class="refDoi">Â DOI: 10.1056/NEJMra1401038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1056%2FNEJMra1401038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25946282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC2MfhsVajuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2015&pages=1832-1843&issue=19&author=C.+Camaschella&title=Iron-deficiency+anemia&doi=10.1056%2FNEJMra1401038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-deficiency anemia</span></div><div class="casAuthors">Camaschella Clara</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1832-43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTD0Ma6Pz-Y57mQt-ICR3qNfW6udTcc2easY9Jqht5eI7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfhsVajuw%253D%253D&md5=eb574f46a2062be164b5fc5ad7c139ba</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1401038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1401038%26sid%3Dliteratum%253Aachs%26aulast%3DCamaschella%26aufirst%3DC.%26atitle%3DIron-deficiency%2520anemia%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D372%26issue%3D19%26spage%3D1832%26epage%3D1843%26doi%3D10.1056%2FNEJMra1401038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peyssonnaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nizet, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span> <span> </span><span class="NLM_article-title">Role of the hypoxia inducible factors HIF in iron metabolism</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">28</span>â <span class="NLM_lpage">32</span>, <span class="refDoi">Â DOI: 10.4161/cc.7.1.5145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4161%2Fcc.7.1.5145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18212530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjsVKntbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=28-32&issue=1&author=C.+Peyssonnauxauthor=V.+Nizetauthor=R.+S.+Johnson&title=Role+of+the+hypoxia+inducible+factors+HIF+in+iron+metabolism&doi=10.4161%2Fcc.7.1.5145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the hypoxia inducible factors in iron metabolism</span></div><div class="casAuthors">Peyssonnaux, Carole; Nizet, Victor; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-32</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  Fe is an essential element in all living organisms and is required as a cofactor for O2-binding proteins.  Fe metab., O2 homeostasis, and erythropoiesis are consequently strongly interconnected.  Fe needs to be tightly regulated, as Fe insufficiency induces a hypoferric anemia in mammals, coupled to hypoxia in tissues, whereas excess Fe is toxic, and causes the generation of free radicals.  Given the links between O2 transport and Fe metab., assocns. between the physiol. of hypoxic response and the control of Fe availability are important.  Numerous lines of investigation have proven that the hypoxia-inducible factors (HIFs) function as central mediators of cellular adaptation to critically low O2 levels in both normal and compromised tissues.  Several of these target genes are involved in Fe homeostasis, reflecting the mol. links between O2 homeostasis and Fe metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPOQCmM5opiLVg90H21EOLACvtfcHk0lhusWB2iRIRoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjsVKntbw%253D&md5=fa9b895b40687527bcce1fe2a2d90afa</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.4161%2Fcc.7.1.5145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.7.1.5145%26sid%3Dliteratum%253Aachs%26aulast%3DPeyssonnaux%26aufirst%3DC.%26aulast%3DNizet%26aufirst%3DV.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DRole%2520of%2520the%2520hypoxia%2520inducible%2520factors%2520HIF%2520in%2520iron%2520metabolism%26jtitle%3DCell%2520Cycle%26date%3D2008%26volume%3D7%26issue%3D1%26spage%3D28%26epage%3D32%26doi%3D10.4161%2Fcc.7.1.5145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reichert, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cunha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maselli, L. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bydlowski, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spada, C.</span></span> <span> </span><span class="NLM_article-title">Hepcidin: homeostasis and diseases related to iron metabolism</span>. <i>Acta Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">220</span>â <span class="NLM_lpage">236</span>, <span class="refDoi">Â DOI: 10.1159/000471838</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1159%2F000471838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28514781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGltb%252FJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2017&pages=220-236&issue=4&author=C.+O.+Reichertauthor=J.+da+Cunhaauthor=D.+Levyauthor=L.+M.+F.+Maselliauthor=S.+P.+Bydlowskiauthor=C.+Spada&title=Hepcidin%3A+homeostasis+and+diseases+related+to+iron+metabolism&doi=10.1159%2F000471838"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Hepcidin: Homeostasis and Diseases Related to Iron Metabolism</span></div><div class="casAuthors">Reichert, Cadiele Oliana; da Cunha, Joel; Levy, Debora; Maselli, Luciana Morganti Ferreira; Bydlowski, Sergio Paulo; Spada, Celso</div><div class="citationInfo"><span class="NLM_cas:title">Acta Haematologica</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">220-236</span>CODEN:
                <span class="NLM_cas:coden">ACHAAH</span>;
        ISSN:<span class="NLM_cas:issn">0001-5792</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Iron is an essential metal for cell survival that is regulated by the peptide hormone hepcidin.  However, its influence on certain diseases is directly related to iron metab. or secondary to underlying diseases.  Genetic alterations influence the serum hepcidin concn., which can lead to an iron overload in tissues, as obsd. in haemochromatosis, in which serum hepcidin or defective hepcidin synthesis is obsd.  Another genetic imbalance of iron is iron-refractory anemia, in which serum concns. of hepcidin are increased, precluding the flow and efflux of extra- and intracellular iron.  During the pathogenesis of certain diseases, the resulting oxidative stress, as well as the increase in inflammatory cytokines, influences the transcription of the HAMP gene to generate a secondary anemia due to the increase in the serum concn. of hepcidin.  To date, there is no available drug to inhibit or enhance hepcidin transcription, mostly due to the cytotoxicity described in the in vitro models.  The proposed therapeutic targets are still in the early stages of clin. trials.  Some candidates are promising, such as heparin derivs. and minihepcidins.  This review describes the main pathways of systemic and genetic regulation of hepcidin, as well as its influence on the disorders related to iron metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzsDoCfNY4mLVg90H21EOLACvtfcHk0lhusWB2iRIRoA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGltb%252FJ&md5=7bd8f19af4a461164e08ec9979361bab</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1159%2F000471838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000471838%26sid%3Dliteratum%253Aachs%26aulast%3DReichert%26aufirst%3DC.%2BO.%26aulast%3Dda%2BCunha%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DMaselli%26aufirst%3DL.%2BM.%2BF.%26aulast%3DBydlowski%26aufirst%3DS.%2BP.%26aulast%3DSpada%26aufirst%3DC.%26atitle%3DHepcidin%253A%2520homeostasis%2520and%2520diseases%2520related%2520to%2520iron%2520metabolism%26jtitle%3DActa%2520Haematol.%26date%3D2017%26volume%3D137%26issue%3D4%26spage%3D220%26epage%3D236%26doi%3D10.1159%2F000471838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hentze, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckenthaler, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camaschella, C.</span></span> <span> </span><span class="NLM_article-title">Two to tango: regulation of mammalian iron metabolism</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">24</span>â <span class="NLM_lpage">38</span>, <span class="refDoi">Â DOI: 10.1016/j.cell.2010.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.cell.2010.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20603012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Cjt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=24-38&issue=1&author=M.+W.+Hentzeauthor=M.+U.+Muckenthalerauthor=B.+Galyauthor=C.+Camaschella&title=Two+to+tango%3A+regulation+of+mammalian+iron+metabolism&doi=10.1016%2Fj.cell.2010.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Two to tango: regulation of mammalian iron metabolism</span></div><div class="casAuthors">Hentze, Matthias W.; Muckenthaler, Martina U.; Galy, Bruno; Camaschella, Clara</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-38</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Disruptions in iron homeostasis from both iron deficiency and overload account for some of the most common human diseases.  Iron metab. is balanced by 2 regulatory systems, 1 that functions systemically and relies on the hormone hepcidin and the iron exporter ferroportin, and another that predominantly controls cellular iron metab. through iron-regulatory proteins that bind iron-responsive elements in regulated mRNAs.  We describe how the 2 distinct systems function and how they tango together in a coordinated manner.  We also highlight some of the current questions in mammalian iron metab. and discuss therapeutic opportunities arising from a better understanding of the underlying biol. principles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ8FBfNAaqRrVg90H21EOLACvtfcHk0lgcqBnGH_2bTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Cjt7k%253D&md5=666a7208872dc65c09a987b0b1f62b24</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DHentze%26aufirst%3DM.%2BW.%26aulast%3DMuckenthaler%26aufirst%3DM.%2BU.%26aulast%3DGaly%26aufirst%3DB.%26aulast%3DCamaschella%26aufirst%3DC.%26atitle%3DTwo%2520to%2520tango%253A%2520regulation%2520of%2520mammalian%2520iron%2520metabolism%26jtitle%3DCell%26date%3D2010%26volume%3D142%26issue%3D1%26spage%3D24%26epage%3D38%26doi%3D10.1016%2Fj.cell.2010.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babitt, J. L.</span></span> <span> </span><span class="NLM_article-title">Overview of iron metabolism in health and disease</span>. <i>Hemodial. Int.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">S6</span>â <span class="NLM_lpage">S20</span>, <span class="refDoi">Â DOI: 10.1111/hdi.12542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fhdi.12542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28296010" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2017&pages=S6-S20&author=S.+Devauthor=J.+L.+Babitt&title=Overview+of+iron+metabolism+in+health+and+disease&doi=10.1111%2Fhdi.12542"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fhdi.12542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fhdi.12542%26sid%3Dliteratum%253Aachs%26aulast%3DDev%26aufirst%3DS.%26aulast%3DBabitt%26aufirst%3DJ.%2BL.%26atitle%3DOverview%2520of%2520iron%2520metabolism%2520in%2520health%2520and%2520disease%26jtitle%3DHemodial.%2520Int.%26date%3D2017%26volume%3D21%26spage%3DS6%26epage%3DS20%26doi%3D10.1111%2Fhdi.12542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, M.</span></span> <span> </span><span class="NLM_article-title">Heme oxygenase and heme degradation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">558</span>â <span class="NLM_lpage">567</span>, <span class="refDoi">Â DOI: 10.1016/j.bbrc.2005.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bbrc.2005.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16115609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrvO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=558-567&issue=1&author=G.+Kikuchiauthor=T.+Yoshidaauthor=M.+Noguchi&title=Heme+oxygenase+and+heme+degradation&doi=10.1016%2Fj.bbrc.2005.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Heme oxygenase and heme degradation</span></div><div class="casAuthors">Kikuchi, Goro; Yoshida, Tadashi; Noguchi, Masato</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">558-567</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The microsomal heme oxygenase system consists of heme oxygenase (HO) and NADPH-cytochrome P 450 reductase, and plays a key role in the physiol. catabolism of heme which yields biliverdin, CO, and Fe as the final products.  Heme degrdn. proceeds essentially as a series of autocatalytic oxidn. reactions involving heme bound to HO.  Large amts. of HO proteins from human and rat can now be prepd. in truncated sol. form, and the crystal structures of some HO proteins have been detd.  These advances have greatly facilitated the understanding of the mechanisms of individual steps of the HO reaction.  HO can be induced in animals by the administration of heme or several other substances; the induction is shown to involve Bach1, a translational repressor.  The induced HO is assumed to have cytoprotective effects.  An uninducible HO isoenzyme, HO-2, has been identified, so the authentic HO is now called HO-1.  HOs are also widely distributed in invertebrates, higher plants, algae, and bacteria, and function in various ways according to the needs of individual species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDtfLjsqFCeLVg90H21EOLACvtfcHk0lgcqBnGH_2bTw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrvO&md5=90b28d7eff7e8f0cc7f7204e73c3e956</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DG.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DNoguchi%26aufirst%3DM.%26atitle%3DHeme%2520oxygenase%2520and%2520heme%2520degradation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D338%26issue%3D1%26spage%3D558%26epage%3D567%26doi%3D10.1016%2Fj.bbrc.2005.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chiabrando, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercurio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrillo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinchi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorito, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagoonee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camporeale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlo, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silengo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altruda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolosano, E.</span></span> <span> </span><span class="NLM_article-title">The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4569</span>â <span class="NLM_lpage">4579</span>, <span class="refDoi">Â DOI: 10.1172/JCI62422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1172%2FJCI62422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23187127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVakt7bE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2012&pages=4569-4579&issue=12&author=D.+Chiabrandoauthor=S.+Marroauthor=S.+Mercurioauthor=C.+Giorgiauthor=S.+Petrilloauthor=F.+Vinchiauthor=V.+Fioritoauthor=S.+Fagooneeauthor=A.+Camporealeauthor=E.+Turcoauthor=G.+R.+Merloauthor=L.+Silengoauthor=F.+Altrudaauthor=P.+Pintonauthor=E.+Tolosano&title=The+mitochondrial+heme+exporter+FLVCR1b+mediates+erythroid+differentiation&doi=10.1172%2FJCI62422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation</span></div><div class="casAuthors">Chiabrando, Deborah; Marro, Samuele; Mercurio, Sonia; Giorgi, Carlotta; Petrillo, Sara; Vinchi, Francesca; Fiorito, Veronica; Fagoonee, Sharmila; Camporeale, Annalisa; Turco, Emilia; Merlo, Giorgio R.; Silengo, Lorenzo; Altruda, Fiorella; Pinton, Paolo; Tolosano, Emanuela</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4569-4579</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Feline leukemia virus subgroup C receptor 1 (FLVCR1) is a cell membrane heme exporter that maintains the balance between heme levels and globin synthesis in erythroid precursors.  It was previously shown that Flvcr1-null mice died in utero due to a failure of erythropoiesis.  Here, we identify Flvcr1b, a mitochondrial Flvcr1 isoform that promotes heme efflux into the cytoplasm.  Flvcr1b overexpression promoted heme synthesis and in vitro erythroid differentiation, whereas silencing of Flvcr1b caused mitochondrial heme accumulation and termination of erythroid differentiation.  Furthermore, mice lacking the plasma membrane isoform (Flvcr1a) but expressing Flvcr1b had normal erythropoiesis, but exhibited hemorrhages, edema, and skeletal abnormalities.  Thus, FLVCR1b regulates erythropoiesis by controlling mitochondrial heme efflux, whereas FLVCR1a expression is required to prevent hemorrhages and edema.  The aberrant expression of Flvcr1 isoforms may play a role in the pathogenesis of disorders characterized by an imbalance between heme and globin synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSVBRWMTlIcrVg90H21EOLACvtfcHk0lhNTfnxbcPA9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVakt7bE&md5=c4036d413d168b8cd9f55a0a21e8c33c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1172%2FJCI62422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI62422%26sid%3Dliteratum%253Aachs%26aulast%3DChiabrando%26aufirst%3DD.%26aulast%3DMarro%26aufirst%3DS.%26aulast%3DMercurio%26aufirst%3DS.%26aulast%3DGiorgi%26aufirst%3DC.%26aulast%3DPetrillo%26aufirst%3DS.%26aulast%3DVinchi%26aufirst%3DF.%26aulast%3DFiorito%26aufirst%3DV.%26aulast%3DFagoonee%26aufirst%3DS.%26aulast%3DCamporeale%26aufirst%3DA.%26aulast%3DTurco%26aufirst%3DE.%26aulast%3DMerlo%26aufirst%3DG.%2BR.%26aulast%3DSilengo%26aufirst%3DL.%26aulast%3DAltruda%26aufirst%3DF.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DTolosano%26aufirst%3DE.%26atitle%3DThe%2520mitochondrial%2520heme%2520exporter%2520FLVCR1b%2520mediates%2520erythroid%2520differentiation%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2012%26volume%3D122%26issue%3D12%26spage%3D4569%26epage%3D4579%26doi%3D10.1172%2FJCI62422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arosio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingrassia, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavadini, P.</span></span> <span> </span><span class="NLM_article-title">Ferritins: a family of molecules for iron storage, antioxidation and more</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1790</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">589</span>â <span class="NLM_lpage">599</span>, <span class="refDoi">Â DOI: 10.1016/j.bbagen.2008.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bbagen.2008.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18929623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1yjtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1790&publication_year=2009&pages=589-599&issue=7&author=P.+Arosioauthor=R.+Ingrassiaauthor=P.+Cavadini&title=Ferritins%3A+a+family+of+molecules+for+iron+storage%2C+antioxidation+and+more&doi=10.1016%2Fj.bbagen.2008.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritins: A family of molecules for iron storage, antioxidation and more</span></div><div class="casAuthors">Arosio, Paolo; Ingrassia, Rosaria; Cavadini, Patrizia</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1790</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">589-599</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Ferritins are characterized by highly conserved 3-dimensional structures similar to spherical shells, designed to accommodate large amts. of Fe in a safe, sol., and bioavailable form.  They can have different architectures with 12 or 24 equiv. or non-equiv. subunits, all surrounding a large cavity.  All ferritins readily interact with Fe(II) to induce its oxidn. and deposition in the cavity in a mineral form, in a reaction that is catalyzed by a ferroxidase center.  This is an anti-oxidant activity that consumes Fe(II) and peroxides, the reagents that produce toxic free radicals in the Fenton reaction.  The mechanism of ferritin Fe incorporation has been characterized in detail, while that of Fe release and recycling has been less thoroughly studied.  Generally ferritin expression is regulated by Fe and by oxidative damage, and in vertebrates it plays a central role in the control of cellular iron homeostasis.  Ferritin is mostly cytosolic, but is also found in mammalian mitochondria and nuclei, in plant plastids, and is secreted in insects.  In vertebrates, the cytosolic ferritins are composed of H and L subunit types and their assembly in a tissue-specific ratio that permits flexibility to adapt to cell needs.  The H-ferritin can translocate to the nuclei in some cell types to protect DNA from Fe toxicity, or can be actively secreted, accomplishing various functions.  Mitochondrial ferritin is found in mammals, has a restricted tissue distribution, and seems to protect mitochondria from Fe toxicity and oxidative damage.  The various functions attributed to the cytosolic, nuclear, secretory, and mitochondrial ferritins are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSpcr96o0_hbVg90H21EOLACvtfcHk0lhNTfnxbcPA9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1yjtL4%253D&md5=f6cf377564ba32153f377a82fd70ec51</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2008.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2008.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DArosio%26aufirst%3DP.%26aulast%3DIngrassia%26aufirst%3DR.%26aulast%3DCavadini%26aufirst%3DP.%26atitle%3DFerritins%253A%2520a%2520family%2520of%2520molecules%2520for%2520iron%2520storage%252C%2520antioxidation%2520and%2520more%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2009%26volume%3D1790%26issue%3D7%26spage%3D589%26epage%3D599%26doi%3D10.1016%2Fj.bbagen.2008.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bogdan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, Y.</span></span> <span> </span><span class="NLM_article-title">Regulators of iron homeostasis: new players in metabolism, cell death, and disease</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">274</span>â <span class="NLM_lpage">286</span>, <span class="refDoi">Â DOI: 10.1016/j.tibs.2015.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tibs.2015.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26725301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVSktbvP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2016&pages=274-286&issue=3&author=A.+R.+Bogdanauthor=M.+Miyazawaauthor=K.+Hashimotoauthor=Y.+Tsuji&title=Regulators+of+iron+homeostasis%3A+new+players+in+metabolism%2C+cell+death%2C+and+disease&doi=10.1016%2Fj.tibs.2015.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">regulators of iron homeostasis-new players in metabolism, cell death, and disease</span></div><div class="casAuthors">Bogdan, Alexander R.; Miyazawa, Masaki; Hashimoto, Kazunori; Tsuji, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">274-286</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Iron is necessary for life, but can also cause cell death.  Accordingly, cells evolved a robust, tightly regulated suite of genes for maintaining iron homeostasis.  Previous mechanistic studies on iron homeostasis have granted insight into the role of iron in human health and disease.  We highlight new regulators of iron metab., including iron-trafficking proteins [solute carrier family 39, SLC39, also known as ZRT/IRT-like protein, ZIP; and poly-(rC)-binding protein, PCBP] and a cargo receptor (NCOA4) that is crucial for release of ferritin-bound iron.  We also discuss emerging roles of iron in apoptosis and a novel iron-dependent cell death pathway termed 'ferroptosis', the dysregulation of iron metab. in human pathologies, and the use of iron chelators in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGA66e9AaR87Vg90H21EOLACvtfcHk0lhNTfnxbcPA9w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVSktbvP&md5=72dae0b46d3d001915cdcc9533de7ee6</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2015.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2015.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DBogdan%26aufirst%3DA.%2BR.%26aulast%3DMiyazawa%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DK.%26aulast%3DTsuji%26aufirst%3DY.%26atitle%3DRegulators%2520of%2520iron%2520homeostasis%253A%2520new%2520players%2520in%2520metabolism%252C%2520cell%2520death%252C%2520and%2520disease%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2016%26volume%3D41%26issue%3D3%26spage%3D274%26epage%3D286%26doi%3D10.1016%2Fj.tibs.2015.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancias, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pontano Vaites, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biancur, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goessling, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span> <span> </span><span class="NLM_article-title">Ferritinophagy <i>via</i> NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">10308</span>â <span class="NLM_lpage">10327</span>, <span class="refDoi">Â DOI: 10.7554/eLife.10308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.7554%2FeLife.10308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXls1Snsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=10308-10327&author=J.+D.+Manciasauthor=L.+Pontano+Vaitesauthor=S.+Nissimauthor=D.+E.+Biancurauthor=A.+J.+Kimauthor=X.+X.+Wangauthor=Y.+Liuauthor=W.+Goesslingauthor=A.+C.+Kimmelmanauthor=J.+W.+Harper&title=Ferritinophagy+via+NCOA4+is+required+for+erythropoiesis+and+is+regulated+by+iron+dependent+HERC2-mediated+proteolysis&doi=10.7554%2FeLife.10308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis</span></div><div class="casAuthors">Mancias, Joseph D.; Vaites, Laura Pontano; Nissim, Sahar; Biancur, Douglas E.; Kim, Andrew J.; Wang, Xiaoxu; Liu, Yu; Goessling, Wolfram; Kimmelman, Alec C.; Harper, J. Wade</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e10308/1-e10308/19</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">NCOA4 is a selective cargo receptor for the autophagic turnover of ferritin, a process crit. for regulation of intracellular iron bioavailability.  However, how ferritinophagy flux is controlled and the roles of NCOA4 in iron-dependent processes are poorly understood.  Through anal. of the NCOA4-FTH1 interaction, we demonstrate that direct assocn. via a key surface arginine in FTH1 and a C-terminal element in NCOA4 is required for delivery of ferritin to the lysosome via autophagosomes.  Moreover, NCOA4 abundance is under dual control via autophagy and the ubiquitin proteasome system.  Ubiquitin-dependent NCOA4 turnover is promoted by excess iron and involves an iron-dependent interaction between NCOA4 and the HERC2 ubiquitin ligase.  In zebrafish and cultured cells, NCOA4 plays an essential role in erythroid differentiation.  This work reveals the mol. nature of the NCOA4-ferritin complex and explains how intracellular iron levels modulate NCOA4-mediated ferritinophagy in cells and in an iron-dependent physiol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHja4uWUDFuLVg90H21EOLACvtfcHk0lg4zdngy_zBlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXls1Snsr4%253D&md5=2669906c24fa9619c03b9ac0b0e58af5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.7554%2FeLife.10308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.10308%26sid%3Dliteratum%253Aachs%26aulast%3DMancias%26aufirst%3DJ.%2BD.%26aulast%3DPontano%2BVaites%26aufirst%3DL.%26aulast%3DNissim%26aufirst%3DS.%26aulast%3DBiancur%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DA.%2BJ.%26aulast%3DWang%26aufirst%3DX.%2BX.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGoessling%26aufirst%3DW.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26atitle%3DFerritinophagy%2520via%2520NCOA4%2520is%2520required%2520for%2520erythropoiesis%2520and%2520is%2520regulated%2520by%2520iron%2520dependent%2520HERC2-mediated%2520proteolysis%26jtitle%3DeLife%26date%3D2015%26volume%3D4%26spage%3D10308%26epage%3D10327%26doi%3D10.7554%2FeLife.10308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwanhaeusser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr-Ivacevic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benes, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selbach, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckenthaler, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hentze, M. W.</span></span> <span> </span><span class="NLM_article-title">Iron regulatory protein-1 and â2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">e168</span>â <span class="NLM_lpage">e179</span>, <span class="refDoi">Â DOI: 10.1182/blood-2011-04-343541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood-2011-04-343541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21940823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2011&pages=e168-e179&issue=22&author=M.+Sanchezauthor=B.+Galyauthor=B.+Schwanhaeusserauthor=J.+Blakeauthor=T.+Bahr-Ivacevicauthor=V.+Benesauthor=M.+Selbachauthor=M.+U.+Muckenthalerauthor=M.+W.+Hentze&title=Iron+regulatory+protein-1+and+%E2%88%922%3A+transcriptome-wide+definition+of+binding+mRNAs+and+shaping+of+the+cellular+proteome+by+iron+regulatory+proteins&doi=10.1182%2Fblood-2011-04-343541"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Iron regulatory protein-1 and -2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins</span></div><div class="casAuthors">Sanchez, Mayka; Galy, Bruno; Schwanhaeusser, Bjoern; Blake, Jonathon; Baehr-Ivacevic, Tomi; Benes, Vladimir; Selbach, Matthias; Muckenthaler, Martina U.; Hentze, Matthias W.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">e168-e179</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Iron regulatory proteins (IRPs) 1 and 2 are RNA-binding proteins that control cellular iron metab. by binding to conserved RNA motifs called iron-responsive elements (IREs).  The currently known IRP-binding mRNAs encode proteins involved in iron uptake, storage, and release as well as heme synthesis.  To systematically define the IRE/IRP regulatory network on a transcriptome-wide scale, IRP1/IRE and IRP2/IRE messenger ribonucleoprotein complexes were immunoselected, and the mRNA compn. was detd. using microarrays.  We identify 35 novel mRNAs that bind both IRP1 and IRP2, and we also report for the first time cellular mRNAs with exclusive specificity for IRP1 or IRP2.  To further explore cellular iron metab. at a system-wide level, we undertook proteomic anal. by pulsed stable isotope labeling by amino acids in cell culture in an iron-modulated mouse hepatic cell line and in bone marrow-derived macrophages from IRP1- and IRP2-deficient mice.  This work investigates cellular iron metab. in unprecedented depth and defines a wide network of mRNAs and proteins with iron-dependent regulation, IRP-dependent regulation, or both.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyXVb4VoW2dLVg90H21EOLACvtfcHk0lg4zdngy_zBlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ShtrfE&md5=8b5c81ae913c190fef0b883707ad2261</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1182%2Fblood-2011-04-343541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2011-04-343541%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DM.%26aulast%3DGaly%26aufirst%3DB.%26aulast%3DSchwanhaeusser%26aufirst%3DB.%26aulast%3DBlake%26aufirst%3DJ.%26aulast%3DBahr-Ivacevic%26aufirst%3DT.%26aulast%3DBenes%26aufirst%3DV.%26aulast%3DSelbach%26aufirst%3DM.%26aulast%3DMuckenthaler%26aufirst%3DM.%2BU.%26aulast%3DHentze%26aufirst%3DM.%2BW.%26atitle%3DIron%2520regulatory%2520protein-1%2520and%2520%25E2%2588%25922%253A%2520transcriptome-wide%2520definition%2520of%2520binding%2520mRNAs%2520and%2520shaping%2520of%2520the%2520cellular%2520proteome%2520by%2520iron%2520regulatory%2520proteins%26jtitle%3DBlood%26date%3D2011%26volume%3D118%26issue%3D22%26spage%3De168%26epage%3De179%26doi%3D10.1182%2Fblood-2011-04-343541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Comporti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signorini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buonocore, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccoli, L.</span></span> <span> </span><span class="NLM_article-title">Iron release, oxidative stress and erythrocyte ageing</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">568</span>â <span class="NLM_lpage">576</span>, <span class="refDoi">Â DOI: 10.1016/S0891-5849(02)00759-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0891-5849%2802%2900759-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11909691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWlsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=568-576&issue=7&author=M.+Comportiauthor=C.+Signoriniauthor=G.+Buonocoreauthor=L.+Ciccoli&title=Iron+release%2C+oxidative+stress+and+erythrocyte+ageing&doi=10.1016%2FS0891-5849%2802%2900759-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Iron release, oxidative stress and erythrocyte aging</span></div><div class="casAuthors">Comporti, Mario; Signorini, Cinzia; Buonocore, Giuseppe; Ciccoli, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">568-576</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 61 refs.  Fe, to be redox cycling active, has to be released from its macromol. complexes (ferritin, transferrin, hemoproteins, etc.).  Fe is released from Hb or its derivs. in a nonprotein-bound, desferrioxamine-chelatable form (DCI) in a no. of conditions in which the erythrocytes are subjected to oxidative stress.  Such conditions can be related to toxicol. events (hemolytic drugs) or to physiol. situations (erythrocyte ageing, reproduced in a model of prolonged aerobic incubation), but can also result from more subtle circumstances in which a state of ischemia-reperfusion is imposed on erythrocytes (e.g., childbirth).  The released Fe could play a central role in the oxidn. of membrane proteins and senescent cell antigen (SCA) formation, one of the major pathways for erythrocyte removal.  Fe chelators able to enter cells (such as ferrozine, quercetin, and fluorobenzoylpyridoxal hydrazone) prevent both membrane protein oxidn. and SCA formation.  The increased release of Fe obsd. in Î²-thalassemia patients and newborns (particularly premature babies) suggests that fetal Hb is more prone to release Fe than adult Hb.  In newborns the release of Fe in erythrocytes is correlated with plasma nonprotein-bound Fe and may contribute to its appearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcgeowwiAdeLVg90H21EOLACvtfcHk0lg4zdngy_zBlQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWlsbw%253D&md5=c649bd698d4cdd430ff01e03e165b765</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2802%2900759-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252802%252900759-1%26sid%3Dliteratum%253Aachs%26aulast%3DComporti%26aufirst%3DM.%26aulast%3DSignorini%26aufirst%3DC.%26aulast%3DBuonocore%26aufirst%3DG.%26aulast%3DCiccoli%26aufirst%3DL.%26atitle%3DIron%2520release%252C%2520oxidative%2520stress%2520and%2520erythrocyte%2520ageing%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2002%26volume%3D32%26issue%3D7%26spage%3D568%26epage%3D576%26doi%3D10.1016%2FS0891-5849%2802%2900759-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haldar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beserra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopfer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrick, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span> <span> </span><span class="NLM_article-title">Prion protein functions as a ferrireductase partner for ZIP14 and DMT1</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">322</span>â <span class="NLM_lpage">330</span>, <span class="refDoi">Â DOI: 10.1016/j.freeradbiomed.2015.03.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.freeradbiomed.2015.03.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25862412" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnvFequ7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2015&pages=322-330&author=A.+K.+Tripathiauthor=S.+Haldarauthor=J.+Qianauthor=A.+Beserraauthor=S.+Sudaauthor=A.+Singhauthor=U.+Hopferauthor=S.+G.+Chenauthor=M.+D.+Garrickauthor=J.+R.+Turnerauthor=M.+D.+Knutsonauthor=N.+Singh&title=Prion+protein+functions+as+a+ferrireductase+partner+for+ZIP14+and+DMT1&doi=10.1016%2Fj.freeradbiomed.2015.03.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Prion protein functions as a ferrireductase partner for ZIP14 and DMT1</span></div><div class="casAuthors">Tripathi, Ajai K.; Haldar, Swati; Qian, Juan; Beserra, Amber; Suda, Srinivas; Singh, Ajay; Hopfer, Ulrich; Chen, Shu G.; Garrick, Michael D.; Turner, Jerrold R.; Knutson, Mitchell D.; Singh, Neena</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-330</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Excess circulating iron is stored in the liver, and requires redn. of non-Tf-bound iron (NTBI) and transferrin (Tf) iron at the plasma membrane and endosomes, resp., by ferrireductase (FR) proteins for transport across biol. membranes through divalent metal transporters.  Here, we report that prion protein (PrPC), a ubiquitously expressed glycoprotein most abundant on neuronal cells, functions as a FR partner for divalent-metal transporter-1 (DMT1) and ZIP14.  Thus, absence of PrPC in PrP-knock-out (PrP-/-) mice resulted in markedly reduced liver iron stores, a deficiency that was not cor. by chronic or acute administration of iron by the oral or i.p. routes.  Likewise, preferential radiolabeling of circulating NTBI with 59Fe revealed significantly reduced uptake and storage of NTBI by the liver of PrP-/- mice relative to matched PrP+/+ controls.  However, uptake, storage, and utilization of ferritin-bound iron that does not require redn. for uptake were increased in PrP-/- mice, indicating a compensatory response to the iron deficiency.  Expression of exogenous PrPC in HepG2 cells increased uptake and storage of ferric iron (Fe3+), not ferrous iron (Fe2+), from the medium, supporting the function of PrPC as a plasma membrane FR.  Coexpression of PrPC with ZIP14 and DMT1 in HepG2 cells increased uptake of Fe3+ significantly, and surprisingly, increased the ratio of N-terminally truncated PrPC forms lacking the FR domain relative to full-length PrPC.  Together, these observations indicate that PrPC promotes, and possibly regulates, the uptake of NTBI through DMT1 and Zip14 via its FR activity.  Implications of these observations for neuronal iron homeostasis under physiol. and pathol. conditions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNTHlYryZ9JrVg90H21EOLACvtfcHk0liazN6EFQl52Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnvFequ7Y%253D&md5=d0282869356ae5b39d41ac390856bd31</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2015.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2015.03.037%26sid%3Dliteratum%253Aachs%26aulast%3DTripathi%26aufirst%3DA.%2BK.%26aulast%3DHaldar%26aufirst%3DS.%26aulast%3DQian%26aufirst%3DJ.%26aulast%3DBeserra%26aufirst%3DA.%26aulast%3DSuda%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DHopfer%26aufirst%3DU.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DGarrick%26aufirst%3DM.%2BD.%26aulast%3DTurner%26aufirst%3DJ.%2BR.%26aulast%3DKnutson%26aufirst%3DM.%2BD.%26aulast%3DSingh%26aufirst%3DN.%26atitle%3DPrion%2520protein%2520functions%2520as%2520a%2520ferrireductase%2520partner%2520for%2520ZIP14%2520and%2520DMT1%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2015%26volume%3D84%26spage%3D322%26epage%3D330%26doi%3D10.1016%2Fj.freeradbiomed.2015.03.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkitkasemwong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparkman, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, M. D.</span></span> <span> </span><span class="NLM_article-title">ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">34032</span>â <span class="NLM_lpage">34043</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M112.367284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1074%2Fjbc.M112.367284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22898811" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=34032-34043&issue=41&author=C.+Y.+Wangauthor=S.+Jenkitkasemwongauthor=S.+Duarteauthor=B.+K.+Sparkmanauthor=A.+Shawkiauthor=B.+Mackenzieauthor=M.+D.+Knutson&title=ZIP8+is+an+iron+and+zinc+transporter+whose+cell-surface+expression+is+up-regulated+by+cellular+iron+loading&doi=10.1074%2Fjbc.M112.367284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">ZIP8 Is an Iron and Zinc Transporter Whose Cell-surface Expression Is Up-regulated by Cellular Iron Loading</span></div><div class="casAuthors">Wang, Chia-Yu; Jenkitkasemwong, Supak; Duarte, Stephanie; Sparkman, Brian K.; Shawki, Ali; MacKenzie, Bryan; Knutson, Mitchell D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">34032-34043</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">ZIP8 (SLC39A8) belongs to the ZIP family of metal-ion transporters.  Among the ZIP proteins, ZIP8 is most closely related to ZIP14, which can transport iron, zinc, manganese, and cadmium.  Here, we investigated the iron transport ability of ZIP8, its subcellular localization, pH dependence, and regulation by iron.  Transfection of HEK 293T cells with ZIP8 cDNA enhanced the uptake of 59Fe and 65Zn by 200 and 40%, resp., compared with controls.  Excess iron inhibited the uptake of zinc and vice versa.  In RNA-injected Xenopus oocytes, ZIP8-mediated 55Fe2+ transport was saturable (K0.5 of â¼0.7 Î¼m) and inhibited by zinc.  ZIP8 also mediated the uptake of 109Cd2+, 57Co2+, 65Zn2+ > 54Mn2+, but not 64Cu (I or II).  By using immunofluorescence anal., we found that ZIP8 expressed in HEK 293T cells localized to the plasma membrane and partially in early endosomes.  Iron loading increased total and cell-surface levels of ZIP8 in H4IIE rat hepatoma cells.  We also detd. by using site-directed mutagenesis that asparagine residues 40, 88, and 96 of rat ZIP8 are glycosylated and that N-glycosylation is not required for iron or zinc transport.  Anal. of 20 different human tissues revealed abundant ZIP8 expression in lung and placenta and showed that its expression profile differs markedly from ZIP14, suggesting nonredundant functions.  Suppression of endogenous ZIP8 expression in BeWo cells, a placental cell line, reduced iron uptake by â¼40%, suggesting that ZIP8 participates in placental iron transport.  Collectively, these data identify ZIP8 as an iron transport protein that may function in iron metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9PjK5H_MI2LVg90H21EOLACvtfcHk0liazN6EFQl52Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVKlsLrM&md5=70d2c40d7f358747a89f2a4da7218030</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.367284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.367284%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%2BY.%26aulast%3DJenkitkasemwong%26aufirst%3DS.%26aulast%3DDuarte%26aufirst%3DS.%26aulast%3DSparkman%26aufirst%3DB.%2BK.%26aulast%3DShawki%26aufirst%3DA.%26aulast%3DMackenzie%26aufirst%3DB.%26aulast%3DKnutson%26aufirst%3DM.%2BD.%26atitle%3DZIP8%2520is%2520an%2520iron%2520and%2520zinc%2520transporter%2520whose%2520cell-surface%2520expression%2520is%2520up-regulated%2520by%2520cellular%2520iron%2520loading%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D41%26spage%3D34032%26epage%3D34043%26doi%3D10.1074%2Fjbc.M112.367284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lane, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation</span>. <i>Nutrients</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2274</span>â <span class="NLM_lpage">2296</span>, <span class="refDoi">Â DOI: 10.3390/nu7042274</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fnu7042274" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25835049" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXotVyqu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2274-2296&issue=4&author=D.+J.+Laneauthor=D.+H.+Baeauthor=A.+M.+Merlotauthor=S.+Sahniauthor=D.+R.+Richardson&title=Duodenal+cytochrome+b+%28DCYTB%29+in+iron+metabolism%3A+an+update+on+function+and+regulation&doi=10.3390%2Fnu7042274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation</span></div><div class="casAuthors">Lane, Darius J. R.; Bae, Dong-Hun; Merlot, Angelica M.; Sahni, Sumit; Richardson, Des R.</div><div class="citationInfo"><span class="NLM_cas:title">Nutrients</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2274-2296</span>CODEN:
                <span class="NLM_cas:coden">NUTRHU</span>;
        ISSN:<span class="NLM_cas:issn">2072-6643</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Iron and ascorbate are vital cellular constituents in mammalian systems.  The bulk-requirement for iron is during erythropoiesis leading to the generation of Hb-contg. erythrocytes.  Addnl., both iron and ascorbate are required as co-factors in numerous metabolic reactions.  Iron homeostasis is controlled at the level of uptake, rather than excretion.  Accumulating evidence strongly suggests that in addn. to the known ability of dietary ascorbate to enhance non-heme iron absorption in the gut, ascorbate regulates iron homeostasis.  The involvement of ascorbate in dietary iron absorption extends beyond the direct chem. redn. of non-heme iron by dietary ascorbate.  Among other activities, intra-enterocyte ascorbate appears to be involved in the provision of electrons to a family of trans-membrane redox enzymes, namely those of the cytochroe b561 class.  These hemoproteins oxidize a pool of ascorbate on one side of the membrane in order to reduce an electron acceptor (e.g., non-heme iron) on the opposite side of the membrane.  One member of this family, duodenal cytochrome b (DCYTB), may play an important role in ascorbate-dependent redn. of non-heme iron in the gut prior to uptake by ferrous-iron transporters.  This review discusses the emerging relationship between cellular iron homeostasis, the emergent "IRP1-HIF2Î± axis", DCYTB and ascorbate in relation to iron metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl-NPgYEANlrVg90H21EOLACvtfcHk0liazN6EFQl52Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXotVyqu70%253D&md5=0c219c57ee57b67a9e8384bb6fa5e1ee</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fnu7042274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fnu7042274%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DD.%2BJ.%26aulast%3DBae%26aufirst%3DD.%2BH.%26aulast%3DMerlot%26aufirst%3DA.%2BM.%26aulast%3DSahni%26aufirst%3DS.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DDuodenal%2520cytochrome%2520b%2520%2528DCYTB%2529%2520in%2520iron%2520metabolism%253A%2520an%2520update%2520on%2520function%2520and%2520regulation%26jtitle%3DNutrients%26date%3D2015%26volume%3D7%26issue%3D4%26spage%3D2274%26epage%3D2296%26doi%3D10.3390%2Fnu7042274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinilla-Tenas, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparkman, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shawki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illing, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuzzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cousins, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knutson, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackenzie, B.</span></span> <span> </span><span class="NLM_article-title">Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron</span>. <i>Am. J. Physiol. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>301</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">C862</span>â <span class="NLM_lpage">C871</span>, <span class="refDoi">Â DOI: 10.1152/ajpcell.00479.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1152%2Fajpcell.00479.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21653899" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2011&pages=C862-C871&issue=4&author=J.+J.+Pinilla-Tenasauthor=B.+K.+Sparkmanauthor=A.+Shawkiauthor=A.+C.+Illingauthor=C.+J.+Mitchellauthor=N.+Zhaoauthor=J.+P.+Liuzziauthor=R.+J.+Cousinsauthor=M.+D.+Knutsonauthor=B.+Mackenzie&title=Zip14+is+a+complex+broad-scope+metal-ion+transporter+whose+functional+properties+support+roles+in+the+cellular+uptake+of+zinc+and+nontransferrin-bound+iron&doi=10.1152%2Fajpcell.00479.2010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00479.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00479.2010%26sid%3Dliteratum%253Aachs%26aulast%3DPinilla-Tenas%26aufirst%3DJ.%2BJ.%26aulast%3DSparkman%26aufirst%3DB.%2BK.%26aulast%3DShawki%26aufirst%3DA.%26aulast%3DIlling%26aufirst%3DA.%2BC.%26aulast%3DMitchell%26aufirst%3DC.%2BJ.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DLiuzzi%26aufirst%3DJ.%2BP.%26aulast%3DCousins%26aufirst%3DR.%2BJ.%26aulast%3DKnutson%26aufirst%3DM.%2BD.%26aulast%3DMackenzie%26aufirst%3DB.%26atitle%3DZip14%2520is%2520a%2520complex%2520broad-scope%2520metal-ion%2520transporter%2520whose%2520functional%2520properties%2520support%2520roles%2520in%2520the%2520cellular%2520uptake%2520of%2520zinc%2520and%2520nontransferrin-bound%2520iron%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell.%2520Physiol.%26date%3D2011%26volume%3D301%26issue%3D4%26spage%3DC862%26epage%3DC871%26doi%3D10.1152%2Fajpcell.00479.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung-Toung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spino, M.</span></span> <span> </span><span class="NLM_article-title">Iron chelator research: past, present, and future</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">983</span>â <span class="NLM_lpage">995</span>, <span class="refDoi">Â DOI: 10.2174/0929867033457593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F0929867033457593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12678671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=983-995&author=T.+F.+Tamauthor=R.+Leung-Toungauthor=W.+Liauthor=Y.+S.+Wangauthor=K.+Karimianauthor=M.+Spino&title=Iron+chelator+research%3A+past%2C+present%2C+and+future&doi=10.2174%2F0929867033457593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelator research: Past, present, and future</span></div><div class="casAuthors">Tam, Tim F.; Leung-Toung, Regis; Li, Wanren; Wang, Yingsheng; Karimian, Khashayar; Spino, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">983-995</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The occurrence of in vivo iron toxicity in the human body can be categorized into iron overload and noniron overload conditions.  Iron overload conditions are common in Î²-thalassemia and hereditary hemochromatosis patients, and anthracycline-mediated cardiotoxicity is an example of a noniron overload condition in cancer patients, in which the toxicity is iron-dependent.  While hundreds of iron chelators have been evaluated in animal studies, only a few have been studied in humans.  Examples of iron chelator drugs are desferrioxamine (DFO), Deferiprone (LI), and Dexrazoxane (ICRF 187).  The compd. ICL670 has completed phase II clin. trials and a phase III trial is planned in 2003.  Triapine is currently in phase II clin. trial as an anticancer agent.  CP502, GT56-252, NaHBED, and MPB0201 are examples of new chelators in preclin./clin. development.  In the past decade, many new viable utilities for iron chelators have been reported.  This includes the use of iron chelators as antiviral, photoprotective, antiproliferative, and antifibrotic agents.  This review will focus on the status of drug development for the treatment of iron overload in patients with Î²-thalassemia and the potential use of iron chelators in the prevention and treatment of other diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprcNjtxrkc9rVg90H21EOLACvtfcHk0ljVz34rY3gzbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtLY%253D&md5=d9efe5f4ace7278ed9fec88145dc5af3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.2174%2F0929867033457593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457593%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DT.%2BF.%26aulast%3DLeung-Toung%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%2BS.%26aulast%3DKarimian%26aufirst%3DK.%26aulast%3DSpino%26aufirst%3DM.%26atitle%3DIron%2520chelator%2520research%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D983%26epage%3D995%26doi%3D10.2174%2F0929867033457593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wessling-Resnick, M.</span></span> <span> </span><span class="NLM_article-title">Iron homeostasis and the inflammatory response</span>. <i>Annu. Rev. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">105</span>â <span class="NLM_lpage">122</span>, <span class="refDoi">Â DOI: 10.1146/annurev.nutr.012809.104804</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1146%2Fannurev.nutr.012809.104804" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20420524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWgsb3E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=105-122&author=M.+Wessling-Resnick&title=Iron+homeostasis+and+the+inflammatory+response&doi=10.1146%2Fannurev.nutr.012809.104804"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Iron homeostasis and the inflammatory response</span></div><div class="casAuthors">Wessling-Resnick, Marianne</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Nutrition</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-122</span>CODEN:
                <span class="NLM_cas:coden">ARNTD8</span>;
        ISSN:<span class="NLM_cas:issn">0199-9885</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Iron and its homeostasis are intimately tied to the inflammatory response.  The adaptation to iron deficiency, which confers resistance to infection and improves the inflammatory condition, underlies what is probably the most obvious link: the anemia of inflammation or chronic disease.  A large no. of stimulatory inputs must be integrated to tightly control iron homeostasis during the inflammatory response.  In order to understand the pathways of iron trafficking and how they are regulated, this article presents a brief overview of iron homeostasis.  A major focus is on the regulation of the peptide hormone hepcidin during the inflammatory response and how its function contributes to the process of iron withdrawal.  The review also summarizes new and emerging information about other iron metabolic regulators and effectors that contribute to the inflammatory response.  Potential benefits of treatment to ameliorate the hypoferremic condition promoted by inflammation are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpI-h7L4t-_JLVg90H21EOLACvtfcHk0ljVz34rY3gzbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWgsb3E&md5=062cc48100f9329ab396758e05a53d63</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1146%2Fannurev.nutr.012809.104804&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.nutr.012809.104804%26sid%3Dliteratum%253Aachs%26aulast%3DWessling-Resnick%26aufirst%3DM.%26atitle%3DIron%2520homeostasis%2520and%2520the%2520inflammatory%2520response%26jtitle%3DAnnu.%2520Rev.%2520Nutr.%26date%3D2010%26volume%3D30%26spage%3D105%26epage%3D122%26doi%3D10.1146%2Fannurev.nutr.012809.104804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Apostolakis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kypraiou, A. M.</span></span> <span> </span><span class="NLM_article-title">Iron in neurodegenerative disorders: being in the wrong place at the wrong time?</span>. <i>Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">893</span>â <span class="NLM_lpage">911</span>, <span class="refDoi">Â DOI: 10.1515/revneuro-2017-0020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1515%2Frevneuro-2017-0020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28792913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsrbO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=893-911&issue=8&author=S.+Apostolakisauthor=A.+M.+Kypraiou&title=Iron+in+neurodegenerative+disorders%3A+being+in+the+wrong+place+at+the+wrong+time%3F&doi=10.1515%2Frevneuro-2017-0020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Iron in neurodegenerative disorders: being in the wrong place at the wrong time?</span></div><div class="casAuthors">Apostolakis, Sotirios; Kypraiou, Anna-Maria</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">893-911</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Walter de Gruyter GmbH</span>)
        </div><div class="casAbstract">A review.  Brain iron deposits have been reported consistently in imaging and histol. examns. of patients with neurodegenerative disorders.  While the origins of this finding have not been clarified yet, it is speculated that impaired iron homeostasis or deficient transport mechanisms result in the accumulation of this highly toxic metal ultimately leading to formation of reactive oxygen species and cell death.  On the other hand, there are also those who support that iron is just an incidental finding, a by product of neuronal loss.  A literature review has been performed in order to present the key findings in support of the iron hypothesis of neurodegeneration, as well as to identify conditions causing or resulting from iron overload and compare and contrast their features with the most prominent neurodegenerative disorders.  There is an abundance of exptl. and observational findings in support of the hypothesis in question; however, as neurodegeneration is a rare incident of commonly encountered iron-assocd. disorders of the nervous system, and this metal is found in non-neurodegenerative disorders as well, it is possible that iron is the result or even an incidental finding in neurodegeneration.  Understanding the underlying processes of iron metab. in the brain and particularly its release during cell damage is expected to provide a deeper understanding of the origins of neurodegeneration in the years to come.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsuxA8GYkFLVg90H21EOLACvtfcHk0ljVz34rY3gzbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFWmsrbO&md5=d744c79a309cf4b13b3ab4016d2e6af2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1515%2Frevneuro-2017-0020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Frevneuro-2017-0020%26sid%3Dliteratum%253Aachs%26aulast%3DApostolakis%26aufirst%3DS.%26aulast%3DKypraiou%26aufirst%3DA.%2BM.%26atitle%3DIron%2520in%2520neurodegenerative%2520disorders%253A%2520being%2520in%2520the%2520wrong%2520place%2520at%2520the%2520wrong%2520time%253F%26jtitle%3DRev.%2520Neurosci.%26date%3D2017%26volume%3D28%26issue%3D8%26spage%3D893%26epage%3D911%26doi%3D10.1515%2Frevneuro-2017-0020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Asbeck, B.S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, N.A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Bruggen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudshoorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottet, H.S.L.M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, J.J.M.</span></span> <span> </span><span class="NLM_article-title">Anti-HIV effect of iron chelators: different mechanisms involved</span>. <i>J. Clin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">141</span>â <span class="NLM_lpage">147</span>, <span class="refDoi">Â DOI: 10.1016/S1386-6532(00)00122-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1386-6532%2800%2900122-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11166663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSmuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=141-147&author=B.S.+van%0AAsbeckauthor=N.A.+Georgiouauthor=T.+van+der+Bruggenauthor=M.+Oudshoornauthor=H.S.L.M.+Nottetauthor=J.J.M.+Marx&title=Anti-HIV+effect+of+iron+chelators%3A+different+mechanisms+involved&doi=10.1016%2FS1386-6532%2800%2900122-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV effect of iron chelators: different mechanisms involved</span></div><div class="casAuthors">van Asbeck, B. S.; Georgiou, N. A.; van der Bruggen, T.; Oudshoorn, M.; Nottet, H. S. L. M.; Marx, J. J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Virology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">141-147</span>CODEN:
                <span class="NLM_cas:coden">JCVIFB</span>;
        ISSN:<span class="NLM_cas:issn">1386-6532</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review and discussion with 40 refs.  Background: Drugs for the treatment of AIDS have been directed to specific events in the human immunodeficiency virus (HIV-1) life cycle, aimed to stop viral replication by inhibition of reverse transcriptase or protease activity.  Studies showing that oxidative stress and iron may be important in the activation of HIV-1 have focused attention on the potential therapeutic use of iron chelators.  Objectives: The goal of this review is to describe several possibilities as to how iron is involved in the replication of HIV and how iron chelation may interfere in this process.  Study design: First some physico-chem. properties of iron concerning soly., oxidn.-redn. potential, catalysis, and chelation will be discussed.  In the second part, the role of iron in various biochem. systems is explained.  Results: Nuclear factor kappa B (NF-ÎºB) activation, regulating proviral transcription, can be influenced by iron through the prodn. of reactive oxygen species.  A second route by which iron chelation could influence HIV replication is by inhibition of DNA synthesis through inactivation of iron-dependent ribonucleotide reductase.  Another strategy which can be employed in targeting iron chelators against HIV-1 is direct oxidative viral RNA/DNA attack.  This could be achieved by bleomycin, a cytostatic agent with the ability to form a complex with DNA and RNA.  Conclusion: Chelation may withhold iron from viral metab. but on the other hand may also favor catalysis of reactive oxygen species directed to viral constituents.  In combination with existing antivirals, iron chelation could add to improve the treatment of HIV disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkq8hQ99PjM7Vg90H21EOLACvtfcHk0liS-JfcyyMODw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSmuw%253D%253D&md5=11ba558a040ad4b321a1fed4a74840c7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1386-6532%2800%2900122-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1386-6532%252800%252900122-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BAsbeck%26aufirst%3DB.S.%26aulast%3DGeorgiou%26aufirst%3DN.A.%26aulast%3Dvan%2Bder%2BBruggen%26aufirst%3DT.%26aulast%3DOudshoorn%26aufirst%3DM.%26aulast%3DNottet%26aufirst%3DH.S.L.M.%26aulast%3DMarx%26aufirst%3DJ.J.M.%26atitle%3DAnti-HIV%2520effect%2520of%2520iron%2520chelators%253A%2520different%2520mechanisms%2520involved%26jtitle%3DJ.%2520Clin.%2520Virol.%26date%3D2001%26volume%3D20%26spage%3D141%26epage%3D147%26doi%3D10.1016%2FS1386-6532%2800%2900122-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sappey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelaert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legrand-poels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forceille, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Favier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piette, J.</span></span> <span> </span><span class="NLM_article-title">Iron chelation decreases NF-ÎºB and HIV type 1 activation due to oxidative stress</span>. <i>AIDS Res. Hum. Retroviruses</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1049</span>â <span class="NLM_lpage">1061</span>, <span class="refDoi">Â DOI: 10.1089/aid.1995.11.1049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1089%2Faid.1995.11.1049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=8554902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2MXos1Cgtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1995&pages=1049-1061&issue=9&author=C.+Sappeyauthor=J.+R.+Boelaertauthor=S.+Legrand-poelsauthor=C.+Forceilleauthor=A.+Favierauthor=J.+Piette&title=Iron+chelation+decreases+NF-%CE%BAB+and+HIV+type+1+activation+due+to+oxidative+stress&doi=10.1089%2Faid.1995.11.1049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelation decreases NF-kB and HIV type 1 activation due to oxidative stress</span></div><div class="casAuthors">Sappey, Christine; Boelaert, Johan R.; Legrand-Poels, Sylvie; Forceille, Christine; Favier, Alain; Piette, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">AIDS Research and Human Retroviruses</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1049-61</span>CODEN:
                <span class="NLM_cas:coden">ARHRE7</span>;
        ISSN:<span class="NLM_cas:issn">0889-2229</span>.
    
            (<span class="NLM_cas:orgname">Liebert</span>)
        </div><div class="casAbstract">An important aspect of human immunodeficiency virus (HIV-1) infection is the regulation of its expression by nuclear factor ÎºB (NF-ÎºB) through redox-controlled signal transduction pathways.  In this study, we demonstrate that iron chelation by deferoxamine (DFO) protects against the cytotoxic and reactivating effects of hydrogen peroxide (H2O2).  These protective effects were obsd. both in lymphocytic (ACH-2) and promonocytic (U1) cells latently infected by HIV-1.  Concomitantly, NF-ÎºB activation by H2O2, when followed by gel retardation assay, was decreased in the DFO-treated U1 and ACH-2 cells.  This latter DFO-mediated effect was specific, as DFO did not clearly affect AP-1 DNA-binding activity when studied after H2O2-induced stress.  More importantly, DFO protected against the H2O2-induced activation of HIV-1 as evidenced by reverse transcriptase activity in the supernatant.  DFO also protected against PMA-induced NF-ÎºB activation as well as TNF-Î±-induced HIV-1 activation.  Furthermore, DFO attenuated the p24 response in PBMC infected with HIV-1 and stimulated with IL-2.  These different effects of DFO were obtained at DFO concns. lower than 5 Î¼M.  Other chem. unrelated iron chelators also provided protection against cytotoxicity, NF-ÎºB activation, and HIV-1 activation in U1 cells challenged with H2O2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMgbUUe7257Vg90H21EOLACvtfcHk0liS-JfcyyMODw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXos1Cgtb0%253D&md5=5a064e12b48eedd9a8d74e448bee1a3b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1089%2Faid.1995.11.1049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Faid.1995.11.1049%26sid%3Dliteratum%253Aachs%26aulast%3DSappey%26aufirst%3DC.%26aulast%3DBoelaert%26aufirst%3DJ.%2BR.%26aulast%3DLegrand-poels%26aufirst%3DS.%26aulast%3DForceille%26aufirst%3DC.%26aulast%3DFavier%26aufirst%3DA.%26aulast%3DPiette%26aufirst%3DJ.%26atitle%3DIron%2520chelation%2520decreases%2520NF-%25CE%25BAB%2520and%2520HIV%2520type%25201%2520activation%2520due%2520to%2520oxidative%2520stress%26jtitle%3DAIDS%2520Res.%2520Hum.%2520Retroviruses%26date%3D1995%26volume%3D11%26issue%3D9%26spage%3D1049%26epage%3D1061%26doi%3D10.1089%2Faid.1995.11.1049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Bruggen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudshoorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nottet, H. S. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Asbeck, B. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">484</span>â <span class="NLM_lpage">490</span>, <span class="refDoi">Â DOI: 10.1086/315223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1086%2F315223" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10669330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFCjsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2000&pages=484-490&author=N.+A.+Georgiouauthor=T.+van+der+Bruggenauthor=M.+Oudshoornauthor=H.+S.+L.+M.+Nottetauthor=J.+J.+M.+Marxauthor=B.+S.+van%0AAsbeck&title=Inhibition+of+human+immunodeficiency+virus+type+1+replication+in+human+mononuclear+blood+cells+by+the+iron+chelators+deferoxamine%2C+deferiprone%2C+and+bleomycin&doi=10.1086%2F315223"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin</span></div><div class="casAuthors">Georgiou, Niki A.; Van der Bruggen, Tjomme; Oudshoorn, Maroeska; Nottet, Hans S. L. M.; Marx, Joannes J. M.; Van Asbeck, B. Sweder</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">484-490</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Replication of human immunodeficiency virus type 1 (HIV-1) can be influenced by iron.  Hence, decreasing the availability of iron may inhibit HIV-1 replication.  Deferoxamine and deferiprone, both forming catalytically inactive iron-chelator complexes, and bleomycin, by use of which iron catalyzes oxidative nucleic acid destruction, were investigated.  Expression of p24 antigen in human monocyte-derived macrophages and peripheral blood lymphocytes (PBL) was reduced by all 3 iron chelators.  In PBL, p24 redn. was mirrored by a decrease in proliferation after incubation with deferoxamine or deferiprone, suggesting that viral inhibition is closely linked to a decrease in cellular proliferation.  In contrast, clin. relevant bleomycin concns. reduced p24 levels by â¼50% without affecting proliferation.  When deferoxamine and the nucleoside analog dideoxyinosine were used in combination, they acted synergistically in inhibiting HIV-1 replication.  These observations suggest that iron chelators with different mechanisms of action could be of addnl. benefit in antiretroviral combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKJKzRN-BKz7Vg90H21EOLACvtfcHk0ljJFPXWLrqlsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFCjsbY%253D&md5=ecb515f7302b5a9bad48774555567e9a</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1086%2F315223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F315223%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiou%26aufirst%3DN.%2BA.%26aulast%3Dvan%2Bder%2BBruggen%26aufirst%3DT.%26aulast%3DOudshoorn%26aufirst%3DM.%26aulast%3DNottet%26aufirst%3DH.%2BS.%2BL.%2BM.%26aulast%3DMarx%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3Dvan%2BAsbeck%26aufirst%3DB.%2BS.%26atitle%3DInhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520in%2520human%2520mononuclear%2520blood%2520cells%2520by%2520the%2520iron%2520chelators%2520deferoxamine%252C%2520deferiprone%252C%2520and%2520bleomycin%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2000%26volume%3D181%26spage%3D484%26epage%3D490%26doi%3D10.1086%2F315223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schalk, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mislin, G. L. A.</span></span> <span> </span><span class="NLM_article-title">Bacterial iron uptake pathways: gates for the import of bactericide compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4573</span>â <span class="NLM_lpage">4576</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00554</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00554" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmslegurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4573-4576&issue=11&author=I.+J.+Schalkauthor=G.+L.+A.+Mislin&title=Bacterial+iron+uptake+pathways%3A+gates+for+the+import+of+bactericide+compounds&doi=10.1021%2Facs.jmedchem.7b00554"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial Iron Uptake Pathways: Gates for the Import of Bactericide Compounds</span></div><div class="casAuthors">Schalk, Isabelle J.; Mislin, Gaetan L. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4573-4576</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Bacterial resistance to most antibiotics in clin. use has reached alarming proportions.  A challenge for modern medicine will be to discover new antibiotics or strategies to combat multidrug resistant bacteria, esp. Gram-neg. bacteria for which the situation is particularly crit.  Vectorization of bactericide compds. by siderophores (iron chelators produced by bacteria) is a promising strategy able to considerably increase the efficacy of drugs.  Such a Trojan horse strategy can also extend activity of Gram-pos. only antibiotics to Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyqDdsohxqRLVg90H21EOLACvtfcHk0ljJFPXWLrqlsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmslegurc%253D&md5=3406ceacf25b62b486f373b0bbcfcf5a</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00554%26sid%3Dliteratum%253Aachs%26aulast%3DSchalk%26aufirst%3DI.%2BJ.%26aulast%3DMislin%26aufirst%3DG.%2BL.%2BA.%26atitle%3DBacterial%2520iron%2520uptake%2520pathways%253A%2520gates%2520for%2520the%2520import%2520of%2520bactericide%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D11%26spage%3D4573%26epage%3D4576%26doi%3D10.1021%2Facs.jmedchem.7b00554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reichmann, H.</span></span> <span> </span><span class="NLM_article-title">Role of iron in neurodegenerative diseases</span>. <i>J. Neural. Transm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">389</span>â <span class="NLM_lpage">399</span>, <span class="refDoi">Â DOI: 10.1007/s00702-016-1508-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00702-016-1508-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26794939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslOitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=389-399&issue=4&author=K.+Liauthor=H.+Reichmann&title=Role+of+iron+in+neurodegenerative+diseases&doi=10.1007%2Fs00702-016-1508-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">role of iron in neurodegenerative diseases</span></div><div class="casAuthors">Li, Kai; Reichmann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">JNTRF3</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag GmbH</span>)
        </div><div class="casAbstract">Currently, we still lack effective measures to modify disease progression in neurodegenerative diseases.  Iron-contg. proteins play an essential role in many fundamental biol. processes in the central nervous system.  In addn., iron is a redox-active ion and can induce oxidative stress in the cell.  Although the causes and pathol. hallmarks of different neurodegenerative diseases vary, iron dyshomeostasis, oxidative stress and mitochondrial injury constitute a common pathway to cell death in several neurodegenerative diseases.  MRI is capable of depicting iron content in the brain, and serves as a potential biomarker for early and differential diagnosis, tracking disease progression and evaluating the effectiveness of neuroprotective therapy.  Iron chelators have shown their efficacy against neurodegeneration in a series of animal models, and been applied in several clin. trials.  In this review, we summarize recent developments on iron dyshomeostasis in Parkinson's disease, Alzheimer's disease, Friedreich ataxia, and Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobktfTwhBVErVg90H21EOLACvtfcHk0ljJFPXWLrqlsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslOitb4%253D&md5=ab652b0d08fc4b6ed939846566119026</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1007%2Fs00702-016-1508-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00702-016-1508-7%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DReichmann%26aufirst%3DH.%26atitle%3DRole%2520of%2520iron%2520in%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Neural.%2520Transm.%26date%3D2016%26volume%3D123%26issue%3D4%26spage%3D389%26epage%3D399%26doi%3D10.1007%2Fs00702-016-1508-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, P.</span></span> <span> </span><span class="NLM_article-title">Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1545</span>â <span class="NLM_lpage">1565</span>, <span class="refDoi">Â DOI: 10.3390/ijms19051545</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fijms19051545" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOqtrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1545-1565&issue=5&author=L.+F.+Zhouauthor=B.+Zhaoauthor=L.+X.+Zhangauthor=S.+H.+Wangauthor=D.+D.+Dongauthor=H.+H.+Lvauthor=P.+Shang&title=Alterations+in+cellular+iron+metabolism+provide+more+therapeutic+opportunities+for+cancer&doi=10.3390%2Fijms19051545"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Alterations in cellular iron metabolism provide more therapeutic opportunities for cancer</span></div><div class="casAuthors">Zhou, Liangfu; Zhao, Bin; Zhang, Lixiu; Wang, Shenghang; Dong, Dandan; Lv, Huanhuan; Shang, Peng</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1545/1-1545/21</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Iron is an essential element for the growth and proliferation of cells.  Cellular iron uptake, storage, utilization and export are tightly regulated to maintain iron homeostasis.  However, cellular iron metab. pathways are disturbed in most cancer cells.  To maintain rapid growth and proliferation, cancer cells acquire large amts. of iron by altering expression of iron metab.-related proteins.  In this paper, normal cellular iron metab. and the alterations of iron metabolic pathways in cancer cells were summarized.  Therapeutic strategies based on targeting the altered iron metab. were also discussed and disrupting redox homeostasis by intracellular high levels of iron provides new insight for cancer therapy.  Altered iron metab. constitutes a promising therapeutic target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQt8v6wc-xgrVg90H21EOLACvtfcHk0ljIVsII9Bf2EA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOqtrbI&md5=d073b8c634336b5cbfdc12700895da1c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fijms19051545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19051545%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%2BF.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DL.%2BX.%26aulast%3DWang%26aufirst%3DS.%2BH.%26aulast%3DDong%26aufirst%3DD.%2BD.%26aulast%3DLv%26aufirst%3DH.%2BH.%26aulast%3DShang%26aufirst%3DP.%26atitle%3DAlterations%2520in%2520cellular%2520iron%2520metabolism%2520provide%2520more%2520therapeutic%2520opportunities%2520for%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26issue%3D5%26spage%3D1545%26epage%3D1565%26doi%3D10.3390%2Fijms19051545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span> <span> </span><span class="NLM_article-title">Iron metabolism in cancer</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>â <span class="NLM_lpage">116</span>, <span class="refDoi">Â DOI: 10.3390/ijms20010095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fijms20010095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFahsbbE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2019&pages=95-116&issue=1&author=Y.+F.+Wangauthor=L.+Yuauthor=J.+Dingauthor=Y.+Chen&title=Iron+metabolism+in+cancer&doi=10.3390%2Fijms20010095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Iron metabolism in cancer</span></div><div class="casAuthors">Wang, Yafang; Yu, Lei; Ding, Jian; Chen, Yi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95/1-95/22</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Demanded as an essential trace element that supports cell growth and basic functions, iron can be harmful and cancerogenic though.  By exchanging between its different oxidized forms, iron overload induces free radical formation, lipid peroxidn., DNA, and protein damages, leading to carcinogenesis or ferroptosis.  Iron also plays profound roles in modulating tumor microenvironment and metastasis, maintaining genomic stability and controlling epigenetics. in order to meet the high requirement of iron, neoplastic cells have remodeled iron metab. pathways, including acquisition, storage, and efflux, which makes manipulating iron homeostasis a considerable approach for cancer therapy.  Several iron chelators and iron oxide nanoparticles (IONPs) has recently been developed for cancer intervention and presented considerable effects.  This review summarizes some latest findings about iron metab. function and regulation mechanism in cancer and the application of iron chelators and IONPs in cancer diagnosis and therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp8mOaOJNVrbVg90H21EOLACvtfcHk0ljIVsII9Bf2EA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFahsbbE&md5=dce81cca77f823bbfb8a555b3a49df56</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.3390%2Fijms20010095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms20010095%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%2BF.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DIron%2520metabolism%2520in%2520cancer%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2019%26volume%3D20%26issue%3D1%26spage%3D95%26epage%3D116%26doi%3D10.3390%2Fijms20010095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of iron chelators with therapeutic application</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6371</span>â <span class="NLM_lpage">6389</span>, <span class="refDoi">Â DOI: 10.1039/c2dt12159j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc2dt12159j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22391807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38Xms1Srsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=6371-6389&issue=21&author=T.+Zhouauthor=Y.+M.+Maauthor=X.+L.+Kongauthor=R.+C.+Hider&title=Design+of+iron+chelators+with+therapeutic+application&doi=10.1039%2Fc2dt12159j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Design of iron chelators with therapeutic application</span></div><div class="casAuthors">Zhou, Tao; Ma, Yongmin; Kong, Xiaole; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6371-6389</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Iron is essential for the proper functioning of all living cells, however it is toxic when present in excess.  Thus, using iron chelators as therapeutic agents, namely chelation therapy, has received increasing attention.  The objective of this review is to discuss the factors which should be considered when designing clin. useful iron chelators, to present the application of iron chelators in the treatment of iron overload assocd. with Î²-thalassemia major and sickle cell anemia, and to highlight the potential applications in the treatment of neurodegenerative disorders and microbial infection.  This article reviews recent knowledge centered on these themes and indicates the growing importance of the concept of iron chelation in medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXM3r1rHtjGbVg90H21EOLACvtfcHk0ljIVsII9Bf2EA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xms1Srsbs%253D&md5=751df1f5f06cb8a7122fb607db0a9ff6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1039%2Fc2dt12159j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2dt12159j%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520iron%2520chelators%2520with%2520therapeutic%2520application%26jtitle%3DDalton%2520Trans.%26date%3D2012%26volume%3D41%26issue%3D21%26spage%3D6371%26epage%3D6389%26doi%3D10.1039%2Fc2dt12159j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of clinically useful iron(III)-selective chelators</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">26</span>â <span class="NLM_lpage">64</span>, <span class="refDoi">Â DOI: 10.1002/med.1027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fmed.1027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11746175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3MnpvVGksw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=26-64&issue=1&author=Z.+D.+Liuauthor=R.+C.+Hider&title=Design+of+clinically+useful+iron%28III%29-selective+chelators&doi=10.1002%2Fmed.1027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Design of clinically useful iron(III)-selective chelators</span></div><div class="casAuthors">Liu Zu D; Hider Robert C</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal research reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">26-64</span>
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">Iron overload is a serious clinical condition which can be largely prevented by the use of iron-specific chelating agents.  Desferrioxamine-B, the most widely used iron chelator in haematology over the past 30 years, has a major disadvantage of being orally inactive.  Consequently, the successful design of an orally active, nontoxic, selective iron chelator has become a much sought after goal.  In order to identify an ideal iron chelator for clinical use, a range of specifications must be considered such as metal selectivity and affinity, kinetic stability of the complex, bioavailability and toxicity.  A wide range of chelator types bind iron(III) and of these, hexa-, tri-, and bidentate are capable of providing iron(III) with the favoured octahedral environment.  In this review, the comparative properties of such ligands are discussed, examples being selected from hydroxamates, aminocarboxylates, hydroxypyridinones, orthosubstituted phenols and triazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVWVkt39Ar8_h3YQQtAhNufW6udTcc2eZOqJINFvbNibntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MnpvVGksw%253D%253D&md5=a7853ebc327a36a048da2169aca3559e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fmed.1027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.1027%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520clinically%2520useful%2520iron%2528III%2529-selective%2520chelators%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2002%26volume%3D22%26issue%3D1%26spage%3D26%26epage%3D64%26doi%3D10.1002%2Fmed.1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of iron chelators with therapeutic application</span>. <i>Coord. Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>232</i></span> (<span class="NLM_issue">1â2</span>),  <span class="NLM_fpage">151</span>â <span class="NLM_lpage">171</span>, <span class="refDoi">Â DOI: 10.1016/S0010-8545(02)00050-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0010-8545%2802%2900050-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XntF2kur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2002&pages=151-171&issue=1%E2%80%932&author=Z.+D.+Liuauthor=R.+C.+Hider&title=Design+of+iron+chelators+with+therapeutic+application&doi=10.1016%2FS0010-8545%2802%2900050-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Design of iron chelators with therapeutic application</span></div><div class="casAuthors">Liu, Zu D.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Coordination Chemistry Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">151-171</span>CODEN:
                <span class="NLM_cas:coden">CCHRAM</span>;
        ISSN:<span class="NLM_cas:issn">0010-8545</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Iron overload is a serious clin. condition which can be largely prevented by the use of iron-specific chelating agents.  Desferrioxamine-B, the most widely used iron chelator in hematol. over the past 30 yr, has a major disadvantage of being orally inactive.  Consequently, the successful design of an orally active, non-toxic, selective iron chelator has become a much sought after goal.  In order to identify an ideal iron chelator for clin. use, a range of specifications must be considered such as metal selectivity and affinity, kinetic stability of the complex, bioavailability and toxicity.  A wide range of chelator types bind iron(III) and of these, hexa-, tri-, and bidentate are capable of providing iron(III) with the favored octahedral environment.  In this review, the comparative properties of such ligands are discussed, examples being selected from hydroxamates, aminocarboxylates, hydroxypyridinones, ortho-substituted phenols and triazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruzUdRBE0uKbVg90H21EOLACvtfcHk0ljIxosx1Sg-0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntF2kur4%253D&md5=ef3674011aab611a6cecfe3471871237</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0010-8545%2802%2900050-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0010-8545%252802%252900050-4%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520iron%2520chelators%2520with%2520therapeutic%2520application%26jtitle%3DCoord.%2520Chem.%2520Rev.%26date%3D2002%26volume%3D232%26issue%3D1%25E2%2580%25932%26spage%3D151%26epage%3D171%26doi%3D10.1016%2FS0010-8545%2802%2900050-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Recent developments centered on orally active iron chelators</span>. <i>Thalassemia Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2261</span>â <span class="NLM_lpage">2269</span>, <span class="refDoi">Â DOI: 10.4081/thal.2014.2261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4081%2Fthal.2014.2261" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=2261-2269&author=R.+C.+Hider&title=Recent+developments+centered+on+orally+active+iron+chelators&doi=10.4081%2Fthal.2014.2261"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4081%2Fthal.2014.2261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4081%252Fthal.2014.2261%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DRecent%2520developments%2520centered%2520on%2520orally%2520active%2520iron%2520chelators%26jtitle%3DThalassemia%2520Rep.%26date%3D2014%26volume%3D4%26spage%3D2261%26epage%3D2269%26doi%3D10.4081%2Fthal.2014.2261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, J.</span></span> <span> </span><span class="NLM_article-title">The potential application of iron chelators for the treatment of neurodegenerative diseases</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">239</span>â <span class="NLM_lpage">249</span>, <span class="refDoi">Â DOI: 10.1039/c0mt00087f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc0mt00087f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21344071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=239-249&issue=3&author=R.+C.+Hiderauthor=S.+Royauthor=Y.+M.+Maauthor=X.+Le+Kongauthor=J.+Preston&title=The+potential+application+of+iron+chelators+for+the+treatment+of+neurodegenerative+diseases&doi=10.1039%2Fc0mt00087f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The potential application of iron chelators for the treatment of neurodegenerative diseases</span></div><div class="casAuthors">Hider, Robert C.; Roy, Sourav; Ma, Yong Min; Le Kong, Xiao; Preston, Jane</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Many forms of neurodegenerative disease, for instance Alzheimer's disease, Parkinson's disease, Friedreich's ataxia, Hallervorden Spatz syndrome and macular degeneration, are assocd. with elevated levels of redox active metals in the brain and eye.  A logical therapeutic approach therefore, is to remove the toxic levels of these metals, copper and iron in particular, by selective chelation.  The increased no. of iron-selective chelators now available for clin. use has enhanced interest in this type of therapy.  This review summarises the recent developments in the design of chelators for treatment of neurodegenerative disease, identifies some of the essential properties for such mols. and suggests some future strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_QWZw98vWsbVg90H21EOLACvtfcHk0ljIxosx1Sg-0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D&md5=d5efb2da19e8a08dccb014614ba4b71e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2Fc0mt00087f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0mt00087f%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DLe%2BKong%26aufirst%3DX.%26aulast%3DPreston%26aufirst%3DJ.%26atitle%3DThe%2520potential%2520application%2520of%2520iron%2520chelators%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DMetallomics%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D239%26epage%3D249%26doi%3D10.1039%2Fc0mt00087f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brittenham, G. M.</span></span> <span> </span><span class="NLM_article-title">Development of iron-chelating agents for clinical use</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">569</span>â <span class="NLM_lpage">574</span>, <span class="refDoi">Â DOI: 10.1182/blood.V80.3.569.bloodjournal803569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V80.3.569.bloodjournal803569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1638016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADyaK38zksFGruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=1992&pages=569-574&issue=3&author=G.+M.+Brittenham&title=Development+of+iron-chelating+agents+for+clinical+use&doi=10.1182%2Fblood.V80.3.569.bloodjournal803569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of iron-chelating agents for clinical use</span></div><div class="casAuthors">Brittenham G M</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">569-74</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7WK6v1nO4Sx0LsK7uFuY7fW6udTcc2eY9G6RtxrC2JLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zksFGruw%253D%253D&md5=a7a32cfc8313378b3005daa25e00c137</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1182%2Fblood.V80.3.569.bloodjournal803569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V80.3.569.bloodjournal803569%26sid%3Dliteratum%253Aachs%26aulast%3DBrittenham%26aufirst%3DG.%2BM.%26atitle%3DDevelopment%2520of%2520iron-chelating%2520agents%2520for%2520clinical%2520use%26jtitle%3DBlood%26date%3D1992%26volume%3D80%26issue%3D3%26spage%3D569%26epage%3D574%26doi%3D10.1182%2Fblood.V80.3.569.bloodjournal803569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Codd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson-Sanchez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telfer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotsbacher, M. P.</span></span> <span> </span><span class="NLM_article-title">Advances in the chemical biology of Desferrioxamine B</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">11</span>â <span class="NLM_lpage">25</span>, <span class="refDoi">Â DOI: 10.1021/acschembio.7b00851</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00851" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=11-25&issue=1&author=R.+Coddauthor=T.+Richardson-Sanchezauthor=T.+J.+Telferauthor=M.+P.+Gotsbacher&title=Advances+in+the+chemical+biology+of+Desferrioxamine+B&doi=10.1021%2Facschembio.7b00851"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in the Chemical Biology of Desferrioxamine B</span></div><div class="casAuthors">Codd, Rachel; Richardson-Sanchez, Tomas; Telfer, Thomas J.; Gotsbacher, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">11-25</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Desferrioxamine B (DFOB) was discovered in the late 1950s as a hydroxamic acid metabolite of the soil bacterium Streptomyces pilosus.  The exquisite affinity of DFOB for Fe(III) identified its potential for removing excess iron from patients with transfusion-dependent Hb disorders.  Many studies have used semisynthetic chem. to produce DFOB adducts with new properties and broad-ranging functions.  More recent approaches in chem. biol. have revealed some nuances of DFOB biosynthesis and discovered new DFOB-derived drugs and radiometal imaging agents.  The current and potential applications of DFOB continue to inspire a rich body of chem. biol. research focused on this bacterial metabolite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrW8DRStp7bVg90H21EOLACvtfcHk0ljFdCXdm8Tlmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOit73O&md5=e06b2bf31367431bd9c0de676063f6a8</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00851%26sid%3Dliteratum%253Aachs%26aulast%3DCodd%26aufirst%3DR.%26aulast%3DRichardson-Sanchez%26aufirst%3DT.%26aulast%3DTelfer%26aufirst%3DT.%2BJ.%26aulast%3DGotsbacher%26aufirst%3DM.%2BP.%26atitle%3DAdvances%2520in%2520the%2520chemical%2520biology%2520of%2520Desferrioxamine%2520B%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26issue%3D1%26spage%3D11%26epage%3D25%26doi%3D10.1021%2Facschembio.7b00851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dionis, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eglikarmakka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huxleytencer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, H. H.</span></span> <span> </span><span class="NLM_article-title">Evaluation of desferrithiocin and its synthetic analogs as orally effective iron chelators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2072</span>â <span class="NLM_lpage">2078</span>, <span class="refDoi">Â DOI: 10.1021/jm00111a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00111a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3MXksV2iu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2072-2078&issue=7&author=R.+J.+Bergeronauthor=J.+Wiegandauthor=J.+B.+Dionisauthor=M.+Eglikarmakkaauthor=J.+Freiauthor=A.+Huxleytencerauthor=H.+H.+Peter&title=Evaluation+of+desferrithiocin+and+its+synthetic+analogs+as+orally+effective+iron+chelators&doi=10.1021%2Fjm00111a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of desferrithiocin and its synthetic analogs as orally effective iron chelators</span></div><div class="casAuthors">Bergeron, Raymond J.; Wiegand, Jan; Dionis, John B.; Egli-Karmakka, Majia; Frei, Joerg; Huxley-Tencer, Alica; Peter, Heinrich H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2072-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Desferrithiocin (I), a novel microbial siderophore isolated from cultures of Streptomyces antibioticus DSM 1865, and a no. of its derivs. and analogs were evaluated for their ability to promote iron clearance.  The compds. were designed to identify the structural features of desferrithiocin which render this ligand an orally effective iron chelator.  The desferrithiocin arom. hydroxyl and the thiazoline ring carboxyl group and sulfur are shown to be central to desferrithiocin's activity.  The animal model chosen for this study, the bile duct cannulated rat, provides information regarding both the chelator-induced total iron output and the kinetics of both biliary and urinary ion excretion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqICbITltkPkrVg90H21EOLACvtfcHk0ljFdCXdm8Tlmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXksV2iu70%253D&md5=ef28c660a101ec5b104e39fba4d6050e</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm00111a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00111a023%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DDionis%26aufirst%3DJ.%2BB.%26aulast%3DEglikarmakka%26aufirst%3DM.%26aulast%3DFrei%26aufirst%3DJ.%26aulast%3DHuxleytencer%26aufirst%3DA.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26atitle%3DEvaluation%2520of%2520desferrithiocin%2520and%2520its%2520synthetic%2520analogs%2520as%2520orally%2520effective%2520iron%2520chelators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26issue%3D7%26spage%3D2072%26epage%3D2078%26doi%3D10.1021%2Fjm00111a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bharti, N.</span></span> <span> </span><span class="NLM_article-title">Desferrithiocin: a search for clinically effective iron chelators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9259</span>â <span class="NLM_lpage">9291</span>, <span class="refDoi">Â DOI: 10.1021/jm500828f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500828f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9259-9291&issue=22&author=R.+J.+Bergeronauthor=J.+Wiegandauthor=J.+S.+McManisauthor=N.+Bharti&title=Desferrithiocin%3A+a+search+for+clinically+effective+iron+chelators&doi=10.1021%2Fjm500828f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Desferrithiocin: A Search for Clinically Effective Iron Chelators</span></div><div class="casAuthors">Bergeron, Raymond J.; Wiegand, Jan; McManis, James S.; Bharti, Neelam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9259-9291</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The successful search for orally active iron chelators to treat transfusional iron-overload diseases, e.g., thalassemia, is overviewed.  The crit. role of iron in nature as a redox engine is first described, as well as how primitive life forms and humans manage the metal.  The problems that derive when iron homeostasis in humans is disrupted and the mechanism of the ensuing damage, uncontrolled Fenton chem., are discussed.  The soln. to the problem, chelator-mediated iron removal, is clear.  Design options for the assembly of ligands that sequester and decorporate iron are reviewed, along with the shortcomings of the currently available therapeutics.  The rationale for choosing desferrithiocin, a natural product iron chelator (a siderophore), as a platform for structure-activity relationship studies in the search for an orally active iron chelator is thoroughly developed.  The study provides an excellent example of how to systematically reengineer a pharmacophore in order to overcome toxicol. problems while maintaining iron clearing efficacy and has led to three ligands being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp30r9OJMpq-rVg90H21EOLACvtfcHk0lgC-xz4f_YnuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFamsrbI&md5=6356fb75827071827d74c2548bc5fef8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm500828f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500828f%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DMcManis%26aufirst%3DJ.%2BS.%26aulast%3DBharti%26aufirst%3DN.%26atitle%3DDesferrithiocin%253A%2520a%2520search%2520for%2520clinically%2520effective%2520iron%2520chelators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D22%26spage%3D9259%26epage%3D9291%26doi%3D10.1021%2Fjm500828f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Donovan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dagher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, J.</span></span> <span> </span><span class="NLM_article-title">Preclinical and clinical development of deferitrin, a novel, orally available iron chelator</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>1054</i></span>,  <span class="NLM_fpage">492</span>â <span class="NLM_lpage">494</span>, <span class="refDoi">Â DOI: 10.1196/annals.1345.071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1196%2Fannals.1345.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16339704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD28XotlKmsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1054&publication_year=2005&pages=492-494&author=J.+M.+Donovanauthor=M.+Ploneauthor=R.+Dagherauthor=M.+Breeauthor=J.+Marquis&title=Preclinical+and+clinical+development+of+deferitrin%2C+a+novel%2C+orally+available+iron+chelator&doi=10.1196%2Fannals.1345.071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical and clinical development of deferitrin, a novel, orally available iron chelator</span></div><div class="casAuthors">Donovan, Joanne M.; Plone, Melissa; Dagher, Rafif; Bree, Mark; Marquis, Judith</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">1054</span>
        (<span class="NLM_cas:issue">Cooley's Anemia</span>),
    <span class="NLM_cas:pages">492-494</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Deferitrin, a novel, orally available iron chelator, is in the early stage of clin. development for the treatment of chronic iron overload due to transfusional therapy.  Preclin. pharmacol. studies demonstrate iron excretion largely by the fecal route.  Initial clin. studies have shown deferitrin to be well absorbed.  Further clin. studies are ongoing to det. the efficiency and safety of deferitrin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6Z9dLXiJtIrVg90H21EOLACvtfcHk0lgC-xz4f_YnuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotlKmsA%253D%253D&md5=e4b0dd09706b2585c064a363278669d3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1196%2Fannals.1345.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1196%252Fannals.1345.071%26sid%3Dliteratum%253Aachs%26aulast%3DDonovan%26aufirst%3DJ.%2BM.%26aulast%3DPlone%26aufirst%3DM.%26aulast%3DDagher%26aufirst%3DR.%26aulast%3DBree%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DJ.%26atitle%3DPreclinical%2520and%2520clinical%2520development%2520of%2520deferitrin%252C%2520a%2520novel%252C%2520orally%2520available%2520iron%2520chelator%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2005%26volume%3D1054%26spage%3D492%26epage%3D494%26doi%3D10.1196%2Fannals.1345.071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harland, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luker, T.</span></span> <span> </span><span class="NLM_article-title">Deferitazole, a new orally active iron chelator</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">5197</span>â <span class="NLM_lpage">5204</span>, <span class="refDoi">Â DOI: 10.1039/C5DT00063G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC5DT00063G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25687725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVClt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2015&pages=5197-5204&issue=11&author=R.+C.+Hiderauthor=X.+L.+Kongauthor=V.+Abbateauthor=R.+Harlandauthor=K.+Conlonauthor=T.+Luker&title=Deferitazole%2C+a+new+orally+active+iron+chelator&doi=10.1039%2FC5DT00063G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Deferitazole, a new orally active iron chelator</span></div><div class="casAuthors">Hider, Robert C.; Kong, Xiaole; Abbate, Vincenzo; Harland, Rachel; Conlon, Kelly; Luker, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5197-5204</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Following a systematic search of desferrithiocin analogs, a polyether deriv., deferitazole (formerly FBS0701), has entered into phase 1 and 2 clin. trials with promising biol. properties.  However, until now, detailed physicochem. properties of this chelator have not been reported.  The compd. displays a high affinity and selectivity for iron(III) as demonstrated by the log Î²2 = 33.39 Â± 0.03 and the pFe3+ value of 22.3.  Two equilibrating isomeric forms of the iron(III) complex exist under biol. conditions.  Deferitazole also binds the trivalent metals AlIII and LaIII with high affinity; log Î²2 values, 26.68 and 21.55 resp.  The affinity of deferitazole for divalent cations is somewhat lower, with the exception of CuII which possesses a log Î²2 value of 25.5; deferitazole scavenges iron from labile sources such as citrate and albumin with efficiencies comparable with those of other therapeutic iron chelators, including deferasirox, deferiprone and desferrioxamine.  The FeIII(deferitazole)2 is stable under physiol. conditions and does not redox cycle.  The high affinity of deferitazole for iron(III) renders it unlikely that this chelator will lead to the redistribution of iron and consequently deferitazole shows considerable promise as a therapeutic iron(III) chelator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdAavFLtWpI7Vg90H21EOLACvtfcHk0lgC-xz4f_YnuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVClt7s%253D&md5=0cca81397522335f582113be0eb4dfec</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1039%2FC5DT00063G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5DT00063G%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DHarland%26aufirst%3DR.%26aulast%3DConlon%26aufirst%3DK.%26aulast%3DLuker%26aufirst%3DT.%26atitle%3DDeferitazole%252C%2520a%2520new%2520orally%2520active%2520iron%2520chelator%26jtitle%3DDalton%2520Trans.%26date%3D2015%26volume%3D44%26issue%3D11%26spage%3D5197%26epage%3D5204%26doi%3D10.1039%2FC5DT00063G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">194</span>â <span class="NLM_lpage">203</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2017.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.jinorgbio.2017.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29329026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmtlejsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2018&pages=194-203&author=Y.+L.+Chenauthor=X.+L.+Kongauthor=Y.+Y.+Xieauthor=R.+C.+Hider&title=The+interaction+of+pyridoxal+isonicotinoyl+hydrazone+%28PIH%29+and+salicylaldehyde+isonicotinoyl+hydrazone+%28SIH%29+with+iron&doi=10.1016%2Fj.jinorgbio.2017.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron</span></div><div class="casAuthors">Chen, Yu-Lin; Kong, Xiaole; Xie, Yuanyuan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">194-203</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH), two important biol. active chelators, with iron has been investigated by spectrophotometric methods.  High iron(III) affinity consts. were detd. for PIH, logÎ²2 = 37.0 and SIH, logÎ²2 = 37.6.  The assocd. redox potentials of the iron complexes were detd. using cyclic voltammetry at pH 7.4 as + 130 mV (vs normal hydrogen electrode, NHE) for PIH and + 136 mV(vs NHE) for SIH.  These redox potentials are much higher than those corresponding to iron chelators in clin. use, namely deferiprone, - 620 mV; desferasirox, - 600 mV and desferrioxamine, - 468 mV.  Although the pos. redox potentials of SIH and PIH are similar to that of EDTA, namely + 120 mV, the iron complexes of these two hydrazone chelators, unlike the iron complex of EDTA, do not redox cycle in the presence of vitamin C.  These properties render PIH and SIH as excellent scavengers of iron, under biol. conditions.  Both SIH and PIH scavenge mononuclear iron(II) and iron(III) rapidly.  These fast kinetic properties of the hydrazone-based chelators provide a ready explanation for the adoption of SIH in fluorescence-based methods for the quantification of cytosolic iron(II).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLuwqxJ_Iu2rVg90H21EOLACvtfcHk0lh-67O85ZDLjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmtlejsQ%253D%253D&md5=f44857681aa713441071a6d4dce8dd96</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520interaction%2520of%2520pyridoxal%2520isonicotinoyl%2520hydrazone%2520%2528PIH%2529%2520and%2520salicylaldehyde%2520isonicotinoyl%2520hydrazone%2520%2528SIH%2529%2520with%2520iron%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D180%26spage%3D194%26epage%3D203%26doi%3D10.1016%2Fj.jinorgbio.2017.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buss, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuzil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponka, P.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>421</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">9</span>, <span class="refDoi">Â DOI: 10.1016/j.abb.2003.09.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.abb.2003.09.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=14678779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWmsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2004&pages=1-9&issue=1&author=J.+L.+Bussauthor=J.+Neuzilauthor=P.+Ponka&title=Oxidative+stress+mediates+toxicity+of+pyridoxal+isonicotinoyl+hydrazone+analogs&doi=10.1016%2Fj.abb.2003.09.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress mediates toxicity of pyridoxal isonicotinoyl hydrazone analogs</span></div><div class="casAuthors">Buss, Joan L.; Neuzil, Jiri; Ponka, Prem</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Pyridoxal isonicotinoyl hydrazone (PIH) and many of its analogs are effective iron chelators in vivo and in vitro, and are of interest for the treatment of secondary iron overload.  Because previous work has implicated the Fe3+-chelator complexes as a determinant of toxicity, the role of iron-based oxidative stress in the toxicity of PIH analogs was assessed.  The Fe3+ complexes of PIH analogs were reduced by K562 cells and the physiol. reductant, ascorbate.  Depletion of the antioxidant, glutathione, sensitized Jurkat T lymphocytes to the toxicity of PIH analogs and their Fe3+ complexes, and toxicity of the chelators increased with oxygen tension.  Fe3+ complexes of pyridoxal benzoyl hydrazone (PBH) and salicyloyl isonicotinoyl hydrazone (SIH) caused lipid peroxidn. and toxicity in K562 cells loaded with eicosapentenoic acid (EPA), a readily oxidized fatty acid, whereas Fe(PIH)2 did not.  The lipophilic antioxidant, vitamin E, completely prevented both the toxicity and lipid peroxidn. caused by Fe(PBH)2 in EPA-loaded cells, indicating a causal relationship between oxidative stress and toxicity.  PBH also caused concomitant lipid peroxidn. and toxicity in EPA-loaded cells, both of which were reversed as its concn. increased.  In contrast, PIH was inactive, while SIH was equally toxic toward control and EPA-loaded cells, without causing lipid peroxidn., indicating a much smaller contribution of oxidative stress to the mechanism of toxicity of these analogs.  In summary, PIH analogs and their Fe3+ complexes are redox active in the intracellular environment.  The contribution of oxidative stress to the overall mechanism of toxicity varies across the series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpECrMgd79RX7Vg90H21EOLACvtfcHk0lh-67O85ZDLjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWmsLY%253D&md5=194d47e3b153ad9a9306e9d5dd1440e9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2003.09.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2003.09.044%26sid%3Dliteratum%253Aachs%26aulast%3DBuss%26aufirst%3DJ.%2BL.%26aulast%3DNeuzil%26aufirst%3DJ.%26aulast%3DPonka%26aufirst%3DP.%26atitle%3DOxidative%2520stress%2520mediates%2520toxicity%2520of%2520pyridoxal%2520isonicotinoyl%2520hydrazone%2520analogs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2004%26volume%3D421%26issue%3D1%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.abb.2003.09.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nick, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acklin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buehlmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauffe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schupp, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberti, D.</span></span> <span> </span><span class="NLM_article-title">Development of tridentate iron chelators: from desferrithiocin to ICL670</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1065</span>â <span class="NLM_lpage">1076</span>, <span class="refDoi">Â DOI: 10.2174/0929867033457610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F0929867033457610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12678677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1065-1076&issue=12&author=H.+Nickauthor=P.+Acklinauthor=R.+Lattmannauthor=P.+Buehlmayerauthor=S.+Hauffeauthor=J.+Schuppauthor=D.+Alberti&title=Development+of+tridentate+iron+chelators%3A+from+desferrithiocin+to+ICL670&doi=10.2174%2F0929867033457610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Development of tridentate iron chelators: From desferrithiocin to ICL670</span></div><div class="casAuthors">Nick, Hanspeter; Acklin, Pierre; Lattmann, Rene; Buchlmayer, Peter; Hauffe, Suzanne; Schupp, Joachim; Alberti, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1065-1076</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Successful treatment of Î²-thalassemia requires two key elements: blood transfusion and iron chelation.  Regular blood transfusions considerably expand the lifespan of patients, however, without the removal of the consequential accumulation of body iron, few patients live beyond their second decade.  In 1963, the introduction of desferrioxamine (DFO), a hexadentate chelator, marked a breakthrough in the treatment of Î²-thalassemia.  DFO significantly reduces body iron burden and iron-related morbidity and mortality.  DFO is still the only drug for general use in the treatment of transfusion dependent iron overload.  However, its very short plasma half-life and poor oral activity necessitate special modes of application (s.c. or i.v. infusion) which are inconvenient, can cause local reactions and are difficult to be accepted by many patients.  Over the past four decades, many different labs. have invested major efforts in the identification of orally active iron chelators from several hundreds of mols. of synthetic, microbial or plant origin.  The discovery of ferrithiocin in 1980, followed by the synthesis of the tridentate chelator desferrithiocin and proof of its oral activity raised a lot of hope.  However, the compd. proved to be toxic in animals.  Over a period of about fifteen years many desferrithiocin derivs. and mols. with broader alterations led to the discovery of numerous new compds. some of which were much better tolerated and were more efficacious than desferrithiocin in animals, however, none was safe enough to proceed to the clin. use.  The discovery of a new chem. class of iron chelators: The bishydroxyphenyltriazoles re-energized the search for a safe tridentate chelator.  The basic structure of this completely new chem. class of iron chelators was discovered by a combination of rational design, intuition and experience.  More than forty derivs. of the triazole series were synthesized at Novartis.  These compds. were evaluated, together with more than 700 chelators from various chem. classes.  Using vigorous selection criteria with a focus on tolerability, the tridentate chelator 4-[(3,5-Bis-(2-hydroxyphenyl)-1,2,4)triazol-1-yl]-benzoic acid (ICL670) emerged as an entity which best combined high oral potency and tolerability in animals.  ICL670 is presently being evaluated in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMGzszYalorVg90H21EOLACvtfcHk0lh-67O85ZDLjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtbo%253D&md5=fd24642d14d46cf2fae2f3eaf0a8bd80</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.2174%2F0929867033457610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457610%26sid%3Dliteratum%253Aachs%26aulast%3DNick%26aufirst%3DH.%26aulast%3DAcklin%26aufirst%3DP.%26aulast%3DLattmann%26aufirst%3DR.%26aulast%3DBuehlmayer%26aufirst%3DP.%26aulast%3DHauffe%26aufirst%3DS.%26aulast%3DSchupp%26aufirst%3DJ.%26aulast%3DAlberti%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520tridentate%2520iron%2520chelators%253A%2520from%2520desferrithiocin%2520to%2520ICL670%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26issue%3D12%26spage%3D1065%26epage%3D1076%26doi%3D10.2174%2F0929867033457610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konijn, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nick, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breuer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabantchik, Z. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, G.</span></span> <span> </span><span class="NLM_article-title">ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1115</span>â <span class="NLM_lpage">1122</span>, <span class="refDoi">Â DOI: 10.1182/blood.V97.4.1115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V97.4.1115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11159545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXht1Gis78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2001&pages=1115-1122&issue=4&author=C.+Hershkoauthor=A.+M.+Konijnauthor=H.+P.+Nickauthor=W.+Breuerauthor=Z.+I.+Cabantchikauthor=G.+Link&title=ICL670A%3A+a+new+synthetic+oral+chelator%3A+evaluation+in+hypertransfused+rats+with+selective+radioiron+probes+of+hepatocellular+and+reticuloendothelial+iron+stores+and+in+iron-loaded+rat+heart+cells+in+culture&doi=10.1182%2Fblood.V97.4.1115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture</span></div><div class="casAuthors">Hershko, Chaim; Konijn, Abraham M.; Nick, Hans Peter; Breuer, William; Cabantchik, Zvi Ioav; Link, Gabriela</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1115-1122</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">ICL670A (formerly CGP 72 670) or 4-[3,5-bis-(hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid is a tridentate iron-selective synthetic chelator of the bis-hydroxyphenyl-triazole class of compds.  The present studies used selective radioiron probes of hepatocellular and reticuloendothelial (RE) iron stores in hypertransfused rats and iron-loaded heart cells to define the source of iron chelated in vivo by ICL670A and its mode of excretion, to examine its ability to remove iron directly from iron-loaded myocardial cells, and to examine its ability to interact with other chelators through a possible additive or synergistic effect.  Results indicate that ICL670A given orally is 4 to 5 times more effective than parenteral deferoxamine (DFO) in promoting the excretion of chelatable iron from hepatocellular iron stores.  The pattern of iron excretion produced by ICL670A is quite different from that of DFO and all iron excretion is restricted to the bile regardless of whether it is derived from RE or hepatocellular iron stores.  Studies in heart cell cultures have shown a favorable interaction between DFO and ICL670A manifested in improved chelating efficiency of ICL670A, which is most probably explained by an exchange of chelated iron between ICL670A and DFO.  These unique chelating properties of ICL670A may have practical implications for current efforts to design better therapeutic strategies for the management of transfusional iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTobgVlg-cr7Vg90H21EOLACvtfcHk0lh-67O85ZDLjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXht1Gis78%253D&md5=f5799e9e85c3b9505436a6d10c988d1c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1182%2Fblood.V97.4.1115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V97.4.1115%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DC.%26aulast%3DKonijn%26aufirst%3DA.%2BM.%26aulast%3DNick%26aufirst%3DH.%2BP.%26aulast%3DBreuer%26aufirst%3DW.%26aulast%3DCabantchik%26aufirst%3DZ.%2BI.%26aulast%3DLink%26aufirst%3DG.%26atitle%3DICL670A%253A%2520a%2520new%2520synthetic%2520oral%2520chelator%253A%2520evaluation%2520in%2520hypertransfused%2520rats%2520with%2520selective%2520radioiron%2520probes%2520of%2520hepatocellular%2520and%2520reticuloendothelial%2520iron%2520stores%2520and%2520in%2520iron-loaded%2520rat%2520heart%2520cells%2520in%2520culture%26jtitle%3DBlood%26date%3D2001%26volume%3D97%26issue%3D4%26spage%3D1115%26epage%3D1122%26doi%3D10.1182%2Fblood.V97.4.1115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cappellini, M. D.</span></span> <span> </span><span class="NLM_article-title">Iron-chelating therapy with the new oral agent ICL670 (Exjade)</span>. <i>Best Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">289</span>â <span class="NLM_lpage">298</span>, <span class="refDoi">Â DOI: 10.1016/j.beha.2004.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.beha.2004.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15737891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=289-298&issue=2&author=M.+D.+Cappellini&title=Iron-chelating+therapy+with+the+new+oral+agent+ICL670+%28Exjade%29&doi=10.1016%2Fj.beha.2004.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Iron-chelating therapy with the new oral agent ICL670 (Exjade)</span></div><div class="casAuthors">Cappellini, M. D.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-298</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Iron-chelation therapy is essential in iron-overloaded patients.  The long-term efficacy of this approach has been demonstrated unequivocally with deferoxamine, which effectively controls iron concns., thereby limiting organ damage and preventing premature death.  However, as deferoxamine is administered parenterally, poor compliance is a significant limitation to successful patient management.  ICL670 (Exjade) is a highly efficient and selective oral iron chelator.  The results of phase I and phase II clin. studies indicate that ICL670 is at least as effective as current std. therapy (deferoxamine), with a tolerability and safety profile suitable for chronic, once-daily administration.  These encouraging results have provided the rationale for the ongoing phase III program, and offer physicians and patients the promise of an oral, once-daily, iron-chelating agent for the prevention and management of iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgubpaNiVNf7Vg90H21EOLACvtfcHk0lh0EoUr3Cm3cQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbo%253D&md5=b1e677bfcd9748ebbd81f858c8ed17e4</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2004.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2004.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DCappellini%26aufirst%3DM.%2BD.%26atitle%3DIron-chelating%2520therapy%2520with%2520the%2520new%2520oral%2520agent%2520ICL670%2520%2528Exjade%2529%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2005%26volume%3D18%26issue%3D2%26spage%3D289%26epage%3D298%26doi%3D10.1016%2Fj.beha.2004.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, M. B.</span></span> <span> </span><span class="NLM_article-title">Deferasirox: oral, once daily iron chelator-an expert opinion</span>. <i>Indian J. Pediatr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">185</span>â <span class="NLM_lpage">191</span>, <span class="refDoi">Â DOI: 10.1007/s12098-010-0030-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs12098-010-0030-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20178010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC3c7ivFarug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=185-191&author=M.+B.+Agarwal&title=Deferasirox%3A+oral%2C+once+daily+iron+chelator-an+expert+opinion&doi=10.1007%2Fs12098-010-0030-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Deferasirox: oral, once daily iron chelator--an expert opinion</span></div><div class="casAuthors">Agarwal M B</div><div class="citationInfo"><span class="NLM_cas:title">Indian journal of pediatrics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-91</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Iron overload is a serious and potentially fatal condition that results from multiple blood transfusions required over a long period of time to treat certain types of anemias such as, that caused by beta-thalassemia, sickle cell disease and myelodysplastic syndrome.  Deferoxamine, which has been used since four decades as an iron chelator has limited efficacy due to its demanding therapeutic regimen, leading to poor compliance.  Deferasirox, once daily oral iron chelator provides an effective alternative to Deferoxamine in the treatment of transfusional hemosiderosis.  In this review, the role of Deferasirox as an ideal iron chelator has been discussed.  Pubmed searches on Deferasirox were carried out for the same.  Several studies demonstrated the safety and efficacy of Deferasirox in reducing iron burden in iron-overloaded patients with beta-thalassemia, sickle cell anemia and myelodysplastic anemia.  Thus, convenient, effective and tolerable chelation therapy with oral Deferasirox is likely to be a significant development in the treatment of transfusional iron overload, due to its ability to provide constant chelation coverage and the potential to improve compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS7yS7-aSqx6bP3FVUi_gf8fW6udTcc2ea7pjQuIFTeD7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7ivFarug%253D%253D&md5=e4a2c72f9a383b9a2f2b8f154f9b5b9b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs12098-010-0030-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12098-010-0030-4%26sid%3Dliteratum%253Aachs%26aulast%3DAgarwal%26aufirst%3DM.%2BB.%26atitle%3DDeferasirox%253A%2520oral%252C%2520once%2520daily%2520iron%2520chelator-an%2520expert%2520opinion%26jtitle%3DIndian%2520J.%2520Pediatr.%26date%3D2010%26volume%3D77%26spage%3D185%26epage%3D191%26doi%3D10.1007%2Fs12098-010-0030-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2185</span>â <span class="NLM_lpage">2195</span>, <span class="refDoi">Â DOI: 10.1021/jm201475u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201475u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XitlCqu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2185-2195&issue=5&author=Y.+M.+Maauthor=S.+Royauthor=X.+L.+Kongauthor=Y.+L.+Chenauthor=D.+Y.+Liuauthor=R.+C.+Hider&title=Design+and+synthesis+of+fluorinated+iron+chelators+for+metabolic+study+and+brain+uptake&doi=10.1021%2Fjm201475u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Fluorinated Iron Chelators for Metabolic Study and Brain Uptake</span></div><div class="casAuthors">Ma, Yongmin; Roy, Sourav; Kong, Xiaole; Chen, Yulin; Liu, Dingyong; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2185-2195</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of fluorinated 3-hydroxypyridin-4-ones has been synthesized where fluorine or fluorinated substituent was attached at 2- or 5- position of the pyridine ring in order to improve chem. and biol. properties of 3-hydroxypyridin-4-ones.  The synthetic route is different from conventional counterparts where a functional group is introduced to a preformed 3-hydroxypyridin-4-one ring.  Herein, we introduce a novel method which starts with a fluorine contg. precursor and the two hydroxyl groups at 3- and 4- positions of the pyridine ring are introduced at a later stage.  The pKa values of the free ligands and the affinity consts. of their iron complexes demonstrate that the presence of fluorine dramatically alters the values.  The distribution coeff. values of the free ligands and corresponding iron(III) complexes between 1-octanol and MOPS buffer (pH 7.4) are also influenced.  Glucuronidation and oxidn. studies of selected fluorinated 3-hydroxypyridin-4-ones demonstrate that some such fluorinated compds. have clear advantage over deferiprone in that they are metabolized more slowly.  Blood-brain barrier permeability studies indicated that although lipophilicity influences the permeability it is not the only factor.  Two of the selected seven fluorinated 3-hydroxypyridin-4-ones have improved brain distribution when compared with deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrddgmxFyu3d7Vg90H21EOLACvtfcHk0lh0EoUr3Cm3cQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitlCqu7o%253D&md5=c2f53c633a5600e64892e23aca5310e9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm201475u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201475u%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520fluorinated%2520iron%2520chelators%2520for%2520metabolic%2520study%2520and%2520brain%2520uptake%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D5%26spage%3D2185%26epage%3D2195%26doi%3D10.1021%2Fjm201475u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span> <span> </span><span class="NLM_article-title">Synthetic and natural iron chelators: therapeutic potential and clinical use</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1643</span>â <span class="NLM_lpage">1670</span>, <span class="refDoi">Â DOI: 10.4155/fmc.09.121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4155%2Ffmc.09.121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21425984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVejuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1643-1670&issue=9&author=H.+C.+Hatcherauthor=R.+N.+Singhauthor=F.+M.+Tortiauthor=S.+V.+Torti&title=Synthetic+and+natural+iron+chelators%3A+therapeutic+potential+and+clinical+use&doi=10.4155%2Ffmc.09.121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic and natural iron chelators: therapeutic potential and clinical use</span></div><div class="casAuthors">Hatcher, Heather C.; Singh, Ravi N.; Torti, Frank M.; Torti, Suzy V.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1643-1670</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Iron-chelation therapy has its origins in the treatment of iron-overload syndromes.  For many years, the std. for this purpose was deferoxamine.  Recently, considerable progress was made in identifying synthetic chelators with improved pharmacol. properties relative to deferoxamine.  Most notable are deferasirox (Exjade) and deferiprone (Ferriprox), which are now available clin.  In addn. to treatment of iron overload, there is an emerging role for iron chelators in the treatment of diseases characterized by oxidative stress, including cardiovascular disease, atherosclerosis, neurodegenerative diseases, and cancer.  While iron is not regarded as the underlying cause of these diseases, it does play an important role in disease progression, either through promotion of cellular growth and proliferation or through participation in redox reactions that catalyze the formation of reactive oxygen species and increase oxidative stress.  Thus, iron chelators may be of therapeutic benefit in many of these conditions.  Phytochems., many of which bind iron, may also owe some of their beneficial properties to iron chelation.  This review will focus on the advances in iron-chelation therapy for the treatment of iron-overload disease and cancer, as well as neurodegenerative and chronic inflammatory diseases.  Established and novel iron chelators will be discussed, as well as the emerging role of dietary plant polyphenols that effectively modulate iron biochem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT6Cm-2BLzOLVg90H21EOLACvtfcHk0lhU6iKGusgubw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVejuw%253D%253D&md5=d4e0da1164fc51106fa87954c8116777</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.4155%2Ffmc.09.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.09.121%26sid%3Dliteratum%253Aachs%26aulast%3DHatcher%26aufirst%3DH.%2BC.%26aulast%3DSingh%26aufirst%3DR.%2BN.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26atitle%3DSynthetic%2520and%2520natural%2520iron%2520chelators%253A%2520therapeutic%2520potential%2520and%2520clinical%2520use%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2009%26volume%3D1%26issue%3D9%26spage%3D1643%26epage%3D1670%26doi%3D10.4155%2Ffmc.09.121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huehns, E. R.</span></span> <span> </span><span class="NLM_article-title">The development of hydroxypyridin-4-ones as orally active iron chelators</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>612</i></span>,  <span class="NLM_fpage">327</span>â <span class="NLM_lpage">338</span>, <span class="refDoi">Â DOI: 10.1111/j.1749-6632.1990.tb24320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1749-6632.1990.tb24320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=2291561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3MXkvVCls7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=612&publication_year=1990&pages=327-338&author=R.+C.+Hiderauthor=S.+Singhauthor=J.+B.+Porterauthor=E.+R.+Huehns&title=The+development+of+hydroxypyridin-4-ones+as+orally+active+iron+chelators&doi=10.1111%2Fj.1749-6632.1990.tb24320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The development of hydroxypyridin-4-ones as orally active iron chelators</span></div><div class="casAuthors">Hider, R. C.; Singh, S.; Porter, J. B.; Huehns, E. R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">612</span>
        (<span class="NLM_cas:issue">Cooley's Anemia Symp., 6th, 1990</span>),
    <span class="NLM_cas:pages">327-38</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">A review with 28 refs., mainly on the authors' work, which led to the development of CP94 (I) as an effective compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKJU4bzUdYo7Vg90H21EOLACvtfcHk0lhU6iKGusgubw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkvVCls7w%253D&md5=294cf4c1dbc45ac09b6d1a56bba4c380</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1990.tb24320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1990.tb24320.x%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DHuehns%26aufirst%3DE.%2BR.%26atitle%3DThe%2520development%2520of%2520hydroxypyridin-4-ones%2520as%2520orally%2520active%2520iron%2520chelators%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1990%26volume%3D612%26spage%3D327%26epage%3D338%26doi%3D10.1111%2Fj.1749-6632.1990.tb24320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Victor
Hoffbrand, A.</span></span> <span> </span><span class="NLM_article-title">Deferiprone therapy for transfusional iron overload</span>. <i>Best. Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">299</span>â <span class="NLM_lpage">317</span>, <span class="refDoi">Â DOI: 10.1016/j.beha.2004.08.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.beha.2004.08.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15737892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=299-317&issue=2&author=A.+Victor%0AHoffbrand&title=Deferiprone+therapy+for+transfusional+iron+overload&doi=10.1016%2Fj.beha.2004.08.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Deferiprone therapy for transfusional iron overload</span></div><div class="casAuthors">Victor Hoffbrand, A.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">299-317</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Iron chelation is needed to prevent damage to the heart, liver and endocrine glands from iron overload in patients with refractory anemias who receive regular blood transfusions.  Desferrioxamine is still the first-line drug, but because of its expense in many countries, and lack of compliance because of difficulty with administration, there is a major need for an orally active (and cheaper) chelating drug.  Seventeen years after the first clin. trials deferiprone, which is orally active, has emerged as suitable for patients for whom desferrioxamine is, for one reason or another, inadequate.  Many patients are successfully chelated at a dose of deferiprone 75 mg/kg/day.  Some patients may need higher doses (up to 100 mg/kg), or combination therapy of deferiprone every day and desferrioxamine on several days each week.  Recent data suggest that deferiprone may be superior to desferrioxamine at protecting the heart from iron overload.  The side-effects of deferiprone-agranulocytosis, neutropenia, gastrointestinal symptoms, arthropathy, transient changes in liver enzymes, and zinc deficiency-are now well recognized; they result in discontinuation of the drug in only 5-10% of patients.  Deferiprone is now licensed in 43 countries for thalassemia major patients for whom desferrioxamine is inadequate.  If results of current trials confirm its superiority at reducing cardiac damage, it may well become the first-line drug for many patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY1tNeTcz2tbVg90H21EOLACvtfcHk0lhU6iKGusgubw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVSmtbs%253D&md5=273a462366256913490ea8c798a8c984</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.beha.2004.08.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.beha.2004.08.026%26sid%3Dliteratum%253Aachs%26aulast%3DVictor%2BHoffbrand%26aufirst%3DA.%26atitle%3DDeferiprone%2520therapy%2520for%2520transfusional%2520iron%2520overload%26jtitle%3DBest.%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2005%26volume%3D18%26issue%3D2%26spage%3D299%26epage%3D317%26doi%3D10.1016%2Fj.beha.2004.08.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span> <span> </span><span class="NLM_article-title">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe<sup>3+</sup> values</span>. <i>Transfus. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">201</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/S0955-3886(00)00090-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0955-3886%2800%2900090-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11099896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=201-209&issue=3&author=R.+C.+Hiderauthor=Z.+D.+Liuauthor=S.+Piyamongkol&title=The+design+and+properties+of+3-hydroxypyridin-4-one+iron+chelators+with+high+pFe3%2B+values&doi=10.1016%2FS0955-3886%2800%2900090-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values</span></div><div class="casAuthors">Hider R C; Liu Z D; Piyamongkol S</div><div class="citationInfo"><span class="NLM_cas:title">Transfusion science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-9</span>
        ISSN:<span class="NLM_cas:issn">0955-3886</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lZ-efNfxxVUIs6wFK5xJfW6udTcc2eaca59dCLn4Ybntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D&md5=af5a6096617fc38e6b49ba48661c87c5</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0955-3886%2800%2900090-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-3886%252800%252900090-4%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26atitle%3DThe%2520design%2520and%2520properties%2520of%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520with%2520high%2520pFe3%252B%2520values%26jtitle%3DTransfus.%2520Sci.%26date%3D2000%26volume%3D23%26issue%3D3%26spage%3D201%26epage%3D209%26doi%3D10.1016%2FS0955-3886%2800%2900090-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cilibrizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinone journey into metal chelation</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>118</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7657</span>â <span class="NLM_lpage">7701</span>, <span class="refDoi">Â DOI: 10.1021/acs.chemrev.8b00254</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00254" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlGhu73K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2018&pages=7657-7701&issue=16&author=A.+Cilibrizziauthor=V.+Abbateauthor=Y.+L.+Chenauthor=Y.+Maauthor=T.+Zhouauthor=R.+C.+Hider&title=Hydroxypyridinone+journey+into+metal+chelation&doi=10.1021%2Facs.chemrev.8b00254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinone Journey into Metal Chelation</span></div><div class="casAuthors">Cilibrizzi, Agostino; Abbate, Vincenzo; Chen, Yu-Lin; Ma, Yongmin; Zhou, Tao; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7657-7701</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Hydroxypyridinones (HOPOs) form outstanding building blocks for the development of a variety of agents in the field of metal chelation.  The pyridinone ring is easily synthesized and readily converted into tetradentate, hexadentate, and octadentate chelators.  There is considerable potential for the control of the stereochem. of the resulting metal complex and hence the properties of these multidentate mols.  Their ability to rapidly bind hard metals in aq. media has facilitated the development of efficient applications in both biol. and medical contexts.  In this Review, an in-depth anal. of the synthetic methodologies for HOPO-based ligands is presented, as well as the many aspects to achieve optimal biol. activity.  Recent advances and current challenges for the future application of HOPO structures are outlined.  The present flourishing development of drug candidates and diagnostic agents based on this chem. scaffold opens access to many new applications in anal., environmental, and clin. science.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFMvYhVBhi07Vg90H21EOLACvtfcHk0lhIAYUQu7gMdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlGhu73K&md5=66d9a710574490018bffef41a8bb8a2c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00254%26sid%3Dliteratum%253Aachs%26aulast%3DCilibrizzi%26aufirst%3DA.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DHydroxypyridinone%2520journey%2520into%2520metal%2520chelation%26jtitle%3DChem.%2520Rev.%26date%3D2018%26volume%3D118%26issue%3D16%26spage%3D7657%26epage%3D7701%26doi%3D10.1021%2Facs.chemrev.8b00254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Potential protection from toxicity by oral iron chelators</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>82/83</i></span>,  <span class="NLM_fpage">961</span>â <span class="NLM_lpage">967</span>, <span class="refDoi">Â DOI: 10.1016/0378-4274(95)03606-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0378-4274%2895%2903606-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK28Xht1KqtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82%2F83&publication_year=1995&pages=961-967&author=R.+C.+Hider&title=Potential+protection+from+toxicity+by+oral+iron+chelators&doi=10.1016%2F0378-4274%2895%2903606-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Potential protection from toxicity by oral iron chelators</span></div><div class="casAuthors">Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">82/83</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">961-7</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review and discussion with 23 refs.  The design of clin. useful iron chelators requires attention to be paid to 3 key parameters: oral absorption, selectivity and affinity for iron(III) and toxicity.  Factors which influence these 3 parameters are discussed.  Hydroxypyridinones are identified as key ligands and properties leading to minimal toxicity and optimum distribution for the treatment of thalassemia are presented.  Key metalloenzymes which are inhibited by iron chelators are identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokkSva8smMpLVg90H21EOLACvtfcHk0lhIAYUQu7gMdg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xht1KqtLk%253D&md5=8c8d0a42563ef31be0935aabe8b7cd54</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0378-4274%2895%2903606-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0378-4274%252895%252903606-7%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DPotential%2520protection%2520from%2520toxicity%2520by%2520oral%2520iron%2520chelators%26jtitle%3DToxicol.%2520Lett.%26date%3D1995%26volume%3D82%252F83%26spage%3D961%26epage%3D967%26doi%3D10.1016%2F0378-4274%2895%2903606-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Oral iron chelators-development and application</span>. <i>Best Pract. Res. Clin. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">369</span>â <span class="NLM_lpage">384</span>, <span class="refDoi">Â DOI: 10.1053/beha.2002.0209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1053%2Fbeha.2002.0209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12401312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ansb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=369-384&issue=2&author=D.+Y.+Liuauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=Oral+iron+chelators-development+and+application&doi=10.1053%2Fbeha.2002.0209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Oral iron chelators - development and application</span></div><div class="casAuthors">Liu, Ding Y.; Liu, Zu D.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Best Practice & Research, Clinical Haematology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">369-384</span>CODEN:
                <span class="NLM_cas:coden">BPRCA5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Bailliere Tindall</span>)
        </div><div class="casAbstract">A review.  Iron chelation therapy is the only therapeutic approach that leads to enhanced iron excretion in Î²-thalassemia major and other transfusion-dependent patients.  Although desferrioxamine has been used in such treatment over the last three decades, it is not an ideal drug due to its poor oral availability.  Consequently extensive research effort has been directed towards the identification of non-toxic, orally active iron chelators.  An ideal candidate must possess a range of crit. physicochem. and biol. properties, such as high selectivity and affinity for iron(III), tightly controlled distribution and metabolic profiles and low toxicity.  Unfortunately, hexadentate ligands are generally assocd. with poor oral bioavailability, whereas many tridentate and bidentate mols. are orally active.  The tridentate triazoles have been investigated for clin. potential; they are readily absorbed from the gastrointestinal tract and promote iron excretion with high efficacy.  In similar fashion, several bidentate hydroxypyridinones have been demonstrated to possess potential as oral chelating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsujkNXu-Lk7Vg90H21EOLACvtfcHk0liWymgzRMIw5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ansb8%253D&md5=d64526ce64ae1a337cd229477da6beda</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1053%2Fbeha.2002.0209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fbeha.2002.0209%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DOral%2520iron%2520chelators-development%2520and%2520application%26jtitle%3DBest%2520Pract.%2520Res.%2520Clin.%2520Haematol.%26date%3D2002%26volume%3D15%26issue%3D2%26spage%3D369%26epage%3D384%26doi%3D10.1053%2Fbeha.2002.0209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span> <span> </span><span class="NLM_article-title">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe<sup>3+</sup> values</span>. <i>Transfus. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">201</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/S0955-3886(00)00090-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0955-3886%2800%2900090-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11099896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=201-209&author=R.+C.+Hiderauthor=Z.+D.+Liuauthor=S.+Piyamongkol&title=The+design+and+properties+of+3-hydroxypyridin-4-one+iron+chelators+with+high+pFe3%2B+values&doi=10.1016%2FS0955-3886%2800%2900090-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values</span></div><div class="casAuthors">Hider R C; Liu Z D; Piyamongkol S</div><div class="citationInfo"><span class="NLM_cas:title">Transfusion science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-9</span>
        ISSN:<span class="NLM_cas:issn">0955-3886</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lZ-efNfxxVUIs6wFK5xJfW6udTcc2eZnaNWvLrCP6Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D&md5=af5a6096617fc38e6b49ba48661c87c5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2FS0955-3886%2800%2900090-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-3886%252800%252900090-4%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26atitle%3DThe%2520design%2520and%2520properties%2520of%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520with%2520high%2520pFe3%252B%2520values%26jtitle%3DTransfus.%2520Sci.%26date%3D2000%26volume%3D23%26spage%3D201%26epage%3D209%26doi%3D10.1016%2FS0955-3886%2800%2900090-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical characterization, and biological evaluation of 2-(1â²-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe<sup>3+</sup> values</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">4814</span>â <span class="NLM_lpage">4823</span>, <span class="refDoi">Â DOI: 10.1021/jm991080o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991080o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4814-4823&author=Z.+D.+Liuauthor=H.+H.+Khodrauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+characterization%2C+and+biological+evaluation+of+2-%281%E2%80%B2-hydroxyalkyl%29-3-hydroxypyridin-4-ones%3A+novel+iron+chelators+with+enhanced+pFe3%2B+values&doi=10.1021%2Fjm991080o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Physicochemical Characterization, and Biological Evaluation of 2-(1'-Hydroxyalkyl)-3-hydroxypyridin-4-ones: Novel Iron Chelators with Enhanced pFe3+ Values</span></div><div class="casAuthors">Liu, Zu D.; Khodr, Hicham H.; Liu, Ding Y.; Lu, Shu L.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4814-4823</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a range of 2-(1-hydroxyalkyl)-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described.  The pKa values of the ligands and the stability consts. of their iron(III) complexes have been detd.  Results indicate that the introduction of a 1'-hydroxyalkyl group at the 2-position leads to a significant improvement in the pFe3+ values.  Such an effect was found to be greater with the hydroxyethyl substituent than with the hydroxymethyl substituent, particularly in the cases of 1-ethyl-2-(1-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.4) and 1,6-dimethyl-2-(1'-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.5) where an enhancement on pFe3+ values in the region of two orders of magnitude is obsd., as compared with Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) (pFe3+ = 19.4).  The ability of these novel 3-hydroxypyridin-4-ones to facilitate the iron excretion in bile was investigated using a [59Fe]ferritin-loaded rat model.  Chelators and prodrug chelators possessing high pFe3+ values show great promise in their ability to remove iron under in vivo conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-7JLiGBw6MLVg90H21EOLACvtfcHk0liWymgzRMIw5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D&md5=6ba15911983ff3fbb19515acf8732dd4</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Fjm991080o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991080o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%25202-%25281%25E2%2580%25B2-hydroxyalkyl%2529-3-hydroxypyridin-4-ones%253A%2520novel%2520iron%2520chelators%2520with%2520enhanced%2520pFe3%252B%2520values%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D4814%26epage%3D4823%26doi%3D10.1021%2Fjm991080o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 2-amido-3-hydroxypyridin-4(1<i>H</i>)-ones: novel iron chelators with enhanced pFe<sup>3+</sup> values</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">563</span>â <span class="NLM_lpage">573</span>, <span class="refDoi">Â DOI: 10.1016/S0968-0896(00)00273-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0968-0896%2800%2900273-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11310590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1aht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=563-573&author=Z.+D.+Liuauthor=S.+Piyamongkolauthor=D.+Y.+Liuauthor=H.+H.+Khodrauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis+of+2-amido-3-hydroxypyridin-4%281H%29-ones%3A+novel+iron+chelators+with+enhanced+pFe3%2B+values&doi=10.1016%2FS0968-0896%2800%2900273-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values</span></div><div class="casAuthors">Liu, Zu D.; Piyamongkol, S.; Liu, Ding Y.; Khodr, Hicham H.; Lu, Shu L.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The synthesis of a range of 2-amido-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described.  The pKa values of the ligands together with the stability consts. of their iron(III) complexes have been detd.  Results indicate that the introduction of an amido substituent at the 2-position leads to an appreciable enhancement of the pFe3+ values.  The ability of these novel 3-hydroxypyridin-4-ones to facilitate iron excretion in bile was investigated using a 59Fe-ferritin loaded rat model.  The optimal effect was obsd. with the N-methylamido deriv. I, which has an assocd. pFe3+ value of 21.7, more than two orders of magnitude higher than that of deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) (pFe3+ = 19.4).  Dose-response studies suggest that chelators with high pFe3+ values scavenge iron more effectively at lower doses when compared with simple dialkyl-substituted hydroxypyridinones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqR7Y7aGKdrVg90H21EOLACvtfcHk0liWymgzRMIw5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1aht7Y%253D&md5=a3bc9b8ff46d17bdd61681c920dc20b8</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2FS0968-0896%2800%2900273-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0896%252800%252900273-X%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%2520of%25202-amido-3-hydroxypyridin-4%25281H%2529-ones%253A%2520novel%2520iron%2520chelators%2520with%2520enhanced%2520pFe3%252B%2520values%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D563%26epage%3D573%26doi%3D10.1016%2FS0968-0896%2800%2900273-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pangjit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banjerdpongchai, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phisalaphong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucharoen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srichairatanakool, S.</span></span> <span> </span><span class="NLM_article-title">Characterisation of a novel oral iron chelator: 1-(<i>N</i>-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">703</span>â <span class="NLM_lpage">713</span>, <span class="refDoi">Â DOI: 10.1111/jphp.12373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fjphp.12373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25627251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslymtLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=703-713&issue=5&author=K.+Pangjitauthor=R.+Banjerdpongchaiauthor=C.+Phisalaphongauthor=S.+Fucharoenauthor=Y.+Y.+Xieauthor=Z.+D.+Luauthor=R.+C.+Hiderauthor=S.+Srichairatanakool&title=Characterisation+of+a+novel+oral+iron+chelator%3A+1-%28N-acetyl-6-aminohexyl%29-3-hydroxy-2-methylpyridin-4-one&doi=10.1111%2Fjphp.12373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of a novel oral iron chelator: 1-(N-Acetyl-6-Aminohexyl)-3-Hydroxy-2-Methylpyridin-4-one</span></div><div class="casAuthors">Pangjit, Kanjana; Banjerdpongchai, Ratana; Phisalaphong, Chada; Fucharoen, Suthat; Xie, Yuan Yuan; Lu, Zi Dong; Hider, Robert C.; Srichairatanakool, Somdet</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">703-713</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Objectives : Desferrioxamine (DFO), deferiprone (DFP) and deferasirox (DFX) are iron chelators currently in clin. use for the treatment of iron overload.  Due to difficulties with administration and assocd. side effects with these three mols., the search continues for an efficient nontoxic orally active iron chelator.  This communication describes the properties of one such candidate, 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1).  Methods : Physicochem. characterization techniques, including partition coeff., pKa values and logK values for iron(III).  Iron scavenging assays, from iron citrate, nontransferrin bound iron and iron-loaded rats.  Cytotoxicity studies using white cells, hepatocytes and cardiomyocytes.  Key findings : CM1 possesses high affinity and selectivity for iron(III) and a suitable partition coeff. to permeate membranes.  CM1 forms a neutral 3 : 1 iron(III) complex under physiol. conditions and so, it is predicted to be capable of entry into mammalian cells to scavenge excess intracellular iron and to efflux from cells as the neutral 3 : 1 complex.  CM1 is demonstrated to be orally active and to possess a higher efficacy than DFP in rats.  CM1 displays no toxicity to a range of cell types.  Conclusion : The above promising studies will be extended to monitor the pharmacokinetics and metab. of CM1.  CM1 is an excellent candidate for phase 1 clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6NrHhHYIVyrVg90H21EOLACvtfcHk0lhA1ht2pj8pfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslymtLg%253D&md5=1d7b7ae01e9aace227f7577546eb5dd2</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12373%26sid%3Dliteratum%253Aachs%26aulast%3DPangjit%26aufirst%3DK.%26aulast%3DBanjerdpongchai%26aufirst%3DR.%26aulast%3DPhisalaphong%26aufirst%3DC.%26aulast%3DFucharoen%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DSrichairatanakool%26aufirst%3DS.%26atitle%3DCharacterisation%2520of%2520a%2520novel%2520oral%2520iron%2520chelator%253A%25201-%2528N-acetyl-6-aminohexyl%2529-3-hydroxy-2-methylpyridin-4-one%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2015%26volume%3D67%26issue%3D5%26spage%3D703%26epage%3D713%26doi%3D10.1111%2Fjphp.12373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R.</span></span> <span> </span><span class="NLM_article-title">Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1<i>H</i>)-pyridones - attempted optimization of the orally active iron chelator, deferiprone</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">132</span>â <span class="NLM_lpage">140</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27014847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVCjs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2016&pages=132-140&author=Y.+Y.+Xieauthor=Z.+Luauthor=X.+L.+Kongauthor=T.+Zhouauthor=S.+Bansalauthor=R.+Hider&title=Systematic+comparison+of+the+mono-%2C+dimethyl-+and+trimethyl+3-hydroxy-4%281H%29-pyridones+-+attempted+optimization+of+the+orally+active+iron+chelator%2C+deferiprone&doi=10.1016%2Fj.ejmech.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone</span></div><div class="casAuthors">Xie, Yuan-Yuan; Lu, Zidong; Kong, Xiao-Le; Zhou, Tao; Bansal, Sukhi; Hider, Robert</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-140</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A range of close analogs of deferiprone have been synthesized.  The group includes mono-, di- and tri-methyl-3-hydroxy-4(1H)-pyridones.  These compds. were found to possess similar pFe3+ values to that of deferiprone, with the exception of the 2.5-dimethylated derivs.  Surprisingly the NH-contg. hydroxy-4(1H)-pyridones were found to be marginally more lipophilic than the corresponding N-Me contg. analogs.  This same group are also metabolised less efficiently by Phase 1 hydroxylating enzymes than the corresponding N-Me analogs.  As result of this study, three compds. have been identified for further investigation centered on neutropenia and agranulocytosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruZa1RQjbhjbVg90H21EOLACvtfcHk0lhA1ht2pj8pfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVCjs70%253D&md5=c315386b9a4ecc09f9b2e11076ae201a</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBansal%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%26atitle%3DSystematic%2520comparison%2520of%2520the%2520mono-%252C%2520dimethyl-%2520and%2520trimethyl%25203-hydroxy-4%25281H%2529-pyridones%2520-%2520attempted%2520optimization%2520of%2520the%2520orally%2520active%2520iron%2520chelator%252C%2520deferiprone%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D115%26spage%3D132%26epage%3D140%26doi%3D10.1016%2Fj.ejmech.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of new iron chelators and their therapeutic potential</span>. <i>Inorg. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">470</span>â <span class="NLM_lpage">480</span>, <span class="refDoi">Â DOI: 10.1016/S0020-1693(02)01040-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0020-1693%2802%2901040-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XosFOks70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2002&pages=470-480&author=F.+Aouadauthor=A.+Florenceauthor=Y.+Zhangauthor=F.+Collinsauthor=C.+Henryauthor=R.+J.+Wardauthor=R.+R.+Crichton&title=Evaluation+of+new+iron+chelators+and+their+therapeutic+potential&doi=10.1016%2FS0020-1693%2802%2901040-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of new iron chelators and their therapeutic potential</span></div><div class="casAuthors">Aouad, Fouad; Florence, Anne; Zhang, Ying; Collins, Fiona; Henry, Christophe; Ward, Roberta J.; Crichton, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Inorganica Chimica Acta</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">470-480</span>CODEN:
                <span class="NLM_cas:coden">ICHAA3</span>;
        ISSN:<span class="NLM_cas:issn">0020-1693</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  One of the most important challenges for biol. inorg. chem. is to understand metal ion homeostasis, particularly since the authors are becoming increasingly aware that its disequil. is at the basis of a large no. of clin. disorders.  It is, therefore, also an important objective of the authors' research to seek solns., which can alleviate the consequences of the perturbation of the homeostasis of key metal ions within cells, tissues, and organisms.  Iron is 1 of the key metals in biol., for which disorders of homeostasis are implicated in a vast panoply of pathol. conditions.  The authors review here the ways in which potential iron chelators can be evaluated, using appropriate in vivo or in vitro screening systems, and discuss their potential applications in the chelation of both Fe and Al in the treatment of a no. of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5iBNkRKdRR7Vg90H21EOLACvtfcHk0lhA1ht2pj8pfQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosFOks70%253D&md5=15f2f4a397020a5ee99bbc396aaee18d</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0020-1693%2802%2901040-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-1693%252802%252901040-X%26sid%3Dliteratum%253Aachs%26aulast%3DAouad%26aufirst%3DF.%26aulast%3DFlorence%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DCollins%26aufirst%3DF.%26aulast%3DHenry%26aufirst%3DC.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26atitle%3DEvaluation%2520of%2520new%2520iron%2520chelators%2520and%2520their%2520therapeutic%2520potential%26jtitle%3DInorg.%2520Chim.%2520Acta%26date%3D2002%26volume%3D339%26spage%3D470%26epage%3D480%26doi%3D10.1016%2FS0020-1693%2802%2901040-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, R.</span></span> <span> </span><span class="NLM_article-title">Iron metabolism: from health to disease</span>. <i>J. Clin. Lab. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">210</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1002/jcla.21668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fjcla.21668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24478115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntFCgu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=210-218&issue=3&author=F.+Oliveiraauthor=S.+Rochaauthor=R.+Fernandes&title=Iron+metabolism%3A+from+health+to+disease&doi=10.1002%2Fjcla.21668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Iron Metabolism: From Health to Disease</span></div><div class="casAuthors">Oliveira, Fernando; Rocha, Sara; Fernandes, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Laboratory Analysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">210-218</span>CODEN:
                <span class="NLM_cas:coden">JCANEM</span>;
        ISSN:<span class="NLM_cas:issn">0887-8013</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Background : Iron is vital for almost all living organisms by participating in a wide range of metabolic processes.  However, iron concn. in body tissues must be tightly regulated since excessive iron may lead to microbial infections or cause tissue damage.  Disorders of iron metab. are among the most common human diseases and cover several conditions with varied clin. manifestations.  Methods : An extensive literature review on the basic aspects of iron metab. was performed, and the most recent findings on this field were highlighted as well.  Results : New insights on iron metab. have shed light into its real complexity, and its role in both healthy and pathol. states has been recognized.  Important discoveries about the iron regulatory machine and imbalances in its regulation have been made, which may lead in a near future to the development of new therapeutic strategies against iron disorders.  Besides, the toxicity of free iron and its assocn. with several pathologies has been addressed, although it requires further investigations.  Conclusion : This review will provide students in the fields of biochem. and health sciences a brief and clear overview of iron physiol. and toxicity, as well as imbalances in the iron homeostasis and assocd. pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMxjm29hqh57Vg90H21EOLACvtfcHk0lhTuRHAOhGoCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntFCgu70%253D&md5=90884bcb63b40900485c194e1c02a4e4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2Fjcla.21668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcla.21668%26sid%3Dliteratum%253Aachs%26aulast%3DOliveira%26aufirst%3DF.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DR.%26atitle%3DIron%2520metabolism%253A%2520from%2520health%2520to%2520disease%26jtitle%3DJ.%2520Clin.%2520Lab.%2520Anal.%26date%3D2014%26volume%3D28%26issue%3D3%26spage%3D210%26epage%3D218%26doi%3D10.1002%2Fjcla.21668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voskaridou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douskou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terpos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamoulakatou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meletis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ourailidis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papassotiriou, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loukopoulos, D.</span></span> <span> </span><span class="NLM_article-title">Deferiprone as an oral iron chelator in sickle cell disease</span>. <i>Ann. Hematol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">434</span>â <span class="NLM_lpage">440</span>, <span class="refDoi">Â DOI: 10.1007/s00277-005-1015-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00277-005-1015-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15809885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkvVCksro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2005&pages=434-440&issue=7&author=E.+Voskaridouauthor=M.+Douskouauthor=E.+Terposauthor=A.+Stamoulakatouauthor=J.+Meletisauthor=A.+Ourailidisauthor=I.+Papassotiriouauthor=D.+Loukopoulos&title=Deferiprone+as+an+oral+iron+chelator+in+sickle+cell+disease&doi=10.1007%2Fs00277-005-1015-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Deferiprone as an oral iron chelator in sickle cell disease</span></div><div class="casAuthors">Voskaridou, Ersi; Douskou, Maroussa; Terpos, Evangelos; Stamoulakatou, Alexandra; Meletis, John; Ourailidis, Akis; Papassotiriou, Ioannis; Loukopoulos, Dimitris</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Hematology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">434-440</span>CODEN:
                <span class="NLM_cas:coden">ANHEE8</span>;
        ISSN:<span class="NLM_cas:issn">0939-5555</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Iron overload is not uncommon in sickle cell disease (SCD) and requires regular chelation therapy in several instances.  The present study evaluates the effect of deferiprone in 15 adult patients with SCD (ten Î²s/Î²0thalassemia and five Î²s/Î²s) and iron overload.  Deferiprone was given at a dose of 75 mg/kg daily for 12 mo.  The evaluation considered pre- and post-treatment values of serum ferritin, urinary iron excretion, and T2 values of liver and heart obtained by magnetic resonance imaging (MRI).  Eleven patients had a liver biopsy prior to starting therapy to evaluate iron concn. (LIC).  Twelve patients completed the study with satisfactory compliance.  In ten of them (83.3%) the serum ferritin levels decreased significantly at the end of the trial; in eight patients (66.6%) the redn. of serum ferritin was accompanied by a significant increase of their liver T2 values.  All patients had a significant increase of urinary iron excretion in response to the drug.  Ferritin levels and liver T2 values correlated with liver iron concn.; on the contrary, ferritin levels and liver T2 values failed to show any correlation with heart T2 values.  Heart T2 values did not also show any correlation with left ventricular ejection fraction.  Deferiprone was well tolerated and did not cause any significant adverse effects.  These results suggest that deferiprone may effectively decrease the iron deposition in patients with SCD; moreover, T2 MRI proves to be a reliable and rapid, noninvasive method for assessing the liver iron load in patients with SCD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6UoktA2JYXbVg90H21EOLACvtfcHk0lhTuRHAOhGoCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkvVCksro%253D&md5=425c4a636df7671ff24f3bf3af06efd0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1007%2Fs00277-005-1015-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00277-005-1015-7%26sid%3Dliteratum%253Aachs%26aulast%3DVoskaridou%26aufirst%3DE.%26aulast%3DDouskou%26aufirst%3DM.%26aulast%3DTerpos%26aufirst%3DE.%26aulast%3DStamoulakatou%26aufirst%3DA.%26aulast%3DMeletis%26aufirst%3DJ.%26aulast%3DOurailidis%26aufirst%3DA.%26aulast%3DPapassotiriou%26aufirst%3DI.%26aulast%3DLoukopoulos%26aufirst%3DD.%26atitle%3DDeferiprone%2520as%2520an%2520oral%2520iron%2520chelator%2520in%2520sickle%2520cell%2520disease%26jtitle%3DAnn.%2520Hematol.%26date%3D2005%26volume%3D84%26issue%3D7%26spage%3D434%26epage%3D440%26doi%3D10.1007%2Fs00277-005-1015-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shander, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berth, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Javidroozi, M.</span></span> <span> </span><span class="NLM_article-title">Iron overload and toxicity: implications for anesthesiologists</span>. <i>J. Clin. Anesth.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">419</span>â <span class="NLM_lpage">425</span>, <span class="refDoi">Â DOI: 10.1016/j.jclinane.2011.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.jclinane.2011.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22658368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVWjsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2012&pages=419-425&issue=5&author=A.+Shanderauthor=U.+Berthauthor=J.+Bettaauthor=M.+Javidroozi&title=Iron+overload+and+toxicity%3A+implications+for+anesthesiologists&doi=10.1016%2Fj.jclinane.2011.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Iron overload and toxicity: implications for anesthesiologists</span></div><div class="casAuthors">Shander, Aryeh; Berth, Ulrike; Betta, Joanne; Javidroozi, Mazyar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Anesthesia</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">419-425</span>CODEN:
                <span class="NLM_cas:coden">JCLBE7</span>;
        ISSN:<span class="NLM_cas:issn">0952-8180</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Conditions leading to iron overload range from rare hereditary disorders to more common medical conditions assocd. with chronic blood transfusions.  Iron overload has deleterious effects on various vital organs (eg, liver, heart, and endocrine glands).  Serum ferritin (in conjunction with transferrin satn.) is the most widely used test to evaluate iron burden and to screen for iron overload.  The management plan should be adjusted to account for iron overload and potential consequences of liver, heart, and other organ involvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJr26zsrSfaLVg90H21EOLACvtfcHk0lhTuRHAOhGoCw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVWjsL8%253D&md5=413d99826cbbf9e3bee89b3368b01b60</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.jclinane.2011.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jclinane.2011.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DShander%26aufirst%3DA.%26aulast%3DBerth%26aufirst%3DU.%26aulast%3DBetta%26aufirst%3DJ.%26aulast%3DJavidroozi%26aufirst%3DM.%26atitle%3DIron%2520overload%2520and%2520toxicity%253A%2520implications%2520for%2520anesthesiologists%26jtitle%3DJ.%2520Clin.%2520Anesth.%26date%3D2012%26volume%3D24%26issue%3D5%26spage%3D419%26epage%3D425%26doi%3D10.1016%2Fj.jclinane.2011.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhoiwala, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunaief, J. L.</span></span> <span> </span><span class="NLM_article-title">Retinal abnormalities in Î²-thalassemia major</span>. <i>Surv. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>â <span class="NLM_lpage">50</span>, <span class="refDoi">Â DOI: 10.1016/j.survophthal.2015.08.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.survophthal.2015.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26325202" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC287otVSjtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2016&pages=33-50&issue=1&author=D.+L.+Bhoiwalaauthor=J.+L.+Dunaief&title=Retinal+abnormalities+in+%CE%B2-thalassemia+major&doi=10.1016%2Fj.survophthal.2015.08.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Retinal abnormalities in Î²-thalassemia major</span></div><div class="casAuthors">Bhoiwala Devang L; Dunaief Joshua L</div><div class="citationInfo"><span class="NLM_cas:title">Survey of ophthalmology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-50</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Patients with beta (Î²)-thalassemia (Î²-TM: Î²-thalassemia major, Î²-TI: Î²-thalassemia intermedia) have a variety of complications that may affect all organs, including the eye.  Ocular abnormalities include retinal pigment epithelial degeneration, angioid streaks, venous tortuosity, night blindness, visual field defects, decreased visual acuity, color vision abnormalities, and acute visual loss.  Patients with Î²-thalassemia major are transfusion dependent and require iron chelation therapy to survive.  Retinal degeneration may result from either retinal iron accumulation from transfusion-induced iron overload or retinal toxicity induced by iron chelation therapy.  Some who were never treated with iron chelation therapy exhibited retinopathy, and others receiving iron chelation therapy had chelator-induced retinopathy.  We will focus on retinal abnormalities present in individuals with Î²-thalassemia major viewed in light of new findings on the mechanisms and manifestations of retinal iron toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQnzeDrdeD2GkwlCcfExbvbfW6udTcc2eYV2xZmVPraa7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287otVSjtA%253D%253D&md5=9a9600888713a7becb52167288ae0b8d</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.survophthal.2015.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.survophthal.2015.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DBhoiwala%26aufirst%3DD.%2BL.%26aulast%3DDunaief%26aufirst%3DJ.%2BL.%26atitle%3DRetinal%2520abnormalities%2520in%2520%25CE%25B2-thalassemia%2520major%26jtitle%3DSurv.%2520Ophthalmol.%26date%3D2016%26volume%3D61%26issue%3D1%26spage%3D33%26epage%3D50%26doi%3D10.1016%2Fj.survophthal.2015.08.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galanello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westwood, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roughton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Assomull, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennell, D. J.</span></span> <span> </span><span class="NLM_article-title">A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">1876</span>â <span class="NLM_lpage">1884</span>, <span class="refDoi">Â DOI: 10.1161/CIRCULATIONAHA.106.648790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1161%2FCIRCULATIONAHA.106.648790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=17372174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs1Oltbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=1876-1884&issue=14&author=M.+A.+Tannerauthor=R.+Galanelloauthor=C.+Dessiauthor=G.+C.+Smithauthor=M.+A.+Westwoodauthor=A.+Agusauthor=M.+Roughtonauthor=R.+Assomullauthor=S.+V.+Nairauthor=J.+M.+Walkerauthor=D.+J.+Pennell&title=A+randomized%2C+placebo-controlled%2C+double-blind+trial+of+the+effect+of+combined+therapy+with+deferoxamine+and+deferiprone+on+myocardial+iron+in+thalassemia+major+using+cardiovascular+magnetic+resonance&doi=10.1161%2FCIRCULATIONAHA.106.648790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">A Randomized, Placebo-Controlled, Double-Blind Trial of the Effect of Combined Therapy With Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia Major Using Cardiovascular Magnetic Resonance</span></div><div class="casAuthors">Tanner, M. A.; Galanello, R.; Dessi, C.; Smith, G. C.; Westwood, M. A.; Agus, A.; Roughton, M.; Assomull, R.; Nair, S. V.; Walker, J. M.; Pennell, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1876-1884</span>CODEN:
                <span class="NLM_cas:coden">CIRCAZ</span>;
        ISSN:<span class="NLM_cas:issn">0009-7322</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Background: Cardiac complications secondary to iron overload are the leading cause of death in Î²-thalassemia major.  Approx. two thirds of patients maintained on the parenteral iron chelator deferoxamine have myocardial iron loading.  The oral iron chelator deferiprone has been demonstrated to remove myocardial iron, and it has been proposed that in combination with deferoxamine it may have addnl. effect.  Methods and Results: Myocardial iron loading was assessed with the use of myocardial T2* cardiovascular magnetic resonance in 167 patients with thalassemia major receiving std. maintenance chelation monotherapy with s.c. deferoxamine.  Of these patients, 65 with mild to moderate myocardial iron loading (T2* 8 to 20 ms) entered the trial with continuation of s.c. deferoxamine and were randomized to receive addnl. oral placebo (deferoxamine group) or oral deferiprone 75 mg/kg per day (combined group).  The primary end point was the change in myocardial T2* over 12 mo.  Secondary end points of endothelial function (flow-mediated dilatation of the brachial artery) and cardiac function were also measured with cardiovascular magnetic resonance.  There were significant improvements in the combined treatment group compared with the deferoxamine group in myocardial T2* (ratio of change in geometric means 1.50 vs. 1.24; P=0.02), abs. left ventricular ejection fraction (2.6% vs. 0.6%; P=0.05), and abs. endothelial function (8.8% vs. 3.3%; P=0.02).  There was also a significantly greater improvement in serum ferritin in the combined group (-976 vs. -233 Î¼g/L; P<0.001).  Conclusions: In comparison to the std. chelation monotherapy of deferoxamine, combination treatment with addnl. deferiprone reduced myocardial iron and improved the ejection fraction and endothelial function in thalassemia major patients with mild to moderate cardiac iron loading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Nqg-rZA8K7Vg90H21EOLACvtfcHk0lgsXRtEBGv6yQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs1Oltbw%253D&md5=c2b83d663873801ab29cef2f63d437b8</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.106.648790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.106.648790%26sid%3Dliteratum%253Aachs%26aulast%3DTanner%26aufirst%3DM.%2BA.%26aulast%3DGalanello%26aufirst%3DR.%26aulast%3DDessi%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DG.%2BC.%26aulast%3DWestwood%26aufirst%3DM.%2BA.%26aulast%3DAgus%26aufirst%3DA.%26aulast%3DRoughton%26aufirst%3DM.%26aulast%3DAssomull%26aufirst%3DR.%26aulast%3DNair%26aufirst%3DS.%2BV.%26aulast%3DWalker%26aufirst%3DJ.%2BM.%26aulast%3DPennell%26aufirst%3DD.%2BJ.%26atitle%3DA%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%2520trial%2520of%2520the%2520effect%2520of%2520combined%2520therapy%2520with%2520deferoxamine%2520and%2520deferiprone%2520on%2520myocardial%2520iron%2520in%2520thalassemia%2520major%2520using%2520cardiovascular%2520magnetic%2520resonance%26jtitle%3DCirculation%26date%3D2007%26volume%3D115%26issue%3D14%26spage%3D1876%26epage%3D1884%26doi%3D10.1161%2FCIRCULATIONAHA.106.648790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontoghiorghes, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neocleous, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolnagou, A.</span></span> <span> </span><span class="NLM_article-title">Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">584</span>, <span class="refDoi">Â DOI: 10.2165/00002018-200326080-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2165%2F00002018-200326080-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12825969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsVenurg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=553-584&author=G.+J.+Kontoghiorghesauthor=K.+Neocleousauthor=A.+Kolnagou&title=Benefits+and+risks+of+deferiprone+in+iron+overload+in+thalassaemia+and+other+conditions%3A+comparison+of+epidemiological+and+therapeutic+aspects+with+deferoxamine&doi=10.2165%2F00002018-200326080-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Benefits and risks of deferiprone in iron overload in thalassemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine</span></div><div class="casAuthors">Kontoghiorghes, George J.; Neocleous, Katia; Kolnagou, Annita</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">553-584</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review. Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload.  It is an orphan drug designed and developed primarily by academic initiatives for the treatment of iron overload in thalassemia, which is endemic in the Mediterranean, Middle East and Southeast Asia and is considered an orphan disease in the European Union and North America.  Deferiprone has been used in several other iron or other metal imbalance conditions and has prospects of wider clin. applications.  Deferiprone has high affinity for iron and interacts with almost all the iron pools at the mol., cellular, tissue and organ levels.  Doses of 50-120 mg/kg/day appear to be effective in bringing patients to neg. iron balance.  It increases urinary iron excretion, which mainly depends on the iron load of patients and the dose of the drug.  At doses >80 mg/kg/day, it decreases serum ferritin and reduces the liver and heart iron content in the majority of chronically transfused iron-loaded patients.  It is metabolized to a glucuronide conjugate and cleared through the urine in the metabolized and s nonmetabolized form, usually a 3 deferiprone:1 iron complex, which gives the characteristic red color to urine.  Peak serum levels of deferiprone occur within 1 h of its oral administration and clearance from blood is within 6 h.  There is variation among patients in iron excretion and the metab. and pharmacokinetics of deferiprone.  Deferiprone has been used in >7500 patients aged 2-85 yr in >50 countries, in some cases daily for >14 yr.  All the adverse effects of deferiprone are considered reversible, controllable and manageable.  These include agranulocytosis with frequency of about 0.6%, neutropenia 6%, musculoskeletal and joint pains 15%, gastrointestinal complaints 6% and zinc deficiency 1%.  Discontinuation of the drug is recommended for patients developing agranulocytosis.  Deferiprone has a therapeutic index similar to that of s.c. deferoxamine but is more effective in iron removal from the heart, which is the target organ of iron toxicity and mortality in iron-loaded thalassemia patients.  Deferiprone is much less expensive to produce than deferoxamine.  Combination therapy with deferoxamine and deferiprone has been used in patients not complying with s.c. deferoxamine or experiencing toxicity or not excreting sufficient amts. of iron with use of either drug alone.  New oral iron-chelating drugs are being developed, but even if successful these are likely to be more expensive than deferiprone and are not likely to become available in the next 5-8 yr.  About 25% of treated thalassemia patients in Europe and >50% in India are using deferiprone.  For most thalassemia patients worldwide who are not at present receiving any form of chelation therapy the choice is between deferiprone and fatal iron toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZUzrBAetCdbVg90H21EOLACvtfcHk0lgsXRtEBGv6yQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsVenurg%253D&md5=2425c5ef9e7a88e9424690222cb93e2f</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2165%2F00002018-200326080-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200326080-00003%26sid%3Dliteratum%253Aachs%26aulast%3DKontoghiorghes%26aufirst%3DG.%2BJ.%26aulast%3DNeocleous%26aufirst%3DK.%26aulast%3DKolnagou%26aufirst%3DA.%26atitle%3DBenefits%2520and%2520risks%2520of%2520deferiprone%2520in%2520iron%2520overload%2520in%2520thalassaemia%2520and%2520other%2520conditions%253A%2520comparison%2520of%2520epidemiological%2520and%2520therapeutic%2520aspects%2520with%2520deferoxamine%26jtitle%3DDrug%2520Saf.%26date%3D2003%26volume%3D26%26spage%3D553%26epage%3D584%26doi%3D10.2165%2F00002018-200326080-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Streiff, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiegand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchetta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creary, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, H. H.</span></span> <span> </span><span class="NLM_article-title">A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one and deferoxamine</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">1882</span>â <span class="NLM_lpage">1890</span>, <span class="refDoi">Â DOI: 10.1182/blood.V79.7.1882.bloodjournal7971882</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V79.7.1882.1882" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1558978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK38XitVOlsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1992&pages=1882-1890&author=R.+J.+Bergeronauthor=R.+R.+Streiffauthor=J.+Wiegandauthor=G.+Luchettaauthor=E.+A.+Crearyauthor=H.+H.+Peter&title=A+comparison+of+the+iron-clearing+properties+of+1%2C2-dimethyl-3-hydroxypyrid-4-one%2C+1%2C2-diethyl-3-hydroxypyrid-4-one+and+deferoxamine&doi=10.1182%2Fblood.V79.7.1882.bloodjournal7971882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine</span></div><div class="casAuthors">Bergeron, Raymond J.; Streiff, Richard R.; Wiegand, Jan; Luchetta, Gabriel; Creary, Elizabeth A.; Peter, Heinrich H.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1882-90</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">A comparative study of the iron-clearing properties of s.c. administered deferoxamine (DFO) with those of orally administered 1,2-dimethyl-3-hydroxypyrid-4-one (CP20) and 1,2-diethyl-3-hydroxypyrid-4-one (CP94) is presented.  The studies were performed in both a non-iron-overloaded, bile duct-cannulated rat model and an iron-loaded Cebus monkey model.  All three drugs performed well in the rodent, promoting the excretion of iron in both the urine and the bile, with total iron output efficiencies of 2.8, 1.2, and 7.1%, resp.  The efficiency of DFO increased slightly in the Cebus model, while that of the hydroxypyridones was essentially the same in the monkey, with total iron output efficiencies of 5.5, 2.1, and 7.4%, resp.  Iron balance studies showed that both DFO and CP94 were able to maintain the animals in a neg. iron balance, while CP20 had little impact.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowgJs9FR55f7Vg90H21EOLACvtfcHk0ljEc6rDUH-iVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XitVOlsLs%253D&md5=7f9cc390cefa196c40ddc768a66ce1a9</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1182%2Fblood.V79.7.1882.1882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V79.7.1882.1882%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DStreiff%26aufirst%3DR.%2BR.%26aulast%3DWiegand%26aufirst%3DJ.%26aulast%3DLuchetta%26aufirst%3DG.%26aulast%3DCreary%26aufirst%3DE.%2BA.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26atitle%3DA%2520comparison%2520of%2520the%2520iron-clearing%2520properties%2520of%25201%252C2-dimethyl-3-hydroxypyrid-4-one%252C%25201%252C2-diethyl-3-hydroxypyrid-4-one%2520and%2520deferoxamine%26jtitle%3DBlood%26date%3D1992%26volume%3D79%26spage%3D1882%26epage%3D1890%26doi%3D10.1182%2Fblood.V79.7.1882.bloodjournal7971882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical characterization, and biological evaluation of 2-(1â²-hydroxyalkyl)-3-hydroxypyridin-4-ones: novel iron chelators with enhanced pFe<sup>3+</sup> values</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">4814</span>â <span class="NLM_lpage">4823</span>, <span class="refDoi">Â DOI: 10.1021/jm991080o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm991080o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=4814-4823&issue=23&author=Z.+D.+Liuauthor=H.+H.+Khodrauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+characterization%2C+and+biological+evaluation+of+2-%281%E2%80%B2-hydroxyalkyl%29-3-hydroxypyridin-4-ones%3A+novel+iron+chelators+with+enhanced+pFe3%2B+values&doi=10.1021%2Fjm991080o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Physicochemical Characterization, and Biological Evaluation of 2-(1'-Hydroxyalkyl)-3-hydroxypyridin-4-ones: Novel Iron Chelators with Enhanced pFe3+ Values</span></div><div class="casAuthors">Liu, Zu D.; Khodr, Hicham H.; Liu, Ding Y.; Lu, Shu L.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4814-4823</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a range of 2-(1-hydroxyalkyl)-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described.  The pKa values of the ligands and the stability consts. of their iron(III) complexes have been detd.  Results indicate that the introduction of a 1'-hydroxyalkyl group at the 2-position leads to a significant improvement in the pFe3+ values.  Such an effect was found to be greater with the hydroxyethyl substituent than with the hydroxymethyl substituent, particularly in the cases of 1-ethyl-2-(1-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.4) and 1,6-dimethyl-2-(1'-hydroxyethyl)-3-hydroxypyridin-4-one (pFe3+ = 21.5) where an enhancement on pFe3+ values in the region of two orders of magnitude is obsd., as compared with Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) (pFe3+ = 19.4).  The ability of these novel 3-hydroxypyridin-4-ones to facilitate the iron excretion in bile was investigated using a [59Fe]ferritin-loaded rat model.  Chelators and prodrug chelators possessing high pFe3+ values show great promise in their ability to remove iron under in vivo conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-7JLiGBw6MLVg90H21EOLACvtfcHk0ljEc6rDUH-iVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvFCksrg%253D&md5=6ba15911983ff3fbb19515acf8732dd4</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm991080o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm991080o%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520characterization%252C%2520and%2520biological%2520evaluation%2520of%25202-%25281%25E2%2580%25B2-hydroxyalkyl%2529-3-hydroxypyridin-4-ones%253A%2520novel%2520iron%2520chelators%2520with%2520enhanced%2520pFe3%252B%2520values%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26issue%3D23%26spage%3D4814%26epage%3D4823%26doi%3D10.1021%2Fjm991080o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarpong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderhelm, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties, and biological evaluation of <i>N</i>-substituted 2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones - orally active iron chelators with clinical potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">2448</span>â <span class="NLM_lpage">2458</span>, <span class="refDoi">Â DOI: 10.1021/jm00069a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00069a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3sXmslSqtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2448-2458&issue=17&author=P.+S.+Dobbinauthor=R.+C.+Hiderauthor=A.+D.+Hallauthor=P.+D.+Taylorauthor=P.+Sarpongauthor=J.+B.+Porterauthor=G.+Y.+Xiaoauthor=D.+Vanderhelm&title=Synthesis%2C+physicochemical+properties%2C+and+biological+evaluation+of+N-substituted+2-alkyl-3-hydroxy-4%281H%29-pyridinones+-+orally+active+iron+chelators+with+clinical+potential&doi=10.1021%2Fjm00069a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential</span></div><div class="casAuthors">Dobbin, Paul S.; Hider, Robert C.; Hall, Adrian D.; Taylor, Paul D.; Sarpong, Patience; Porter, John B.; Xiao, Gaoyi; van der Helm, Dick</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2448-58</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis of a range of novel bidentate ligands contg. the chelating moiety 3-hydroxy-4(1H)-pyridinone is described.  The pKa values of the ligands and the stability consts. of their iron(III) complexes have been detd.  The crystal structures of one of the ligands and one of the iron(III) complexes are presented.  The distribution coeffs. of the ligands are reported and are related to the ability of the ligands to remove iron from hepatocytes.  The influence of 3-hydroxy-4(1H)-pyridinones on oxidative damage to cells is described.  In contrast to the iron chelator in current therapeutic use, desferrioxamine-B, many of the bidentate ligands described in this study are orally active in iron-overloaded mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqK247sbJ3DrVg90H21EOLACvtfcHk0ljEc6rDUH-iVw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmslSqtLw%253D&md5=f6e0ff0febe3b6bd408ada4cb445fdbd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm00069a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00069a002%26sid%3Dliteratum%253Aachs%26aulast%3DDobbin%26aufirst%3DP.%2BS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DHall%26aufirst%3DA.%2BD.%26aulast%3DTaylor%26aufirst%3DP.%2BD.%26aulast%3DSarpong%26aufirst%3DP.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DXiao%26aufirst%3DG.%2BY.%26aulast%3DVanderhelm%26aufirst%3DD.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%252C%2520and%2520biological%2520evaluation%2520of%2520N-substituted%25202-alkyl-3-hydroxy-4%25281H%2529-pyridinones%2520-%2520orally%2520active%2520iron%2520chelators%2520with%2520clinical%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D17%26spage%3D2448%26epage%3D2458%26doi%3D10.1021%2Fjm00069a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekhordi, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties, and evaluation of <i>N</i>-substituted-2-alkyl-3-hydroxy-4(1<i>H</i>)-pyridinones</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">3347</span>â <span class="NLM_lpage">3359</span>, <span class="refDoi">Â DOI: 10.1021/jm9707784</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9707784" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXkvF2nt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3347-3359&issue=18&author=B.+L.+Raiauthor=L.+S.+Dekhordiauthor=H.+Khodrauthor=Y.+Jinauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+properties%2C+and+evaluation+of+N-substituted-2-alkyl-3-hydroxy-4%281H%29-pyridinones&doi=10.1021%2Fjm9707784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Physicochemical Properties, and Evaluation of N-Substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones</span></div><div class="casAuthors">Rai, Bijaya L.; Dekhordi, Lotfollah S.; Khodr, Hicham; Jin, Yi; Liu, Zudong; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3347-3359</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a range of 3-hydroxy-4(1H)-pyridinones with potential for the chelation of iron(III) is described.  The pKa values of resp. ligands and the stability consts. of their iron(III) complexes are presented.  The distribution coeff. values of a range of 48 hydroxypyridinones and their corresponding iron(III) complexes between 1-octanol and MOPS buffer (pH 7.4) are reported.  The range of log Dcomplex values covers 7 orders of magnitude.  The results suggest the existence of a biphasic relationship between the distribution coeff. values of the chelator and the corresponding iron(III) complexes.  For ligands with a log Dligand = -1, a linear relationship exists with a value of the slope 2.53, whereas with ligands with a log Dligand < -1, a linear relationship exists with a slope of 0.49.  The reduced slope for the more hydrophilic mols. of the series offers some advantage for this type of hydroxypyridinone as the distribution coeffs. for such complexes do not change so rapidly with increasing ligand hydrophilicity.  The ability of selected 3-hydroxypyridinones to facilitate the excretion of iron in bile was investigated in non-iron-overloaded, bile duct-cannulated rats and in a [59Fe]ferritin-loaded rat model.  Both systems compare the ability of chelators to remove iron from the liver, the prime target organ in thalassemia.  The N-(hydroxyalkyl)-3-hydroxypyridin-4-ones are demonstrated to be orally active under the in vivo conditions adopted.  Thus both 1-(hydroxyalkyl)- and 1-(carboxyalkyl)pyridinones are able to remove iron from the liver.  Although 1-(carboxyalkyl)hydroxypyridinones are active, they do not demonstrate any clear advantage over Deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one).  Indeed 1-(hydroxyalkyl)hydroxypyridinones which are known to be rapidly converted to 1-(carboxyalkyl)hydroxypyridinones are also marginally superior to Deferiprone.  In contrast, 2-ethyl-1-(2'-hydroxyethyl)-3-hydroxypyridin-4-one, which is not metabolized to the corresponding (carboxyalkyl)hydroxypyridinone, was found to be superior to Deferiprone and therefore deserves further consideration as an orally active iron chelator with potential for the treatment of iron overload assocd. with transfusion-dependent thalassemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2cgWCGM5bJLVg90H21EOLACvtfcHk0lhKo_BuEN1_KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvF2nt74%253D&md5=82ec8ae0997f72d9b12a115219edc3c4</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fjm9707784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9707784%26sid%3Dliteratum%253Aachs%26aulast%3DRai%26aufirst%3DB.%2BL.%26aulast%3DDekhordi%26aufirst%3DL.%2BS.%26aulast%3DKhodr%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%252C%2520and%2520evaluation%2520of%2520N-substituted-2-alkyl-3-hydroxy-4%25281H%2529-pyridinones%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26issue%3D18%26spage%3D3347%26epage%3D3359%26doi%3D10.1021%2Fjm9707784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2â²-hydroxyethyl)-2-ethyl-3hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">555</span>â <span class="NLM_lpage">564</span>, <span class="refDoi">Â DOI: 10.1211/0022357991772655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1211%2F0022357991772655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10411215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXksVKhtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1999&pages=555-564&author=Z.+D.+Liuauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+properties+and+biological+evaluation+of+aromatic+ester+prodrugs+of+1-%282%E2%80%B2-hydroxyethyl%29-2-ethyl-3hydroxypyridin-4-one+%28CP102%29%3A+orally+active+iron+chelators+with+clinical+potential&doi=10.1211%2F0022357991772655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential</span></div><div class="casAuthors">Liu, Zu Dong; Liu, Ding Yong; Lu, Shu Li; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-564</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">The synthesis of seven arom. ester derivs. of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one is described.  These ester prodrugs have been designed to target iron chelators to the liver, the major iron storage organ.  In principle this should improve chelation efficacy and minimize toxicity.  The distribution coeffs. of these ester prodrugs between 1-octanol and MOPS buffer pH 7.4 were measured together with their rates of hydrolysis at pH 2 and pH 7.4, in rat blood and liver homogenate.  Esters with heteroarom. acid moieties were less stable than benzoyl analogs.  The in-vivo iron mobilization efficacy of these ester prodrugs has been compared with that of the parent drug using a 59Fe-ferritin loaded rat model.  Many prodrugs were found to enhance the ability of the parent hydroxypyridinone to facilitate 59Fe excretion.  However, not all prodrugs provided increased efficacy, demonstrating that lipophilicity is not the only factor which influences drug efficacy.  Furthermore, no clear correlation between efficacy and susceptibility to hydrolysis was detected.  The picolinic and nicotinic ester derivs. appear to offer the best potential as prodrugs as they have a relatively low Log-P value and yet lead to enhanced efficacy over the parent hydroxypyridinone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq72iY_wXRkprVg90H21EOLACvtfcHk0lhKo_BuEN1_KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVKhtb0%253D&md5=1c6d0c34482fa76b19b123e2ab65d8db</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1211%2F0022357991772655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357991772655%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%2520and%2520biological%2520evaluation%2520of%2520aromatic%2520ester%2520prodrugs%2520of%25201-%25282%25E2%2580%25B2-hydroxyethyl%2529-2-ethyl-3hydroxypyridin-4-one%2520%2528CP102%2529%253A%2520orally%2520active%2520iron%2520chelators%2520with%2520clinical%2520potential%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1999%26volume%3D51%26spage%3D555%26epage%3D564%26doi%3D10.1211%2F0022357991772655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nandi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y. P.</span></span> <span> </span><span class="NLM_article-title">CN128: A new orally active hydroxypyridinone iron chelator</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4215</span>â <span class="NLM_lpage">4226</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.0c00137</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00137" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls1CjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4215-4226&issue=8&author=W.+T.+Chenauthor=X.+Yuanauthor=Z.+Liauthor=Z.+D.+Luauthor=S.+S.+Kongauthor=H.+D.+Jiangauthor=H.+B.+Duauthor=X.+H.+Panauthor=M.+Nandiauthor=X.+L.+Kongauthor=K.+Brownauthor=Z.+D.+Liuauthor=G.+L.+Zhangauthor=R.+C.+Hiderauthor=Y.+P.+Yu&title=CN128%3A+A+new+orally+active+hydroxypyridinone+iron+chelator&doi=10.1021%2Facs.jmedchem.0c00137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">CN128: A New Orally Active Hydroxypyridinone Iron Chelator</span></div><div class="casAuthors">Chen, Wenteng; Yuan, Xin; Li, Zhi; Lu, Zidong; Kong, Sisi; Jiang, Huidi; Du, Houbing; Pan, Xiuhong; Nandi, Manasi; Kong, Xiaole; Brown, Kathryn; Liu, Zudong; Zhang, Guolin; Hider, Robert C.; Yu, Yongping</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4215-4226</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Deferoxamine, deferiprone, and deferasirox are used for the treatment of systemic iron overload, although they possess limitations due to lack of oral activity, lower efficacy, and side effects.  These limitations led to a search for an orally active iron chelator with an improved therapeutic index.  The lower efficacy of deferiprone is due to rapid glucuronidation, leading to the formation of a nonchelating metabolite.  Here, we demonstrate that the influence of metab. can be reduced by introducing a sacrificial site for glucuronidation.  A log P-guided investigation of 20 hydroxpyridinones led to the identification of CN128 (I).  The Fe(III) affinity and metal selectivity of CN128 are similar to those of deferiprone, the log P value is more lipophilic, and its iron scavenging ability is superior.  Overall, CN128 was demonstrated to be safe in a range of toxicity assessments and is now in clin. trials for the treatment of Î²-thalassemia after regular blood transfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWwz1TyBtEULVg90H21EOLACvtfcHk0lhKo_BuEN1_KA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls1CjtbY%253D&md5=7c33de49bc80e50c669cc27f852db37d</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DZ.%2BD.%26aulast%3DKong%26aufirst%3DS.%2BS.%26aulast%3DJiang%26aufirst%3DH.%2BD.%26aulast%3DDu%26aufirst%3DH.%2BB.%26aulast%3DPan%26aufirst%3DX.%2BH.%26aulast%3DNandi%26aufirst%3DM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DZhang%26aufirst%3DG.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DYu%26aufirst%3DY.%2BP.%26atitle%3DCN128%253A%2520A%2520new%2520orally%2520active%2520hydroxypyridinone%2520iron%2520chelator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D8%26spage%3D4215%26epage%3D4226%26doi%3D10.1021%2Facs.jmedchem.0c00137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zanninelli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guyader, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span> <span> </span><span class="NLM_article-title">Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats</span>. <i>J. Hepatol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">176</span>â <span class="NLM_lpage">184</span>, <span class="refDoi">Â DOI: 10.1016/S0168-8278(97)80299-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0168-8278%2897%2980299-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9252093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2sXltVOrsLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1997&pages=176-184&author=G.+Zanninelliauthor=R.+Chouduryauthor=O.+Lorealauthor=D.+Guyaderauthor=G.+Lescoatauthor=J.+Arnaudauthor=R.+Vernaauthor=B.+Cossonauthor=S.+Singhauthor=R.+C.+Hiderauthor=P.+Brissot&title=Novel+orally+active+iron+chelators+%283-hydroxypyridin-4-ones%29+enhance+the+biliary+excretion+of+plasma+non-transferrin-bound+iron+in+rats&doi=10.1016%2FS0168-8278%2897%2980299-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats</span></div><div class="casAuthors">Zanninelli, Giuliana; Choudury, Ruksana; Loreal, Olivier; Guyader, Dominique; Lescoat, Gerard; Arnaud, Josiane; Verna, Roberto; Cosson, Bertrand; Singh, Surinder; Hider, Robert C.; Brissot, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-184</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">It is well documented that levels of plasma non-transferrin-bound iron (NTBI), a particularly toxic form of iron, are increased in iron overload disorders.  In light of the pathogenetic importance of NTBI in chronic iron overload, we have studied the ability of new orally active iron chelators to promote the biliary excretion of iron originating as plasma 55Fe-NTBI.  Biliary iron kinetics of plasma 55Fe-labeled NTBI and cumulative recoveries of 55Fe in bile were detd. in normal and carbonyl iron-loaded rats receiving a single intragastric dose of iron chelator.  These chelators were the novel hydroxypyridin-4-one compds. CP102, CP41, and their resp. prodrugs CP117 and CP165.  The cumulative recovery of 55Fe in bile of normal rats was increased by 5.2-, 7.9-, 11.5-, and 9.2-fold with CP102, CP117, CP41 and CP165, resp.  In iron overloaded rats, these compds. increased the cumulative recovery by 28.6-, 48.6-, 72.6-, and 32-fold, resp.  All the chelators had a choleretic effect, were metabolized by the liver as demonstrated by HPLC study of bile, and were not cytotoxic since normal plasma transaminase levels were maintained at the end of the expts.  These chelators have potential interest for the treatment of iron overload conditions and may offer advantages over simple N-alkyl-hydroxypyridinones such as deferiprone (CP20, L1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovXlA0iiBsYLVg90H21EOLACvtfcHk0lgCw6FViRo0fQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXltVOrsLY%253D&md5=24818350919564cd7e28ba4624a22754</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0168-8278%2897%2980299-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0168-8278%252897%252980299-1%26sid%3Dliteratum%253Aachs%26aulast%3DZanninelli%26aufirst%3DG.%26aulast%3DChoudury%26aufirst%3DR.%26aulast%3DLoreal%26aufirst%3DO.%26aulast%3DGuyader%26aufirst%3DD.%26aulast%3DLescoat%26aufirst%3DG.%26aulast%3DArnaud%26aufirst%3DJ.%26aulast%3DVerna%26aufirst%3DR.%26aulast%3DCosson%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBrissot%26aufirst%3DP.%26atitle%3DNovel%2520orally%2520active%2520iron%2520chelators%2520%25283-hydroxypyridin-4-ones%2529%2520enhance%2520the%2520biliary%2520excretion%2520of%2520plasma%2520non-transferrin-bound%2520iron%2520in%2520rats%26jtitle%3DJ.%2520Hepatol.%26date%3D1997%26volume%3D27%26spage%3D176%26epage%3D184%26doi%3D10.1016%2FS0168-8278%2897%2980299-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physicochemical properties and biological evaluation of ester prodrugs of 3-hydroxypyridin-4-ones: design of orally active chelators with clinical potential</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">475</span>â <span class="NLM_lpage">485</span>, <span class="refDoi">Â DOI: 10.1016/S0223-5234(99)80097-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0223-5234%2899%2980097-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXmtFGkt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=475-485&issue=6&author=B.+L.+Raiauthor=Z.+D.+Liuauthor=D.+Y.+Liuauthor=S.+L.+Luauthor=R.+C.+Hider&title=Synthesis%2C+physicochemical+properties+and+biological+evaluation+of+ester+prodrugs+of+3-hydroxypyridin-4-ones%3A+design+of+orally+active+chelators+with+clinical+potential&doi=10.1016%2FS0223-5234%2899%2980097-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physicochemical properties and biological evaluation of ester prodrugs of 3-hydroxypyridin-4-ones: design of orally active chelators with clinical potential</span></div><div class="casAuthors">Rai, Bijaya L.; Liu, Zu Dong; Liu, Ding Yong; Lu, Shu Li; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">475-485</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The synthesis of a range of hydrophobic ester prodrugs of 3-hydroxypyridin-4-ones, I (R = CMe3, Ph, Me, CHMe2, R2 = Et, Me, n = 2, 3), with potential for oral administration is described.  The distribution coeff. values of a range of these ester prodrugs and the corresponding alcs. in 1-octanol and MOPS buffer pH 7.4 are presented together with their rates of hydrolysis at pH 2, pH 7.4, in rat blood and liver homogenate.  In vivo iron mobilization efficacy of the pivaloyl and benzoyl prodrugs has been compared with their parent drugs using a 59Fe-ferritin loaded rat model.  Both classes of prodrug enhanced the ability of the parent hydroxypyridinone to facilitate the excretion of 59Fe.  The influence of the pivaloyl function was more marked than that of the benzoyl function.  The optimal effect was obsd. with 1-[2'-(pivaloyloxy)ethyl]-2-methyl-3-hydroxy-4(1H)-pyridinone I (R = CMe3, R2 = Me, n = 2).  However, not all the prodrugs provide increased efficacy which suggests that lipophilicity is not the only factor which influences the drug efficacy.  The metab. of the compd. may have a dominating influence on the overall efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeDhrRuEyBBrVg90H21EOLACvtfcHk0lgCw6FViRo0fQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtFGkt78%253D&md5=63c42ce4c514cd0226bd3bb7071b7838</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2899%2980097-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252899%252980097-X%26sid%3Dliteratum%253Aachs%26aulast%3DRai%26aufirst%3DB.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLu%26aufirst%3DS.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physicochemical%2520properties%2520and%2520biological%2520evaluation%2520of%2520ester%2520prodrugs%2520of%25203-hydroxypyridin-4-ones%253A%2520design%2520of%2520orally%2520active%2520chelators%2520with%2520clinical%2520potential%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1999%26volume%3D34%26issue%3D6%26spage%3D475%26epage%3D485%26doi%3D10.1016%2FS0223-5234%2899%2980097-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellwig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markwardt, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandsch, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form</span>. <i>Eur. J. Pharm. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>78</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">75</span>â <span class="NLM_lpage">82</span>, <span class="refDoi">Â DOI: 10.1016/j.ejpb.2010.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejpb.2010.12.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21216287" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVOru7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2011&pages=75-82&issue=1&author=S.+Geisslerauthor=M.+Hellwigauthor=F.+Markwardtauthor=T.+Henleauthor=M.+Brandsch&title=Synthesis+and+intestinal+transport+of+the+iron+chelator+maltosine+in+free+and+dipeptide+form&doi=10.1016%2Fj.ejpb.2010.12.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form</span></div><div class="casAuthors">Geissler, Stefanie; Hellwig, Michael; Markwardt, Fritz; Henle, Thomas; Brandsch, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-82</span>CODEN:
                <span class="NLM_cas:coden">EJPBEL</span>;
        ISSN:<span class="NLM_cas:issn">0939-6411</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Maltosine, a 3-hydroxy-4-pyridinone deriv. of lysine formed in the course of the advanced Maillard reaction, is an effective metal chelating agent.  It therefore represents an interesting compd. for the treatment of metal ion storage diseases.  We synthesized 6-(3-hydroxy-4-oxo-2-methyl-4(1H)-pyridin-1-yl)-L-norleucine (free maltosine) and its dipeptide derivs. alanylmaltosine (Ala-Mal) and maltosinylalanine (Mal-Ala) and examd. the transepithelial flux of these compds. across Caco-2 cells and their interaction with membrane transporters.  Transepithelial flux of maltosine was significantly higher when added as Ala-Mal and Mal-Ala than in free form.  Assays at Caco-2 cells and at HeLa cells expressing the human peptide transporter (hPEPT) 1 revealed that Ala-Mal and Mal-Ala show medium to high affinity to the system.  Only free but not peptide-bound maltosine inhibited the uptake of L-[3H]lysine in Caco-2 and OK cells.  Maltosine dipeptides were transported by hPEPT1 across cell membranes and accumulated in hPEPT1-transfected HeLa cells.  In electrophysiol. measurements at hPEPT1-expressing Xenopus laevis oocytes, Ala-Mal and Mal-Ala induced significant inward directed currents.  We conclude that Ala-Mal and Mal-Ala are transported by hPEPT1 into intestinal cells and then hydrolyzed to free maltosine and alanine.  The results suggest that the oral bioavailability of maltosine can be increased significantly by applying this drug candidate in peptide-bound form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog2zS-MWQfoLVg90H21EOLACvtfcHk0ljcZAto7oOhGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVOru7o%253D&md5=de0246dd311ab487913e7c1e55bc6682</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejpb.2010.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejpb.2010.12.032%26sid%3Dliteratum%253Aachs%26aulast%3DGeissler%26aufirst%3DS.%26aulast%3DHellwig%26aufirst%3DM.%26aulast%3DMarkwardt%26aufirst%3DF.%26aulast%3DHenle%26aufirst%3DT.%26aulast%3DBrandsch%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520intestinal%2520transport%2520of%2520the%2520iron%2520chelator%2520maltosine%2520in%2520free%2520and%2520dipeptide%2520form%26jtitle%3DEur.%2520J.%2520Pharm.%2520Biopharm.%26date%3D2011%26volume%3D78%26issue%3D1%26spage%3D75%26epage%3D82%26doi%3D10.1016%2Fj.ejpb.2010.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrel-Groussard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasdeloup, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span> <span> </span><span class="NLM_article-title">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1479</span>â <span class="NLM_lpage">1487</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2003.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bcp.2003.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15041465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=1479-1487&issue=8&author=F.+Gaboriauauthor=K.+Chantrel-Groussardauthor=N.+Rakbaauthor=P.+Loyerauthor=N.+Pasdeloupauthor=R.+C.+Hiderauthor=P.+Brissotauthor=G.+Lescoat&title=Iron+mobilization%2C+cytoprotection%2C+and+inhibition+of+cell+proliferation+in+normal+and+transformed+rat+hepatocyte+cultures+by+the+hydroxypyridinone+CP411%2C+compared+to+CP20%3A+a+biological+and+physicochemical+study&doi=10.1016%2Fj.bcp.2003.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span></div><div class="casAuthors">Gaboriau, Francois; Chantrel-Groussard, Karine; Rakba, Nafissa; Loyer, Pascal; Pasdeloup, Nicole; Hider, Robert C.; Brissot, Pierre; Lescoat, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1479-1487</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study analyzes the iron mobilization, the cytoprotective, and the antiproliferative effects of the lipophilic hydroxypyridinone CP411, in comparison with the hydrophilic chelator CP20 or deferiprone used in the treatment of iron overload.  Primary rat hepatocyte cultures and the rat hepatoma cell line Fao were used.  Chelator cell uptake was evaluated by mass spectrometry in the two models.  This method was also used to investigate the stability of the chelators in an acellular system as well as their scavenging and chelating effects against the hydroxyl radical generated by the Fenton reaction.  The iron mobilization and the cytoprotective effects of the chelators were evaluated in primary cultures by measuring resp. 55Fe and lactate dehydrogenase release in the culture medium.  The antiproliferative effect of the chelators was studied using the Fao cell line and measuring DNA synthesis by thymidine incorporation and DNA content by flow cytometry.  The authors obsd. that CP411 entered the hepatocytes and the Fao cells resp. 4 and 13 times more than CP20.  CP411 was 2.5 times more effective than CP20 to mobilize iron from preloaded hepatocytes.  Pretreatment of the hepatocytes with CP20 or CP411 decreased the toxic effect of iron and CP411 was 1.6 times more effective than CP20.  A dose-dependent decrease of DNA synthesis, correlated to an accumulation of cells in S phase, was obsd. in the Fao cell line in the presence of CP411, while CP20 was without effect.  CP411 effect was inhibited by addn. of iron simultaneously with the chelator, the addn. of Zn or Cu was without effect.  The inhibitory effect of CP411 was reversible since, 24 h after removal of the chelator, DNA replication reached the control level.  The results show that CP411 is more efficient to protect the hepatocyte from the toxic effect of iron load and to inhibit tumor cell proliferation.  Its higher efficiency may result from its better cell uptake since equimolar solns. of the two chelators in an acellular system exhibit the same ability to inhibit the Fenton reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUGkeFexh2rVg90H21EOLACvtfcHk0ljcZAto7oOhGg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D&md5=d1063e9c5ddc87451852258c44f900e3</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2003.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriau%26aufirst%3DF.%26aulast%3DChantrel-Groussard%26aufirst%3DK.%26aulast%3DRakba%26aufirst%3DN.%26aulast%3DLoyer%26aufirst%3DP.%26aulast%3DPasdeloup%26aufirst%3DN.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBrissot%26aufirst%3DP.%26aulast%3DLescoat%26aufirst%3DG.%26atitle%3DIron%2520mobilization%252C%2520cytoprotection%252C%2520and%2520inhibition%2520of%2520cell%2520proliferation%2520in%2520normal%2520and%2520transformed%2520rat%2520hepatocyte%2520cultures%2520by%2520the%2520hydroxypyridinone%2520CP411%252C%2520compared%2520to%2520CP20%253A%2520a%2520biological%2520and%2520physicochemical%2520study%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26issue%3D8%26spage%3D1479%26epage%3D1487%26doi%3D10.1016%2Fj.bcp.2003.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bansal, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel pegylated iron chelators with decreased metabolic rate</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">2439</span>â <span class="NLM_lpage">2349</span>, <span class="refDoi">Â DOI: 10.4155/fmc.15.154</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.4155%2Ffmc.15.154" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26670054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVeqtL7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=2439-2349&issue=18&author=J.+P.+Liauthor=Z.+D.+Luauthor=X.+L.+Kongauthor=Y.+M.+Maauthor=X.+Y.+Zhangauthor=S.+S.+Bansalauthor=V.+Abbateauthor=R.+C.+Hider&title=Design+and+synthesis+of+novel+pegylated+iron+chelators+with+decreased+metabolic+rate&doi=10.4155%2Ffmc.15.154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of novel pegylated iron chelators with decreased metabolic rate</span></div><div class="casAuthors">Li, Junpei; Lu, Zidong; Kong, Xiaole; Ma, Yongmin; Zhang, Xingyuan; Bansal, Sukhvinder S.; Abbate, Vincenzo; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2439-2449</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Background: Deferiprone has proved to be a successful iron selective chelator in a range of pathologies.  However, its use is limited by rapid Phase II metab., necessitating the administration of large doses.  In an attempt to modify metabolic rate of this class of compds., a range of pegylated 3-hydroxypyridin-4-ones has been synthesized.  Exptl.: The synthetic route in which the polyethylene glycol counterparts are introduced to a protected pyran ring involves either a Williamson etherification reaction or direct addn. leading to polyethylene glycol-contg. precursors.  Results & discussion: The introduction of the pegylated substituent was found to lead to a relatively low rate of metab. for some of the derivs. (6a, 6b, 8a and 8b), offering a possible improvement over deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtCr-cUoR99LVg90H21EOLACvtfcHk0liwCB6uO76QtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVeqtL7N&md5=21e2fc00c64b13d38ea48e6d1c0e2c8a</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.4155%2Ffmc.15.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.15.154%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DLu%26aufirst%3DZ.%2BD.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DBansal%26aufirst%3DS.%2BS.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520pegylated%2520iron%2520chelators%2520with%2520decreased%2520metabolic%2520rate%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2015%26volume%3D7%26issue%3D18%26spage%3D2439%26epage%3D2349%26doi%3D10.4155%2Ffmc.15.154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span> <span> </span><span class="NLM_article-title">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe<sup>3+</sup> values</span>. <i>Transfusion Science</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">201</span>â <span class="NLM_lpage">209</span>, <span class="refDoi">Â DOI: 10.1016/S0955-3886(00)00090-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0955-3886%2800%2900090-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11099896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2000&pages=201-209&author=R.+C.+Hiderauthor=Z.+D.+Liuauthor=S.+Piyamongkol&title=The+design+and+properties+of+3-hydroxypyridin-4-one+iron+chelators+with+high+pFe3%2B+values&doi=10.1016%2FS0955-3886%2800%2900090-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values</span></div><div class="casAuthors">Hider R C; Liu Z D; Piyamongkol S</div><div class="citationInfo"><span class="NLM_cas:title">Transfusion science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-9</span>
        ISSN:<span class="NLM_cas:issn">0955-3886</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7lZ-efNfxxVUIs6wFK5xJfW6udTcc2eZQKYNJ4sDv3Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7ht1Wksg%253D%253D&md5=af5a6096617fc38e6b49ba48661c87c5</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1016%2FS0955-3886%2800%2900090-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-3886%252800%252900090-4%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DPiyamongkol%26aufirst%3DS.%26atitle%3DThe%2520design%2520and%2520properties%2520of%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520with%2520high%2520pFe3%252B%2520values%26jtitle%3DTransfusion%2520Science%26date%3D2000%26volume%3D23%26spage%3D201%26epage%3D209%26doi%3D10.1016%2FS0955-3886%2800%2900090-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piyamongkol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aytemir, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Amido-3-hydroxypyridin-4-ones as iron(III) ligands</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6374</span>â <span class="NLM_lpage">6381</span>, <span class="refDoi">Â DOI: 10.1002/chem.200902455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fchem.200902455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20397153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVGqtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=6374-6381&issue=21&author=S.+Piyamongkolauthor=Y.+M.+Maauthor=X.+L.+Kongauthor=Z.+D.+Liuauthor=M.+D.+Aytemirauthor=D.+van+der+Helmauthor=R.+C.+Hider&title=Amido-3-hydroxypyridin-4-ones+as+iron%28III%29+ligands&doi=10.1002%2Fchem.200902455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Amido-3-hydroxypyridin-4-ones as Iron(III) Ligands</span></div><div class="casAuthors">Piyamongkol, Sirivipa; Ma, Yong M.; Kong, Xiao L.; Liu, Zu D.; Aytemir, Mutlu D.; van der Helm, Dick; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6374-6381, S6374/1-S6374/53</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The synthesis and physicochem. properties of a range of 2- and 6-amido-3-hydroxypyridin-4-ones are described.  All the amido-substituted 3-hydroxypyridin-4-ones have lower pKa values than 1,2-dimethyl-3-hydroxypyridin-4-one (deferiprone).  This is due to the inductive effect of the amido group.  Also, the pKa values of the 3-hydroxy group in 1-nonsubstituted pyridinones are dramatically lower than those of the corresponding 1-alkyl analogs, indicating that a strong hydrogen bond exists between the 2-amido function and the 3-oxygen anion, which stabilizes the anion.  As a result of the decreased competition with protons, the pFe3+ values of this group of mols. are higher than that of deferiprone.  The distribution coeffs. of these mols. are also increased despite the lack of a hydrophobic 1-alkyl substituent and this is ascribed to the intramol. hydrogen bond.  X-ray diffraction studies confirm the existence of the intramol. hydrogen bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr66U4MU4X9HrVg90H21EOLACvtfcHk0liwCB6uO76QtQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVGqtb8%253D&md5=5ff945a48139d6a74408c87968b8df72</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1002%2Fchem.200902455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200902455%26sid%3Dliteratum%253Aachs%26aulast%3DPiyamongkol%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DAytemir%26aufirst%3DM.%2BD.%26aulast%3Dvan%2Bder%2BHelm%26aufirst%3DD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DAmido-3-hydroxypyridin-4-ones%2520as%2520iron%2528III%2529%2520ligands%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26issue%3D21%26spage%3D6374%26epage%3D6381%26doi%3D10.1002%2Fchem.200902455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lachowicz, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurchi, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crisponi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaraquemada-Pelaez, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pintus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintanova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szewczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoroddu, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez-Martin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choquesillo-Lazarte, D.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinones with enhanced iron chelating properties. synthesis, characterization and <i>in vivo</i> tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1<i>H</i>)-one</span>. <i>Dalton. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6517</span>â <span class="NLM_lpage">6528</span>, <span class="refDoi">Â DOI: 10.1039/C6DT00129G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC6DT00129G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26956442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFKls7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=6517-6528&issue=15&author=J.+I.+Lachowiczauthor=V.+M.+Nurchiauthor=G.+Crisponiauthor=M.+G.+Jaraquemada-Pelaezauthor=M.+Arcaauthor=A.+Pintusauthor=M.+A.+Santosauthor=C.+Quintanovaauthor=L.+Ganoauthor=Z.+Szewczukauthor=M.+A.+Zorodduauthor=M.+Peanaauthor=A.+Dominguez-Martinauthor=D.+Choquesillo-Lazarte&title=Hydroxypyridinones+with+enhanced+iron+chelating+properties.+synthesis%2C+characterization+and+in+vivo+tests+of+5-hydroxy-2-%28hydroxymethyl%29pyridine-4%281H%29-one&doi=10.1039%2FC6DT00129G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one</span></div><div class="casAuthors">Lachowicz, J. I.; Nurchi, V. M.; Crisponi, G.; Jaraquemada-Pelaez, M. G.; Arca, M.; Pintus, A.; Santos, M. A.; Quintanova, C.; Gano, L.; Szewczuk, Z.; Zoroddu, M. A.; Peana, M.; Dominguez-Martin, A.; Choquesillo-Lazarte, D.</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6517-6528</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The synthesis of 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one (P1) is presented, together with the evaluation of its coordination ability towards Fe3+ (I), studied by a combination of chem., computational, and animal approaches.  The use of complementary anal. techniques has allowed the authors to give evidence of the tautomeric changes of P1 as a function of pH, and to det. their influence on the coordinating ability of P1 towards Fe3+.  The pFe3+ value 22.0 of P1-iron complexes is noticeably higher than that of deferiprone (20.6), one of the three clin. chelating agents in therapeutic use for iron overload diseases.  This is due on one side to the tautomeric change to the catechol form, and on the other to the lower protonation const. of the OH group.  Bio-distribution studies on mice allowed the authors to confirm in vivo the efficacy of P1.  Furthermore the coordinating ability toward Al3+, Cu2+ and Zn2+ was studied to evaluate the possible use of P1 against a second toxic metal ion (Al3+), and to envisage its potential influence on the homeostatic equil. of essential metal ions.  The chelating ability of P1 toward these ions, not higher than that of the corresponding deferiprone, contributes to render P1 a more selective iron chelator.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzh8qcYwKH5rVg90H21EOLACvtfcHk0li4BVJrb1ljlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFKls7s%253D&md5=5be541e65ab8ef796361a495e50d3f2c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1039%2FC6DT00129G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6DT00129G%26sid%3Dliteratum%253Aachs%26aulast%3DLachowicz%26aufirst%3DJ.%2BI.%26aulast%3DNurchi%26aufirst%3DV.%2BM.%26aulast%3DCrisponi%26aufirst%3DG.%26aulast%3DJaraquemada-Pelaez%26aufirst%3DM.%2BG.%26aulast%3DArca%26aufirst%3DM.%26aulast%3DPintus%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26aulast%3DQuintanova%26aufirst%3DC.%26aulast%3DGano%26aufirst%3DL.%26aulast%3DSzewczuk%26aufirst%3DZ.%26aulast%3DZoroddu%26aufirst%3DM.%2BA.%26aulast%3DPeana%26aufirst%3DM.%26aulast%3DDominguez-Martin%26aufirst%3DA.%26aulast%3DChoquesillo-Lazarte%26aufirst%3DD.%26atitle%3DHydroxypyridinones%2520with%2520enhanced%2520iron%2520chelating%2520properties.%2520synthesis%252C%2520characterization%2520and%2520in%2520vivo%2520tests%2520of%25205-hydroxy-2-%2528hydroxymethyl%2529pyridine-4%25281H%2529-one%26jtitle%3DDalton.%2520Trans.%26date%3D2016%26volume%3D45%26issue%3D15%26spage%3D6517%26epage%3D6528%26doi%3D10.1039%2FC6DT00129G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Iron binding dendrimers: a novel approach for the treatment of haemochromatosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4171</span>â <span class="NLM_lpage">4182</span>, <span class="refDoi">Â DOI: 10.1021/jm0600949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0600949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVSiuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4171-4182&issue=14&author=T.+Zhouauthor=H.+Neubertauthor=D.+Y.+Liuauthor=Z.+D.+Liuauthor=Y.+M.+Maauthor=X.+L.+Kongauthor=W.+Luoauthor=S.+Markauthor=R.+C.+Hider&title=Iron+binding+dendrimers%3A+a+novel+approach+for+the+treatment+of+haemochromatosis&doi=10.1021%2Fjm0600949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Iron Binding Dendrimers: A Novel Approach for the Treatment of Hemochromatosis</span></div><div class="casAuthors">Zhou, Tao; Neubert, Hendrik; Liu, Ding Yong; Liu, Zu Dong; Ma, Yong Min; Kong, Xiao Le; Luo, Wei; Mark, Sykes; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4171-4182</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of iron binding dendrimers terminated with hexadentate ligands formed from hydroxypyridinone, hydroxypyranone, and catechol moieties have been synthesized in order to investigate their potential as clin. useful iron(III)-selective chelators capable of removing dietary iron from the gastrointestinal tract and preventing the development of iron overload typical of hemochromatosis and thalassemia intermedia.  The iron chelating abilities of these mols. have been characterized by MALDI-TOF mass spectrometry and UV spectrometry.  Hydroxypyridinone-terminated dendrimers were found to possess a high affinity and selectivity for iron(III).  A hydroxypyridinone-based dendrimer was demonstrated to be highly efficient at reducing the absorption of iron(III) in rat intestine.  This family of dendrimers may find an application in the treatment of iron overload.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ_MHunLD_srVg90H21EOLACvtfcHk0li4BVJrb1ljlA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVSiuro%253D&md5=0fa8f8c882058c3c3cae339c50215d20</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Fjm0600949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0600949%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DNeubert%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DMark%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DIron%2520binding%2520dendrimers%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520haemochromatosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D14%26spage%3D4171%26epage%3D4182%26doi%3D10.1021%2Fjm0600949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers</span>. <i>Biomacromolecules</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1372</span>â <span class="NLM_lpage">1380</span>, <span class="refDoi">Â DOI: 10.1021/bm701122u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bm701122u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvFOluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1372-1380&author=T.+Zhouauthor=X.+L.+Kongauthor=Z.+D.+Liuauthor=D.+Y.+Liuauthor=R.+C.+Hider&title=Synthesis+and+iron%28III%29-chelating+properties+of+novel+3-hydroxypyridin-4-one+hexadentate+ligand-containing+copolymers&doi=10.1021%2Fbm701122u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Iron(III)-Chelating Properties of Novel 3-Hydroxypyridin-4-one Hexadentate Ligand-Containing Copolymers</span></div><div class="casAuthors">Zhou, Tao; Kong, Xiao Le; Liu, Zu Dong; Liu, Ding Yong; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Biomacromolecules</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1372-1380</span>CODEN:
                <span class="NLM_cas:coden">BOMAF6</span>;
        ISSN:<span class="NLM_cas:issn">1525-7797</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iron overload is a crit. clin. problem that can be prevented by the use of iron-specific chelating agents.  An alternative method of relieving iron overload is to reduce the efficiency of iron absorption from the intestine by administering iron chelators, which can bind iron irreversibly to form nontoxic, kinetically inert complexes that are not absorbed and are therefore excreted in the feces.  A series of polymeric chelators with various iron binding capacities were therefore prepd. as nonabsorbable iron-selective additives.  A novel 3-hydroxypyridin-4-one hexadentate ligand CP254 has been synthesized and incorporated into polymers by copolymn. with N,N-dimethylacrylamide (DMAA), and N,N'-ethylene-bis-acrylamide (EBAA) using (NH4)2S2O8 as the initiator.  The physicochem. properties of CP254 were detd., namely, log K = 33.2 and pFe3+ = 27.24.  The chelating capacity of the CP254-DMAA copolymers was detd. at physiol. pH.  The iron(III) chelation was found to achieve 80% capacity after 1 h and was virtually complete after 5 h, which is much quicker than that of the com. available chelating resin Chelex100.  The chelating copolymers were found to be readily regenerated and reusable.  The copolymers possess a high selectivity for iron(III).  The conditional affinity (log K') for iron(III) at pH 7.46 was detd. to be 26.55, which is not significantly different to that of the hexadentate ligand CP254 (log K' = 26.47).  In vitro perfusion studies indicate that the polymeric chelators described in this study can reduce iron absorption from the intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp3V-cqnjrorVg90H21EOLACvtfcHk0lhwxhNHO0s30Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvFOluro%253D&md5=e0d95739749a769b3513447463ddeb77</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fbm701122u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbm701122u%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLiu%26aufirst%3DD.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%2520and%2520iron%2528III%2529-chelating%2520properties%2520of%2520novel%25203-hydroxypyridin-4-one%2520hexadentate%2520ligand-containing%2520copolymers%26jtitle%3DBiomacromolecules%26date%3D2008%26volume%3D9%26spage%3D1372%26epage%3D1380%26doi%3D10.1021%2Fbm701122u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, A. M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">New tris(hydroxypyridinones) as iron and aluminium sequestering agents: synthesis, complexation and <i>in vivo</i> studies</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">10535</span>â <span class="NLM_lpage">10545</span>, <span class="refDoi">Â DOI: 10.1002/chem.201001335</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fchem.201001335" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20665585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=10535-10545&issue=34&author=S.+Chavesauthor=S.+M.+Marquesauthor=A.+M.+F.+Matosauthor=A.+Nunesauthor=L.+Ganoauthor=T.+Tuccinardiauthor=A.+Martinelliauthor=M.+A.+Santos&title=New+tris%28hydroxypyridinones%29+as+iron+and+aluminium+sequestering+agents%3A+synthesis%2C+complexation+and+in+vivo+studies&doi=10.1002%2Fchem.201001335"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">New Tris(hydroxypyridinones) as Iron and Aluminium Sequestering Agents: synthesis, Complexation and In Vivo Studies</span></div><div class="casAuthors">Chaves, Silvia; Marques, Sergio M.; Matos, Andre M. F.; Nunes, Andreia; Gano, Lurdes; Tuccinardi, Tiziano; Martinelli, Adriano; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10535-10545</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Two new tripodal tris(3-hydroxy-4-pyridinone) hexadentate chelators-NTA(BuHP)3 and NTP(PrHP)3 (NTA=nitrilotriacetic acid, NTP=nitrilotripropionic acid, HP=hydroxypyridone)-have been developed and studied in soln. for their iron and aluminum binding affinity, and also assayed in vivo for their capacity to remove metal from an animal model that is overloaded.  These chelators are positional isomers, possessing identical general structures based on aminotricarboxylic acid skeletons attached to three bidentate 3-hydroxy-4-pyridinones (3,4-HPs), but differing in the position of the amide linkage along the chelating "arm".  In spite of expected differences in the tripodal ligands, such as acidity and hydrogen-bonding networks, they share important properties, namely, a mild hydrophilic character (log P ca. -1.2 to -1.4) and a strong chelating affinity for Fe and Al (pFe=27.9 and pAl=22.0 for NTA(BuHP)3; pFe=29.4 and pAl=22.4 for NTP(PrHP)3).  They also evidenced identical effects on the biodistribution and on the excretion of a radiotracer (67Ga) previously administered to mice, as models of iron overload animals.  Comparison of the new compds. with reported analogs shows good improvement in terms of soln. and in vivo sequestering properties, thus giving support to expectations about their potential clin. application as metal removal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXKBLX9o9CWrVg90H21EOLACvtfcHk0lhwxhNHO0s30Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGnsbrP&md5=7cf028ffe7847aa32504f0a825ba7dde</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1002%2Fchem.201001335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201001335%26sid%3Dliteratum%253Aachs%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DMarques%26aufirst%3DS.%2BM.%26aulast%3DMatos%26aufirst%3DA.%2BM.%2BF.%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DGano%26aufirst%3DL.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DNew%2520tris%2528hydroxypyridinones%2529%2520as%2520iron%2520and%2520aluminium%2520sequestering%2520agents%253A%2520synthesis%252C%2520complexation%2520and%2520in%2520vivo%2520studies%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2010%26volume%3D16%26issue%3D34%26spage%3D10535%26epage%3D10545%26doi%3D10.1002%2Fchem.201001335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkelmann, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design of clinically useful macromolecular iron chelators</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">893</span>â <span class="NLM_lpage">903</span>, <span class="refDoi">Â DOI: 10.1111/j.2042-7158.2011.01291.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.2042-7158.2011.01291.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21635254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotV2iur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=893-903&issue=7&author=T.+Zhouauthor=G.+Winkelmannauthor=Z.+Y.+Daiauthor=R.+C.+Hider&title=Design+of+clinically+useful+macromolecular+iron+chelators&doi=10.1111%2Fj.2042-7158.2011.01291.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Design of clinically useful macromolecular iron chelators</span></div><div class="casAuthors">Zhou, Tao; Winkelmann, Gunther; Dai, Zhi-Yuan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-903</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  In recent years, macromol. Fe chelators have received increasing attention as human therapeutic agents.  The objectives of this article are: one, to discuss the factors which should be considered when designing iron binding macromols. as human therapeutic agents, and two, to report recent achievements in the design and synthesis of appropriate macromol. chelators that have resulted in the prodn. of a no. of agents with therapeutic potential.  Macromol. drugs exhibit unique pharmaceutical properties that are fundamentally different from their traditional small-mol. counterparts.  By virtue of their high-mol.-wt. characteristics, many are confined to extracellular compartments, for instance, the serum and the gastrointestinal tract.  In addn., they have potential for topical administration.  Consequently, these macromol. drugs are free from many of the toxic effects that are assocd. with their low-mol.-wt. analogs.  The design and synthesis of macromol. Fe chelators provides a novel aspect to chelation therapy.  3-Hydroxypyridin-4-one hexadentate-based macromol. chelators have considerable potential for the development of new treatments for iron overload and for topical treatment of infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOxMX43pL_3bVg90H21EOLACvtfcHk0lhwxhNHO0s30Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotV2iur8%253D&md5=7296f0399ea06878424308c2ea3657b7</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.2011.01291.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.2011.01291.x%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DWinkelmann%26aufirst%3DG.%26aulast%3DDai%26aufirst%3DZ.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520of%2520clinically%2520useful%2520macromolecular%2520iron%2520chelators%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2011%26volume%3D63%26issue%3D7%26spage%3D893%26epage%3D903%26doi%3D10.1111%2Fj.2042-7158.2011.01291.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galanello, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agus, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danjou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giardina, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, R. W.</span></span> <span> </span><span class="NLM_article-title">Combined iron chelation therapy</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1202</i></span>,  <span class="NLM_fpage">79</span>â <span class="NLM_lpage">86</span>, <span class="refDoi">Â DOI: 10.1111/j.1749-6632.2010.05591.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1749-6632.2010.05591.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20712777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFGms7fN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1202&publication_year=2010&pages=79-86&author=R.+Galanelloauthor=A.+Agusauthor=S.+Campusauthor=F.+Danjouauthor=P.+J.+Giardinaauthor=R.+W.+Grady&title=Combined+iron+chelation+therapy&doi=10.1111%2Fj.1749-6632.2010.05591.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Combined iron chelation therapy</span></div><div class="casAuthors">Galanello, Renzo; Agus, Annalisa; Campus, Simona; Danjou, Fabrice; Giardina, Patricia J.; Grady, Robert W.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1202</span>
        (<span class="NLM_cas:issue">Cooley's Anemia</span>),
    <span class="NLM_cas:pages">79-86</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Patients with thalassemia major accumulate body iron over time as a consequence of continuous red blood cell transfusions which cause hepatic, endocrine, and cardiac complications.  Despite the availability of three iron chelators, some patients fail to respond adequately to monotherapy with any of them.  Combination therapy, consisting in the use of two chelators on the same day, has been introduced to increase the efficacy and to induce neg. iron balance in patients with severe iron overload.  Extensive long-term experience has shown that combined chelation with deferiprone and deferoxamine (DFO) rapidly reduces liver iron, serum ferritin, and myocardial siderosis, improves cardiac function, reverses and prevents endocrine complications, reduces cardiac mortality, and improves survival.  Side effects, though significant, are manageable if properly monitored.  Preliminary promising results have been obtained using combined chelation with deferasirox and DFO.  As more drug combination regimes are evaluated, it should be possible to better tailor iron chelation to the needs of the patients, minimizing toxicity and maximizing efficacy throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6yCxDDoxizLVg90H21EOLACvtfcHk0ljt1hJbruJ3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFGms7fN&md5=5f22ea73095cc2ab58111651b42e76b4</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2010.05591.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2010.05591.x%26sid%3Dliteratum%253Aachs%26aulast%3DGalanello%26aufirst%3DR.%26aulast%3DAgus%26aufirst%3DA.%26aulast%3DCampus%26aufirst%3DS.%26aulast%3DDanjou%26aufirst%3DF.%26aulast%3DGiardina%26aufirst%3DP.%2BJ.%26aulast%3DGrady%26aufirst%3DR.%2BW.%26atitle%3DCombined%2520iron%2520chelation%2520therapy%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1202%26spage%3D79%26epage%3D86%26doi%3D10.1111%2Fj.1749-6632.2010.05591.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kontoghiorghes, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eracleous, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Economides, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolnagou, A.</span></span> <span> </span><span class="NLM_article-title">Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56â252, L1NAll and their combinations</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2663</span>â <span class="NLM_lpage">2681</span>, <span class="refDoi">Â DOI: 10.2174/092986705774463003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F092986705774463003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16305464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrrI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2663-2681&author=G.+J.+Kontoghiorghesauthor=E.+Eracleousauthor=C.+Economidesauthor=A.+Kolnagou&title=Advances+in+iron+overload+therapies.+Prospects+for+effective+use+of+deferiprone+%28L1%29%2C+deferoxamine%2C+the+new+experimental+chelators+ICL670%2C+GT56%E2%80%93252%2C+L1NAll+and+their+combinations&doi=10.2174%2F092986705774463003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NA11 and their combinations</span></div><div class="casAuthors">Kontoghiorghes, George J.; Eracleous, Eleni; Economides, Charalambos; Kolnagou, Annita</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2663-2681</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Effective new therapies and mechanisms have been developed for the targeting and prevention of iron overload and toxicity in thalassemia and idiopathic haemochromatosis patients.  A new era in the development of chelating drugs began with the introduction of deferiprone or L1, which as a monotherapy or in combination with deferoxamine can be used universally for effective chelation treatments, rapid iron removal, maintenance of low iron stores and prevention of heart and other organ damage caused by iron overload.  Several exptl. iron chelators such as deferasirox (4-[3,5-bis (2-hydroxyphenyl)-1,2,4-triazol-1-yl]-benzoic acid) or ICL670, deferitrin (4,5-dihydro-2- (2,4-dihydroxyphenyl)-4-methylthiazole-4 (S)-carboxylic acid) or GT56-252, 1-allyl-2-methyl-3-hydroxypyrid-4-one or L1NAll and starch deferoxamine polymers have reached different stages of clin. development.  The lipophilic ICL670, which can only be administered once daily is generally ineffective in causing neg. iron balance but is effective in reducing liver iron.  It is suspected that it may increase iron absorption and the redistribution of iron from the liver to the heart and other organs.  The exptl. iron chelators do not appear to have significant advantages in efficacy and toxicity by comparison to deferiprone, deferoxamine or their combination.  However, the prospect of combination therapies using deferiprone, deferoxamine and new chelators will provide new mechanisms of chelator interactions, which may lead to higher efficacy and lower toxicity by comparison to monotherapies.  A major disadvantage of the exptl. chelators is that even if they are approved for clin. use, they are unlikely to be as inexpensive as deferiprone and become available to the vast majority of thalassemia patients, who live in developing countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGdjCvfb55tLVg90H21EOLACvtfcHk0ljt1hJbruJ3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrrI&md5=e5f8a0fba238a6f66f45693bb9f3daf1</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2174%2F092986705774463003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774463003%26sid%3Dliteratum%253Aachs%26aulast%3DKontoghiorghes%26aufirst%3DG.%2BJ.%26aulast%3DEracleous%26aufirst%3DE.%26aulast%3DEconomides%26aufirst%3DC.%26aulast%3DKolnagou%26aufirst%3DA.%26atitle%3DAdvances%2520in%2520iron%2520overload%2520therapies.%2520Prospects%2520for%2520effective%2520use%2520of%2520deferiprone%2520%2528L1%2529%252C%2520deferoxamine%252C%2520the%2520new%2520experimental%2520chelators%2520ICL670%252C%2520GT56%25E2%2580%2593252%252C%2520L1NAll%2520and%2520their%2520combinations%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2663%26epage%3D2681%26doi%3D10.2174%2F092986705774463003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastava, S. K.</span></span> <span> </span><span class="NLM_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimerâs disease and potential therapeutic strategies</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">53</span>â <span class="NLM_lpage">89</span>, <span class="refDoi">Â DOI: 10.1016/j.pneurobio.2018.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.pneurobio.2018.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30599179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXksFajsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2019&pages=53-89&author=P.+Sharmaauthor=P.+Srivastavaauthor=A.+Sethauthor=P.+N.+Tripathiauthor=A.+G.+Banerjeeauthor=S.+K.+Shrivastava&title=Comprehensive+review+of+mechanisms+of+pathogenesis+involved+in+Alzheimer%E2%80%99s+disease+and+potential+therapeutic+strategies&doi=10.1016%2Fj.pneurobio.2018.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies</span></div><div class="casAuthors">Sharma, Piyoosh; Srivastava, Pavan; Seth, Ankit; Tripathi, Prabhash Nath; Banerjee, Anupam G.; Shrivastava, Sushant K.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">53-89</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  AD is a progressive neurodegenerative disorder and a leading cause of dementia in an aging population worldwide.  An in-depth anal. of the extensive available data assocd. with the AD is needed for a more comprehensive understanding of underlying mol. mechanisms and pathophysiol. pathways assocd. with the onset and progression of the AD.  The currently understood pathol. and biochem. manifestations include cholinergic, AÎ², tau, excitotoxicity, oxidative stress, ApoE, CREB signaling pathways, insulin resistance, etc.  However, these hypotheses have been criticized with several conflicting reports for their involvement in the disease progression.  Several issues need to be addressed such as benefits to cost ratio with cholinesterase therapy, the dilemma of AChE selectivity over BChE, BBB permeability of peptidic BACE-1 inhibitors, hurdles related to the implementation of vaccination and immunization therapy, and clin. failure of candidates related to newly available targets.  The present review provides an insight to the different mol. mechanisms involved in the development and progression of the AD and potential therapeutic strategies, enlightening perceptions into structural information of conventional and novel targets along with the successful applications of computational approaches for the design of target-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ggPpSxf8_bVg90H21EOLACvtfcHk0ljt1hJbruJ3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXksFajsQ%253D%253D&md5=0d4cf0a5d03797cbc07f5112c30550c8</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DP.%26aulast%3DSrivastava%26aufirst%3DP.%26aulast%3DSeth%26aufirst%3DA.%26aulast%3DTripathi%26aufirst%3DP.%2BN.%26aulast%3DBanerjee%26aufirst%3DA.%2BG.%26aulast%3DShrivastava%26aufirst%3DS.%2BK.%26atitle%3DComprehensive%2520review%2520of%2520mechanisms%2520of%2520pathogenesis%2520involved%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520potential%2520therapeutic%2520strategies%26jtitle%3DProg.%2520Neurobiol.%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89%26doi%3D10.1016%2Fj.pneurobio.2018.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reelfs, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cilibrizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pook, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourzand, C.</span></span> <span> </span><span class="NLM_article-title">The role of mitochondrial labile iron in Friedreichâs ataxia skin fibroblasts sensitivity to ultraviolet A</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">656</span>â <span class="NLM_lpage">665</span>, <span class="refDoi">Â DOI: 10.1039/C8MT00257F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC8MT00257F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30778428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtlClt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=656-665&issue=3&author=O.+Reelfsauthor=V.+Abbateauthor=A.+Cilibrizziauthor=M.+A.+Pookauthor=R.+C.+Hiderauthor=C.+Pourzand&title=The+role+of+mitochondrial+labile+iron+in+Friedreich%E2%80%99s+ataxia+skin+fibroblasts+sensitivity+to+ultraviolet+A&doi=10.1039%2FC8MT00257F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitochondrial labile iron in Friedreich's ataxia skin fibroblasts sensitivity to ultraviolet A</span></div><div class="casAuthors">Reelfs, Olivier; Abbate, Vincenzo; Cilibrizzi, Agostino; Pook, Mark A.; Hider, Robert C.; Pourzand, Charareh</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">656-665</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Mitochondrial labile iron (LI) is a major contributor to the susceptibility of skin fibroblasts to UV A (UVA)-induced oxidative damage leading to necrotic cell death via ATP depletion.  Mitochondria iron overload is a key feature of the neurodegenerative disease Friedreich's ataxia (FRDA).  We demonstrate that FRDA cells display higher levels of mitochondrial LI (up to 6-fold on av. compared to healthy counterparts) and show higher increase in mitochondrial reactive oxygen species (ROS) generation after UVA irradn. (up to 2-fold on av.), consistent with their differential sensitivity to UVA.  Pre-treatment of the FRDA cells with a bespoke mitochondrial iron chelator fully abrogates the UVA-mediated cell death and reduces UVA-induced damage to mitochondrial membrane and the resulting ATP depletion by a factor of 2.  Our results reveal a link between FRDA as a disease of mitochondrial iron overload and sensitivity to UVA of skin fibroblasts.  Our findings suggest that the high levels of mitochondrial LI in FRDA cells which contribute to high levels of mitochondrial ROS prodn. after UVA irradn. are likely to play a crucial role in the marked sensitivity of these cells to UVA-induced oxidative damage.  This study may have implications not only for FRDA but also for other diseases of mitochondrial iron overload, with the view to develop topical mitochondria-targeted iron chelators as skin photoprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFFOkOcdEP-bVg90H21EOLACvtfcHk0ljt1hJbruJ3SQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtlClt74%253D&md5=533867dc87771b4ec6166889644c73bb</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1039%2FC8MT00257F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MT00257F%26sid%3Dliteratum%253Aachs%26aulast%3DReelfs%26aufirst%3DO.%26aulast%3DAbbate%26aufirst%3DV.%26aulast%3DCilibrizzi%26aufirst%3DA.%26aulast%3DPook%26aufirst%3DM.%2BA.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DPourzand%26aufirst%3DC.%26atitle%3DThe%2520role%2520of%2520mitochondrial%2520labile%2520iron%2520in%2520Friedreich%25E2%2580%2599s%2520ataxia%2520skin%2520fibroblasts%2520sensitivity%2520to%2520ultraviolet%2520A%26jtitle%3DMetallomics%26date%3D2019%26volume%3D11%26issue%3D3%26spage%3D656%26epage%3D665%26doi%3D10.1039%2FC8MT00257F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucca, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duyn, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecca, L.</span></span> <span> </span><span class="NLM_article-title">The role of iron in brain ageing and neurodegenerative disorders</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1045</span>â <span class="NLM_lpage">1060</span>, <span class="refDoi">Â DOI: 10.1016/S1474-4422(14)70117-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1474-4422%2814%2970117-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25231526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFyrt7zN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=1045-1060&issue=10&author=R.+J.+Wardauthor=F.+A.+Zuccaauthor=J.+H.+Duynauthor=R.+R.+Crichtonauthor=L.+Zecca&title=The+role+of+iron+in+brain+ageing+and+neurodegenerative+disorders&doi=10.1016%2FS1474-4422%2814%2970117-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The role of iron in brain aging and neurodegenerative disorders</span></div><div class="casAuthors">Ward, Roberta J.; Zucca, Fabio A.; Duyn, Jeff H.; Crichton, Robert R.; Zecca, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1045-1060</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In the CNS, iron in several proteins is involved in many important processes such as oxygen transportation, oxidative phosphorylation, myelin prodn., and the synthesis and metab. of neurotransmitters.  Abnormal iron homoeostasis can induce cellular damage through hydroxyl radical prodn., which can cause the oxidn. and modification of lipids, proteins, carbohydrates, and DNA.  During aging, different iron complexes accumulate in brain regions assocd. with motor and cognitive impairment.  In various neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, changes in iron homoeostasis result in altered cellular iron distribution and accumulation.  MRI can often identify these changes, thus providing a potential diagnostic biomarker of neurodegenerative diseases.  An important avenue to reduce iron accumulation is the use of iron chelators that are able to cross the blood-brain barrier, penetrate cells, and reduce excessive iron accumulation, thereby affording neuroprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUvbm7wD6rkbVg90H21EOLACvtfcHk0lh1_FDwMe9IwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFyrt7zN&md5=469d9dd8f50e41d5795c9bf45354bc64</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970117-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970117-6%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DZucca%26aufirst%3DF.%2BA.%26aulast%3DDuyn%26aufirst%3DJ.%2BH.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26aulast%3DZecca%26aufirst%3DL.%26atitle%3DThe%2520role%2520of%2520iron%2520in%2520brain%2520ageing%2520and%2520neurodegenerative%2520disorders%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26issue%3D10%26spage%3D1045%26epage%3D1060%26doi%3D10.1016%2FS1474-4422%2814%2970117-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, J.</span></span> <span> </span><span class="NLM_article-title">The potential application of iron chelators for the treatment of neurodegenerative diseases</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">239</span>â <span class="NLM_lpage">249</span>, <span class="refDoi">Â DOI: 10.1039/c0mt00087f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc0mt00087f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21344071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=239-249&issue=3&author=R.+C.+Hiderauthor=S.+Royauthor=Y.+M.+Maauthor=X.+Le+Kongauthor=J.+Preston&title=The+potential+application+of+iron+chelators+for+the+treatment+of+neurodegenerative+diseases&doi=10.1039%2Fc0mt00087f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">The potential application of iron chelators for the treatment of neurodegenerative diseases</span></div><div class="casAuthors">Hider, Robert C.; Roy, Sourav; Ma, Yong Min; Le Kong, Xiao; Preston, Jane</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-249</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Many forms of neurodegenerative disease, for instance Alzheimer's disease, Parkinson's disease, Friedreich's ataxia, Hallervorden Spatz syndrome and macular degeneration, are assocd. with elevated levels of redox active metals in the brain and eye.  A logical therapeutic approach therefore, is to remove the toxic levels of these metals, copper and iron in particular, by selective chelation.  The increased no. of iron-selective chelators now available for clin. use has enhanced interest in this type of therapy.  This review summarises the recent developments in the design of chelators for treatment of neurodegenerative disease, identifies some of the essential properties for such mols. and suggests some future strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_QWZw98vWsbVg90H21EOLACvtfcHk0lh1_FDwMe9IwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksVGlsb8%253D&md5=d5efb2da19e8a08dccb014614ba4b71e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1039%2Fc0mt00087f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc0mt00087f%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DLe%2BKong%26aufirst%3DX.%26aulast%3DPreston%26aufirst%3DJ.%26atitle%3DThe%2520potential%2520application%2520of%2520iron%2520chelators%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520diseases%26jtitle%3DMetallomics%26date%3D2011%26volume%3D3%26issue%3D3%26spage%3D239%26epage%3D249%26doi%3D10.1039%2Fc0mt00087f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florence, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aouad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span> <span> </span><span class="NLM_article-title">Brain iron in the freeocene-loaded rat: its chelation and influence on dopamine metabolism</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1821</span>â <span class="NLM_lpage">1826</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(94)00521-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0006-2952%2894%2900521-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=7598744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2MXms1enur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=1821-1826&issue=12&author=R.+J.+Wardauthor=D.+Dexterauthor=A.+Florenceauthor=F.+Aouadauthor=R.+C.+Hiderauthor=P.+Jennerauthor=R.+R.+Crichton&title=Brain+iron+in+the+freeocene-loaded+rat%3A+its+chelation+and+influence+on+dopamine+metabolism&doi=10.1016%2F0006-2952%2894%2900521-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Brain iron in the ferrocene-loaded rat: its chelation and influence of dopamine metabolism</span></div><div class="casAuthors">Ward, Roberta J.; Dexter, David; Florence, Anne; Aouad, Fouad; Hider, Robert; Jenner, Peter; Crichton, Robert R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1821-6</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">After administration of the ferrocene deriv. 3,5,5-tri-Me hexanoyl ferrocene to rats for 4 wk, various brain regions including substantia nigra, cerebellum and cerebral cortex showed â¤50% increase in iron content.  Subsequent administration of one of the hydroxypyridones CP20, CP24, and CP94, or the siderophore desferrioxamine caused a significant decrease in the iron content of these various brain regions.  Each of the hydroxypyridones and the siderophore influenced dopamine metab. by causing significant variations in both homovanillic acid and dopamine turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFZ1wuH8PVhbVg90H21EOLACvtfcHk0lh1_FDwMe9IwQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1enur8%253D&md5=22cfa34d1b45d886e9f23008a69995c3</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2894%2900521-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252894%252900521-M%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DDexter%26aufirst%3DD.%26aulast%3DFlorence%26aufirst%3DA.%26aulast%3DAouad%26aufirst%3DF.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26atitle%3DBrain%2520iron%2520in%2520the%2520freeocene-loaded%2520rat%253A%2520its%2520chelation%2520and%2520influence%2520on%2520dopamine%2520metabolism%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1995%26volume%3D49%26issue%3D12%26spage%3D1821%26epage%3D1826%26doi%3D10.1016%2F0006-2952%2894%2900521-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habgood, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehkordi, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodr, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1305</span>â <span class="NLM_lpage">1310</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(99)00031-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-2952%2899%2900031-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10230774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1MXivVCjtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1999&pages=1305-1310&issue=11&author=M.+D.+Habgoodauthor=Z.+D.+Liuauthor=L.+S.+Dehkordiauthor=H.+H.+Khodrauthor=J.+Abbottauthor=R.+C.+Hider&title=Investigation+into+the+correlation+between+the+structure+of+hydroxypyridinones+and+blood-brain+barrier+permeability&doi=10.1016%2FS0006-2952%2899%2900031-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability</span></div><div class="casAuthors">Habgood, Mark D.; Liu, Zu Dong; Dehkordi, Lotfollah S.; Khodr, Hicham H.; Abbott, Joan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1305-1310</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Bidentate hydroxypyridinones are under active development as orally active iron chelators.  With applications for the treatment of general body iron overload, for instance with thalassemia, the distribution of the chelators should be limited to peripheral tissue and they should not enter the central nervous system.  This study compares the predictive abilities of LogPoctanol and LogPcyclohexane and reports the existence of good correlations between blood-brain barrier (BBB) permeability and both values for N-alkylpyridinones.  1,Ï-Hydroxyalkyl hydroxypyridinones penetrate the BBB much more slowly than the simple 1-alkyl derivs.  This observation is likely to have important toxicol. implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5j4-vbHr9urVg90H21EOLACvtfcHk0ljhBJCnSd2mdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivVCjtbY%253D&md5=ba96880d418da2ac6f0909ad8469e2ad</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2899%2900031-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252899%252900031-3%26sid%3Dliteratum%253Aachs%26aulast%3DHabgood%26aufirst%3DM.%2BD.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DDehkordi%26aufirst%3DL.%2BS.%26aulast%3DKhodr%26aufirst%3DH.%2BH.%26aulast%3DAbbott%26aufirst%3DJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DInvestigation%2520into%2520the%2520correlation%2520between%2520the%2520structure%2520of%2520hydroxypyridinones%2520and%2520blood-brain%2520barrier%2520permeability%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1999%26volume%3D57%26issue%3D11%26spage%3D1305%26epage%3D1310%26doi%3D10.1016%2FS0006-2952%2899%2900031-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwiatkowski, J. L.</span></span> <span> </span><span class="NLM_article-title">Current recommendations for chelation for transfusion-dependent thalassemia</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>1368</i></span>,  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">114</span>, <span class="refDoi">Â DOI: 10.1111/nyas.13088</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fnyas.13088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27186943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XotVSksrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1368&publication_year=2016&pages=107-114&author=J.+L.+Kwiatkowski&title=Current+recommendations+for+chelation+for+transfusion-dependent+thalassemia&doi=10.1111%2Fnyas.13088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Current recommendations for chelation for transfusion-dependent thalassemia</span></div><div class="casAuthors">Kwiatkowski, Janet L.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1368</span>
        (<span class="NLM_cas:issue">1, Cooley's Anemia</span>),
    <span class="NLM_cas:pages">107-114</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Regular red cell transfusions used to treat thalassemia cause iron loading that must be treated with chelation therapy.  Morbidity and mortality in thalassemia major are closely linked to the adequacy of chelation.  Chelation therapy removes accumulated iron and detoxifies iron, which can prevent and reverse much of the iron-mediated organ injury.  Currently, three chelators are com. available--deferoxamine, deferasirox, and deferiprone--and each can be used as monotherapy or in combination.  Close monitoring of hepatic and cardiac iron burden is central to tailoring chelation.  Other factors, including properties of the individual chelators, ongoing transfusional iron burden, and patient preference, must be considered.  Monotherapy generally is utilized if the iron burden is in an acceptable or near-acceptable range and the dose is adjusted accordingly.  Combination chelation often is employed for patients with high iron burden, iron-related organ injury, or where adverse effects of chelators preclude administration of an appropriate chelator dose.  The combination of deferoxamine and deferiprone is the best studied, but increasing data are available on the safety and efficacy of newer chelator combinations, including deferasirox with deferoxamine and the oral-only combination of deferasirox with deferiprone.  The expanding chelation repertoire should enable better control of iron burden and improved outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxD5luP4JAYLVg90H21EOLACvtfcHk0ljhBJCnSd2mdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XotVSksrk%253D&md5=7bfe90fadf4cd928bcdae42c0547692c</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1111%2Fnyas.13088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fnyas.13088%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DJ.%2BL.%26atitle%3DCurrent%2520recommendations%2520for%2520chelation%2520for%2520transfusion-dependent%2520thalassemia%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D2016%26volume%3D1368%26spage%3D107%26epage%3D114%26doi%3D10.1111%2Fnyas.13088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devedjian, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kluza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrault, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laloux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonneaux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckewaert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouaix, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jissendi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dujardin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auger, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravasi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grolez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firdaus, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablonniere, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strubi-Vuillaume, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahr, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Destee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poltl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Defebvre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabantchik, Z. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bordet, R.</span></span> <span> </span><span class="NLM_article-title">Targeting chelatable iron as a therapeutic modality in Parkinsonâs disease</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">195</span>â <span class="NLM_lpage">210</span>, <span class="refDoi">Â DOI: 10.1089/ars.2013.5593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1089%2Fars.2013.5593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24251381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWmurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=195-210&issue=2&author=D.+Devosauthor=C.+Moreauauthor=J.+C.+Devedjianauthor=J.+Kluzaauthor=M.+Petraultauthor=C.+Lalouxauthor=A.+Jonneauxauthor=G.+Ryckewaertauthor=G.+Garconauthor=N.+Rouaixauthor=A.+Duhamelauthor=P.+Jissendiauthor=K.+Dujardinauthor=F.+Augerauthor=L.+Ravasiauthor=L.+Hopesauthor=G.+Grolezauthor=W.+Firdausauthor=B.+Sablonniereauthor=I.+Strubi-Vuillaumeauthor=N.+Zahrauthor=A.+Desteeauthor=J.+C.+Corvolauthor=D.+Poltlauthor=M.+Leistauthor=C.+Roseauthor=L.+Defebvreauthor=P.+Marchettiauthor=Z.+I.+Cabantchikauthor=R.+Bordet&title=Targeting+chelatable+iron+as+a+therapeutic+modality+in+Parkinson%E2%80%99s+disease&doi=10.1089%2Fars.2013.5593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease</span></div><div class="casAuthors">Devos, David; Moreau, Caroline; Devedjian, Jean Christophe; Kluza, Jerome; Petrault, Maud; Laloux, Charlotte; Jonneaux, Aurelie; Ryckewaert, Gilles; Garcon, Guillaume; Rouaix, Nathalie; Duhamel, Alain; Jissendi, Patrice; Dujardin, Kathy; Auger, Florent; Ravasi, Laura; Hopes, Lucie; Grolez, Guillaume; Firdaus, Wance; Sablonniere, Bernard; Strubi-Vuillaume, Isabelle; Zahr, Noel; Destee, Alain; Corvol, Jean-Christophe; Poeltl, Dominik; Leist, Marcel; Rose, Christian; Defebvre, Luc; Marchetti, Philippe; Cabantchik, Z. Ioav; Bordet, Regis</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">195-210</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: The pathophysiol. role of iron in Parkinson's disease (PD) was assessed by a chelation strategy aimed at reducing oxidative damage assocd. with regional iron deposition without affecting circulating metals.  Translational cell and animal models provided concept proofs and a delayed-start (DS) treatment paradigm, the basis for preliminary clin. assessments.  Results: For translational studies, we assessed the effect of oxidative insults in mice systemically prechelated with deferiprone (DFP) by following motor functions, striatal dopamine (HPLC and MRI-PET), and brain iron deposition (relaxation-R2*-MRI) aided by spectroscopic measurements of neuronal labile iron (with fluorescence-sensitive iron sensors) and oxidative damage by markers of protein, lipid, and DNA modification.  DFP significantly reduced labile iron and biol. damage in oxidn.-stressed cells and animals, improving motor functions while raising striatal dopamine.  For a pilot, double-blind, placebo-controlled randomized clin. trial, early-stage Parkinson's patients on stabilized dopamine regimens enrolled in a 12-mo single-center study with DFP (30 mg/kg/day).  Based on a 6-mo DS paradigm, early-start patients (n=19) compared to DS patients (n=18) (37/40 completed) responded significantly earlier and sustainably to treatment in both substantia nigra iron deposits (R2* MRI) and Unified Parkinson's Disease Rating Scale motor indicators of disease progression (p<0.03 and p<0.04, resp.).  Apart from three rapidly resolved neutropenia cases, safety was maintained throughout the trial.  Innovation: A moderate iron chelation regimen that avoids changes in systemic iron levels may constitute a novel therapeutic modality for PD.  Conclusions: The therapeutic features of a chelation modality established in translational models and in pilot clin. trials warrant comprehensive evaluation of symptomatic and/or disease-modifying potential of chelation in PD.  Antioxid. Redox Signal. 21, 195-210.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOSmNzpWgbCLVg90H21EOLACvtfcHk0ljhBJCnSd2mdA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWmurk%253D&md5=9124979c22409bfbfba32180c84df393</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1089%2Fars.2013.5593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2013.5593%26sid%3Dliteratum%253Aachs%26aulast%3DDevos%26aufirst%3DD.%26aulast%3DMoreau%26aufirst%3DC.%26aulast%3DDevedjian%26aufirst%3DJ.%2BC.%26aulast%3DKluza%26aufirst%3DJ.%26aulast%3DPetrault%26aufirst%3DM.%26aulast%3DLaloux%26aufirst%3DC.%26aulast%3DJonneaux%26aufirst%3DA.%26aulast%3DRyckewaert%26aufirst%3DG.%26aulast%3DGarcon%26aufirst%3DG.%26aulast%3DRouaix%26aufirst%3DN.%26aulast%3DDuhamel%26aufirst%3DA.%26aulast%3DJissendi%26aufirst%3DP.%26aulast%3DDujardin%26aufirst%3DK.%26aulast%3DAuger%26aufirst%3DF.%26aulast%3DRavasi%26aufirst%3DL.%26aulast%3DHopes%26aufirst%3DL.%26aulast%3DGrolez%26aufirst%3DG.%26aulast%3DFirdaus%26aufirst%3DW.%26aulast%3DSablonniere%26aufirst%3DB.%26aulast%3DStrubi-Vuillaume%26aufirst%3DI.%26aulast%3DZahr%26aufirst%3DN.%26aulast%3DDestee%26aufirst%3DA.%26aulast%3DCorvol%26aufirst%3DJ.%2BC.%26aulast%3DPoltl%26aufirst%3DD.%26aulast%3DLeist%26aufirst%3DM.%26aulast%3DRose%26aufirst%3DC.%26aulast%3DDefebvre%26aufirst%3DL.%26aulast%3DMarchetti%26aufirst%3DP.%26aulast%3DCabantchik%26aufirst%3DZ.%2BI.%26aulast%3DBordet%26aufirst%3DR.%26atitle%3DTargeting%2520chelatable%2520iron%2520as%2520a%2520therapeutic%2520modality%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D21%26issue%3D2%26spage%3D195%26epage%3D210%26doi%3D10.1089%2Fars.2013.5593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Bastida, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newbould, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabba, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tricta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dexter, D. T.</span></span> <span> </span><span class="NLM_article-title">Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinsonâs disease</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1398</span>â <span class="NLM_lpage">1406</span>, <span class="refDoi">Â DOI: 10.1038/s41598-017-01402-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2Fs41598-017-01402-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28469157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BC1crjslOktA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1398-1406&issue=1&author=A.+Martin-Bastidaauthor=R.+J.+Wardauthor=R.+Newbouldauthor=P.+Picciniauthor=D.+Sharpauthor=C.+Kabbaauthor=M.+C.+Patelauthor=M.+Spinoauthor=J.+Connellyauthor=F.+Trictaauthor=R.+R.+Crichtonauthor=D.+T.+Dexter&title=Brain+iron+chelation+by+deferiprone+in+a+phase+2+randomised+double-blinded+placebo+controlled+clinical+trial+in+Parkinson%E2%80%99s+disease&doi=10.1038%2Fs41598-017-01402-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease</span></div><div class="casAuthors">Martin-Bastida Antonio; Ward Roberta J; Piccini Paola; Sharp David; Kabba Christina; Dexter David T; Ward Roberta J; Crichton Robert R; Newbould Rexford; Patel Maneesh C; Spino Michael; Connelly John; Tricta Fernando</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1398</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Parkinson's disease (PD) is associated with increased iron levels in the substantia nigra (SNc).  This study evaluated whether the iron chelator, deferiprone, is well tolerated, able to chelate iron from various brain regions and improve PD symptomology.  In a randomised double-blind, placebo controlled trial, 22 early onset PD patients, were administered deferiprone, 10 or 15 mg/kg BID or placebo, for 6 months.  Patients were evaluated for PD severity, cognitive function, depression rating and quality of life.  Iron concentrations were assessed in the substantia nigra (SNc), dentate and caudate nucleus, red nucleus, putamen and globus pallidus by T2* MRI at baseline and after 3 and 6 months of treatment.  Deferiprone therapy was well tolerated and was associated with a reduced dentate and caudate nucleus iron content compared to placebo.  Reductions in iron content of the SNc occurred in only 3 patients, with no changes being detected in the putamen or globus pallidus.  Although 30 mg/kg deferiprone treated patients showed a trend for improvement in motor-UPDRS scores and quality of life, this did not reach significance.  Cognitive function and mood were not adversely affected by deferiprone therapy.  Such data supports more extensive clinical trials into the potential benefits of iron chelation in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQcf_k-H9XLw2x8TEN9K18QfW6udTcc2eYq4uOGtzZd87ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1crjslOktA%253D%253D&md5=b6f45da6d098961227e00eb0a25845cf</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-01402-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-01402-2%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Bastida%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DNewbould%26aufirst%3DR.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DSharp%26aufirst%3DD.%26aulast%3DKabba%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DM.%2BC.%26aulast%3DSpino%26aufirst%3DM.%26aulast%3DConnelly%26aufirst%3DJ.%26aulast%3DTricta%26aufirst%3DF.%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26aulast%3DDexter%26aufirst%3DD.%2BT.%26atitle%3DBrain%2520iron%2520chelation%2520by%2520deferiprone%2520in%2520a%2520phase%25202%2520randomised%2520double-blinded%2520placebo%2520controlled%2520clinical%2520trial%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D1398%26epage%3D1406%26doi%3D10.1038%2Fs41598-017-01402-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crichton, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">The efficacy of iron chelators for removing iron from specific brain regions and the pituitary-ironing out the brain</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">138</span>â <span class="NLM_lpage">150</span>, <span class="refDoi">Â DOI: 10.3390/ph12030138</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3390%2Fph12030138" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotFGht7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=138-150&issue=3&author=R.+R.+Crichtonauthor=R.+J.+Wardauthor=R.+C.+Hider&title=The+efficacy+of+iron+chelators+for+removing+iron+from+specific+brain+regions+and+the+pituitary-ironing+out+the+brain&doi=10.3390%2Fph12030138"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The efficacy of iron chelators for removing iron from specific brain regions and the pituitary-ironing out the brain</span></div><div class="casAuthors">Crichton, Robert R.; Ward, Roberta J.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">138</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Iron chelation therapy, either s.c. or orally administered, has been used successfully in various clin. conditions.  The removal of excess iron from various tissues, e.g., the liver spleen, heart, and the pituitary, in beta thalassemia patients, has become an essential therapy to prolong life.  More recently, the use of deferiprone to chelate iron from various brain regions in Parkinson's Disease and Friederich's Ataxia has yielded encouraging results, although the side effects, in <2% of Parkinson's Disease(PD) patients, have limited its long-term use.  A new class of hydroxpyridinones has recently been synthesized, which showed no adverse effects in preliminary trials.  A vital question remaining is whether inflammation may influence chelation efficacy, with a recent study suggesting that high levels of inflammation may diminish the ability of the chelator to bind the excess iron.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpybJThsYfyzrVg90H21EOLACvtfcHk0lga2HpKyeGNHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotFGht7c%253D&md5=bd0b7413a7f2afb3fdfe51394321baef</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.3390%2Fph12030138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph12030138%26sid%3Dliteratum%253Aachs%26aulast%3DCrichton%26aufirst%3DR.%2BR.%26aulast%3DWard%26aufirst%3DR.%2BJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520efficacy%2520of%2520iron%2520chelators%2520for%2520removing%2520iron%2520from%2520specific%2520brain%2520regions%2520and%2520the%2520pituitary-ironing%2520out%2520the%2520brain%26jtitle%3DPharmaceuticals%26date%3D2019%26volume%3D12%26issue%3D3%26spage%3D138%26epage%3D150%26doi%3D10.3390%2Fph12030138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of fluorine-substituted 3-hydroxypyridin-4-ones</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">40</span>),  <span class="NLM_fpage">5230</span>â <span class="NLM_lpage">5233</span>, <span class="refDoi">Â DOI: 10.1016/j.tetlet.2010.07.134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tetlet.2010.07.134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaiu73E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=5230-5233&issue=40&author=Y.+M.+Maauthor=R.+C.+Hider&title=Design+and+synthesis+of+fluorine-substituted+3-hydroxypyridin-4-ones&doi=10.1016%2Fj.tetlet.2010.07.134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of fluorine-substituted 3-hydroxypyridin-4-ones</span></div><div class="casAuthors">Ma, Yong Min; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">5230-5233</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The presence of fluorine in an org. mol. can dramatically alter its chem. and biol. properties due to its unique characteristics.  Several 2- and 5-fluorine-substituted 3-hydroxypyridin-4-ones, e.g I [R1 = R2 = H, R3 = OH, R4 = F; R1 = OH, R2 = Me, R3 = F, R4 = H] have been synthesized with the intention of improving the pharmaceutical profile of deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHnaMqmoIPPrVg90H21EOLACvtfcHk0lga2HpKyeGNHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaiu73E&md5=cb60e452df8c5bd73663393e419a14b0</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2010.07.134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2010.07.134%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520fluorine-substituted%25203-hydroxypyridin-4-ones%26jtitle%3DTetrahedron%2520Lett.%26date%3D2010%26volume%3D51%26issue%3D40%26spage%3D5230%26epage%3D5233%26doi%3D10.1016%2Fj.tetlet.2010.07.134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaeta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina-Holgado, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakih, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1<i>H</i>)-ones: iron chelators with the potential for treating Alzheimerâs disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1285</span>â <span class="NLM_lpage">1297</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2010.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmc.2010.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21236688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlKks7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1285-1297&issue=3&author=A.+Gaetaauthor=F.+Molina-Holgadoauthor=X.+L.+Kongauthor=S.+Salvageauthor=S.+Fakihauthor=P.+T.+Francisauthor=R.+J.+Williamsauthor=R.+C.+Hider&title=Synthesis%2C+physical-chemical+characterisation+and+biological+evaluation+of+novel+2-amido-3-hydroxypyridin-4%281H%29-ones%3A+iron+chelators+with+the+potential+for+treating+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2010.12.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physical-chemical characterization and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease</span></div><div class="casAuthors">Gaeta, Alessandra; Molina-Holgado, Francisco; Kong, Xiao L.; Salvage, Sarah; Fakih, Sarah; Francis, Paul T.; Williams, Robert J.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1285-1297</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A novel class of 2-amido-3-hydroxypyridin-4-one iron chelators is described.  These compds. have been designed to behave as suitable mol. probes which will improve our knowledge of the role of iron in neurodegenerative conditions.  Neurodegenerative disorders, such as Alzheimer's disease (AD) and Parkinson disease (PD), can be considered as diverse pathol. conditions sharing crit. metabolic processes such as protein aggregation and oxidative stress.  Interestingly, both these metabolic alterations seem to be assocd. with the involvement of metal ions, including iron.  Iron chelation is therefore a potential therapeutic approach.  The physico-chem. (pKa, pFe3+ and log P) and biol. properties (inhibition of iron-contg. enzymes) of these chelators have been investigated in order to obtain a suitable profile for the treatment of neurodegenerative conditions.  Studies with neuronal cell cultures confirm that the new iron chelators are neuroprotective against Î²-amyloid-induced toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRwAhEYhCUJbVg90H21EOLACvtfcHk0liCBX-dVDsInQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlKks7o%253D&md5=af9ab71746b35530f0fc01072428d05b</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DMolina-Holgado%26aufirst%3DF.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DSalvage%26aufirst%3DS.%26aulast%3DFakih%26aufirst%3DS.%26aulast%3DFrancis%26aufirst%3DP.%2BT.%26aulast%3DWilliams%26aufirst%3DR.%2BJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520physical-chemical%2520characterisation%2520and%2520biological%2520evaluation%2520of%2520novel%25202-amido-3-hydroxypyridin-4%25281H%2529-ones%253A%2520iron%2520chelators%2520with%2520the%2520potential%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26issue%3D3%26spage%3D1285%26epage%3D1297%26doi%3D10.1016%2Fj.bmc.2010.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Workman, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsatsanis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mousadoust, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peers, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tetard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duce, J. A.</span></span> <span> </span><span class="NLM_article-title">Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinsonâs with novel 1-hydroxypyridin-2-one metal chelators</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">867</span>â <span class="NLM_lpage">876</span>, <span class="refDoi">Â DOI: 10.1039/C4MT00326H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC4MT00326H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25781076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkt1Onu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=867-876&issue=5&author=D.+G.+Workmanauthor=A.+Tsatsanisauthor=F.+W.+Lewisauthor=J.+P.+Boyleauthor=M.+Mousadoustauthor=N.+T.+Hettiarachchiauthor=M.+Hunterauthor=C.+S.+Peersauthor=D.+Tetardauthor=J.+A.+Duce&title=Protection+from+neurodegeneration+in+the+6-hydroxydopamine+%286-OHDA%29+model+of+Parkinson%E2%80%99s+with+novel+1-hydroxypyridin-2-one+metal+chelators&doi=10.1039%2FC4MT00326H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators</span></div><div class="casAuthors">Workman, David G.; Tsatsanis, Andrew; Lewis, Frank W.; Boyle, John P.; Mousadoust, Maryam; Hettiarachchi, Nishani T.; Hunter, Michael; Peers, Chris S.; Tetard, David; Duce, James A.</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">867-876</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Brain iron accumulation has been assocd. with inciting the generation of oxidative stress in a host of chronic neurol. diseases, including Parkinson's disease.  Using the catecholaminergic neurotoxin 6-hydroxydopamine to lesion cellular dopaminergic pathways as a model of Parkinson's disease in culture, a selection of 1-hydroxypyridin-2-one (1,2-HOPO) metal chelators were synthesized and their neuroprotective properties were compared to the 3-hydroxypyridin-4-one; deferiprone (3,4-HOPO; DFP).  Protection against 6-OHDA and iron insult by the novel compds. 6 and 9 was comparable to DFP.  Iron assocd. changes by 6-OHDA imply that the neuroprotective capacity of these compds. are due to chelation of the neuronal labile iron pool and the requirement of the iron binding moiety of compd. 6 for efficacy supported this hypothesis.  In conclusion, two novel 1,2-HOPO's and DFP have comparable neuroprotection against Parkinsonian-assocd. neurotoxins and supports the continued development of hydroxypyridinone compds. as a non-toxic therapeutic agent in the treatment of neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqonDB_JRKPjLVg90H21EOLACvtfcHk0liCBX-dVDsInQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Onu78%253D&md5=757d5a5f8aec3199931886c689f90723</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1039%2FC4MT00326H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4MT00326H%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DD.%2BG.%26aulast%3DTsatsanis%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DF.%2BW.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DMousadoust%26aufirst%3DM.%26aulast%3DHettiarachchi%26aufirst%3DN.%2BT.%26aulast%3DHunter%26aufirst%3DM.%26aulast%3DPeers%26aufirst%3DC.%2BS.%26aulast%3DTetard%26aufirst%3DD.%26aulast%3DDuce%26aufirst%3DJ.%2BA.%26atitle%3DProtection%2520from%2520neurodegeneration%2520in%2520the%25206-hydroxydopamine%2520%25286-OHDA%2529%2520model%2520of%2520Parkinson%25E2%2580%2599s%2520with%2520novel%25201-hydroxypyridin-2-one%2520metal%2520chelators%26jtitle%3DMetallomics%26date%3D2015%26volume%3D7%26issue%3D5%26spage%3D867%26epage%3D876%26doi%3D10.1039%2FC4MT00326H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruck, T. P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murayama, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamoto, T.</span></span> <span> </span><span class="NLM_article-title">A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated Ï of Alzheimerâs disease</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>961</i></span>,  <span class="NLM_fpage">139</span>â <span class="NLM_lpage">146</span>, <span class="refDoi">Â DOI: 10.1016/S0006-8993(02)03893-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-8993%2802%2903893-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12535786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVGitg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=961&publication_year=2003&pages=139-146&author=R.+W.+Shinauthor=T.+P.+A.+Kruckauthor=H.+Murayamaauthor=T.+Kitamoto&title=A+novel+trivalent+cation+chelator+Feralex+dissociates+binding+of+aluminum+and+iron+associated+with+hyperphosphorylated+%CF%84+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2FS0006-8993%2802%2903893-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated Ï of Alzheimer's disease</span></div><div class="casAuthors">Shin, Ryong-Woon; Kruck, Theo P. A.; Murayama, Harunobu; Kitamoto, Tetsuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">961</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-146</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Aluminum (Al(III)) and iron (Fe(III)) are reported to accumulate in neurofibrillary tangles of the Alzheimer's disease (AD) brain.  In these lesions Al (III) and Fe (III) bind with hyperphosphorylated Ï (PHFÏ), the major constituent of the lesions, and induce its aggregation.  It is thought that inhibition and dissocn. of such Al (III)/Fe (III) binding assocd. with PHFÏ could slow or halt the Ï-related neurofibrillary degeneration in patients with AD.  A study, using a previously developed in vitro system in which Al (III) and Fe (III) interact with PHFÏ on AD brain sections and on immunoblot membranes showed that the potent Al (III)/Fe (III) chelator desferrioxamine elicited Al (III) chelation when subjected to autoclave heating.  Here, the ability of a recently developed chem. chelator Feralex-G to remove PHFÏ-bound Al (III)/Fe (III), using reaction conditions at 37, was examd. and compared with that of desferrioxamine.  Chelation of Fe(III) was achieved by both compds. with no discernible difference in their chelating ability.  In contrast, in the present system, the two chelators gave a different Al (III) chelation response.  When incubated at 37, desferrioxamine failed to attain notable Al (III) chelation, while Feralex-G displayed efficient Al (III) chelation.  Thus, when considering competitive Al (III) removal from brain PHFÏ, Feralex-G is a stronger chelator for Al(III) than desferrioxamine.  The efficient Al (III) chelation attainable by Feralex-G adds wt. to its potential clin. usefulness as a medicine in the aluminum/iron chelation therapy for patients with AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfnz9rqCNJOrVg90H21EOLACvtfcHk0liCBX-dVDsInQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVGitg%253D%253D&md5=c0abd148b3a9788775968eaac468f098</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2802%2903893-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252802%252903893-3%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DR.%2BW.%26aulast%3DKruck%26aufirst%3DT.%2BP.%2BA.%26aulast%3DMurayama%26aufirst%3DH.%26aulast%3DKitamoto%26aufirst%3DT.%26atitle%3DA%2520novel%2520trivalent%2520cation%2520chelator%2520Feralex%2520dissociates%2520binding%2520of%2520aluminum%2520and%2520iron%2520associated%2520with%2520hyperphosphorylated%2520%25CF%2584%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%2520Res.%26date%3D2003%26volume%3D961%26spage%3D139%26epage%3D146%26doi%3D10.1016%2FS0006-8993%2802%2903893-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schugar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohmerle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockman, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Combating Alzheimerâs disease with multifunctional molecules designed for metal passivation</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1716</span>â <span class="NLM_lpage">1718</span>, <span class="refDoi">Â DOI: 10.1002/anie.200603866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fanie.200603866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFWisbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=1716-1718&issue=10&author=H.+Schugarauthor=D.+E.+Greenauthor=M.+L.+Bowenauthor=L.+E.+Scottauthor=T.+Storrauthor=K.+Bohmerleauthor=F.+Thomasauthor=D.+D.+Allenauthor=P.+R.+Lockmanauthor=M.+Merkelauthor=K.+H.+Thompsonauthor=C.+Orvig&title=Combating+Alzheimer%E2%80%99s+disease+with+multifunctional+molecules+designed+for+metal+passivation&doi=10.1002%2Fanie.200603866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Combating Alzheimer's disease with multifunctional molecules designed for metal passivation</span></div><div class="casAuthors">Schugar, Harvey; Green, David E.; Bowen, Meryn L.; Scott, Lauren E.; Storr, Tim; Bohmerle, Karin; Thomas, Fancy; Allen, David D.; Lockman, Paul R.; Merkel, Michael; Thompson, Katherine H.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1716-1718</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A trifunctional approach: 3-hydroxy-4-pyridinones that contain phenol groups for antioxidant functionality are further elaborated with pendant glucosyl moieties for improved blood-brain barrier targeting (R = Ph, 4-hydroxyphenyl).  Glycosidase removal of the carbohydrate substituents gives ligands that are ready to passivate excess metal ions, esp. copper and zinc, in the brain.  These mols. are potential prodrugs for treatment of neurodegenerative diseases, including Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFC1-rUojBSLVg90H21EOLACvtfcHk0lifRp9roxPZOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFWisbs%253D&md5=75c067beafdf6c17db1ae4ed64889772</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1002%2Fanie.200603866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200603866%26sid%3Dliteratum%253Aachs%26aulast%3DSchugar%26aufirst%3DH.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DBohmerle%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DThompson%26aufirst%3DK.%2BH.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DCombating%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520multifunctional%2520molecules%2520designed%2520for%2520metal%2520passivation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26issue%3D10%26spage%3D1716%26epage%3D1718%26doi%3D10.1002%2Fanie.200603866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Altering pyridinone <i>N</i>-substituents to optimize activity as potential prodrugs for Alzheimerâs disease</span>. <i>Dalton Trans.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">6364</span>â <span class="NLM_lpage">6367</span>, <span class="refDoi">Â DOI: 10.1039/b815404j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fb815404j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19002321" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2008&pages=6364-6367&author=L.+E.+Scottauthor=B.+D.+Pageauthor=B.+O.+Patrickauthor=C.+Orvig&title=Altering+pyridinone+N-substituents+to+optimize+activity+as+potential+prodrugs+for+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fb815404j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1039%2Fb815404j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb815404j%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DAltering%2520pyridinone%2520N-substituents%2520to%2520optimize%2520activity%2520as%2520potential%2520prodrugs%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDalton%2520Trans.%26date%3D2008%26volume%3D45%26spage%3D6364%26epage%3D6367%26doi%3D10.1039%2Fb815404j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">RodrÃ­guez-RodrÃ­guez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merkel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowen, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storr, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockman, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-Aryl-substituted 3-(Î²-D-glucopyranosyloxy)-2-methyl-4(1<i>H</i>)-pyridinones as agents for Alzheimerâs therapy</span>. <i>Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">642</span>â <span class="NLM_lpage">648</span>, <span class="refDoi">Â DOI: 10.1039/C0SC00544D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC0SC00544D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjtFGltb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=642-648&issue=4&author=L.+E.+Scottauthor=M.+Telpoukhovskaiaauthor=C.+Rodr%C3%ADguez-Rodr%C3%ADguezauthor=M.+Merkelauthor=M.+L.+Bowenauthor=B.+D.+G.+Pageauthor=D.+E.+Greenauthor=T.+Storrauthor=F.+Thomasauthor=D.+D.+Allenauthor=P.+R.+Lockmanauthor=B.+O.+Patrickauthor=M.+J.+Adamauthor=C.+Orvig&title=N-Aryl-substituted+3-%28%CE%B2-D-glucopyranosyloxy%29-2-methyl-4%281H%29-pyridinones+as+agents+for+Alzheimer%E2%80%99s+therapy&doi=10.1039%2FC0SC00544D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">N-Aryl-substituted 3-(Î²-D-glucopyranosyloxy)-2-methyl-4(1H)-pyridinones as agents for Alzheimer's therapy</span></div><div class="casAuthors">Scott, Lauren E.; Telpoukhovskaia, Maria; Rodriguez-Rodriguez, Cristina; Merkel, Michael; Bowen, Meryn L.; Page, Brent D. G.; Green, David E.; Storr, Tim; Thomas, Fancy; Allen, David D.; Lockman, Paul R.; Patrick, Brian O.; Adam, Michael J.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">642-648</span>CODEN:
                <span class="NLM_cas:coden">CSHCCN</span>;
        ISSN:<span class="NLM_cas:issn">2041-6520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Mols. designed to sequester, redistribute and/or remove metal ions are attractive therapeutic agents in neurodegenerative diseases such as Alzheimer's disease.  The multifactorial nature of the condition and the generally poor target specificity assocd. with metal ion-binding therapy has led to the development of multifunctional 3-hydroxy-4-(1H)-pyridinone pro-ligands.  The excellent qualities of the basic 3-hydroxy-4-pyridinone framework as a low toxicity metal chelator and an antioxidant, as well as its antibacterial and analgesic properties among other functions, inspired us to functionalize it with a framework derived from thioflavin-T, the well-known traditional dye used as a marker to detect amyloid deposits in tissue sections.  Thus 2-methyl-3-hydroxy-1-(4-dimethylaminophenyl)-4(1H)-pyridinone (HL1), 2-methyl-3-hydroxy-1-(4-methylaminophenyl)-4(1H)-pyridinone (HL2), 1-(4-aminophenyl)-3-hydroxy-2-methyl-4(1H)-pyridinone (HL3), 1-(6-benzothiazolyl)-3-hydroxy-2-methyl-4(1H)-pyridinone (HL4), 1-(2-benzothiazolyl)-3-hydroxy-2-methyl-4(1H)-pyridinone (HL5) and 2-methyl-3-hydroxy-1-[4-(4-bromophenyl)-2-thiazolyl]-4(1H)-pyridinone (HL6) were obtained.  Glycosylation, as well as incorporation of structures mimicking those of known amyloid imaging agents, may target drug action to the site of interest, the metal-overloaded amyloid plaques in the Alzheimer's brain.  The pro-ligands were assessed for their antioxidant activity, cytotoxicity and ability to interfere with metal ion-induced amyloid peptide aggregation to screen promising lead compds.  Finally, in a brain uptake study with a radiolabeled glucoconjugate pyridinone, 3-(Î²-D-glucopyranosyloxy)-1-[4-(4-[125I]iodophenyl)-2-thiazolyl]-2-methyl-4(1H)-pyridinone ([125I]-GL7) was shown to cross the blood-brain barrier using an in situ rat brain perfusion technique.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjckkaMqjd_LVg90H21EOLACvtfcHk0lifRp9roxPZOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjtFGltb4%253D&md5=81d4f0e8fd01b8ca8aa1247c16c1a230</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1039%2FC0SC00544D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC0SC00544D%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%26aulast%3DRodr%25C3%25ADguez-Rodr%25C3%25ADguez%26aufirst%3DC.%26aulast%3DMerkel%26aufirst%3DM.%26aulast%3DBowen%26aufirst%3DM.%2BL.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DGreen%26aufirst%3DD.%2BE.%26aulast%3DStorr%26aufirst%3DT.%26aulast%3DThomas%26aufirst%3DF.%26aulast%3DAllen%26aufirst%3DD.%2BD.%26aulast%3DLockman%26aufirst%3DP.%2BR.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DAdam%26aufirst%3DM.%2BJ.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DN-Aryl-substituted%25203-%2528%25CE%25B2-D-glucopyranosyloxy%2529-2-methyl-4%25281H%2529-pyridinones%2520as%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520therapy%26jtitle%3DChem.%2520Sci.%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D642%26epage%3D648%26doi%3D10.1039%2FC0SC00544D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preston, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span> <span> </span><span class="NLM_article-title">Glucosylated deferiprone and its brain uptake: implications for developing glucosylated hydroxypyridinone analogues intended to cross the blood-brain barrier</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5886</span>â <span class="NLM_lpage">5889</span>, <span class="refDoi">Â DOI: 10.1021/jm100380k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100380k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFemsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5886-5889&issue=15&author=S.+Royauthor=J.+E.+Prestonauthor=R.+C.+Hiderauthor=Y.+M.+Ma&title=Glucosylated+deferiprone+and+its+brain+uptake%3A+implications+for+developing+glucosylated+hydroxypyridinone+analogues+intended+to+cross+the+blood-brain+barrier&doi=10.1021%2Fjm100380k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Glucosylated Deferiprone and Its Brain Uptake: Implications for Developing Glucosylated Hydroxypyridinone Analogues Intended to Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Roy, Sourav; Preston, Jane E.; Hider, Robert C.; Ma, Yong Min</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5886-5889</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report presents that Deferiprone, the only clin. used 3-hydroxypyridin-4-one (HPO), is able to penetrate the blood-brain barrier (BBB) in guinea pigs, whereas its glucosylated analog is unable to do so.  This finding is contrary to published information suggesting that the glucosylation of HPOs is a viable means of enhancing the brain uptake of this group of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUW7x7AHjPU7Vg90H21EOLACvtfcHk0lh-i-5VHOKcXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFemsLg%253D&md5=588a4a077d3ecb7b28b1ff4e670eaa76</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1021%2Fjm100380k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100380k%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DS.%26aulast%3DPreston%26aufirst%3DJ.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DMa%26aufirst%3DY.%2BM.%26atitle%3DGlucosylated%2520deferiprone%2520and%2520its%2520brain%2520uptake%253A%2520implications%2520for%2520developing%2520glucosylated%2520hydroxypyridinone%2520analogues%2520intended%2520to%2520cross%2520the%2520blood-brain%2520barrier%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D15%26spage%3D5886%26epage%3D5889%26doi%3D10.1021%2Fjm100380k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimerâs disease</span>. <i>Mol. BioSyst.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">792</span>â <span class="NLM_lpage">805</span>, <span class="refDoi">Â DOI: 10.1039/c3mb25600f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc3mb25600f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23435553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsVKrsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=792-805&issue=4&author=M.+A.+Telpoukhovskaiaauthor=B.+O.+Patrickauthor=C.+Rodriguez-Rodriguezauthor=C.+Orvig&title=Exploring+the+multifunctionality+of+thioflavin-+and+deferiprone-based+molecules+as+acetylcholinesterase+inhibitors+for+potential+application+in+Alzheimer%E2%80%99s+disease&doi=10.1039%2Fc3mb25600f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Patrick, Brian O.; Rodriguez-Rodriguez, Cristina; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Molecular BioSystems</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">792-805</span>CODEN:
                <span class="NLM_cas:coden">MBOIBW</span>;
        ISSN:<span class="NLM_cas:issn">1742-2051</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a devastating neurodegenerative disease that affects millions of people worldwide.  With no prevention or cure available, this progressive disease has a significant impact on society - dementia patients and their caretakers, healthcare systems, and the economy.  Previously, we have reported initial developments of multifunctional drug candidates for AD based on two scaffolds - thioflavin-T and deferiprone.  Individually, these mols. have shown several favorable functionalities, including dissocn. of toxic amyloid-Î² aggregates, antioxidant and/or metal chelating ability that can pacify reactive oxygen species, plaque targeting, and blood-brain barrier penetration.  In this work, the two scaffolds are augmented with a new functionality - acetylcholinesterase inhibition.  This functionality is incorporated by derivatization with a carbamate group, which is the active group in some AD drugs currently in the market.  We present the rationale for designing three novel compds., their synthesis and characterization, including X-ray crystallog. data, and encouraging results from in vitro and computational acetylcholinesterase inhibition studies.  Also, we evaluate the compds. as potential drug candidates by Lipinski's rules and cytotoxicity studies in a neuronal cell line.  Overall, we demonstrate the feasibility of improving on two well established scaffolds, as well as show in vitro efficacy plus initial mode of action and biol. compatibility data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbZH1FdJg6LVg90H21EOLACvtfcHk0lh-i-5VHOKcXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsVKrsL0%253D&md5=51b2998a266314ba4186cc52bffedb14</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1039%2Fc3mb25600f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3mb25600f%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DExploring%2520the%2520multifunctionality%2520of%2520thioflavin-%2520and%2520deferiprone-based%2520molecules%2520as%2520acetylcholinesterase%2520inhibitors%2520for%2520potential%2520application%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520BioSyst.%26date%3D2013%26volume%3D9%26issue%3D4%26spage%3D792%26epage%3D805%26doi%3D10.1039%2Fc3mb25600f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">In silico to <i>in vitro</i> screening of hydroxypyridinones as acetylcholinesterase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1624</span>â <span class="NLM_lpage">1628</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2016.01.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2016.01.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26869193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XisValsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1624-1628&issue=6&author=M.+A.+Telpoukhovskaiaauthor=B.+O.+Patrickauthor=C.+Rodriguez-Rodriguezauthor=C.+Orvig&title=In+silico+to+in+vitro+screening+of+hydroxypyridinones+as+acetylcholinesterase+inhibitors&doi=10.1016%2Fj.bmcl.2016.01.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">In silico to in vitro screening of hydroxypyridinones as acetylcholinesterase inhibitors</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Patrick, Brian O.; Rodriguez-Rodriguez, Cristina; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1624-1628</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors have previously shown the improved acetylcholinesterase inhibitory activity of a model hydroxypyridinone compd. transforming the hydroxyl group on the main ring into an N,N-dimethylcarbamate group; in the course of that study the authors developed a computational model to screen compds. for enzymic activity.  Herein the authors report development of second generation libraries.  Candidates that adhere to drug-like criteria from a virtual library of compds. were tested using computational docking studies.  Synthesis and characterization of chosen test compds. and their acetylcholinesterase inhibitory activity are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2VSMQ8l0arVg90H21EOLACvtfcHk0lh-i-5VHOKcXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisValsrs%253D&md5=40bb05a0dd6ab64d40e3b816b53dc555</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.01.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.01.080%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DIn%2520silico%2520to%2520in%2520vitro%2520screening%2520of%2520hydroxypyridinones%2520as%2520acetylcholinesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D1624%26epage%3D1628%26doi%3D10.1016%2Fj.bmcl.2016.01.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bebbington, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monck, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benwell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harvey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcolm, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, R. H.</span></span> <span> </span><span class="NLM_article-title">3,5-Disubstituted-4-hydroxyphenyls linked to 3-hydroxy-2-methyl-4(1<i>H</i>)-pyridinone: potent inhibitors of lipid peroxidation and cell toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">2779</span>â <span class="NLM_lpage">2782</span>, <span class="refDoi">Â DOI: 10.1021/jm990945v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990945v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1Wnsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2779-2782&issue=15&author=D.+Bebbingtonauthor=N.+J.+Monckauthor=S.+Gaurauthor=A.+M.+Palmerauthor=K.+Benwellauthor=V.+Harveyauthor=C.+S.+Malcolmauthor=R.+H.+Porter&title=3%2C5-Disubstituted-4-hydroxyphenyls+linked+to+3-hydroxy-2-methyl-4%281H%29-pyridinone%3A+potent+inhibitors+of+lipid+peroxidation+and+cell+toxicity&doi=10.1021%2Fjm990945v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">3,5-Disubstituted-4-hydroxyphenyls Linked to 3-Hydroxy-2-methyl-4(1H)-pyridinone: Potent Inhibitors of Lipid Peroxidation and Cell Toxicity</span></div><div class="casAuthors">Bebbington, David; Monck, Nathaniel J. T.; Gaur, Suneel; Palmer, Alan M.; Benwell, Karen; Harvey, Victoria; Malcolm, Craig S.; Porter, Richard H. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2779-2782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The title compds., 1-[2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethyl]-3-hydroxy-2-methyl-4(1H)-pyridinone, 1-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]propyl]-3-hydroxy-2-methyl-4(1H)-pyridinone, 1-[4-[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]butyl]-3-hydroxy-2-methyl-4(1H)-pyridinone, 1-[2-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]ethyl]-3-hydroxy-2-methyl-4(1H)-pyridinone and derivs. and salts thereof were prepd. and evaluated as lipid peroxidn. inhibitors and neuroprotective, cytoprotective agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru8sIAI4TJuLVg90H21EOLACvtfcHk0lj0J4kV93FFFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1Wnsbs%253D&md5=7ba047350e850fde02a4b63653728b63</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Fjm990945v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990945v%26sid%3Dliteratum%253Aachs%26aulast%3DBebbington%26aufirst%3DD.%26aulast%3DMonck%26aufirst%3DN.%2BJ.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DA.%2BM.%26aulast%3DBenwell%26aufirst%3DK.%26aulast%3DHarvey%26aufirst%3DV.%26aulast%3DMalcolm%26aufirst%3DC.%2BS.%26aulast%3DPorter%26aufirst%3DR.%2BH.%26atitle%3D3%252C5-Disubstituted-4-hydroxyphenyls%2520linked%2520to%25203-hydroxy-2-methyl-4%25281H%2529-pyridinone%253A%2520potent%2520inhibitors%2520of%2520lipid%2520peroxidation%2520and%2520cell%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D15%26spage%3D2779%26epage%3D2782%26doi%3D10.1021%2Fjm990945v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span> <span> </span><span class="NLM_article-title">Novel 1-phenyl-3-hydroxy-4-pyridinone derivatives as multifunctional agents for the therapy of Alzheimerâs disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">69</span>â <span class="NLM_lpage">81</span>, <span class="refDoi">Â DOI: 10.1021/acschemneuro.5b00224</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00224" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurnJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=69-81&issue=1&author=R.+Shengauthor=L.+Tangauthor=L.+Jiangauthor=L.+Hongauthor=Y.+Shiauthor=N.+Zhouauthor=Y.+Hu&title=Novel+1-phenyl-3-hydroxy-4-pyridinone+derivatives+as+multifunctional+agents+for+the+therapy+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.5b00224"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease</span></div><div class="casAuthors">Sheng, Rong; Tang, Li; Jiang, Liu; Hong, Lingjuan; Shi, Ying; Zhou, Naiming; Hu, Yongzhou</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-81</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 1-phenyl-3-hydroxy-4-pyridinone derivs. were designed and synthesized as multifunctional agents for Alzheimer's disease (AD) therapy through incorporation of 3-hydroxy-4-pyridinone moiety from deferiprone into the scaffold of H3 receptor antagonists.  Most of these new compds. displayed designed quadruple functions, H3 receptor antagonism, AÎ² aggregation inhibition, metal ion chelation, and radical scavenging.  Esp., the most promising compd. I displayed nanomolar IC50 values in H3 receptor antagonism with high selectivity, efficient capability to interrupt the formation of AÎ²1-42 fibrils, good copper and iron chelating properties, and more potent 2,2'-azino-bis(3-ethyl-benzothiazoline-6-sulfonic acid) radical cation (ABTSâ¢+) scavenging activity than Trolox.  Further biol. evaluation revealed that it did not show obvious cytotoxicity and hERG potassium channel inhibition at micromolar concn.  In addn., compd. I demonstrated suitable pharmacokinetic properties and acceptable blood-brain barrier permeability in vivo.  All these results indicate that compd. I is a potential multifunctional candidate for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIWDXJyxn1bVg90H21EOLACvtfcHk0lj0J4kV93FFFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1OhurnJ&md5=66c8440d6a02d18c7cbbd948f5b97540</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00224%26sid%3Dliteratum%253Aachs%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26atitle%3DNovel%25201-phenyl-3-hydroxy-4-pyridinone%2520derivatives%2520as%2520multifunctional%2520agents%2520for%2520the%2520therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26issue%3D1%26spage%3D69%26epage%3D81%26doi%3D10.1021%2Facschemneuro.5b00224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arduino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs</span>. <i>Front. Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">6763</span>â <span class="NLM_lpage">6774</span>, <span class="refDoi">Â DOI: 10.2741/3187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2741%2F3187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18508693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOitbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=6763-6774&author=D.+Arduinoauthor=D.+Silvaauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=C.+R.+Oliveiraauthor=M.+A.+Santos&title=New+hydroxypyridinone+iron-chelators+as+potential+anti-neurodegenerative+drugs&doi=10.2741%2F3187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs</span></div><div class="casAuthors">Arduino, Daniela; Silva, Daniel; Cardoso, Sandra M.; Chaves, Silvia; Oliveira, Catarina R.; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6763-6774</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">The neuroprotective action of a set of new hydroxypyridinone-based (3,4-HP) compds. (A, B and C), which are iron chelators extra-functionalized with a propargylamino group for potential MAO-B inhibition, was evaluated after cell treatment with MPP+ (an in vivo inducer of parkinsonism) and Abeta1-40 and/or Abeta1-42 peptides.  Our results show that all these compds. improved cell viability in cells treated with MPP+ and Abeta1-40 peptide or Abeta1-42 peptide.  In order to evaluate the cellular mechanisms underlying the activity of these compds., we studied their protective role in caspase activation All compds. tested were able to prevent MPP+ and Brefeldin A induced caspase-2 activation.  They also sowed quite effective in the inhibition of caspase-4 and caspase-3 activity, an effector caspase in the apoptotic process.  Finally, detection of apoptotic-like cell death after cell exposure to MPP+ was also performed by TUNEL assay.  Our results demonstrated that all tested compds. prevented DNA fragmentation by decreasing TUNEL pos. cells.  A, B and C were more effective than DFP (a 3,4-HP iron-chelating agent in clin. use) in MPP+ induced cell death.  Therefore, these results evidenced a neuroprotective and antiapoptotic role for the compds. studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYVwyCd5V27bVg90H21EOLACvtfcHk0lj0J4kV93FFFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOitbo%253D&md5=a84b7def01a9234f15ac198039881610</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.2741%2F3187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3187%26sid%3Dliteratum%253Aachs%26aulast%3DArduino%26aufirst%3DD.%26aulast%3DSilva%26aufirst%3DD.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DNew%2520hydroxypyridinone%2520iron-chelators%2520as%2520potential%2520anti-neurodegenerative%2520drugs%26jtitle%3DFront.%2520Biosci.%26date%3D2008%26volume%3D13%26spage%3D6763%26epage%3D6774%26doi%3D10.2741%2F3187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintanova, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Multifunctional iron-chelators with protective roles against neurodegenerative diseases</span>. <i>Dalton. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6058</span>â <span class="NLM_lpage">6073</span>, <span class="refDoi">Â DOI: 10.1039/c3dt50406a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fc3dt50406a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23487286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlt1agu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=6058-6073&issue=17&author=A.+Nunesauthor=S.+M.+Marquesauthor=C.+Quintanovaauthor=D.+F.+Silvaauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Multifunctional+iron-chelators+with+protective+roles+against+neurodegenerative+diseases&doi=10.1039%2Fc3dt50406a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional iron-chelators with protective roles against neurodegenerative diseases</span></div><div class="casAuthors">Nunes, Andreia; Marques, Sergio M.; Quintanova, Catarina; Silva, Diana F.; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Dalton Transactions</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6058-6073</span>CODEN:
                <span class="NLM_cas:coden">DTARAF</span>;
        ISSN:<span class="NLM_cas:issn">1477-9226</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The multifactorial nature of Alzheimer's disease (AD), and the absence of a disease modifying drug, makes the development of new multifunctional drugs an attractive therapeutic strategy.  Taking into account the hallmarks of AD patient brains, such as low levels of acetylcholine, misfolding of proteins and assocd. beta-amyloid (AÎ²) aggregation, oxidative stress and metal dyshomeostasis, the authors have developed a series of compds. that merge three different approaches: metal attenuation, anti-AÎ² aggregation and anti-acetylcholinesterase activity.  Therefore, 3-hydroxy-4-pyridinone (3,4-HP) and benzothiazole mol. moieties were selected as starting frameworks due to their well known affinity for iron and AÎ² peptides, resp.  The linkers between these two main functional groups were selected on the basis of virtual screening, so that the final mol. could further inhibit the acetylcholinesterase, responsible for the cholinergic losses.  The authors describe herein the design and synthesis of the new hybrid compds., followed by the assessment of soln. properties, namely iron chelation and anti-oxidant capacity.  The compds. were bioassayed for their capacity to inhibit AChE, as well as self- and Zn mediated-AÎ²1-42 aggregation.  Finally, the authors assessed their effects on the viability of neuronal cells stressed with AÎ²42.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyXIOGOGFYObVg90H21EOLACvtfcHk0lg8bbIHwvUuWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlt1agu7c%253D&md5=67cb5814ab29cbe487b22f0fdb443bef</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1039%2Fc3dt50406a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3dt50406a%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DMarques%26aufirst%3DS.%2BM.%26aulast%3DQuintanova%26aufirst%3DC.%26aulast%3DSilva%26aufirst%3DD.%2BF.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DMultifunctional%2520iron-chelators%2520with%2520protective%2520roles%2520against%2520neurodegenerative%2520diseases%26jtitle%3DDalton.%2520Trans.%26date%3D2013%26volume%3D42%26issue%3D17%26spage%3D6058%26epage%3D6073%26doi%3D10.1039%2Fc3dt50406a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawthray, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali-Torres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">249</span>â <span class="NLM_lpage">262</span>, <span class="refDoi">Â DOI: 10.1039/C3MT00135K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC3MT00135K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23999879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslyktbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=249-262&issue=2&author=M.+A.+Telpoukhovskaiaauthor=C.+Rodriguez-Rodriguezauthor=J.+F.+Cawthrayauthor=L.+E.+Scottauthor=B.+D.+Pageauthor=J.+Ali-Torresauthor=M.+Sodupeauthor=G.+A.+Baileyauthor=B.+O.+Patrickauthor=C.+Orvig&title=3-Hydroxy-4-pyridinone+derivatives+as+metal+ion+and+amyloid+binding+agents&doi=10.1039%2FC3MT00135K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Rodriguez-Rodriguez, Cristina; Cawthray, Jacqueline F.; Scott, Lauren E.; Page, Brent D. G.; Ali-Torres, Jorge; Sodupe, Mariona; Bailey, Gwendolyn A.; Patrick, Brian O.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">249-262</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Metal ions have been implicated in several neurodegenerative diseases, including Alzheimer's disease, as their dyshomeostasis may lead to prodn. of reactive oxygen species as well as increased toxicity of amyloid protein aggregates.  In this work, we present design and synthesis of three novel multifunctional hydroxypyridinone ligands, HL11, HL12, and HL13, bearing benzothiazole and benzoxazole functionalities.  We study the ability of these compds. to bind metal ions Cu(II), Zn(II), and Fe(III), as well as their antioxidant activity and cytotoxicity.  Addnl., we det. the pro-ligands' (compds. prior to chelation) propensity to target amyloid protein.  Through these studies we det. the effect of combining amyloid- and metal-binding functionalities within the HPO scaffold on different aspects of AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodP3C4WeqQ5bVg90H21EOLACvtfcHk0lg8bbIHwvUuWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslyktbo%253D&md5=9d17919474a429077d5c86e1a1c7fdd1</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1039%2FC3MT00135K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3MT00135K%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DCawthray%26aufirst%3DJ.%2BF.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DAli-Torres%26aufirst%3DJ.%26aulast%3DSodupe%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DG.%2BA.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3D3-Hydroxy-4-pyridinone%2520derivatives%2520as%2520metal%2520ion%2520and%2520amyloid%2520binding%2520agents%26jtitle%3DMetallomics%26date%3D2014%26volume%3D6%26issue%3D2%26spage%3D249%26epage%3D262%26doi%3D10.1039%2FC3MT00135K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Telpoukhovskaia, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cawthray, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, B. D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">3654</span>â <span class="NLM_lpage">3657</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.06.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2015.06.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26141772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtLjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3654-3657&issue=17&author=M.+A.+Telpoukhovskaiaauthor=J.+F.+Cawthrayauthor=C.+Rodriguez-Rodriguezauthor=L.+E.+Scottauthor=B.+D.+G.+Pageauthor=B.+O.+Patrickauthor=C.+Orvig&title=3-Hydroxy-4-pyridinone+derivatives+designed+for+fluorescence+studies+to+determine+interaction+with+amyloid+protein+as+well+as+cell+permeability&doi=10.1016%2Fj.bmcl.2015.06.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxy-4-pyridinone derivatives designed for fluorescence studies to determine interaction with amyloid protein as well as cell permeability</span></div><div class="casAuthors">Telpoukhovskaia, Maria A.; Cawthray, Jacqueline F.; Rodriguez-Rodriguez, Cristina; Scott, Lauren E.; Page, Brent D. G.; Patrick, Brian O.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3654-3657</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Finding a cure for Alzheimer's disease is an urgent goal.  Multifunctional metal binders are used to elucidate its pathol. features and investigated as potential therapeutics.  The use of physicochem. and TD-DFT calcns. constituted successful strategy in the design of 1-(4-(benzo[d]oxazol-2-yl)phenyl)-3-hydroxy-2-methylpyridin-4(1H)-one (HL21) and 1-(4-(benzo[d]thiazol-2-yl)phenyl)-3-hydroxy-2-methylpyridin-4(1H)-one (HL22).  We report the synthesis and full characterization of these compds., including X-ray crystallog.  Using fluorescent signal as the readout, it was detd. that HL22 interacts with amyloid-beta protein fibrils, and permeates into bEnd.3 cells used as a mimic of the blood-brain barrier.  This provides the first example of direct investigation of our hydroxypyridinone compds. within a biol. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_4prGh1Ku0rVg90H21EOLACvtfcHk0lg8bbIHwvUuWA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOhtLjE&md5=fc8c03c3ebfe59044d0afa33cf8e7b31</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.059%26sid%3Dliteratum%253Aachs%26aulast%3DTelpoukhovskaia%26aufirst%3DM.%2BA.%26aulast%3DCawthray%26aufirst%3DJ.%2BF.%26aulast%3DRodriguez-Rodriguez%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DL.%2BE.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DPatrick%26aufirst%3DB.%2BO.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3D3-Hydroxy-4-pyridinone%2520derivatives%2520designed%2520for%2520fluorescence%2520studies%2520to%2520determine%2520interaction%2520with%2520amyloid%2520protein%2520as%2520well%2520as%2520cell%2520permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3654%26epage%3D3657%26doi%3D10.1016%2Fj.bmcl.2015.06.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span> <span> </span><span class="NLM_article-title">Identification of 2-subsituted benzothiazole derivatives as triple-functional agents with potential for AD therapy</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">17318</span>â <span class="NLM_lpage">17327</span>, <span class="refDoi">Â DOI: 10.1039/C5RA25788C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC5RA25788C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSjsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=17318-17327&author=L.+Jiangauthor=M.+Zhangauthor=L.+Tangauthor=Q.+Wengauthor=Y.+Shenauthor=Y.+Huauthor=R.+Sheng&title=Identification+of+2-subsituted+benzothiazole+derivatives+as+triple-functional+agents+with+potential+for+AD+therapy&doi=10.1039%2FC5RA25788C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of 2-substituted benzothiazole derivatives as triple-functional agents with potential for AD therapy</span></div><div class="casAuthors">Jiang, Liu; Zhang, Minkui; Tang, Li; Weng, Qinjie; Shen, Yanhong; Hu, Yongzhou; Sheng, Rong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">17318-17327</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel series of 2-substituted benzothiazole derivs. as MTDLs were designed and synthesized for AD therapy using pharmacophore-combine strategy.  The benzothiazole moiety from ThT and the HPO moiety from deferiprone were connected with vinyl linker to achieve target compds.  The biol. evaluation results revealed that the majority of them demonstrated desirable triple functions by interfering with AÎ² aggregation, oxidative stress and metal dyshomeostasis simultaneously.  The two most attractive compds. 9c and 9i exhibited excellent self-AÎ²1-42 aggregation inhibitory activity, efficient ABTSÌ + scavenging activity, potent biometals chelating properties, as well as disaggregation activity against previous formed AÎ²1-42 fibrils.  In addn. to these advantages, both of them displayed no cytotoxicity to human glioma U251 cells up to 50 Î¼M, thereby meriting further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRLYEs5ITYbVg90H21EOLACvtfcHk0lhVW3uNTF31QA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSjsLo%253D&md5=c24a4a35ba6d9596b6ab99e12a337776</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1039%2FC5RA25788C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA25788C%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DTang%26aufirst%3DL.%26aulast%3DWeng%26aufirst%3DQ.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DR.%26atitle%3DIdentification%2520of%25202-subsituted%2520benzothiazole%2520derivatives%2520as%2520triple-functional%2520agents%2520with%2520potential%2520for%2520AD%2520therapy%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D17318%26epage%3D17327%26doi%3D10.1039%2FC5RA25788C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, AÎ²<sub>1â42</sub> aggregation inhibitors and metal-chelating agents for Alzheimerâs disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">174</span>â <span class="NLM_lpage">186</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2016.12.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2016.12.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28061347" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislGnsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=174-186&author=P.+Xuauthor=M.+Zhangauthor=R.+Shengauthor=Y.+Ma&title=Synthesis+and+biological+evaluation+of+deferiprone-resveratrol+hybrids+as+antioxidants%2C+A%CE%B21%E2%80%9342+aggregation+inhibitors+and+metal-chelating+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2016.12.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, AÎ²1-42 aggregation inhibitors and metal-chelating agents for Alzheimer's disease</span></div><div class="casAuthors">Xu, Ping; Zhang, Minkui; Sheng, Rong; Ma, Yongmin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">174-186</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of deferiprone-resveratrol hybrids have been designed and synthesized as multitarget-directed ligands (MTDLs) through merging the chelating moiety 3-hydroxypyridin-4-one into the structure of resveratrol, a natural antioxidant agent and Î²-amyloid peptide (AÎ²) aggregation inhibitor.  The in vitro biol. evaluation revealed that most of these newly synthesized compds. exhibited good inhibitory activity against self-induced AÎ²1-42 aggregation, excellent antioxidant activity and potent metal chelating capability.  Compds. I (R1 = H, R2 = OH) and I (R1 = Me, R2 = OEt) were identified as the most promising MTDLs with triple functions, possessing micromolar IC50 values for AÎ²1-42 aggregation inhibition, greater 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTSâ¢+) scavenging activity than Trolox and similar pFe(III) values to that of deferiprone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKEBgf65MBK7Vg90H21EOLACvtfcHk0lhVW3uNTF31QA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislGnsA%253D%253D&md5=4a5137ac2246f2afe1d65cbcd2e15ee4</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.12.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.12.045%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DSheng%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520deferiprone-resveratrol%2520hybrids%2520as%2520antioxidants%252C%2520A%25CE%25B21%25E2%2580%259342%2520aggregation%2520inhibitors%2520and%2520metal-chelating%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D174%26epage%3D186%26doi%3D10.1016%2Fj.ejmech.2016.12.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeshwari</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candeias, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimerâs disease: a two-in-one drug</span>. <i>Metallomics</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1460</span>â <span class="NLM_lpage">1475</span>, <span class="refDoi">Â DOI: 10.1039/C8MT00143J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC8MT00143J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30183790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtb3K" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1460-1475&issue=10&author=K.+Chandauthor=+Rajeshwariauthor=E.+Candeiasauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Tacrine-deferiprone+hybrids+as+multi-target-directed+metal+chelators+against+Alzheimer%E2%80%99s+disease%3A+a+two-in-one+drug&doi=10.1039%2FC8MT00143J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-deferiprone hybrids as multi-target-directed metal chelators against Alzheimer's disease: a two-in-one drug</span></div><div class="casAuthors">Chand, Karam; Rajeshwari; Candeias, Emanuel; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Metallomics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1460-1475</span>CODEN:
                <span class="NLM_cas:coden">METAJS</span>;
        ISSN:<span class="NLM_cas:issn">1756-591X</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a severe age-dependent neurodegenerative disorder affecting several million people worldwide.  So far, there is no adequate medication to prevent or slow down the progression of the disease, only medication with palliative effects allowing temporary symptomatic reliefs.  As part of our continuing efforts into the development of innovative drugs following a polypharmacol. strategy, we decided to use a former anti-AD palliative drug (tacrine) and to reposition it by hybridization with a metal chelating drug (deferiprone, DFP).  This combination endows the hybrids with good capacity to inhibit acetylcholinesterase (low micromolar range) and self-/Cu-induced AÎ² aggregation (up to ca. 90%) as well as a good radical scavenging ability (micromolar range) and metal (M) chelating capacity, with pM (pM = -log[M], CL/CM = 10, CM = 10-6 M at pH = 7.4, M = Fe, Cu, Zn) values close to those of DFP.  The most promising compds. have 2-hydroxypropyl linkers, and a selection of compds. have demonstrated neuroprotective roles in neuroblastoma cells treated with AÎ²1-42 and ascorbate/iron stressors.  Consequently, these hybrids can be considered as attractive multipotent therapeutic mols. that will eventually play key roles against AD progression, namely in the control of cholinergic dysfunction, amyloid peptide aggregation, oxidative stress, and metal modulation, besides presenting a good pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruaIf7wxvIdLVg90H21EOLACvtfcHk0lhVW3uNTF31QA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtb3K&md5=08c03fbff71a09f319633f8f710bee8a</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1039%2FC8MT00143J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MT00143J%26sid%3Dliteratum%253Aachs%26aulast%3DChand%26aufirst%3DK.%26aulast%3DRajeshwari%26aulast%3DCandeias%26aufirst%3DE.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DTacrine-deferiprone%2520hybrids%2520as%2520multi-target-directed%2520metal%2520chelators%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520two-in-one%2520drug%26jtitle%3DMetallomics%26date%3D2018%26volume%3D10%26issue%3D10%26spage%3D1460%26epage%3D1475%26doi%3D10.1039%2FC8MT00143J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiremathad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolayan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajeshwari</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keri, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteves, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimerâs disease therapy</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>179</i></span>,  <span class="NLM_fpage">82</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1016/j.jinorgbio.2017.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.jinorgbio.2017.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29182921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOhsr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2018&pages=82-96&author=A.+Hiremathadauthor=K.+Chandauthor=L.+Tolayanauthor=+Rajeshwariauthor=R.+S.+Keriauthor=A.+R.+Estevesauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Hydroxypyridinone-benzofuran+hybrids+with+potential+protective+roles+for+Alzheimer%E2%80%99s+disease+therapy&doi=10.1016%2Fj.jinorgbio.2017.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinone-benzofuran hybrids with potential protective roles for Alzheimer's disease therapy</span></div><div class="casAuthors">Hiremathad, Asha; Chand, Karam; Tolayan, Lori; Rajeshwari; Keri, Rangappa S.; Esteves, A. Raquel; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">179</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">82-96</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A series of (3-hydroxy-4-pyridinone)-benzofuran hybrids have been developed and studied as potential multitargeting drugs for Alzheimer's disease (AD).  Their design envisaged mainly to mimic the donepezil drug, a marketed inhibitor of acetylcholinesterase (AChE), and to endow the conjugate mols. with extra-properties such as metal chelation, radical scavenging and inhibition of amyloid peptide (AÎ²) aggregation.  Thus, a set of eleven new hybrid compds. was developed and evaluated for chem. and biol. properties, in soln. and in neuronal cell environment.  The results are discussed in terms of the type of substituents on both main moieties and the linker size.  The closest similarity with donepezil, in terms of AChE inhibitory activity, was obtained for the O-benzyl-hydroxypyridinone hybrids contg. a 2-methylene linker, although still less active than the drug.  However, the free-hydroxypyridinone hybrids present higher activity for the AÎ² aggregation inhibition, metal chelating capacity and radical scavenging activity.  Overall, some compds. demonstrated capacity to exert a multiple action by hitting three- (7d (N-(2-(3-(benzyloxy)-2-methyl-4-oxopyridin-1(4H)-yl)ethyl)-7-methoxybenzofuran-2-carboxamide)) or four- (8d (N-(2-(3-hydroxy-2-methyl-4-oxopyridin-1(4H)-yl)ethyl)-7-methoxybenzofuran-2-carboxamide), 8f (N-(4-(3-hydroxy-2-methyl-4-oxopyridin-1(4H)-yl)butyl)-7-methoxybenzofuran-2-carboxamide)) pathophysiol. targets of AD.  Furthermore, the compds. showed neuroprotective effects in neuronal cells subjected to model stressors of AD, but not significant dependence on the substituent groups.  Importantly, the compds. evidenced drug-likeness properties, including good membrane permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5zXYMWURzTLVg90H21EOLACvtfcHk0lj4I3afwa6RpQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOhsr7F&md5=9c2b08a2f02c2e03f1bb525c5e990873</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2017.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2017.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DHiremathad%26aufirst%3DA.%26aulast%3DChand%26aufirst%3DK.%26aulast%3DTolayan%26aufirst%3DL.%26aulast%3DRajeshwari%26aulast%3DKeri%26aufirst%3DR.%2BS.%26aulast%3DEsteves%26aufirst%3DA.%2BR.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DHydroxypyridinone-benzofuran%2520hybrids%2520with%2520potential%2520protective%2520roles%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520therapy%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2018%26volume%3D179%26spage%3D82%26epage%3D96%26doi%3D10.1016%2Fj.jinorgbio.2017.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Dual-target anti-Alzheimerâs disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1489</span>â <span class="NLM_lpage">1497</span>, <span class="refDoi">Â DOI: 10.1080/14756366.2019.1634703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1080%2F14756366.2019.1634703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=31416364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyktr7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=1489-1497&issue=1&author=Z.+S.+Miauthor=B.+Ganauthor=S.+H.+Yuauthor=J.+N.+Guoauthor=C.+J.+Zhangauthor=X.+Y.+Jiangauthor=T.+Zhouauthor=J.+Suauthor=R.+R.+Baiauthor=Y.+Y.+Xie&title=Dual-target+anti-Alzheimer%E2%80%99s+disease+agents+with+both+iron+ion+chelating+and+monoamine+oxidase-B+inhibitory+activity&doi=10.1080%2F14756366.2019.1634703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity</span></div><div class="casAuthors">Mi, Zhisheng; Gan, Bing; Yu, Sihang; Guo, Jianan; Zhang, Changjun; Jiang, Xiaoying; Zhou, Tao; Su, Jing; Bai, Renren; Xie, Yuanyuan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1489-1497</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">MAO-B leads to an increase in the levels of hydrogen peroxide and oxidative free radicals, which contribute to the etiol. of the AD.  Thus, both iron ion chelators and MAO-B inhibitors can be used to treat AD.  Taking the coumarin derivs. and hydroxypyridinones as the lead compds., a series of dual-target hybrids were designed and synthesized by Click Chem.  The compds. were biol. evaluated for their iron ion chelating and MAO-B inhibitory activity.  Most of the compds. displayed excellent iron ion chelating activity and moderate to good anti-MAO-B activity.  Compds. and exhibited the most potent MAO-B inhibitory activity, with IC50 values of 0.68 and 0.86 Î¼M, resp.  In summary, these dual-target compds. have the potential anti-AD activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc25Ihf5dF_7Vg90H21EOLACvtfcHk0lj4I3afwa6RpQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyktr7N&md5=d743ef80bf4011b0f8abaa7e69c1fb88</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1634703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1634703%26sid%3Dliteratum%253Aachs%26aulast%3DMi%26aufirst%3DZ.%2BS.%26aulast%3DGan%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%2BH.%26aulast%3DGuo%26aufirst%3DJ.%2BN.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DJiang%26aufirst%3DX.%2BY.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DR.%2BR.%26aulast%3DXie%26aufirst%3DY.%2BY.%26atitle%3DDual-target%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%2520with%2520both%2520iron%2520ion%2520chelating%2520and%2520monoamine%2520oxidase-B%2520inhibitory%2520activity%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1489%26epage%3D1497%26doi%3D10.1080%2F14756366.2019.1634703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimerâs disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">367</span>â <span class="NLM_lpage">382</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2019.07.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2019.07.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=31325784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVWltLvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2019&pages=367-382&author=C.+J.+Zhangauthor=K.+Yangauthor=S.+H.+Yuauthor=J.+Suauthor=S.+L.+Yuanauthor=J.+X.+Hanauthor=Y.+Chenauthor=J.+P.+Guauthor=T.+Zhouauthor=R.+R.+Baiauthor=Y.+Y.+Xie&title=Design%2C+synthesis+and+biological+evaluation+of+hydroxypyridinone-coumarin+hybrids+as+multimodal+monoamine+oxidase+B+inhibitors+and+iron+chelates+against+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.07.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease</span></div><div class="casAuthors">Zhang, Changjun; Yang, Ke; Yu, Sihang; Su, Jing; Yuan, Shengli; Han, Jiaxin; Chen, Yan; Gu, Jinping; Zhou, Tao; Bai, Renren; Xie, Yuanyuan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">367-382</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Hydroxypyridinone-substituted coumarins I (R1 = H, Me; R2 = H, Me, Et; R3 = H, R4O; R4 = Me, PhCH2, HCâ¡CCH2, 3-ClC6H4CH2, 3-FC6H4CH2, 4-FC6H4CH2, 3,5-F2C6H3CH2) were prepd. as dual iron chelators and monoamine oxidase B (MAO-B) inhibitors for potential use in the treatment of Alzheimer's disease.  I (R1 = H; R2 = Me; R3 = 3-FC6H4CH2O) (II) exhibited the most potent activity against MAO-B, with an IC50 value of 14.7 nM.  II protected U251 cells against oxidative stress and ameliorated murine scopolamine-induced cognitive dysfunction in a model for Alzheimer's disease.  Mol. docking calcns. for the binding of II to MAO-B were performed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgVzvO3fV-0LVg90H21EOLACvtfcHk0lj4I3afwa6RpQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVWltLvK&md5=422cebd0966ebb383e0e5384e276ea21</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.07.031%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DYu%26aufirst%3DS.%2BH.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DYuan%26aufirst%3DS.%2BL.%26aulast%3DHan%26aufirst%3DJ.%2BX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%2BP.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DR.%2BR.%26aulast%3DXie%26aufirst%3DY.%2BY.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520hydroxypyridinone-coumarin%2520hybrids%2520as%2520multimodal%2520monoamine%2520oxidase%2520B%2520inhibitors%2520and%2520iron%2520chelates%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D180%26spage%3D367%26epage%3D382%26doi%3D10.1016%2Fj.ejmech.2019.07.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mi, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span> <span> </span><span class="NLM_article-title">Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">115550</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2020.115550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmc.2020.115550" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=32503694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVWis7bL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2020&pages=115550&issue=12&author=X.+Y.+Jiangauthor=J.+N.+Guoauthor=Y.+J.+Lvauthor=C.+S.+Yaoauthor=C.+J.+Zhangauthor=Z.+S.+Miauthor=Y.+Shiauthor=J.+P.+Guauthor=T.+Zhouauthor=R.+R.+Baiauthor=Y.+Y.+Xie&title=Rational+design%2C+synthesis+and+biological+evaluation+of+novel+multitargeting+anti-AD+iron+chelators+with+potent+MAO-B+inhibitory+and+antioxidant+activity&doi=10.1016%2Fj.bmc.2020.115550"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design, synthesis and biological evaluation of novel multitargeting anti-AD iron chelators with potent MAO-B inhibitory and antioxidant activity</span></div><div class="casAuthors">Jiang, Xiaoying; Guo, Jianan; Lv, Yangjing; Yao, Chuansheng; Zhang, Changjun; Mi, Zhisheng; Shi, Yuan; Gu, Jinping; Zhou, Tao; Bai, Renren; Xie, Yuanyuan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">115550</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of (3-hydroxypyridin-4-one)-coumarin hybrids I (R1 = H, OMe; R2, R3 = H, Me), II (R1, R3 = H, OH, Me, OMe, OBn; R2 = Me, OEt, 4-F-OBn, etc.) were developed and investigated as potential multitargeting candidates for the treatment of Alzheimer's disease (AD) through the incorporation of iron-chelating and monoamine oxidase B (MAO-B) inhibition.  This combination endowed the hybrids with good capacity to inhibit MAO-B as well as excellent iron-chelating effects.  The pFe3+ values of the compds. were ranging from 16.91 to 20.16, comparable to more potent than the ref. drug deferiprone (DFP).  Among them, compd. I (R1 = OMe; R2 = Me; R3 = H) exhibited the most promising activity against MAO-B, with an IC50 value of 87.9 nM.  Moreover, compd. I (R1 = OMe; R2 = Me; R3 = H) exerted favorable antioxidant activity, significantly reversed the amyloid-Î²1-42 (AÎ²1-42) induced PC12 cell damage.  More importantly, I (R1 = OMe; R2 = Me; R3 = H) remarkably ameliorated the cognitive dysfunction in a scopolamine-induced mice AD model.  In brief, a series of hybrids with potential anti-AD effect were successfully obtained, indicating that the design of iron chelators with MAO-B inhibitory and antioxidant activities is an attractive strategy against AD progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph5JdPfXWFVbVg90H21EOLACvtfcHk0lhMU6ln-vjdKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVWis7bL&md5=5dc324488081d4ce09411efbff7f725b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2020.115550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2020.115550%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%2BY.%26aulast%3DGuo%26aufirst%3DJ.%2BN.%26aulast%3DLv%26aufirst%3DY.%2BJ.%26aulast%3DYao%26aufirst%3DC.%2BS.%26aulast%3DZhang%26aufirst%3DC.%2BJ.%26aulast%3DMi%26aufirst%3DZ.%2BS.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DJ.%2BP.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBai%26aufirst%3DR.%2BR.%26aulast%3DXie%26aufirst%3DY.%2BY.%26atitle%3DRational%2520design%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520multitargeting%2520anti-AD%2520iron%2520chelators%2520with%2520potent%2520MAO-B%2520inhibitory%2520and%2520antioxidant%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2020%26volume%3D28%26issue%3D12%26spage%3D115550%26doi%3D10.1016%2Fj.bmc.2020.115550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bilitewski, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blodgett, J. A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhme-Klair, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallavalle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laschat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Routledge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schobert, R.</span></span> <span> </span><span class="NLM_article-title">Chemical and biological aspects of nutritional immunity-perspectives for new anti-infectives that target iron uptake systems</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">14360</span>â <span class="NLM_lpage">14382</span>, <span class="refDoi">Â DOI: 10.1002/anie.201701586</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fanie.201701586" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrrP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=14360-14382&issue=46&author=U.+Bilitewskiauthor=J.+A.+V.+Blodgettauthor=A.+K.+Duhme-Klairauthor=S.+Dallavalleauthor=S.+Laschatauthor=A.+Routledgeauthor=R.+Schobert&title=Chemical+and+biological+aspects+of+nutritional+immunity-perspectives+for+new+anti-infectives+that+target+iron+uptake+systems&doi=10.1002%2Fanie.201701586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical and Biological Aspects of Nutritional Immunity-Perspectives for New Anti-Infectives that Target Iron Uptake Systems</span></div><div class="casAuthors">Bilitewski, Ursula; Blodgett, Joshua A. V.; Duhme-Klair, Anne-Kathrin; Dallavalle, Sabrina; Laschat, Sabine; Routledge, Anne; Schobert, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">14360-14382</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Upon bacterial infection, one of the defense mechanisms of the host is the withdrawal of essential metal ions, in particular iron, which leads to "nutritional immunity".  However, bacteria have evolved strategies to overcome iron starvation, for example, by stealing iron from the host or other bacteria through specific iron chelators with high binding affinity.  Fortunately, these complex interactions between the host and pathogen that lead to metal homeostasis provide several opportunities for interception and, thus, allow the development of novel antibacterial compds.  This Review focuses on iron, discusses recent highlights, and gives some future perspectives which are relevant in the fight against antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9b1dRctsmobVg90H21EOLACvtfcHk0lhMU6ln-vjdKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1CntrrP&md5=f7541941c314f5793bca2899708c47e8</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1002%2Fanie.201701586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201701586%26sid%3Dliteratum%253Aachs%26aulast%3DBilitewski%26aufirst%3DU.%26aulast%3DBlodgett%26aufirst%3DJ.%2BA.%2BV.%26aulast%3DDuhme-Klair%26aufirst%3DA.%2BK.%26aulast%3DDallavalle%26aufirst%3DS.%26aulast%3DLaschat%26aufirst%3DS.%26aulast%3DRoutledge%26aufirst%3DA.%26aulast%3DSchobert%26aufirst%3DR.%26atitle%3DChemical%2520and%2520biological%2520aspects%2520of%2520nutritional%2520immunity-perspectives%2520for%2520new%2520anti-infectives%2520that%2520target%2520iron%2520uptake%2520systems%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2017%26volume%3D56%26issue%3D46%26spage%3D14360%26epage%3D14382%26doi%3D10.1002%2Fanie.201701586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span> <span> </span><span class="NLM_article-title">Chemistry and biology of siderophores</span>. <i>Nat. Prod. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">637</span>â <span class="NLM_lpage">657</span>, <span class="refDoi">Â DOI: 10.1039/b906679a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2Fb906679a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20376388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXls1Wrsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2010&pages=637-657&issue=5&author=R.+C.+Hiderauthor=X.+L.+Kong&title=Chemistry+and+biology+of+siderophores&doi=10.1039%2Fb906679a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and biology of siderophores</span></div><div class="casAuthors">Hider, Robert C.; Kong, Xiao-Le</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">637-657</span>CODEN:
                <span class="NLM_cas:coden">NPRRDF</span>;
        ISSN:<span class="NLM_cas:issn">0265-0568</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Siderophores are compds. produced by bacteria, fungi and graminaceous plants for scavenging iron from the environment.  They are low-mol.-wt. compds. (500-1500 daltons) possessing a high affinity for iron(iii) (Kf > 1030), the biosynthesis of which is regulated by iron levels and the function of which is to supply iron to the cell.  This article briefly describes the classification and chem. properties of siderophores, before outlining research on siderophore biosynthesis and transport.  Clin. important siderophores and the therapeutic potential of siderophore design are described.  Appendix 1 provides a comprehensive list of siderophore structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqych5anPlbwLVg90H21EOLACvtfcHk0lhMU6ln-vjdKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXls1Wrsb0%253D&md5=e4e2a8e10cc41de3d7f526b33802b4f7</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1039%2Fb906679a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb906679a%26sid%3Dliteratum%253Aachs%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DKong%26aufirst%3DX.%2BL.%26atitle%3DChemistry%2520and%2520biology%2520of%2520siderophores%26jtitle%3DNat.%2520Prod.%2520Rep.%26date%3D2010%26volume%3D27%26issue%3D5%26spage%3D637%26epage%3D657%26doi%3D10.1039%2Fb906679a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fassihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghaie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazeli, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bostaki, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deilami, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadinpour, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2145</span>â <span class="NLM_lpage">2157</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2008.10.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2008.10.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19056147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsl2gs70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=2145-2157&issue=5&author=A.+Fassihiauthor=D.+Abediauthor=L.+Saghaieauthor=R.+Sabetauthor=H.+Fazeliauthor=G.+Bostakiauthor=O.+Deilamiauthor=H.+Sadinpour&title=Synthesis%2C+antimicrobial+evaluation+and+QSAR+study+of+some+3-hydroxypyridine-4-one+and+3-hydroxypyran-4-one+derivatives&doi=10.1016%2Fj.ejmech.2008.10.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives</span></div><div class="casAuthors">Fassihi, Afshin; Abedi, Daryoush; Saghaie, Lotfollah; Sabet, Razieh; Fazeli, Hossein; Bostaki, Ghasem; Deilami, Omid; Sadinpour, Hekmatollah</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2145-2157</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of Mannich bases of 2-alkyl-3-hydroxy-pyridine-4-ones were prepd.  They were screened for their antibacterial and antifungal activities against a variety of microorganisms using micro plate Alamar Blue assay (MABA) method.  Multiple linear regressions (MLR) anal. was performed for the synthesized compds. as well as a series of pyridinone and pyranone derivs. which have been synthesized and evaluated for antimicrobial activity by other researchers previously.  Studied compds. showed a better quant. structure-activity relationship (QSAR) model for the antimicrobial activity against Candida albicans and Staphylococcus aureus in comparison with other tested microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriOVnfcChq27Vg90H21EOLACvtfcHk0lhpBHNnMapHTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsl2gs70%253D&md5=ee162cf8d85fb7a35ea6727ec2abdbe1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2008.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2008.10.022%26sid%3Dliteratum%253Aachs%26aulast%3DFassihi%26aufirst%3DA.%26aulast%3DAbedi%26aufirst%3DD.%26aulast%3DSaghaie%26aufirst%3DL.%26aulast%3DSabet%26aufirst%3DR.%26aulast%3DFazeli%26aufirst%3DH.%26aulast%3DBostaki%26aufirst%3DG.%26aulast%3DDeilami%26aufirst%3DO.%26aulast%3DSadinpour%26aufirst%3DH.%26atitle%3DSynthesis%252C%2520antimicrobial%2520evaluation%2520and%2520QSAR%2520study%2520of%2520some%25203-hydroxypyridine-4-one%2520and%25203-hydroxypyran-4-one%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26issue%3D5%26spage%3D2145%26epage%3D2157%26doi%3D10.1016%2Fj.ejmech.2008.10.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sabet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmateenejad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghaei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gholami, M.</span></span> <span> </span><span class="NLM_article-title">Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">349</span>â <span class="NLM_lpage">361</span>, <span class="refDoi">Â DOI: 10.1007/s10822-012-9561-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs10822-012-9561-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22456859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XltFOqsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=349-361&issue=3&author=R.+Sabetauthor=A.+Fassihiauthor=B.+Hemmateenejadauthor=L.+Saghaeiauthor=R.+Miriauthor=M.+Gholami&title=Computer-aided+design+of+novel+antibacterial+3-hydroxypyridine-4-ones%3A+application+of+QSAR+methods+based+on+the+MOLMAP+approach&doi=10.1007%2Fs10822-012-9561-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach</span></div><div class="casAuthors">Sabet, Razieh; Fassihi, Afshin; Hemmateenejad, Bahram; Saghaei, Lotfollah; Miri, Ramin; Gholami, Maryam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">349-361</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">3-Hydroxypyridine-4-one derivs. have shown good inhibitory activity against bacterial strains.  In this work we report the application of MOLMAP descriptors based on empirical physicochem. properties with genetic algorithm partial least squares (GA-PLS) and counter propagation artificial neural networks (CP-ANN) methods to propose some novel 3-hydroxypyridine-4-one derivs. with improved antibacterial activity against Staphylococcus aureus.  A large collection of 302 novel derivs. of this chem. scaffold was selected for this purpose.  The activity classes of these compds. were detd. using the two quant. structure activity relationships models.  To evaluate the predictability and accuracy of the obtained models, nineteen compds. belonging to all three activity classes were prepd. and the activity of them was detd. against S. aureus.  Comparing the exptl. results and the predicted activity classes revealed the accuracy of the obtained models.  Seventeen of the nineteen synthesized mols. were correctly predicted by GA-PLS model according to the antimicrobial evaluation method.  Mols. 5f and 5h proved to be moderately active and active exptl., but were predicted as inactive and moderately active compds., resp. by this model.  The CP-ANN based prediction was correct for sixteen out of the nineteen synthesized mols. 5a, 5h and 5q were moderately active and active based on the antimicrobial assays, but they were introduced as members of inactive, moderately active and inactive classes of compds., resp. according to CP-ANN model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT3fsStFzNxbVg90H21EOLACvtfcHk0lhpBHNnMapHTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltFOqsrk%253D&md5=9fb8e3cacf14ae4b5e7884f6feecbf7b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1007%2Fs10822-012-9561-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-012-9561-2%26sid%3Dliteratum%253Aachs%26aulast%3DSabet%26aufirst%3DR.%26aulast%3DFassihi%26aufirst%3DA.%26aulast%3DHemmateenejad%26aufirst%3DB.%26aulast%3DSaghaei%26aufirst%3DL.%26aulast%3DMiri%26aufirst%3DR.%26aulast%3DGholami%26aufirst%3DM.%26atitle%3DComputer-aided%2520design%2520of%2520novel%2520antibacterial%25203-hydroxypyridine-4-ones%253A%2520application%2520of%2520QSAR%2520methods%2520based%2520on%2520the%2520MOLMAP%2520approach%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26issue%3D3%26spage%3D349%26epage%3D361%26doi%3D10.1007%2Fs10822-012-9561-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faidallah, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostom, S. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basaif, S. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">926</span>â <span class="NLM_lpage">935</span>, <span class="refDoi">Â DOI: 10.3109/14756366.2012.694880</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3109%2F14756366.2012.694880" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=22803670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSlsb7M" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2013&pages=926-935&issue=5&author=H.+M.+Faidallahauthor=S.+A.+F.+Rostomauthor=K.+A.+Khanauthor=S.+A.+Basaif&title=Synthesis+and+characterization+of+some+hydroxypyridone+derivatives+and+their+evaluation+as+antimicrobial+agents&doi=10.3109%2F14756366.2012.694880"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of some hydroxypyridone derivatives and their evaluation as antimicrobial agents</span></div><div class="casAuthors">Faidallah, Hassan M.; Rostom, Sherif A. F.; Khan, Khalid A.; Basaif, Salem A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">926-935</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The synthesis, in vitro antimicrobial activities of some novel hydroxy pyridines supported with various pharmacophores is described.  Twenty-six out of the tested 58 compds. exhibited variable inhibitory effects on the growth of the tested Gram pos. and Gram neg. bacteria.  The tested compds. revealed better activity against the Gram pos. rather than the Gram neg. strains.  The synthesized hydroxypyridones have shown significant inhibitory effect against Staphylococcus aureus and Bacillus subtilis.  Twelve compds. namely; 5d, 5f, 6a, 6b, 8b, 18b, 18c, 19c, 21d, 22b, 22d and 23d were able to produce appreciable growth inhibitory activity against Candida albicans when compared to Clotrimazole.  Among these, 22d (I) proved to be the most potent antifungal agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkqQtnXXCkrVg90H21EOLACvtfcHk0lhpBHNnMapHTA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSlsb7M&md5=9cdd0c8868c8a2de22a935280de07a68</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3109%2F14756366.2012.694880&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2012.694880%26sid%3Dliteratum%253Aachs%26aulast%3DFaidallah%26aufirst%3DH.%2BM.%26aulast%3DRostom%26aufirst%3DS.%2BA.%2BF.%26aulast%3DKhan%26aufirst%3DK.%2BA.%26aulast%3DBasaif%26aufirst%3DS.%2BA.%26atitle%3DSynthesis%2520and%2520characterization%2520of%2520some%2520hydroxypyridone%2520derivatives%2520and%2520their%2520evaluation%2520as%2520antimicrobial%2520agents%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2013%26volume%3D28%26issue%3D5%26spage%3D926%26epage%3D935%26doi%3D10.3109%2F14756366.2012.694880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> inhibition of bacterial growth by iron chelators</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>314</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">107</span>â <span class="NLM_lpage">111</span>, <span class="refDoi">Â DOI: 10.1111/j.1574-6968.2010.02153.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1574-6968.2010.02153.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21114684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2qt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2011&pages=107-111&issue=2&author=D.+H.+Qiuauthor=Z.+L.+Huangauthor=T.+Zhouauthor=C.+Shenauthor=R.+C.+Hider&title=In+vitro+inhibition+of+bacterial+growth+by+iron+chelators&doi=10.1111%2Fj.1574-6968.2010.02153.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro inhibition of bacterial growth by iron chelators</span></div><div class="casAuthors">Qiu, Di-Hong; Huang, Zhu-Liang; Zhou, Tao; Shen, Chen; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-111</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antimicrobial activity of the iron(III)-selective 3-hydroxypyridin-4-one chelators, CP251(1) and CP252(2), was evaluated in comparison with that of diethylenetriamine-penta acetic acid (3).  CP251 was found to exhibit an inhibitory effect on the growth of both Gram-pos. and Gram-neg. bacteria.  CP251 may find application in the treatment of external infections such as those assocd. with wounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDlfXNRfP00bVg90H21EOLACvtfcHk0lgOOssQwjVYIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2qt7o%253D&md5=b383ed9bb538d56548217683f7482316</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1111%2Fj.1574-6968.2010.02153.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1574-6968.2010.02153.x%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DHuang%26aufirst%3DZ.%2BL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DIn%2520vitro%2520inhibition%2520of%2520bacterial%2520growth%2520by%2520iron%2520chelators%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2011%26volume%3D314%26issue%3D2%26spage%3D107%26epage%3D111%26doi%3D10.1111%2Fj.1574-6968.2010.02153.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, iron(III)-binding affinity and <i>in vitro</i> evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6376</span>â <span class="NLM_lpage">6380</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2011.08.097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2011.08.097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21937227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6376-6380&issue=21&author=B.+Xuauthor=X.+L.+Kongauthor=T.+Zhouauthor=D.+H.+Qiuauthor=Y.+L.+Chenauthor=M.+S.+Liuauthor=R.+H.+Yangauthor=R.+C.+Hider&title=Synthesis%2C+iron%28III%29-binding+affinity+and+in+vitro+evaluation+of+3-hydroxypyridin-4-one+hexadentate+ligands+as+potential+antimicrobial+agents&doi=10.1016%2Fj.bmcl.2011.08.097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, iron(III)-binding affinity and in vitro evaluation of 3-hydroxypyridin-4-one hexadentate ligands as potential antimicrobial agents</span></div><div class="casAuthors">Xu, Bo; Kong, Xiao-Le; Zhou, Tao; Qiu, Di-Hong; Chen, Yu-Lin; Liu, Mu-Song; Yang, Rong-Hua; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6376-6380</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Iron is a crit. element for the survival of bacteria.  Two novel 3-hydroxypyridin-4-one hexadentate ligands with high affinity for iron(III), which disrupt bacterial iron absorption, were designed and synthesized.  Biol. studies demonstrate that these two chelators have significant inhibitory effect against both Gram-pos. and Gram-neg. bacteria, and therefore have potential as antimicrobial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWdpVdFgTLrLVg90H21EOLACvtfcHk0lgOOssQwjVYIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12jtr%252FE&md5=29b17e9c31f88d851f2b5de91a24cfd3</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.097%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DB.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BL.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DYang%26aufirst%3DR.%2BH.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520iron%2528III%2529-binding%2520affinity%2520and%2520in%2520vitro%2520evaluation%2520of%25203-hydroxypyridin-4-one%2520hexadentate%2520ligands%2520as%2520potential%2520antimicrobial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D21%26spage%3D6376%26epage%3D6380%26doi%3D10.1016%2Fj.bmcl.2011.08.097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis, physico-chemical properties, and antimicrobial evaluation of a new series of iron(III) hexadentate chelators</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2351</span>â <span class="NLM_lpage">2359</span>, <span class="refDoi">Â DOI: 10.1007/s00044-012-0229-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00044-012-0229-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsbnK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=2351-2359&issue=5&author=Y.+Y.+Xieauthor=M.+S.+Liuauthor=P.+P.+Huauthor=X.+L.+Kongauthor=D.+H.+Qiuauthor=J.+L.+Xuauthor=R.+C.+Hiderauthor=T.+Zhou&title=Synthesis%2C+physico-chemical+properties%2C+and+antimicrobial+evaluation+of+a+new+series+of+iron%28III%29+hexadentate+chelators&doi=10.1007%2Fs00044-012-0229-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, physico-chemical properties, and antimicrobial evaluation of a new series of iron(III) hexadentate chelators</span></div><div class="casAuthors">Xie, Yuan-Yuan; Liu, Mu-Song; Hu, Pan-Pan; Kong, Xiao-Le; Qiu, Di-Hong; Xu, Ji-Lin; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2351-2359</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">A series of related 3-hydroxypyridin-4-one hexadentate ligands I (R = H, Me, n-hexyl, CH2CH2OH, etc.) have been synthesized.  These chelators were found to possess a high affinity for iron(III), with a pFe value of about 30.  As iron is a crit. element to the survival of bacteria, these chelators were predicted to inhibit the growth of bacteria by disrupting bacterial iron absorption.  Indeed, they were demonstrated to possess appreciable inhibitory activity against both Gram-pos. and Gram-neg. bacteria, and therefore, they have potential as antimicrobial agents.  I (R = Et, CH2CH2OMe) were found to be particularly effective against Gram-neg. species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplFM1R6mDebbVg90H21EOLACvtfcHk0lgOOssQwjVYIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2gsbnK&md5=ed75aac8960cda4f672d0e94b8d90df4</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1007%2Fs00044-012-0229-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-012-0229-1%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DHu%26aufirst%3DP.%2BP.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DXu%26aufirst%3DJ.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DSynthesis%252C%2520physico-chemical%2520properties%252C%2520and%2520antimicrobial%2520evaluation%2520of%2520a%2520new%2520series%2520of%2520iron%2528III%2529%2520hexadentate%2520chelators%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2013%26volume%3D22%26issue%3D5%26spage%3D2351%26epage%3D2359%26doi%3D10.1007%2Fs00044-012-0229-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in-vitro</i> antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">512</span>â <span class="NLM_lpage">520</span>, <span class="refDoi">Â DOI: 10.1111/jphp.12013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fjphp.12013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23488779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtFaqtbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=512-520&issue=4&author=C.+F.+Zhuauthor=D.+H.+Qiuauthor=X.+L.+Kongauthor=R.+C.+Hiderauthor=T.+Zhou&title=Synthesis+and+in-vitro+antimicrobial+evaluation+of+a+high-affinity+iron+chelator+in+combination+with+chloramphenicol&doi=10.1111%2Fjphp.12013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in-vitro antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol</span></div><div class="casAuthors">Zhu, Chun-Feng; Qiu, Di-Hong; Kong, Xiao-Le; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">512-520</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The objectives of this study were first to design and synthesize a hexadentate chelator with high iron(III) affinity and, second, to evaluate its antimicrobial activity in the presence and absence of chloramphenicol.  A hexadentate ligand was synthesized by conjugating a protected bidentate compd. onto a tripodal structure.  The pKa values and iron affinity of the chelator were detd. by spectrophotometric titrn.  Min. inhibitory concns. were detd. by visual inspection of broth turbidity.  The bactericidal rates were calcd. by counting the colony nos. on a light board after incubation with and without an antimicrobial agent.  A hexadentate 3-hydroxypyridin-4-one was found to possess a high affinity for iron(III), with a pFe value of 31.2 (neg. logarithm of concn. of the free iron(III) in soln. (when [Fe3+]Total = 10-6 M; [Ligand]Total = 10-5 M; pH = 7.4).  We found that this chelator had an appreciable inhibitory effect in vitro against the two bacterial strains Providencia stuartii and Staphylococcus aureus, particularly in the presence of chloramphenicol.  A 3-hydroxypyridin-4-one hexadentate ligand has potential as an antimicrobial agent.  Combination therapy with this iron chelator plus chloramphenicol has potential for the treatment of extracellular infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqniQzxR7CBGLVg90H21EOLACvtfcHk0lgOOssQwjVYIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtFaqtbY%253D&md5=3ac460fce2e2df43057006111be615e7</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1111%2Fjphp.12013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjphp.12013%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DQiu%26aufirst%3DD.%2BH.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520in-vitro%2520antimicrobial%2520evaluation%2520of%2520a%2520high-affinity%2520iron%2520chelator%2520in%2520combination%2520with%2520chloramphenicol%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D2013%26volume%3D65%26issue%3D4%26spage%3D512%26epage%3D520%26doi%3D10.1111%2Fjphp.12013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antimicrobial evaluation of hexadentate hydroxypyridinones with high iron(III) affinity</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">659</span>â <span class="NLM_lpage">668</span>, <span class="refDoi">Â DOI: 10.1111/cbdd.12358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fcbdd.12358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24890019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSqurzO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=659-668&issue=6&author=M.+X.+Zhangauthor=C.+F.+Zhuauthor=Y.+J.+Zhouauthor=X.+L.+Kongauthor=R.+C.+Hiderauthor=T.+Zhou&title=Design%2C+synthesis%2C+and+antimicrobial+evaluation+of+hexadentate+hydroxypyridinones+with+high+iron%28III%29+affinity&doi=10.1111%2Fcbdd.12358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Antimicrobial Evaluation of Hexadentate Hydroxypyridinones with High Iron(III) Affinity</span></div><div class="casAuthors">Zhang, Ming-Xia; Zhu, Chun-Feng; Zhou, Ying-Jun; Kong, Xiao-Le; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">659-668</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A range of hexadentate 3-hydroxy-4-pyridinone derivs. (HPOs) with a high affinity for iron(III) has been synthesized.  The log stability consts. of two HPO-iron complexes (logK1) were detd. to be over 34 and pFe values of the two HPOs were detd. to be over 31.  An antimicrobial assay indicated that they are able to markedly inhibit the growth of both Gram-pos. and Gram-neg. bacteria.  Two compds. were found to exhibit the strongest inhibitory activity against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, and Escherichia coli with MIC values of 8, 8, 16, 8 Î¼g/mL, resp.  These results indicate that hexadentate 3-hydroxy-4-pyridinone derivs. have potential application as antimicrobial agents, esp. in the treatment of wound infection.  The synthesis of the target compds. was achieved using N-[4-amino-7-[[(1,1-dimethylethoxy)carbonyl]amino]-4-[3-[[(1,1-dimethylethoxy)carbonyl]amino]propyl]heptyl]carbamic acid 1,1-dimethylethyl ester and butanoyl chloride and N-[(phenylmethoxy)carbonyl]--L-leucine as reactants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYwPO10zEyzbVg90H21EOLACvtfcHk0lggXLAC1BPpQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSqurzO&md5=ccf203cd741fbcdcea06b0b10945d539</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12358%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BX.%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antimicrobial%2520evaluation%2520of%2520hexadentate%2520hydroxypyridinones%2520with%2520high%2520iron%2528III%2529%2520affinity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2014%26volume%3D84%26issue%3D6%26spage%3D659%26epage%3D668%26doi%3D10.1111%2Fcbdd.12358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Novel 3-hydroxypyridin-4-one hexadentate ligand-based polymeric iron chelator: synthesis, characterization and antimicrobial evaluation</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1620</span>â <span class="NLM_lpage">1625</span>, <span class="refDoi">Â DOI: 10.1039/C5MD00264H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC5MD00264H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2hsb%252FK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1620-1625&issue=9&author=Y.+J.+Zhouauthor=X.+L.+Kongauthor=J.+P.+Liauthor=Y.+M.+Maauthor=R.+C.+Hiderauthor=T.+Zhou&title=Novel+3-hydroxypyridin-4-one+hexadentate+ligand-based+polymeric+iron+chelator%3A+synthesis%2C+characterization+and+antimicrobial+evaluation&doi=10.1039%2FC5MD00264H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Novel 3-hydroxypyridin-4-one hexadentate ligand-based polymeric iron chelator: synthesis, characterization and antimicrobial evaluation</span></div><div class="casAuthors">Zhou, Ying-Jun; Kong, Xiao-Le; Li, Jun-Pei; Ma, Yong-Min; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1620-1625</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel 3-hydroxypyridin-4-one (HPO) hexadentate monomeric chelator 14 has been synthesized and incorporated into polymers by copolymn. with 2-hydroxyethyl acrylate (HEA), using azobisisobutyronitrile (AIBN) as an initiator.  The monomeric chelator was found to possess very high affinity for iron(III), with the log stability const. of the iron complex (log K1) = 33.61 and pFe3+ = 30.37.  The iron binding capacity and monomer recovery of the copolymers were detd. using spectrophotometry.  The in vitro antimicrobial activity of monomeric chelator 14 and polymeric chelator 16-4 against both Gram-pos. bacteria (Staphylococcus aureus and Bacillus subtilis) and Gram-neg. bacteria (Escherichia coli, Salmonella spp., and Pseudomonas aeruginosa) was evaluated by inhibition zone and min. inhibitory concn. (MIC) assays, which demonstrated that both monomeric and polymeric chelators possess inhibitory activity.  The polymeric chelators possess potential application for the treatment of wound infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWNLonC1Y8EbVg90H21EOLACvtfcHk0lggXLAC1BPpQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2hsb%252FK&md5=1d91abccb08b0e16fb7c4fdb17a2f0e2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1039%2FC5MD00264H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5MD00264H%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DLi%26aufirst%3DJ.%2BP.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DNovel%25203-hydroxypyridin-4-one%2520hexadentate%2520ligand-based%2520polymeric%2520iron%2520chelator%253A%2520synthesis%252C%2520characterization%2520and%2520antimicrobial%2520evaluation%26jtitle%3DMedChemComm%26date%3D2015%26volume%3D6%26issue%3D9%26spage%3D1620%26epage%3D1625%26doi%3D10.1039%2FC5MD00264H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osamah, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant <i>Staphylococcus aureus</i> and <i>Pseudomonas strains</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">8</span>â <span class="NLM_lpage">21</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2015.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2015.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25747496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslCjs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=8-21&author=Y.+J.+Zhouauthor=M.+S.+Liuauthor=A.+R.+Osamahauthor=X.+L.+Kongauthor=S.+Alsamauthor=S.+Battahauthor=Y.+Y.+Xieauthor=R.+C.+Hiderauthor=T.+Zhou&title=Hexadentate+3-hydroxypyridin-4-ones+with+high+iron%28III%29+affinity%3A+design%2C+synthesis+and+inhibition+on+methicillin+resistant+Staphylococcus+aureus+and+Pseudomonas+strains&doi=10.1016%2Fj.ejmech.2015.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: Design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains</span></div><div class="casAuthors">Zhou, Ying-Jun; Liu, Mu-Song; Osamah, Al Rugaie; Kong, Xiao-Le; Alsam, Selwa; Battah, Sinan; Xie, Yuan-Yuan; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-21</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A range of hexadentate 3-hydroxypyridin-4-ones (I; R, R1 = alkyl, alkoxyalkyl) have been synthesized.  These compds. were found to possess a high affinity for iron(III), with logK1 values of about 34 and pFe values over 30.  Antimicrobial assays indicated that they can inhibit the growth of three clin. isolates of methicillin resistant Staphylococcus aureus (MRSA) and three clin. isolates of Pseudomonas, suggesting that hexadentate 3-hydroxypyridin-4-ones have potential application in the treatment of wound infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquYgjqlnQ3FbVg90H21EOLACvtfcHk0lggXLAC1BPpQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslCjs7Y%253D&md5=fc815116906155261600bd4060e98f10</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.02.050%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DOsamah%26aufirst%3DA.%2BR.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DAlsam%26aufirst%3DS.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DHexadentate%25203-hydroxypyridin-4-ones%2520with%2520high%2520iron%2528III%2529%2520affinity%253A%2520design%252C%2520synthesis%2520and%2520inhibition%2520on%2520methicillin%2520resistant%2520Staphylococcus%2520aureus%2520and%2520Pseudomonas%2520strains%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D8%26epage%3D21%26doi%3D10.1016%2Fj.ejmech.2015.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, M. S.</span></span> <span> </span><span class="NLM_article-title">Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of <i>Mycobacterium avium</i></span>. <i>Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">287</span>â <span class="NLM_lpage">294</span>, <span class="refDoi">Â DOI: 10.1016/j.micinf.2010.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.micinf.2010.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20097303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFynsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=287-294&issue=4&author=S.+S.+Fernandesauthor=A.+Nunesauthor=A.+R.+Gomesauthor=B.+de+Castroauthor=R.+C.+Hiderauthor=M.+Rangelauthor=R.+Appelbergauthor=M.+S.+Gomes&title=Identification+of+a+new+hexadentate+iron+chelator+capable+of+restricting+the+intramacrophagic+growth+of+Mycobacterium+avium&doi=10.1016%2Fj.micinf.2010.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium</span></div><div class="casAuthors">Fernandes, Sofia Sousa; Nunes, Ana; Gomes, Ana Rita; de Castro, Baltazar; Hider, Robert C.; Rangel, Maria; Appelberg, Rui; Gomes, Maria Salome</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-294</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Iron accumulation has been suggested to contribute to an increase of the susceptibility to mycobacterial infections.  In this study we tested the effect of an array of iron chelating ligands of the 3-hydroxy-4-pyridinone family, in the intramacrophagic growth of Mycobacterium avium.  We found that bidentate chelators, namely N-alkyl-3-hydroxy-4-pyridinones and N-aryl-3-hydroxy-4-pyridinones, did not affect the growth of M. avium inside mouse macrophages.  In the case of the hexadentate chelators, those synthesized using an alkylamine (CP262) or a benzene ring (CP252) to link the three bidentate units, did not have an inhibitory effect on intramacrophagic growth of M. avium while those synthesized from a tripodal structure to anchor the bidentate units were capable of inhibiting the intramacrophagic growth of M. avium.  The mol. we designated CP777 had the strongest inhibitory activity.  The growth-reducing activity of CP777 was abrogated when this mol. was satd. with iron.  These results confirm that iron deprivation, by the use of iron chelating compds., restricts M. avium growth and that new iron chelators offer an approach to controlling mycobacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjtnjRP6r327Vg90H21EOLACvtfcHk0lgPRcHU4XuSYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFynsr4%253D&md5=9f24a4512c992a329197e125e145b5e4</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.micinf.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.micinf.2010.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DFernandes%26aufirst%3DS.%2BS.%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DGomes%26aufirst%3DA.%2BR.%26aulast%3Dde%2BCastro%26aufirst%3DB.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRangel%26aufirst%3DM.%26aulast%3DAppelberg%26aufirst%3DR.%26aulast%3DGomes%26aufirst%3DM.%2BS.%26atitle%3DIdentification%2520of%2520a%2520new%2520hexadentate%2520iron%2520chelator%2520capable%2520of%2520restricting%2520the%2520intramacrophagic%2520growth%2520of%2520Mycobacterium%2520avium%26jtitle%3DMicrobes%2520Infect.%26date%3D2010%26volume%3D12%26issue%3D4%26spage%3D287%26epage%3D294%26doi%3D10.1016%2Fj.micinf.2010.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podinovskaia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leite, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gameiro, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaible, U. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span> <span> </span><span class="NLM_article-title">Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties</span>. <i>JBIC, J. Biol. Inorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">861</span>â <span class="NLM_lpage">877</span>, <span class="refDoi">Â DOI: 10.1007/s00775-010-0650-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00775-010-0650-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20364296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1aqtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=861-877&issue=6&author=A.+Nunesauthor=M.+Podinovskaiaauthor=A.+Leiteauthor=P.+Gameiroauthor=T.+Zhouauthor=Y.+Maauthor=X.+Kongauthor=U.+E.+Schaibleauthor=R.+C.+Hiderauthor=M.+Rangel&title=Fluorescent+3-hydroxy-4-pyridinone+hexadentate+iron+chelators%3A+intracellular+distribution+and+the+relevance+to+antimycobacterial+properties&doi=10.1007%2Fs00775-010-0650-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties</span></div><div class="casAuthors">Nunes, Ana; Podinovskaia, Maria; Leite, Andreia; Gameiro, Paula; Zhou, Tao; Ma, Yongmin; Kong, Xiaole; Schaible, Ulrich E.; Hider, Robert C.; Rangel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">JBIC, Journal of Biological Inorganic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">861-877</span>CODEN:
                <span class="NLM_cas:coden">JJBCFA</span>;
        ISSN:<span class="NLM_cas:issn">0949-8257</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: We report the synthesis and characterization of a fluorescent iron chelator (4), shown to be effective in inhibiting the growth of Mycobacterium avium in macrophages, together with the synthesis and characterization of two unsuccessful analogs selected to facilitate identification of the mol. properties responsible for the antimicrobial activity.  Partition of the chelators in liposomes was investigated and the compds. were assessed with respect to uptake by macrophages, responsiveness to iron overload/iron deprivation and intracellular distribution by flow cytometry and confocal microscopy.  The synthesis of the hexadentate chelators is based on a tetrahedral structure to which three bidentate 3-hydroxy-4-pyridinone chelating units are linked via amide bonds.  The structure is synthetically versatile, allowing further addn. of functional groups such as fluorophores.  Here, we analyze the non-functionalized hexadentate unit (3) and the corresponding rhodamine B (4) and fluorescein (5) labeled chelators.  The iron(III) stability const. was detd. for 3 and the values log Î² = 34.4 and pFe3+ = 29.8 indicate an affinity for iron of the same order of magnitude as that of mycobacteria siderophores.  Fluorescence properties in the presence of liposomes show that 4 strongly interacts with the lipid phase, whereas 5 does not.  Such different behavior may explain their distinct intracellular localization as revealed by confocal microscopy.  The flow cytometry and confocal microscopy studies indicate that 4 is readily engulfed by macrophages and targeted to cytosol and vesicles of the endolysosomal continuum, whereas 5 is differentially distributed and only partially colocalizes with 4 after prolonged incubation.  Differential distribution of the compds. is likely to account for their different efficacy against mycobacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpknrfgdG0GjrVg90H21EOLACvtfcHk0lgPRcHU4XuSYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1aqtbk%253D&md5=bab314f755a7aab465d892f97d9b6d18</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1007%2Fs00775-010-0650-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00775-010-0650-1%26sid%3Dliteratum%253Aachs%26aulast%3DNunes%26aufirst%3DA.%26aulast%3DPodinovskaia%26aufirst%3DM.%26aulast%3DLeite%26aufirst%3DA.%26aulast%3DGameiro%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DSchaible%26aufirst%3DU.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DRangel%26aufirst%3DM.%26atitle%3DFluorescent%25203-hydroxy-4-pyridinone%2520hexadentate%2520iron%2520chelators%253A%2520intracellular%2520distribution%2520and%2520the%2520relevance%2520to%2520antimycobacterial%2520properties%26jtitle%3DJBIC%252C%2520J.%2520Biol.%2520Inorg.%2520Chem.%26date%3D2010%26volume%3D15%26issue%3D6%26spage%3D861%26epage%3D877%26doi%3D10.1007%2Fs00775-010-0650-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span> <span> </span><span class="NLM_article-title">Study of the effect of thiourea and <i>N</i>-ethyl groups on antibacterial activity of rhodamine-labeled 3,4-HPO iron chelators against Gram (Â±) bacteria</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1472</span>â <span class="NLM_lpage">1477</span>, <span class="refDoi">Â DOI: 10.1007/s00044-018-2165-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00044-018-2165-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktlGqtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=1472-1477&issue=5&author=T.+Monizauthor=M.+Feioauthor=D.+Silvaauthor=B.+de+Castroauthor=M.+Rangel&title=Study+of+the+effect+of+thiourea+and+N-ethyl+groups+on+antibacterial+activity+of+rhodamine-labeled+3%2C4-HPO+iron+chelators+against+Gram+%28%C2%B1%29+bacteria&doi=10.1007%2Fs00044-018-2165-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Study of the effect of thiourea and N-ethyl groups on antibacterial activity of rhodamine-labeled 3,4-HPO iron chelators against Gram (+/-) bacteria</span></div><div class="casAuthors">Moniz, Tania; Feio, Maria; Silva, Daniel; de Castro, Baltazar; Rangel, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1472-1477</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the sequence of the work in which we identified functional groups of rhodamine labeled 3,4-HPO chelators that are crucial for their activity against Mycobacterium avium infection we now scrutinize if the same groups are also relevant for the chelators antibacterial activity against Gram (+/-) bacteria.  In this new infection scenario, we confirmed that a thiourea linkage and N-Et substituents on the xanthene ring are important and there is an advantage of the assocn. of both groups in the mol. framework.  In particular, we found that three hexadentate chelators (MRH7, MRH8, and MRH10) inhibit bacterial growth of Staphylococcus (S). aureus ATCC 25923 and S. epidermis ATCC 12228 and one hexadentate chelator (MRH7) also inhibits the growth of Escherichia (E.) coli ATCC 25922.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcaFNytKPOVrVg90H21EOLACvtfcHk0lgPRcHU4XuSYw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktlGqtLk%253D&md5=6f52b6f2f90305fb023e6d46f457a643</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1007%2Fs00044-018-2165-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-018-2165-1%26sid%3Dliteratum%253Aachs%26aulast%3DMoniz%26aufirst%3DT.%26aulast%3DFeio%26aufirst%3DM.%26aulast%3DSilva%26aufirst%3DD.%26aulast%3Dde%2BCastro%26aufirst%3DB.%26aulast%3DRangel%26aufirst%3DM.%26atitle%3DStudy%2520of%2520the%2520effect%2520of%2520thiourea%2520and%2520N-ethyl%2520groups%2520on%2520antibacterial%2520activity%2520of%2520rhodamine-labeled%25203%252C4-HPO%2520iron%2520chelators%2520against%2520Gram%2520%2528%25C2%25B1%2529%2520bacteria%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2018%26volume%3D27%26issue%3D5%26spage%3D1472%26epage%3D1477%26doi%3D10.1007%2Fs00044-018-2165-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novais, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rebelo, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, A. M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixe, L.</span></span> <span> </span><span class="NLM_article-title">New fluorescent rosamine chelator showing promising antibacterial activity against Gram-positive bacteria</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">341</span>â <span class="NLM_lpage">349</span>, <span class="refDoi">Â DOI: 10.1016/j.bioorg.2018.05.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bioorg.2018.05.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29807207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVamsrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2018&pages=341-349&author=A.+Novaisauthor=T.+Monizauthor=A.+R.+Rebeloauthor=A.+M.+G.+Silvaauthor=M.+Rangelauthor=L.+Peixe&title=New+fluorescent+rosamine+chelator+showing+promising+antibacterial+activity+against+Gram-positive+bacteria&doi=10.1016%2Fj.bioorg.2018.05.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">New fluorescent rosamine chelator showing promising antibacterial activity against Gram-positive bacteria</span></div><div class="casAuthors">Novais, Angela; Moniz, Tania; Rebelo, Ana Rita; Silva, Ana M. G.; Rangel, Maria; Peixe, Luisa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The restricted no. of antibiotics to treat infections caused by common multidrug resistant bacterial pathogens in the clin. setting demands a continuous search for new mols. with antibacterial properties.  Bacterial iron deprivation represents a promising alternative, being iron chelators an attractive class for drug design in which particular compds. seem to have antibacterial effect.  In this work, we report the synthesis and characterization of a new fluorescent 3-hydroxy-4-pyridinone (3,4-HPO) iron chelator functionalized with a carboxyrosamine fluorophore (MRB20).  The antibacterial activity of MRB20 was assessed against representative strains from clin. relevant Gram-pos. and Gram-neg. bacterial species and further compared with the inhibitory effect of a set of structurally related iron chelators including Deferiprone (1,2-dimethyl-3-hydroxy-4-pyridinone).  Compds. exhibiting a promising minimal inhibitory concn. (MIC<10mg/L) were further tested against a wider range of bacterial genera and species (Staphylococcus spp. Enterococcus spp. Listeria monocytogenes, Bacillus spp.), including multidrug resistant bacteria.  With the exception of the novel compd. (MRB20), all chelators inhibited the strains assayed at very high concns. [min. inhibitory concns. (MIC) ranging from 70mg/L to >180mg/L].  MRB20 revealed a good antibacterial activity (6.7-13.2mg/L) against Gram-pos. strains from different genera and species, including clin. relevant species (Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecium, Enterococcus faecalis), which might be eventually compatible with a therapeutic application or as adjuvant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZEaeFFujaobVg90H21EOLACvtfcHk0lhqRNYROiqjqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVamsrfJ&md5=e9ac7991af1fb4bef523280e64fe9607</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2018.05.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2018.05.013%26sid%3Dliteratum%253Aachs%26aulast%3DNovais%26aufirst%3DA.%26aulast%3DMoniz%26aufirst%3DT.%26aulast%3DRebelo%26aufirst%3DA.%2BR.%26aulast%3DSilva%26aufirst%3DA.%2BM.%2BG.%26aulast%3DRangel%26aufirst%3DM.%26aulast%3DPeixe%26aufirst%3DL.%26atitle%3DNew%2520fluorescent%2520rosamine%2520chelator%2520showing%2520promising%2520antibacterial%2520activity%2520against%2520Gram-positive%2520bacteria%26jtitle%3DBioorg.%2520Chem.%26date%3D2018%26volume%3D79%26spage%3D341%26epage%3D349%26doi%3D10.1016%2Fj.bioorg.2018.05.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dhal, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polomoscanik, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes-Farley, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. J.</span></span> <span> </span><span class="NLM_article-title">Functional polymers as therapeutic agents: concept to market place</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1121</span>â <span class="NLM_lpage">1130</span>, <span class="refDoi">Â DOI: 10.1016/j.addr.2009.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.addr.2009.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19682515" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWht7fJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2009&pages=1121-1130&issue=13&author=P.+K.+Dhalauthor=S.+C.+Polomoscanikauthor=L.+Z.+Avilaauthor=S.+R.+Holmes-Farleyauthor=R.+J.+Miller&title=Functional+polymers+as+therapeutic+agents%3A+concept+to+market+place&doi=10.1016%2Fj.addr.2009.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Functional polymers as therapeutic agents: Concept to market place</span></div><div class="casAuthors">Dhal, Pradeep K.; Polomoscanik, Steven C.; Avila, Louis Z.; Holmes-Farley, S. Randall; Miller, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1121-1130</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Biol. active synthetic polymers have received considerable scientific interest and attention in recent years for their potential as promising novel therapeutic agents to treat human diseases.  Although a significant amt. of research has been carried out involving polymer-linked drugs as targeted and sustained release drug delivery systems and prodrugs, examples on bioactive polymers that exhibit intrinsic therapeutic properties are relatively less.  Several appealing characteristics of synthetic polymers including high mol. wt., mol. architecture, and controlled polydispersity can all be utilized to discover a new generation of therapies.  For example, high mol. wt. bioactive polymers can be restricted to gastrointestinal tract, where they can selectively recognize, bind, and remove target disease causing substances from the body.  The appealing features of GI tract restriction and stability in biol. environment render these polymeric drugs to be devoid of systemic toxicity that are generally assocd. with small mol. systemic drugs.  The present article highlights recent developments in the rational design and synthesis of appropriate functional polymers that have resulted in a no. of promising polymer based therapies and biomaterials, including some marketed products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDQZgGslmborVg90H21EOLACvtfcHk0lhqRNYROiqjqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWht7fJ&md5=67b98d7c4d52f7fb0b112d5fd1871814</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2009.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2009.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DDhal%26aufirst%3DP.%2BK.%26aulast%3DPolomoscanik%26aufirst%3DS.%2BC.%26aulast%3DAvila%26aufirst%3DL.%2BZ.%26aulast%3DHolmes-Farley%26aufirst%3DS.%2BR.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DFunctional%2520polymers%2520as%2520therapeutic%2520agents%253A%2520concept%2520to%2520market%2520place%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2009%26volume%3D61%26issue%3D13%26spage%3D1121%26epage%3D1130%26doi%3D10.1016%2Fj.addr.2009.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderdoes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantjes, A.</span></span> <span> </span><span class="NLM_article-title">Iron(III)-chelating resins. 3. synthesis, iron(III)-chelating properties, and <i>in-vitro</i> antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1<i>H</i>)-pyridinone ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">2822</span>â <span class="NLM_lpage">2827</span>, <span class="refDoi">Â DOI: 10.1021/jm00071a013</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00071a013" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3sXlsFKjsLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=2822-2827&issue=19&author=M.+H.+Fengauthor=L.+Vanderdoesauthor=A.+Bantjes&title=Iron%28III%29-chelating+resins.+3.+synthesis%2C+iron%28III%29-chelating+properties%2C+and+in-vitro+antibacterial+activity+of+compounds+containing+3-hydroxy-2-methyl-4%281H%29-pyridinone+ligands&doi=10.1021%2Fjm00071a013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Iron(III)-chelating resins. 3. Synthesis, iron(III)-chelating properties, and in vitro antibacterial activity of compounds containing 3-hydroxy-2-methyl-4(1H)-pyridinone ligands</span></div><div class="casAuthors">Feng, Min Hua; van der Does, Leen; Bantjes, Adriaan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2822-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis, iron(III)-chelating properties, and antibacterial activity of several compds. contg. the 3-hydroxy-2-methyl-4(1H)-pyridinone (HMP) moiety are described.  Using the HMP derivs., iron(III) could be mobilized from iron(III)-binding proteins at physiol. pH with a rate order of transferrin > lactoferrin > ferritin.  Addn. of HMP-contg. compds. to a growth medium at a concn. of 20 mM/L resulted in a complete inhibition of the growth of Escherichia coli and about 90% inhibition for Listeria inocua after 7 h of incubation at 37 Â°C.  After inhibition of bacteria growth by the HMP derivs., growth started again when ferric ions were added to the medium, which implies that the antibacterial activity is due to a limitation of iron available to the organisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjP8tmq10cPbVg90H21EOLACvtfcHk0lhqRNYROiqjqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlsFKjsLg%253D&md5=bb48168ab601c31942907e798617b027</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1021%2Fjm00071a013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00071a013%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DM.%2BH.%26aulast%3DVanderdoes%26aufirst%3DL.%26aulast%3DBantjes%26aufirst%3DA.%26atitle%3DIron%2528III%2529-chelating%2520resins.%25203.%2520synthesis%252C%2520iron%2528III%2529-chelating%2520properties%252C%2520and%2520in-vitro%2520antibacterial%2520activity%2520of%2520compounds%2520containing%25203-hydroxy-2-methyl-4%25281H%2529-pyridinone%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26issue%3D19%26spage%3D2822%26epage%3D2827%26doi%3D10.1021%2Fjm00071a013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanderdoes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantjes, A.</span></span> <span> </span><span class="NLM_article-title">Iron(III)-chelating resins. IX. antibacterial activity of a water-insoluble iron(III)-chelating resin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">924</span>â <span class="NLM_lpage">927</span>, <span class="refDoi">Â DOI: 10.1021/jm00033a009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00033a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2cXitVOqu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=924-927&issue=7&author=M.+H.+Fengauthor=L.+Vanderdoesauthor=A.+Bantjes&title=Iron%28III%29-chelating+resins.+IX.+antibacterial+activity+of+a+water-insoluble+iron%28III%29-chelating+resin&doi=10.1021%2Fjm00033a009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Iron(III)-Chelating Resins. IX. Antibacterial Activity of a Water-Insoluble Iron(III)-Chelating Resin</span></div><div class="casAuthors">Feng, Minhua; van der Does, Leen; Bantjes, Adriaan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">924-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Antibacterial activity of a water-insol. iron(III)-chelating resin with covalently bonded 3-hydroxy-2-methyl-4(1H)-pyridinone (HMP) groups was evaluated in a brain heart infusion (BHI) medium.  The activity of the resin against Escherichia coli was lower than that of sol. HMP iron(III) chelators, whereas against Listeria inocua, an activity approx. equal to those of the sol. chelators was found.  It was obsd. that the growth of E. coli and L. inocua was reduced by increasing the amts. of the resin from 2 to 40 mg of resin/mL of medium.  Inhibition of bacterial growth in the presence of the resin (10 mg/mL) was abolished by addn. of ferric ion to the medium, indicating that the growth of E. coli and L. inocua was dependent on the available iron in the medium.  Reducing the iron concn. in the medium from 14.2 to 0.16 Î¼M (by action of the resin) resulted in a decrease in the growth response from 100% to 19% for E. coli and from 100% to 10% for L. inocua.  In addn., the influence of citrate was studied, but only small effects of citrate supplementation on the growth of bacteria and on the antibacterial activity of the resin were obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1Oo86zLVlj7Vg90H21EOLACvtfcHk0lgmDojkHl59aA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitVOqu7k%253D&md5=f520b0955a8f57e8605f653cc26f1945</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fjm00033a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00033a009%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DM.%2BH.%26aulast%3DVanderdoes%26aufirst%3DL.%26aulast%3DBantjes%26aufirst%3DA.%26atitle%3DIron%2528III%2529-chelating%2520resins.%2520IX.%2520antibacterial%2520activity%2520of%2520a%2520water-insoluble%2520iron%2528III%2529-chelating%2520resin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D7%26spage%3D924%26epage%3D927%26doi%3D10.1021%2Fjm00033a009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olaleye, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jurach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Rugaie, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alsam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbate, V.</span></span> <span> </span><span class="NLM_article-title">Macromolecular iron-chelators <i>via</i> RAFT-polymerization for the inhibition of methicillin-resistant <i>Staphylococcus aureus</i> growth</span>. <i>Polymer</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">64</span>â <span class="NLM_lpage">72</span>, <span class="refDoi">Â DOI: 10.1016/j.polymer.2016.01.073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.polymer.2016.01.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XisVahsbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2016&pages=64-72&author=J.+Liauthor=E.+D.+Olaleyeauthor=X.+Kongauthor=T.+Zhouauthor=Y.+Maauthor=J.+Jurachauthor=O.+Al+Rugaieauthor=R.+C.+Hiderauthor=G.+Zhangauthor=S.+Alsamauthor=V.+Abbate&title=Macromolecular+iron-chelators+via+RAFT-polymerization+for+the+inhibition+of+methicillin-resistant+Staphylococcus+aureus+growth&doi=10.1016%2Fj.polymer.2016.01.073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Macromolecular iron-chelators via RAFT-polymerization for the inhibition of methicillin-resistant Staphylococcus aureus growth</span></div><div class="casAuthors">Li, Junpei; Olaleye, Eniola D.; Kong, Xiaole; Zhou, Tao; Ma, Yongmin; Jurach, Jagoda; Al Rugaie, Osamah; Hider, Robert C.; Zhang, Guoqing; Alsam, Selwa; Abbate, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">Polymer</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-72</span>CODEN:
                <span class="NLM_cas:coden">POLMAG</span>;
        ISSN:<span class="NLM_cas:issn">0032-3861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of linear poly (glycidyl methacrylate) (PGMA) polymers were synthesized via RAFT polymn. and conjugated with amine-contg. 3-hydroxypyridin-4-ones (HPOs) to generate a panel of HPO-contg. materials with controlled structures and specific iron-binding functions.  The structures of the resulting polymers were characterized via 1H NMR, GPC and FT-IR and their chelating capacity for iron was investigated using UV-Vis spectrophotometric titrn. of the iron(III) complexes.  In vitro antimicrobial studies of selected ligand-contg. homopolymers demonstrate that the homopolymers are capable of inhibiting the growth of methicillin-resistant Staphylococcus aureus (MRSA).  It is proposed that the inhibition activity of MRSA is derived from the iron-chelating capability of the iron-binding polymers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkLLYRNmB5d7Vg90H21EOLACvtfcHk0lgmDojkHl59aA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisVahsbo%253D&md5=f1207e9ce02a66e793fabc4b3cce339f</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.polymer.2016.01.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.polymer.2016.01.073%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DOlaleye%26aufirst%3DE.%2BD.%26aulast%3DKong%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DJurach%26aufirst%3DJ.%26aulast%3DAl%2BRugaie%26aufirst%3DO.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DAlsam%26aufirst%3DS.%26aulast%3DAbbate%26aufirst%3DV.%26atitle%3DMacromolecular%2520iron-chelators%2520via%2520RAFT-polymerization%2520for%2520the%2520inhibition%2520of%2520methicillin-resistant%2520Staphylococcus%2520aureus%2520growth%26jtitle%3DPolymer%26date%3D2016%26volume%3D87%26spage%3D64%26epage%3D72%26doi%3D10.1016%2Fj.polymer.2016.01.073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin</span>. <i>FEMS Microbiol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>355</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">124</span>â <span class="NLM_lpage">130</span>, <span class="refDoi">Â DOI: 10.1111/1574-6968.12465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2F1574-6968.12465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=24813898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsb3I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2014&pages=124-130&issue=2&author=Y.+J.+Zhouauthor=M.+X.+Zhangauthor=R.+C.+Hiderauthor=T.+Zhou&title=In+vitro+antimicrobial+activity+of+hydroxypyridinone+hexadentate-based+dendrimeric+chelators+alone+and+in+combination+with+norfloxacin&doi=10.1111%2F1574-6968.12465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro antimicrobial activity of hydroxypyridinone hexadentate-based dendrimeric chelators alone and in combination with norfloxacin</span></div><div class="casAuthors">Zhou, Ying-Jun; Zhang, Ming-Xia; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Microbiology Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">124-130</span>CODEN:
                <span class="NLM_cas:coden">FMLED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-1097</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The antimicrobial activity of one 3-hydroxypyridin-4-one (HPO) hexadentate (1) and three HPO hexadentate-based dendrimeric chelators (2-4) was evaluated.  They were found to exhibit marked inhibitory effect on the growth of two Gram-pos. bacteria and two Gram-neg. bacteria.  The combination treatment of dendrimeric chelator 2 with norfloxacin against Staphyloccocus aureus and Escherichia coli showed a dramatic synergistic bactericidal effect.  As the dendrimeric chelator has a large mol. wt., its combination with norfloxacin may find application in the treatment of external infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv-3AbL0iS97Vg90H21EOLACvtfcHk0ljGgMfHw1vYzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsb3I&md5=0878bde8da2644e8b1b80c97026ba820</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1111%2F1574-6968.12465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1574-6968.12465%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%2BJ.%26aulast%3DZhang%26aufirst%3DM.%2BX.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DIn%2520vitro%2520antimicrobial%2520activity%2520of%2520hydroxypyridinone%2520hexadentate-based%2520dendrimeric%2520chelators%2520alone%2520and%2520in%2520combination%2520with%2520norfloxacin%26jtitle%3DFEMS%2520Microbiol.%2520Lett.%26date%3D2014%26volume%3D355%26issue%3D2%26spage%3D124%26epage%3D130%26doi%3D10.1111%2F1574-6968.12465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Synthesis, iron binding and antimicrobial properties of hexadentate 3-hydroxypyridinones-terminated dendrimers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2504</span>â <span class="NLM_lpage">2512</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2018.05.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2018.05.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29886020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtV2gt7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=2504-2512&issue=14&author=T.+Zhouauthor=K.+Chenauthor=L.+M.+Kongauthor=M.+S.+Liuauthor=Y.+M.+Maauthor=Y.+Y.+Xieauthor=R.+C.+Hider&title=Synthesis%2C+iron+binding+and+antimicrobial+properties+of+hexadentate+3-hydroxypyridinones-terminated+dendrimers&doi=10.1016%2Fj.bmcl.2018.05.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, iron binding and antimicrobial properties of hexadentate 3-hydroxypyridinones-terminated dendrimers</span></div><div class="casAuthors">Zhou, Tao; Chen, Kai; Kong, Li-Min; Liu, Mu-Song; Ma, Yong-Min; Xie, Yuan-Yuan; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2504-2512</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Macromol. chelators have potential applications in the medical area, for instance, in treatment of iron overload-related disorders and in the treatment of external infections.  In this investigation, several novel iron(III)-selective hydroxypyridinone hexadentate-terminated first and second generation dendrimeric chelators were synthesized using a convergent strategy.  Their iron chelating ability was demonstrated by UV/Visible spectrometry and high resoln. mass spectrometry (HRMS).  The iron binding affinities were also investigated by the competition with a fluorescent iron chelator CP691.  The result indicated that these dendrimers possesses a high affinity for iron with a very high pFe3+ value, which is close to that of an isolated hexadentate unit.  These dendrimeric chelators were found to exhibit inhibitory effect on the growth of both Gram-pos. and Gram-neg. bacteria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovKTghr5PgdLVg90H21EOLACvtfcHk0ljGgMfHw1vYzA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtV2gt7nK&md5=bd934c67f08fd7339138b9e70671ee11</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.05.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.05.058%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DKong%26aufirst%3DL.%2BM.%26aulast%3DLiu%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DY.%2BM.%26aulast%3DXie%26aufirst%3DY.%2BY.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%252C%2520iron%2520binding%2520and%2520antimicrobial%2520properties%2520of%2520hexadentate%25203-hydroxypyridinones-terminated%2520dendrimers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D28%26issue%3D14%26spage%3D2504%26epage%3D2512%26doi%3D10.1016%2Fj.bmcl.2018.05.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ang, M. T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gumbau-Brisa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bierenstiel, M.</span></span> <span> </span><span class="NLM_article-title">DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1206</span>â <span class="NLM_lpage">1212</span>, <span class="refDoi">Â DOI: 10.1039/C8MD00192H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC8MD00192H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30109009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFCmtLvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1206-1212&issue=7&author=M.+T.+C.+Angauthor=R.+Gumbau-Brisaauthor=D.+S.+Allanauthor=R.+McDonaldauthor=M.+J.+Fergusonauthor=B.+E.+Holbeinauthor=M.+Bierenstiel&title=DIBI%2C+a+3-hydroxypyridin-4-one+chelator+iron-binding+polymer+with+enhanced+antimicrobial+activity&doi=10.1039%2FC8MD00192H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity</span></div><div class="casAuthors">Ang, M. Trisha C.; Gumbau-Brisa, Roger; Allan, David S.; McDonald, Robert; Ferguson, Michael J.; Holbein, Bruce E.; Bierenstiel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1206-1212</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Depriving microorganisms of bioavailable iron is a promising strategy for new anti-infective agents.  The new, highly water-sol., low mol. wt. co-polymer DIBI was developed to selectively bind iron(III) ions as a tris chelate and acts as a standalone anti-infective.  Min. inhibitory concn. (MIC) studies show DIBI is effective against representative ref. strains for Gram-pos. and Gram-neg. bacteria S. aureus and A. baumannii, and the fungus C. albicans.  Compared to the small mol. iron chelators, deferiprone and deferoxamine, DIBI outclassed these by factors of 100 to 1000 for inhibition of initial growth.  DIBI and a series of related co-polymers (Mw of 2-9 kDa) were synthesized via reversible addn.-fragmentation chain transfer (RAFT) polymn. of a chelating 3-hydroxypyridin-4-one (HPO) methacrylamide monomer and N-vinylpyrrolidone (NVP).  Full incorporation of the HPO monomer into the co-polymers from the reaction soln. was detd. by 1H NMR spectroscopy and ranged from 4.6 to 25.6 mol%.  UV-vis spectroscopy showed that all the HPO in DIBI binds readily to iron(III) in a tris chelate mode to the max. theor. iron(III) binding capacity of the co-polymer.  Chem. characterization including single crystal X-ray diffraction analyses of the O-benzyl protected and the functional HPO monomer are discussed.  By design, DIBI is highly water sol.; the highest mass fraction in water tested was 70% wt./wt., without the need of org. co-solvents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWgqj6WHYL_bVg90H21EOLACvtfcHk0liHr4k-4Ef-Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmtLvM&md5=7fbf6b641592fe2624535978ad990712</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1039%2FC8MD00192H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8MD00192H%26sid%3Dliteratum%253Aachs%26aulast%3DAng%26aufirst%3DM.%2BT.%2BC.%26aulast%3DGumbau-Brisa%26aufirst%3DR.%26aulast%3DAllan%26aufirst%3DD.%2BS.%26aulast%3DMcDonald%26aufirst%3DR.%26aulast%3DFerguson%26aufirst%3DM.%2BJ.%26aulast%3DHolbein%26aufirst%3DB.%2BE.%26aulast%3DBierenstiel%26aufirst%3DM.%26atitle%3DDIBI%252C%2520a%25203-hydroxypyridin-4-one%2520chelator%2520iron-binding%2520polymer%2520with%2520enhanced%2520antimicrobial%2520activity%26jtitle%3DMedChemComm%26date%3D2018%26volume%3D9%26issue%3D7%26spage%3D1206%26epage%3D1212%26doi%3D10.1039%2FC8MD00192H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parquet, M. D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B. E.</span></span> <span> </span><span class="NLM_article-title">Novel iron-chelator DIBI inhibits staphylococcus aureus growth, suppresses experimental MRSA infection in mice and enhances the activities of diverse antibiotics <i>in vitro</i></span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1811</span>â <span class="NLM_lpage">1821</span>, <span class="refDoi">Â DOI: 10.3389/fmicb.2018.01811</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3389%2Ffmicb.2018.01811" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30154764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BB3c3islyisQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1811-1821&author=M.+D.+C.+Parquetauthor=K.+A.+Savageauthor=D.+S.+Allanauthor=R.+J.+Davidsonauthor=B.+E.+Holbein&title=Novel+iron-chelator+DIBI+inhibits+staphylococcus+aureus+growth%2C+suppresses+experimental+MRSA+infection+in+mice+and+enhances+the+activities+of+diverse+antibiotics+in+vitro&doi=10.3389%2Ffmicb.2018.01811"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro</span></div><div class="casAuthors">Parquet Maria Del Carmen; Savage Kimberley A; Allan David S; Holbein Bruce E; Davidson Ross J; Holbein Bruce E; Davidson Ross J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1811</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">DIBI, a purpose-designed hydroxypyridinone-containing iron-chelating antimicrobial polymer was studied for its anti-staphylococcal activities in vitro in comparison to deferiprone, the chemically related, small molecule hydroxypyridinone chelator.  The sensitivities of 18 clinical isolates of Staphylococcus aureus from human, canine and bovine infections were determined.  DIBI was strongly inhibitory to all isolates, displaying approximately 100-fold more inhibitory activity than deferiprone when compared on their molar iron-binding capacities.  Sensitivity to DIBI was similar for both antibiotic-resistant and -sensitive isolates, including hospital- and community-acquired (United States 300) MRSA.  DIBI inhibition was primarily bacteriostatic in nature at low concentration and was reversible by addition of Fe.  DIBI also exhibited in vivo anti-infective activity in two distinct MRSA ATCC43300 infection and colonization models in mice.  In a superficial skin wound infection model, topical application of DIBI provided a dose-dependent suppression of infection along with reduced wound inflammation.  Intranasal DIBI reduced staphylococcal burden by >2 log in a MRSA nares carriage model.  DIBI was also examined for its influence on antibiotic activities with a reference isolate ATCC6538, typically utilized to assess new antimicrobials.  Sub-bacteriostatic concentrations of DIBI resulted in Fe-restricted growth and this physiological condition displayed increased sensitivity to GEN, CIP, and VAN.  DIBI did not impair antibiotic activity but rather it enhanced overall killing.  Importantly, recovery growth of survivors that typically followed an initial sub-MIC antibiotic killing phase was substantially suppressed by DIBI for each of the antibiotics examined.  DIBI has promise for restricting staphylococcal infection on its own, regardless of the isolate's animal source or antibiotic resistance profile.  DIBI also has potential for use in combination with various classes of currently available antibiotics to improve their responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQXDbfJpItTH4hLSh9fo81bfW6udTcc2eaH5ppPQxjxX7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3islyisQ%253D%253D&md5=84e201118675b8bfccd6595a7a0647af</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2018.01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2018.01811%26sid%3Dliteratum%253Aachs%26aulast%3DParquet%26aufirst%3DM.%2BD.%2BC.%26aulast%3DSavage%26aufirst%3DK.%2BA.%26aulast%3DAllan%26aufirst%3DD.%2BS.%26aulast%3DDavidson%26aufirst%3DR.%2BJ.%26aulast%3DHolbein%26aufirst%3DB.%2BE.%26atitle%3DNovel%2520iron-chelator%2520DIBI%2520inhibits%2520staphylococcus%2520aureus%2520growth%252C%2520suppresses%2520experimental%2520MRSA%2520infection%2520in%2520mice%2520and%2520enhances%2520the%2520activities%2520of%2520diverse%2520antibiotics%2520in%2520vitro%26jtitle%3DFront.%2520Microbiol.%26date%3D2018%26volume%3D9%26spage%3D1811%26epage%3D1821%26doi%3D10.3389%2Ffmicb.2018.01811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kojima, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological-activity of a novel class of cephalosporins with a oxadiazolyl hydroxypyridone moiety at C-7</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">2777</span>â <span class="NLM_lpage">2782</span>, <span class="refDoi">Â DOI: 10.1016/0960-894X(95)00485-C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0960-894X%2895%2900485-C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2MXhtVShs73N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2777-2782&issue=23&author=K.+Obiauthor=A.+Kojimaauthor=H.+Fukudaauthor=K.+Hirai&title=Synthesis+and+biological-activity+of+a+novel+class+of+cephalosporins+with+a+oxadiazolyl+hydroxypyridone+moiety+at+C-7&doi=10.1016%2F0960-894X%2895%2900485-C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of a novel class of cephalosporins with a oxadiazolyl hydroxypyridone moiety at C-7</span></div><div class="casAuthors">Obi, Kikoh; Kojima, Akihiko; Fukuda, Hideyuki; Hirai, Keiji</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2777-82</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Synthesis and biol. properties of a novel class of cephalosporins I [R = heterocyclylthio] are described.  Among them, the compds. having a pyridiniumthiomethyl group at C-3 position were found to possess high in vitro potency and showed excellent in vivo efficacy against both S. aureus and P. aeruginosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppVoVWD8QIzLVg90H21EOLACvtfcHk0ljPcsjp6SiAFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXhtVShs73N&md5=6598a7076846fef21f79c6da26009270</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2F0960-894X%2895%2900485-C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0960-894X%252895%252900485-C%26sid%3Dliteratum%253Aachs%26aulast%3DObi%26aufirst%3DK.%26aulast%3DKojima%26aufirst%3DA.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DHirai%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520biological-activity%2520of%2520a%2520novel%2520class%2520of%2520cephalosporins%2520with%2520a%2520oxadiazolyl%2520hydroxypyridone%2520moiety%2520at%2520C-7%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26issue%3D23%26spage%3D2777%26epage%3D2782%26doi%3D10.1016%2F0960-894X%2895%2900485-C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy-Benenato, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhagunde, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand-Reville, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehmann, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galullo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatoum-Mokdad, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manjunatha, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manyak, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quiroga, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uria-Nickelsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambrowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S. X.</span></span> <span> </span><span class="NLM_article-title">Discovery of efficacious <i>Pseudomonas aeruginosa</i>-targeted siderophore-conjugated monocarbams by application of a semi-mechanistic pharmacokinetic/pharmacodynamic model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2195</span>â <span class="NLM_lpage">2205</span>, <span class="refDoi">Â DOI: 10.1021/jm501506f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501506f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Sguro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2195-2205&issue=5&author=K.+E.+Murphy-Benenatoauthor=P.+R.+Bhagundeauthor=A.+Chenauthor=H.+E.+Davisauthor=T.+F.+Durand-Revilleauthor=D.+E.+Ehmannauthor=V.+Galulloauthor=J.+J.+Harrisauthor=H.+Hatoum-Mokdadauthor=H.+Jahicauthor=A.+Kimauthor=M.+R.+Manjunathaauthor=E.+L.+Manyakauthor=J.+Muellerauthor=S.+Pateyauthor=O.+Quirogaauthor=M.+Rooneyauthor=L.+Shaauthor=A.+B.+Shapiroauthor=M.+Sylvesterauthor=B.+Tanauthor=A.+S.+Tsaiauthor=M.+Uria-Nickelsenauthor=Y.+Wuauthor=M.+Zambrowskiauthor=S.+X.+Zhao&title=Discovery+of+efficacious+Pseudomonas+aeruginosa-targeted+siderophore-conjugated+monocarbams+by+application+of+a+semi-mechanistic+pharmacokinetic%2Fpharmacodynamic+model&doi=10.1021%2Fjm501506f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Efficacious Pseudomonas aeruginosa-Targeted Siderophore-Conjugated Monocarbams by Application of a Semi-mechanistic Pharmacokinetic/Pharmacodynamic Model</span></div><div class="casAuthors">Murphy-Benenato, Kerry E.; Bhagunde, Pratik R.; Chen, April; Davis, Hajnalka E.; Durand-Reville, Thomas F.; Ehmann, David E.; Galullo, Vincent; Harris, Jennifer J.; Hatoum-Mokdad, Holia; Jahic, Haris; Kim, Aryun; Manjunatha, M. R.; Manyak, Erika L.; Mueller, John; Patey, Sara; Quiroga, Olga; Rooney, Michael; Sha, Li; Shapiro, Adam B.; Sylvester, Mark; Tan, Beesan; Tsai, Andy S.; Uria-Nickelsen, Maria; Wu, Ye; Zambrowski, Mark; Zhao, Shannon X.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2195-2205</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To identify new agents for the treatment of multidrug-resistant Pseudomonas aeruginosa, the authors focused on siderophore-conjugated monocarbams.  This class of monocyclic Î²-lactams are stable to metallo-Î²-lactamases and have excellent P. aeruginosa activities due to their ability to exploit the iron uptake machinery of Gram-neg. bacteria.  The medicinal chem. plan focused on identifying a mol. with optimal potency and phys. properties and activity for in vivo efficacy.  Modifications to the monocarbam linker, siderophore, and oxime portion of the mols. were examd.  Through these efforts, a series of pyrrolidinone-based monocarbams with good P. aeruginosa cellular activity (P. aeruginosa MIC90 = 2 Î¼g/mL), free fraction levels (>20% free), and hydrolytic stability (t1/2 â¥ 100 h) were identified.  To differentiate the lead compds. and enable prioritization for in vivo studies, the authors applied a semi-mechanistic pharmacokinetic/pharmacodynamic model to enable prediction of in vivo efficacy from in vitro data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcG0PvqAMbi7Vg90H21EOLACvtfcHk0ljPcsjp6SiAFw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Sguro%253D&md5=ff3e470724b850b37ae818216f4471b2</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm501506f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501506f%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy-Benenato%26aufirst%3DK.%2BE.%26aulast%3DBhagunde%26aufirst%3DP.%2BR.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DDavis%26aufirst%3DH.%2BE.%26aulast%3DDurand-Reville%26aufirst%3DT.%2BF.%26aulast%3DEhmann%26aufirst%3DD.%2BE.%26aulast%3DGalullo%26aufirst%3DV.%26aulast%3DHarris%26aufirst%3DJ.%2BJ.%26aulast%3DHatoum-Mokdad%26aufirst%3DH.%26aulast%3DJahic%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DA.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DManyak%26aufirst%3DE.%2BL.%26aulast%3DMueller%26aufirst%3DJ.%26aulast%3DPatey%26aufirst%3DS.%26aulast%3DQuiroga%26aufirst%3DO.%26aulast%3DRooney%26aufirst%3DM.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DA.%2BB.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DB.%26aulast%3DTsai%26aufirst%3DA.%2BS.%26aulast%3DUria-Nickelsen%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZambrowski%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520efficacious%2520Pseudomonas%2520aeruginosa-targeted%2520siderophore-conjugated%2520monocarbams%2520by%2520application%2520of%2520a%2520semi-mechanistic%2520pharmacokinetic%252Fpharmacodynamic%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D5%26spage%3D2195%26epage%3D2205%26doi%3D10.1021%2Fjm501506f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baltimore, D.</span></span> <span> </span><span class="NLM_article-title">An inducible transcription factor activates expression of human immunodeficiency virus in T cells</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>326</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">711</span>â <span class="NLM_lpage">713</span>, <span class="refDoi">Â DOI: 10.1038/326711a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2F326711a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=3031512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaL2sXitVyls7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=1987&pages=711-713&issue=16&author=G.+Nabelauthor=D.+Baltimore&title=An+inducible+transcription+factor+activates+expression+of+human+immunodeficiency+virus+in+T+cells&doi=10.1038%2F326711a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">An inducible transcription factor activates expression of human immunodeficiency virus in T cells</span></div><div class="casAuthors">Nabel, Gary; Baltimore, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">6114</span>),
    <span class="NLM_cas:pages">711-13</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Human immunodeficiency virus (HIV) prodn. from latently infected T lymphocytes can be induced with compds. that activate the cells to secrete lymphokines.  The elements in the HIV genome which control activation are not known but expression might be regulated through a variety of DNA elements.  The cis-acting control elements of the viral genome are enhancer and promoter regions.  The virus also encodes trans-acting factors specified by the tat-III and art genes.  The authors examd. whether products specific to activated T cells might stimulate viral transcription by binding to regions on viral DNA.  Activation of T cells, which increases HIV expression up to 50-fold, correlated with induction of a DNA binding protein indistinguishable from a recognized transcription factor, called NF-ÎºB, with binding sites in the viral enhancer.  Mutation of these binding sites abolished inducibility.  That NF-ÎºB acts in synergy with the viral tat-III gene product to enhance HIV expression in T cells may have implications for the pathogenesis of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroPK8QwklBhbVg90H21EOLACvtfcHk0lguwuUQrTNkxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXitVyls7Y%253D&md5=2dc52c063f31c15a7dd01a09a8066b21</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2F326711a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F326711a0%26sid%3Dliteratum%253Aachs%26aulast%3DNabel%26aufirst%3DG.%26aulast%3DBaltimore%26aufirst%3DD.%26atitle%3DAn%2520inducible%2520transcription%2520factor%2520activates%2520expression%2520of%2520human%2520immunodeficiency%2520virus%2520in%2520T%2520cells%26jtitle%3DNature%26date%3D1987%26volume%3D326%26issue%3D16%26spage%3D711%26epage%3D713%26doi%3D10.1038%2F326711a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffbrand, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeshaguru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooton, J. W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattersall, M. H. N.</span></span> <span> </span><span class="NLM_article-title">Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells</span>. <i>Br. J. Haematol.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">517</span>â <span class="NLM_lpage">526</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2141.1976.tb03570.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1365-2141.1976.tb03570.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1009024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaE28XltFKlsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1976&pages=517-526&author=A.+V.+Hoffbrandauthor=K.+Ganeshaguruauthor=J.+W.+L.+Hootonauthor=M.+H.+N.+Tattersall&title=Effect+of+iron+deficiency+and+desferrioxamine+on+DNA+synthesis+in+human+cells&doi=10.1111%2Fj.1365-2141.1976.tb03570.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells</span></div><div class="casAuthors">Hoffbrand, A. V.; Ganeshaguru, K.; Hooton, J. W. L.; Tattersall, M. H. N.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Haematology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">517-26</span>CODEN:
                <span class="NLM_cas:coden">BJHEAL</span>;
        ISSN:<span class="NLM_cas:issn">0007-1048</span>.
    </div><div class="casAbstract">Desferrioxamine [70-51-9] (10-3M) caused a fall in the deoxyadenosine triphosphate [1927-31-7] level after 4 hr incubation in normal phytohemagglutinin-stimulated lymphocytes.  There was a rise in the concns. of the other 3 deoxyribonucleoside triphosphates (deoxythymidine- [365-08-2], deoxycytidine- [2056-98-6], and deoxyguanosine triphosphate [2564-35-4]).  The changes were similar to those caused by hydroxyurea [127-07-1], a known inhibitor of ribonucleotide reductase.  Desferrioxamine (10-3M) inhibited human lymphocyte ribonucleotide reductase [9040-57-7] to a mean of 11% of control activity after 45 min incubation.  Both drugs, desferrioxamine and hydroxyurea, inhibited incorporation of [3H]thymidine DNA into lymphocytes in the presence or absence of deoxyuridine, and inhibited prodn. of lymphocytic thymidine kinase [9002-06-6], having opposite effects to methotrexate [59-05-2] on both [3H]thymidine incorporation and thymidine kinase activity.  Phytohemagglutinin-stimulated lymphocytes from patients with chronic iron deficiency showed lower levels of all 4 deoxyribonucleoside triphosphates than normal lymphocytes.  It is suggested that this may be due to reduced ribonucleotide reductase activity of the iron-deficient cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgAXi9HM0xrVg90H21EOLACvtfcHk0lguwuUQrTNkxA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XltFKlsro%253D&md5=a20ded5b109ab1c23cb3a7299923477a</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2141.1976.tb03570.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2141.1976.tb03570.x%26sid%3Dliteratum%253Aachs%26aulast%3DHoffbrand%26aufirst%3DA.%2BV.%26aulast%3DGaneshaguru%26aufirst%3DK.%26aulast%3DHooton%26aufirst%3DJ.%2BW.%2BL.%26aulast%3DTattersall%26aufirst%3DM.%2BH.%2BN.%26atitle%3DEffect%2520of%2520iron%2520deficiency%2520and%2520desferrioxamine%2520on%2520DNA%2520synthesis%2520in%2520human%2520cells%26jtitle%3DBr.%2520J.%2520Haematol.%26date%3D1976%26volume%3D33%26spage%3D517%26epage%3D526%26doi%3D10.1111%2Fj.1365-2141.1976.tb03570.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Georgiou, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Bruggen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oudshoorn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marx, J. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Asbeck, B. S.</span></span> <span> </span><span class="NLM_article-title">Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis</span>. <i>Eur. J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">91</span>â <span class="NLM_lpage">96</span>, <span class="refDoi">Â DOI: 10.1046/j.1365-2362.2002.0320s1091.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1046%2Fj.1365-2362.2002.0320s1091.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11886438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFaksb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2002&pages=91-96&issue=1&author=N.+A.+Georgiouauthor=T.+van+der+Bruggenauthor=M.+Oudshoornauthor=R.+C.+Hiderauthor=J.+J.+M.+Marxauthor=B.+S.+van%0AAsbeck&title=Human+immunodeficiency+virus+type+1+replication+inhibition+by+the+bidentate+iron+chelators+CP502+and+CP511+is+caused+by+proliferation+inhibition+and+the+onset+of+apoptosis&doi=10.1046%2Fj.1365-2362.2002.0320s1091.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Human immunodeficiency virus type I replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis</span></div><div class="casAuthors">Georgiou, N. A.; van der Bruggen, T.; Oudshoorn, M.; Hider, R. C.; Marx, J. J. M.; van Asbeck, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">EJCIB8</span>;
        ISSN:<span class="NLM_cas:issn">0014-2972</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Background: The iron chelators deferoxamine (DF) and deferiprone (CP20) have been shown to inhibit human immunodeficiency virus type 1 (HIV-1) replication in human peripheral blood lymphocytes (PBL).  The orally active bidentate chelators CP502 and CP511, which also belong to the 3-hydroxypyridin-4-one family, but with higher affinities for iron than CP20, were monitored for their antiviral properties by checking for p24 antigen prodn. and nuclear factor (NF)-ÎºB activation, and their ability to induce apoptosis.  Materials and methods: Human PBLs were isolated from HIV-1 seroneg. donors and subsequently infected with HIV-1Ba-L for 2 h.  After 5 days' incubation, HIV-1 replication was monitored by p24 antigen prodn.  Cellular proliferation as well as caspase-3 activity were monitored in uninfected cells after a period of 5 days and after 1 day infection, resp.  NF-ÎºB activity was also monitored by electromobility shift assays (EMSA) performed on nuclear exts. of Jurkat cells treated with the different chelators for 4 h.  Results CP502 and CP511 decrease HIV-1 replication by decreasing cellular proliferation in a similar manner to DF and CP20.  CP511 seemed to be more potent than either CP502 or CP20.  Due to the redn. in cellular proliferation, there was an increase in caspase-3 activity after 24 h incubation.  NF-ÎºB activity was not affected by any of the chelators.  Conclusions: Iron chelators with high affinities for iron, which are under development for the treatment of iron overload, could contribute to the redn. of HIV-1 replication in infected patients by cellular proliferation inhibition rather than by a direct antiviral action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZI54sKUSZArVg90H21EOLACvtfcHk0ljkh9zR7cdr7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFaksb8%253D&md5=d2d5d9f4534518854376e72a327d6821</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2362.2002.0320s1091.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2362.2002.0320s1091.x%26sid%3Dliteratum%253Aachs%26aulast%3DGeorgiou%26aufirst%3DN.%2BA.%26aulast%3Dvan%2Bder%2BBruggen%26aufirst%3DT.%26aulast%3DOudshoorn%26aufirst%3DM.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DMarx%26aufirst%3DJ.%2BJ.%2BM.%26aulast%3Dvan%2BAsbeck%26aufirst%3DB.%2BS.%26atitle%3DHuman%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520inhibition%2520by%2520the%2520bidentate%2520iron%2520chelators%2520CP502%2520and%2520CP511%2520is%2520caused%2520by%2520proliferation%2520inhibition%2520and%2520the%2520onset%2520of%2520apoptosis%26jtitle%3DEur.%2520J.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D32%26issue%3D1%26spage%3D91%26epage%3D96%26doi%3D10.1046%2Fj.1365-2362.2002.0320s1091.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hecht, S. M.</span></span> <span> </span><span class="NLM_article-title">RNA degradation by bleomycin, a naturally occurring bioconjugate</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">513</span>â <span class="NLM_lpage">526</span>, <span class="refDoi">Â DOI: 10.1021/bc00030a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc00030a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2cXmsVCksb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=513-526&author=S.+M.+Hecht&title=RNA+degradation+by+bleomycin%2C+a+naturally+occurring+bioconjugate&doi=10.1021%2Fbc00030a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">RNA Degradation by Bleomycin, a Naturally Occurring Bioconjugate</span></div><div class="casAuthors">Hecht, Sidney M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">513-26</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    </div><div class="casAbstract">A review with 93 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKcKIUxsaH7Vg90H21EOLACvtfcHk0ljkh9zR7cdr7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmsVCksb0%253D&md5=a85b2647c3cf66b3cda8c0ab307c31c0</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Fbc00030a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc00030a006%26sid%3Dliteratum%253Aachs%26aulast%3DHecht%26aufirst%3DS.%2BM.%26atitle%3DRNA%2520degradation%2520by%2520bleomycin%252C%2520a%2520naturally%2520occurring%2520bioconjugate%26jtitle%3DBioconjugate%2520Chem.%26date%3D1994%26volume%3D5%26spage%3D513%26epage%3D526%26doi%3D10.1021%2Fbc00030a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrus, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grady, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanauske, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huima-Byron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slowinska, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagulska, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanauske-Abel, H. M.</span></span> <span> </span><span class="NLM_article-title">Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors-a hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1)</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1807</span>â <span class="NLM_lpage">1818</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(98)00053-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-2952%2898%2900053-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9714299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXjvVehtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1998&pages=1807-1818&issue=11&author=L.+Andrusauthor=P.+Szaboauthor=R.+W.+Gradyauthor=A.+R.+Hanauskeauthor=T.+Huima-Byronauthor=B.+Slowinskaauthor=S.+Zagulskaauthor=H.+M.+Hanauske-Abel&title=Antiretroviral+effects+of+deoxyhypusyl+hydroxylase+inhibitors-a+hypusine-dependent+host+cell+mechanism+for+replication+of+human+immunodeficiency+virus+type+1+%28HIV-1%29&doi=10.1016%2FS0006-2952%2898%2900053-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Antiretroviral effects of deoxyhypusyl hydroxylase inhibitors. A hypusine-dependent host cell mechanism for replication of human immunodeficiency virus type 1 (HIV-1)</span></div><div class="casAuthors">Andrus, Linda; Szabo, Paul; Grady, Robert W.; Hanauske, Axel-R.; Huima-Byron, Tellervo; Slowinska, Bozena; Zagulska, Sylwia; Hanauske-Abel, Hartmut M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1807-1818</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The HIV-1 protein Rev, crit. for translation of incompletely spliced retroviral mRNAs encoding capsid elements, requires a host cell protein termed "eukaryotic initiation factor 5A" (eIF-5A).  This is the only protein contg. hypusine, a lysine-derived hydroxylated residue that dets. its proposed bioactivity, the translation of a subset of cellular mRNAs controlling G1-to-S transit of the cell cycle.  We postulated that inhibiting the hypusine-forming deoxyhypusyl hydroxylase (DOHH) should, by depleting eukaryotic initiation factor 5A, compromise Rev function and thus reduce HIV-1 multiplication.  We now report that the Î±-hydroxypyridones, specifically mimosine, a natural product, and deferiprone, an exptl. drug, inhibited deoxyhypusyl hydroxylase in T-lymphocytic and promonocytic cell lines and, in a concn.-dependent manner, suppressed replication of HIV-1.  However, the Î±-hydroxypyridones did not affect the formation of unspliced or multiply spliced HIV-1 transcripts.  Rather, these agents caused Rev-dependent incompletely spliced HIV-1 mRNA such as gag, but not cellular "housekeeping" mRNAs, to disappear from polysomes.  Consequently, Î±-hydroxypyridone-mediated depletion of eIF-5A decreased biosynthesis of structural HIV-1 protein encoded by gag, measured as p24, whereas the induced formation of cellular protein like tumor necrosis factor alpha remained unaffected.  By interfering with the translation of incompletely spliced retroviral mRNAs, these compds. restrict HIV-1 to the early, nongenerative phase of its reproductive cycle.  In the inducibly HIV-1 expressing T-cell line ACH-2, the deoxyhypusyl hydroxylase inhibitors triggered extensive apoptosis, particularly of cells that actively produce HIV-1.  Selective suppression of retroviral protein biosynthesis and preferential apoptosis of retrovirally infected cells by Î±-hydroxypyridones point to a novel mode of antiretroviral action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8AGxV_zaQ5bVg90H21EOLACvtfcHk0ljkh9zR7cdr7w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvVehtr8%253D&md5=8eeb3fc388ee90231973d0232c7b477f</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2898%2900053-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252898%252900053-7%26sid%3Dliteratum%253Aachs%26aulast%3DAndrus%26aufirst%3DL.%26aulast%3DSzabo%26aufirst%3DP.%26aulast%3DGrady%26aufirst%3DR.%2BW.%26aulast%3DHanauske%26aufirst%3DA.%2BR.%26aulast%3DHuima-Byron%26aufirst%3DT.%26aulast%3DSlowinska%26aufirst%3DB.%26aulast%3DZagulska%26aufirst%3DS.%26aulast%3DHanauske-Abel%26aufirst%3DH.%2BM.%26atitle%3DAntiretroviral%2520effects%2520of%2520deoxyhypusyl%2520hydroxylase%2520inhibitors-a%2520hypusine-dependent%2520host%2520cell%2520mechanism%2520for%2520replication%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520%2528HIV-1%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1998%26volume%3D55%26issue%3D11%26spage%3D1807%26epage%3D1818%26doi%3D10.1016%2FS0006-2952%2898%2900053-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camplo, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">4371</span>â <span class="NLM_lpage">4374</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2003.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2003.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=14643328" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1yrtb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4371-4374&issue=24&author=K.+Barralauthor=R.+C.+Hiderauthor=J.+Balzariniauthor=J.+Neytsauthor=E.+De+Clercqauthor=M.+Camplo&title=Synthesis+and+antiviral+evaluation+of+3-hydroxy-2-methylpyridin-4-one+dideoxynucleoside+derivatives&doi=10.1016%2Fj.bmcl.2003.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives</span></div><div class="casAuthors">Barral, Karine; Hider, Robert C.; Balzarini, Jan; Neyts, Johan; De Clercq, Erik; Camplo, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4371-4374</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We describe the synthesis and the antiviral evaluation of novel Î± and Î² dideoxynucleoside derivs. in which the base has been replaced by a 3-hydroxy-2-methylpyridin-4-one.  The syntheses were successfully achieved by the use of the std. Vorbruggen coupling conditions.  Moderate activity of these compds. (between 32 to 900 Î¼M) were found on herpes simplex virus (HSV) type 1 and type 2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiNMyf76qAPbVg90H21EOLACvtfcHk0liviptnB1k2Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1yrtb0%253D&md5=7a6a09c7afea7a07db57e5c8edb08da1</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DBarral%26aufirst%3DK.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DCamplo%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antiviral%2520evaluation%2520of%25203-hydroxy-2-methylpyridin-4-one%2520dideoxynucleoside%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D24%26spage%3D4371%26epage%3D4374%26doi%3D10.1016%2Fj.bmcl.2003.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barral, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camplo, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>â <span class="NLM_lpage">50</span>, <span class="refDoi">Â DOI: 10.1021/jm0504306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0504306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht12nsrfJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=43-50&issue=1&author=K.+Barralauthor=J.+Balzariniauthor=J.+Neytsauthor=E.+De+Clercqauthor=R.+C.+Hiderauthor=M.+Camplo&title=Synthesis+and+antiviral+evaluation+of+cyclic+and+acyclic+2-methyl-3-hydroxy-4-pyridinone+nucleoside+derivatives&doi=10.1021%2Fjm0504306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiviral Evaluation of Cyclic and Acyclic 2-Methyl-3-hydroxy-4-pyridinone Nucleoside Derivatives</span></div><div class="casAuthors">Barral, Karine; Balzarini, Jan; Neyts, Johan; De Clercq, Erik; Hider, Robert C.; Camplo, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-50</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of cyclic and acyclic nucleoside analogs derived from 3-hydroxy-4-pyridinone were synthesized using the Vorbrueggen reaction.  Iron chelation studies, and antiviral evaluation against a broad panel of viruses, were performed.  The pKa value of ligand 25 and the stability const. of the corresponding iron(III) complex were compared to those of deferiprone.  The pFe3+ values were found to be similar.  Some compds. showed moderate activity against both wild-type HSV-1 and HSV-2, as well as against a thymidine kinase deficient strain of HSV-1.  These results suggest a novel mode of action for this group of nucleoside analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_SZ97sVPypLVg90H21EOLACvtfcHk0liviptnB1k2Cw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht12nsrfJ&md5=8a38c86017017ebe8b575ed5cdc4042c</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1021%2Fjm0504306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504306%26sid%3Dliteratum%253Aachs%26aulast%3DBarral%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DCamplo%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520antiviral%2520evaluation%2520of%2520cyclic%2520and%2520acyclic%25202-methyl-3-hydroxy-4-pyridinone%2520nucleoside%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26issue%3D1%26spage%3D43%26epage%3D50%26doi%3D10.1021%2Fjm0504306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershko, C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peto, T E</span></span> <span> </span><span class="NLM_article-title">Deferoxamine inhibition of malaria is independent of host iron status</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>168</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">375</span>â <span class="NLM_lpage">387</span>, <span class="refDoi">Â DOI: 10.1084/jem.168.1.375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1084%2Fjem.168.1.375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=3294334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaL1cXltVChsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=1988&pages=375-387&issue=1&author=C+Hershkoauthor=T+E+Peto&title=Deferoxamine+inhibition+of+malaria+is+independent+of+host+iron+status&doi=10.1084%2Fjem.168.1.375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Deferoxamine inhibition of malaria is independent of host iron status</span></div><div class="casAuthors">Hershko, Chaim; Peto, Timothy E. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">375-87</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">The mechanism whereby deferoxamine (DF) inhibits the growth of malaria parasites was studied in rats infected with Plasmodium berghei.  Peak parasitemia was 32.6% (day 14) in untreated controls and 0.15% (day 7) in rats receiving 0.33 mg DF/g/day s.c.  DF inhibition of parasite growth was achieved without any redn. in transferrin satn. or Hb synthesis and with only a partial (56%) depletion of hepatic iron stores.  Dietary iron depletion resulted in anemia, microcytosis, and reduced transferrin satn. without any effect on infection.  Similarly, parenteral iron loading with ferric citrate over 10 days (75 mg iron/kg) failed to aggravate infection.  In a search for evidence of direct interaction between DF and parasitized erythrocytes, gel filtration and ultrafiltration was performed on hemolyzates obtained from in vivo 59Fe-labeled parasitized erythrocytes.  This showed that 1.1-1.9% of the intracellular radioiron was located in a chelatable, labile iron pool.  Incubation of intact cells with 0-500 Î¼M DF resulted in a proportional increase in intracellular iron chelation, and the chelation of all available labile intracellular iron was completed within 6 h.  These observations indicate that the severity of P. berghei infection in rats and its in vivo suppression by DF are independent of host iron status and suggest that DF inhibition of malaria involves intracellular chelation of a labile iron pool in parasitized erythrocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAu182JG4XiLVg90H21EOLACvtfcHk0li_ISylc4btfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXltVChsbs%253D&md5=a16d3668a64c61095e4f8b85347ee838</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1084%2Fjem.168.1.375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.168.1.375%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DC%26aulast%3DPeto%26aufirst%3DT%2BE%26atitle%3DDeferoxamine%2520inhibition%2520of%2520malaria%2520is%2520independent%2520of%2520host%2520iron%2520status%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1988%26volume%3D168%26issue%3D1%26spage%3D375%26epage%3D387%26doi%3D10.1084%2Fjem.168.1.375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mabeza, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyevsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordeuk, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, G.</span></span> <span> </span><span class="NLM_article-title">Iron chelation therapy for malaria: a review</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">53</span>â <span class="NLM_lpage">75</span>, <span class="refDoi">Â DOI: 10.1016/S0163-7258(98)00037-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0163-7258%2898%2900037-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10051178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADyaK1M7lvVCrtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1999&pages=53-75&issue=1&author=G.+F.+Mabezaauthor=M.+Loyevskyauthor=V.+R.+Gordeukauthor=G.+Weiss&title=Iron+chelation+therapy+for+malaria%3A+a+review&doi=10.1016%2FS0163-7258%2898%2900037-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelation therapy for malaria: a review</span></div><div class="casAuthors">Mabeza G F; Loyevsky M; Gordeuk V R; Weiss G</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-75</span>
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    </div><div class="casAbstract">Malaria is one of the major global health problems, and an urgent need for the development of new antimalarial agents faces the scientific community.  A considerable number of iron(III) chelators, designed for purposes other than treating malaria, have antimalarial activity in vitro, apparently through the mechanism of withholding iron from vital metabolic pathways of the intra-erythrocytic parasite.  Certain iron(II) chelators also have antimalarial activity, but the mechanism of action appears to be the formation of toxic complexes with iron rather than the withholding of iron.  Several of the iron(III)-chelating compounds also have antimalarial activity in animal models of plasmodial infection.  Iron chelation therapy with desferrioxamine, the only compound of this nature that is widely available for use in humans, has clinical activity in both uncomplicated and severe malaria in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSr6JXMYvtZGgyMywPm6HgQfW6udTcc2eaSS0Ao_O0iIrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7lvVCrtQ%253D%253D&md5=8a35b795b890b124497de08b6188a809</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900037-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900037-0%26sid%3Dliteratum%253Aachs%26aulast%3DMabeza%26aufirst%3DG.%2BF.%26aulast%3DLoyevsky%26aufirst%3DM.%26aulast%3DGordeuk%26aufirst%3DV.%2BR.%26aulast%3DWeiss%26aufirst%3DG.%26atitle%3DIron%2520chelation%2520therapy%2520for%2520malaria%253A%2520a%2520review%26jtitle%3DPharmacol.%2520Ther.%26date%3D1999%26volume%3D81%26issue%3D1%26spage%3D53%26epage%3D75%26doi%3D10.1016%2FS0163-7258%2898%2900037-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershko, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theanacho, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spira, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">The effect of <i>N</i>-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>77</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">637</span>â <span class="NLM_lpage">643</span>, <span class="refDoi">Â DOI: 10.1182/blood.V77.3.637.637</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1182%2Fblood.V77.3.637.637" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1991172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK3MXktVShs7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1991&pages=637-643&issue=3&author=C.+Hershkoauthor=E.+N.+Theanachoauthor=D.+T.+Spiraauthor=H.+H.+Peterauthor=P.+Dobbinauthor=R.+C.+Hider&title=The+effect+of+N-alkyl+modification+on+the+antimalarial+activity+of+3-hydroxypyridin-4-one+oral+iron+chelators&doi=10.1182%2Fblood.V77.3.637.637"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators</span></div><div class="casAuthors">Hershko, C.; Theanacho, E. N.; Spira, D. T.; Peter, H. H.; Dobbin, P.; Hider, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-43</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">The antimalarial effect of iron chelators is attributed to their interaction with a labile iron pool within parasitized erythrocytes, and it was postulated that increased affinity to iron as well as increased lipophilicity may improve antimalarial activity.  The authors have examd. the antimalarial effect of 3-hydroxypyridin-4-ones (I; R1 = Me, Et; R2 = Me, Et, C2H4CO2H, C2H4OH, C2H4OMe), a family of bidentate orally effective iron chelators whose lipophilicity may be modified by altering the length of the R2 substituent on the ring nitrogen.  A significant dose-related suppression of Plasmodium falciparum cultures was obsd. with all drugs tested in vitro at concns. of 5 Î¼mol/L or higher.  In contrast, there was a clear segregation of the in vivo effect on P. berghei in rats (300 mg/kg/d s.c.) into two categories: compds. CP20, 38, and 40 failed to suppress malaria, whereas CP51, 94, and 96 had a strong antimalarial effect, similar or better than deferoxamine.  There was a close linear correlation between the suppression of peak parasite counts and the redn. in hepatic nonheme iron induced by the various drugs tested.  The most lipophilic compds. were also the most effective in suppressing malaria and in depleting hepatic iron stores.  These data indicate that 3-hydroxypyridin-4-ones are able to suppress malaria in vivo and in vitro.  Because lipid soly. is an important determinant of antimalarial action, this study provides useful information regarding the selection of orally effective iron-chelating compds. that may be suitable for clin. application as antimalarial agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNldImTtcvfLVg90H21EOLACvtfcHk0li_ISylc4btfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXktVShs7c%253D&md5=8a1cc8421a16b7f82e8181599836954f</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1182%2Fblood.V77.3.637.637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V77.3.637.637%26sid%3Dliteratum%253Aachs%26aulast%3DHershko%26aufirst%3DC.%26aulast%3DTheanacho%26aufirst%3DE.%2BN.%26aulast%3DSpira%26aufirst%3DD.%2BT.%26aulast%3DPeter%26aufirst%3DH.%2BH.%26aulast%3DDobbin%26aufirst%3DP.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DThe%2520effect%2520of%2520N-alkyl%2520modification%2520on%2520the%2520antimalarial%2520activity%2520of%25203-hydroxypyridin-4-one%2520oral%2520iron%2520chelators%26jtitle%3DBlood%26date%3D1991%26volume%3D77%26issue%3D3%26spage%3D637%26epage%3D643%26doi%3D10.1182%2Fblood.V77.3.637.637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fakorede, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">3-Hydroxpyridin-4-one prodrugs as novel antimalarials</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">113</span>â <span class="NLM_lpage">113</span>, <span class="refDoi">Â DOI: 10.1111/j.2042-7158.1998.tb02313.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.2042-7158.1998.tb02313.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlKltro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=113-113&author=F.+A.+Fakoredeauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=3-Hydroxpyridin-4-one+prodrugs+as+novel+antimalarials&doi=10.1111%2Fj.2042-7158.1998.tb02313.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">3-Hydroxypyridin-4-one prodrugs as novel antimalarials</span></div><div class="casAuthors">Fakorede, F. A.; Liu, Z. D.; Hider, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Suppl., British Pharmaceutical Conference 1998</span>),
    <span class="NLM_cas:pages">113</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    
            (<span class="NLM_cas:orgname">Royal Pharmaceutical Society of Great Britain</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpr2am0Z1VrVg90H21EOLACvtfcHk0li_ISylc4btfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlKltro%253D&md5=e24b105df3841a963687520daa9077b0</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1998.tb02313.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1998.tb02313.x%26sid%3Dliteratum%253Aachs%26aulast%3DFakorede%26aufirst%3DF.%2BA.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3D3-Hydroxpyridin-4-one%2520prodrugs%2520as%2520novel%2520antimalarials%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1998%26volume%3D50%26spage%3D113%26epage%3D113%26doi%3D10.1111%2Fj.2042-7158.1998.tb02313.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehkordi, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Basic 3-hydroxypyridin-4-ones: potential antimalarial agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1035</span>â <span class="NLM_lpage">1047</span>, <span class="refDoi">Â DOI: 10.1016/j.ejmech.2007.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.ejmech.2007.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=17869385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlslKmtbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1035-1047&issue=5&author=L.+S.+Dehkordiauthor=Z.+D.+Liuauthor=R.+C.+Hider&title=Basic+3-hydroxypyridin-4-ones%3A+potential+antimalarial+agents&doi=10.1016%2Fj.ejmech.2007.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Basic 3-hydroxypyridin-4-ones: Potential antimalarial agents</span></div><div class="casAuthors">Dehkordi, Lotfollah S.; Liu, Zu D.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1035-1047</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">3-Hydroxypyridin-4-ones selectively bind iron under biol. conditions and one such compd. has found application in the treatment of thalassemia-linked iron overload.  Related mols. have also been demonstrated to possess an antimalarial effect at levels which are nontoxic to mammalian cells.  In an attempt to improve the efficiency of such mols. the authors have investigated the effect of introducing basic nitrogen centers into 3-hydroxypyridin-4-ones in an attempt to achieve targeting to lysosomes and other intracellular acidic vacuoles.  Several of the compds. reported in this communication possess enhanced antimalarial activity over that of the simple hydroxypyridinone class.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnQAOfMSEHLVg90H21EOLACvtfcHk0lhrmsOrnC2G9g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlslKmtbs%253D&md5=f5d69004b70ebe5401e56747a52d84e4</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2007.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2007.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DDehkordi%26aufirst%3DL.%2BS.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DBasic%25203-hydroxypyridin-4-ones%253A%2520potential%2520antimalarial%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26issue%3D5%26spage%3D1035%26epage%3D1047%26doi%3D10.1016%2Fj.ejmech.2007.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saeftel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarite, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Njuguna, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span> <span> </span><span class="NLM_article-title">Piperidones with activity against Plasmodium falciparum</span>. <i>Parasitol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">281</span>â <span class="NLM_lpage">286</span>, <span class="refDoi">Â DOI: 10.1007/s00436-006-0173-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00436-006-0173-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=16550432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD28vgtlGiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2006&pages=281-286&issue=3&author=M.+Saeftelauthor=R.+S.+Sariteauthor=T.+Njugunaauthor=U.+Holzgrabeauthor=D.+Ulmerauthor=A.+Hoeraufauthor=A.+Kaiser&title=Piperidones+with+activity+against+Plasmodium+falciparum&doi=10.1007%2Fs00436-006-0173-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidones with activity against Plasmodium falciparum</span></div><div class="casAuthors">Saeftel Michael; Sarite Ramadan Salem; Njuguna Tujo; Holzgrabe Ulrike; Ulmer Daniela; Hoerauf Achim; Kaiser Annette</div><div class="citationInfo"><span class="NLM_cas:title">Parasitology research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-6</span>
        ISSN:<span class="NLM_cas:issn">0932-0113</span>.
    </div><div class="casAbstract">The increasing resistance of the malaria parasites has enforced new strategies of finding new drug targets.  We have isolated two genes involved in spermidine metabolism, encoding deoxyhypusine synthase (DHS) and eukaryotic initiation factor 5A (eIF-5A) in the malaria parasites. eIF-5A is activated by the formation of the unusual amino acid hypusine.  This process occurs in two steps.  DHS transfers an aminobutyl moiety from the triamine spermidine to a specific lysine residue in the eIF-5A precursor protein to form deoxyhypusine.  In a second step, deoxyhypusine hydroxylase (DHH), completes hypusine biosynthesis.  We used DHH inhibitors, being effective in mammalian cells, to study an antiplasmodicidal effect in Plasmodium falciparum.  Experiments with the antifungal drug ciclopiroxolamine, an alpha-hydroxypyridone, and the plant amino acid L: -mimosine, a 4-pyridone, resulted in an antiplasmodial effect in vitro.  Using mimosine as a lead structure, alkyl 4-oxo-piperidine 3-carboxylates were found to have the most efficient antiplasmodial effects in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6Di7xJiS0yEloaUqgkFHkfW6udTcc2eYyhxd6qQpzObntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vgtlGiuw%253D%253D&md5=35c902517b711bc782f9cf6afa68cf0c</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1007%2Fs00436-006-0173-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00436-006-0173-4%26sid%3Dliteratum%253Aachs%26aulast%3DSaeftel%26aufirst%3DM.%26aulast%3DSarite%26aufirst%3DR.%2BS.%26aulast%3DNjuguna%26aufirst%3DT.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DUlmer%26aufirst%3DD.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DKaiser%26aufirst%3DA.%26atitle%3DPiperidones%2520with%2520activity%2520against%2520Plasmodium%2520falciparum%26jtitle%3DParasitol.%2520Res.%26date%3D2006%26volume%3D99%26issue%3D3%26spage%3D281%26epage%3D286%26doi%3D10.1007%2Fs00436-006-0173-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehrke, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steverding, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleban, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempone, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of deferiprone-type iron chelators</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">805</span>â <span class="NLM_lpage">813</span>, <span class="refDoi">Â DOI: 10.1016/j.bmc.2012.11.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmc.2012.11.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=23266185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqu7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=805-813&issue=3&author=S.+S.+Gehrkeauthor=E.+G.+Pintoauthor=D.+Steverdingauthor=K.+Plebanauthor=A.+G.+Temponeauthor=R.+C.+Hiderauthor=G.+K.+Wagner&title=Conjugation+to+4-aminoquinoline+improves+the+anti-trypanosomal+activity+of+deferiprone-type+iron+chelators&doi=10.1016%2Fj.bmc.2012.11.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators</span></div><div class="casAuthors">Gehrke, Sebastian S.; Pinto, Erika G.; Steverding, Dietmar; Pleban, Karin; Tempone, Andre G.; Hider, Robert C.; Wagner, Gerd K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">805-813</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Iron is an essential growth component in all living organisms and plays a central role in numerous biochem. processes due to its redox potential and high affinity for oxygen.  The use of iron chelators has been suggested as a novel therapeutic approach towards parasitic infections, such as malaria, sleeping sickness and leishmaniasis.  Known iron chelating agents such as Deferoxamine and the 3-hydroxypyridin-4-one (HPO) Deferiprone possess anti-parasitic activity but suffer from mammalian toxicity, relatively modest potency, and/or poor oral availability.  In this study, we have developed novel derivs. of Deferiprone with increased anti-parasitic activity and reduced cytotoxicity against human cell lines.  Of particular interest are several new derivs. in which the HPO scaffold has been conjugated, via a linker, to the 4-aminoquinoline ring system present in the known anti-malaria drug Chloroquine.  We report the inhibitory activity of these novel analogs against four parasitic protozoa, Trypanosoma brucei, Trypanosoma cruzi, Leishmania infantum and Plasmodium falciparum, and, for direct comparison, against human cells lines.  We also present data, which support the hypothesis that iron starvation is the major cause of growth inhibition of these new Deferiprone-Chloroquine conjugates in T. brucei.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooOuVYNxfv5bVg90H21EOLACvtfcHk0lgal8k1J_hDaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqu7nK&md5=f4898e3e3b444c58541d0990c5bb158f</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2012.11.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2012.11.009%26sid%3Dliteratum%253Aachs%26aulast%3DGehrke%26aufirst%3DS.%2BS.%26aulast%3DPinto%26aufirst%3DE.%2BG.%26aulast%3DSteverding%26aufirst%3DD.%26aulast%3DPleban%26aufirst%3DK.%26aulast%3DTempone%26aufirst%3DA.%2BG.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DWagner%26aufirst%3DG.%2BK.%26atitle%3DConjugation%2520to%25204-aminoquinoline%2520improves%2520the%2520anti-trypanosomal%2520activity%2520of%2520deferiprone-type%2520iron%2520chelators%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26issue%3D3%26spage%3D805%26epage%3D813%26doi%3D10.1016%2Fj.bmc.2012.11.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andayi, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis, antiplasmodial activity, and beta-hematin inhibition of hydroxypyridone-chloroquine hybrids</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">642</span>â <span class="NLM_lpage">646</span>, <span class="refDoi">Â DOI: 10.1021/ml4001084</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml4001084" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvFyitLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=642-646&issue=7&author=W.+A.+Andayiauthor=T.+J.+Eganauthor=J.+Gutauthor=P.+J.+Rosenthalauthor=K.+Chibale&title=Synthesis%2C+antiplasmodial+activity%2C+and+beta-hematin+inhibition+of+hydroxypyridone-chloroquine+hybrids&doi=10.1021%2Fml4001084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, Antiplasmodial Activity, and Î²-Hematin Inhibition of Hydroxypyridone-Chloroquine Hybrids</span></div><div class="casAuthors">Andayi, Warren A.; Egan, Timothy J.; Gut, Jiri; Rosenthal, Philip J.; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">642-646</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of noncytotoxic 4-aminoquinoline-3-hydroxypyridin-4-one hybrids I [R2 = Me, Et, R3 = Bn, H, Me, X = (CH2)n, n = 1, 2, 3, 5] were synthesized on the basis of a synergistic in vitro combination of a precursor N-alkyl-3-hydroxypyridin-4-one with chloroquine (CQ) and tested in vitro against CQ resistant (K1 and W2) and sensitive (3D7) strains of Plasmodium falciparum.  In vitro antiplasmodial activity of the precursors was negated by blocking the chelator moiety via complexation with gallium(III) or benzyl protection.  None of the precursors inhibited Î²-hematin formation.  Most hybrids were more potent inhibitors of Î²-hematin formation than CQ, and a correlation between antiplasmodial activity and inhibition of Î²-hematin formation was obsd.  Potent hybrids against K1, 3D7, and W2, resp., were I [R2 = Et, R3 = Bn, X = (CH2)3] (0.13, 0.004, and 0.1 Î¼M); I [R2 = Et, R3 = Bn, X = (CH2)5] (0.08, 0.01, and 0.02 Î¼M); and I [R2 = Me, R3 = H, X = (CH2)3] (0.07, 0.03, and 0.08 Î¼M).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbaoGOOnhBLrVg90H21EOLACvtfcHk0lgal8k1J_hDaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvFyitLk%253D&md5=1a24c2a65d73199d8b7e6cd6bae9369f</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1021%2Fml4001084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml4001084%26sid%3Dliteratum%253Aachs%26aulast%3DAndayi%26aufirst%3DW.%2BA.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DGut%26aufirst%3DJ.%26aulast%3DRosenthal%26aufirst%3DP.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DSynthesis%252C%2520antiplasmodial%2520activity%252C%2520and%2520beta-hematin%2520inhibition%2520of%2520hydroxypyridone-chloroquine%2520hybrids%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D7%26spage%3D642%26epage%3D646%26doi%3D10.1021%2Fml4001084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dambuza, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andayi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesner, L.</span></span> <span> </span><span class="NLM_article-title">Antiplasmodial activity, <i>in vivo</i> pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">505</span>â <span class="NLM_lpage">512</span>, <span class="refDoi">Â DOI: 10.1186/s12936-015-1032-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1186%2Fs12936-015-1032-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26671222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVamtA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=505-512&author=N.+S.+Dambuzaauthor=P.+Smithauthor=A.+Evansauthor=J.+Normanauthor=D.+Taylorauthor=A.+Andayiauthor=T.+Eganauthor=K.+Chibaleauthor=L.+Wiesner&title=Antiplasmodial+activity%2C+in+vivo+pharmacokinetics+and+anti-malarial+efficacy+evaluation+of+hydroxypyridinone+hybrids+in+a+mouse+model&doi=10.1186%2Fs12936-015-1032-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model</span></div><div class="casAuthors">Dambuza, Ntokozo S.; Smith, Peter; Evans, Alicia; Norman, Jennifer; Taylor, Dale; Andayi, Andrew; Egan, Timothy; Chibale, Kelly; Wiesner, Lubbe</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">505/1-505/8</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: During the erythrocytic stage in humans, malaria parasites digest Hb of the host cell, and the toxic haem moiety crystallizes into haemozoin.  Chloroquine acts by forming toxic complexes with haem mols. and interfering with their crystn.  In chloroquine-resistant strains, the drug is excluded from the site of action, which causes the parasites to accumulate less chloroquine in their acid food vacuoles than chloroquine-sensitive parasites.  3-Hydroxylpyridin-4-ones are known to chelate iron; hydroxypyridone-chloroquine (HPO-CQ) hybrids were synthesized in order to det. whether they can inhibit parasites proliferation in the parasitic digestive vacuole by withholding iron from plasmodial parasite metabolic pathway.  Methods: Two HPO-CQ hybrids were tested against Plasmodium falciparum chloroquine-sensitive (D10 and 3D7) and -resistant strains (Dd2 and K1).  The pharmacokinetic properties of active compds. were detd. using a mouse model and blood samples were collected at different time intervals and analyzed using LC-MS/MS.  For in vivo efficacy the mice were infected with Plasmodium berghei in a 4-day Peters' test.  The parasitemia was detd. from day 3 and the course of the infection was followed by microscopic examn. of stained blood films every 2-3 days until a rise in parasitemia was obsd. in all test subjects.  Results: IC50 values of the two compds. for sensitive and resistant strains were 0.064 and 0.047 Î¼M (compd. 1), 0.041 and 0.122 Î¼M (compd. 2) and 0.505 and 0.463 Î¼M (compd. 1), 0.089 and 0.076 Î¼M (compd. 2), resp.  Pharmacokinetic evaluation of these compds. showed low oral bioavailability and this affected in vivo efficacy when compds. were dosed orally.  However, when dosed i.v. compd. 1 showed a clearance rate of 28 mL/min/kg, an apparent vol. of distribution of 20 l/kg and a half-life of 4.3 h.  A redn. in parasitemia was obsd. when compd. 1 was dosed i.v. for four consecutive days in P. berghei-infected mice.  However, a rise in parasitemia levels was obsd. on day 6 and on day 9 for chloroquine-treated mice.  Conclusion: The hybrid compds. that were tested were able to reduce parasitemia levels in P. berghei-infected mice when dosed i.v., but parasites recrudesced 24 h after the administration of the least dose.  Despite low oral bioavailability, the IV data obtained suggests that further structural modifications may lead to the identification of more HPO-CQ hybrids with improved pharmacokinetic properties and in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh53X88-Apq7Vg90H21EOLACvtfcHk0lgal8k1J_hDaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVamtA%253D%253D&md5=00f5489e2e36782f48e6b2fff1f759b0</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-1032-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-1032-5%26sid%3Dliteratum%253Aachs%26aulast%3DDambuza%26aufirst%3DN.%2BS.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DA.%26aulast%3DNorman%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DAndayi%26aufirst%3DA.%26aulast%3DEgan%26aufirst%3DT.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DWiesner%26aufirst%3DL.%26atitle%3DAntiplasmodial%2520activity%252C%2520in%2520vivo%2520pharmacokinetics%2520and%2520anti-malarial%2520efficacy%2520evaluation%2520of%2520hydroxypyridinone%2520hybrids%2520in%2520a%2520mouse%2520model%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26spage%3D505%26epage%3D512%26doi%3D10.1186%2Fs12936-015-1032-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varesio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battaglia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raggi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledda, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosco, M. C.</span></span> <span> </span><span class="NLM_article-title">Macrophage-inflammatory protein-3Î±/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-ÎºB</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>47</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">685</span>â <span class="NLM_lpage">693</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2009.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.molimm.2009.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19939449" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjsFKl" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2010&pages=685-693&issue=4&author=L.+Varesioauthor=F.+Battagliaauthor=F.+Raggiauthor=B.+Leddaauthor=M.+C.+Bosco&title=Macrophage-inflammatory+protein-3%CE%B1%2FCCL-20+is+transcriptionally+induced+by+the+iron+chelator+desferrioxamine+in+human+mononuclear+phagocytes+through+nuclear+factor+%28NF%29-%CE%BAB&doi=10.1016%2Fj.molimm.2009.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage-inflammatory protein-3Î±/CCL-20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-ÎºB</span></div><div class="casAuthors">Varesio, Luigi; Battaglia, Florinda; Raggi, Federica; Ledda, Bernadetta; Bosco, Maria Carla</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">685-693</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Alterations in iron availability can trigger pro-inflammatory signals in various cell types.  The authors demonstrate that desferrioxamine (DFX), an iron chelator used in clinics for the treatment of iron overload, neoplasias, and Alzheimer disease, stimulates the expression and secretion of CCL20, a chemoattractant for immature dendritic cells, activated/memory T lymphocytes, and naive B cells, in primary human monocytes and monocyte-derived macrophages.  Iron chelation was part of the mechanism by which DFX induced CCL20, because addn. of iron sulfate counteracted its stimulatory effects.  Functional studies of the CCL20 promoter, using a series of 5'-deleted and mutated reporter constructs, demonstrated that CCL20 mRNA induction was dependent on gene transcription activation and mediated by the NF-ÎºB pathway.  The NF-ÎºB element located at position -92/-82 of the CCL20 promoter was required for gene transactivation by DFX because: (i) transcription was abrogated by a 3 bp mutation of the NF-ÎºB-binding motif; (ii) treatment with DFX increased specific NF-ÎºB binding to this sequence.  Nuclear translocation of both NF-ÎºBp65 and NF-ÎºBp50 family members was increased in response to DFX and assocd. with I-ÎºBÎ± degrdn., suggesting a role for these subunits in CCL20 promoter transactivation.  In conclusion, this study provides the first evidence that iron chelation can transcriptionally induce CCL20 in mononuclear phagocytes and identify the NF-ÎºB binding site as a regulatory sequence of the CCL20 promoter that is activated by iron deprivation.  These results add new insights into the authors' understanding of the mechanisms by which iron perturbations affect mononuclear phagocyte immune functions and regulate inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUyCET0z4AGLVg90H21EOLACvtfcHk0lgc-IFLWGdRnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjsFKl&md5=bc6864575be0320b42ab1c077e61e2d4</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2009.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2009.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DVaresio%26aufirst%3DL.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DRaggi%26aufirst%3DF.%26aulast%3DLedda%26aufirst%3DB.%26aulast%3DBosco%26aufirst%3DM.%2BC.%26atitle%3DMacrophage-inflammatory%2520protein-3%25CE%25B1%252FCCL-20%2520is%2520transcriptionally%2520induced%2520by%2520the%2520iron%2520chelator%2520desferrioxamine%2520in%2520human%2520mononuclear%2520phagocytes%2520through%2520nuclear%2520factor%2520%2528NF%2529-%25CE%25BAB%26jtitle%3DMol.%2520Immunol.%26date%3D2010%26volume%3D47%26issue%3D4%26spage%3D685%26epage%3D693%26doi%3D10.1016%2Fj.molimm.2009.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozturk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erol, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzbay, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aytemir, M. D.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 4(1<i>H</i>)-pyridinone derivatives and investigation of analgesic and antiinflammatory activities</span>. <i>Farmaco</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">251</span>â <span class="NLM_lpage">256</span>, <span class="refDoi">Â DOI: 10.1016/S0014-827X(01)01083-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0014-827X%2801%2901083-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11421252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFKru7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=251-256&author=G.+Ozturkauthor=D.+D.+Erolauthor=T.+Uzbayauthor=M.+D.+Aytemir&title=Synthesis+of+4%281H%29-pyridinone+derivatives+and+investigation+of+analgesic+and+antiinflammatory+activities&doi=10.1016%2FS0014-827X%2801%2901083-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 4(1H)-pyridinone derivatives and investigation of analgesic and antiinflammatory activities</span></div><div class="casAuthors">Ozturk, Gulcan; Erol, Dilek Demir; Uzbay, Tayfun; Aytemir, Mutlu Dilsiz</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">251-256</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">This paper describes recent results of a research program aimed at the synthesis and pharmacol. evaluation of new 4(1H)-pyridinone derivs. belonging to the 1,3-disubstituted series, i.e., I (R = piperidino, 2-pyridinyl, 1-methyl-2-pyrrolidinyl, morpholino; R1 = benzyl, H).  These compds. were structurally planned by applying the mol. hybridization strategy on previously described 1,2-disubstituted 4(1H)-pyridinone derivs., considered as lead compds., which present potent analgesic properties.  Their chem. structures have been proved by means of their IR and 1H NMR data and by elemental anal.  The analgesic profile of I, evaluated by the model of abdominal constrictions induced by acetic acid, showed that all the 4(1H)-pyridinone derivs. were active, exhibiting an analgesic activity comparable with that of aspirin (acetylsalicylic acid) used as a std.  The antiinflammatory profile of I, evaluated by the model of carrageenan rat paw edema, showed that all compds. were active and were comparable with an indomethacin std.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosgO-jvJtIKrVg90H21EOLACvtfcHk0lgc-IFLWGdRnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFKru7k%253D&md5=1aefde2e13d05d7149d225f5860cedb1</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2801%2901083-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252801%252901083-7%26sid%3Dliteratum%253Aachs%26aulast%3DOzturk%26aufirst%3DG.%26aulast%3DErol%26aufirst%3DD.%2BD.%26aulast%3DUzbay%26aufirst%3DT.%26aulast%3DAytemir%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520of%25204%25281H%2529-pyridinone%2520derivatives%2520and%2520investigation%2520of%2520analgesic%2520and%2520antiinflammatory%2520activities%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D251%26epage%3D256%26doi%3D10.1016%2FS0014-827X%2801%2901083-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ozturk, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erol, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aytemir, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uzbay, T.</span></span> <span> </span><span class="NLM_article-title">New analgesic and antiinflammatory agents 4(1<i>H</i>)-pyridinone derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">829</span>â <span class="NLM_lpage">834</span>, <span class="refDoi">Â DOI: 10.1016/S0223-5234(02)01390-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0223-5234%2802%2901390-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12446041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38Xosl2itLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=829-834&issue=10&author=G.+Ozturkauthor=D.+D.+Erolauthor=M.+D.+Aytemirauthor=T.+Uzbay&title=New+analgesic+and+antiinflammatory+agents+4%281H%29-pyridinone+derivatives&doi=10.1016%2FS0223-5234%2802%2901390-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">New analgesic and antiinflammatory agents 4(1H)-pyridinone derivatives</span></div><div class="casAuthors">Ozturk, Gulcan; Erol, Dilek Demir; Aytemir, Mutlu Dilsiz; Uzbay, Tayfun</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">829-834</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">A series of 1,2,5-trisubstituted 4(1H)-pyridinone derivs. were synthesized by using 4-pyrone derivs. with primary amines in ethanol.  Analgesic and antiinflammatory activities of the synthesized compds. were investigated by acetic acid-induced writhing syndrome and carrageenan rat paw edema tests.  All of the test compds. exhibited higher analgesic activities than acetyl salicylic acid and showed higher antiinflammatory activities than indomethacin.  The anti-inflammatory activity and gastric ulceration potential of the compds. were tested using indomethacin as ref. drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoavaRsF34SsbVg90H21EOLACvtfcHk0lgc-IFLWGdRnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xosl2itLk%253D&md5=e6f81d6ae833df5061d6b1640013b800</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2802%2901390-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252802%252901390-9%26sid%3Dliteratum%253Aachs%26aulast%3DOzturk%26aufirst%3DG.%26aulast%3DErol%26aufirst%3DD.%2BD.%26aulast%3DAytemir%26aufirst%3DM.%2BD.%26aulast%3DUzbay%26aufirst%3DT.%26atitle%3DNew%2520analgesic%2520and%2520antiinflammatory%2520agents%25204%25281H%2529-pyridinone%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26issue%3D10%26spage%3D829%26epage%3D834%26doi%3D10.1016%2FS0223-5234%2802%2901390-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorburn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeTourneau-Paci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colp, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoskin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, C.</span></span> <span> </span><span class="NLM_article-title">Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis</span>. <i>Clin. Hemorheol. Microcirc.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">3â4</span>),  <span class="NLM_fpage">241</span>â <span class="NLM_lpage">250</span>, <span class="refDoi">Â DOI: 10.3233/CH-179205</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3233%2FCH-179205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28869457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtL%252FM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2017&pages=241-250&issue=3%E2%80%934&author=T.+Thorburnauthor=M.+Aaliauthor=L.+Kostekauthor=C.+LeTourneau-Paciauthor=P.+Colpauthor=J.+Zhouauthor=B.+Holbeinauthor=D.+Hoskinauthor=C.+Lehmann&title=Anti-inflammatory+effects+of+a+novel+iron+chelator%2C+DIBI%2C+in+experimental+sepsis&doi=10.3233%2FCH-179205"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-inflammatory effects of a novel iron chelator, DIBI, in experimental sepsis</span></div><div class="casAuthors">Thorburn, Taylor; Aali, Maral; Kostek, Lisanne; LeTourneau-Paci, Chloe; Colp, Patricia; Zhou, Juan; Holbein, Bruce; Hoskin, David; Lehmann, Christian; Juenger, M.; Krueger-Genge, A.; Jung, F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Hemorheology and Microcirculation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">241-250</span>CODEN:
                <span class="NLM_cas:coden">CHMIFQ</span>;
        ISSN:<span class="NLM_cas:issn">1386-0291</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Iron catalyzes the generation of reactive oxygen species (ROS) as part of the innate antimicrobial defense.  During sepsis, the dysregulated systemic inflammatory response to infection, iron homeostasis becomes disrupted, generating an excess of ROS causing damage to tissues.  This can be potentially suppressed using iron chelators that selectively bind iron to prevent its participation in ROS-related inflammatory reactions.  We hypothesize that administration of DIBI, a novel iron-chelator, attenuates the dysregulated systemic immune response and reduces tissue damage in exptl. endotoxemia.  Five groups of animals (n=5-10) were included in this study: control, untreated endotoxemia, and endotoxemia animals treated with either DIBI-A, MAHMP, or DIBI-B.  Intravital microscopy was performed on the intestine of anesthesized mice to observe leukocyte endothelial interactions and evaluate the intestinal microcirculation.  Treatment of endotoxemic mice with DIBI-B reduced the no. of adhering leukocytes in submucosal collecting (V1) venules by 68%.  DIBI-B, MAHMP, and DIBI-A were able to restore functional capillary d. (FCD) in the intestinal muscle layer by 74%, 44%, and 11%, resp.  DIBI-B reduces leukocyte recruitment and improves FCD in exptl. endotoxemia, outperforming other chelators tested.  These findings suggest a potential role for DIBI-B as a candidate drug for sepsis treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqUYCcJ_2urbVg90H21EOLACvtfcHk0ljnMj8pr4ar-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOgtL%252FM&md5=e1d549c0358f87cdd84919c785c4da21</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.3233%2FCH-179205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FCH-179205%26sid%3Dliteratum%253Aachs%26aulast%3DThorburn%26aufirst%3DT.%26aulast%3DAali%26aufirst%3DM.%26aulast%3DKostek%26aufirst%3DL.%26aulast%3DLeTourneau-Paci%26aufirst%3DC.%26aulast%3DColp%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHolbein%26aufirst%3DB.%26aulast%3DHoskin%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DC.%26atitle%3DAnti-inflammatory%2520effects%2520of%2520a%2520novel%2520iron%2520chelator%252C%2520DIBI%252C%2520in%2520experimental%2520sepsis%26jtitle%3DClin.%2520Hemorheol.%2520Microcirc.%26date%3D2017%26volume%3D67%26issue%3D3%25E2%2580%25934%26spage%3D241%26epage%3D250%26doi%3D10.3233%2FCH-179205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczesniak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Banna, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharawy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Islam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbein, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, C.</span></span> <span> </span><span class="NLM_article-title">DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis</span>. <i>Clin. Hemorheol. Microcirc.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">1â2</span>),  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">164</span>, <span class="refDoi">Â DOI: 10.3233/CH-189109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.3233%2FCH-189109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=29630535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptlyhsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2018&pages=153-164&issue=1%E2%80%932&author=N.+Aroraauthor=A.+Caldwellauthor=K.+Wafaauthor=A.+Szczesniakauthor=M.+Caldwellauthor=N.+Al-Bannaauthor=N.+Sharawyauthor=S.+Islamauthor=J.+Zhouauthor=B.+E.+Holbeinauthor=M.+E.+M.+Kellyauthor=C.+Lehmann&title=DIBI%2C+a+polymeric+hydroxypyridinone+iron+chelator%2C+reduces+ocular+inflammation+in+local+and+systemic+endotoxin-induced+uveitis&doi=10.3233%2FCH-189109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitis</span></div><div class="casAuthors">Arora, N.; Caldwell, A.; Wafa, K.; Szczesniak, A.; Caldwell, M.; Al-Banna, N.; Sharawy, N.; Islam, S.; Zhou, J.; Holbein, B. E.; Kelly, M. E. M.; Lehmann, Ch.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Hemorheology and Microcirculation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">153-164</span>CODEN:
                <span class="NLM_cas:coden">CHMIFQ</span>;
        ISSN:<span class="NLM_cas:issn">1386-0291</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Non-infectious uveitis is an inflammatory disease of the eye commonly treated by corticosteroids, though important side effects may result.  A main mediator of inflammation are oxygen free radicals generated in iron-dependent pathways.  As such, we investigated the efficacy of a novel iron chelator, DIBI, as an anti-inflammatory agent in local and systemic models of endotoxin induced uveitis (EIU).  Firstly, the effects of DIBI in systemic EIU in Lewis rats were established.  In 2 h post i.v. LPS or LPS/DIBI injections, leukocyte activation and functional capillary d. (FCD) were examd. using intravital microscopy (IVM) of the iridial microcirculation.  Secondly, the toxicity of DIBI was evaluated in BALB/C mice for both acute and chronic dosages through gross ocular examn., intraocular pressure measurements and hematoxylin-eosin staining of ocular tissue.  Lastly, three groups of BALB/C mice, control, LPS or DIBI + LPS, were studied to evaluate the effectiveness of DIBI in treating local EIU.  Five hours post-local intravitreal (i.v) injection, leukocyte activation and capillary d. were examd. via IVM.  Treatment of systemic EIU with DIBI resulted in a redn. of leukocyte activation and FCD improvement within the iridial microcirculation.  Toxicity studies suggested that acute and chronic DIBI administration had no adverse effects in the eye.  In the local EIU model, DIBI was shown to reduce leukocyte activation and restored the FCD/DCD ratio, providing evidence for its anti-inflammatory properties.  This study has provided evidence that DIBI has anti-inflammatory effects in exptl. uveitis.  Addnl., no local ocular toxicity was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7yg1W5hy69rVg90H21EOLACvtfcHk0ljnMj8pr4ar-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptlyhsL4%253D&md5=a4d2dae305e9e75d4c53928659cdfbeb</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.3233%2FCH-189109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FCH-189109%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DN.%26aulast%3DCaldwell%26aufirst%3DA.%26aulast%3DWafa%26aufirst%3DK.%26aulast%3DSzczesniak%26aufirst%3DA.%26aulast%3DCaldwell%26aufirst%3DM.%26aulast%3DAl-Banna%26aufirst%3DN.%26aulast%3DSharawy%26aufirst%3DN.%26aulast%3DIslam%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DHolbein%26aufirst%3DB.%2BE.%26aulast%3DKelly%26aufirst%3DM.%2BE.%2BM.%26aulast%3DLehmann%26aufirst%3DC.%26atitle%3DDIBI%252C%2520a%2520polymeric%2520hydroxypyridinone%2520iron%2520chelator%252C%2520reduces%2520ocular%2520inflammation%2520in%2520local%2520and%2520systemic%2520endotoxin-induced%2520uveitis%26jtitle%3DClin.%2520Hemorheol.%2520Microcirc.%26date%3D2018%26volume%3D69%26issue%3D1%25E2%2580%25932%26spage%3D153%26epage%3D164%26doi%3D10.3233%2FCH-189109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crielaard, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammers, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivella, S.</span></span> <span> </span><span class="NLM_article-title">Targeting iron metabolism in drug discovery and delivery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">400</span>â <span class="NLM_lpage">423</span>, <span class="refDoi">Â DOI: 10.1038/nrd.2016.248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2Fnrd.2016.248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=28154410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWnu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=400-423&issue=6&author=B.+J.+Crielaardauthor=T.+Lammersauthor=S.+Rivella&title=Targeting+iron+metabolism+in+drug+discovery+and+delivery&doi=10.1038%2Fnrd.2016.248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting iron metabolism in drug discovery and delivery</span></div><div class="casAuthors">Crielaard, Bart J.; Lammers, Twan; Rivella, Stefano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">400-423</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Iron fulfils a central role in many essential biochem. processes in human physiol.; thus, proper processing of iron is crucial.  Although iron metab. is subject to relatively strict physiol. control, numerous disorders, such as cancer and neurodegenerative diseases, have recently been linked to deregulated iron homeostasis.  Consequently, iron metab. constitutes a promising and largely unexploited therapeutic target for the development of new pharmacol. treatments for these diseases.  Several iron metab.-targeted therapies are already under clin. evaluation for haematol. disorders, and these and newly developed therapeutic agents are likely to have substantial benefit in the clin. management of iron metab.-assocd. diseases, for which few efficacious treatments are currently available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUIjZKhRkw6bVg90H21EOLACvtfcHk0ljnMj8pr4ar-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWnu70%253D&md5=c67f64a3d87dab3d6843b10b8d426c0b</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.248%26sid%3Dliteratum%253Aachs%26aulast%3DCrielaard%26aufirst%3DB.%2BJ.%26aulast%3DLammers%26aufirst%3DT.%26aulast%3DRivella%26aufirst%3DS.%26atitle%3DTargeting%2520iron%2520metabolism%2520in%2520drug%2520discovery%2520and%2520delivery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26issue%3D6%26spage%3D400%26epage%3D423%26doi%3D10.1038%2Fnrd.2016.248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galaris, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skiada, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbouti, A.</span></span> <span> </span><span class="NLM_article-title">Redox signaling and cancer: the role of â³labileâ³ iron</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>266</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">21</span>â <span class="NLM_lpage">29</span>, <span class="refDoi">Â DOI: 10.1016/j.canlet.2008.02.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.canlet.2008.02.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18374479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFKlu7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=2008&pages=21-29&issue=1&author=D.+Galarisauthor=V.+Skiadaauthor=A.+Barbouti&title=Redox+signaling+and+cancer%3A+the+role+of+%E2%80%B3labile%E2%80%B3+iron&doi=10.1016%2Fj.canlet.2008.02.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Redox signaling and cancer: The role of "labile" iron</span></div><div class="casAuthors">Galaris, Dimitrios; Skiada, Vasiliki; Barbouti, Alexandra</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-29</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  Reactive oxygen species (ROS) were viewed for a long time as unavoidable byproducts of normal cell catabolism.  This view has recently changed and it is now apparent that ROS generation is a tightly regulated process that plays a central role in cell signaling.  Thus, it is known that regulated changes in intracellular ROS levels can induce biochem. signaling processes that control basic cellular functions, such as proliferation and apoptosis which are prevalent in the development of cancer.  In this short review, we will try to provide a background to this emerging field by summarizing the biochem. of ROS-mediated cell signaling and its relation to carcinogenesis.  Special emphasis will be focused on the emerging role of the so called "labile" iron (the redox-active form of iron) in ROS-mediated signaling in relation to cancer development.  It is tempting to speculate that elucidation of the exact mol. mechanisms that govern ROS-mediated regulation of cell signaling will provide the basis for development of new therapeutic strategies for cancer prevention and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYafQ17MgQKbVg90H21EOLACvtfcHk0lieeDFzlL-5Vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFKlu7k%253D&md5=e358581c913eaf72d362c5b524af2713</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2008.02.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2008.02.038%26sid%3Dliteratum%253Aachs%26aulast%3DGalaris%26aufirst%3DD.%26aulast%3DSkiada%26aufirst%3DV.%26aulast%3DBarbouti%26aufirst%3DA.%26atitle%3DRedox%2520signaling%2520and%2520cancer%253A%2520the%2520role%2520of%2520%25E2%2580%25B3labile%25E2%2580%25B3%2520iron%26jtitle%3DCancer%2520Lett.%26date%3D2008%26volume%3D266%26issue%3D1%26spage%3D21%26epage%3D29%26doi%3D10.1016%2Fj.canlet.2008.02.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buss, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, S. V.</span></span> <span> </span><span class="NLM_article-title">The role of iron chelation in cancer therapy</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1021</span>â <span class="NLM_lpage">1034</span>, <span class="refDoi">Â DOI: 10.2174/0929867033457638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F0929867033457638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12678674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1021-1034&author=J.+L.+Bussauthor=F.+M.+Tortiauthor=S.+V.+Torti&title=The+role+of+iron+chelation+in+cancer+therapy&doi=10.2174%2F0929867033457638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The role of iron chelation in cancer therapy</span></div><div class="casAuthors">Buss, Joan L.; Torti, Frank M.; Torti, Suzy V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1021-1034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review which focuses on advances and strategies in the use of iron chelators as antitumor therapies.  Although the development of iron chelators for human disease has focused primarily on their use in the treatment of secondary iron overload, chelators may also be useful antitumor agents.  They can deplete iron or cause oxidative stress in the tumor due to redox perturbations in its environment.  Iron chelators have been tested for their antitumor activity in cell culture expts., animal models, and human clin. trials.  Largely for pragmatic reasons, clin. studies of the antitumor activity of iron chelators have generally focused on desferrioxamine (DFO), a drug approved for the treatment of iron overload.  These studies have shown that DFO can retard tumor growth in many different exptl. contexts.  However, the activity of DFO is modest, and advances in the use of chelators as anticancer agents will require the development of new chelators based on new paradigms.  Examples of iron chelators that have shown promising antitumor activity (in various stages of development) include heterocyclic carboxaldehyde thiosemicarbazones, analogs of pyridoxal isonicotinoyl hydrazone, tachpyridine, O-Trensox, desferrithiocin, and other natural and synthetic chelators.  Apart from their use as single agents, chelators may also synergize with other anticancer therapies.  The development of chelators as anticancer agents is largely an unexplored field, but one with extraordinary potential to impact human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj9aYolI-AdbVg90H21EOLACvtfcHk0lgVLcu7hl6a1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1yjtb8%253D&md5=b5ac5166c32ae335bb5ed58b16ec8c2c</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.2174%2F0929867033457638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867033457638%26sid%3Dliteratum%253Aachs%26aulast%3DBuss%26aufirst%3DJ.%2BL.%26aulast%3DTorti%26aufirst%3DF.%2BM.%26aulast%3DTorti%26aufirst%3DS.%2BV.%26atitle%3DThe%2520role%2520of%2520iron%2520chelation%2520in%2520cancer%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2003%26volume%3D10%26spage%3D1021%26epage%3D1034%26doi%3D10.2174%2F0929867033457638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span> <span> </span><span class="NLM_article-title">Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal</span>. <i>Mutat. Res., Fundam. Mol. Mech. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>533</i></span> (<span class="NLM_issue">1â2</span>),  <span class="NLM_fpage">153</span>â <span class="NLM_lpage">171</span>, <span class="refDoi">Â DOI: 10.1016/j.mrfmmm.2003.08.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.mrfmmm.2003.08.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=14643418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1eru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=533&publication_year=2003&pages=153-171&issue=1%E2%80%932&author=X.+Huang&title=Iron+overload+and+its+association+with+cancer+risk+in+humans%3A+evidence+for+iron+as+a+carcinogenic+metal&doi=10.1016%2Fj.mrfmmm.2003.08.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal</span></div><div class="casAuthors">Huang, Xi</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">533</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">153-171</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Unlike arsenic, chromium, or nickel, the carcinogenicity of iron is still under debate.  In this review, evidence for iron as a carcinogenic metal was summarized from epidemiol., animal, and cell culture studies.  The role of iron in various cancers, such as colorectal cancer and liver cancer was presented.  Recent advancements on the mol. mechanisms of iron carcinogenesis were also reviewed.  These include: (1) iron autoxidn. involving only Fe2++O2 in oxidant formation in biol. systems and its pH dependency; (2) activation of oxidative responsive transcription factors and pro-inflammatory cytokines; and (3) iron-induced hypoxia signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKAhbCERVpqbVg90H21EOLACvtfcHk0lgVLcu7hl6a1Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1eru74%253D&md5=6881582cd029a92cdde45fe64004b5f7</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2003.08.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2003.08.023%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26atitle%3DIron%2520overload%2520and%2520its%2520association%2520with%2520cancer%2520risk%2520in%2520humans%253A%2520evidence%2520for%2520iron%2520as%2520a%2520carcinogenic%2520metal%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2003%26volume%3D533%26issue%3D1%25E2%2580%25932%26spage%3D153%26epage%3D171%26doi%3D10.1016%2Fj.mrfmmm.2003.08.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">The iron metabolism of neoplastic cells: alterations that facilitate proliferation?</span>. <i>Crit. Rev. Oncol. Hemat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">65</span>â <span class="NLM_lpage">78</span>, <span class="refDoi">Â DOI: 10.1016/S1040-8428(01)00213-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1040-8428%2801%2900213-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11923069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD387ptVWjsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=65-78&author=J.+C.+Kwokauthor=D.+R.+Richardson&title=The+iron+metabolism+of+neoplastic+cells%3A+alterations+that+facilitate+proliferation%3F&doi=10.1016%2FS1040-8428%2801%2900213-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">The iron metabolism of neoplastic cells: alterations that facilitate proliferation?</span></div><div class="casAuthors">Kwok Juliana C; Richardson Des R</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-78</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">For many years it has been known that neoplastic cells express high levels of the transferrin receptor 1 (TfR1) and internalize iron (Fe) from transferrin (Tf) at a tremendous rate.  Considering the high requirement of neoplastic cells for Fe, understanding its metabolism is vital in terms of devising potential new therapies.  Apart from TfR1, a number of molecules have been identified that may have roles in Fe metabolism and cellular proliferation.  These molecules include transferrin (Tf), the oestrogen-inducible transferrin receptor-like protein, transferrin receptor 2 (TfR2), melanotransferrin (MTf), ceruloplasmin, and ferritin.  In the present review these latter molecules are discussed in terms of their potential functions in tumour cell Fe metabolism and proliferation.  Further studies are essential to determine the specific roles of these proteins in the pathogenesis of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTb9RtHss_DR5PlX7E30qdzfW6udTcc2ebT89jJBa2Vnbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ptVWjsQ%253D%253D&md5=580e73c9d1a27818900294e646e24d8e</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1016%2FS1040-8428%2801%2900213-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-8428%252801%252900213-X%26sid%3Dliteratum%253Aachs%26aulast%3DKwok%26aufirst%3DJ.%2BC.%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DThe%2520iron%2520metabolism%2520of%2520neoplastic%2520cells%253A%2520alterations%2520that%2520facilitate%2520proliferation%253F%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hemat.%26date%3D2002%26volume%3D42%26spage%3D65%26epage%3D78%26doi%3D10.1016%2FS1040-8428%2801%2900213-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. R.</span></span> <span> </span><span class="NLM_article-title">Iron chelators as therapeutic agents for the treatment of cancer</span>. <i>Crit. Rev. Oncol. Hemat.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">267</span>â <span class="NLM_lpage">281</span>, <span class="refDoi">Â DOI: 10.1016/S1040-8428(01)00218-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS1040-8428%2801%2900218-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=12050019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A280%3ADC%252BD38zgsl2quw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=267-281&author=D.+R.+Richardson&title=Iron+chelators+as+therapeutic+agents+for+the+treatment+of+cancer&doi=10.1016%2FS1040-8428%2801%2900218-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Iron chelators as therapeutic agents for the treatment of cancer</span></div><div class="casAuthors">Richardson D R</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncology/hematology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-81</span>
        ISSN:<span class="NLM_cas:issn">1040-8428</span>.
    </div><div class="casAbstract">A wide variety of studies in vitro, in vivo, and in clinical trials have demonstrated that the chelator currently used to treat iron overload disease, desferrioxamine, has anti-proliferative effects against both leukemia and neuroblastoma.  However, the efficacy of desferrioxamine is severely limited due to its poor ability to permeate cell membranes and chelate intracellular iron pools.  These studies have led to the development of other iron chelators that are far more effective than desferrioxamine.  Some of these chelators such as 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine) have entered phase I clinical trials, while other chelators such as 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone or tachpyridine require evaluation in animal models.  The high anti-tumor activity observed with these ligands certainly suggests further development of chelators as anti-cancer agents is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRjdTjmMHxKL2K_SFaaT9INfW6udTcc2ebT89jJBa2Vnbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zgsl2quw%253D%253D&md5=dd926b5db7f5b8dc9c322c006d8f87fd</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1016%2FS1040-8428%2801%2900218-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1040-8428%252801%252900218-9%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DD.%2BR.%26atitle%3DIron%2520chelators%2520as%2520therapeutic%2520agents%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DCrit.%2520Rev.%2520Oncol.%2520Hemat.%26date%3D2002%26volume%3D42%26spage%3D267%26epage%3D281%26doi%3D10.1016%2FS1040-8428%2801%2900218-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarangelo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S. J.</span></span> <span> </span><span class="NLM_article-title">An iron age for cancer therapy</span>. <i>Nat. Nanotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">921</span>â <span class="NLM_lpage">922</span>, <span class="refDoi">Â DOI: 10.1038/nnano.2016.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1038%2Fnnano.2016.199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27668797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFyms7fM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=921-922&author=A.+Tarangeloauthor=S.+J.+Dixon&title=An+iron+age+for+cancer+therapy&doi=10.1038%2Fnnano.2016.199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomedicine An iron age for cancer therapy</span></div><div class="casAuthors">Tarangelo, Amy; Dixon, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Nanotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">921-922</span>CODEN:
                <span class="NLM_cas:coden">NNAABX</span>;
        ISSN:<span class="NLM_cas:issn">1748-3387</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Two reports show FDA-approved nanoparticles can kill cancer cells through iron- and reactive oxygen species-dependent mechanisms, offering new strategies for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouDJzQMIALp7Vg90H21EOLACvtfcHk0lgHgvbnTstg3Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFyms7fM&md5=947732fe431e41f74435c02a7f453afb</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1038%2Fnnano.2016.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnnano.2016.199%26sid%3Dliteratum%253Aachs%26aulast%3DTarangelo%26aufirst%3DA.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26atitle%3DAn%2520iron%2520age%2520for%2520cancer%2520therapy%26jtitle%3DNat.%2520Nanotechnol.%26date%3D2016%26volume%3D11%26spage%3D921%26epage%3D922%26doi%3D10.1038%2Fnnano.2016.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoyes, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span> <span> </span><span class="NLM_article-title">Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in Leukemia cell lines</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4591</span>â <span class="NLM_lpage">4599</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1511427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK38XlvVCnsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1992&pages=4591-4599&author=K.+P.+Hoyesauthor=R.+C.+Hiderauthor=J.+B.+Porter&title=Cell+cycle+synchronization+and+growth+inhibition+by+3-hydroxypyridin-4-one+iron+chelators+in+Leukemia+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines</span></div><div class="casAuthors">Hoyes, Katharine P.; Hider, Robert C.; Porter, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4591-9</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    </div><div class="casAbstract">The effect of the bidentate 3-hydroxypyridin-4-one (HPO) iron chelator CP94 (I) on cell cycle arrest with subsequent cycle synchronization has been compared with that of the hexadentate desferrioxamine (DFO) in K562 and Daudi cells.  The relationships between chelator concn. and inhibition of growth, DNA synthesis and ribonucleotide reductase, and phase of cell cycle arrest have also been explored.  HPOs and DFO arrest the cell cycle in a dose-dependent manner causing a blockade at the G1-S border after 24 h at concns. above 30 mM iron-binding equiv.  This is assocd. with reduced ribonucleotide reductase activity and concomitant cessation of DNA synthesis and growth.  When the chelator is subsequently removed, HPO-treated cells synchronously cascade into S phase, unlike DFO-treated cells which resume cycling in a nonsynchronous manner.  Chelator concns. of approx. 25 Î¼M and 3 Î¼M iron-binding equiv. inhibited growth, DNA synthesis, and ribonucleotide reductase activity by 50% in K562 and Daudi cells, resp.  Concns. less than 10 Î¼M iron-binding equiv. inhibited K562 cell growth without an effect on DNA synthesis but with accumulation of cells in G2 and M phases.  These results suggest that HPOs have advantages over DFO as cell cycle synchronization agents and may be useful adjuncts in cell cycle-specific treatment regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJl3Z_cyYZvrVg90H21EOLACvtfcHk0lj4dbtxk4mtmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XlvVCnsLo%253D&md5=4cf82738818f3fae91cb0a890702a624</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoyes%26aufirst%3DK.%2BP.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26atitle%3DCell%2520cycle%2520synchronization%2520and%2520growth%2520inhibition%2520by%25203-hydroxypyridin-4-one%2520iron%2520chelators%2520in%2520Leukemia%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D1992%26volume%3D52%26spage%3D4591%26epage%3D4599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Renton, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeitner, T. M.</span></span> <span> </span><span class="NLM_article-title">Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1553</span>â <span class="NLM_lpage">1561</span>, <span class="refDoi">Â DOI: 10.1016/0006-2952(96)00099-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2F0006-2952%2896%2900099-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=8630097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK28XjtVSmtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=1553-1561&author=F.+J.+Rentonauthor=T.+M.+Jeitner&title=Cell+cycle-dependent+inhibition+of+the+proliferation+of+human+neural+tumor+cell+lines+by+iron+chelators&doi=10.1016%2F0006-2952%2896%2900099-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle-dependent inhibition of the proliferation of human neural tumor cell lines by iron chelators</span></div><div class="casAuthors">Renton, Fiona J.; Jeitner, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1553-1561</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The current studies were designed to examine the conditions under which the ferritic iron chelator desferrioxamine (DFO) arrested cell cycle progression and hence the proliferation of neural cell lines in vitro.  DFO arrested proliferation at different stages of the cell cycle depending on the concn. and duration of drug exposure.  Twenty-four-hour treatment with 160 Î¼M DFO arrested glioma cells in G1, whereas 72-h treatment with 10 Î¼M DFO acted to slow the passage of glioma cells through the cell cycle, eventually accumulating in G2/M.  Another iron chelator, ADR 529, also inhibited the proliferation of glioma cells by lengthening the period of the cycle and causing the cells to arrest in G2/M.  The effects of 10 and 160 Î¼M DFO were irreversible after 24 and 48 h, resp., and 10 Î¼M DFO became cytotoxic after 3 days.  These observations demonstrate that DFO has different effects on the proliferation of neural tumor cell lines depending on the concn. and time of exposure, which result in different sites of cell cycle arrest.  These different in vitro actions of DFO may have ramifications for the successful application of iron chelator therapy in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWhwhszTrcA7Vg90H21EOLACvtfcHk0lj4dbtxk4mtmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVSmtbk%253D&md5=f4b30bc75f3ce686b7b97cf8c4f58b05</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2896%2900099-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252896%252900099-8%26sid%3Dliteratum%253Aachs%26aulast%3DRenton%26aufirst%3DF.%2BJ.%26aulast%3DJeitner%26aufirst%3DT.%2BM.%26atitle%3DCell%2520cycle-dependent%2520inhibition%2520of%2520the%2520proliferation%2520of%2520human%2520neural%2520tumor%2520cell%2520lines%2520by%2520iron%2520chelators%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D51%26spage%3D1553%26epage%3D1561%26doi%3D10.1016%2F0006-2952%2896%2900099-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leray, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouffier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannie, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troadec, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loreal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span> <span> </span><span class="NLM_article-title">Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG</span>. <i>BioMetals</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">231</span>â <span class="NLM_lpage">245</span>, <span class="refDoi">Â DOI: 10.1007/s10534-009-9281-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs10534-009-9281-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=19997770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFelu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=231-245&issue=2&author=F.+Gaboriauauthor=A.+M.+Lerayauthor=M.+Ropertauthor=L.+Gouffierauthor=I.+Cannieauthor=M.+B.+Troadecauthor=O.+Lorealauthor=P.+Brissotauthor=G.+Lescoat&title=Effects+of+deferasirox+and+deferiprone+on+cellular+iron+load+in+the+human+hepatoma+cell+line+HepaRG&doi=10.1007%2Fs10534-009-9281-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG</span></div><div class="casAuthors">Gaboriau, Francois; Leray, Anne-Marie; Ropert, Martine; Gouffier, Lucie; Cannie, Isabelle; Troadec, Marie-Berengere; Loreal, Olivier; Brissot, Pierre; Lescoat, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">BioMetals</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-245</span>CODEN:
                <span class="NLM_cas:coden">BOMEEH</span>;
        ISSN:<span class="NLM_cas:issn">0966-0844</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Two oral chelators, CP20 (deferiprone) and ICL670 (deferasirox), have been synthesized for the purpose of treating iron overload diseases, esp. thalassemias.  Given their antiproliferative effects resulting from the essential role played by iron in cell processes, such compds. might also be useful as anticancer agents.  In the present study, we tested the impact of these two iron chelators on iron metab., in the HepaRG cell line which allowed us to study proliferating and differentiated hepatocytes.  ICL670 uptake was greater than the CP20 uptake.  The iron depletion induced by ICL670 in differentiated cells increased sol. transferrin receptor expression, decreased intracellular ferritin expression, inhibited 55Fe (III) uptake, and reduced the hepatocyte concn. of the labile iron pool.  In contrast, CP20 induced an unexpected slight increase in intracellular ferritin, which was amplified by iron-treated chelator exposure.  CP20 also promoted Fe(III) uptake in differentiated HepaRG cells, thus leading to an increase of both the labile pool and storage forms of iron evaluated by calcein fluorescence and Perls staining, resp.  In acellular conditions, compared to CP20, iron removing ability from the calcein-Fe(III) complex was 40 times higher for ICL670.  On the whole, biol. responses of HepaRG cells to ICL670 treatment were characteristic of expected iron depletion.  In contrast, the effects of CP20 suggest the potential involvement of this compd. in the iron uptake from the external medium into the hepatocytes from the HepaRG cell line, therefore acting like a siderophore in this cell model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMVE3XnMNgobVg90H21EOLACvtfcHk0lj4dbtxk4mtmg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFelu78%253D&md5=7371937823dbd369bf39e194451be33d</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1007%2Fs10534-009-9281-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10534-009-9281-9%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriau%26aufirst%3DF.%26aulast%3DLeray%26aufirst%3DA.%2BM.%26aulast%3DRopert%26aufirst%3DM.%26aulast%3DGouffier%26aufirst%3DL.%26aulast%3DCannie%26aufirst%3DI.%26aulast%3DTroadec%26aufirst%3DM.%2BB.%26aulast%3DLoreal%26aufirst%3DO.%26aulast%3DBrissot%26aufirst%3DP.%26aulast%3DLescoat%26aufirst%3DG.%26atitle%3DEffects%2520of%2520deferasirox%2520and%2520deferiprone%2520on%2520cellular%2520iron%2520load%2520in%2520the%2520human%2520hepatoma%2520cell%2520line%2520HepaRG%26jtitle%3DBioMetals%26date%3D2010%26volume%3D23%26issue%3D2%26spage%3D231%26epage%3D245%26doi%3D10.1007%2Fs10534-009-9281-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonart, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boelaert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosselmans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span> <span> </span><span class="NLM_article-title">Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells</span>. <i>Gynecol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>85</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>â <span class="NLM_lpage">102</span>, <span class="refDoi">Â DOI: 10.1006/gyno.2001.6570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1006%2Fgyno.2001.6570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11925126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XisVamu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2002&pages=95-102&issue=1&author=T.+Simonartauthor=J.+R.+Boelaertauthor=R.+Mosselmansauthor=G.+Andreiauthor=J.+C.+Noelauthor=E.+De+Clercqauthor=R.+Snoeck&title=Antiproliferative+and+apoptotic+effects+of+iron+chelators+on+human+cervical+carcinoma+cells&doi=10.1006%2Fgyno.2001.6570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Antiproliferative and Apoptotic Effects of Iron Chelators on Human Cervical Carcinoma Cells</span></div><div class="casAuthors">Simonart, Thierry; Boelaert, Johan R.; Mosselmans, Roger; Andrei, Graciela; Noel, Jean-Christophe; De Clercq, Erik; Snoeck, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Gynecologic Oncology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-102</span>CODEN:
                <span class="NLM_cas:coden">GYNOA3</span>;
        ISSN:<span class="NLM_cas:issn">0090-8258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Objective. Cervical carcinoma is a human papillomavirus (HPV)-assocd. cancer for which treatment options still mainly rely on surgical procedures, with or without adjuvant radiotherapy and chemotherapy.  As iron may participate in the pathogenesis of viral infections and cancer in several ways, the present study was designed to investigate the effect of iron chelation on HPV-16- and HPV-18-pos. cervical carcinoma cell lines.  Methods.  Desferrioxamine and deferiprone, two chem. unrelated iron chelators, were used to investigate the effect of iron chelation on SiHa and HeLa cells.  Proliferation was investigated by cells counts, by [3H]thymidine uptake assay, and by immunostaining with Ki-67 and proliferating cell nuclear antigen (PCNA).  Apoptosis was detd. by morphol. anal., by a TUNEL assay, and by flow cytometry detecting FITC-conjugated annexin-V.  Results.  Desferrioxamine and deferiprone induced a time- and dose-dependent inhibition of SiHa and HeLa cell growth.  The inhibition of cell growth was assocd. with a decrease in the expression of both stable and total PCNA and Ki-67, a proliferation marker whose expression may predict survival in uterine cervical carcinoma.  TUNEL assay, flow cytometry with annexin-V-fluorescein, and morphol. anal. indicated that iron chelation also induced a time- and dose-dependent apoptosis of both cell lines.  This apoptotic effect was prevented by the addn. of exogenous iron.  Conclusion.  These results show that iron chelation inhibits the growth and induces the apoptosis of HPV-pos. carcinoma cells.  This suggests that iron chelators may represent a potential therapeutic approach for the management of cervical carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3hpcKrzjPVrVg90H21EOLACvtfcHk0liebNuP9IMj8w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisVamu7o%253D&md5=6980d669f7144b9c576e117c9a1f1e8b</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1006%2Fgyno.2001.6570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fgyno.2001.6570%26sid%3Dliteratum%253Aachs%26aulast%3DSimonart%26aufirst%3DT.%26aulast%3DBoelaert%26aufirst%3DJ.%2BR.%26aulast%3DMosselmans%26aufirst%3DR.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DNoel%26aufirst%3DJ.%2BC.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSnoeck%26aufirst%3DR.%26atitle%3DAntiproliferative%2520and%2520apoptotic%2520effects%2520of%2520iron%2520chelators%2520on%2520human%2520cervical%2520carcinoma%2520cells%26jtitle%3DGynecol.%2520Oncol.%26date%3D2002%26volume%3D85%26issue%3D1%26spage%3D95%26epage%3D102%26doi%3D10.1006%2Fgyno.2001.6570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chantrel-Groussard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rakba, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasdeloup, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brissot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescoat, G.</span></span> <span> </span><span class="NLM_article-title">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1479</span>â <span class="NLM_lpage">1487</span>, <span class="refDoi">Â DOI: 10.1016/j.bcp.2003.12.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bcp.2003.12.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=15041465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=1479-1487&issue=8&author=F.+Gaboriauauthor=K.+Chantrel-Groussardauthor=N.+Rakbaauthor=P.+Loyerauthor=N.+Pasdeloupauthor=R.+C.+Hiderauthor=P.+Brissotauthor=G.+Lescoat&title=Iron+mobilization%2C+cytoprotection%2C+and+inhibition+of+cell+proliferation+in+normal+and+transformed+rat+hepatocyte+cultures+by+the+hydroxypyridinone+CP411%2C+compared+to+CP20%3A+a+biological+and+physicochemical+study&doi=10.1016%2Fj.bcp.2003.12.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study</span></div><div class="casAuthors">Gaboriau, Francois; Chantrel-Groussard, Karine; Rakba, Nafissa; Loyer, Pascal; Pasdeloup, Nicole; Hider, Robert C.; Brissot, Pierre; Lescoat, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1479-1487</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The present study analyzes the iron mobilization, the cytoprotective, and the antiproliferative effects of the lipophilic hydroxypyridinone CP411, in comparison with the hydrophilic chelator CP20 or deferiprone used in the treatment of iron overload.  Primary rat hepatocyte cultures and the rat hepatoma cell line Fao were used.  Chelator cell uptake was evaluated by mass spectrometry in the two models.  This method was also used to investigate the stability of the chelators in an acellular system as well as their scavenging and chelating effects against the hydroxyl radical generated by the Fenton reaction.  The iron mobilization and the cytoprotective effects of the chelators were evaluated in primary cultures by measuring resp. 55Fe and lactate dehydrogenase release in the culture medium.  The antiproliferative effect of the chelators was studied using the Fao cell line and measuring DNA synthesis by thymidine incorporation and DNA content by flow cytometry.  The authors obsd. that CP411 entered the hepatocytes and the Fao cells resp. 4 and 13 times more than CP20.  CP411 was 2.5 times more effective than CP20 to mobilize iron from preloaded hepatocytes.  Pretreatment of the hepatocytes with CP20 or CP411 decreased the toxic effect of iron and CP411 was 1.6 times more effective than CP20.  A dose-dependent decrease of DNA synthesis, correlated to an accumulation of cells in S phase, was obsd. in the Fao cell line in the presence of CP411, while CP20 was without effect.  CP411 effect was inhibited by addn. of iron simultaneously with the chelator, the addn. of Zn or Cu was without effect.  The inhibitory effect of CP411 was reversible since, 24 h after removal of the chelator, DNA replication reached the control level.  The results show that CP411 is more efficient to protect the hepatocyte from the toxic effect of iron load and to inhibit tumor cell proliferation.  Its higher efficiency may result from its better cell uptake since equimolar solns. of the two chelators in an acellular system exhibit the same ability to inhibit the Fenton reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWUGkeFexh2rVg90H21EOLACvtfcHk0lgNmYUzMX8dgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVemsLw%253D&md5=d1063e9c5ddc87451852258c44f900e3</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2003.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2003.12.019%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriau%26aufirst%3DF.%26aulast%3DChantrel-Groussard%26aufirst%3DK.%26aulast%3DRakba%26aufirst%3DN.%26aulast%3DLoyer%26aufirst%3DP.%26aulast%3DPasdeloup%26aufirst%3DN.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DBrissot%26aufirst%3DP.%26aulast%3DLescoat%26aufirst%3DG.%26atitle%3DIron%2520mobilization%252C%2520cytoprotection%252C%2520and%2520inhibition%2520of%2520cell%2520proliferation%2520in%2520normal%2520and%2520transformed%2520rat%2520hepatocyte%2520cultures%2520by%2520the%2520hydroxypyridinone%2520CP411%252C%2520compared%2520to%2520CP20%253A%2520a%2520biological%2520and%2520physicochemical%2520study%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2004%26volume%3D67%26issue%3D8%26spage%3D1479%26epage%3D1487%26doi%3D10.1016%2Fj.bcp.2003.12.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManis, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franklin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weimar, W. R.</span></span> <span> </span><span class="NLM_article-title">Polyamine-iron chelator conjugate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5478</span>â <span class="NLM_lpage">5483</span>, <span class="refDoi">Â DOI: 10.1021/jm0302694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0302694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVClt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5478-5483&author=R.+J.+Bergeronauthor=J.+S.+McManisauthor=A.+M.+Franklinauthor=H.+Yaoauthor=W.+R.+Weimar&title=Polyamine-iron+chelator+conjugate&doi=10.1021%2Fjm0302694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Polyamine-Iron Chelator Conjugate</span></div><div class="casAuthors">Bergeron, Raymond J.; McManis, James S.; Franklin, April M.; Yao, Hua; Weimar, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">5478-5483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The current study demonstrates unequivocally that polyamines can serve as vectors for the intracellular delivery of the bidentate chelator 1,2-dimethyl-3-hydroxypyridin-4-one (L1).  The polyamine-hydroxypyridinone conjugate 1-(12-amino-4,9-diazadodecyl)-2-methyl-3-hydroxy-4(1H)-pyridinone is assembled from spermine and 3-O-benzylmaltol.  The conjugate is shown to form a 3:1 complex with Fe(III) and to be taken up by the polyamine transporter 1900-fold against a concn. gradient.  The Ki of the conjugate is 3.7 Î¼M vs. spermidine for the polyamine transporter.  The conjugate is also at least 230 times more active in suppressing the growth of L1210 murine leukemia cells than is the parent ligand, decreases the activities of the polyamine biosynthetic enzymes ornithine decarboxylase and S-adenosylmethionine decarboxylase, and upregulates spermidine-spermine N 1-acetyltransferase.  However, the effect on native polyamine pools is a moderate one.  These findings are in keeping with the idea that polyamines can also serve as efficient vectors for the intracellular delivery of other iron chelators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp2TTYL13vZbVg90H21EOLACvtfcHk0lgUIPaSJIMKKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVClt7s%253D&md5=4ab7c219ccfa8e79113c8e3e094ff0c3</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Fjm0302694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0302694%26sid%3Dliteratum%253Aachs%26aulast%3DBergeron%26aufirst%3DR.%2BJ.%26aulast%3DMcManis%26aufirst%3DJ.%2BS.%26aulast%3DFranklin%26aufirst%3DA.%2BM.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DWeimar%26aufirst%3DW.%2BR.%26atitle%3DPolyamine-iron%2520chelator%2520conjugate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5478%26epage%3D5483%26doi%3D10.1021%2Fjm0302694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">FÃ¼rstner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feyen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of the antitumor agent TMC-69â6H and a focused library of analogs</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">9543</span>â <span class="NLM_lpage">9558</span>, <span class="refDoi">Â DOI: 10.1016/j.tet.2004.06.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.tet.2004.06.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFagsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=9543-9558&issue=43&author=A.+F%C3%BCrstnerauthor=F.+Feyenauthor=H.+Prinzauthor=H.+Waldmann&title=Synthesis+and+evaluation+of+the+antitumor+agent+TMC-69%E2%80%936H+and+a+focused+library+of+analogs&doi=10.1016%2Fj.tet.2004.06.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of the antitumor agent TMC-69-6H and a focused library of analogs</span></div><div class="casAuthors">Fuerstner, Alois; Feyen, Fabian; Prinz, Heino; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">9543-9558</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A concise, efficient and flexible total synthesis of the potent antitumor agent TMC-69-6H (I) is described.  Key steps involved the palladium-catalyzed regioselective addn. of 4-hydroxy-2-pyridone to pyranyl acetate which was accompanied by a spontaneous 1,4-addn. of the phenolic -OH group to the emerging enone to give the corresponding tricyclic product in excellent yield.  When this reaction was carried out with optically enriched pyranyl acetate in the presence of a chiral ligand and allylpalladium chloride dimer, the ensuing matched situation delivers the key building block in excellent enantiomeric excess.  Its further elaboration into I involved a Julia-Kocienski olefination with a tetrazolylsulfone and a final N-oxidn. effected by the peroxomolybdenum complex [(pyridine)MoO5(HMPA)] to form the hydroxamic acid motif.  The flexibility inherent to this route allowed for the prepn. of a focused library of analogs for biochem. evaluation.  The results obtained showed that N-hydroxy-2-pyridone derivs. constituted a promising class of selective phosphatase inhibitors.  In contrast to previous reports in the literature, however, TMC-69-6H and congeners were found to exhibit pronounced activities against the tyrosine protein phosphatase PTB1B, the dual specific phosphatase VHR, and the serine/threonine phosphatase PP1, while being only weak inhibitors for the dual specific phosphatases Cdc25 A and B.  Two of the key intermediates have been characterized by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPCJr36kVLq7Vg90H21EOLACvtfcHk0lgUIPaSJIMKKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFagsr0%253D&md5=a28b017976b841a704c26c94e8d602c1</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.06.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.06.139%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCrstner%26aufirst%3DA.%26aulast%3DFeyen%26aufirst%3DF.%26aulast%3DPrinz%26aufirst%3DH.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520the%2520antitumor%2520agent%2520TMC-69%25E2%2580%25936H%2520and%2520a%2520focused%2520library%2520of%2520analogs%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26issue%3D43%26spage%3D9543%26epage%3D9558%26doi%3D10.1016%2Fj.tet.2004.06.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, F. Y.</span></span> <span> </span><span class="NLM_article-title">New 3-[(4-hydroxy-6-methly-2(1<i>H</i>)-pyridinones)-3-yl]-4-substituted-(1<i>H</i>) 1,2,4-triazole-5-thiones: efficient synthesis, X-ray crystallographic analysis, and antitumor activity</span>. <i>Lett. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">137</span>â <span class="NLM_lpage">141</span>, <span class="refDoi">Â DOI: 10.2174/157017807780414181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.2174%2F157017807780414181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslSksr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=137-141&author=J.+G.+Yangauthor=F.+Y.+Pan&title=New+3-%5B%284-hydroxy-6-methly-2%281H%29-pyridinones%29-3-yl%5D-4-substituted-%281H%29+1%2C2%2C4-triazole-5-thiones%3A+efficient+synthesis%2C+X-ray+crystallographic+analysis%2C+and+antitumor+activity&doi=10.2174%2F157017807780414181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">New 3-[(4-hydroxy-6-methyl-2(1H)-pyridinones)-3-yl]-4-substituted-(1H)-1,2,4-triazole-5-thiones. Efficient synthesis, X-ray crystallographic analysis, and antitumor activity</span></div><div class="casAuthors">Yang, Jian-Guo; Pan, Fu-You</div><div class="citationInfo"><span class="NLM_cas:title">Letters in Organic Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-141</span>CODEN:
                <span class="NLM_cas:coden">LOCEC7</span>;
        ISSN:<span class="NLM_cas:issn">1570-1786</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Fifteen new 3-(4-hydroxy-6-methyl-2(1H)-pyridinone-3-yl)-4-substituted-(1H)-1,2,4-triazole-5-thione compds. were synthesized from Me 4-hydroxy-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate in good overall yields by four step reactions.  Mol. structure of these compds. was confirmed by IR, NMR, MS, elemental anal. and X-ray diffraction.  Their antitumor activities were evaluated in vitro by the SRB and MTT methods.  The results show that there are two compds. which are highly effective against KB cells and one compd. which is highly effective against Bel-7402 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQr3RQ5wrRQ7Vg90H21EOLACvtfcHk0lgUIPaSJIMKKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslSksr0%253D&md5=0ebec407660024a09bdd88bf9585c4c6</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.2174%2F157017807780414181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157017807780414181%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%2BG.%26aulast%3DPan%26aufirst%3DF.%2BY.%26atitle%3DNew%25203-%255B%25284-hydroxy-6-methly-2%25281H%2529-pyridinones%2529-3-yl%255D-4-substituted-%25281H%2529%25201%252C2%252C4-triazole-5-thiones%253A%2520efficient%2520synthesis%252C%2520X-ray%2520crystallographic%2520analysis%252C%2520and%2520antitumor%2520activity%26jtitle%3DLett.%2520Org.%2520Chem.%26date%3D2007%26volume%3D4%26spage%3D137%26epage%3D141%26doi%3D10.2174%2F157017807780414181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillen, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakrania, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khurana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coombs, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stennett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bureau, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brownlees, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melton, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxty, B.</span></span> <span> </span><span class="NLM_article-title">Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">4097</span>â <span class="NLM_lpage">4103</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2015.08.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2015.08.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=26318993" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqt7%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4097-4103&issue=19&author=T.+M.+Chapmanauthor=K.+J.+Gillenauthor=C.+Wallaceauthor=M.+T.+Leeauthor=P.+Bakraniaauthor=P.+Khuranaauthor=P.+J.+Coombsauthor=L.+Stennettauthor=S.+Foxauthor=E.+A.+Bureauauthor=J.+Brownleesauthor=D.+W.+Meltonauthor=B.+Saxty&title=Catechols+and+3-hydroxypyridones+as+inhibitors+of+the+DNA+repair+complex+ERCC1-XPF&doi=10.1016%2Fj.bmcl.2015.08.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1-XPF</span></div><div class="casAuthors">Chapman, Timothy M.; Gillen, Kevin J.; Wallace, Claire; Lee, Maximillian T.; Bakrania, Preeti; Khurana, Puneet; Coombs, Peter J.; Stennett, Laura; Fox, Simon; Bureau, Emilie A.; Brownlees, Janet; Melton, David W.; Saxty, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4097-4103</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Catechol-based inhibitors of ERCC1-XPF endonuclease activity were identified from a high-throughput screen.  Exploration of the structure-activity relationships within this series yielded compd. 13, which displayed an ERCC1-XPF IC50 of 0.6 Î¼M, high selectivity against FEN-1 and DNase I and activity in nucleotide excision repair, cisplatin enhancement and Î³H2AX assays in A375 melanoma cells.  Screening of fragments as potential alternatives to the catechol group revealed that 3-hydroxypyridones are able to inhibit ERCC1-XPF with high ligand efficiency, and elaboration of the hit gave compds. 36 and 37 which showed promising ERCC1-XPF IC50 values of <10 Î¼M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphJYIaCd3V3bVg90H21EOLACvtfcHk0ljM2BOQFiSpHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqt7%252FI&md5=1d27d6aa3a959de7ec370b72c8229fa4</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.08.031%26sid%3Dliteratum%253Aachs%26aulast%3DChapman%26aufirst%3DT.%2BM.%26aulast%3DGillen%26aufirst%3DK.%2BJ.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DM.%2BT.%26aulast%3DBakrania%26aufirst%3DP.%26aulast%3DKhurana%26aufirst%3DP.%26aulast%3DCoombs%26aufirst%3DP.%2BJ.%26aulast%3DStennett%26aufirst%3DL.%26aulast%3DFox%26aufirst%3DS.%26aulast%3DBureau%26aufirst%3DE.%2BA.%26aulast%3DBrownlees%26aufirst%3DJ.%26aulast%3DMelton%26aufirst%3DD.%2BW.%26aulast%3DSaxty%26aufirst%3DB.%26atitle%3DCatechols%2520and%25203-hydroxypyridones%2520as%2520inhibitors%2520of%2520the%2520DNA%2520repair%2520complex%2520ERCC1-XPF%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D19%26spage%3D4097%26epage%3D4103%26doi%3D10.1016%2Fj.bmcl.2015.08.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullagar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Identifying chelators for metalloprotein inhibitors using a fragment-based approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">591</span>â <span class="NLM_lpage">602</span>, <span class="refDoi">Â DOI: 10.1021/jm101266s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101266s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=591-602&issue=2&author=J.+A.+Jacobsenauthor=J.+L.+Fullagarauthor=M.+T.+Millerauthor=S.+M.+Cohen&title=Identifying+chelators+for+metalloprotein+inhibitors+using+a+fragment-based+approach&doi=10.1021%2Fjm101266s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Jacobsen, Jennifer A.; Fullagar, Jessica L.; Miller, Melissa T.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors.  When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compds. produced hit rates ranging from 29% to 43% for five matrix metalloproteases (MMPs), 24% for anthrax lethal factor (LF), 49% for 5-lipoxygenase (5-LO), and 60% for tyrosinase (TY).  The ligand efficiencies (LE) of the fragment hits are excellent, in the range of 0.4-0.8 kcal/mol.  The MMP enzymes all generally elicit the same chelators as hits from CFL-1.1; however, the chelator fragments that inhibit structurally unrelated metalloenzymes (LF, 5-LO, TY) vary considerably.  To develop more advanced hits, one hit from CFL-1.1, 8-hydroxyquinoline, was elaborated at four different positions around the ring system to generate new fragments. 8-Hydroxyquinoline fragments substituted at either the 5- or 7-positions gave potent hits against MMP-2, with IC50 values in the low micromolar range.  The 8-hydroxyquinoline represents a promising new chelator scaffold for the development of MMP inhibitors that was discovered by use of a metalloprotein-focused chelator fragment library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEhMn4K1QBJLVg90H21EOLACvtfcHk0ljM2BOQFiSpHg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE&md5=1ef31ce8e5939f7d1c69aed8a409cd8d</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1021%2Fjm101266s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101266s%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DFullagar%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DIdentifying%2520chelators%2520for%2520metalloprotein%2520inhibitors%2520using%2520a%2520fragment-based%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D2%26spage%3D591%26epage%3D602%26doi%3D10.1021%2Fjm101266s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buczynski, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dennis, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">A macrophage cell model for selective metalloproteinase inhibitor design</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2087</span>â <span class="NLM_lpage">2095</span>, <span class="refDoi">Â DOI: 10.1002/cbic.200800148</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1002%2Fcbic.200800148" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18666306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFansrvM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2087-2095&issue=13&author=F.+E.+Jacobsenauthor=M.+W.+Buczynskiauthor=E.+A.+Dennisauthor=S.+M.+Cohen&title=A+macrophage+cell+model+for+selective+metalloproteinase+inhibitor+design&doi=10.1002%2Fcbic.200800148"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">A macrophage cell model for selective metalloproteinase inhibitor design</span></div><div class="casAuthors">Jacobsen, Faith E.; Buczynski, Matthew W.; Dennis, Edward A.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2087-2095</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The desire to inhibit zinc-dependent matrix metalloproteinases (MMPs) has, over the course of the last 30 years, led to the development of a plethora of MMP inhibitors that bind directly to the active-site metal.  With one exception, all of these drugs have failed in clin. trials, due to many factors, including an apparent lack of specificity for MMPs.  To address the question of whether these inhibitors are selective for MMPs in a biol. setting, a cell-based screening method is presented to compare the relative activities of zinc, heme iron, and non-heme iron enzymes in the presence of these compds. using the RAW264.7 macrophage cell line.  We screened nine different zinc-binding groups (ZBGs), four established MMP inhibitors (MMPis), and two novel MMP inhibitors developed in our lab. to det. their selectivities against five different metalloenzymes.  Using this model, we identified two nitrogen donor compds.-2,2'-dipyridylamine (DPA) and triazacyclononane (TACN)-as the most selective ZBGs for zinc metalloenzyme inhibitor development.  We also demonstrated that the model could predict known nonspecific interactions of some of the most commonly used MMPis, and could also give cross-reactivity information for newly developed MMPis.  This work demonstrates the utility of cell-based assays in both the design and the screening of novel metalloenzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-1TJwCwwW6bVg90H21EOLACvtfcHk0ljJN1vc3sLPug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFansrvM&md5=9a8edf352232edb040bf25558307540d</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200800148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200800148%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DF.%2BE.%26aulast%3DBuczynski%26aufirst%3DM.%2BW.%26aulast%3DDennis%26aufirst%3DE.%2BA.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DA%2520macrophage%2520cell%2520model%2520for%2520selective%2520metalloproteinase%2520inhibitor%2520design%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26issue%3D13%26spage%3D2087%26epage%3D2095%26doi%3D10.1002%2Fcbic.200800148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynagh, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyes, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cammack, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span> <span> </span><span class="NLM_article-title">The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">20291</span>â <span class="NLM_lpage">20299</span>, <span class="refDoi">Â DOI: 10.1074/jbc.271.34.20291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1074%2Fjbc.271.34.20291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=8702762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK28Xlt1ygtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=20291-20299&issue=34&author=C.+E.+Cooperauthor=G.+R.+Lynaghauthor=K.+P.+Hoyesauthor=R.+C.+Hiderauthor=R.+Cammackauthor=J.+B.+Porter&title=The+relationship+of+intracellular+iron+chelation+to+the+inhibition+and+regeneration+of+human+ribonucleotide+reductase&doi=10.1074%2Fjbc.271.34.20291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase</span></div><div class="casAuthors">Cooper, Chris E.; Lynagh, Gayle R.; Hoyes, Katharine P.; Hider, Robert C.; Cammack, Richard; Porter, John B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">20291-20299</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation.  ESR (EPR) spectroscopy has been used to examine simultaneously for the first time the relation between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells.  The different physicochem. characteristics of relatively hydrophobic low mol. wt. bidentate hydroxypyridinone chelators and the higher mol. wt. hexadentate ferrioxamine have been exploited to elucidate these interactions further.  The base-line concn. of EPR-detectable mononuclear nonheme iron complexes was 3.15Â±1.05 Î¼M, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine.  Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity.  The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase.  Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopSMGlPXmrGrVg90H21EOLACvtfcHk0ljjx4yVbAU4lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xlt1ygtLo%253D&md5=d3ee03092a3ccd245fc2c9445995e7d1</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.34.20291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.34.20291%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DC.%2BE.%26aulast%3DLynagh%26aufirst%3DG.%2BR.%26aulast%3DHoyes%26aufirst%3DK.%2BP.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DCammack%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520relationship%2520of%2520intracellular%2520iron%2520chelation%2520to%2520the%2520inhibition%2520and%2520regeneration%2520of%2520human%2520ribonucleotide%2520reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D34%26spage%3D20291%26epage%3D20299%26doi%3D10.1074%2Fjbc.271.34.20291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kayyali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">48814</span>â <span class="NLM_lpage">48822</span>, <span class="refDoi">Â DOI: 10.1074/jbc.M109551200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1074%2Fjbc.M109551200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11602611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XktleisA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48814-48822&issue=52&author=R.+Kayyaliauthor=J.+B.+Porterauthor=Z.+D.+Liuauthor=N.+A.+Daviesauthor=J.+H.+Nugentauthor=C.+E.+Cooperauthor=R.+C.+Hider&title=Structure-function+investigation+of+the+interaction+of+1-+and+2-substituted+3-hydroxypyridin-4-ones+with+5-lipoxygenase+and+ribonucleotide+reductase&doi=10.1074%2Fjbc.M109551200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase</span></div><div class="casAuthors">Kayyali, Reem; Porter, John B.; Liu, Zu Dong; Davies, Nathan A.; Nugent, Jonathan H.; Cooper, Chris E.; Hider, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">48814-48822</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The structural and physiochem. properties of 3-hydroxypyridin-4-one chelators (HPOs) which influence inhibition of the iron-contg. metalloenzymes ribonucleotide reductase (RR) and 5-lipoxygenase (5-LO) have been investigated.  HPOs with substituents at the 1- and 2-positions of the pyridinone ring have been synthesized, and their inhibitory properties compared with those of desferrioxamine (DFO).  Varying the alkyl substituents does not affect the affinity const. of these ligands for iron(III), but permits a systematic investigation of the effect of hydrophobicity and mol. shape on inhibitory properties.  The inhibition of RR was monitored, indirectly by measuring tritiated thymidine incorporation into DNA and directly by the quantification of the EPR signal of the enzyme tyrosyl radical.  5-LO inhibition was examd. spectrophotometrically, measuring the rate of linoleic hydroperoxide formation by soybean lipoxygenase.  The results indicate that the substituent size introduced at the 2-position of the HPO ring is crit. for detg. inhibition of both enzymes.  Large substituents on the 2-position, introduce a steric factor which interferes with accessibility to the iron centers.  These studies have identified chelators such as 1,6-dimethyl-2-(N-4',N-propylsuccinamido) methyl-3-hydroxypyridin-4-one (CP358), which causes only a 10% inhibition of 5-LO after 24 h of incubation at 110 Î¼M IBE (iron-binding equiv.) in comparison to simple dialkyl HPOs such as Deferiprone (CP20) which cause up to 70% inhibition.  Using EPR spectroscopy, CP358 inhibits RR at a slower rate than CP20, while chelating intracellular iron(III) at a similar rate, a finding consistent with an indirect inhibition of the tyrosyl radical.  However, hepatocellular iron is mobilized at a faster rate by CP358 (P < 0.001).  These findings demonstrate that it is possible to design bidentate HPOs which access intracellular iron pools rapidly while inhibiting non-heme iron-contg. enzymes relatively slowly, at rates comparable to DFO.  It is anticipated that such compds. will possess a superior therapeutic safety margin to currently available bidentate HPOs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRj2V4i6As1LVg90H21EOLACvtfcHk0ljjx4yVbAU4lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktleisA%253D%253D&md5=686d50f9e3eb835da3dcb55e63eeee4c</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109551200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109551200%26sid%3Dliteratum%253Aachs%26aulast%3DKayyali%26aufirst%3DR.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DDavies%26aufirst%3DN.%2BA.%26aulast%3DNugent%26aufirst%3DJ.%2BH.%26aulast%3DCooper%26aufirst%3DC.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DStructure-function%2520investigation%2520of%2520the%2520interaction%2520of%25201-%2520and%25202-substituted%25203-hydroxypyridin-4-ones%2520with%25205-lipoxygenase%2520and%2520ribonucleotide%2520reductase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D52%26spage%3D48814%26epage%3D48822%26doi%3D10.1074%2Fjbc.M109551200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayyali, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, A. E.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">631</span>â <span class="NLM_lpage">639</span>, <span class="refDoi">Â DOI: 10.1021/jm010817i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010817i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD38XhsVaisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=631-639&issue=3&author=Z.+D.+Liuauthor=R.+Kayyaliauthor=R.+C.+Hiderauthor=J.+B.+Porterauthor=A.+E.+Theobald&title=Design%2C+synthesis%2C+and+evaluation+of+novel+2-substituted+3-hydroxypyridin-4-ones%3A+structure-activity+investigation+of+metalloenzyme+inhibition+by+iron+chelators&doi=10.1021%2Fjm010817i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Novel 2-Substituted 3-Hydroxypyridin-4-ones: Structure-Activity Investigation of Metalloenzyme Inhibition by Iron Chelators</span></div><div class="casAuthors">Liu, Zu D.; Kayyali, Reem; Hider, Robert C.; Porter, John B.; Theobald, Anthony E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-639</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A range of novel 3-hydroxy-1-methylpyridin-4-ones with different substituents at the 2-position has been synthesized for the investigation of the structure-activity relationship between the chem. nature of the ligand and the inhibitory activity of the iron-contg. metalloenzyme 5-lipoxygenase.  Results indicate that the mol. dimensions, together with the lipophilicity, have a crit. impact on the ability of this class of chelator to inhibit 5-lipoxygenase.  Hydrophilic ligands with a bulky 2-substituent tend to be weak inhibitors; thus 1,6-dimethyl-2-(4'-N-propylsuccinamido)methyl-3-hydroxypyridin-4(1H)-one which has the largest 2-substituent only caused 2% inhibition of the enzyme activity after 30 min incubation at 110 Î¼M IBE (iron-binding equiv.), as compared with deferiprone which caused 40% inhibition of the enzyme activity, under the same conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrReo2mZMAgwbVg90H21EOLACvtfcHk0ljjx4yVbAU4lQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhsVaisg%253D%253D&md5=a93837cadbedc6e801d2afef179a075c</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1021%2Fjm010817i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010817i%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DKayyali%26aufirst%3DR.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DPorter%26aufirst%3DJ.%2BB.%26aulast%3DTheobald%26aufirst%3DA.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520novel%25202-substituted%25203-hydroxypyridin-4-ones%253A%2520structure-activity%2520investigation%2520of%2520metalloenzyme%2520inhibition%2520by%2520iron%2520chelators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26issue%3D3%26spage%3D631%26epage%3D639%26doi%3D10.1021%2Fjm010817i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockwood, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theobald, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure-activity investigation of the inhibition of 3-hydroxypyridin-4ones on mammalian tyrosine hydroxylase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">285</span>â <span class="NLM_lpage">290</span>, <span class="refDoi">Â DOI: 10.1016/S0006-2952(00)00551-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2FS0006-2952%2800%2900551-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=11172732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhtFegsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=285-290&author=Z.+D.+Liuauthor=M.+Lockwoodauthor=S.+Roseauthor=A.+E.+Theobaldauthor=R.+C.+Hider&title=Structure-activity+investigation+of+the+inhibition+of+3-hydroxypyridin-4ones+on+mammalian+tyrosine+hydroxylase&doi=10.1016%2FS0006-2952%2800%2900551-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase</span></div><div class="casAuthors">Liu, Z. D.; Lockwood, M.; Rose, S.; Theobald, A. E.; Hider, R. C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">285-290</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">3-Hydroxypyridin-4-ones are currently one of the main candidates for the development of orally active iron chelators.  Small bidentate ligands tend to inhibit iron-contg. metalloenzymes and therefore can cause undesirable side effects.  A range of 3-hydroxypyridin-4-ones with different substituents at position 2 was selected for the investigation of the structure-activity relation between the chem. nature of the ligand and the inhibition of mammalian tyrosine hydroxylase.  Results indicated that lipophilicity was the dominant factor in controlling the ability of this class of chelator to inhibit mammalian tyrosine hydroxylase.  Ligands with hydrophilic substituents tended to be weak inhibitors.  No significant correlation was found in this study between iron-binding affinity, extended substituent chain length, and enzyme inhibitory activity.  In contrast, both the LogP values of the entire mol. and of the substituent segment correlated well with inhibitory activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdKaujaly94rVg90H21EOLACvtfcHk0lj0j4yLh9XFHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhtFegsrs%253D&md5=fa438d391d5ee52d39a94739f15d1031</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2800%2900551-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252800%252900551-7%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%2BD.%26aulast%3DLockwood%26aufirst%3DM.%26aulast%3DRose%26aufirst%3DS.%26aulast%3DTheobald%26aufirst%3DA.%2BE.%26aulast%3DHider%26aufirst%3DR.%2BC.%26atitle%3DStructure-activity%2520investigation%2520of%2520the%2520inhibition%2520of%25203-hydroxypyridin-4ones%2520on%2520mammalian%2520tyrosine%2520hydroxylase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2001%26volume%3D61%26spage%3D285%26epage%3D290%26doi%3D10.1016%2FS0006-2952%2800%2900551-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">How does photodynamic therapy work</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">145</span>â <span class="NLM_lpage">157</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.1992.tb04222.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.1992.tb04222.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1603846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK38XnvFCiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1992&pages=145-157&issue=1&author=B.+W.+Hendersonauthor=T.+J.+Dougherty&title=How+does+photodynamic+therapy+work&doi=10.1111%2Fj.1751-1097.1992.tb04222.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">How does photodynamic therapy work?</span></div><div class="casAuthors">Henderson, Barbara W.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-57</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    </div><div class="casAbstract">A review with many refs. on the mechanisms relevant to photodynamic therapy and in vivo responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR2ylXEYQKO7Vg90H21EOLACvtfcHk0lj0j4yLh9XFHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XnvFCiuw%253D%253D&md5=fe907b7bcadce2313ddae92d36389309</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1992.tb04222.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1992.tb04222.x%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DHow%2520does%2520photodynamic%2520therapy%2520work%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1992%26volume%3D55%26issue%3D1%26spage%3D145%26epage%3D157%26doi%3D10.1111%2Fj.1751-1097.1992.tb04222.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kloek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkermans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegouwen, G.</span></span> <span> </span><span class="NLM_article-title">Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">150</span>â <span class="NLM_lpage">154</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.1998.tb05178.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.1998.tb05178.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9477773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK1cXmvVWqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1998&pages=150-154&issue=1&author=J.+Kloekauthor=W.+Akkermansauthor=G.+Henegouwen&title=Derivatives+of+5-aminolevulinic+acid+for+photodynamic+therapy%3A+enzymatic+conversion+into+protoporphyrin&doi=10.1111%2Fj.1751-1097.1998.tb05178.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymic conversion into protoporphyrin</span></div><div class="casAuthors">Kloek, Joris; Akkermans, Willem; Van Henegouwen, Gerard M. J. Beijersbergen</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">150-154</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">American Society for Photobiology</span>)
        </div><div class="casAbstract">In recent years, 5-aminolevulinic acid (ALA) has become a widespread agent for photodynamic therapy (PDT).  In nucleated cells, ALA is converted into the endogenous photosensitizer protoporphyrin IX (PpIX).  A major drawback of ALA is its low bioavailability.  As a result, high doses of ALA must be administered in order to reach clin. relevant levels of PpIX.  Moreover, only superficially located lesions can be treated as a result of the poor penetration of ALA into tissues.  A possible soln. for this problem may be provided by the prodrug concept.  In the present study, prodrugs of ALA have been synthesized.  These ALA prodrugs are shown to result in higher PpIX levels in cells than does ALA itself.  Of a range of ester prodrugs of ALA, the ALA-pentyl ester elicits the highest fluorescence.  Furthermore, the enzymic conversion of the derivs. into ALA and PpIX has been studied in lysed cells.  Under these circumstances, the esters with the shorter alkyl chains induce the highest fluorescence.  The alcs. that arise as side products from enzymic conversion of the prodrugs are shown to have no influence on the expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofIL9upgTDe7Vg90H21EOLACvtfcHk0lj0j4yLh9XFHQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmvVWqsg%253D%253D&md5=e900697151e7a52c02fffd3578958744</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1998.tb05178.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1998.tb05178.x%26sid%3Dliteratum%253Aachs%26aulast%3DKloek%26aufirst%3DJ.%26aulast%3DAkkermans%26aufirst%3DW.%26aulast%3DHenegouwen%26aufirst%3DG.%26atitle%3DDerivatives%2520of%25205-aminolevulinic%2520acid%2520for%2520photodynamic%2520therapy%253A%2520enzymatic%2520conversion%2520into%2520protoporphyrin%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1998%26volume%3D67%26issue%3D1%26spage%3D150%26epage%3D154%26doi%3D10.1111%2Fj.1751-1097.1998.tb05178.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongshaug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesland, J. M.</span></span> <span> </span><span class="NLM_article-title">5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">235</span>â <span class="NLM_lpage">251</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.1997.tb08549.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.1997.tb08549.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=9066303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVejtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1997&pages=235-251&issue=2&author=Q.+Pengauthor=K.+Bergauthor=J.+Moanauthor=M.+Kongshaugauthor=J.+M.+Nesland&title=5-Aminolevulinic+acid-based+photodynamic+therapy%3A+principles+and+experimental+research&doi=10.1111%2Fj.1751-1097.1997.tb08549.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">5-aminolevulinic acid-based photodynamic therapy: principles and experimental research</span></div><div class="casAuthors">Peng, Qian; Berg, Kristian; Moan, Johan; Kongshaug, Magne; Nesland, Jahn M.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">235-251</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">American Society for Photobiology</span>)
        </div><div class="casAbstract">A review, with 234 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9U7C0t7IiULVg90H21EOLACvtfcHk0liLQQAJCUEiGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVejtrs%253D&md5=e8bee8821dff2f8966d0761c29e5e9d6</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1997.tb08549.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1997.tb08549.x%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DQ.%26aulast%3DBerg%26aufirst%3DK.%26aulast%3DMoan%26aufirst%3DJ.%26aulast%3DKongshaug%26aufirst%3DM.%26aulast%3DNesland%26aufirst%3DJ.%2BM.%26atitle%3D5-Aminolevulinic%2520acid-based%2520photodynamic%2520therapy%253A%2520principles%2520and%2520experimental%2520research%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1997%26volume%3D65%26issue%3D2%26spage%3D235%26epage%3D251%26doi%3D10.1111%2Fj.1751-1097.1997.tb08549.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alyahya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma</span>. <i>Br. J. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>159</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">387</span>â <span class="NLM_lpage">393</span>, <span class="refDoi">Â DOI: 10.1111/j.1365-2133.2008.08668.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1365-2133.2008.08668.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18544077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCqs7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2008&pages=387-393&issue=2&author=S.+M.+Campbellauthor=C.+A.+Mortonauthor=R.+Alyahyaauthor=S.+Hortonauthor=A.+Pyeauthor=A.+Curnow&title=Clinical+investigation+of+the+novel+iron-chelating+agent%2C+CP94%2C+to+enhance+topical+photodynamic+therapy+of+nodular+basal+cell+carcinoma&doi=10.1111%2Fj.1365-2133.2008.08668.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma</span></div><div class="casAuthors">Campbell, S. M.; Morton, C. A.; Alyahya, R.; Horton, S.; Pye, A.; Curnow, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Dermatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">159</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">387-393</span>CODEN:
                <span class="NLM_cas:coden">BJDEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0007-0963</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) involves the activation of a photosensitizer by visible light to produce activated oxygen species within target cells, resulting in their destruction.  Evidence-based guidelines support the efficacy of PDT using topical 5-aminolaevulinic acid (ALA-PDT) in actinic keratoses, Bowen disease and basal cell carcinoma (BCC).  Efficacy for nodular BCC appears inferior to that for superficial BCC unless prior debulking or repeat treatments are performed.  The aim of this study was to assess the safety and efficacy of adding a novel iron-chelating agent, CP94 (1,2-diethyl-3-hydroxypyridin-4-one hydrochloride), to topical ALA, to temporarily increase the accumulation of the photosensitizer in the tumor.  A mixed topical formulation of ALA + increasing concns. of CP94, was used to carry out PDT on previously biopsied nodular BCC with no prior lesion prepn. using std. light delivery.  The area was assessed clin. and surgically excised 6 wk later for histol. examn.  Enhanced PDT using 40% CP94 resulted in significantly greater clearance rates in nodular BCC than with ALA-PDT alone, in our protocol of single-treatment PDT with no lesion prepn.  The results of this study demonstrate the safe and effective use of an enhanced ALA-PDT protocol for nodular BCC using CP94, with no adverse reactions to this modification.  This is the first time this formulation has been used in patients.  This formulation is now the focus of further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2LSpmPqKnLrVg90H21EOLACvtfcHk0liLQQAJCUEiGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCqs7nK&md5=f05550d56dc365ad30187d3bea4ff689</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2133.2008.08668.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2133.2008.08668.x%26sid%3Dliteratum%253Aachs%26aulast%3DCampbell%26aufirst%3DS.%2BM.%26aulast%3DMorton%26aufirst%3DC.%2BA.%26aulast%3DAlyahya%26aufirst%3DR.%26aulast%3DHorton%26aufirst%3DS.%26aulast%3DPye%26aufirst%3DA.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DClinical%2520investigation%2520of%2520the%2520novel%2520iron-chelating%2520agent%252C%2520CP94%252C%2520to%2520enhance%2520topical%2520photodynamic%2520therapy%2520of%2520nodular%2520basal%2520cell%2520carcinoma%26jtitle%3DBr.%2520J.%2520Dermatol.%26date%3D2008%26volume%3D159%26issue%3D2%26spage%3D387%26epage%3D393%26doi%3D10.1111%2Fj.1365-2133.2008.08668.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pye, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an <i>in vitro</i> investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma</span>. <i>J. Cancer Res. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">841</span>â <span class="NLM_lpage">849</span>, <span class="refDoi">Â DOI: 10.1007/s00432-008-0358-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1007%2Fs00432-008-0358-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=18239941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWktrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2008&pages=841-849&issue=8&author=A.+Pyeauthor=S.+Campbellauthor=A.+Curnow&title=Enhancement+of+methyl-aminolevulinate+photodynamic+therapy+by+iron+chelation+with+CP94%3A+an+in+vitro+investigation+and+clinical+dose-escalating+safety+study+for+the+treatment+of+nodular+basal+cell+carcinoma&doi=10.1007%2Fs00432-008-0358-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Enhancement of methyl-aminolevulinate photodynamic therapy by iron chelation with CP94: an in vitro investigation and clinical dose-escalating safety study for the treatment of nodular basal cell carcinoma</span></div><div class="casAuthors">Pye, Andrew; Campbell, Sandra; Curnow, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer Research and Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">841-849</span>CODEN:
                <span class="NLM_cas:coden">JCROD7</span>;
        ISSN:<span class="NLM_cas:issn">0171-5216</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Methyl-aminolevulinate (MAL) photodynamic therapy (PDT) is a cancer therapy that combines the selective accumulation of a photosensitizer in tumor tissue with visible light (and tissue oxygen) to produce reactive oxygen species.  This results in cellular damage and ablation of tumor tissue.  Combining iron chelators with MAL has the potential to increase the accumulation of the photosensitizer protoporphyrin IX (PpIX) by reducing its bioconversion to heme.  This paper investigates this method of enhancement both in vitro and for the first time clin. for the treatment of nodular basal cell carcinoma (BCC).  Enhancement of MAL-induced PpIX accumulation by the iron chelator CP94 was quantified fluorometrically in human cultured cells (including three dermatol. cell types).  An open, dose-escalating, pilot study was then conducted in patients with nodular BCC, to det. the safety of this pharmacol. modification.  Large enhancements in PpIX accumulation were obsd. in the cultured cells when co-incubated with the iron chelator CP94.  Clin. the addn. of CP94 was found to be feasible and safe.  In addn. greater redns. in tumor depth were obsd. in the CP94 co-incubated tumors.  Iron chelation by CP94 is an effective enhancer of MAL-induced PpIX accumulation in vitro.  This method of enhancement was safely applied to a clin. PDT protocol with no unexpected adverse effects reported.  Although the clin. investigation was only intended to be a small pilot to assess safety, enhancements in tumor clearance were obsd. both clin. and histol. when CP94 was included in the photosensitizing cream.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOPZexxeyvELVg90H21EOLACvtfcHk0liLQQAJCUEiGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWktrw%253D&md5=aa4dcb8df4f0880f6750c5245c3b43b0</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1007%2Fs00432-008-0358-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00432-008-0358-6%26sid%3Dliteratum%253Aachs%26aulast%3DPye%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DEnhancement%2520of%2520methyl-aminolevulinate%2520photodynamic%2520therapy%2520by%2520iron%2520chelation%2520with%2520CP94%253A%2520an%2520in%2520vitro%2520investigation%2520and%2520clinical%2520dose-escalating%2520safety%2520study%2520for%2520the%2520treatment%2520of%2520nodular%2520basal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Cancer%2520Res.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D134%26issue%3D8%26spage%3D841%26epage%3D849%26doi%3D10.1007%2Fs00432-008-0358-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">1154</span>â <span class="NLM_lpage">1160</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.2010.00770.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.2010.00770.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=20573043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtleqtr3J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2010&pages=1154-1160&author=E.+Blakeauthor=A.+Curnow&title=The+hydroxypyridinone+iron+chelator+CP94+can+enhance+PpIX-induced+PDT+of+cultured+human+glioma+cells&doi=10.1111%2Fj.1751-1097.2010.00770.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">The hydroxypyridinone iron chelator CP94 can enhance PpIX-induced PDT of cultured human glioma cells</span></div><div class="casAuthors">Blake, Emma; Curnow, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1154-1160</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) with the pro-drugs 5-aminolevulinic acid (ALA) or Me aminolevulinate (MAL) utilizes the combined interaction of a photosensitizer, light and mol. oxygen to ablate tumor tissue.  To potentially increase accumulation of the photosensitizer, protoporphyrin IX (PpIX), within tumor cells an iron chelator can be employed.  This study analyzed the effects of ALA/MAL-induced PDT combined with the iron chelator 1, 2-diethyl-3-hydroxypyridin-4-one hydrochloride (CP94) on the accumulation of PpIX in human glioma cells in vitro.  Cells were incubated for 0, 3 and 6 h with various concns. of ALA/MAL with or without CP94 and the resulting accumulations of PpIX, which naturally fluoresces, were quantified prior to and following light irradn.  In addn., counts of viable cells were recorded.  The use of CP94 in combination with ALA/MAL produced significant enhancements of PpIX fluorescence in human glioma cells.  At the highest concns. of each prodrug, CP94 enhanced PpIX fluorescence significantly at 3 h for ALA and by more than 50% at 6 h for MAL.  Cells subsequently treated with ALA/MAL-induced PDT in combination with CP94 produced the greatest cytotoxicity.  It is therefore concluded that with further study CP94 may be a useful adjuvant to photodiagnosis and/or PpIX-induced PDT treatment of glioma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo95LzZ6u6IN7Vg90H21EOLACvtfcHk0lgtiIpG77QymA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtleqtr3J&md5=d15626f8fd55fc94429a6ab3fe14a81e</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2010.00770.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2010.00770.x%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DE.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DThe%2520hydroxypyridinone%2520iron%2520chelator%2520CP94%2520can%2520enhance%2520PpIX-induced%2520PDT%2520of%2520cultured%2520human%2520glioma%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2010%26volume%3D86%26spage%3D1154%26epage%3D1160%26doi%3D10.1111%2Fj.1751-1097.2010.00770.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span> <span> </span><span class="NLM_article-title">An <i>in vitro</i> comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1419</span>â <span class="NLM_lpage">1426</span>, <span class="refDoi">Â DOI: 10.1111/j.1751-1097.2011.00985.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1111%2Fj.1751-1097.2011.00985.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=21834866" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2011&pages=1419-1426&issue=6&author=E.+Blakeauthor=J.+Allenauthor=A.+Curnow&title=An+in+vitro+comparison+of+the+effects+of+the+iron-chelating+agents%2C+CP94+and+dexrazoxane%2C+on+protoporphyrin+IX+accumulation+for+photodynamic+therapy+and%2For+fluorescence+guided+resection&doi=10.1111%2Fj.1751-1097.2011.00985.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro comparison of the effects of the iron-chelating agents, CP94 and dexrazoxane, on protoporphyrin IX accumulation for photodynamic therapy and/or fluorescence guided resection</span></div><div class="casAuthors">Blake, Emma; Allen, James; Curnow, Alison</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1419-1426</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) utilizes the combined interaction of a photosensitizer, light and mol. oxygen to ablate tumor tissue.  Maximizing the accumulation of the photosensitizer protoporphyrin IX (PpIX) within different cell types would be clin. useful.  Dermatol. PpIX-induced PDT regimes produce good clin. outcomes but this currently only applies when the lesion remains superficial.  Also, as an adjuvant therapy for the treatment of primary brain tumors, fluorescence guided resection (FGR) and PDT can be used to highlight and destroy tumor cells unreachable by surgical resection.  By employing iron chelators PpIX accumulation can be enhanced.  Two iron-chelating agents, 1,2-diethyl-3-hydroxypyridin-4-one hydrochloride (CP94) and dexrazoxane, were individually combined with the porphyrin precursors aminolevulinic acid (ALA), Me aminolevulinate (MAL) and hexyl aminolevulinate (HAL).  Efficacies of the iron-chelating agents were compared by recording the PpIX fluorescence in human squamous epithelial carcinoma cells (A431) and human glioma cells (U-87 MG) every hour for up to 6 h.  Coincubation of ALA/MAL/HAL with CP94 resulted in a greater accumulation of PpIX compared to that produced by coincubation of these congeners with dexrazoxane.  Therefore the clin. employment of iron chelation, particularly with CP94 could potentially increase and/or accelerate the accumulation of ALA/MAL/HAL-induced PpIX for PDT or FGR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvyaEjtyk7V7Vg90H21EOLACvtfcHk0lgtiIpG77QymA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nK&md5=a3df7449f9fcbd7d50ea95b5968e054e</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2011.00985.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2011.00985.x%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DE.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DCurnow%26aufirst%3DA.%26atitle%3DAn%2520in%2520vitro%2520comparison%2520of%2520the%2520effects%2520of%2520the%2520iron-chelating%2520agents%252C%2520CP94%2520and%2520dexrazoxane%252C%2520on%2520protoporphyrin%2520IX%2520accumulation%2520for%2520photodynamic%2520therapy%2520and%252For%2520fluorescence%2520guided%2520resection%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2011%26volume%3D87%26issue%3D6%26spage%3D1419%26epage%3D1426%26doi%3D10.1111%2Fj.1751-1097.2011.00985.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dogra, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, D. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, N. J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smerdon, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winyard, P. G.</span></span> <span> </span><span class="NLM_article-title">The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">90</span>â <span class="NLM_lpage">99</span>, <span class="refDoi">Â DOI: 10.1016/j.redox.2016.07.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.redox.2016.07.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=27454766" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1eis7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=90-99&author=Y.+Dograauthor=D.+C.+J.+Fergusonauthor=N.+J.+F.+Doddauthor=G.+R.+Smerdonauthor=A.+Curnowauthor=P.+G.+Winyard&title=The+hydroxypyridinone+iron+chelator+CP94+increases+methyl-aminolevulinate-based+photodynamic+cell+killing+by+increasing+the+generation+of+reactive+oxygen+species&doi=10.1016%2Fj.redox.2016.07.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species</span></div><div class="casAuthors">Dogra, Yuktee; Ferguson, Daniel C. J.; Dodd, Nicholas J. F.; Smerdon, Gary R.; Curnow, Alison; Winyard, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90-99</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Methyl-aminolevulinate-based photodynamic therapy (MAL-PDT) is utilized clin. for the treatment of non-melanoma skin cancers and pre-cancers and the hydroxypyridinone iron chelator, CP94, has successfully been demonstrated to increase MAL-PDT efficacy in an initial clin. pilot study.  However, the biochem. and photochem. processes leading to CP94-enhanced photodynamic cell death, beyond the well-documented increases in accumulation of the photosensitizer protoporphyrin IX (PpIX), have not yet been fully elucidated.  This investigation demonstrated that MAL-based photodynamic cell killing of cultured human squamous carcinoma cells (A431) occurred in a predominantly necrotic manner following the generation of singlet oxygen and ROS.  Augmenting MAL-based photodynamic cell killing with CP94 co-treatment resulted in increased PpIX accumulation, MitoSOX-detectable ROS generation (probably of mitochondrial origin) and necrotic cell death, but did not affect singlet oxygen generation.  We also report (to our knowledge, for the first time) the detection of intracellular PpIX-generated singlet oxygen in whole cells via ESR spectroscopy in conjunction with a spin trap.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlb_6IW4EfMrVg90H21EOLACvtfcHk0lgtiIpG77QymA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1eis7nJ&md5=16d5ba70b278c85f51a28048b5b5daca</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2016.07.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2016.07.002%26sid%3Dliteratum%253Aachs%26aulast%3DDogra%26aufirst%3DY.%26aulast%3DFerguson%26aufirst%3DD.%2BC.%2BJ.%26aulast%3DDodd%26aufirst%3DN.%2BJ.%2BF.%26aulast%3DSmerdon%26aufirst%3DG.%2BR.%26aulast%3DCurnow%26aufirst%3DA.%26aulast%3DWinyard%26aufirst%3DP.%2BG.%26atitle%3DThe%2520hydroxypyridinone%2520iron%2520chelator%2520CP94%2520increases%2520methyl-aminolevulinate-based%2520photodynamic%2520cell%2520killing%2520by%2520increasing%2520the%2520generation%2520of%2520reactive%2520oxygen%2520species%26jtitle%3DRedox%2520Biol.%26date%3D2016%26volume%3D9%26spage%3D90%26epage%3D99%26doi%3D10.1016%2Fj.redox.2016.07.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">558</span>â <span class="NLM_lpage">561</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2014.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.bmcl.2014.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=25556100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2rsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=558-561&issue=3&author=C.+F.+Zhuauthor=S.+Battahauthor=X.+L.+Kongauthor=B.+J.+Reederauthor=R.+C.+Hiderauthor=T.+Zhou&title=Design%2C+synthesis+and+biological+evaluation+of+5-aminolaevulinic+acid%2F3-hydroxypyridinone+conjugates+as+potential+photodynamic+therapeutical+agents&doi=10.1016%2Fj.bmcl.2014.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates as potential photodynamic therapeutical agents</span></div><div class="casAuthors">Zhu, Chun-Feng; Battah, Sinan; Kong, Xiaole; Reeder, Brandon J.; Hider, Robert C.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">558-561</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">5-Aminolaevulinic acid (ALA) prodrugs have been widely used in photodynamic therapy (PDT) as precursors to the natural photosensitizer, protoporphyrin IX (PpIX).  The main disadvantage of this therapy is that ALA is poorly absorbed by cells due to its high hydrophilicity.  In order to improve the therapeutical effect and induce higher yields of PpIX, a range of prodrugs of ALA conjugated to 3-hydroxypyridin-4-ones (HPO) were synthesized.  Pharmacokinetic studies indicated that some of the ALA-HPO conjugates are more efficient than ALA for PpIX prodn. in the human breast adenocarcinoma cell line (MDA-MB-468).  The intracellular porphyrin fluorescence levels showed good correlation with cellular phototoxicity following light exposure, suggesting the potential application of the ALA-HPO conjugates in photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUt3cW-UJD3bVg90H21EOLACvtfcHk0liqvJjf4jfa0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2rsw%253D%253D&md5=80f5710febca397fbe839512e11ba009</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DKong%26aufirst%3DX.%2BL.%26aulast%3DReeder%26aufirst%3DB.%2BJ.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%25205-aminolaevulinic%2520acid%252F3-hydroxypyridinone%2520conjugates%2520as%2520potential%2520photodynamic%2520therapeutical%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D3%26spage%3D558%26epage%3D561%26doi%3D10.1016%2Fj.bmcl.2014.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeder, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabeen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRobert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X. L.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates for photodynamic therapy: enhancement of protoporphyrin IX production and photo-toxicity in tumor cells</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1190</span>â <span class="NLM_lpage">1196</span>, <span class="refDoi">Â DOI: 10.1039/C6MD00040A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1039%2FC6MD00040A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsF2lu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1190-1196&issue=6&author=T.+Zhouauthor=L.+L.+Shaoauthor=S.+Battahauthor=C.+F.+Zhuauthor=R.+C.+Hiderauthor=B.+J.+Reederauthor=A.+Jabeenauthor=A.+J.+MacRobertauthor=G.+R.+Renauthor=X.+L.+Liang&title=Design+and+synthesis+of+5-aminolaevulinic+acid%2F3-hydroxypyridinone+conjugates+for+photodynamic+therapy%3A+enhancement+of+protoporphyrin+IX+production+and+photo-toxicity+in+tumor+cells&doi=10.1039%2FC6MD00040A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of 5-aminolaevulinic acid/3-hydroxypyridinone conjugates for photodynamic therapy: enhancement of protoporphyrin IX production and photo-toxicity in tumor cells</span></div><div class="casAuthors">Zhou, Tao; Shao, Le-Le; Battah, Sinan; Zhu, Chun-Feng; Hider, Robert C.; Reeder, Brandon J.; Jabeen, Asma; MacRobert, Alexander J.; Ren, Gerui; Liang, Xinle</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1190-1196</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">5-Aminolaevulinic acid (ALA) and its derivs. have been widely used in photodynamic therapy (PDT) as precursors of the photosensitizer, protoporphyrin IX (PpIX) in dermatol. and urol.  However, ALA-PDT is limited by the low bioavailability of ALA due to the fact that ALA is poorly absorbed by cells by virtue of its zwitterionic nature at physiol. pH.  In order to improve the therapeutic effect and induce higher levels of PpIX, a series of ALA prodrugs were synthesized by the conjugation of ALA to 3-hydroxypyridin-4-one (HPO) iron chelator using an amino acid linkage via amide bonds.  Pharmacokinetic studies indicated that one ALA-HPO conjugate significantly enhanced PpIX prodn. in a range of tumor cell lines over ALA alone or the co-administration of ALA and CP94 (1,2-diethyl-3-hydroxypyridin-4-one).  The intracellular porphyrin fluorescence levels showed good correlation with cellular photo-toxicity following light exposure, suggesting the potential application of the ALA-HPO conjugates in photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiT54Rmu9p87Vg90H21EOLACvtfcHk0liqvJjf4jfa0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsF2lu7g%253D&md5=b6b58eb36ccb603c696436644ef5679b</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1039%2FC6MD00040A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00040A%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DShao%26aufirst%3DL.%2BL.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DC.%2BF.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DReeder%26aufirst%3DB.%2BJ.%26aulast%3DJabeen%26aufirst%3DA.%26aulast%3DMacRobert%26aufirst%3DA.%2BJ.%26aulast%3DRen%26aufirst%3DG.%2BR.%26aulast%3DLiang%26aufirst%3DX.%2BL.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205-aminolaevulinic%2520acid%252F3-hydroxypyridinone%2520conjugates%2520for%2520photodynamic%2520therapy%253A%2520enhancement%2520of%2520protoporphyrin%2520IX%2520production%2520and%2520photo-toxicity%2520in%2520tumor%2520cells%26jtitle%3DMedChemComm%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D1190%26epage%3D1196%26doi%3D10.1039%2FC6MD00040A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRobert, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span> <span> </span><span class="NLM_article-title">Hydroxypyridinone and 5-aminolaevulinic acid conjugates for photodynamic therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3498</span>â <span class="NLM_lpage">3510</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00346</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00346" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVygtrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3498-3510&issue=8&author=S.+Battahauthor=R.+C.+Hiderauthor=A.+J.+MacRobertauthor=P.+S.+Dobbinauthor=T.+Zhou&title=Hydroxypyridinone+and+5-aminolaevulinic+acid+conjugates+for+photodynamic+therapy&doi=10.1021%2Facs.jmedchem.7b00346"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy</span></div><div class="casAuthors">Battah, Sinan; Hider, Robert C.; MacRobert, Alexander J.; Dobbin, Paul S.; Zhou, Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3498-3510</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a promising treatment strategy for malignant and non-malignant lesions. 5-Aminolevulinic acid (ALA) is used has a precursor of the photosensitizer, protoporphyrin IX (PpIX) in dermatol. and urol.  However, the effectiveness of ALA-PDT is limited by the relatively poor bioavailability of ALA and rapid conversion of PpIX to haem.  The main goal of this study was to prep. and investigate a library of single conjugates designed to co-administer the bioactive agents ALA and hydroxypyridinone (HPO) iron chelators.  A significant increase in intracellular PpIX levels was obsd. in all cell lines tested when compared to the administration of ALA alone.  The higher PpIX levels obsd. using the conjugates correlated well with the obsd. phototoxicity following exposure of cells to light.  Passive diffusion appears to be the main mechanism for the majority of ALA-HPOs investigated.  This study demonstrates that ALA-HPOs significantly enhance phototherapeutic metabolite formation and phototoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4V_Sqk-tKLVg90H21EOLACvtfcHk0liqvJjf4jfa0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVygtrc%253D&md5=0f83ed82793fce2ed87174a12276347a</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00346%26sid%3Dliteratum%253Aachs%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DMacRobert%26aufirst%3DA.%2BJ.%26aulast%3DDobbin%26aufirst%3DP.%2BS.%26aulast%3DZhou%26aufirst%3DT.%26atitle%3DHydroxypyridinone%2520and%25205-aminolaevulinic%2520acid%2520conjugates%2520for%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D8%26spage%3D3498%26epage%3D3510%26doi%3D10.1021%2Facs.jmedchem.7b00346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Curnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M.</span></span> <span> </span><span class="NLM_article-title">Improving <i>in vitro</i> photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug</span>. <i>Photodiagn. Photodyn. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">157</span>â <span class="NLM_lpage">165</span>, <span class="refDoi">Â DOI: 10.1016/j.pdpdt.2018.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=10.1016%2Fj.pdpdt.2018.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=30553949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXis1Snsb%252FI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=157-165&author=A.+Curnowauthor=A.+Perryauthor=M.+Wood&title=Improving+in+vitro+photodynamic+therapy+through+the+development+of+a+novel+iron+chelating+aminolaevulinic+acid+prodrug&doi=10.1016%2Fj.pdpdt.2018.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug</span></div><div class="casAuthors">Curnow, Alison; Perry, Alexis; Wood, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Photodiagnosis and Photodynamic Therapy</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-165</span>CODEN:
                <span class="NLM_cas:coden">PPTHBF</span>;
        ISSN:<span class="NLM_cas:issn">1572-1000</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a light activated drug therapy that can be used to treat a no. of cancers and precancers.  It is particularly useful in its topical form in dermatol. but improvement of efficacy is required to widen its application.  An ester between aminolaevulinic acid (ALA) and CP94 was synthesized (AP2-18) and exptl. evaluated to det. whether protoporphyrin IX (PpIX)-induced PDT effectiveness could be improved.  A biol. evaluation of AP2-18 was conducted in cultured human primary cells with both PpIX fluorescence and cell viability (as detd. via the neutral red assay) being assessed in comparison to the PpIX prodrugs normally utilized in clin. practice (aminolaevulinic acid (ALA) or its Me ester (MAL)) either administered alone or with the comparator iron chelator, CP94.  No significant dark toxicity was obsd. in human lung fibroblasts but AP2-18 significantly increased PpIX accumulation above and beyond that achieved with ALA or MAL administration +/- CP94 in both human dermal fibroblasts and epithelial squamous carcinoma cells.  On light exposure, the combined hydroxypyridinone iron chelating ALA prodrug AP2-18 generated significantly greater cytotoxicity than any of the other treatment parameters investigated when the lowest concn. (250Î¼M) was employed.  Newly synthesized AP2-18 is therefore concluded to be an efficacious prodrug for PpIX-induced PDT in these dermatol. relevant human cells, achieving enhanced effects at lower concns. than currently possible with existing pharmaceuticals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0LyU82b2u2bVg90H21EOLACvtfcHk0liqvJjf4jfa0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXis1Snsb%252FI&md5=5f9abe319b1a48388b1059afc2f99b78</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1016%2Fj.pdpdt.2018.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pdpdt.2018.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DCurnow%26aufirst%3DA.%26aulast%3DPerry%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DM.%26atitle%3DImproving%2520in%2520vitro%2520photodynamic%2520therapy%2520through%2520the%2520development%2520of%2520a%2520novel%2520iron%2520chelating%2520aminolaevulinic%2520acid%2520prodrug%26jtitle%3DPhotodiagn.%2520Photodyn.%2520Ther.%26date%3D2019%26volume%3D25%26spage%3D157%26epage%3D165%26doi%3D10.1016%2Fj.pdpdt.2018.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Battah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzacuva, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hider, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacRobert, A. J.</span></span> <span> </span><span class="NLM_article-title">Design of bifunctional dendritic 5-aminolevulinic acid and hydroxypyridinone conjugates for photodynamic therapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3411</span>â <span class="NLM_lpage">3428</span>, <span class="refDoi">Â DOI: 10.1021/acs.bioconjchem.8b00574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhslOhsLvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=3411-3428&issue=10&author=T.+Zhouauthor=S.+Battahauthor=F.+Mazzacuvaauthor=R.+C.+Hiderauthor=P.+Dobbinauthor=A.+J.+MacRobert&title=Design+of+bifunctional+dendritic+5-aminolevulinic+acid+and+hydroxypyridinone+conjugates+for+photodynamic+therapy&doi=10.1021%2Facs.bioconjchem.8b00574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Bifunctional Dendritic 5-Aminolevulinic Acid and Hydroxypyridinone Conjugates for Photodynamic Therapy</span></div><div class="casAuthors">Zhou, Tao; Battah, Sinan; Mazzacuva, Francesca; Hider, Robert C.; Dobbin, Paul; MacRobert, Alexander J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3411-3428</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Iron chelators have recently attracted interest in the field of photodynamic therapy (PDT) owing to their role in enhancement of intracellular protoporphyrin IX (PpIX) generation induced by 5-aminolevulinic acid (ALA) via the biosynthetic heme cycle.  Although ALA is widely used in PDT, cellular uptake of ALA is limited by its hydrophilicity.  In order to improve ALA delivery and enhance the PpIX prodn., several dendrimers incorporating both ALA and 3-hydroxy-4-pyridinone (HPO) were synthesized.  The ability of the dendrimers to enter cells and be metabolized to the PpIX photosensitizer was studied in several human cancer cell lines.  The dendrimers were found to be significantly more efficient than ALA alone in PpIX prodn.  The higher intracellular PpIX levels showed a clear correlation with enhanced cellular phototoxicity following light exposure.  Dendritic derivs. are therefore capable of efficiently delivering both ALA and HPO, which act synergistically to amplify in vitro PpIX levels and enhance PDT efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIHxzvmrXz-rVg90H21EOLACvtfcHk0lgrJcLEMSAjyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhslOhsLvJ&md5=28811890431818f70f08d8e1e4de1969</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00574%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DBattah%26aufirst%3DS.%26aulast%3DMazzacuva%26aufirst%3DF.%26aulast%3DHider%26aufirst%3DR.%2BC.%26aulast%3DDobbin%26aufirst%3DP.%26aulast%3DMacRobert%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520of%2520bifunctional%2520dendritic%25205-aminolevulinic%2520acid%2520and%2520hydroxypyridinone%2520conjugates%2520for%2520photodynamic%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26issue%3D10%26spage%3D3411%26epage%3D3428%26doi%3D10.1021%2Facs.bioconjchem.8b00574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01480&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-23%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01480%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01480" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994181ebb2d1d3","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
